Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 35.5;neutrophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	17.2	37.7	18.3	12.1	25.5	8.1	15.2	14.4	20.2	8.1	20.0	14.1	17.5	4.9	3.9	4.1	6.3	13.8	10.5	15.5	17.0	10.2	6.3	29.4	18.1	12.0	19.9	6.3	5.3	24.4	10.7	13.7	13.3	6.2	15.0	29.1	16.1	7.0	19.6	16.8	22.0	4.0	12.2	31.2	15.9	1.1	20.3	18.9	8.5	6.2	12.1	12.9	5.0	24.7	0.0	6.0	4.6	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.1	1.9	0.8	0.0	0.7	0.9	0.0	8.8	0.0	8.5	0.5	10.2	19.2	0.0	17.4	0.0	0.4	2.0	25.5	0.1	3.9	0.0	18.2	38.4	0.0	0.1	0.0	33.2	31.5	0.2	1.4	54.9	10.3	0.4	0.0	25.8	0.0	2.8	22.3	5.8	3.7	13.5	0.0	0.4	5.7	0.9	11.8	0.0	4.7	0.1	0.0	13.1	4.2	0.0	0.1	3.3	0.5	1.7	1.7	35.5	3.0	0.5	5.6	5.5	6.1	6.0	1.1	7.0	5.8	5.0	36.6	7.4	0.3	2.5	7.4	2.1	18.3	25.5	14.4	20.2	15.5	17.0	12.0	19.9	13.3	12.2	20.3	24.7	38.2	6.4	8.2	0.3	21.3	8.9	6.9	3.2	5.7	48.4	4.1	6.9	9.5	4.3	5.9	25.8	50.1	7.0	7.0	33.4	3.9	2.6	4.5	21.6	6.3	33.8	3.5	5.7	13.2	1.2	1.8	7.5	11.2	45.3	0.0	1.2	42.8	0.6	16.0	11.8	17.8	12.1	8.2	44.5	23.4	7.6	0.3	20.9	3.6	7.5	4.3	16.1	3.1	43.2	40.6	2.3	8.3	1.9	4.0	3.0	36.6	1.1	4.5	122.6	6.6	1.6	3.5	0.6	0.5	1.0	6.7	63.1	21.4	10.4	1.1	9.1
ACAP3	"CENTB5, KIAA1716"	ENSG00000131584	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 3"	Q96P50	1	1292390-1309609	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 148.3;Cone photoreceptor cells: 104.3;Rod photoreceptor cells: 201.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049317, HPA058381"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus"	"HPA049317: AB_2680710, HPA058381: AB_2683699"	"unprognostic (5.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	14.1	17.1	40.9	2.9	48.0	9.0	10.1	46.1	62.4	23.0	27.9	21.2	6.0	16.3	2.5	32.4	14.2	3.5	26.7	47.7	32.9	17.3	20.6	12.8	3.1	35.1	33.6	16.4	13.3	2.7	40.2	2.9	34.0	17.3	2.1	12.1	14.5	5.0	17.4	33.5	13.7	3.7	35.0	16.3	16.4	6.5	41.7	4.8	10.7	5.7	2.3	19.6	25.3	43.9	9.7	10.5	5.2	8.5	11.8	8.1	5.2	23.7	7.6	6.7	5.0	13.2	8.1	10.5	12.1	13.2	6.7	22.0	4.7	6.3	1.7	11.8	21.1	4.5	43.7	25.2	8.3	9.1	10.8	6.0	5.0	5.7	3.5	6.4	3.2	12.7	12.5	14.2	7.6	12.9	19.1	13.9	5.1	12.8	24.6	18.7	10.9	40.7	4.1	5.1	36.4	25.9	14.1	9.2	22.8	4.4	9.4	7.1	10.7	12.4	8.9	10.3	8.4	11.5	8.6	9.0	17.0	23.6	5.5	0.0	0.2	0.3	0.2	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.1	40.9	48.0	46.1	62.4	47.7	32.9	35.1	33.6	34.0	35.0	41.7	43.9	10.0	0.0	4.7	20.5	11.0	32.1	5.8	7.0	12.5	148.3	15.4	11.9	23.4	14.3	5.6	1.8	104.3	9.0	9.3	22.2	3.9	9.4	3.5	4.3	18.3	8.8	32.3	12.6	48.2	5.1	8.8	16.0	39.3	8.0	0.0	8.2	13.2	17.3	7.2	53.8	31.7	14.4	8.2	17.9	15.5	9.0	15.2	11.2	8.8	15.0	11.9	18.9	12.3	80.9	44.4	12.7	13.7	13.2	11.1	6.1	12.6	7.8	6.9	201.6	6.6	12.9	15.2	3.9	15.2	23.5	34.2	10.1	10.4	12.2	16.8	9.9
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 98.2;skeletal muscle: 163.2;tongue: 48.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 86.2;Erythroid cells: 37.7;Exocrine glandular cells: 39.7;Horizontal cells: 55.5;Paneth cells: 118.3;Proximal enterocytes: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 13.0;K-562: 13.9;Karpas-707: 19.7;U-2 OS: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		990000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.7	20.9	2.2	16.8	7.9	2.0	37.1	32.5	5.0	0.0	7.6	4.9	2.6	0.2	2.3	3.2	1.3	12.5	8.0	98.2	8.8	4.1	4.4	3.5	66.1	54.2	4.6	4.3	4.7	8.3	0.7	72.7	8.1	1.8	5.7	7.1	1.6	163.2	1.3	9.1	0.5	26.2	3.5	2.4	3.9	58.1	3.6	2.3	48.0	1.5	1.4	3.7	10.5	0.0	0.2	0.2	0.2	0.3	0.0	7.9	0.3	0.0	0.1	0.2	13.0	0.1	0.0	0.6	0.0	1.2	0.6	2.0	0.1	0.0	4.6	0.5	0.2	0.1	0.2	0.1	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.1	13.9	19.7	0.1	4.3	0.0	0.2	1.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.8	1.5	0.1	0.8	0.0	2.9	0.0	0.0	0.2	0.5	6.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	16.8	37.1	32.5	8.0	98.2	66.1	54.2	72.7	26.2	58.1	10.5	0.5	0.0	0.0	3.3	0.5	0.8	20.9	0.9	6.2	13.5	2.9	1.1	6.4	5.7	0.4	0.0	0.0	8.2	0.9	86.2	0.0	10.5	0.0	0.5	1.5	2.1	3.5	37.7	4.7	39.7	2.6	3.0	1.5	2.4	0.0	7.4	2.2	0.4	0.8	55.5	9.7	12.0	0.0	0.3	6.6	0.4	0.6	1.7	1.8	1.0	4.6	11.4	0.0	8.5	0.8	20.1	118.3	0.7	1.8	20.4	45.6	1.1	0.1	6.8	0.0	13.5	4.9	4.1	8.0	1.7	1.0	7.1	0.6	1.4	4.6	15.2
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 184.3;Glandular and luminal cells: 208.8;granulocytes: 633.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		16000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	44.2	40.6	11.9	38.8	14.1	16.2	19.8	13.2	14.8	48.2	5.6	12.7	15.4	19.2	17.7	15.8	13.4	29.2	29.4	16.5	23.7	46.4	13.9	39.0	24.6	17.6	20.8	14.9	11.9	19.8	9.2	21.4	21.3	13.4	13.6	24.7	10.6	15.2	42.6	9.9	13.4	22.0	13.7	22.2	19.3	26.8	14.6	20.3	18.6	16.9	18.5	68.0	10.6	18.9	67.3	21.3	24.2	28.3	97.8	61.6	20.3	94.0	107.6	91.0	97.4	21.1	45.0	46.2	35.4	71.7	100.9	19.4	22.4	92.0	143.0	15.7	23.3	181.4	26.6	223.3	44.8	44.8	360.0	51.4	36.7	103.6	74.0	50.2	71.8	25.5	5.6	54.2	100.7	4.7	40.7	60.7	31.6	15.2	37.2	26.4	45.4	39.6	136.3	20.9	15.2	12.3	109.3	0.4	63.2	49.0	1.9	45.8	128.5	81.1	22.6	129.3	85.9	28.1	31.7	41.2	139.7	97.8	52.2	32.5	10.9	35.0	4.2	15.5	3.2	3.3	3.9	3.5	10.6	3.1	3.0	3.8	29.6	4.0	19.4	4.0	6.7	6.5	11.9	14.1	13.2	14.8	16.5	23.7	17.6	20.8	21.3	13.7	14.6	18.9	27.9	76.9	184.3	29.0	19.5	22.3	25.7	20.0	81.4	44.2	7.3	8.1	37.2	15.7	40.1	73.5	2.1	7.3	18.3	0.8	50.9	27.7	1.4	79.5	27.0	29.8	7.7	26.1	76.7	25.4	36.9	46.0	7.1	208.8	633.8	151.6	18.2	44.2	23.9	6.7	78.3	5.7	2.0	64.9	59.1	4.9	5.6	67.8	16.0	57.1	70.4	10.9	8.2	71.4	116.4	32.3	3.0	10.1	36.1	19.4	0.7	12.4	12.2	16.7	0.0	20.0	27.9	3.7	5.3	10.1	8.1	31.6	25.2	34.9	2.7	18.4
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;U-937: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044500	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"	Cytosol	"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.1	0.1	0.5	0.4	0.3	0.4	0.0	1.0	0.6	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.1	0.1	0.5	0.6	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	0.5	0.4	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.2	0.0	1.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	1.4	0.4	0.9	0.0	0.0	0.8	0.7	0.3	0.0	1.1	0.8	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.7	1.2	0.0	1.4	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.3	1.0	0.6	0.4	0.4	0.6	0.3	0.4	0.3	0.4	0.4	0.4	0.0	0.0	11.4	1.3	0.0	0.3	0.0	0.0	0.9	0.3	0.4	0.7	0.0	0.0	0.0	2.1	0.1	0.8	0.0	0.0	0.1	12.0	0.9	1.1	0.2	0.0	0.0	3.4	0.0	0.1	0.2	0.5	0.8	0.0	0.2	0.0	0.2	0.1	1.7	4.1	0.1	0.0	0.0	0.0	28.0	0.0	0.5	0.0	5.6	0.3	0.2	0.0	3.0	6.3	0.1	0.0	0.0	2.7	0.1	0.4	0.1	0.0	1.2	0.0	0.2	0.3	1.5	0.4	0.1	0.0	0.1	0.9	0.2	0.2	0.1
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497366-3519531	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 590.7"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 888.3;Hepatocytes: 1234.6;Proximal tubular cells: 1546.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	55.1	76.9	31.1	28.0	32.6	31.7	50.4	31.7	42.1	54.2	43.3	58.3	105.2	45.6	43.3	48.2	45.2	66.7	146.4	32.0	31.0	200.2	590.7	44.6	30.1	33.0	32.2	50.0	34.9	49.6	33.5	41.3	33.6	101.1	52.3	17.1	53.6	55.9	121.1	35.7	68.9	37.9	31.6	57.2	82.4	16.7	31.6	26.9	36.5	56.0	34.5	57.9	36.5	34.7	46.5	64.5	55.9	50.2	187.5	85.0	91.9	95.6	124.1	102.7	74.5	86.9	59.2	22.1	143.4	109.5	21.4	45.1	62.9	49.0	59.2	39.5	131.4	67.6	42.2	184.1	165.4	71.2	151.3	91.4	72.3	55.0	63.7	45.3	75.8	36.1	51.8	45.3	87.4	137.8	25.6	147.1	44.4	131.9	86.4	27.1	31.3	128.2	90.2	83.3	57.0	54.0	53.0	75.0	37.2	36.8	55.6	95.5	54.1	75.9	29.0	35.9	56.6	35.4	91.6	88.7	58.6	115.5	41.0	87.6	134.3	336.9	28.5	126.5	31.8	66.8	67.4	26.7	127.7	53.4	79.3	25.6	59.4	54.5	117.4	186.3	67.4	189.0	31.1	32.6	31.7	42.1	32.0	31.0	33.0	32.2	33.6	31.6	31.6	34.7	44.8	67.3	111.1	25.1	73.1	76.0	154.5	107.8	92.2	9.2	103.0	88.9	275.8	338.8	109.5	152.6	14.6	395.0	80.6	140.1	888.3	157.2	8.8	65.9	116.3	61.6	57.2	123.1	9.4	87.2	247.1	129.1	66.3	116.3	41.8	75.1	207.8	1234.6	263.2	8.4	15.0	146.1	236.0	168.8	67.6	23.8	137.0	90.0	204.5	7.5	108.2	197.2	40.2	5.5	19.0	79.7	272.5	210.3	97.4	143.6	409.8	1546.8	38.0	15.3	164.3	45.5	109.3	5.3	11.3	113.6	76.9	381.4	53.0	120.8	147.2	156.9
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	44.1	50.3	26.6	30.2	28.5	132.3	44.3	27.1	32.4	34.6	44.0	29.3	11.2	24.7	47.7	53.6	48.3	25.2	37.0	24.5	30.5	65.8	29.5	62.3	23.4	37.3	28.8	26.9	67.3	25.7	31.2	22.0	31.3	79.1	9.3	3.4	39.0	21.0	54.3	38.8	25.7	20.3	28.4	83.4	33.7	24.7	31.8	11.3	40.8	12.4	13.3	43.9	43.3	31.1	55.9	66.7	16.7	36.9	27.5	34.9	30.5	28.6	49.0	34.8	30.2	42.0	129.7	5.4	126.7	35.4	87.3	45.8	27.9	135.3	10.7	3.1	61.5	1.6	38.4	51.8	84.9	27.6	64.3	34.6	105.4	112.9	59.2	42.4	46.9	17.3	73.8	52.8	19.8	44.6	13.7	80.9	29.7	24.0	67.3	4.6	15.0	27.5	56.7	5.2	14.6	22.0	52.5	26.4	48.4	22.3	59.8	57.4	26.0	44.1	30.8	70.3	30.9	19.6	24.2	33.3	111.7	196.1	20.7	483.4	844.2	694.6	185.7	442.7	90.4	47.0	66.9	109.8	312.2	38.2	72.0	93.5	756.8	73.0	385.2	25.5	90.8	577.4	26.6	28.5	27.1	32.4	24.5	30.5	37.3	28.8	31.3	28.4	31.8	31.1	46.2	22.4	27.4	3.9	12.1	11.6	30.7	112.4	16.5	1.0	54.8	56.0	12.0	32.9	41.6	36.8	6.2	15.7	60.1	6.9	9.8	95.5	20.6	75.3	30.8	36.1	7.2	21.0	0.2	446.7	92.4	45.3	11.2	41.1	88.0	19.1	42.1	7.7	118.3	3.3	0.2	12.3	20.3	143.5	18.9	23.4	37.9	97.8	28.4	1.9	107.4	19.4	122.6	0.5	7.0	96.9	22.5	27.1	8.6	66.5	8.6	55.3	78.5	5.6	13.1	13.0	23.8	3.5	36.1	34.4	13.5	13.1	45.0	50.4	18.2	25.2
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971177-22982551	"Cancer-related genes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 61.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 217.0;hTCEpi: 222.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Golgi apparatus"		"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	4.8	3.0	2.3	1.4	1.8	0.5	6.7	2.0	2.2	14.4	9.2	3.2	1.5	12.1	8.5	18.3	7.5	4.9	6.3	2.2	1.5	17.7	43.4	15.2	2.6	2.5	2.1	12.2	11.6	7.2	2.0	19.3	1.6	10.6	2.5	3.7	8.2	15.9	1.9	61.7	1.9	8.4	2.2	3.8	4.2	5.5	1.9	8.2	10.9	2.3	5.5	7.6	15.5	2.7	46.9	54.1	71.0	27.6	6.8	12.2	57.4	44.9	58.5	102.6	91.4	116.0	47.3	1.2	45.5	92.9	70.8	146.2	54.9	217.0	124.6	4.5	5.0	3.5	90.8	131.4	78.9	4.9	3.1	38.9	222.3	42.9	164.3	72.7	40.0	8.3	1.9	2.8	96.2	37.3	4.5	5.7	4.5	86.6	73.9	12.7	59.0	1.2	103.9	71.3	0.2	6.2	135.5	39.4	8.8	57.4	55.3	4.5	36.1	44.2	88.4	7.3	43.6	0.4	1.3	0.5	7.0	4.2	20.6	0.7	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.5	0.1	0.2	0.3	0.2	0.5	0.5	0.2	0.2	0.0	0.1	2.3	1.8	2.0	2.2	2.2	1.5	2.5	2.1	1.6	2.2	1.9	2.7	2.1	19.2	6.4	0.7	0.0	47.5	13.0	27.6	35.3	0.1	3.7	9.7	4.5	20.0	10.2	7.3	0.0	10.0	0.1	0.3	5.9	14.3	5.8	13.0	2.5	4.0	0.0	0.0	0.0	14.9	9.8	3.4	0.0	4.4	0.0	12.8	2.5	17.1	1.7	0.0	0.0	0.4	2.0	0.0	2.2	5.0	3.7	0.6	3.6	0.0	0.0	8.1	0.0	0.5	0.0	33.8	0.1	0.7	1.2	34.2	0.3	21.0	8.3	0.2	32.9	2.7	14.0	7.0	2.7	14.2	49.6	4.0	0.5	1.6	0.8	18.0
AKR1E2	"AKR1CL2, AKRDC1, htAKR, HTSP1, MGC10612"	ENSG00000165568	"Aldo-keto reductase family 1 member E2"	Q96JD6	10	4786629-4848062	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 19.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 153.8;Late spermatids: 174.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 12.3;RT4: 10.4;U-2197: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037821, HPA037822"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037821: AB_2675687, HPA037822: AB_10671722"	"unprognostic (2.33e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.62e-4)"	"unprognostic (5.62e-2)"	2.0	0.8	1.7	0.7	1.8	2.1	3.1	1.5	2.3	1.8	0.0	1.3	1.4	1.1	0.9	1.4	1.0	1.3	1.9	2.0	2.4	0.9	0.5	2.0	0.8	1.6	2.0	0.7	2.1	1.0	0.5	1.8	2.7	0.9	1.2	3.5	1.1	1.8	1.5	1.2	1.0	2.1	0.5	1.2	1.5	19.0	1.6	0.7	3.3	0.8	0.5	1.1	1.3	1.6	0.5	5.9	2.2	1.0	0.0	0.0	0.1	2.3	0.2	0.1	0.1	9.0	0.8	0.0	0.0	6.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	1.1	6.2	1.1	0.0	0.0	6.5	12.3	5.6	0.0	0.0	5.4	0.7	0.0	2.2	6.9	4.4	0.0	0.0	0.0	1.6	10.4	0.0	4.8	8.2	2.4	4.7	2.4	4.6	2.6	4.1	0.0	2.0	19.5	0.0	2.8	0.0	0.0	0.1	0.0	1.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.7	1.8	1.5	2.3	2.0	2.4	1.6	2.0	2.7	0.5	1.6	1.6	0.9	0.0	0.0	1.6	0.2	0.0	0.1	0.5	0.6	0.2	1.1	0.6	0.8	0.0	0.6	1.8	0.0	0.1	0.1	0.0	0.0	0.3	153.8	0.5	0.7	1.4	0.0	1.3	7.1	0.0	0.0	2.2	0.0	0.6	0.0	0.6	2.2	0.0	1.2	1.7	8.9	0.1	0.0	0.6	0.6	174.2	2.8	0.8	3.6	5.6	0.6	0.3	0.0	9.0	0.0	0.1	0.1	1.5	0.0	0.2	0.0	0.5	0.3	1.2	0.0	0.8	1.2	32.0	10.0	0.7	0.1	0.0	0.2	0.2	0.1	0.5
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 711.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		950000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	33.3	67.9	45.3	17.5	48.0	25.0	33.8	47.4	44.2	57.2	66.2	46.4	81.1	34.7	22.4	47.8	48.4	29.1	39.1	45.9	46.1	76.7	62.7	24.6	25.3	48.8	49.4	45.7	47.9	32.7	32.6	19.0	44.9	31.6	27.5	16.0	31.4	27.7	55.4	37.1	56.8	22.6	49.2	28.3	42.7	33.1	48.2	31.3	28.6	39.6	20.5	29.6	38.5	54.1	65.3	40.2	43.3	40.2	67.0	64.7	28.8	47.6	57.6	65.0	58.2	51.5	53.6	46.8	49.6	64.2	36.6	50.8	48.7	71.5	30.5	37.5	77.4	29.4	37.5	83.3	51.9	32.9	22.9	64.8	55.5	50.0	30.6	61.5	55.8	60.2	43.6	42.6	67.7	64.9	64.2	31.9	12.4	90.8	50.1	66.7	54.0	83.2	64.2	28.3	80.9	30.2	51.8	46.1	84.6	24.6	91.9	112.7	44.2	40.6	42.7	44.0	36.2	51.4	34.8	57.9	87.6	74.4	58.5	0.7	82.2	40.6	61.4	69.7	71.7	63.8	54.4	54.2	113.5	57.6	61.7	54.1	9.5	69.4	54.1	98.8	78.9	73.7	45.3	48.0	47.4	44.2	45.9	46.1	48.8	49.4	44.9	49.2	48.2	54.1	47.6	16.0	22.3	15.3	42.6	24.3	73.2	56.4	37.5	33.1	94.6	98.8	27.7	98.7	31.7	77.3	6.2	167.5	52.8	95.0	254.3	64.0	94.6	85.8	35.8	35.3	99.7	33.4	8.6	36.2	99.8	67.9	44.9	33.4	10.2	62.5	43.2	90.6	104.6	21.9	7.5	97.9	46.8	58.4	34.2	57.6	77.3	47.6	53.4	5.6	64.6	128.7	63.8	5.5	9.2	39.4	131.5	67.7	36.3	39.3	273.8	711.5	61.0	30.1	46.0	57.8	54.4	56.3	24.9	76.0	34.1	102.6	40.4	88.4	136.4	62.3
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282573-19288770	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 248.9;liver: 154.6;pancreas: 288.4;stomach 1: 224.4"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 15.9;SK-BR-3: 25.0"									HPA064638			Supported	"Golgi apparatus,Cytosol"		NA	NA		1900000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	1.6	4.0	2.3	2.6	2.4	0.3	4.2	2.8	3.2	2.3	16.7	29.2	248.9	1.4	0.4	1.8	1.8	38.0	0.6	3.3	2.6	71.1	154.6	1.0	0.4	2.7	2.9	2.6	288.4	0.3	2.2	0.2	2.6	1.9	17.4	1.5	3.5	0.3	0.4	2.6	144.8	1.4	2.5	1.3	224.4	2.1	2.9	0.1	1.8	0.1	0.2	1.0	1.6	2.6	0.5	0.0	0.5	0.3	0.5	0.2	1.8	0.1	0.1	0.2	0.1	0.5	1.9	0.2	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.5	0.2	0.7	0.8	0.2	0.2	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.7	0.5	1.7	0.3	15.9	0.6	0.7	0.1	1.6	0.0	0.1	0.9	1.4	0.3	25.0	0.6	0.1	4.1	0.5	0.4	0.3	0.2	0.9	0.3	1.2	0.3	0.3	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	2.4	2.8	3.2	3.3	2.6	2.7	2.9	2.6	2.5	2.9	2.6	0.4	0.0	0.0	7.5	3.3	0.8	0.7	0.2	0.6	1.0	13.8	9.5	0.8	140.2	0.3	29.5	0.0	0.5	0.5	133.3	119.3	3.9	3.5	0.5	0.4	0.8	20.8	11.2	4.1	31.8	0.3	0.5	348.1	0.4	4.5	0.9	4.2	119.0	0.3	0.0	3.6	87.6	4.1	3.5	0.0	4.7	0.3	4.4	0.0	1.9	0.1	3.6	0.0	2.5	1.9	18.3	125.0	0.4	0.8	1.2	1132.3	766.6	3.2	1.1	0.0	0.7	0.4	1.8	1.1	1.1	0.6	0.5	3.0	0.7	130.2	0.4
AL049629.2		ENSG00000284969	"Novel protein"		11	33698261-33722467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Ductal cells: 9.1;Exocrine glandular cells: 14.4;Pancreatic endocrine cells: 44.8"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 42.8;HUVEC TERT2: 55.1;TIME: 66.2;U-2197: 57.6"									HPA026494	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Vesicles"		"HPA026494: AB_1846321"																		2.5	0.7	1.5	2.3	1.4	1.5	1.1	1.5	1.6	0.5	2.5	0.7	1.4	1.3	1.8	1.2	0.6	2.1	1.1	1.4	1.7	1.6	0.8	1.7	0.3	1.8	2.0	0.6	0.7	1.0		1.5	1.8	0.5	0.7	0.6	2.4	0.7	3.5	0.3	0.3	0.6	1.8	0.5	2.9	1.1	1.8	0.2	0.8	1.1	1.4	2.3		2.1	1.3	3.3	0.2	2.4	3.4	7.9	0.1	18.5	8.4	2.3	2.2	0.1	9.6	0.0	2.3	12.5	1.1	2.2	0.3	42.8	4.0	2.0	0.4	0.3	7.1	0.8	0.8	0.4	1.2	3.0	2.7	1.0	14.7	1.9	55.1	0.3	0.5	7.4	15.4	1.0	1.8	0.8	0.5	1.3	24.8	0.4	1.5	1.3	4.9	2.2	0.0	0.3	2.0	3.4	7.3	0.2	1.0	0.0	66.2	7.0	2.7	57.6	7.4	3.8	3.7	0.3	16.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	1.4	1.5	1.6	1.4	1.7	1.8	2.0	1.8	1.8	1.8	2.1	0.5	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.7	0.2	2.1	0.0	0.0	0.0	14.4	0.0	0.2	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425545	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.5;Hepatocytes: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	29.6	53.1	49.7	22.8	58.0	36.9	27.5	56.6	48.0	34.4	78.5	29.1	47.5	33.6	51.5	44.2	31.7	29.2	32.1	50.2	56.7	64.8	75.4	27.1	40.2	62.1	58.4	40.1	29.2	70.6	24.2	41.0	62.6	28.0	25.0	57.6	25.6	37.4	159.4	24.9	36.0	33.9	65.3	26.9	24.6	83.7	57.2	20.6	33.8	56.5	43.5	25.8	29.4	75.7	55.5	75.2	32.4	59.2	98.2	54.7	28.4	56.8	71.2	77.0	60.1	66.4	49.4	142.0	65.3	79.1	45.2	50.3	49.9	45.1	72.9	31.7	51.2	40.9	29.2	73.4	85.7	33.2	45.6	64.1	64.3	61.7	73.1	53.6	45.6	41.0	45.7	18.8	56.9	33.7	50.7	35.8	15.3	28.2	51.1	57.0	64.8	53.6	47.9	57.0	32.2	24.6	135.6	47.3	45.5	30.3	142.3	35.0	59.4	72.3	39.4	36.9	39.7	40.7	38.5	75.8	52.7	23.4	33.7	37.1	10.0	14.4	7.9	12.5	11.2	21.7	9.9	8.3	9.9	17.9	10.1	10.9	12.5	14.2	17.9	13.2	11.4	5.5	49.7	58.0	56.6	48.0	50.2	56.7	62.1	58.4	62.6	65.3	57.2	75.7	25.7	9.6	9.0	23.8	34.0	25.7	18.1	11.0	10.8	17.7	58.9	23.0	19.9	28.6	11.7	99.3	39.6	27.5	17.4	53.6	25.4	20.8	154.5	16.4	26.4	23.5	24.7	29.0	20.5	43.0	6.8	31.9	8.6	32.4	8.8	31.8	38.9	166.4	17.0	32.0	23.7	23.6	12.2	69.1	33.2	118.7	41.0	25.5	30.2	23.4	25.5	50.1	10.3	27.6	31.5	35.6	25.3	34.3	12.0	36.0	53.4	54.3	9.2	43.3	13.1	29.4	24.1	30.5	11.7	12.0	20.9	24.4	17.1	34.1	22.9	29.7
ANAPC10	"APC10, DKFZP564L0562, DOC1"	ENSG00000164162	"Anaphase promoting complex subunit 10"	Q9UM13	4	144831908-145098541	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044547	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA044547: AB_2678979"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.55e-2)"	11.4	9.4	7.7	6.1	8.2	10.1	14.3	9.6	11.2	11.0	7.9	9.1	4.4	11.6	13.3	7.7	10.7	7.7	13.9	7.9	8.5	12.9	13.6	9.8	10.3	8.3	8.9	11.9	7.5	9.0	7.5	12.3	8.3	8.9	9.8	9.2	8.1	9.2	14.9	8.2	6.6	11.8	8.5	8.4	7.4	19.0	8.4	13.8	11.8	15.1	10.7	11.0	9.0	9.1	14.3	7.8	20.0	7.8	19.5	21.2	13.0	17.1	16.9	21.6	15.7	18.9	18.6	19.6	11.1	11.8	15.6	8.4	17.6	22.6	23.1	19.0	14.0	12.1	6.0	15.6	24.5	23.9	13.7	17.2	15.9	17.7	28.8	18.0	17.1	23.0	32.2	28.2	22.8	10.3	40.5	29.1	14.1	17.0	15.7	20.5	15.5	11.8	24.1	9.0	14.0	10.4	11.1	10.4	23.1	18.6	9.4	19.7	15.6	14.7	8.9	13.7	21.7	22.3	25.2	31.3	19.2	30.2	18.7	25.5	7.8	9.7	13.0	10.3	13.4	15.1	13.5	13.2	11.5	12.4	13.4	13.7	2.2	16.4	9.6	15.6	18.1	7.4	7.7	8.2	9.6	11.2	7.9	8.5	8.3	8.9	8.3	8.5	8.4	9.1	30.7	12.8	17.0	31.3	16.7	16.3	22.0	61.6	10.8	9.9	16.9	26.0	14.8	4.3	34.3	14.7	0.0	38.9	20.2	7.6	46.9	25.8	83.3	26.4	21.0	22.2	3.0	8.6	61.2	26.1	35.8	20.7	9.2	15.6	26.0	15.3	19.6	15.6	35.1	5.0	58.0	13.0	40.7	12.7	18.2	22.8	33.8	17.6	10.6	36.5	27.8	19.0	22.6	55.8	62.3	27.3	15.5	27.1	10.5	26.9	14.3	49.8	27.6	9.8	32.9	21.0	36.2	126.8	41.5	14.2	19.9	29.6	19.5	26.1	13.7	29.4
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 409.8"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 151.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"Hep G2: 37.0;MCF7: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	350000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	35.7	0.8	1.1	0.2	1.0	0.1	22.5	0.1	1.7	1.2	0.0	1.4	0.4	0.9	1.6	0.3	0.8	0.4	1.8	0.9	0.6	4.0	409.8	0.4	0.1	0.7	0.6	1.1	0.9	0.0	0.3	0.1	0.5	0.8	0.0	0.1	1.3	0.1	0.8	0.9	1.2	0.1	0.3	0.4	0.7	0.5	1.1	0.0	1.0	0.0	0.0	1.1	1.0	0.9	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	1.3	37.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	21.2	0.0	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.0	0.3	0.0	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	1.7	0.9	0.6	0.7	0.6	0.5	0.3	1.1	0.9	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.4	0.2	0.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	2.7	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	4.6	151.2	0.1	0.0	0.0	0.0	0.0	4.4	0.0	1.9	0.9	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.1
ANKRD26	"KIAA1074, THC2"	ENSG00000107890	"Ankyrin repeat domain 26"	Q9UPS8	10	26973793-27100494	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 130.6;Cone photoreceptor cells: 200.1;Excitatory neurons: 136.8;Inhibitory neurons: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA040654, HPA041460"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA040654: AB_10795370, HPA041460: AB_10795120"	"unprognostic (1.92e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.99e-1)"	2.3	2.6	4.7	1.6	5.4	1.5	3.8	5.9	8.6	3.9	5.0	2.5	1.7	3.3	3.0	2.0	3.0	2.0	4.1	4.4	4.0	2.7	2.8	1.9	3.5	4.7	3.8	4.0	2.6	4.0	4.6	3.2	2.7	2.6	2.8	10.0	2.3	2.5	6.7	2.5	2.0	2.5	2.8	2.5	2.2	4.0	4.9	3.1	2.7	7.5	2.2	2.2	2.7	5.8	7.7	5.4	9.8	3.7	6.1	6.7	3.4	10.1	3.7	9.2	8.5	5.2	5.1	17.9	3.1	4.7	6.5	8.1	9.6	4.7	11.0	7.4	7.2	1.1	7.9	7.9	4.5	4.5	1.2	4.7	2.9	9.5	3.2	7.5	8.4	5.5	14.8	4.8	9.3	4.3	5.5	2.8	3.9	2.8	3.5	6.6	13.8	4.3	5.7	3.1	8.5	4.7	9.6	2.0	8.1	7.1	8.5	3.1	7.6	7.7	5.2	9.9	5.7	1.9	2.6	11.7	7.3	9.9	3.5	1.0	0.2	0.2	0.2	0.1	0.7	1.2	0.4	0.4	0.3	0.6	1.6	0.5	0.1	1.6	0.1	2.1	0.4	0.2	4.7	5.4	5.9	8.6	4.4	4.0	4.7	3.8	2.7	2.8	4.9	5.8	19.5	22.4	28.8	130.6	14.3	4.2	7.6	9.0	8.6	77.8	13.5	17.7	70.9	7.2	19.4	3.7	200.1	24.8	8.6	8.3	5.9	14.5	19.0	47.7	38.6	20.4	20.9	6.3	136.8	13.1	13.1	21.3	8.2	16.5	5.1	43.5	13.6	8.3	11.9	79.1	185.9	9.3	10.2	5.7	5.4	6.4	30.4	11.8	3.6	45.0	12.4	45.0	18.6	87.0	67.2	11.3	4.2	27.1	7.8	5.3	12.1	5.6	49.5	117.9	32.9	30.1	15.6	60.7	57.2	8.9	8.0	13.7	12.9	46.1	14.6	5.0
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 422.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 307.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	422.8	48.4	2.6	31.9	3.2	1.4	169.2	2.5	4.2	52.8	2.7	210.8	17.3	95.1	33.5	88.0	84.8	50.7	50.2	2.9	2.5	24.1	19.1	218.6	12.4	2.5	2.5	26.5	12.0	8.4	5.4	28.0	2.6	59.1	41.0	1.7	14.7	103.6	17.8	24.6	57.6	144.8	2.3	21.4	66.6	12.8	2.4	5.9	28.2	22.9	3.9	142.1	50.9	2.5	0.1	1.5	0.2	1.0	307.5	0.3	5.0	0.3	0.1	0.2	0.8	0.9	0.0	0.7	0.7	0.1	0.2	0.5	0.8	0.2	0.8	1.5	5.7	0.4	0.5	18.4	0.8	0.3	1.0	3.3	1.0	0.3	0.8	0.0	0.2	2.2	0.3	1.7	0.6	0.2	0.2	1.4	0.7	0.1	0.4	0.7	0.8	3.0	0.1	2.2	0.3	0.4	0.0	0.2	2.0	2.2	0.1	0.1	0.0	0.3	2.7	1.2	0.4	4.8	5.9	0.6	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	3.2	2.5	4.2	2.9	2.5	2.5	2.5	2.6	2.3	2.4	2.5	58.2	3.2	6.0	0.0	0.5	2.9	0.1	0.0	2.2	0.0	1.1	2.2	9.5	0.0	1.9	0.0	0.0	0.1	0.4	0.1	0.0	0.2	4.5	0.8	2.3	12.3	0.0	0.0	0.4	0.2	0.1	11.3	0.0	1.4	1.3	2.1	20.7	0.2	1.4	0.0	0.3	0.1	0.0	1.4	2.7	2.6	3.4	0.9	3.6	3.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	74.9	0.0	0.4	0.1	1.4	1.0	0.4	118.3	2.6	93.0	1.1	1.3	0.7	1.8	0.3	0.6	74.6	0.1	0.3
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 subunit sigma 2"	P56377	X	15825806-15854931	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 663.3"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 221.1;monocytes: 326.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 298.0;SK-MEL-30: 442.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	28.3	21.4	24.6	36.7	28.4	38.3	15.0	32.0	36.9	31.6	27.3	42.1	11.9	52.2	663.3	21.4	13.5	20.1	74.8	25.1	48.0	13.1	15.9	25.8	33.2	42.7	35.8	8.8	7.8	16.7	19.4	42.0	47.0	11.6	22.0	43.7	9.5	30.5	70.1	14.0	20.1	76.3	34.4	43.0	19.5	23.4	29.6	28.7	12.5	93.7	28.8	26.1	12.7	33.8	12.0	14.2	130.1	78.4	29.5	19.1	5.0	47.1	22.7	31.1	41.1	9.6	11.1	22.6	183.0	72.6	50.4	16.1	31.7	10.8	57.0	30.1	64.9	15.3	16.7	14.7	24.2	63.1	16.9	12.2	11.2	36.0	33.1	50.4	78.1	19.1	14.3	298.0	72.4	8.7	12.9	39.5	171.0	6.4	42.5	29.5	116.7	50.6	37.4	2.5	14.8	69.2	18.4	4.8	442.2	84.1	52.7	69.2	43.9	67.8	21.2	92.5	41.9	25.5	58.7	37.3	33.6	28.0	159.7	50.9	326.8	34.6	21.1	325.0	24.8	30.8	25.5	20.6	221.1	28.0	18.5	18.1	52.8	27.9	175.4	82.2	38.1	228.0	24.6	28.4	32.0	36.9	25.1	48.0	42.7	35.8	47.0	34.4	29.6	33.8	130.8	3.2	13.1	37.2	77.0	55.2	12.7	9.1	8.6	34.7	12.0	11.4	195.6	12.8	3.2	9.2	12.5	5.3	114.2	9.2	33.2	13.7	5.1	50.4	32.6	166.3	26.9	32.6	15.1	6.4	18.9	38.0	7.7	78.0	78.6	15.6	147.4	8.6	259.8	11.8	73.2	8.4	12.2	392.6	609.2	17.5	17.4	362.7	149.4	31.9	630.0	21.1	62.8	19.1	85.0	10.3	14.0	7.2	26.0	19.0	6.5	9.0	1.6	39.3	39.5	26.7	39.1	55.7	28.8	10.6	51.6	5.6	58.3	4.0	8.5	6.7
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 subunit beta 1"	O00203	5	78002326-78294698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		38000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	21.5	21.5	21.1	19.6	26.1	21.9	21.3	22.3	26.4	20.7	23.0	24.1	19.8	17.8	53.9	30.8	15.8	15.9	19.0	19.6	23.4	30.3	15.9	17.2	22.5	23.4	24.4	13.0	24.9	29.3	40.4	19.6	24.5	16.9	28.3	8.8	26.4	16.4	15.8	22.5	20.8	20.5	23.3	21.6	23.0	13.2	23.6	23.2	27.2	13.0	24.8	20.1	21.9	26.5	51.3	40.3	45.4	63.1	53.2	64.5	39.5	56.3	66.1	50.1	67.5	31.4	44.1	53.7	32.5	69.4	41.7	36.6	45.0	94.1	62.7	61.7	31.7	37.4	33.9	55.5	31.1	33.7	47.1	46.2	34.0	42.3	42.5	47.7	64.1	10.9	27.3	34.3	86.9	31.6	43.4	52.2	24.1	37.4	23.9	45.2	80.2	74.4	72.7	47.5	16.0	25.7	52.3	33.7	49.7	37.1	40.9	55.6	65.0	37.4	29.1	45.4	57.4	26.3	43.3	36.3	48.5	48.5	48.4	18.3	12.6	11.3	9.6	12.5	10.6	31.3	8.0	10.0	17.2	40.1	6.6	8.8	15.4	9.6	17.3	14.2	10.4	8.1	21.1	26.1	22.3	26.4	19.6	23.4	23.4	24.4	24.5	23.3	23.6	26.5	31.6	44.8	33.7	82.3	59.0	15.8	22.1	28.1	22.8	16.2	18.8	14.1	29.0	10.0	37.5	31.3	22.9	30.9	37.1	36.9	25.4	35.8	12.0	27.7	38.8	33.3	19.2	27.3	59.7	38.0	38.7	32.0	35.2	40.8	32.9	26.1	23.2	17.0	39.5	20.2	57.3	34.1	26.4	41.9	24.8	20.2	15.8	47.3	26.6	118.0	66.5	21.5	32.0	86.5	231.0	43.5	25.0	16.6	44.0	20.7	30.0	27.2	29.8	27.5	26.3	36.2	28.5	16.1	10.1	28.9	23.4	29.8	39.9	31.2	28.0	22.2
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 870.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 38.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 38.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		26000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	249.9	498.0	413.0	157.4	457.6	134.4	447.5	413.1	572.4	264.2	396.8	357.2	226.4	281.1	293.3	178.6	308.1	350.8	389.0	456.2	405.3	532.5	298.2	279.4	78.9	425.0	481.9	306.2	323.5	278.6	155.4	451.9	448.7	260.6	328.5	209.3	270.7	343.6	107.5	218.6	200.3	379.9	419.7	154.4	213.5	165.6	426.4	159.2	469.9	176.0	78.2	304.9	151.7	523.5	388.7	489.9	538.4	448.5	707.7	869.8	559.8	757.1	1029.2	386.6	449.3	286.4	941.0	0.9	848.3	614.8	505.1	255.6	326.4	921.6	324.4	14.7	253.1	0.8	275.6	204.1	688.0	372.0	19.6	790.4	990.7	456.8	823.0	1584.3	1750.7	158.6	0.8	39.0	614.5	433.1	6.5	4.0	416.2	644.9	418.6	241.2	505.2	325.3	1283.3	270.1	267.3	385.6	824.0	549.0	393.4	720.0	482.4	400.1	1837.1	850.8	350.2	310.4	371.6	232.3	3.1	4.8	690.4	1.6	836.3	1.1	7.5	0.0	0.2	2.2	0.3	0.8	2.2	0.7	5.6	2.2	2.3	0.6	1.5	0.5	1.6	38.1	0.6	3.3	413.0	457.6	413.1	572.4	456.2	405.3	425.0	481.9	448.7	419.7	426.4	523.5	330.2	109.0	39.6	70.5	47.6	181.6	215.6	449.0	306.7	45.2	280.3	199.6	143.2	296.0	214.0	502.1	29.2	472.6	180.7	395.2	56.7	398.7	46.1	78.8	162.2	416.0	162.6	29.2	481.6	180.4	141.2	309.5	164.7	110.7	8.2	100.3	539.7	125.7	76.3	84.1	525.5	303.1	256.3	61.6	79.9	61.8	242.6	69.9	161.9	189.3	89.9	329.9	4.1	423.2	870.8	205.4	223.1	296.8	24.0	187.5	95.2	165.8	164.7	24.5	118.3	336.5	198.5	38.3	86.9	85.9	106.1	552.1	27.0	111.4	283.5	133.6
ARFGAP3	ARFGAP1	ENSG00000242247	"ADP ribosylation factor GTPase activating protein 3"	Q9NP61	22	42796502-42858106	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000638	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Golgi apparatus"	"HPA000638: AB_1078188"	"unprognostic (3.29e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (8.97e-6)"	"unprognostic (5.83e-2)"	"unprognostic (8.85e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.65e-4)"	"unprognostic (1.73e-1)"	30.1	88.9	16.5	34.1	17.4	47.8	30.9	19.5	20.4	56.1	23.2	26.9	36.5	32.2	53.3	22.1	22.9	36.6	23.6	17.9	20.6	53.2	49.2	32.3	28.1	20.5	18.7	20.7	85.8	38.0	38.1	34.8	20.3	64.7	30.6	35.5	68.5	40.2	31.3	20.7	51.1	30.8	19.0	26.0	43.2	49.5	19.6	25.9	61.3	21.8	32.6	45.2	23.4	21.0	59.6	19.3	41.1	24.7	57.2	94.1	17.3	111.8	76.4	50.5	60.9	23.5	32.8	30.1	24.5	102.9	41.8	14.4	18.7	33.0	54.7	18.5	25.4	35.7	27.6	37.4	79.6	31.9	53.2	42.0	57.6	42.6	75.9	71.9	52.4	27.4	16.1	132.0	89.6	15.7	49.4	17.5	6.7	32.7	23.2	31.1	92.3	38.3	80.7	27.5	14.6	9.0	54.3	21.5	46.0	30.6	22.7	24.4	67.0	58.7	42.5	52.1	30.7	94.7	48.2	33.1	41.9	34.0	46.7	86.2	33.2	36.8	45.1	44.4	58.8	27.1	29.7	39.8	32.5	26.1	19.2	27.2	50.8	49.4	50.9	53.1	28.8	30.1	16.5	17.4	19.5	20.4	17.9	20.6	20.5	18.7	20.3	19.0	19.6	21.0	40.8	38.5	54.8	27.4	41.7	26.6	86.9	43.0	19.9	42.8	43.1	29.5	26.5	37.1	62.1	57.0	18.8	18.8	67.3	36.4	66.5	65.9	19.1	60.5	89.9	42.4	49.1	17.5	26.1	64.3	23.7	58.1	30.1	96.3	65.9	28.4	30.4	37.3	28.7	33.7	28.8	53.0	46.8	21.7	89.3	15.0	48.1	68.2	69.4	35.6	33.7	40.5	38.1	43.7	40.0	83.0	15.6	45.5	110.0	121.5	70.9	62.9	65.5	33.7	39.5	80.0	65.5	178.7	67.6	14.6	26.7	59.9	49.6	39.0	22.7	86.7
ARL4D	ARF4L	ENSG00000175906	"ADP ribosylation factor like GTPase 4D"	P49703	17	43398993-43401137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.3;Early spermatids: 220.8;Rod photoreceptor cells: 259.6;Squamous epithelial cells: 223.4;Suprabasal keratinocytes: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 32.3;naive B-cell: 36.1"	"Lineage enriched"	"Detected in all"	4	"B-cells: 36.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 57.1;hTCEpi: 76.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.7;cerebral cortex: 8.8;hippocampal formation: 5.7;olfactory bulb: 4.2;spinal cord: 5.4"	HPA060379	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles	"Golgi apparatus"	"HPA060379: AB_2684269"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-2)"	"prognostic favorable (1.16e-5)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (9.25e-4)"	21.0	4.3	7.9	2.2	8.7	0.9	7.2	9.1	11.6	29.3	12.6	27.9	2.0	20.2	4.7	82.2	22.1	7.3	12.7	8.1	7.1	30.5	56.4	16.2	1.6	5.6	5.7	9.7	2.2	8.1	21.6	7.7	5.7	11.0	3.5	85.1	16.9	15.2	1.9	44.9	6.0	14.8	5.4	16.7	7.6	32.1	5.7	1.6	38.3	3.4	3.0	28.5	39.5	9.3	8.7	10.9	6.7	5.2	12.5	17.2	3.1	21.0	21.5	14.6	18.8	9.7	37.7	0.1	10.3	22.6	10.0	23.4	4.5	32.0	10.0	1.9	7.5	0.7	8.7	22.5	57.1	2.4	2.1	19.2	76.1	21.3	45.8	13.2	6.3	2.3	1.4	0.4	14.3	0.5	5.4	5.0	7.1	0.8	10.1	9.1	1.5	1.0	24.9	18.8	7.9	5.6	16.5	0.4	15.8	14.4	30.6	8.5	1.3	21.0	6.7	27.2	6.4	2.1	1.1	0.0	25.8	1.9	7.1	0.1	2.8	2.1	5.1	4.3	3.2	32.3	4.2	4.7	8.4	36.1	4.6	5.2	0.0	2.1	1.4	2.5	1.0	4.6	7.9	8.7	9.1	11.6	8.1	7.1	5.6	5.7	5.7	5.4	5.7	9.3	28.8	0.0	1.7	0.7	37.9	224.3	41.4	142.2	132.1	155.5	35.3	60.6	12.7	5.7	49.5	132.4	116.7	39.9	37.4	1.5	76.3	2.3	220.8	55.5	33.3	32.2	11.9	4.0	9.1	1.8	24.1	52.3	5.6	69.6	0.0	20.7	22.9	29.7	8.1	16.8	9.3	5.4	26.4	4.1	77.9	55.3	15.8	16.6	26.6	1.0	1.4	70.1	2.1	2.5	1.3	3.7	0.9	22.6	1.4	9.5	0.3	17.6	7.6	259.6	13.1	11.1	45.1	25.0	9.2	223.4	254.6	105.5	31.7	19.3	4.6	78.1
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		5600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	28.8	25.1	14.4	15.6	18.0	18.4	27.2	16.8	21.8	21.3	27.5	31.3	30.8	22.4	8.6	28.1	25.1	15.7	33.0	14.9	15.2	31.4	42.8	29.1	19.8	20.0	15.9	11.3	46.7	11.7	34.7	10.9	19.1	28.9	8.2	4.4	39.6	16.2	25.3	17.5	33.8	6.5	16.3	44.5	30.3	54.0	19.4	9.8	32.3	5.1	9.5	23.9	24.7	21.0	8.5	11.0	5.3	10.9	41.8	21.8	13.5	13.0	15.9	5.7	9.3	3.3	12.9	5.3	8.2	22.9	10.8	12.8	1.2	12.3	1.0	2.7	8.0	3.4	14.3	12.5	28.3	5.2	32.7	26.0	24.4	9.5	6.3	19.9	12.8	11.5	3.5	80.4	12.1	9.6	4.6	5.8	1.7	9.0	11.2	4.0	0.4	26.7	9.9	13.5	2.5	8.2	18.2	17.2	10.1	5.1	7.7	6.6	22.1	3.8	15.1	14.9	4.1	18.4	1.9	4.5	11.7	4.3	13.6	10.4	27.7	36.1	17.3	33.3	15.1	10.4	12.4	14.2	22.7	12.5	7.3	10.0	60.4	8.9	43.2	32.1	18.2	16.3	14.4	18.0	16.8	21.8	14.9	15.2	20.0	15.9	19.1	16.3	19.4	21.0	22.8	6.4	12.9	24.5	22.2	4.7	14.0	23.8	18.8	5.3	18.9	13.1	8.0	27.1	15.5	12.9	4.2	11.5	14.0	85.4	1.9	29.4	62.4	24.4	10.3	13.4	36.7	9.7	9.4	21.3	19.9	19.6	41.3	21.3	6.3	15.3	8.2	28.6	36.8	6.7	8.6	30.6	14.2	29.0	9.5	127.5	10.8	29.2	17.8	10.3	28.7	10.3	8.2	8.0	11.9	24.2	75.2	6.0	132.0	10.8	93.9	22.7	21.2	7.2	0.0	6.6	9.9	48.3	4.1	18.3	5.5	13.3	17.2	7.2	25.0	16.1
ASB13	"FLJ13134, MGC19879"	ENSG00000196372	"Ankyrin repeat and SOCS box containing 13"	Q8WXK3	10	5638867-5666595	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 66.7;RPMI-8226: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048293, HPA061742"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"		"HPA048293: AB_2680344, HPA061742: AB_2684599"	"unprognostic (3.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	11.2	19.7	4.9	7.2	4.9	3.5	15.9	6.3	7.0	10.1	5.5	14.4	25.4	9.2	1.8	10.3	12.8	7.6	8.9	3.7	4.5	21.3	44.0	6.5	18.2	5.9	5.9	14.8	10.7	4.8	8.2	3.3	5.9	9.6	6.6	6.7	8.9	6.5	11.9	11.9	25.4	5.7	5.2	9.7	8.7	3.3	8.4	3.8	6.2	10.1	12.9	11.7	9.1	4.8	10.6	13.7	5.5	24.6	21.5	5.8	9.5	1.9	4.1	6.1	7.0	11.4	19.4	66.7	16.2	3.9	2.2	17.3	12.2	13.6	0.8	3.4	24.0	10.0	7.7	8.5	14.4	8.5	0.9	9.6	20.7	3.2	5.3	6.1	5.0	18.0	12.1	1.3	1.7	7.6	11.0	7.8	12.0	28.6	8.0	4.5	0.8	68.8	7.9	16.3	11.5	27.2	12.9	8.7	21.5	1.6	25.9	10.6	2.1	3.5	6.2	14.6	5.7	3.6	8.6	44.0	10.8	22.9	2.8	0.0	12.9	0.3	1.5	8.3	2.6	1.8	3.9	1.7	13.6	2.4	4.1	2.0	0.4	1.2	6.6	0.4	1.2	7.5	4.9	4.9	6.3	7.0	3.7	4.5	5.9	5.9	5.9	5.2	8.4	4.8	4.7	0.0	5.8	9.1	1.7	1.7	1.9	2.5	2.2	45.0	8.8	7.4	7.8	8.6	4.7	1.8	18.8	5.8	0.4	21.3	5.9	5.3	2.7	3.2	7.9	5.3	4.2	1.7	6.7	4.5	1.6	9.1	1.5	2.3	3.8	20.1	5.3	55.9	7.0	16.8	13.3	5.7	4.1	12.6	2.6	0.7	13.4	7.3	8.8	6.5	7.0	8.5	0.0	7.1	8.1	4.5	12.6	21.4	0.4	3.3	41.1	39.5	4.9	14.2	6.6	7.2	10.7	0.2	1.6	5.7	1.7	2.1	2.1	16.5	12.4	1.5
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	6.0	6.6	4.1	10.0	5.3	11.2	9.2	6.6	4.2	10.2	7.7	9.3	8.2	7.9	8.5	8.4	5.8	7.5	6.5	3.9	5.2	5.0	12.5	7.1	10.1	4.7	4.3	5.9	6.4	10.7	6.2	12.9	5.1	9.2	11.3	5.7	6.3	8.1	6.0	7.2	8.5	8.5	4.7	8.3	8.6	8.6	4.6	12.7	7.2	5.4	11.0	14.8	7.4	6.0	16.8	21.1	30.1	18.6	32.9	41.7	48.0	71.5	45.5	24.1	27.6	43.3	13.0	52.1	14.4	48.3	19.0	37.6	26.2	63.5	38.7	35.2	23.2	38.7	36.0	27.8	30.1	41.0	28.5	38.1	31.7	35.4	44.2	22.6	45.1	20.5	47.1	23.0	67.3	16.5	21.1	12.7	15.9	31.8	16.4	24.7	23.3	18.7	23.7	46.6	20.2	15.3	30.1	26.7	12.5	53.3	14.7	23.2	64.2	26.9	20.6	23.3	30.4	9.9	11.3	46.4	19.4	30.6	29.0	6.2	2.7	1.8	4.3	4.3	5.2	4.2	3.8	4.0	2.9	5.7	4.3	4.2	0.2	4.4	3.8	6.4	3.1	1.4	4.1	5.3	6.6	4.2	3.9	5.2	4.7	4.3	5.1	4.7	4.6	6.0	32.7	32.1	24.9	58.1	45.4	25.5	41.3	33.3	19.4	27.0	24.1	24.0	32.0	20.0	37.7	3.7	22.9	24.4	49.0	17.3	11.7	23.1	11.3	30.1	77.3	25.2	13.8	20.8	166.0	25.1	66.3	32.2	46.9	35.0	22.1	29.9	10.4	30.3	17.7	28.6	166.2	22.8	22.4	17.2	12.5	3.7	23.0	27.5	5.4	103.0	26.2	14.6	29.9	150.8	132.3	28.6	14.4	17.3	66.4	66.9	17.5	10.6	32.0	31.1	6.6	39.6	30.0	50.2	30.3	38.2	27.4	38.0	43.7	42.6	23.5	65.4
ASH1L	"ASH1, ASH1L1, huASH1, KMT2H"	ENSG00000116539	"ASH1 like histone lysine methyltransferase"	Q9NR48	1	155335268-155563162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004806	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA004806: AB_1845087"	"unprognostic (2.98e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.84e-2)"	"prognostic favorable (3.80e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.94e-1)"	14.1	12.8	21.3	8.5	23.4	11.9	16.8	27.0	25.7	14.4	14.8	13.0	9.7	14.4	20.8	9.2	11.4	9.0	12.6	23.8	19.2	13.9	10.0	10.3	10.9	18.7	19.8	21.3	9.9	18.2	8.4	10.3	18.9	15.7	11.5	26.2	14.8	15.4	30.3	20.4	10.2	12.7	19.3	10.5	11.9	6.8	20.7	12.1	15.8	24.3	9.7	11.7	10.0	23.4	17.2	12.3	9.5	9.4	28.0	22.8	9.6	14.7	13.5	8.3	6.5	10.5	12.3	5.4	14.2	17.0	5.4	19.2	13.6	12.6	13.6	7.6	8.9	8.0	13.2	9.8	14.5	8.8	6.6	16.2	18.0	13.6	15.0	17.1	11.0	6.0	12.3	8.3	18.8	19.0	6.4	8.8	8.3	28.8	13.1	6.1	18.5	10.4	18.6	16.0	9.1	14.3	20.1	25.9	12.9	9.3	16.6	26.6	17.4	13.6	15.8	13.4	17.9	8.0	5.3	8.9	10.7	9.1	13.1	1.0	0.4	0.8	0.7	0.2	0.5	0.9	0.5	0.5	0.2	0.8	0.8	0.5	1.0	0.6	0.1	0.7	0.9	0.2	21.3	23.4	27.0	25.7	23.8	19.2	18.7	19.8	18.9	19.3	20.7	23.4	96.5	60.9	103.2	171.7	108.3	103.9	97.4	52.9	109.3	147.6	75.9	58.3	107.8	50.1	82.7	51.5	202.3	53.6	83.3	76.2	17.6	41.5	25.9	72.0	107.4	77.6	67.5	46.7	220.6	39.8	25.2	93.7	101.4	87.9	81.1	72.3	63.1	39.0	24.6	114.4	211.8	59.0	26.4	42.1	106.9	22.8	102.2	69.1	53.4	203.3	85.2	68.4	89.6	190.5	265.0	37.5	64.8	118.8	110.1	112.0	68.9	31.0	47.1	116.7	98.6	134.4	104.6	85.6	56.1	80.9	112.0	76.2	98.7	87.3	60.2	111.6
ASIC1	"ACCN2, BNaC2, hBNaC2"	ENSG00000110881	"Acid sensing ion channel subunit 1"	P78348	12	50057548-50083611	"Predicted membrane proteins"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 31.3;Inhibitory neurons: 16.4;Oligodendrocyte precursor cells: 64.8;Oligodendrocytes: 11.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 34.8;SH-SY5Y: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058870			Supported	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus, Plasma membrane"		"HPA058870: AB_2683841"	"unprognostic (5.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.97e-7)"	"unprognostic (7.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-5)"	1.6	0.7	19.3	0.9	22.2	0.1	1.6	14.4	19.8	3.2	6.4	6.3	0.8	1.9	0.0	2.3	3.0	2.5	2.6	18.2	21.0	0.7	0.2	0.6	0.4	18.0	24.9	1.1	0.5	5.0	0.8	0.6	15.9	2.8	1.2	1.0	3.5	1.9	0.3	0.9	2.5	2.3	13.7	0.3	2.8	0.7	23.7	1.5	0.5	0.0	0.2	1.9	1.7	13.8	3.3	7.2	8.7	19.7	2.7	4.2	4.9	2.2	6.1	4.0	4.0	4.8	2.3	2.1	4.7	1.1	2.4	3.2	8.7	7.7	2.3	1.9	25.1	6.2	9.0	3.2	3.8	9.5	22.7	10.7	3.7	0.4	1.0	34.8	0.5	22.8	4.3	0.0	3.3	4.0	8.8	18.3	3.9	6.9	12.5	9.3	8.5	4.0	2.0	0.1	13.4	27.4	5.3	1.8	3.2	1.4	11.0	6.5	0.3	4.1	12.8	2.5	1.2	0.1	0.0	0.0	5.1	7.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.2	14.4	19.8	18.2	21.0	18.0	24.9	15.9	13.7	23.7	13.8	0.3	0.0	0.0	31.3	0.0	0.0	0.4	0.5	0.0	2.8	2.0	2.8	0.9	0.0	2.1	1.8	0.0	0.4	0.1	0.1	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.0	7.0	0.0	0.9	3.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	3.3	16.4	0.1	0.0	0.0	0.3	0.0	1.5	0.1	0.0	1.9	0.0	1.4	0.0	64.8	11.2	0.2	0.0	1.2	0.2	0.5	0.0	3.2	6.0	0.5	0.0	1.3	0.7	0.1	0.9	2.3	0.0	0.3	0.9	0.4	0.0	0.2
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.9;brain: 29.8;retina: 14.0"	"Group enriched"	"Detected in some"	6	"Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	0.8	14.9	22.9	0.4	27.1	0.0	0.7	3.0	29.8	0.4	0.0	0.5	0.3	0.9	3.3	0.0	1.6	0.6	0.5	28.5	23.3	0.1	0.2	0.2	0.1	6.1	10.7	5.7	0.5	0.1	9.0	0.3	7.5	1.0	0.3	14.0	0.9	1.6	0.1	0.1	0.3	0.9	11.5	2.2	0.3	0.7	22.7	0.0	0.0	0.3	0.3	0.0	0.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	27.1	3.0	29.8	28.5	23.3	6.1	10.7	7.5	11.5	22.7	11.5	0.0	0.0	0.0	191.3	0.0	0.1	0.0	0.0	0.0	7.9	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.3	0.2	0.0	0.0	218.7	0.0	0.1	0.7	0.0	0.2	0.0	4.0	5.0	0.0	0.5	23.5	275.6	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	25.3	0.0	0.8	0.0	280.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.7	4.4	1.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.6;Late spermatids: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;AN3-CA: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	5.3	6.0	2.3	0.6	2.9	0.6	7.6	1.8	3.3	12.4	0.9	8.6	0.5	9.7	3.6	7.6	9.8	0.7	5.5	2.6	3.3	11.3	7.6	5.8	0.6	2.3	2.7	13.4	6.0	0.2	21.3	0.4	2.5	13.5	0.6	2.5	7.7	0.3	4.9	6.6	7.8	0.7	1.9	5.6	7.4	13.5	2.5	0.7	9.3	0.0	0.7	9.2	8.4	3.1	1.4	0.7	8.0	5.3	0.9	0.7	0.6	0.3	0.0	0.2	0.4	2.3	1.4	0.1	1.1	1.1	2.2	1.5	2.5	0.9	0.0	1.0	4.2	0.1	0.1	2.6	0.4	0.5	1.1	1.4	0.5	0.3	0.0	1.0	0.5	3.8	1.5	0.0	1.3	1.5	1.0	0.3	0.4	2.2	0.0	1.0	0.1	0.4	1.3	2.4	0.3	3.2	0.6	0.6	0.4	0.0	2.9	0.4	1.0	3.0	1.3	0.0	0.5	0.9	2.5	0.8	1.6	3.4	2.1	0.5	0.4	0.3	0.1	0.3	0.1	0.5	0.2	0.1	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.5	0.1	0.1	2.3	2.9	1.8	3.3	2.6	3.3	2.3	2.7	2.5	1.9	2.5	3.1	6.2	0.0	1.5	14.7	6.4	5.6	14.0	16.9	14.2	9.0	9.4	11.4	1.9	5.7	8.6	14.7	10.4	11.9	4.1	7.6	7.9	11.9	87.6	9.0	7.7	7.9	18.0	3.0	7.8	4.5	6.3	6.9	8.2	8.0	1.3	16.0	3.3	2.9	6.1	1.7	11.4	8.9	14.2	1.6	3.1	42.4	4.1	3.1	0.0	5.6	9.1	12.5	6.2	16.6	13.1	9.3	10.8	8.6	4.1	11.6	9.7	5.4	10.8	10.7	6.6	8.0	7.8	12.4	11.8	8.0	5.4	8.9	4.7	6.1	11.1	15.3
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Golgi apparatus"	"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	10.2	10.4	12.3	8.9	22.0	18.2	6.1	18.3	16.8	13.0	5.7	4.4	9.9	10.1	5.8	7.0	8.7	15.0	21.4	9.7	12.5	12.7	10.1	39.5	5.8	25.3	22.2	6.5	12.4	23.1	16.2	10.1	22.9	4.3	3.2	14.9	9.0	3.9	13.1	8.9	8.3	9.1	15.7	8.9	5.3	8.9	21.9	8.2	13.9	17.3	6.1	6.5	5.9	40.2	28.0	14.0	17.5	20.5	8.7	11.7	30.9	13.0	7.6	10.9	8.8	44.5	31.5	14.1	15.5	11.0	14.0	23.2	15.8	10.8	10.5	14.2	14.9	16.3	11.9	23.3	13.6	30.8	25.5	7.9	8.2	13.2	8.0	8.8	29.0	12.6	11.4	2.3	7.7	10.5	14.1	19.4	7.5	31.8	9.9	12.2	7.1	8.1	59.3	6.4	27.8	7.7	12.7	16.3	10.7	22.4	6.2	40.4	19.2	0.0	23.3	14.1	9.9	7.4	15.5	5.9	4.8	28.3	12.2	0.0	1.1	1.7	0.4	1.6	0.3	0.6	0.2	0.2	0.6	1.8	0.3	0.2	3.1	0.0	1.5	0.5	0.0	0.3	12.3	22.0	18.3	16.8	9.7	12.5	25.3	22.2	22.9	15.7	21.9	40.2	25.6	218.0	215.0	22.2	11.3	10.8	3.4	4.9	1.2	42.0	5.2	3.7	42.3	31.5	29.4	16.5	235.6	1.7	7.0	2.4	5.9	32.7	0.9	51.2	24.2	34.2	12.0	3.8	35.0	11.4	32.2	16.5	8.6	176.3	12.0	62.2	27.1	16.5	20.7	13.5	32.5	3.5	14.2	33.6	16.9	1.9	11.1	29.3	10.6	48.7	36.9	11.0	6.2	33.7	138.3	24.3	6.1	4.9	7.7	7.7	10.5	15.7	13.3	44.8	0.0	9.5	12.8	4.0	10.1	6.3	9.7	8.6	8.4	8.7	5.9	3.9
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449007-142578733	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	3.0	8.6	0.7	4.1	1.1	1.2	3.2	0.9	1.4	3.8	3.7	2.7	1.7	3.3	2.3	3.1	3.3	3.4	2.3	1.2	1.9	3.7	3.6	2.9	4.8	1.5	1.2	2.7	3.8	5.2	3.7	3.1	1.4	3.0	2.9	2.9	3.5	2.5	2.9	2.7	3.1	3.2	1.0	4.2	2.8	5.2	1.2	4.9	5.0	1.4	4.6	4.1	2.7	1.2	28.6	13.2	7.1	7.0	9.6	13.6	8.8	14.8	8.4	10.1	9.7	6.4	6.8	19.9	14.6	10.1	14.6	16.1	10.9	12.8	15.0	7.5	7.9	11.9	8.2	4.1	4.2	20.5	5.3	9.8	4.8	9.5	10.3	5.8	11.6	8.7	8.2	7.5	9.6	7.5	13.9	2.6	7.3	15.6	9.6	11.8	12.5	13.5	6.3	11.1	5.2	5.1	28.6	8.3	8.0	7.8	12.0	5.4	14.6	10.5	4.9	12.3	15.2	10.8	7.4	18.5	13.8	6.5	8.5	0.0	0.3	0.0	0.5	0.4	1.0	0.1	0.3	0.5	0.7	0.3	0.4	0.4	0.0	1.3	0.2	0.2	0.4	0.2	0.7	1.1	0.9	1.4	1.2	1.9	1.5	1.2	1.4	1.0	1.2	1.2	11.5	6.4	10.6	39.2	22.4	4.0	7.2	8.8	14.2	14.1	9.2	6.5	7.6	5.7	10.1	3.7	37.5	7.7	14.9	3.5	0.0	5.9	16.4	18.8	18.6	10.2	7.7	14.5	93.0	4.9	3.6	8.3	14.8	10.3	1.3	16.3	7.9	7.3	6.4	8.4	94.4	4.8	14.2	9.4	4.0	8.7	6.5	12.8	10.6	73.1	12.0	6.0	9.2	65.4	71.9	6.4	1.8	7.2	23.1	8.1	1.9	6.5	25.4	23.6	0.0	14.6	9.8	50.1	18.5	14.7	4.5	5.1	15.1	13.8	7.6	6.1
B3GNT9	MGC4655	ENSG00000237172	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9"	Q6UX72	16	67148104-67150998	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 12.9;Leydig cells: 11.5;Peritubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052743, HPA062734"	Approved		Approved	"Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA052743: AB_2681934, HPA062734: AB_2684854"	"unprognostic (2.56e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.56e-3)"	7.7	8.4	7.1	4.2	8.0	0.2	5.7	7.5	6.8	15.0	8.4	7.6	3.2	13.4	7.3	5.2	13.7	6.8	13.8	7.1	8.0	7.4	2.5	9.0	2.9	8.7	9.7	15.0	3.5	21.8	20.5	7.9	8.7	11.8	3.3	1.4	9.0	14.8	1.9	5.9	5.6	7.8	9.3	5.6	6.1	6.0	7.7	1.5	18.7	2.1	2.5	11.7	8.9	11.1	4.9	8.8	0.7	0.9	27.7	28.6	1.0	22.5	36.2	14.4	18.5	4.0	0.8	0.6	1.5	34.9	6.0	11.1	0.3	1.0	7.8	7.6	3.2	0.7	9.7	3.5	22.3	0.6	0.5	23.7	8.3	14.0	0.4	35.8	2.0	0.5	1.0	2.7	22.6	2.6	2.6	1.2	5.4	3.8	7.7	7.4	12.9	4.4	2.3	6.0	5.0	11.2	50.9	0.2	0.8	4.3	1.3	3.9	4.6	25.6	1.1	25.9	10.2	3.2	2.4	0.8	31.9	1.3	12.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.1	8.0	7.5	6.8	7.1	8.0	8.7	9.7	8.7	9.3	7.7	11.1	1.2	6.4	5.0	1.0	1.2	3.2	2.8	2.4	9.6	1.6	3.2	2.3	2.6	5.7	2.4	3.7	0.0	0.3	0.1	0.4	0.0	1.3	5.3	2.5	7.6	2.0	2.4	0.0	0.4	1.7	0.5	12.9	2.6	2.2	0.0	3.0	6.4	0.1	1.8	0.0	1.3	0.9	2.0	0.6	3.3	6.9	11.5	0.4	1.8	0.0	0.1	0.9	0.0	1.0	2.3	0.9	0.1	13.5	4.7	2.4	0.1	0.9	4.2	0.3	6.6	3.2	6.6	4.4	2.8	2.7	4.1	0.8	1.5	2.9	0.8	1.3
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	459939-563509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 61.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.2	7.0	0.5	3.2	0.7	2.1	1.3	0.0	1.0	7.4	1.0	18.4	1.0	6.2	2.7	7.5	3.7	2.2	23.9	0.5	0.0	4.6	0.1	5.2	0.1	0.0	0.0	0.4	2.6	16.9	9.3	0.1	0.0	2.0	12.5	0.1	4.8	0.7	1.5	14.8	2.0	2.2	0.0	0.3	61.0	8.0	0.0	2.3	2.3	0.1	0.7	1.4	5.6	0.7	0.0	0.0	0.3	1.2	0.0	0.0	33.5	0.0	0.0	0.0	0.0	8.0	6.6	0.0	0.9	0.0	0.7	3.6	8.0	1.1	0.1	13.2	12.5	0.0	0.0	1.8	0.0	0.1	5.3	0.0	5.3	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.1	14.8	10.5	0.6	0.5	5.0	0.0	7.1	6.8	3.8	2.7	0.8	0.3	1.0	4.9	0.8	2.9	0.0	0.0	2.7	0.2	0.9	0.0	0.0	0.0	0.0	9.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	7.0	1.3	0.3	7.5	6.0	3.4	0.0	0.6	2.9	0.6	15.1	1.5	6.2	9.2	0.0	0.0	0.6	81.1	0.0	12.0	26.3	20.4	4.8	0.6	10.3	0.0	32.6	4.8	0.1	1.6	128.0	47.4	0.0	0.1	0.0	0.1	0.7	0.0	5.2	18.6	2.0	0.0	1.1	89.2	0.0	0.5	0.0	2.8	0.6	0.0	0.0	1.0	3.6	16.6	33.4	0.0	0.2	12.7	1.9	0.2	9.1	0.2	0.0	0.2	0.8	2.8	1.3	0.9	17.3	0.0	1.5	1.9	26.1	14.4
B4GALT2	beta4Gal-T2	ENSG00000117411	"Beta-1,4-galactosyltransferase 2"	O60909	1	43978943-43991170	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007620, HPA047739"	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA		3100000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA007620: AB_2667879, HPA047739: AB_2680141"	"unprognostic (1.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (3.62e-5)"	"unprognostic (6.54e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.12e-3)"	29.0	19.0	61.4	13.0	55.0	6.6	24.6	48.0	70.1	28.4	44.0	43.7	12.5	31.0	9.6	32.4	20.0	14.9	40.8	58.4	51.6	24.6	38.8	19.6	5.9	53.6	53.6	19.6	51.5	14.2	24.7	10.1	53.0	31.2	10.2	8.9	27.3	23.8	61.0	32.8	15.2	26.3	52.6	12.0	22.4	22.6	55.2	3.1	14.3	33.2	6.8	37.0	26.8	52.6	61.6	38.4	45.3	76.0	51.3	54.5	37.8	54.2	55.9	54.8	50.9	30.4	51.4	38.4	31.6	112.3	52.5	39.9	36.8	72.8	14.0	39.6	80.2	23.2	37.8	66.9	43.2	20.6	0.8	47.0	79.1	39.3	71.4	55.3	65.5	15.9	51.7	25.3	46.7	45.3	15.3	18.6	65.6	35.7	56.7	44.3	48.2	62.7	33.9	29.3	72.7	58.5	31.1	89.4	38.5	16.9	38.6	17.5	39.3	90.8	102.4	63.8	78.5	7.6	17.8	15.9	40.4	16.9	64.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	61.4	55.0	48.0	70.1	58.4	51.6	53.6	53.6	53.0	52.6	55.2	52.6	9.7	0.0	8.8	7.5	2.2	7.8	10.3	10.8	1.8	13.3	15.0	18.9	14.0	7.2	7.4	14.7	4.2	2.0	1.2	10.2	1.9	13.3	16.4	6.2	16.2	10.4	16.3	1.3	8.0	20.6	8.0	15.2	13.7	8.7	0.0	23.8	6.1	18.7	2.3	18.5	5.6	22.6	2.0	1.0	3.3	6.7	16.4	1.5	3.6	1.0	1.6	15.0	0.0	5.0	9.8	27.3	6.1	12.4	5.0	25.9	6.4	8.8	4.4	12.2	6.6	9.8	14.3	6.2	15.6	7.6	12.6	0.5	1.7	21.1	15.3	16.1
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 114.8;Syncytiotrophoblasts: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		130000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	28.4	21.9	20.0	16.0	20.5	19.0	21.6	17.9	21.1	21.8	18.6	19.4	17.2	14.7	18.3	25.1	19.0	14.4	24.9	20.5	22.0	27.7	22.5	25.1	23.4	18.4	19.3	29.0	34.0	21.9	32.5	21.7	19.1	21.8	17.5	8.0	32.3	12.3	24.6	24.6	18.6	10.6	18.2	31.2	27.6	19.4	22.9	16.9	21.9	16.3	20.7	23.7	21.4	19.3	35.2	22.3	32.8	43.6	47.5	24.7	52.5	19.2	34.7	39.6	36.3	44.8	68.4	32.2	54.2	22.1	37.8	34.3	34.9	21.7	22.8	34.1	42.5	18.6	14.2	35.8	34.1	37.0	48.6	33.7	31.1	36.5	39.6	47.0	45.2	41.3	60.3	69.3	32.2	35.4	24.1	34.4	40.9	70.3	48.0	28.5	18.2	79.4	33.5	20.9	46.6	54.7	19.7	50.4	41.7	44.2	50.7	64.8	18.9	19.5	35.4	22.4	57.7	246.6	146.5	43.0	28.5	31.2	32.0	10.7	14.9	12.6	27.0	17.2	24.3	26.2	25.9	26.0	18.0	21.2	25.0	23.2	9.7	25.9	23.3	37.4	43.1	21.0	20.0	20.5	17.9	21.1	20.5	22.0	18.4	19.3	19.1	18.2	22.9	19.3	18.1	19.2	20.0	1.6	34.7	38.5	36.6	26.2	19.9	17.3	32.8	19.9	10.2	15.7	17.7	25.8	2.1	44.8	30.3	15.3	5.9	28.7	10.1	8.2	7.8	24.4	28.8	34.5	6.2	22.9	91.7	24.7	15.3	10.9	9.5	21.0	27.8	13.2	29.7	26.9	7.1	20.7	26.4	16.6	17.9	5.7	9.6	16.2	23.2	4.7	10.2	9.4	47.4	5.0	4.5	31.4	20.0	7.2	114.8	46.1	19.0	20.9	12.4	8.6	26.3	11.1	24.7	14.9	46.9	21.7	41.9	114.2	29.5	11.8	22.7	51.4
BET1L	"GOLIM3, GS15"	ENSG00000177951	"Bet1 golgi vesicular membrane trafficking protein like"	Q9NYM9	11	167784-207428	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039819	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA039819: AB_10673020"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.49e-2)"	36.2	38.2	26.8	29.4	28.2	18.0	35.5	26.5	27.6	43.2	33.2	37.0	29.1	37.0	37.3	30.1	38.8	27.5	34.3	25.6	27.1	40.4	53.5	35.4	32.9	31.0	28.5	53.6	79.9	39.9	56.0	29.8	28.0	43.4	29.8	17.1	52.9	41.6	22.5	36.1	39.4	31.3	27.5	39.4	43.1	33.0	27.5	28.2	37.5	23.4	35.7	37.4	33.2	30.1	46.2	37.6	22.0	27.3	66.5	58.3	31.8	48.1	62.8	50.6	51.5	47.3	43.4	40.5	22.9	87.7	36.4	42.1	25.6	44.0	38.3	31.6	27.7	37.5	21.5	48.2	61.4	43.2	70.2	66.2	58.1	29.8	79.6	58.7	34.7	28.2	55.7	41.3	32.7	25.0	31.7	27.3	33.6	66.8	42.3	32.6	32.6	27.7	41.8	20.3	23.9	29.0	42.9	68.5	47.7	31.5	35.2	33.6	38.6	39.0	18.0	16.0	24.0	72.2	35.9	35.6	52.7	35.6	36.4	58.5	19.0	66.0	28.4	27.5	34.1	31.9	32.5	29.1	19.0	25.0	37.4	29.6	43.5	27.9	25.8	22.1	27.4	32.5	26.8	28.2	26.5	27.6	25.6	27.1	31.0	28.5	28.0	27.5	27.5	30.1	9.8	12.8	17.0	3.9	23.0	9.3	16.8	12.8	16.5	6.8	21.3	19.0	14.5	15.7	10.7	14.7	8.4	15.8	16.9	24.4	21.5	12.8	58.8	8.6	13.2	10.6	7.8	12.0	3.6	23.4	28.2	19.4	20.9	10.1	38.0	10.2	18.2	39.3	22.7	3.3	4.4	23.1	14.2	16.4	12.7	142.9	22.1	18.4	7.2	2.8	14.8	9.1	10.3	4.0	4.7	18.6	26.1	18.8	68.3	29.2	39.2	28.7	12.6	10.4	6.6	12.8	15.9	47.2	21.8	11.9	11.6	26.3	19.4	8.9	17.1	29.3
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494980-153509546	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 795.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 223.5;Peritubular cells: 782.7;Sertoli cells: 1485.7;Smooth muscle cells: 401.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 312.6;BJ hTERT+: 400.8;fHDF/TERT166: 568.9;HSkMC: 283.9;hTEC/SVTERT24-B: 235.2;HUVEC TERT2: 561.2;U-138 MG: 249.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		3300000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	165.8	213.0	54.1	93.1	57.6	0.3	118.0	51.2	91.5	371.0	69.5	69.3	22.0	234.4	83.7	45.8	143.7	326.1	795.8	56.1	48.7	396.5	347.9	477.3	42.4	50.6	50.8	94.9	67.9	26.6	144.1	199.1	53.2	184.2	24.8	1.1	107.7	135.5	32.4	118.9	48.8	213.2	45.5	352.1	51.6	69.9	64.6	15.9	250.0	46.7	35.9	126.8	180.0	65.4	0.0	0.0	29.7	0.1	31.5	70.5	1.1	312.6	400.8	56.7	18.6	39.5	0.0	0.0	56.9	568.9	2.0	0.1	0.0	0.0	10.2	0.0	0.0	0.0	0.6	3.9	27.0	0.0	0.2	283.9	2.2	235.2	10.7	29.0	561.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.5	0.3	0.2	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.1	11.8	1.3	0.0	120.0	249.5	2.3	1.0	1.5	0.9	0.1	0.0	0.1	0.3	114.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	57.6	51.2	91.5	56.1	48.7	50.6	50.8	53.2	45.5	64.6	65.4	30.5	3.2	5.6	5.9	0.6	104.1	1.3	7.3	5.7	0.2	1.2	5.6	16.1	4.3	2.5	9.2	0.0	15.5	0.7	0.0	1.9	2.7	1.8	1.4	28.3	45.2	0.0	5.3	0.1	0.2	50.0	180.0	7.7	1.1	3.8	8.4	223.5	1.6	4.4	3.3	0.1	0.0	0.0	4.0	43.6	13.5	147.9	3.0	35.6	25.3	2.0	0.1	0.0	20.6	0.0	1.2	0.0	782.7	0.0	3.0	0.0	0.8	1.6	0.2	1485.7	3.1	401.3	0.8	1.2	1.8	54.1	56.9	3.0	7.7	0.0	1.6
BHLHA15	"BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211439-98215457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 502.8;salivary gland: 145.9"	"Cell type enriched"	"Detected in single"	25	"Plasma cells: 12.6"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 53.5;RPMI-8226: 72.0;U-266/70: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Golgi apparatus"		"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.8	3.6	0.6	0.3	1.5	0.1	2.0	1.9	0.1	4.0	4.0	0.1	0.8	0.9	0.1	0.7	0.2	1.3	0.9	0.6	5.2	0.9	3.8	0.6	0.5	0.4	502.8	0.1	1.5	0.1	0.6	8.5	1.5	0.0	145.9	3.9	0.2	0.6	3.4	0.0	1.0	5.0	31.3	0.2	1.5	0.7	1.9	0.0	4.7	2.5	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.1	0.8	0.9	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.6	6.7	5.9	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.2	0.0	0.0	53.5	0.0	0.9	0.0	0.0	0.8	6.2	0.8	0.4	0.0	72.0	0.3	0.0	4.3	1.2	0.0	11.2	0.0	0.0	0.7	0.1	0.0	0.0	0.7	0.1	0.1	67.6	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.6	0.1	2.0	1.3	0.9	0.6	0.5	0.6	1.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
BLZF1	JEM-1	ENSG00000117475	"Basic leucine zipper nuclear factor 1"	Q9H2G9	1	169367970-169396540	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 85.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025703, HPA027331, HPA067113"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781"	"unprognostic (5.25e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-3)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (3.28e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.18e-1)"	14.9	13.1	8.2	12.5	10.3	25.6	19.4	11.3	10.3	14.6	9.4	13.9	12.3	15.6	14.3	32.4	11.3	16.3	16.0	8.9	9.0	17.0	14.9	13.0	11.8	9.9	9.4	14.5	9.5	15.1	8.7	18.2	9.7	15.6	15.6	22.8	12.7	16.0	11.3	18.0	12.7	17.9	9.7	12.5	13.1	35.0	9.3	13.7	18.7	11.0	16.2	16.6	14.7	14.3	52.8	16.6	16.5	13.6	24.9	37.6	26.2	46.6	32.0	48.1	52.5	19.5	33.3	7.5	26.8	31.6	30.7	38.6	16.6	30.3	37.4	16.8	16.1	13.7	20.0	13.6	26.4	27.2	18.9	27.6	36.9	35.8	31.7	27.3	25.1	14.9	25.6	20.0	46.0	10.8	12.1	12.7	19.9	38.2	25.2	6.8	26.0	16.6	48.1	17.5	9.3	30.6	30.3	41.3	36.9	28.3	44.8	20.4	30.5	28.9	22.5	26.7	39.6	20.4	26.1	19.5	22.1	11.7	44.6	85.6	12.2	51.5	12.2	16.2	16.0	11.3	15.0	14.1	10.8	10.4	13.2	14.4	25.1	19.8	15.8	8.2	23.9	10.9	8.2	10.3	11.3	10.3	8.9	9.0	9.9	9.4	9.7	9.7	9.3	14.3	14.7	22.4	16.4	34.9	11.7	18.4	46.7	22.6	16.5	14.3	18.0	12.1	29.6	11.5	24.4	11.0	14.6	18.3	15.2	18.2	23.5	24.2	131.4	28.0	18.6	11.9	12.6	16.0	30.2	13.2	17.3	18.7	22.4	28.5	26.0	12.3	12.5	4.8	14.3	33.7	32.8	11.7	14.2	10.7	6.8	72.8	14.6	11.6	14.2	17.8	10.3	21.2	17.5	30.2	57.8	36.7	11.6	17.7	13.9	17.0	15.4	22.4	31.6	27.9	0.0	23.0	21.7	84.9	25.8	16.7	15.6	20.1	18.8	17.1	11.6	65.3
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188345-8190180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		11000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA045415: AB_10964575, HPA060791: AB_2684367"	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	6.4	8.4	9.8	5.0	9.9	4.2	5.7	10.1	10.4	5.7	7.9	8.3	7.2	6.6	3.7	10.9	5.2	2.3	10.1	9.1	8.9	7.7	8.0	5.4	6.7	11.8	10.0	4.1	14.4	6.1	4.7	4.0	10.7	6.2	2.7	3.1	6.2	4.9	15.0	12.5	8.6	2.8	9.8	11.6	8.2	5.5	9.9	5.3	5.7	6.0	4.9	7.1	6.5	10.8	6.3	7.5	2.5	5.1	5.3	3.9	10.0	4.6	5.1	4.4	4.7	4.2	4.2	5.9	9.9	3.7	4.2	9.2	3.9	5.4	1.5	17.8	16.3	4.5	7.0	6.5	6.0	2.7	9.5	4.0	5.7	4.0	4.6	3.9	7.2	8.6	5.1	12.0	2.7	6.7	9.0	7.7	1.8	4.0	8.3	10.6	3.2	8.9	6.1	3.5	3.0	6.9	4.7	3.5	4.2	2.5	5.1	4.2	5.8	2.7	2.4	4.2	5.0	18.0	8.8	2.7	3.9	9.5	3.3	46.4	18.6	50.7	27.8	18.7	22.7	23.5	23.4	29.6	20.9	23.3	22.0	24.9	17.0	28.5	23.1	18.3	23.5	21.4	9.8	9.9	10.1	10.4	9.1	8.9	11.8	10.0	10.7	9.8	9.9	10.8	13.5	9.6	6.4	0.0	21.6	0.0	2.6	0.0	14.2	23.1	9.0	9.5	0.0	11.5	0.6	5.5	6.2	20.4	22.3	12.2	7.9	9.7	2.4	5.6	3.8	10.9	1.2	11.4	0.0	17.7	12.0	4.4	4.1	5.7	3.8	5.2	12.5	9.4	20.9	18.5	0.0	8.6	0.0	21.1	0.0	3.2	5.9	21.5	0.0	0.0	25.6	23.8	45.3	0.0	0.0	11.3	18.3	6.8	18.5	3.5	29.8	10.3	0.0	19.7	32.9	4.3	6.7	9.0	1.3	17.3	0.0	6.2	18.7	9.4	7.5	1.5
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32364633-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 37.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	36.8	63.0	28.0	17.4	29.4	77.1	37.8	31.7	30.6	38.7	27.3	35.9	25.4	35.3	24.9	36.7	35.3	23.3	35.9	28.9	27.2	38.7	73.2	33.7	22.4	32.5	27.8	54.5	56.0	42.3	46.5	22.1	28.8	41.0	22.5	21.7	45.0	24.3	36.7	47.5	34.8	20.7	28.1	35.8	41.0	51.3	28.4	19.5	37.9	16.3	21.8	33.2	36.5	35.9	24.3	16.2	32.8	25.2	38.6	29.6	25.6	23.0	43.9	39.8	41.0	18.1	19.9	17.8	27.0	41.3	22.6	26.1	23.4	21.6	25.6	33.4	33.3	14.2	35.5	22.1	33.2	17.6	24.7	35.5	46.4	30.7	23.2	47.8	24.8	28.0	36.4	30.8	22.3	10.7	18.7	10.3	20.8	14.1	19.0	18.8	18.8	24.7	22.6	19.5	34.6	25.0	22.1	22.7	25.2	37.7	21.4	13.9	30.1	22.1	19.8	28.3	22.6	42.2	41.6	15.9	25.8	22.3	13.5	37.4	5.1	18.3	6.2	5.9	6.1	7.0	5.5	5.2	4.9	8.3	6.0	5.6	8.4	6.1	5.0	6.5	7.3	6.2	28.0	29.4	31.7	30.6	28.9	27.2	32.5	27.8	28.8	28.1	28.4	35.9	24.6	32.1	18.6	23.5	42.8	28.4	56.6	31.5	25.6	53.6	38.9	26.7	19.4	55.8	21.9	25.8	83.4	51.1	38.8	59.3	19.6	37.8	88.9	23.7	26.3	35.2	40.1	76.0	25.6	44.1	31.0	32.7	27.0	34.4	21.0	36.1	50.0	56.7	20.0	85.8	31.6	47.8	28.5	25.8	13.1	100.7	54.7	20.1	32.0	25.3	28.0	30.3	57.7	29.1	35.0	45.6	40.0	47.4	32.1	58.4	63.9	28.0	18.4	69.8	39.5	33.1	38.1	42.9	45.9	21.2	25.9	96.5	34.6	60.5	39.3	57.2
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405630	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 694.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA017060, HPA073472"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		260000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA017060: AB_1845467, HPA073472: "	"prognostic favorable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	226.0	509.8	86.7	95.6	87.6	103.7	152.9	84.0	125.7	93.4	81.7	94.1	47.4	58.7	59.5	40.3	248.0	109.4	111.2	85.1	84.5	160.1	227.8	141.4	128.0	101.5	85.9	694.2	26.3	13.8	56.8	203.0	88.4	88.6	33.3	2.0	77.7	105.2	46.1	24.8	109.1	76.0	97.0	238.5	84.1	35.4	91.1	123.5	54.0	50.8	65.8	82.9	88.6	90.8	327.0	0.5	0.9	145.6	0.0	1.0	49.6	1.3	24.9	459.5	615.0	150.5	286.1	252.2	338.2	197.6	14.6	1.3	212.9	23.9	14.3	279.1	1.8	3.6	525.7	149.8	256.7	120.1	304.7	1.3	0.0	153.0	0.1	4.4	119.0	6.0	146.3	603.4	0.0	89.5	57.7	208.6	158.0	0.1	407.9	105.5	0.8	530.7	110.1	1.5	0.6	1.4	325.5	12.3	410.5	12.3	243.1	166.3	1.5	1.9	11.4	0.5	3.3	308.3	439.3	168.0	1.3	470.8	2.2	229.7	345.3	125.3	171.4	385.5	163.0	115.2	143.2	160.0	283.8	146.5	114.8	132.6	113.3	353.2	359.3	421.7	143.3	367.9	86.7	87.6	84.0	125.7	85.1	84.5	101.5	85.9	88.4	97.0	91.1	90.8	1193.2	57.7	13.6	4.9	90.7	33.1	19.6	255.7	48.9	0.2	86.2	168.5	7.0	50.1	68.5	49.7	0.0	7.8	184.2	1.5	37.2	18.7	10.7	27.8	11.2	420.2	1.2	74.0	0.0	1.2	61.5	152.4	14.8	50.1	227.8	260.9	455.8	211.1	388.9	0.0	0.0	2.8	28.5	189.4	187.6	12.0	346.7	220.4	74.7	32.8	214.5	1.3	211.2	0.5	0.3	3.3	4.8	419.4	192.8	10.3	3.7	1.3	27.4	2.1	164.3	30.7	146.3	1.3	1.2	15.5	26.1	13.1	135.8	490.6	5.0	28.6
BTG4	"APRO3, PC3B"	ENSG00000137707	"BTG anti-proliferation factor 4"	Q9NY30	11	111467526-111512354	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 26.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 61.3;Late spermatids: 80.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.3;Karpas-707: 4.5;U-266/70: 3.1;U-266/84: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057157			Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum, Golgi apparatus"		"HPA057157: AB_2683354"		"unprognostic (1.58e-1)"		"unprognostic (2.68e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.80e-4)"		"unprognostic (1.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.39e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	5.2	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.7	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	26.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.1	0.2	3.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.5	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.2	3.1	1.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.7	1.0	0.5	0.4	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	80.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	10.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C12orf40	FLJ40126	ENSG00000180116	"Chromosome 12 open reading frame 40"	Q86WS4	12	39626167-39908300	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039032			Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA039032: AB_2676316"					"unprognostic (1.75e-1)"								"unprognostic (2.76e-6)"	"unprognostic (3.45e-1)"	"unprognostic (1.96e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	7.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0
C12orf43	"Custos, FLJ12448"	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	9.8	8.1	11.7	6.9	11.9	7.4	9.3	8.8	13.6	7.8	7.2	11.2	5.0	9.5	4.4	7.2	9.0	5.1	7.4	12.3	9.5	8.2	10.5	6.7	8.7	10.9	9.6	11.2	7.5	9.0	7.4	7.2	10.8	7.7	5.3	6.0	8.7	6.2	7.2	6.7	6.7	8.4	8.6	7.8	8.2	6.1	9.4	7.2	6.4	5.9	7.4	9.6	7.0	10.4	14.2	31.4	16.2	12.8	14.0	11.0	17.8	17.2	17.5	28.3	17.9	22.8	13.0	26.2	17.2	16.8	15.0	15.7	19.2	26.3	16.8	31.6	21.4	21.1	12.4	17.1	16.7	28.1	16.2	12.9	13.6	26.0	16.4	17.9	16.4	27.0	25.5	6.7	15.1	23.3	30.9	22.0	28.8	11.1	23.2	27.4	19.0	19.8	17.5	20.8	22.0	14.0	23.0	9.9	18.6	13.4	27.0	13.1	15.9	15.6	18.7	12.8	18.4	12.3	19.1	20.5	20.5	16.5	23.6	5.7	15.6	9.0	23.8	21.3	21.8	23.8	23.5	23.2	16.1	19.0	27.5	23.6	2.2	18.4	18.5	13.3	23.8	20.6	11.7	11.9	8.8	13.6	12.3	9.5	10.9	9.6	10.8	8.6	9.4	10.4	16.1	25.6	18.1	3.3	17.3	8.8	16.4	12.2	6.8	19.6	12.4	12.4	7.0	11.5	9.6	18.4	20.9	24.3	13.9	8.6	23.5	16.5	5.9	9.8	17.1	16.0	2.4	10.7	6.8	18.5	22.3	16.3	8.2	10.1	14.5	22.3	12.5	11.7	16.7	16.8	6.4	9.5	10.2	10.4	7.3	13.8	13.7	13.2	14.2	3.7	21.7	18.8	24.7	4.0	4.8	15.6	12.3	12.8	11.3	13.8	5.3	16.7	16.3	15.7	19.7	19.6	16.9	16.3	16.4	12.7	7.7	13.7	17.6	16.0	10.9	14.0
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041947, HPA042980"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA041947: , HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.4	13.5	8.3	10.1	8.1	13.9	13.2	12.4	10.8	11.0	6.1	12.4	13.7	9.2	19.8	12.1	9.0	6.5	8.1	8.1	6.7	19.1	13.0	8.2	13.5	8.1	6.3	10.5	12.4	9.7	9.3	7.6	7.6	9.4	8.2	10.2	12.4	5.8	12.4	14.7	12.9	6.1	4.2	11.9	11.2	13.9	7.0	10.7	10.3	6.7	11.2	10.1	10.7	15.3	16.8	19.7	12.8	17.4	15.9	14.4	11.6	10.1	16.0	9.7	10.9	13.7	26.6	16.6	13.4	7.6	23.8	29.5	28.5	20.2	10.9	32.1	19.0	15.7	26.4	15.9	15.3	26.6	15.6	12.1	28.8	16.1	18.1	12.8	16.8	43.6	22.1	26.6	9.3	15.7	22.6	14.3	21.4	23.8	12.5	30.5	17.3	22.7	16.7	23.5	29.7	18.2	26.0	20.4	40.8	16.2	23.3	15.4	10.4	20.0	29.1	15.5	17.7	25.4	42.0	31.8	26.0	26.4	22.4	58.0	20.9	31.2	28.1	22.0	31.4	46.7	29.7	29.5	21.2	38.8	34.7	29.9	20.6	42.2	21.4	29.6	41.1	20.5	8.3	8.1	12.4	10.8	8.1	6.7	8.1	6.3	7.6	4.2	7.0	15.3	27.3	28.9	32.5	16.6	41.1	12.0	27.8	45.2	51.2	28.9	33.6	41.0	11.6	38.6	46.2	25.8	12.5	46.6	22.3	42.3	93.9	47.3	36.7	30.0	21.1	27.2	28.8	32.4	11.6	56.1	30.0	29.9	32.1	19.0	27.8	33.7	26.0	37.7	30.0	30.3	14.3	26.4	34.6	28.4	12.0	30.8	33.2	28.0	26.6	8.4	42.7	32.1	63.8	11.6	19.9	62.7	29.6	36.1	41.2	26.7	77.6	127.3	51.2	30.1	19.7	28.6	25.9	107.3	66.8	46.5	15.3	35.6	39.3	39.9	29.9	26.3
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	8.1	15.9	10.9	10.4	11.4	7.5	13.2	12.1	13.5	8.9	12.3	11.7	13.3	12.4	18.7	8.7	15.0	7.0	19.4	10.8	11.7	21.3	14.5	8.7	12.9	11.2	10.9	16.1	13.2	27.8	13.4	10.4	11.8	11.6	12.6	26.1	12.2	10.6	17.5	7.2	10.8	10.4	10.5	9.5	12.9	26.3	11.1	16.0	14.1	14.3	13.2	9.6	8.2	11.2	39.2	33.4	51.0	15.5	13.3	14.5	27.9	25.5	22.4	34.3	29.1	18.2	14.9	23.5	28.6	18.2	52.6	42.5	32.8	27.6	46.6	18.0	37.9	18.7	39.8	39.5	26.6	26.3	14.1	13.4	33.0	25.2	17.4	28.6	25.3	43.6	38.9	31.8	22.8	29.2	76.5	26.9	37.7	23.9	14.7	50.1	31.5	44.0	21.4	18.2	50.4	44.3	21.1	19.1	62.7	37.2	50.4	16.8	19.8	18.8	35.4	9.3	42.4	42.5	51.0	82.9	15.3	23.0	5.7	34.6	12.4	16.4	17.6	12.0	20.1	18.2	16.9	18.3	16.1	19.9	18.2	17.0	3.2	19.0	17.1	12.8	19.6	15.4	10.9	11.4	12.1	13.5	10.8	11.7	11.2	10.9	11.8	10.5	11.1	11.2	12.6	12.8	30.7	7.2	13.8	5.9	13.4	27.8	12.5	25.0	11.3	13.5	25.8	8.6	19.3	14.7	8.4	31.8	10.7	3.8	43.0	16.2	10.0	17.2	8.8	10.5	12.6	13.5	11.1	13.8	18.0	9.8	9.7	10.5	11.4	18.3	6.4	11.0	9.7	32.0	15.0	8.0	28.5	7.5	3.7	6.3	7.5	7.8	5.4	2.8	6.7	17.5	11.3	10.1	8.7	11.8	3.2	8.2	14.0	6.4	6.9	29.9	29.9	23.0	39.5	9.7	13.1	88.0	31.8	12.0	6.1	16.3	15.1	10.5	8.4	8.2
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.0;lymphoid tissue: 134.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 182.3;Hofbauer cells: 195.3;Kupffer cells: 797.4;Langerhans cells: 226.7;Macrophages: 413.5;monocytes: 278.6;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"HDLM-2: 141.3;HL-60: 70.4;NB-4: 40.3;THP-1: 55.2;U-937: 117.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	45.4	23.6	16.3	70.8	16.2	115.0	22.3	17.2	29.0	13.2	19.6	15.8	7.3	11.5	6.3	9.8	22.5	31.2	18.1	16.3	18.4	12.5	41.9	85.7	70.4	20.6	17.3	9.4	9.4	4.8	9.1	15.2	19.7	11.7	17.9	9.5	11.2	6.6	10.1	7.8	21.2	37.6	16.7	134.5	12.5	7.6	23.3	27.7	10.0	7.4	55.9	25.1	10.8	21.4	0.3	0.1	0.5	1.1	0.4	0.6	0.6	0.9	0.1	0.3	0.3	0.2	0.4	0.5	0.5	0.2	0.1	0.2	0.8	0.5	0.6	141.3	0.4	0.4	0.5	0.0	0.4	70.4	11.1	0.0	2.6	0.8	0.9	1.0	2.0	0.7	0.5	0.4	0.5	0.5	0.6	40.3	0.2	0.7	0.8	0.1	0.7	0.1	0.3	0.1	0.5	0.2	0.5	0.6	0.8	0.6	0.3	55.2	0.0	0.8	1.0	0.7	0.6	0.6	0.1	0.6	0.3	117.9	1.2	1114.1	1026.8	1294.8	166.6	1529.2	47.6	231.0	206.5	97.3	1021.6	296.4	318.0	193.6	143.3	536.7	1173.4	302.8	66.7	1189.5	16.3	16.2	17.2	29.0	16.3	18.4	20.6	17.3	19.7	16.7	23.3	21.4	4.4	22.4	43.9	8.1	84.1	7.9	0.7	0.4	0.6	4.0	2.2	5.2	3.8	10.0	4.5	7.3	2.1	1.0	103.4	0.6	0.0	0.2	36.7	0.8	0.9	8.1	1.8	23.5	9.2	0.2	2.0	3.2	0.5	1.0	182.3	0.9	15.7	8.9	195.3	0.0	13.0	0.0	0.0	797.4	226.7	90.7	2.8	413.5	12.4	12.2	278.6	0.2	355.3	6.0	7.7	0.2	0.0	0.7	4.2	0.8	0.9	1.0	0.9	4.2	32.9	2.4	2.9	2.4	2.0	0.2	6.5	1.6	59.8	0.3	0.7	0.3
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347754-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 23.7;Leydig cells: 23.3;Peritubular cells: 29.7;Skeletal myocytes: 16.9;Smooth muscle cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 34.4;U-138 MG: 15.1;U-2 OS: 8.3;WM-115: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Centrosome"		"HPA061290: AB_2684468"	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	2.8	0.6	0.9	0.7	0.9	0.1	1.9	1.2	1.3	4.7	0.1	2.5	1.2	3.3	1.1	1.4	2.3	1.8	3.9	0.9	0.8	0.6	0.4	2.4	0.3	0.3	1.3	1.3	0.3	0.2	0.5	0.8	0.2	1.9	1.1	0.2	1.3	1.0	1.9	1.4	2.3	1.8	0.2	0.6	2.0	1.8	2.5	0.1	2.1	2.1	0.3	2.1	2.6	0.8	0.3	0.0	0.5	0.1	0.0	0.0	0.0	3.9	5.3	0.9	3.3	0.1	0.9	0.0	0.1	1.4	0.6	0.2	0.1	0.4	0.2	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	34.4	0.0	0.0	0.2	0.0	0.8	1.0	0.1	0.2	0.1	0.4	0.1	0.2	15.1	8.3	1.5	4.4	0.1	0.0	0.0	0.5	0.0	6.8	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.9	0.9	1.2	1.3	0.9	0.8	0.3	1.3	0.2	0.2	2.5	0.8	2.0	0.0	0.0	0.0	0.0	6.5	0.2	0.2	0.6	0.8	0.3	0.4	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.1	0.0	0.1	1.0	4.2	0.0	0.0	0.6	0.2	0.3	23.7	0.5	0.2	0.0	0.2	1.1	0.0	1.1	0.0	6.2	0.1	0.0	0.0	6.2	0.4	23.3	0.5	5.4	1.0	0.6	0.1	0.0	1.0	0.3	0.1	0.1	29.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	16.9	22.8	0.1	0.5	0.6	3.8	0.8	0.3	2.1	0.1	0.3
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589667-47594411	"Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.0;pituitary gland: 17.1"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0"	"Group enriched"	"Detected in some"	4	"glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"REH: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041032	Approved		Uncertain	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus, Vesicles"		"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	1.7	1.5	7.9	0.0	33.0	1.1	2.2	13.2	17.6	5.3	0.0	3.9	0.1	5.8	0.0	0.5	4.2	0.0	1.0	7.5	1.1	1.4	0.9	0.7	0.0	6.0	4.9	12.0	0.4	0.7	17.1	0.0	2.1	2.8	0.0	0.1	1.1	0.1	0.9	1.8	1.5	0.1	1.0	1.0	1.5	5.8	6.7	0.0	1.5	0.0	0.0	1.3	2.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	33.0	13.2	17.6	7.5	1.1	6.0	4.9	2.1	1.0	6.7	3.4	2.4	0.0	0.0	18.9	0.0	2.4	6.5	0.2	0.0	15.8	1.3	25.8	0.7	1.5	0.3	3.7	16.7	1.3	0.1	0.2	3.9	0.1	11.3	0.8	21.2	4.5	0.0	2.5	15.5	0.2	2.7	20.7	0.5	0.6	0.0	31.3	2.5	0.2	3.3	5.0	17.8	0.1	0.0	0.3	3.0	51.7	46.0	0.7	10.6	4.7	0.0	54.5	0.0	5.0	8.0	0.1	0.1	38.4	0.0	4.3	0.1	0.6	0.6	24.7	26.3	12.8	8.5	13.5	44.5	0.3	1.8	3.6	0.6	39.0	0.2	2.4
C2orf50	FLJ25143	ENSG00000150873	"Chromosome 2 open reading frame 50"	Q96LR7	2	11133128-11151317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.7;fallopian tube: 7.4"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 8.4;Endometrial ciliated cells: 21.5;Excitatory neurons: 9.7;Respiratory ciliated cells: 27.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.0"									"HPA062894, HPA067681"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	Cytosol	"HPA062894: AB_2684897, HPA067681: "	"unprognostic (6.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.92e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.97e-4)"	"unprognostic (7.03e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.25e-3)"	"unprognostic (7.36e-2)"	0.1	0.2	1.5	0.2	1.8	0.5	0.2	0.4	1.6	0.4	5.7	0.1	0.3	0.3	0.2	0.1	7.4	0.1	0.0	1.3	1.4	0.2	0.1	0.6	0.3	1.8	1.9	0.3	0.2	0.1	0.7	0.1	0.5	0.2	0.2	1.5	0.3	0.1	0.2	0.4	0.1	0.1	1.0	0.3	0.2	0.3	1.0	0.2	0.2	0.0	0.1	0.1	0.0	1.0	0.1	0.5	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.0	0.2	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.0	0.7	0.1	0.3	0.2	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.7	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.1	0.6	0.2	0.2	0.2	0.1	0.1	1.5	1.8	0.4	1.6	1.3	1.4	1.8	1.9	0.5	1.0	1.0	1.0	0.0	0.0	1.8	0.7	0.5	0.0	0.5	0.5	0.0	0.4	0.4	0.5	0.4	0.0	3.5	0.0	8.4	0.0	0.1	0.0	0.0	0.3	0.2	21.5	0.4	0.0	0.0	0.0	9.7	0.2	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.0	2.5	0.4	0.2	0.0	1.5	0.0	0.1	0.0	0.2	27.1	3.0	0.0	1.0	0.5	0.5	1.4	0.0	0.0	0.0	0.3	0.9	0.0	0.1
C4orf33	FLJ33703	ENSG00000151470	"Chromosome 4 open reading frame 33"	Q8N1A6	4	129093317-129116640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA061199	Uncertain		Approved	"Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	"Nuclear bodies"	"HPA061199: AB_2684450"	"unprognostic (7.27e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.14e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.49e-5)"	7.8	10.3	4.6	6.4	5.2	16.1	9.5	11.6	5.6	5.5	3.9	20.5	17.0	4.8	9.4	9.1	8.4	9.2	5.8	4.7	5.4	14.2	9.9	8.4	6.5	6.3	6.5	11.1	9.4	6.0	12.2	9.4	7.0	4.6	16.7	13.4	6.7	4.1	2.6	6.8	15.1	5.7	6.2	7.9	16.2	5.6	5.5	8.9	12.0	2.7	5.8	9.9	5.8	7.0	7.7	4.3	9.7	9.8	7.8	7.5	15.7	7.2	10.0	8.4	10.8	2.2	36.1	6.4	17.8	10.4	13.0	4.8	11.2	11.5	6.8	38.3	8.6	15.7	11.4	3.0	9.5	7.8	16.0	7.6	10.2	10.0	4.0	15.5	6.9	22.9	20.5	26.9	8.6	3.1	12.7	6.2	0.5	16.2	5.4	5.3	10.3	8.3	23.7	8.7	12.4	2.8	5.5	13.1	8.7	2.2	12.2	5.9	5.0	7.4	2.7	5.5	5.8	14.4	6.8	11.3	15.4	20.4	6.4	18.7	11.7	30.3	3.3	11.6	2.5	5.6	2.6	4.0	11.8	2.7	2.7	4.3	5.7	9.3	12.3	6.4	4.8	4.9	4.6	5.2	11.6	5.6	4.7	5.4	6.3	6.5	7.0	6.2	5.5	7.0	10.7	6.4	14.1	11.8	9.2	10.5	7.4	22.9	10.8	15.1	13.4	8.3	4.2	18.6	16.3	12.9	8.4	21.5	19.8	24.7	50.9	10.4	6.9	34.8	7.4	7.9	4.9	8.2	12.8	9.3	18.9	8.3	18.8	17.5	14.5	5.9	8.6	5.2	14.2	1.7	11.2	14.7	22.4	18.1	16.7	3.0	2.1	18.6	12.4	10.3	13.3	11.8	7.2	12.1	21.5	8.1	17.9	2.2	9.6	2.7	25.6	30.9	36.9	11.5	0.0	5.0	12.9	4.6	5.4	13.5	9.2	18.9	12.2	15.5	16.4	8.9
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101119-42142620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 157.0;skin 1: 73.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	3.7	1.0	0.4	2.2	0.4	1.0	8.7	0.6	0.7	31.7	0.3	14.1	33.4	1.0	0.1	157.0	5.8	6.6	1.8	0.4	0.1	14.9	0.5	5.8	0.3	0.4	0.1	0.2	18.0	2.5	1.7	1.5	0.4	12.1	11.7	0.9	47.1	2.3	0.9	73.6	20.7	0.5	0.0	0.1	36.2	0.7	0.3	0.7	10.7	0.3	13.9	9.9	54.9	0.6	57.8	0.5	0.0	0.1	0.3	6.1	29.0	2.9	4.4	7.6	7.6	52.0	44.0	0.0	5.4	5.4	0.1	37.5	0.1	17.3	5.2	5.1	7.2	2.8	5.0	12.1	2.0	0.0	0.2	4.0	30.4	5.9	8.8	3.1	0.0	0.3	1.7	0.5	1.7	20.4	0.4	0.3	3.6	181.7	1.5	0.1	0.0	0.3	6.2	25.5	3.0	0.1	4.7	35.2	0.1	4.1	25.2	0.3	0.8	0.4	3.5	13.5	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.4	0.4	0.6	0.7	0.4	0.1	0.4	0.1	0.4	0.0	0.3	0.6	0.8	44.8	16.6	0.3	0.2	52.5	88.6	31.8	19.4	0.8	41.7	19.8	5.1	45.8	63.1	51.5	20.9	12.4	1.2	89.9	0.0	57.9	22.2	91.9	9.4	2.8	7.3	0.0	0.5	134.7	1.0	9.2	57.1	135.8	1.3	18.3	1.4	0.0	0.8	5.0	0.5	41.3	38.7	1.2	6.8	163.8	0.6	1.5	12.4	0.0	3.8	0.5	4.1	0.5	0.2	219.9	66.8	1.5	0.3	144.6	102.7	7.7	92.1	7.9	0.0	7.9	4.9	4.9	9.1	81.4	82.0	4.1	1.5	45.4	43.7	226.0
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.9;U-937: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (1.77e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.12e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	10.1	3.9	67.9	2.8	69.9	1.3	9.0	56.8	84.2	33.7	44.1	18.1	4.1	31.1	8.5	21.5	19.6	7.2	8.4	72.6	56.7	12.4	1.9	11.8	1.8	50.2	56.2	43.7	4.5	5.1	12.3	5.8	53.4	13.7	8.2	4.7	13.0	9.1	2.8	11.5	10.8	23.1	49.9	6.1	9.2	8.6	59.6	7.6	9.6	5.9	4.1	14.5	20.2	58.7	17.3	13.2	21.1	46.1	26.8	18.0	12.9	16.8	39.4	25.6	14.5	4.5	13.4	2.2	21.5	30.7	4.4	17.2	21.6	19.5	10.1	18.4	5.9	8.5	11.7	0.6	11.0	1.7	9.1	11.7	10.6	10.2	5.5	75.9	31.1	18.6	1.2	7.2	16.9	42.6	22.1	2.2	13.3	18.1	10.9	24.0	5.0	6.6	19.9	31.6	32.9	31.8	5.5	37.1	12.0	18.6	25.2	7.7	27.3	15.5	21.7	7.7	9.5	7.1	3.5	0.7	12.9	109.9	5.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.6	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.2	67.9	69.9	56.8	84.2	72.6	56.7	50.2	56.2	53.4	49.9	59.6	58.7	5.6	3.2	4.3	1.0	0.5	2.9	3.2	5.9	4.0	3.2	8.7	5.7	2.8	1.5	5.1	1.8	4.2	0.8	2.1	12.6	1.9	9.5	1.0	10.0	22.0	5.9	10.2	0.8	15.1	4.3	10.4	7.9	6.1	7.1	1.3	12.0	3.6	0.2	1.6	0.0	4.5	9.5	16.2	0.6	2.9	2.7	13.4	2.4	1.8	3.7	3.7	1.0	2.1	2.0	1.1	10.4	4.6	10.9	1.3	2.9	8.7	0.7	9.4	1.0	0.0	1.5	12.2	1.6	8.1	9.6	5.1	1.1	3.5	6.1	14.4	1.9
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.2;stomach 1: 60.3"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 25.6;Gastric mucus-secreting cells: 93.8;Intestinal goblet cells: 71.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 10.7;SCLC-21H: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483, HPA062050"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Golgi apparatus"	"CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: "	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.0	0.6	1.4	0.9	2.2	0.0	0.4	1.3	1.2	0.4	0.0	13.7	6.6	0.2	0.5	0.2	2.5	0.6	0.4	1.1	1.4	0.0	0.0	7.5	0.0	2.1	1.7	0.6	0.2	1.0	0.0	0.0	1.8	0.6	22.2	5.0	11.3	0.1	0.2	0.1	11.7	0.5	1.9	0.0	60.3	0.2	1.7	0.1	0.1	0.1	0.0	2.0	0.1	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.5	10.7	0.0	0.4	0.0	0.0	0.0	0.1	14.7	0.0	0.0	0.4	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.3	1.2	1.1	1.4	2.1	1.7	1.8	1.9	1.7	3.4	0.0	25.6	3.0	0.3	0.1	0.0	0.6	0.7	0.0	0.0	0.6	0.3	6.0	0.0	3.2	0.0	0.0	0.1	0.0	4.1	0.0	0.2	5.2	1.5	0.1	0.1	3.0	0.0	0.4	0.2	0.0	0.4	93.8	0.5	2.5	0.1	0.0	0.0	0.1	0.0	0.4	71.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.6	1.7	5.0	0.0	0.2	0.5	3.3	0.1	8.2	1.7	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.1	1.5
CASP10	"FLICE-2, MCH4"	ENSG00000003400	"Caspase 10"	Q92851	2	201182898-201229406	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.3;NK-cells: 44.3;Paneth cells: 44.5;Plasma cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.3"					"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	8.8	2.4	5.7	9.2	5.5	19.5	6.5	4.5	5.8	4.0	4.4	13.2	21.8	3.3	6.2	8.8	5.4	7.4	6.7	4.7	5.1	8.1	6.2	11.5	8.9	6.0	5.0	1.6	4.8	2.3	1.3	9.6	5.8	3.9	13.4	1.3	5.4	3.1	4.9	5.7	18.4	5.1	5.6	22.6	10.2	1.2	7.3	8.7	5.3	2.8	10.4	9.0	5.1	5.4	4.4	3.5	0.3	0.4	0.1	0.3	7.5	0.7	4.6	0.4	1.8	4.6	9.8	0.5	7.0	2.5	1.7	2.9	0.2	2.3	1.3	2.1	4.8	12.2	4.0	15.1	1.6	8.3	12.7	0.5	2.0	5.3	0.4	0.3	25.3	5.1	14.9	17.4	0.4	0.3	15.9	7.8	0.6	6.0	2.4	8.8	0.5	18.4	8.7	6.2	0.2	0.1	4.1	0.2	1.9	3.0	0.2	7.8	10.0	0.4	0.8	3.4	0.2	18.7	12.1	0.5	4.5	6.3	0.2	5.9	11.7	0.7	6.4	16.5	5.6	8.2	5.2	3.6	6.5	7.7	7.2	6.4	2.1	8.5	19.3	6.6	1.2	7.2	5.7	5.5	4.5	5.8	4.7	5.1	6.0	5.0	5.8	5.6	7.3	5.4	20.7	19.2	10.0	0.3	15.8	6.0	2.7	10.6	5.2	0.0	1.3	0.9	1.8	8.6	9.4	9.2	0.0	1.1	20.5	71.3	1.9	16.2	1.2	7.7	7.4	29.7	2.4	14.9	0.3	10.4	0.7	4.2	26.5	12.0	7.6	0.8	26.4	7.1	9.4	0.0	0.5	21.6	4.1	26.6	17.5	0.0	0.6	16.2	7.2	33.7	22.0	0.5	44.3	0.0	0.9	8.6	44.5	0.0	49.7	2.5	26.1	8.7	24.4	0.4	0.0	2.9	2.2	0.1	0.1	6.6	4.5	0.4	12.9	4.1	16.4	10.3
CCAR1	"CARP-1, CARP1, FLJ10590"	ENSG00000060339	"Cell division cycle and apoptosis regulator 1"	Q8IX12	10	68721012-68792377	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Transcription, Transcription regulation"	"Activator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007856, HPA048513"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA007856: AB_1078415, HPA048513: AB_2680424"	"unprognostic (1.71e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (4.05e-5)"	"unprognostic (2.89e-2)"	"unprognostic (3.21e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-2)"	17.4	21.4	14.4	20.2	16.0	23.4	17.2	21.1	25.4	15.9	15.2	17.9	16.8	16.7	16.1	20.1	14.5	16.5	15.6	13.6	17.0	18.4	19.1	15.9	30.3	16.9	14.9	19.9	20.4	15.9	14.5	21.7	16.4	17.3	22.2	20.9	18.5	13.5	20.6	23.9	19.4	16.0	13.2	21.5	17.8	14.3	16.8	29.8	18.2	17.9	28.7	21.7	17.0	19.2	64.0	64.8	73.9	49.7	31.4	30.3	57.7	56.0	47.4	59.3	40.0	87.2	50.8	74.7	29.9	39.1	29.8	49.3	78.4	44.3	64.8	51.5	48.2	60.1	46.1	54.5	35.7	96.2	67.5	30.5	54.2	50.1	61.7	36.7	48.5	37.5	83.5	46.8	58.8	46.5	64.2	60.7	74.1	49.7	58.4	74.2	44.1	44.7	52.5	48.6	42.7	36.9	55.1	89.1	57.1	57.6	60.6	58.9	48.1	36.8	46.3	40.1	61.4	32.2	45.5	78.5	30.8	63.8	35.6	6.1	14.6	14.3	16.3	13.0	14.6	14.2	11.3	15.8	21.0	17.3	13.5	14.3	3.3	10.6	15.5	13.1	18.4	11.3	14.4	16.0	21.1	25.4	13.6	17.0	16.9	14.9	16.4	13.2	16.8	19.2	50.5	35.3	85.5	61.4	69.2	37.0	49.6	54.7	66.0	51.0	36.1	40.0	65.5	41.5	49.0	46.0	58.4	73.1	62.9	44.1	23.5	68.0	28.8	55.2	68.5	54.0	46.1	61.2	49.7	78.1	83.8	49.2	45.3	62.2	67.2	76.8	39.3	40.4	49.2	55.5	51.2	55.1	30.5	47.4	36.3	14.5	53.7	49.8	21.4	41.2	65.4	36.5	66.9	47.7	66.1	77.7	34.2	50.4	61.0	45.3	36.0	18.3	49.1	68.7	65.7	53.2	62.3	128.7	77.2	50.4	37.4	109.5	61.3	83.2	67.2	49.4
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pancreas: 30.7;testis: 100.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0"					"Low region specificity"	"Detected in many"			HPA078808			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA078808: "	"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.6	1.0	1.8	1.0	3.4	0.0	3.6	2.6	2.1	2.6	1.6	1.8	0.9	1.4	5.1	1.8	2.9	1.2	1.1	1.2	1.2	2.5	0.8	0.9	1.2	2.0	1.6	4.5	30.7	2.0	2.9	0.8	2.4	2.2	1.9	7.9	6.2	2.0	2.1	1.1	0.8	1.4	0.8	0.6	2.5	100.0	1.7	0.4	7.7	0.9	0.7	1.3	0.5	0.9	0.4	0.0	0.2	0.1	2.2	2.4	0.1	0.0	0.0	0.0	0.2	0.0	1.7	2.7	0.3	0.0	2.3	0.3	1.7	0.0	0.2	1.0	1.7	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.0	1.0	0.0	1.4	0.8	0.7	0.2	0.2	2.9	0.7	0.0	0.0	0.2	0.3	1.3	0.1	0.0	0.4	0.6	0.0	8.4	1.5	0.0	0.9	0.7	0.4	3.8	0.0	0.5	0.3	0.7	0.1	0.1	5.3	8.8	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	2.6	2.1	1.2	1.2	2.0	1.6	2.4	0.8	1.7	0.9	0.4	0.0	0.0	0.7	0.9	0.3	0.4	0.3	1.8	0.5	2.9	4.7	4.2	0.0	0.0	1.8	0.0	0.1	0.0	0.3	1.9	2.6	796.2	1.8	0.2	1.2	0.0	0.0	3.5	3.5	0.1	2.1	0.5	1.0	0.0	0.2	2.2	0.5	0.1	0.0	1.3	1.1	4.1	0.0	0.3	175.5	7.2	0.9	3.6	1.9	0.1	3.1	1.0	0.5	1.8	2.2	0.3	6.0	9.3	0.4	0.0	2.3	4.4	5.3	0.0	1.7	2.5	552.8	6.1	1.5	0.4	0.0	0.3	0.7	1.1	0.1
CCDC154	"C16orf29, LOC645811"	ENSG00000197599	"Coiled-coil domain containing 154"		16	1434383-1444556	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 11.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 51.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.5;NB-4: 4.7;SCLC-21H: 33.2;U-266/70: 5.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"HPA041158, HPA043535, HPA048237"	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"	"Golgi apparatus"	"HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323"	"unprognostic (2.40e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.35e-2)"	"unprognostic (8.02e-6)"	"unprognostic (9.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.35e-5)"	0.6	0.8	1.5	0.9	1.7	1.0	0.8	1.7	2.2	1.9	0.5	1.2	1.4	1.0	0.3	0.4	1.9	0.5	0.7	1.4	1.3	2.3	0.7	0.8	1.4	1.8	1.4	1.5	1.2	0.1	3.8	0.4	1.6	1.5	0.1	0.8	0.7	0.4	0.8	1.5	1.2	0.2	0.9	2.2	2.0	11.6	1.5	0.4	2.8	0.1	0.4	0.8	0.9	2.4	9.5	0.4	0.3	0.6	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.4	0.3	0.1	0.5	0.1	0.3	0.1	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.7	0.0	4.7	0.2	0.0	0.1	2.8	0.1	0.2	0.0	0.2	33.2	0.5	0.1	0.2	1.4	0.1	1.0	2.4	0.0	0.4	0.1	0.4	0.0	5.8	1.6	0.1	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.7	2.2	1.4	1.3	1.8	1.4	1.6	0.9	1.5	2.4	0.2	0.0	0.0	9.8	1.4	0.0	0.5	0.2	0.0	3.2	0.5	0.6	0.6	1.5	0.1	3.7	8.4	0.0	0.4	0.1	0.0	0.1	51.6	0.3	0.3	0.1	0.0	0.0	3.9	0.4	0.0	0.3	1.1	0.3	1.3	1.5	0.4	0.2	0.8	6.7	4.8	0.5	0.0	0.3	0.8	11.1	1.5	0.6	1.8	7.5	0.8	2.4	0.0	2.0	3.8	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.8	4.2	0.0	0.3	0.6	10.1	1.2	0.0	0.4	0.0	0.7	0.4	0.0	0.2
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494017-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"fallopian tube: 33.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 236.6;Late spermatids: 82.6;Respiratory ciliated cells: 379.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 10.4;T-47d: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	4.2	1.5	1.3	1.4	0.1	3.7	0.9	0.7	3.0	8.0	0.7	2.5	3.6	0.4	0.4	33.4	1.3	0.8	1.3	1.8	0.8	1.3	4.1	1.4	3.6	4.9	5.6	0.1	0.1	0.2	1.4	3.1	0.4	0.6	0.2	0.2	0.4	0.3	0.2	1.1	0.9	3.2	2.2	1.7	2.7	1.7	0.3	5.6	0.1	0.6	1.1	0.5	2.8	0.0	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	5.9	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	6.2	0.0	2.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.1	2.8	0.1	0.0	0.6	1.5	1.4	0.9	0.7	1.3	1.8	3.6	4.9	3.1	3.2	1.7	2.8	1.2	3.2	1.5	7.5	0.4	0.6	0.3	6.5	1.2	0.3	27.3	8.9	0.7	0.0	39.5	0.0	22.9	0.1	0.4	1.1	0.0	0.3	53.0	236.6	23.6	1.2	0.0	0.0	5.5	1.1	0.4	5.2	3.1	14.1	3.8	3.5	1.1	1.5	11.9	0.0	5.9	0.0	12.2	17.5	11.3	82.6	7.2	16.8	0.0	0.0	11.0	2.5	0.0	3.0	0.8	2.7	5.8	0.0	0.1	0.9	0.5	5.8	379.4	1.0	0.0	0.4	6.5	19.1	1.1	0.2	1.0	0.0	1.2	14.0	0.3	0.5
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.8;placenta: 32.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"		No	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA040865: AB_2677176, HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.5	3.8	1.6	4.1	1.5	0.4	3.4	1.4	2.7	4.2	2.3	18.9	20.2	3.3	0.8	1.8	2.4	5.1	5.7	1.5	3.6	2.8	9.5	13.0	0.8	2.0	2.3	15.7	2.8	0.8	3.6	32.4	2.0	4.2	18.2	0.6	1.8	1.3	1.5	0.9	24.8	2.7	1.2	7.2	14.3	8.8	3.3	0.6	2.6	4.4	1.3	2.3	1.8	1.3	10.8	3.3	0.0	0.0	3.0	8.3	0.0	0.3	4.2	0.6	0.7	5.9	6.2	0.0	7.6	0.0	0.1	0.1	0.7	6.8	0.5	0.0	1.6	0.8	3.6	1.2	13.6	0.0	0.0	14.9	0.0	3.2	0.1	0.0	4.9	0.0	0.0	0.1	0.4	0.8	0.0	0.2	0.0	7.6	3.6	0.3	0.0	0.3	1.2	10.5	0.1	2.5	3.3	1.0	0.1	1.2	0.0	0.0	28.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.6	1.5	1.4	2.7	1.5	3.6	2.0	2.3	2.0	1.2	3.3	1.3	38.5	19.2	10.3	0.3	1.0	0.3	7.4	4.8	1.2	0.1	2.0	1.9	5.5	10.0	13.3	1.8	0.0	2.3	0.3	95.2	1.9	7.2	95.4	15.0	2.5	40.8	6.0	3.6	5.7	35.6	2.7	9.6	38.2	27.1	8.8	2.6	37.5	7.0	0.4	0.0	0.5	21.8	8.2	3.2	1.3	36.7	3.4	0.6	0.0	12.2	1.0	3.3	1.0	0.0	0.1	87.9	68.7	0.7	0.0	32.4	61.1	5.3	4.2	0.2	6.6	0.9	3.0	1.2	2.2	1.1	0.0	6.0	0.4	3.8	20.2	6.4
CCDC91	"DKFZp779L1558, FLJ11088, p56"	ENSG00000123106	"Coiled-coil domain containing 91"	Q7Z6B0	12	28133249-28581511	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	18	"Early spermatids: 2093.1;Late spermatids: 7910.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038169	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038169: AB_10672506"	"unprognostic (6.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.98e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-1)"	17.5	18.3	15.0	13.0	15.8	12.3	16.1	23.2	29.3	11.5	3.5	14.4	12.1	17.8	17.3	14.3	12.3	14.6	30.9	16.6	12.3	20.2	14.3	12.0	16.4	20.7	13.8	17.7	27.1	30.8	12.1	8.5	20.7	15.1	12.6	27.1	13.6	14.0	41.6	10.2	13.1	13.0	11.1	13.6	17.1	34.5	14.6	21.7	24.6	21.7	13.7	16.6	10.5	20.7	21.2	14.8	13.4	0.4	13.6	12.6	25.1	17.5	18.5	15.1	19.3	8.4	27.6	11.0	14.7	20.9	9.0	23.7	12.3	28.2	22.6	29.7	10.2	36.2	29.4	7.7	21.3	35.0	17.1	12.5	27.6	15.0	43.7	28.5	12.3	19.2	33.4	36.0	14.6	7.6	34.8	29.7	27.5	16.2	13.5	21.1	38.7	18.3	24.6	14.3	11.3	20.4	32.7	10.9	55.4	36.4	21.3	27.3	9.3	31.8	22.1	31.5	10.3	44.4	52.5	30.1	27.6	28.0	18.4	21.8	2.3	3.6	5.1	4.5	6.7	6.7	6.5	7.4	3.4	5.2	7.6	7.0	0.7	7.1	5.9	4.1	8.4	3.4	15.0	15.8	23.2	29.3	16.6	12.3	20.7	13.8	20.7	11.1	14.6	20.7	23.4	38.5	41.0	129.3	47.2	34.9	37.4	49.5	34.7	61.5	42.1	36.8	80.8	20.0	40.8	22.0	45.9	14.0	48.4	26.0	43.0	46.2	2093.1	36.9	19.0	19.7	38.4	19.1	199.3	47.3	16.3	24.8	21.4	26.2	40.4	21.9	11.7	26.7	30.6	45.4	266.0	23.9	28.5	35.0	39.3	7910.6	57.8	39.0	37.4	135.9	35.7	52.0	53.5	152.8	221.0	33.8	25.0	51.9	34.2	33.6	25.5	35.0	54.5	74.9	39.5	28.6	31.7	72.0	39.0	19.9	40.5	16.0	50.6	28.5	18.3	33.6
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36001553	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 83.0;liver: 31.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 35.4;OE19: 28.7"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	3270000	11000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.2	0.4	0.1	7.8	0.1	0.1	0.4	0.1	0.3	0.3	0.0	59.7	37.6	0.1	0.0	0.2	9.6	9.2	0.0	0.1	0.1	10.0	31.6	2.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	83.0	0.0	0.1	0.1	0.0	0.1	62.0	1.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	4.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	7.2	5.0	0.0	0.0	0.0	0.0	262.6	0.0	0.0	0.0	12.2	0.1	0.7	71.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	8.9	0.0	2.5	40.2	0.1	0.0	0.0	208.3	2.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	380.6	0.0	0.0	0.0	461.4	61.3	76.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	138.2	0.2
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 756.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 7.5;eosinophil: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.0;monocytes: 7.5"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 1902.2;HMC-1: 2427.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 9.9;spinal cord: 39.4"	"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	323000		"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	390.9	129.8	15.6	167.2	15.1	96.5	76.8	14.7	26.8	20.4	24.4	169.5	41.2	30.2	15.0	47.1	85.6	256.5	305.8	16.0	21.1	229.5	161.1	405.1	78.4	32.7	16.5	19.3	141.6	34.6	70.5	39.1	21.9	153.1	103.5	11.5	47.0	45.4	19.6	40.3	80.3	150.7	21.4	73.2	121.2	12.1	43.3	142.7	84.4	47.0	16.6	756.1	36.3	25.3	0.1	15.3	40.4	0.0	110.7	94.5	0.3	116.6	1902.2	243.3	516.8	7.1	0.2	0.3	90.4	27.6	3.8	64.0	4.3	0.1	122.9	0.6	0.9	0.2	13.5	0.0	3.5	0.4	2427.9	105.9	0.0	50.6	2.9	162.6	112.4	0.0	6.5	20.2	0.0	0.0	0.7	19.6	5.8	0.0	0.4	0.6	3.3	20.9	354.7	0.0	0.1	8.1	0.3	6.0	3.3	108.4	4.6	2.5	6.4	129.0	5.7	3.6	0.7	1.2	0.5	0.1	75.7	37.6	84.3	0.0	7.5	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.6	15.6	15.1	14.7	26.8	16.0	21.1	32.7	16.5	21.9	21.4	43.3	25.3	218.3	182.7	126.5	2.0	3.6	568.6	866.2	595.3	1152.5	0.1	23.5	50.9	29.5	92.9	120.7	138.0	0.0	2.7	2.2	0.0	0.0	3382.2	0.0	8.4	37.8	577.2	0.0	0.0	0.7	919.2	3.6	840.5	5.6	11.4	353.0	0.1	50.3	0.4	439.1	0.0	0.1	0.0	6.1	8.9	408.5	0.4	12.2	593.1	213.5	8.4	37.8	13.8	0.0	0.0	0.1	781.2	0.0	1.5	2.9	889.0	0.0	67.7	27.7	0.7	131.5	994.7	1507.0	0.4	0.3	13.0	222.8	4.5	44.3	1.7	0.1	40.6
CCN2	"CTGF, IGFBP8"	ENSG00000118523	"Cellular communication network factor 2"	P29279	6	131948176-131951372	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	81	"B-cells: 8.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	265.9	107.5	18.9	168.0	18.8	2.0	206.4	16.3	34.0	531.0	31.5	148.8	43.7	418.5	34.4	271.9	243.8	441.4	371.8	25.8	14.2	235.7	82.9	226.3	73.6	18.8	32.1	77.0	194.0	43.0	44.8	198.2	20.2	364.6	136.1	2.4	138.2	154.3	51.8	155.1	151.2	576.3	14.2	569.1	182.6	24.7	20.8	49.5	464.7	61.9	14.9	324.0	102.5	18.2	4.6	7.5	126.8	3.7	279.9	158.5	1.8	373.1	178.2	226.8	119.4	0.2	12.2	0.6	1605.0	482.7	185.0	6.2	4.2	26.4	211.3	2.5	3.5	0.2	55.7	137.3	109.6	0.3	0.5	232.2	5.9	163.9	40.2	340.7	1377.0	0.0	0.4	0.3	650.8	2.5	0.5	1.2	61.8	41.3	21.7	32.6	6.0	0.7	81.9	0.4	0.5	0.8	38.3	62.2	18.3	308.5	6.1	3.1	2874.4	311.6	242.4	397.8	694.0	11.5	1.7	4.1	42.5	0.7	399.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.9	18.8	16.3	34.0	25.8	14.2	18.8	32.1	20.2	14.2	20.8	18.2	101.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	17.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	47.1	261.8	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCNJ	"bA690P14.1, FLJ10895"	ENSG00000107443	"Cyclin J"	Q5T5M9	10	96043394-96060870	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 42.1;AN3-CA: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036531, HPA058151"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA036531: AB_10696656, HPA058151: AB_2683623"	"unprognostic (1.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	3.6	4.5	1.9	4.2	2.4	11.5	3.9	2.9	2.1	3.3	1.7	3.3	4.4	4.3	3.1	2.7	2.8	3.8	2.2	1.7	2.5	2.6	2.5	3.1	4.9	2.5	2.2	2.8	4.3	5.0	2.1	3.5	2.4	3.3	3.6	4.0	2.7	3.1	3.8	2.9	3.6	3.4	2.1	5.0	2.8	4.2	2.4	4.0	3.2	4.0	3.9	4.4	1.8	2.6	9.0	6.6	42.1	42.2	4.2	3.1	6.1	5.6	5.9	7.7	6.9	17.2	3.7	12.3	6.4	5.4	6.5	5.2	27.4	5.9	10.0	6.1	11.8	12.0	5.2	26.0	9.7	12.0	5.4	5.7	8.2	7.5	17.3	7.6	18.8	11.0	17.6	0.2	4.9	8.6	20.9	14.8	23.6	0.8	6.0	24.3	2.0	0.9	9.4	8.1	6.4	22.2	6.2	1.8	12.6	14.1	10.1	13.7	9.1	4.8	11.1	5.6	13.1	2.5	1.0	11.5	5.8	20.5	3.3	0.1	1.7	0.5	0.9	1.4	1.2	0.7	0.8	0.4	2.9	0.7	1.1	1.1	0.1	0.4	1.3	0.6	0.7	0.9	1.9	2.4	2.9	2.1	1.7	2.5	2.5	2.2	2.4	2.1	2.4	2.6	2.6	6.4	3.1	2.3	3.3	1.9	3.1	1.3	2.8	5.1	3.1	2.0	4.0	1.5	2.4	5.5	14.6	1.5	2.1	3.4	3.9	2.9	3.7	2.6	4.8	4.8	4.2	4.2	4.2	2.7	3.0	3.2	2.0	2.5	0.0	4.6	10.4	1.4	3.6	1.7	5.8	3.5	2.0	6.5	4.6	7.6	1.8	5.0	1.8	1.9	2.8	3.1	1.0	5.5	3.7	4.0	1.5	1.9	1.9	4.0	1.4	2.1	4.3	3.2	0.0	4.1	4.0	10.1	6.9	2.3	1.4	1.1	2.2	3.1	3.2	2.9
CCPG1	"CPR8, KIAA1254"	ENSG00000260916	"Cell cycle progression 1"	Q9ULG6	15	55340032-55408510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 279.2;neutrophil: 296.6"	"Group enriched"	"Detected in all"	7	"granulocytes: 296.6;monocytes: 84.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009432, HPA026861"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA009432: AB_2668242, HPA026861: AB_1846192"	"unprognostic (3.14e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (5.07e-4)"	"prognostic unfavorable (5.02e-5)"	"unprognostic (1.15e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.72e-2)"	38.9	37.8	24.0	23.7	27.7	63.8	34.1	23.1	28.4	61.1	36.8	33.3	24.3	26.7	36.1	20.1	22.0	53.8	56.2	24.7	26.9	51.5	66.9	39.3	22.2	18.4	17.3	22.9	84.8	73.3	32.3	27.4	17.7	41.0	33.2	48.2	77.1	42.3	53.0	13.5	25.6	33.5	17.2	28.7	47.5	29.6	27.3	12.2	84.4	35.3	24.2	29.9	9.7	22.9	13.9	47.7	10.9	24.4	173.6	59.3	15.5	30.0	56.4	17.2	26.1	14.4	23.5	20.8	99.5	97.5	33.6	18.7	9.5	25.1	14.4	55.5	14.2	28.1	58.4	12.8	223.9	39.6	84.2	49.5	59.8	35.6	34.4	143.3	65.2	0.8	47.7	337.4	55.1	17.9	0.2	19.3	6.5	54.4	11.8	6.2	17.4	84.8	36.1	10.1	14.0	21.5	35.3	19.5	151.4	35.0	31.0	85.1	65.7	50.8	11.1	38.9	20.4	65.2	259.6	13.0	95.6	77.2	41.0	220.8	59.4	279.2	26.8	50.7	22.5	18.1	16.6	20.7	27.6	13.4	13.9	20.0	296.6	25.7	84.2	4.7	23.0	32.9	24.0	27.7	23.1	28.4	24.7	26.9	18.4	17.3	17.7	17.2	27.3	22.9	92.3	115.4	118.1	0.0	44.6	15.4	30.3	99.2	13.6	68.7	40.2	40.1	14.4	50.1	136.5	88.3	93.8	29.3	42.9	43.7	5.9	60.9	136.2	49.6	41.0	60.1	16.7	25.2	0.0	145.3	23.2	78.6	33.1	62.3	39.1	30.0	76.1	96.1	51.0	85.8	0.0	28.8	114.0	55.9	25.2	216.1	56.5	71.7	48.0	0.0	89.8	72.6	38.1	0.0	0.0	67.6	45.1	116.6	180.8	42.6	29.5	36.7	123.8	128.0	52.6	80.2	48.1	43.3	41.1	11.8	16.6	24.6	41.8	70.0	16.2	21.8
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	69	"lymphoid tissue: 962.6"	"Cell type enriched"	"Detected in some"	13	"Langerhans cells: 549.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	14	"myeloid DC: 62.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 62.5"	"Cell line enriched"	"Detected in some"	43	"MOLT-4: 1276.2"					"Not detected"	"Not detected"			"HPA057769, HPA070634"	Uncertain		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoli	"HPA057769: AB_2683522, HPA070634: "	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	0.7	0.5	0.0	4.4	0.0	0.0	1.8	0.0	0.0	2.1	0.0	2.1	2.2	1.1	0.4	7.9	0.9	4.8	1.0	0.0	0.0	0.8	1.5	3.1	6.4	0.0	0.0	0.6	0.3	0.5	0.1	0.0	0.0	1.1	5.6	0.0	1.5	0.6	0.4	13.9	2.8	0.9	0.0	5.1	4.7	0.5	0.0	962.6	0.8	0.2	9.9	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.1	0.0	0.0	0.5	1276.2	0.0	0.3	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	2.5	0.2	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	0.8	8.4	0.0	0.0	0.6	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.8	549.5	0.0	0.0	41.7	8.8	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	7.1	0.1	0.7	0.0	0.0	0.0
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	16.6	7.0	7.5	100.2	7.4	155.2	6.5	9.4	13.7	4.2	5.9	13.9	8.2	3.7	0.7	7.3	5.8	13.9	5.2	6.3	11.4	7.6	6.4	46.9	215.0	17.0	12.0	1.7	3.2	1.8	3.4	15.1	16.5	6.9	3.8	0.3	11.5	2.8	1.9	4.1	116.3	3.9	16.7	235.7	14.8	7.4	15.6	57.5	8.3	2.4	88.0	19.1	5.2	28.7	0.2	0.6	1.5	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	306.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	49.5	0.2	53.1	0.0	0.5	0.0	9.4	290.0	0.0	0.0	0.0	0.0	0.2	0.0	18.5	2.6	16.3	0.0	0.0	0.4	5.8	0.2	0.0	0.0	2.9	0.3	110.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	109.0	0.8	0.3	1.0	0.2	0.0	0.3	0.1	69.4	0.2	81.4	0.1	550.2	658.2	829.6	353.2	601.6	357.4	1511.6	426.3	376.2	449.7	1722.2	435.3	368.6	903.8	321.8	747.8	586.3	467.1	816.2	7.5	7.4	9.4	13.7	6.3	11.4	17.0	12.0	16.5	16.7	15.6	28.7	7.1	9.6	14.3	0.3	1643.9	11.7	1.3	0.1	4.6	12.1	4.6	12.1	1.6	2.8	2.5	1.8	6.2	1.9	489.6	2.2	0.0	0.5	94.2	1.2	1.9	9.7	1.2	67.7	0.1	0.0	2.3	6.9	11.7	1.5	264.6	0.3	11.4	4.1	345.3	0.0	0.2	1.7	0.0	272.0	358.4	221.3	2.8	319.7	28.4	21.5	365.0	1.1	394.4	0.0	0.1	0.0	8.0	0.7	119.8	1.1	0.6	2.9	0.9	6.3	0.0	3.2	5.7	1.1	1.3	2.6	11.8	2.9	390.3	0.9	1.9	1.1
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 15.5"	"Cell type enriched"	"Detected in some"	8	"T-cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1"	"Lineage enriched"	"Detected in many"	39	"T-cells: 80.5"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 23.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA	776000	20000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	0.8	0.3	0.1	7.9	0.0	1.9	1.1	0.2	0.2	0.9	0.2	1.9	1.8	0.3	0.2	1.0	0.4	2.0	0.2	0.1	0.2	0.4	1.0	2.4	15.5	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.8	3.1	0.0	0.6	0.3	0.1	0.6	3.8	0.6	0.0	4.9	2.0	0.3	0.1	15.5	0.5	0.2	14.8	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.3	26.3	0.1	64.1	0.1	80.5	11.7	0.2	0.0	76.1	0.7	1.3	0.8	0.1	0.1	10.5	13.6	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.2	0.6	0.0	2.4	0.0	2.4	1.3	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.6	2.6	0.0	1.3	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.6	4.0	8.9	0.0	2.9	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.1	2.0	0.0	76.6	0.0	0.0	0.1
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736479	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 3747.5;U-2197: 3049.9"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		58000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	517.4	248.3	284.5	209.6	310.8	198.8	555.9	329.0	365.1	305.5	542.2	255.1	120.7	290.7	971.7	478.9	368.1	475.3	608.3	288.2	359.7	577.4	339.8	553.5	148.8	327.9	340.2	228.5	353.6	706.1	250.3	485.6	340.9	256.8	271.4	130.7	693.6	443.2	529.3	282.8	167.9	380.0	330.5	131.8	422.7	127.7	337.0	167.7	308.1	915.0	288.6	550.5	325.5	315.6	297.2	278.4	77.6	212.0	1697.1	1314.9	46.8	1765.7	1778.5	408.9	451.9	129.7	822.1	23.9	291.5	1802.5	475.5	314.0	141.0	1589.9	561.1	475.5	218.2	31.3	846.7	193.1	483.2	183.4	94.8	631.8	387.2	343.3	1550.6	1104.9	2475.5	109.3	207.9	585.9	2575.4	282.7	79.9	70.3	43.5	541.8	1421.8	30.1	232.1	227.8	1304.4	510.0	54.3	79.5	576.2	243.7	298.2	218.0	187.5	18.1	3747.5	838.6	235.5	3049.9	595.9	273.8	558.8	30.4	734.2	1.3	1556.9	164.9	22.3	209.6	50.9	7.9	64.8	63.9	104.9	56.6	95.4	59.6	68.2	41.4	134.3	92.5	4.8	49.9	298.2	53.5	284.5	310.8	329.0	365.1	288.2	359.7	327.9	340.2	340.9	330.5	337.0	315.6	728.0	272.4	247.2	32.3	39.1	286.0	1103.2	951.4	82.0	51.3	434.9	270.0	315.5	444.7	569.7	242.8	33.3	553.5	29.2	344.6	164.4	1445.2	129.4	94.3	91.6	792.6	166.6	206.0	25.1	618.3	407.2	303.5	109.6	115.6	139.4	88.2	585.0	185.7	486.7	47.1	29.9	112.8	722.2	139.4	374.2	61.6	237.3	88.2	1270.0	54.4	161.7	198.3	26.8	32.6	22.2	1195.7	392.2	204.7	149.7	1678.0	41.7	208.2	1042.5	56.2	276.1	159.1	410.7	130.6	31.2	83.7	284.4	836.6	52.4	139.5	104.9	1531.0
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579491-7582111	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 358.0;lymphoid tissue: 370.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 1378.6;monocytes: 3740.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 472.0;U-87 MG: 751.0"					"Low region specificity"	"Detected in all"			"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	139.6	78.3	10.4	236.1	9.8	266.2	72.6	11.2	33.4	77.8	14.6	88.8	279.5	26.7	9.0	126.4	43.1	161.1	38.9	8.2	26.7	50.6	156.7	358.0	217.3	45.5	31.2	19.4	22.1	14.2	8.9	173.1	36.0	13.1	91.9	4.8	52.6	19.8	23.0	24.8	240.2	79.0	16.1	370.7	87.5	15.2	58.5	44.2	22.7	21.3	84.2	149.3	50.6	31.6	243.4	48.6	3.2	3.5	472.0	177.6	2.1	75.6	203.9	97.8	113.4	10.1	71.3	2.9	84.2	220.8	174.6	10.6	1.2	47.6	65.9	2.2	9.0	38.8	13.2	59.0	42.0	19.2	207.8	57.1	9.8	205.4	150.4	162.6	26.3	4.3	15.7	24.2	95.5	2.2	1.7	17.2	2.8	63.1	36.0	3.3	4.5	144.4	20.9	10.9	1.6	3.0	63.2	31.3	72.1	2.2	1.6	146.1	82.4	123.7	8.0	125.7	100.1	1.4	2.1	1.9	751.0	46.4	64.0	243.5	3255.5	21.4	9.1	3655.9	11.1	80.2	4.1	6.2	817.3	59.0	5.8	5.1	219.4	18.7	3740.6	1378.6	6.5	3324.3	10.4	9.8	11.2	33.4	8.2	26.7	45.5	31.2	36.0	16.1	58.5	31.6	10.4	0.0	19.7	1.3	20.5	15.7	39.0	58.8	3.4	0.2	7.2	9.8	0.0	12.8	53.2	5.5	0.0	8.9	110.3	22.5	5.9	82.1	0.8	8.3	11.3	15.9	4.9	6.6	0.3	156.8	58.1	45.6	29.6	18.7	43.6	0.9	16.4	23.9	1820.4	0.0	0.4	15.8	16.2	701.2	341.5	2.1	6.5	791.2	39.2	5.6	179.2	0.3	7.2	0.0	0.1	121.0	86.1	1.9	8.5	33.3	335.3	50.2	20.6	1.0	26.3	8.7	11.7	0.5	1.2	12.4	14.3	33.4	10.8	0.5	28.9	99.9
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454, HPA073595"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Golgi apparatus"	"CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: "	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	10.2	19.9	14.7	34.9	13.9	209.6	7.0	16.1	17.9	26.2	23.0	5.2	4.6	7.3	4.0	4.5	5.1	17.0	4.8	15.6	19.2	18.7	14.9	39.9	51.3	20.2	16.6	16.5	4.2	6.6	7.2	9.2	21.0	8.3	9.2	5.0	19.5	13.8	1.3	5.0	11.5	6.9	16.7	20.1	5.7	5.2	21.0	38.0	5.3	2.9	70.2	15.5	15.4	21.6	18.1	0.8	12.7	17.7	18.2	4.2	0.4	5.1	17.6	8.3	14.4	1.3	11.6	79.1	14.6	1.3	16.8	2.0	4.8	5.5	27.0	71.9	7.6	10.6	21.4	2.1	0.6	15.8	16.5	4.8	2.3	8.0	2.6	2.5	0.2	26.4	2.4	0.0	0.8	6.5	12.6	29.7	5.3	3.2	3.7	12.1	28.1	10.9	6.0	17.2	2.8	5.2	1.0	0.6	13.5	7.3	3.0	12.3	0.4	12.8	8.1	1.9	12.0	0.7	0.2	121.5	2.8	21.6	19.7	0.0	3.1	2.0	4.4	19.0	4.8	19.7	4.0	3.7	9.0	31.0	2.8	3.3	2.2	5.0	29.3	3.2	6.2	4.4	14.7	13.9	16.1	17.9	15.6	19.2	20.2	16.6	21.0	16.7	21.0	21.6	41.3	19.2	77.9	5.2	668.5	49.5	16.0	10.0	41.5	4.2	26.5	46.4	30.9	2.8	8.2	11.0	6.2	1.5	100.4	5.4	3.9	0.9	0.9	29.0	24.1	39.1	24.0	3.0	5.6	1.6	2.4	31.1	11.2	74.8	238.8	8.1	2.9	1.1	145.6	1.7	6.1	7.3	4.1	83.0	1390.2	1.9	0.3	539.4	44.4	13.1	513.6	3.5	1.0	2.5	1.3	2.1	0.4	0.0	20.4	26.2	1.7	17.7	4.9	2.7	0.0	17.2	17.0	2.1	10.2	17.2	38.5	2.7	69.2	21.0	11.6	3.5
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.8	15.3	1.1	0.7	1.0	0.6	0.7	3.5	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.8	2.0	0.7	0.8	0.3	4.4	1.1	1.9	2.2	0.7	0.8	0.8	2.6	1.7	0.6	3.9	2.0	0.8	0.6	0.4	0.6	1.8	1.1	0.8	2.0	0.9	13.3	2.0	8.8	1.8	0.3	5.6	0.9	0.9	0.7	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.0	0.8	2.0	1.1	1.9	1.7	0.8	2.0	0.7	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171748-89195492	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 24.4;skeletal muscle: 57.0"	"Cell type enriched"	"Detected in some"	13	"Skeletal myocytes: 76.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	15	"cerebellum: 24.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 145.8"	"Region enriched"	"Detected in many"	7	"cerebellum: 15.7"	"Region enriched"	"Detected in some"	17	"cerebellum: 18.7"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		870000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.0	0.2	0.1	0.0	0.2	0.0	0.0	24.4	0.8	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	1.3	0.4	0.0	0.1	0.8	0.2	1.4	0.0	0.1	0.7	1.6	0.4	0.0	0.0	0.9	0.0	57.0	0.1	0.0	0.0	0.3	1.2	0.2	0.6	0.1	0.0	0.0	5.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.7	0.0	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	31.5	0.1	0.0	0.1	0.0	0.2	0.3	0.0	145.8	0.3	0.0	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	24.4	0.8	0.0	0.1	0.1	0.8	1.6	0.3	0.1	0.6	0.2	0.0	2.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.1	1.2	0.0	0.1	0.0	0.3	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.0	76.1	0.4	1.5	5.5	0.0	0.0	0.1	0.2	0.8	0.1	0.1
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 15.2;ovary: 6.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"	"Group enriched"	"Detected in some"	28	"basophil: 1.8;eosinophil: 3.7"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	0.7	0.3	0.0	0.2	0.0	0.0	0.8	2.4	0.4	0.8	0.0	0.5	0.3	0.6	15.2	0.6	0.5	1.9	0.2	0.5	0.0	0.3	0.0	1.0	0.1	0.4	0.1	6.1	0.1	0.2	0.3	0.0	0.4	0.7	0.7	0.0	0.3	0.3	0.9	0.6	0.8	0.4	0.1	0.0	0.7	1.9	0.1	0.2	0.1	0.7	0.1	0.8	0.5	0.3	0.3	0.0	0.0	0.0	1.6	2.8	0.0	5.9	22.6	10.2	20.7	0.0	3.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	30.9	0.0	0.1	1.9	0.0	0.0	0.3	0.1	58.4	3.4	0.0	2.7	1.5	0.4	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.3	0.1	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	40.3	0.3	0.1	3.6	1.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.5	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0
CERT1	"CERT, COL4A3BP, GPBP, STARD11"	ENSG00000113163	"Ceramide transporter 1"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 132.3;WM-115: 118.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	38.1	26.1	12.4	16.5	16.1	27.2	17.6	18.0	15.4	33.9	14.0	20.8	18.7	20.6	15.1	24.9	22.4	23.3	20.8	14.0	15.1	27.9	31.2	24.3	20.3	14.7	17.5	23.1	16.4	26.1	8.0	22.9	16.7	24.3	19.6	18.2	14.0	19.9	28.9	18.7	21.1	18.3	14.7	25.3	23.5	28.8	15.5	21.2	49.9	28.3	22.7	23.7	16.0	17.6	44.9	22.7	21.6	19.0	132.3	36.6	29.0	24.8	30.8	18.8	24.8	34.4	25.3	21.5	52.3	26.9	25.8	26.7	33.4	34.4	28.6	27.1	15.2	18.2	24.4	18.4	33.6	18.2	20.1	27.9	23.8	22.3	24.9	30.5	22.1	28.3	33.0	32.0	25.0	23.0	21.6	13.2	27.9	10.2	16.8	18.0	28.5	20.2	30.5	54.0	16.4	16.5	31.6	21.6	31.8	45.4	21.3	30.5	30.1	12.6	15.1	22.8	20.3	29.1	41.6	24.8	21.4	30.7	118.2	9.6	19.8	16.0	8.2	22.4	7.8	9.1	8.3	7.7	14.5	9.1	7.7	7.8	29.6	7.8	25.4	8.3	13.0	9.0	12.4	16.1	18.0	15.4	14.0	15.1	14.7	17.5	16.7	14.7	15.5	17.6	23.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	17.7	20.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	16.8	10.5	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	27.8	3.8	0.0	0.0	0.0
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	4.5	6.2	2.4	8.8	2.5	15.4	5.8	2.4	3.7	5.0	2.8	8.8	6.3	4.1	7.3	7.2	3.7	4.7	4.2	2.3	2.8	4.5	6.3	4.4	12.1	2.6	2.6	8.2	2.3	1.3	2.7	7.8	2.8	4.1	10.9	0.4	3.2	3.8	1.3	6.7	7.0	4.8	2.6	6.7	4.1	8.5	2.8	9.4	3.3	1.1	12.0	6.8	5.0	2.9	30.7	9.7	31.1	32.4	10.1	42.7	18.7	15.2	19.9	18.7	27.8	29.1	21.8	36.3	13.0	11.5	21.6	32.1	42.7	29.0	25.0	24.6	31.2	45.3	25.5	46.2	9.4	33.4	38.0	18.6	13.5	25.0	23.0	14.1	25.4	29.4	30.5	33.9	19.8	39.2	24.6	61.5	40.6	41.3	21.6	52.6	18.2	42.7	17.1	11.2	17.8	9.7	16.7	31.4	17.4	22.8	22.6	32.2	7.8	17.1	19.4	14.3	9.1	21.8	28.3	65.4	17.1	34.9	21.0	9.9	4.0	1.2	1.1	8.1	2.4	11.9	2.1	2.1	8.2	7.8	4.0	2.6	0.6	3.4	4.1	6.1	2.8	3.6	2.4	2.5	2.4	3.7	2.3	2.8	2.6	2.6	2.8	2.6	2.8	2.9	2.3	9.6	4.8	2.9	5.5	6.4	5.3	8.3	8.6	1.1	3.2	3.9	1.8	0.0	5.0	1.8	0.0	15.4	1.1	3.8	0.0	1.8	7.0	2.9	10.1	3.0	1.2	11.2	2.9	1.4	13.6	12.4	5.1	7.0	3.8	7.4	2.5	1.3	9.7	0.0	1.2	5.3	8.2	2.4	8.5	1.2	6.2	5.1	1.8	2.8	3.9	0.8	6.2	0.0	1.0	1.0	4.7	4.5	11.4	2.7	3.0	3.9	2.9	1.1	0.0	10.2	3.0	6.7	31.2	8.3	2.3	3.4	3.3	5.7	10.0	4.5
CHI3L1	"GP39, YK-40, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186704	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 232.4;brain: 239.4;liver: 447.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 88.7;Ductal cells: 88.9;Hepatocytes: 61.8;Hofbauer cells: 317.5"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	495	"neutrophil: 470.4"	"Lineage enriched"	"Detected in single"	495	"granulocytes: 470.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 322.9;ASC TERT1: 712.9;HSkMC: 637.0;THP-1: 1068.4;U-138 MG: 303.5;U-87 MG: 303.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	10	"olfactory bulb: 16.0"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	180000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	79.8	2.0	58.9	138.9	75.9	232.4	62.8	55.3	94.7	30.5	56.8	6.5	0.4	19.5	1.0	14.4	23.4	3.0	9.8	47.4	129.6	60.9	447.8	38.4	32.4	239.4	112.8	6.6	13.8	0.2	134.5	10.1	135.6	13.7	2.0	50.9	99.4	0.9	21.0	75.6	16.8	6.8	70.0	13.9	9.7	1.0	156.4	12.4	15.0	1.0	36.9	97.8	9.1	70.8	0.8	0.0	0.0	0.3	322.9	712.9	0.0	0.0	0.2	0.0	0.0	75.3	0.2	0.1	1.2	0.4	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	8.3	0.3	0.3	637.0	0.0	1.9	0.3	30.8	0.0	0.0	0.0	1.0	0.2	0.3	0.0	5.8	2.7	0.0	0.0	0.0	0.1	15.4	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.2	0.0	1068.4	0.0	303.5	1.6	0.0	0.4	2.3	41.9	0.3	303.7	1.2	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	470.4	0.0	0.9	0.0	0.0	1.3	58.9	75.9	55.3	94.7	47.4	129.6	239.4	112.8	135.6	70.0	156.4	70.8	0.7	6.4	42.8	20.5	0.1	4.2	47.1	88.7	0.0	0.1	29.8	21.5	1.0	2.8	17.3	27.6	0.0	1.3	0.6	0.0	0.0	88.9	0.0	4.8	2.2	2.1	0.0	0.4	1.1	0.0	1.1	18.6	0.0	7.2	0.0	0.0	0.0	61.8	317.5	0.0	0.1	0.0	6.1	0.8	0.4	0.0	0.9	23.7	14.2	0.0	1.0	45.1	0.0	0.0	0.1	2.0	0.0	0.0	1.4	4.2	0.0	0.2	3.4	2.8	0.0	1.0	2.3	0.0	0.0	1.5	1.1	0.8	0.9	0.0	0.0	2.2
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 18.5;intestine: 6.8;lymphoid tissue: 15.9;testis: 5.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 18.5;cerebral cortex: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 3.4;SCLC-21H: 10.0;U-2 OS: 2.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.8"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.1	0.5	1.6	0.2	18.5	1.7	0.1	0.0	4.6	0.1	0.0	1.5	3.2	0.1	0.0	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.2	1.2	0.0	0.0	0.0	0.1	2.4	0.1	0.0	0.0	2.0	6.8	0.1	0.0	15.9	0.6	5.0	1.7	2.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.1	0.0	2.1	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	0.0	1.8	0.1	1.3	0.1	0.0	1.6	0.2	0.4	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.1	0.4	0.1	0.1	0.0	3.4	0.0	0.0	0.1	10.0	0.2	0.2	0.0	0.1	0.2	0.1	1.7	0.0	0.3	2.8	0.0	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	18.5	0.0	4.6	1.8	0.1	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964395-72013558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		690000		"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA047523: AB_2680075, HPA055704: AB_2682891"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	18.4	13.4	10.7	5.5	17.9	0.0	11.4	16.8	11.5	10.7	6.2	11.9	0.9	16.0	3.7	6.4	12.9	4.7	14.3	9.9	12.9	7.9	1.2	7.9	1.6	27.9	18.2	20.6	4.6	1.2	4.6	8.0	19.8	11.1	2.1	2.1	6.4	14.8	17.7	8.7	5.4	17.1	14.0	2.5	14.7	18.1	17.3	4.2	5.5	9.0	1.4	9.4	8.4	25.3	15.4	16.4	8.2	20.3	36.6	14.4	0.3	32.0	30.4	19.3	12.8	14.4	30.1	0.0	21.4	37.9	15.5	19.7	7.4	21.9	15.3	0.4	5.5	0.1	27.8	13.8	18.7	0.0	0.1	19.8	24.9	19.0	25.9	37.3	5.7	0.7	4.7	0.0	20.6	0.4	0.0	0.1	3.5	0.5	5.3	0.2	9.9	0.0	26.9	15.7	0.5	8.1	24.2	0.6	24.1	9.9	1.8	3.1	11.9	23.6	27.1	39.6	65.1	0.0	0.1	0.1	17.2	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	17.9	16.8	11.5	9.9	12.9	27.9	18.2	19.8	14.0	17.3	25.3	23.9	0.0	1.9	14.0	0.1	2.8	4.9	6.1	13.6	0.1	4.3	8.0	10.4	5.7	2.5	7.3	0.0	4.6	0.0	0.1	3.9	9.7	0.8	20.1	24.7	5.6	0.0	0.0	0.2	2.7	2.2	9.3	2.6	17.9	1.3	26.9	13.6	0.3	0.8	0.0	0.3	0.0	2.0	0.6	1.9	3.2	20.5	0.7	8.8	4.7	0.7	6.6	0.0	26.7	27.1	12.7	0.0	21.8	0.0	4.2	0.0	3.6	2.0	0.2	6.6	26.8	13.9	1.0	2.1	7.5	2.4	1.1	0.4	5.5	0.1	1.3
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 176.6;retina: 126.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA067071: AB_2685775"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	14.0	25.1	43.4	12.1	84.1	12.3	15.8	100.7	79.1	21.4	0.0	16.9	9.9	20.5	11.3	17.9	16.0	17.7	40.4	44.8	57.5	18.1	10.8	15.3	15.4	69.0	49.9	27.3	11.5	17.7	33.3	15.6	85.9	16.6	13.1	126.4	8.8	20.7	64.9	13.0	11.0	19.4	67.8	14.5	11.2	11.8	60.0	16.1	14.1	63.4	15.9	14.5	11.5	176.6	13.5	29.4	32.9	27.8	20.9	20.4	23.6	24.8	23.2	28.5	30.6	17.2	13.8	44.4	14.1	19.6	18.3	11.5	43.0	19.7	34.4	36.0	30.5	43.7	24.6	15.4	9.9	43.6	35.8	12.7	19.3	30.9	29.2	16.5	28.0	27.0	43.3	24.8	31.1	7.6	32.5	18.6	24.5	13.5	18.4	34.5	30.9	24.1	17.9	15.2	27.4	46.4	28.7	22.1	24.7	26.5	20.9	38.1	27.0	22.3	19.4	16.9	27.7	17.3	34.6	36.5	20.2	29.6	28.8	3.7	4.6	2.6	3.3	4.5	5.1	6.1	2.9	3.2	6.5	3.7	3.9	3.6	0.9	9.1	7.0	6.1	3.5	4.8	43.4	84.1	100.7	79.1	44.8	57.5	69.0	49.9	85.9	67.8	60.0	176.6	19.7	6.4	11.7	294.5	29.9	21.0	8.6	8.8	18.8	103.3	26.0	13.8	37.4	15.7	12.7	14.7	156.4	12.3	36.2	9.9	1.9	6.4	2.8	20.8	15.6	16.1	14.4	12.2	514.2	7.0	8.1	19.2	26.5	27.9	12.0	17.8	16.1	13.9	15.0	92.5	526.3	8.8	8.2	32.3	26.6	2.9	14.3	26.0	16.0	128.4	19.5	32.0	22.6	739.9	1315.9	8.0	5.6	13.5	28.8	12.3	6.1	12.2	13.8	120.6	6.6	34.2	22.9	11.1	14.4	19.3	30.7	12.9	25.6	15.5	11.2	8.8
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254000-38256093	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		4100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	67.1	9.5	13.6	7.9	13.4	0.1	50.6	13.8	15.2	24.8	10.9	15.2	10.1	31.2	7.6	11.1	22.6	19.0	65.1	11.5	13.3	15.9	9.4	55.5	6.6	15.0	13.9	9.5	7.8	10.5	6.1	25.0	15.4	14.5	7.2	0.8	13.6	9.8	33.2	15.8	18.8	19.8	13.1	16.7	13.8	3.5	14.9	4.6	31.4	43.3	4.2	19.2	16.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	451.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	13.4	13.8	15.2	11.5	13.3	15.0	13.9	15.4	13.1	14.9	15.6	396.6	0.0	3.2	0.0	0.9	3.4	0.2	0.0	1.8	0.1	1.5	2.5	6.4	1.5	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.2	0.5	272.8	0.0	0.0	0.4	0.2	0.1	31.0	0.0	0.3	1.3	0.1	567.2	2.1	0.4	0.0	0.2	0.0	0.0	6.4	3.1	1.0	0.6	1.1	5.4	15.0	0.0	0.2	0.0	4.0	2.9	0.0	0.0	0.4	1.4	0.2	0.0	0.0	0.0	0.5	0.0	14.1	7.5	1.6	0.9	0.9	3.1	0.1	1.3	6.7	0.0	0.3
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 22.6;retina: 17.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.7;Excitatory neurons: 497.7;Inhibitory neurons: 143.6;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 86.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.9;AF22: 4.0;NTERA-2: 8.9;PC-3: 4.8;RH-30: 8.2;U-251 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	1.5	2.6	8.4	0.3	12.2	0.2	1.4	22.6	16.4	1.0	0.0	0.7	0.1	0.3	0.5	0.0	1.3	0.1	0.8	20.3	0.0	0.1	0.7	1.2	0.9	0.0	0.0	0.6	2.5	0.0	1.6	0.1	0.0	0.7	0.0	17.9	0.5	0.1	4.7	0.8	0.6	0.1	0.0	0.5	1.2	0.6	0.0	0.9	0.9	1.3	1.0	0.6	0.9	5.3	0.0	5.9	4.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	2.0	0.0	8.9	0.0	4.8	0.0	8.2	0.0	0.0	0.0	3.9	1.6	0.0	0.1	0.3	2.1	0.0	0.6	0.0	0.1	1.9	0.0	5.3	3.1	0.0	3.4	0.8	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	8.4	12.2	22.6	16.4	20.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.3	16.0	1.3	111.7	9.0	1.3	0.5	0.0	1.2	17.8	0.3	0.6	5.7	1.5	5.6	0.0	20.9	0.1	2.1	0.4	0.0	0.3	0.3	1.0	13.6	0.3	0.0	0.8	497.7	2.3	0.0	6.7	0.0	1.3	1.3	1.0	0.0	2.1	0.1	23.5	143.6	0.5	0.0	0.0	2.6	0.0	0.6	0.2	0.0	15.9	0.2	12.7	0.0	93.5	10.6	0.6	0.1	1.5	3.1	2.0	1.3	0.3	0.0	86.1	0.0	0.6	0.9	6.0	7.7	0.1	1.8	0.0	2.9	1.5	0.4	0.0
COG4	"COD1, DKFZP586E1519"	ENSG00000103051	"Component of oligomeric golgi complex 4"		16	70480568-70523560	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040924, HPA042539"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA040924: AB_2677203, HPA042539: AB_2678044"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.79e-1)"	17.8	22.0	25.3	12.8	27.2	14.2	15.7	27.8	27.0	20.2	29.0	20.3	10.5	17.4	11.1	30.1	19.7	12.8	25.7	25.3	26.5	16.9	16.9	18.3	15.4	26.9	26.3	18.8	10.6	27.9	19.0	19.8	26.6	14.4	16.6	14.5	17.1	16.5	67.7	23.8	16.3	19.2	25.9	17.9	17.4	19.2	27.7	22.3	15.9	49.4	17.7	18.5	20.7	28.3	37.3	59.9	47.1	31.3	62.6	43.7	53.0	41.0	53.7	51.0	43.9	48.3	66.7	25.0	57.7	64.9	35.5	53.4	60.8	65.3	70.9	21.5	36.7	23.1	59.8	47.5	36.7	15.3	15.0	51.9	41.9	66.1	40.6	59.7	51.7	31.6	55.9	18.1	57.6	75.9	25.1	23.4	45.2	50.4	30.9	46.8	31.2	57.4	42.3	31.0	43.9	45.5	80.7	30.5	24.3	48.0	77.9	26.4	49.7	46.3	29.1	35.3	29.8	19.1	26.2	78.0	50.7	15.8	46.1	20.6	26.4	23.8	19.7	28.8	14.4	11.8	19.3	17.9	32.8	14.6	16.9	15.7	13.8	14.4	34.4	15.2	24.4	25.1	25.3	27.2	27.8	27.0	25.3	26.5	26.9	26.3	26.6	25.9	27.7	28.3	13.6	16.0	16.0	21.9	11.0	9.1	12.1	22.6	11.4	24.5	9.2	8.0	23.3	2.8	21.1	3.7	14.6	47.7	13.1	20.8	9.8	23.4	3.1	11.9	13.0	16.8	12.6	12.6	10.9	16.0	26.8	16.5	18.8	13.4	8.8	28.7	16.8	17.8	24.7	8.4	13.0	18.0	24.4	14.1	8.9	6.7	14.6	11.1	8.8	7.5	14.7	29.3	12.3	19.6	19.1	17.6	21.0	19.2	12.3	6.3	21.7	13.8	18.5	29.9	32.9	14.0	18.6	37.5	25.7	13.1	10.7	39.0	12.9	37.3	19.4	8.9
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201372-107564261	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	11.4	12.1	6.7	9.5	7.7	14.2	10.8	7.7	8.5	20.4	8.1	12.0	9.3	17.1	10.0	12.8	9.0	12.9	19.7	7.1	7.5	9.7	6.8	10.2	9.5	7.0	7.5	12.4	14.7	19.4	10.2	10.5	7.6	17.8	12.4	11.8	22.8	11.0	14.0	12.9	10.1	14.4	6.3	9.0	11.7	8.6	7.5	6.2	20.3	15.4	10.4	10.5	16.7	9.4	39.3	14.9	16.1	15.1	14.7	16.2	12.6	27.0	28.2	11.7	20.5	12.0	17.5	7.9	14.9	27.0	26.5	15.5	10.7	16.0	18.2	23.5	9.6	8.7	9.9	15.1	17.4	18.8	19.0	15.4	15.3	20.4	24.0	32.1	31.7	17.1	16.6	25.1	21.5	18.5	19.2	17.8	5.9	30.0	19.1	6.8	13.6	18.6	13.6	17.9	7.6	21.8	16.6	27.2	31.2	23.8	6.2	12.2	36.6	12.6	16.0	39.7	17.2	16.3	16.9	17.3	24.2	21.0	33.9	9.4	6.6	7.5	6.1	7.6	8.4	6.0	7.7	6.9	5.4	5.8	6.4	6.4	3.4	5.1	9.3	3.7	6.5	5.9	6.7	7.7	7.7	8.5	7.1	7.5	7.0	7.5	7.6	6.3	7.5	9.4	14.8	3.2	15.5	124.4	21.7	12.2	15.0	11.1	24.5	23.2	10.0	7.7	27.6	7.2	16.5	14.7	33.3	10.2	16.5	15.8	1.9	10.5	22.6	11.8	21.8	11.0	10.3	5.9	147.0	10.9	8.5	14.4	14.8	19.8	3.8	12.3	9.7	5.8	11.3	11.8	196.1	36.2	18.3	14.8	12.3	22.1	11.8	15.3	12.4	147.1	15.7	9.0	11.3	136.7	183.2	10.8	10.1	12.4	20.7	20.6	14.5	6.5	16.3	17.4	26.3	15.4	10.2	18.2	14.0	19.0	13.4	10.5	18.9	7.5	14.9	16.1
COG6	"COD2, KIAA1134"	ENSG00000133103	"Component of oligomeric golgi complex 6"	Q9Y2V7	13	39655627-39791665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 123.1;Inhibitory neurons: 99.9;Oligodendrocyte precursor cells: 82.9;Oligodendrocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040410, HPA040441"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles, Golgi apparatus"		"HPA040410: AB_10793964, HPA040441: AB_10794030"	"unprognostic (2.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	8.7	10.5	2.1	7.9	3.8	2.1	9.7	5.3	5.8	12.0	5.0	9.3	10.5	9.2	4.4	10.6	9.9	10.5	15.8	5.5	2.6	9.8	8.9	6.8	8.3	2.1	2.3	14.2	19.0	18.3	13.3	13.7	3.2	13.0	8.4	7.2	13.0	8.8	6.4	10.1	9.7	7.7	1.7	8.0	12.5	16.4	2.1	8.8	14.0	8.5	7.7	10.2	6.4	6.1	10.8	7.0	10.8	7.7	21.0	26.5	20.6	17.0	24.1	14.2	17.4	8.6	16.8	18.2	9.6	24.7	16.7	13.5	11.5	12.9	15.1	21.5	16.1	17.7	7.0	12.5	12.0	17.9	18.1	11.2	15.9	8.9	10.0	17.8	13.9	16.5	7.5	6.8	23.1	11.0	13.4	16.5	10.6	30.2	8.9	12.8	29.3	8.8	10.0	13.6	6.3	8.2	15.4	12.8	13.0	14.8	14.9	11.2	20.7	7.9	9.3	17.6	8.5	5.3	5.5	13.6	23.4	9.5	23.6	3.0	3.2	4.0	3.8	5.0	6.6	4.7	4.9	5.3	4.5	4.4	4.1	5.4	0.7	7.1	3.1	2.5	6.4	4.2	2.1	3.8	5.3	5.8	5.5	2.6	2.1	2.3	3.2	1.7	2.1	6.1	8.7	19.2	7.8	46.0	12.6	9.7	5.9	9.5	8.0	15.2	11.0	8.4	22.0	2.8	10.2	12.9	10.4	15.6	9.5	9.9	5.9	7.7	23.4	13.9	14.8	8.5	9.1	9.5	123.1	10.0	29.6	12.3	10.7	13.0	10.1	9.7	12.1	9.6	8.6	5.0	99.9	19.8	8.2	6.7	3.9	12.6	13.4	7.6	1.8	37.5	5.9	15.5	7.2	82.9	89.4	8.7	10.8	12.8	17.7	5.0	10.2	12.4	13.2	12.5	6.6	12.2	9.7	39.0	27.4	11.9	13.4	16.0	10.3	12.6	10.3	5.7
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104085880	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 580.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 227.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	1.5	0.4	0.8	6.6	1.1	12.2	37.3	1.0	1.4	50.1	0.6	37.4	10.7	0.6	6.6	116.6	1.1	0.3	0.5	0.5	0.6	0.3	0.3	0.9	0.1	0.6	0.7	0.2	0.4	0.0	1.2	35.4	0.6	17.9	27.3	0.0	82.2	9.6	0.5	580.3	37.2	1.0	0.5	2.3	19.8	25.4	0.6	42.7	5.1	0.0	19.8	9.9	102.0	0.8	26.3	0.4	1.5	0.2	0.1	0.0	80.6	0.5	0.3	0.1	0.2	0.3	204.3	0.0	5.1	0.3	3.9	463.8	0.7	745.8	0.7	0.0	0.7	0.0	0.3	0.2	0.1	0.0	0.4	0.7	914.1	0.5	783.7	0.2	3.5	0.1	0.1	0.9	0.0	0.0	0.0	0.3	1.7	5.1	2.6	0.0	0.0	0.3	35.9	26.4	0.2	0.3	0.0	0.2	0.9	4.0	0.2	0.0	1.5	0.5	5.0	0.3	5.5	0.1	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	1.0	1.4	0.5	0.6	0.6	0.7	0.6	0.5	0.6	0.8	1.0	0.0	1.1	0.7	0.3	585.7	17.7	136.0	299.9	0.6	1.7	85.5	1.1	0.0	16.5	0.0	0.0	10.2	0.3	211.5	0.0	0.8	14.2	23.7	2.3	3.7	2.4	0.0	0.1	0.9	18.9	2.4	23.0	8.1	0.0	0.1	0.0	0.0	1.3	0.0	0.2	5.7	6.1	0.0	28.9	3.6	0.3	0.7	33.8	0.0	0.0	0.4	0.0	0.0	0.4	78.8	35.7	0.7	1.4	16.6	108.5	0.1	5.9	0.4	0.0	0.4	3.0	22.7	1.5	31.9	139.4	5.6	1.3	0.1	21.6	10.7
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"COPI coat complex subunit beta 2"	P35606	3	139353946-139389736	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		63000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA036867: AB_10672271, HPA058180: AB_2683630"	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	46.7	58.2	17.9	50.5	19.7	22.3	60.4	20.4	21.0	76.5	35.9	62.5	57.4	48.5	62.5	55.0	47.5	48.4	47.9	17.4	21.8	52.9	71.1	44.3	44.8	20.5	18.9	38.9	89.7	68.2	60.0	68.9	20.4	72.2	71.7	37.0	71.1	57.0	33.5	37.4	53.4	63.5	20.8	42.8	60.7	35.0	20.2	54.4	64.3	31.2	61.5	56.2	42.2	25.0	192.1	84.0	111.2	99.0	247.2	214.9	96.8	223.9	235.9	158.2	204.7	143.4	83.5	90.2	203.0	287.1	145.1	110.9	136.2	141.0	210.6	139.0	85.2	138.2	114.9	152.3	152.7	121.9	139.7	160.1	114.7	132.2	138.5	178.6	161.6	76.5	86.7	105.7	199.4	138.6	59.4	59.7	102.2	215.0	99.5	75.8	93.6	149.5	141.2	133.4	85.2	61.7	254.6	212.0	147.2	168.6	193.2	123.2	185.1	90.3	66.4	122.8	83.7	148.0	80.8	129.7	115.2	61.0	138.0	74.4	49.8	52.0	36.0	56.3	35.8	35.3	31.0	37.6	57.7	23.8	24.2	31.1	45.0	44.1	57.2	30.2	38.1	44.2	17.9	19.7	20.4	21.0	17.4	21.8	20.5	18.9	20.4	20.8	20.2	25.0	36.6	57.7	46.6	18.3	45.8	19.6	39.5	61.2	29.6	38.0	41.3	29.3	58.5	32.9	74.5	20.2	31.3	83.3	34.9	52.4	41.1	83.4	40.8	64.9	62.9	45.2	63.9	51.1	25.1	82.1	76.1	66.6	75.4	54.8	45.0	50.4	36.4	48.5	52.7	42.1	25.5	86.7	46.8	34.6	21.3	8.6	54.7	42.8	21.4	13.1	60.1	62.0	29.9	20.1	30.8	79.7	34.8	50.0	118.6	46.6	46.9	42.4	108.6	51.1	19.7	47.3	69.6	83.1	45.6	36.5	14.9	133.1	37.5	74.4	44.7	52.9
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 112.0;lung: 86.3"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	18.2	2.6	0.0	19.9	0.4	25.7	20.9	0.0	0.0	59.4	0.3	39.2	27.3	26.1	19.3	41.1	6.6	112.0	6.2	0.0	0.0	3.3	2.7	86.3	11.2	0.0	0.0	0.9	21.0	2.8	0.9	1.7	0.0	18.5	56.6	0.0	12.1	15.1	1.6	17.7	45.9	25.7	0.0	1.1	45.3	3.8	0.0	14.9	0.9	10.2	15.1	54.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645242-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 225.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 150.2;Oligodendrocytes: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 250.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	46.2	35.9	22.6	25.4	33.9	31.8	34.7	28.0	26.7	75.1	20.6	39.6	29.3	46.0	36.2	25.9	39.8	57.8	51.8	21.6	27.0	80.5	70.0	32.3	22.8	32.6	27.5	87.4	46.7	60.7	25.6	39.2	33.2	40.2	33.1	16.8	32.8	54.2	13.3	20.6	35.0	64.7	25.9	31.3	32.1	13.9	30.3	8.2	225.9	33.2	17.0	46.3	38.6	38.6	0.6	2.1	2.1	0.1	116.1	131.4	0.5	35.3	55.6	12.8	26.5	2.0	0.9	0.4	27.2	59.0	15.7	1.0	2.4	2.8	12.0	31.4	4.4	28.4	1.5	17.7	25.6	4.9	37.0	69.6	6.5	15.0	3.7	108.2	6.0	0.1	27.1	97.0	29.4	1.2	0.5	14.1	2.5	0.2	5.2	4.3	0.0	0.6	26.7	13.2	2.4	0.3	10.2	0.4	28.2	25.8	12.3	28.6	21.3	51.9	4.9	0.8	11.5	7.9	0.9	0.3	32.2	21.6	33.5	32.0	71.3	45.1	27.3	49.6	27.6	5.4	20.3	24.0	51.8	7.4	17.6	24.6	250.5	25.9	47.5	14.8	22.2	40.6	22.6	33.9	28.0	26.7	21.6	27.0	32.6	27.5	33.2	25.9	30.3	38.6	46.6	12.8	12.5	150.2	11.7	19.4	25.7	21.3	9.6	12.7	12.1	27.9	27.2	42.9	13.9	47.8	29.2	12.1	40.8	9.3	17.6	22.7	5.0	6.6	43.3	27.1	13.8	7.2	24.0	10.7	1.8	123.8	10.7	8.6	38.0	43.1	51.0	48.3	54.0	10.1	31.3	7.9	24.4	56.0	44.9	9.0	72.4	39.4	78.2	131.2	33.7	43.4	39.1	44.7	299.6	11.7	9.5	73.0	11.9	12.4	42.4	56.0	9.7	16.3	52.6	71.1	67.8	5.6	3.4	2.8	13.1	6.0	23.8	38.6	12.2	13.5
CRACD	"CRAD, KIAA1211"	ENSG00000109265	"Capping protein inhibiting regulator of actin dynamics"	Q6ZU35	4	56049073-56328625	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;intestine: 19.7;testis: 29.6"	"Cell type enriched"	"Detected in single"	11	"Cardiomyocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.7;SH-SY5Y: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		59000		"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	0.5	2.3	6.6	3.1	9.6	3.9	0.3	8.7	5.6	1.6	0.0	9.5	13.8	3.5	4.2	0.5	2.9	11.3	0.8	5.7	12.8	0.7	0.6	1.0	2.2	18.8	13.3	1.2	1.8	6.3	0.9	0.6	19.1	1.7	8.1	4.1	1.0	3.5	0.0	0.5	19.7	4.4	8.7	2.5	2.7	29.6	11.9	0.6	0.1	0.2	1.9	1.3	1.2	6.2	0.0	2.9	11.2	0.9	0.3	0.0	4.1	0.1	0.4	0.5	1.2	3.4	0.4	10.2	0.3	0.0	9.1	0.0	9.6	0.2	0.3	0.9	5.6	5.7	5.1	0.5	1.6	4.8	0.8	0.4	0.2	0.0	0.1	3.6	5.3	9.1	0.0	9.8	0.1	1.4	7.1	0.4	6.0	8.7	7.2	6.8	6.1	0.2	0.1	2.6	26.7	56.7	1.0	0.3	6.9	9.4	2.4	0.5	2.1	0.3	2.8	0.7	2.6	9.7	6.9	0.1	2.8	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	9.6	8.7	5.6	5.7	12.8	18.8	13.3	19.1	8.7	11.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 86.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 494.3;Excitatory neurons: 144.4;Granulosa cells: 214.1;Microglial cells: 224.9;Oligodendrocyte precursor cells: 355.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 62.6"	"Group enriched"	"Detected in all"	5	"B-cells: 44.5;granulocytes: 24.9;T-cells: 62.6"	"Cell line enhanced"	"Detected in many"		"A549: 57.8;BJ hTERT+: 32.3;GAMG: 22.9;RPTEC TERT1: 39.6;U-2197: 36.8;U-87 MG: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	19.4	12.5	20.3	8.8	15.7	11.1	7.4	4.8	18.3	18.0	0.7	4.7	3.5	7.0	5.4	31.2	11.8	16.1	35.8	16.3	11.5	6.0	2.8	11.7	7.6	6.3	11.2	57.0	7.9	11.4	3.0	38.8	7.6	31.8	2.5	2.5	6.8	9.8	5.8	4.8	4.7	12.3	6.7	8.7	6.9	2.8	8.9	11.7	86.7	11.0	8.8	23.4	8.1	10.7	2.1	57.8	0.5	0.0	9.3	2.1	7.9	1.4	32.3	0.3	0.3	3.1	1.0	0.0	0.3	0.0	22.9	0.7	0.0	0.0	0.4	7.5	0.4	0.2	16.2	1.9	4.1	0.0	0.1	0.9	1.6	0.7	0.3	0.4	11.6	0.2	0.0	0.1	0.1	2.6	2.9	0.2	0.3	8.3	1.7	0.3	0.1	0.0	39.6	1.6	0.2	0.3	17.2	6.9	2.4	1.5	0.1	0.4	1.0	1.1	1.3	36.8	0.9	0.3	0.0	0.0	26.0	3.4	11.4	0.1	2.9	24.9	5.6	0.1	0.6	44.5	25.7	8.5	2.8	15.9	44.6	11.6	15.6	8.4	0.4	4.2	62.6	11.7	20.3	15.7	4.8	18.3	16.3	11.5	6.3	11.2	7.6	6.7	8.9	10.7	33.3	3.2	1.1	494.3	27.3	4.5	7.4	0.2	0.6	0.3	4.1	0.8	45.8	0.0	0.9	12.9	10.4	1.9	6.2	0.0	1.9	5.7	6.9	7.5	1.2	38.5	3.0	3.2	144.4	1.7	14.6	20.9	2.0	2.0	0.0	214.1	26.7	0.2	15.8	18.5	76.5	0.0	16.2	27.4	6.5	7.4	5.3	14.1	12.4	224.9	3.5	1.0	6.2	355.9	4.6	3.1	0.0	12.0	21.3	21.8	0.0	0.1	1.5	1.0	6.6	2.1	12.0	0.7	0.1	0.5	3.1	8.3	9.6	77.0	0.1	2.8
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 4217.6"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 18746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4"	"Group enriched"	"Detected in all"	9	"dendritic cells: 7959.0;monocytes: 6424.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1733.4;ASC TERT1: 1179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	2800000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	1046.2	707.6	3041.2	262.3	3117.9	170.8	900.3	2823.3	4217.6	587.8	3094.8	788.7	389.6	708.3	875.9	557.1	802.7	583.0	1275.3	2976.3	2707.6	517.4	833.6	595.8	463.5	3258.4	3096.2	575.8	944.1	320.0	670.1	165.9	2939.3	773.9	416.9	46.9	2008.0	441.5	749.0	497.1	800.3	367.6	3028.1	723.7	979.9	761.3	3302.7	418.9	658.8	517.4	208.1	703.0	618.4	2883.1	155.2	328.2	75.4	175.8	1733.4	1179.8	145.3	261.4	350.7	170.3	137.7	625.1	219.7	0.8	241.0	345.2	221.3	496.2	69.6	499.9	51.9	0.9	253.5	157.6	61.1	1082.9	621.2	7.5	251.0	919.0	415.9	226.6	241.5	352.5	268.5	18.5	147.6	4.0	239.5	234.4	1.5	162.2	103.5	461.9	752.2	5.7	96.4	215.2	708.0	328.3	84.7	98.2	191.1	54.6	343.3	107.7	156.5	548.2	702.0	163.4	119.0	231.6	97.7	157.1	6.2	1.8	138.0	339.5	184.0	48.1	4967.5	33.2	66.9	6424.5	25.5	23.1	18.3	45.8	7959.0	13.6	16.9	31.1	809.3	191.4	4297.7	4427.4	13.6	4250.8	3041.2	3117.9	2823.3	4217.6	2976.3	2707.6	3258.4	3096.2	2939.3	3028.1	3302.7	2883.1	662.4	115.4	168.8	849.5	93.8	942.9	571.1	568.2	213.9	152.4	660.2	512.1	240.7	1361.2	514.5	641.9	29.2	476.8	603.3	1889.9	414.8	489.9	46.2	441.1	795.0	728.2	882.1	252.1	4.5	783.6	308.7	3026.2	981.7	631.0	359.9	687.0	491.9	2563.0	1816.7	48.8	11.2	1360.6	691.7	4301.1	18746.6	184.3	2132.6	4542.6	1563.5	87.1	2025.6	248.7	99.9	263.9	6.0	1458.5	2342.1	1790.4	67.9	786.0	4301.1	1098.6	364.4	36.3	2195.7	1417.0	846.2	125.5	400.6	461.5	822.0	469.0	117.4	208.1	1039.4	1079.7
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87724051-87731469	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 563.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 128.1;non-classical monocyte: 195.2"	"Lineage enriched"	"Detected in many"	12	"monocytes: 195.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2305.0;HSkMC: 1061.0"					"Low region specificity"	"Detected in all"			"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	232.4	86.6	49.2	136.0	55.4	84.8	110.0	52.9	67.5	69.5	67.9	110.3	39.7	108.1	81.6	33.3	108.4	85.0	112.5	47.0	52.3	207.3	333.5	154.9	101.1	54.4	54.0	96.4	61.9	151.1	69.5	563.6	57.5	68.2	58.8	32.3	77.6	91.7	71.9	39.8	57.1	125.2	52.4	124.4	71.4	80.1	112.2	33.0	76.1	79.8	49.4	209.8	48.0	59.6	88.1	423.0	32.6	55.3	514.0	2305.0	198.4	267.2	781.8	232.2	300.6	43.0	86.3	0.0	128.9	355.4	754.0	67.5	49.8	86.0	198.4	1.9	37.8	18.1	111.2	105.1	352.6	0.1	51.4	1061.0	138.9	373.7	134.9	186.6	194.9	0.0	162.5	0.7	326.6	115.6	0.5	9.9	67.7	128.6	77.5	21.6	21.5	0.6	158.6	39.0	42.8	50.6	62.1	133.5	312.3	177.9	14.5	97.9	296.9	190.8	104.7	750.6	125.9	18.5	84.1	0.9	692.6	0.2	67.9	0.3	13.5	0.6	0.3	128.1	0.0	0.0	6.6	0.1	7.9	0.1	16.7	1.3	0.5	0.2	195.2	0.3	1.7	10.1	49.2	55.4	52.9	67.5	47.0	52.3	54.4	54.0	57.5	52.4	112.2	59.6	86.1	41.7	52.9	15.3	11.2	37.7	82.1	58.0	15.4	43.8	12.2	33.4	96.8	87.2	46.4	75.4	18.8	1081.6	0.3	16.3	27.4	91.8	5.3	48.1	119.9	110.0	11.5	251.2	18.6	93.4	1012.3	261.7	10.2	27.6	29.7	63.6	580.4	122.6	1105.7	13.5	24.0	8.5	20.3	206.9	105.4	17.4	156.9	537.2	64.0	14.0	16.2	79.5	0.0	17.6	31.7	67.2	5.6	187.3	1.9	34.5	8.0	138.3	67.3	45.4	92.1	176.9	136.3	207.4	60.5	6.8	34.0	1543.6	10.8	30.8	11.7	44.8
CUL5	VACM-1	ENSG00000166266	"Cullin 5"	Q93034	11	108008898-108107761	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002185, CAB017787"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Cytosol"		"CAB017787: , HPA002185: AB_1078587"	"unprognostic (5.66e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (3.83e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	9.8	11.5	6.8	9.5	7.0	28.3	13.0	10.9	9.1	11.8	7.3	9.1	9.0	13.1	9.9	10.6	9.6	8.5	15.2	6.8	8.0	16.3	14.2	8.8	11.2	6.4	6.8	12.4	8.9	13.4	5.7	11.4	6.5	12.1	9.1	12.7	8.5	9.5	46.4	11.4	8.6	10.5	7.4	9.8	9.4	6.5	6.8	12.7	14.4	37.5	10.3	10.0	7.0	10.3	14.4	6.6	19.6	15.1	12.5	20.2	9.7	15.0	16.3	13.4	15.0	21.3	16.5	20.1	27.3	18.8	14.0	18.0	18.4	12.3	19.4	13.2	11.1	18.9	6.2	15.7	21.1	21.8	14.9	15.8	16.1	14.1	18.6	17.5	18.7	16.2	25.0	7.2	21.4	7.9	20.9	18.1	10.3	18.4	11.6	15.0	14.6	21.8	16.4	21.2	13.9	19.6	20.4	21.1	12.3	12.0	31.1	17.0	19.7	24.6	11.4	17.6	16.2	7.2	6.2	26.5	9.6	24.0	16.0	1.2	2.3	1.6	2.1	2.1	2.0	1.7	2.1	1.9	2.3	2.2	2.3	2.3	0.4	1.6	2.2	2.5	1.7	1.3	6.8	7.0	10.9	9.1	6.8	8.0	6.4	6.8	6.5	7.4	6.8	10.3	50.2	57.7	42.5	66.3	49.0	29.8	29.3	26.0	44.3	52.7	35.1	25.7	111.9	37.1	39.2	31.3	66.7	37.6	49.2	21.8	50.9	29.6	6.0	45.4	48.7	41.3	17.6	34.3	84.9	23.5	23.6	42.6	33.1	40.9	43.1	42.8	40.0	54.8	27.1	55.5	83.8	28.7	22.4	41.6	20.3	8.0	30.7	41.2	14.2	61.8	51.7	31.5	30.9	74.4	101.7	29.1	29.0	38.0	48.4	36.6	27.9	76.7	36.6	59.4	19.7	56.0	53.1	35.5	44.0	43.9	30.3	35.8	38.8	48.0	30.3	32.9
CUX1	"CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6"	ENSG00000257923	"Cut like homeobox 1"	"P39880, Q13948"	7	101815904-102283958	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Transport"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 35.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003277, HPA003317"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"		"HPA003277: AB_10601804, HPA003317: AB_2666891"	"unprognostic (5.86e-2)"	"unprognostic (5.39e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.12e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-1)"	30.5	18.0	23.8	24.8	33.6	33.4	17.9	54.0	48.2	35.5	28.0	40.5	33.7	60.9	16.9	32.6	35.3	31.7	82.8	21.5	23.3	40.0	23.2	33.1	19.4	30.8	27.5	46.9	63.3	46.0	24.6	23.1	27.4	30.7	25.3	19.2	36.1	23.2	45.5	24.0	37.3	40.8	26.2	16.9	35.3	9.6	29.3	34.7	49.4	38.8	20.6	32.4	24.8	30.5	41.8	44.0	30.3	37.7	24.1	49.3	18.4	41.1	43.0	17.0	10.9	26.2	26.2	53.6	64.2	40.8	31.3	33.4	19.4	32.9	10.1	25.9	21.8	18.8	32.8	22.2	63.7	24.7	9.9	34.6	65.9	13.1	29.5	48.7	22.3	34.0	44.5	44.2	16.3	85.9	80.8	30.1	12.3	64.0	45.4	52.6	25.1	64.4	27.6	46.5	27.7	82.6	35.8	88.4	35.4	25.1	17.4	29.0	33.5	71.2	47.8	54.4	23.7	28.8	14.5	114.7	65.8	22.3	50.8	3.3	13.9	2.3	3.1	13.4	3.0	2.9	2.3	3.1	10.8	2.4	2.2	3.1	7.0	4.5	35.0	18.2	2.2	8.4	23.8	33.6	54.0	48.2	21.5	23.3	30.8	27.5	27.4	26.2	29.3	30.5	33.7	99.3	60.5	78.4	35.3	26.3	30.9	30.9	33.6	67.2	23.9	17.1	110.5	31.5	40.3	40.5	68.8	54.6	59.6	69.2	9.8	34.4	9.5	50.6	165.2	42.1	42.5	50.0	129.0	24.0	55.5	51.8	62.2	85.0	12.0	97.8	37.5	36.1	32.8	53.8	116.2	48.7	38.7	70.2	42.5	9.4	41.3	75.4	17.8	139.6	65.2	47.7	32.0	96.0	117.5	34.1	50.2	60.9	46.0	55.5	42.9	64.5	37.9	57.3	26.3	105.2	56.6	13.5	14.4	39.9	43.3	88.0	25.7	34.7	46.0	43.8
CWF19L1	"FLJ10998, hDrn1"	ENSG00000095485	"CWF19 like cell cycle control factor 1"	Q69YN2	10	100232298-100267680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036889, HPA036890"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Golgi apparatus"		"HPA036889: AB_10670928, HPA036890: AB_10696789"	"unprognostic (2.76e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.04e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.61e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.10e-1)"	8.1	6.9	5.9	11.4	6.3	18.8	11.6	7.5	7.6	7.9	5.1	7.2	6.8	8.2	5.7	6.9	8.7	6.7	7.4	5.9	6.5	7.8	8.2	7.5	16.4	6.0	5.8	10.3	8.0	9.0	6.1	9.0	6.3	6.8	8.6	10.3	8.6	6.5	10.1	11.2	8.1	9.3	6.3	11.8	6.6	14.3	6.0	14.8	8.1	10.2	16.9	8.5	6.6	8.4	29.1	18.8	18.7	29.2	9.1	10.8	20.7	17.2	23.8	37.5	30.6	21.5	22.6	30.5	19.4	16.6	16.3	27.9	42.2	24.9	39.6	19.4	20.8	17.5	15.8	20.6	15.8	44.7	19.6	15.2	10.4	28.0	26.2	14.2	26.6	30.8	20.7	26.8	21.9	18.3	36.2	32.4	14.7	15.0	23.2	12.6	29.2	21.2	15.0	16.5	9.4	16.8	20.6	10.3	26.0	12.6	37.3	19.1	18.6	15.8	21.5	18.3	32.8	23.9	29.6	17.9	20.1	39.1	11.4	10.0	17.0	22.7	12.8	15.9	16.3	14.0	13.3	14.4	14.9	13.0	14.9	15.0	9.6	18.1	14.7	6.8	17.7	13.8	5.9	6.3	7.5	7.6	5.9	6.5	6.0	5.8	6.3	6.3	6.0	8.4	8.0	19.2	10.8	14.0	16.2	4.5	7.7	6.8	4.6	9.5	4.8	3.9	8.0	5.7	11.3	5.5	4.2	10.4	13.5	4.3	7.9	6.0	23.6	6.8	6.4	8.3	4.2	11.2	26.8	7.7	11.0	6.7	4.6	6.3	17.7	8.3	7.5	5.9	9.5	10.1	24.3	4.2	10.2	13.1	5.7	5.3	6.8	11.3	8.8	14.0	15.5	5.1	19.6	18.6	24.0	7.2	6.7	4.1	11.3	5.3	4.5	6.2	12.5	12.3	0.0	8.4	6.9	18.4	12.2	5.8	7.7	10.9	12.8	6.7	5.3	4.4
CWH43	"CWH43-C, FLJ21511, PGAP2IP"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986275-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.0;prostate: 42.8;skin 1: 25.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"		"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	6.0	0.0	16.9	0.4	0.6	0.4	21.0	14.5	0.0	0.0	0.0	0.0	9.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	42.8	15.6	0.0	3.0	7.7	0.0	25.5	0.0	0.8	0.1	0.0	9.6	0.0	0.1	0.1	10.2	0.0	1.5	2.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.9	0.1	0.8	0.0	0.0	0.6	0.1	0.6	0.0	2.3	7.3	0.0	0.0	0.0	10.4	1.9	0.0	0.2	41.3	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.7	21.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.4	0.0	0.0	7.6	0.0	2.9	29.5	0.0	0.0	0.0	0.5	0.0	0.5	3.2	9.1	0.0	0.2	0.0	15.0	0.3
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733533-4739928	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 4051.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 63.3;intermediate monocyte: 107.5;myeloid DC: 38.2;neutrophil: 103.2;non-classical monocyte: 141.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 38.2;granulocytes: 103.2;monocytes: 141.6"	"Cell line enhanced"	"Detected in many"		"A-431: 86.5;CACO-2: 63.5;CAPAN-2: 58.4;HaCaT: 97.9;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1100000	6800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	27.6	18.1	18.7	56.0	19.4	70.4	29.3	20.0	30.7	19.8	20.8	21.9	45.7	11.7	15.3	24.6	24.0	54.0	7.8	17.4	23.0	19.6	52.6	106.0	23.7	32.5	22.7	10.5	20.8	61.8	14.4	31.1	27.9	16.3	25.8	10.2	47.1	14.4	2.6	21.8	39.3	17.6	25.2	43.8	41.2	112.6	28.7	12.5	10.5	3.3	17.9	60.6	14.3	34.2	86.5	12.4	0.4	44.7	0.7	3.1	11.5	1.1	8.9	11.2	15.6	63.5	58.4	0.1	10.0	1.5	8.6	97.9	20.0	14.1	5.3	8.9	14.8	0.4	1.7	29.5	8.5	0.1	15.8	0.7	26.6	5.9	1.3	7.4	3.1	0.9	0.4	0.7	0.8	20.9	0.3	1.8	0.4	42.1	7.2	1.2	0.0	13.2	30.4	15.8	0.4	1.4	17.6	11.3	5.5	2.3	57.4	1.4	0.4	1.5	6.8	2.2	5.3	3.0	3.9	0.1	0.5	2.9	2.4	0.6	63.3	16.7	0.5	107.5	0.7	9.5	1.1	0.8	38.2	13.0	0.8	1.2	103.2	0.6	141.6	16.0	0.1	29.2	18.7	19.4	20.0	30.7	17.4	23.0	32.5	22.7	27.9	25.2	28.7	34.2	9.7	73.7	46.6	1.6	17.4	70.1	130.4	133.4	40.5	2.6	64.8	50.3	0.8	58.6	132.4	40.5	2.1	3.4	11.1	28.1	3.9	151.0	795.4	22.1	4.1	25.4	30.9	2.7	0.1	145.9	2.5	14.2	36.7	32.7	74.1	2.3	132.1	9.0	196.4	3.3	0.3	32.2	44.7	231.6	406.3	4051.5	24.5	270.6	26.6	15.0	556.1	13.2	1.0	5.0	1.2	188.1	44.5	30.1	2.2	277.2	51.3	17.4	62.4	1.3	19.7	3.4	14.4	22.7	11.5	33.7	76.4	2.9	11.7	1.6	23.7	272.7
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468308-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 16.1;retina: 7.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 48.0;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 102.1;Horizontal cells: 45.4;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 30.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;AN3-CA: 9.7;Karpas-707: 9.0;RPMI-8226: 5.5;SCLC-21H: 12.0;U-266/70: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	0.6	1.3	4.9	0.1	3.9	0.0	1.4	3.0	16.1	0.7	0.2	1.3	1.8	0.4	1.7	0.1	2.3	0.3	1.9	4.3	10.1	0.4	0.8	0.6	0.0	5.0	6.1	1.8	3.0	0.7	4.4	0.3	4.5	0.5	0.8	7.3	2.9	0.4	0.3	0.2	1.9	0.4	4.4	0.4	1.3	1.6	11.9	0.5	2.4	0.1	0.0	0.2	0.3	4.8	0.0	0.2	7.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	9.0	0.0	0.0	2.7	0.0	2.5	0.1	0.1	0.0	0.0	5.5	0.0	0.1	12.0	2.2	0.0	0.6	0.0	2.8	0.3	0.0	0.0	0.0	1.5	0.0	0.1	9.7	2.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	3.9	3.0	16.1	4.3	10.1	5.0	6.1	4.5	4.4	11.9	4.8	12.4	0.0	6.4	10.4	0.1	0.3	1.0	0.8	1.2	48.0	8.4	5.6	15.9	2.8	2.2	0.0	31.3	0.2	0.8	0.4	0.0	0.1	0.3	13.0	0.9	2.9	102.1	0.0	23.8	3.3	0.0	1.0	0.0	0.6	0.0	1.2	1.1	2.7	0.1	45.4	27.5	6.2	0.0	0.3	0.3	0.9	0.3	0.1	1.8	0.0	0.0	13.8	1.0	64.3	30.8	1.5	1.2	10.9	0.3	0.6	10.2	1.1	12.6	26.7	0.0	15.6	0.9	0.0	4.8	0.1	0.0	0.3	0.5	0.1	2.6	0.5
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.9;Endometrial ciliated cells: 45.5;Late spermatids: 42.6;Respiratory ciliated cells: 47.3;Skeletal myocytes: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	17.2	13.0	8.6	5.5	9.4	7.8	12.1	9.6	9.7	10.2	16.0	9.4	6.2	10.1	15.2	8.2	26.4	8.7	15.0	9.0	10.1	17.9	12.6	8.3	4.8	10.0	10.8	13.0	11.4	10.8	16.6	6.6	9.0	11.3	7.1	30.0	10.3	11.6	10.6	9.6	6.3	8.7	9.3	6.0	8.8	8.8	11.5	7.5	21.3	13.6	5.4	7.4	7.8	8.0	24.6	17.9	8.5	22.4	14.8	13.0	5.0	12.5	12.2	13.0	12.4	11.3	4.6	10.5	8.6	10.0	7.6	21.3	18.9	16.1	19.4	7.1	21.9	6.9	24.6	16.3	6.7	12.4	4.7	11.2	19.9	22.8	20.2	8.0	14.0	25.3	5.2	7.0	7.3	10.7	19.5	5.0	10.7	16.0	18.2	13.2	3.9	10.7	20.4	4.7	11.4	7.6	19.9	10.8	11.6	8.5	12.6	5.0	9.9	9.9	8.7	17.8	15.9	3.7	9.7	5.8	20.8	6.7	6.5	0.3	0.9	0.0	1.0	0.7	1.1	1.2	0.8	0.5	1.2	0.5	2.1	1.1	0.9	0.6	0.4	0.5	0.8	0.7	8.6	9.4	9.6	9.7	9.0	10.1	10.0	10.8	9.0	9.3	11.5	8.0	21.8	12.8	19.5	5.9	4.5	5.1	6.7	4.9	1.8	4.8	22.2	18.4	0.3	7.2	11.0	5.5	20.9	4.2	7.7	5.0	13.7	4.2	71.9	45.5	16.3	14.7	6.0	0.8	6.8	3.1	2.7	13.2	13.3	27.2	10.8	4.6	6.8	8.3	3.9	1.7	5.9	8.5	4.1	1.6	4.3	42.6	4.7	29.1	5.4	2.8	0.3	6.7	0.0	0.5	2.2	7.7	4.5	3.8	5.1	7.8	4.5	11.9	47.3	20.3	6.6	41.9	7.5	4.4	2.7	8.5	6.1	2.6	4.4	2.9	8.3	2.5
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 139.2;testis: 133.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 268.0;Late spermatids: 601.1;Spermatocytes: 115.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.1;memory B-cell: 10.6;naive B-cell: 2.8"	"Group enriched"	"Detected in many"	9	"B-cells: 10.6;granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.1;BJ hTERT+ SV40 Large T+: 65.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.4;HBF TERT88: 52.0;NTERA-2: 69.8;WM-115: 96.3"	"Low region specificity"	"Detected in single"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	8.8	3.6	17.2	5.7	23.1	4.1	15.6	18.7	25.3	15.6	13.2	4.6	2.4	22.8	25.5	19.6	10.1	6.8	4.7	18.2	19.7	5.9	5.1	11.5	2.7	19.5	22.5	29.3	4.3	29.0	1.3	13.8	19.2	19.5	5.3	139.2	35.7	22.3	1.7	51.1	4.3	13.2	16.9	3.0	5.6	133.6	21.8	0.9	5.1	1.7	10.5	13.3	17.7	28.0	7.1	3.6	1.5	0.0	0.3	1.7	22.8	43.9	125.1	65.9	59.4	0.7	9.4	0.2	10.3	22.7	20.2	0.8	0.1	0.3	52.0	0.1	0.2	0.0	3.8	0.9	35.0	0.4	6.6	17.7	1.4	0.3	3.7	0.1	5.6	0.0	6.9	0.1	0.5	0.0	0.0	0.1	69.8	7.4	3.4	34.1	0.1	0.0	0.0	4.4	0.0	0.7	0.3	28.0	1.9	11.1	4.8	9.4	0.0	6.1	0.1	0.3	3.4	0.2	0.0	10.7	0.5	0.0	96.3	0.0	0.9	6.1	0.0	0.5	0.0	10.6	0.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	17.2	23.1	18.7	25.3	18.2	19.7	19.5	22.5	19.2	16.9	21.8	28.0	0.6	22.4	5.1	0.0	2.3	7.0	8.4	12.3	8.6	1.3	8.8	12.8	3.0	1.5	6.3	3.7	20.9	5.3	0.1	0.6	0.0	1.4	268.0	5.5	11.2	1.7	0.0	0.0	0.0	4.7	20.0	8.1	1.5	14.3	2.5	0.5	0.4	1.8	2.5	0.0	0.1	1.8	6.1	0.0	0.5	601.1	4.7	1.5	5.4	1.9	0.5	0.8	0.0	0.5	8.5	6.0	1.4	6.0	2.9	11.2	0.3	0.4	10.2	35.2	13.1	2.3	7.5	115.6	9.8	12.8	10.1	4.5	0.2	1.8	1.8	11.4
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 50.2;thyroid gland: 41.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 213.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	12.5	2.2	5.9	2.7	7.6	15.9	8.8	5.9	8.1	6.7	4.3	9.8	20.6	1.6	0.2	3.3	1.7	1.5	28.0	5.5	6.7	4.5	2.0	20.0	3.1	6.2	6.8	0.9	2.7	0.9	1.6	0.4	6.6	5.1	6.6	0.4	7.5	3.6	50.2	8.1	21.3	1.7	6.0	7.8	9.9	3.1	6.6	1.5	41.9	19.6	2.6	2.4	9.5	9.5	3.1	2.3	6.1	1.5	10.6	0.5	0.0	2.1	6.7	1.1	1.2	1.0	1.6	0.2	0.7	6.7	3.7	9.2	3.8	0.1	0.6	0.2	0.2	1.3	4.5	0.1	0.1	0.1	18.3	1.1	7.9	0.4	0.2	7.0	0.7	0.1	0.4	0.1	0.7	9.7	0.0	0.4	0.7	3.1	2.2	2.9	0.0	0.3	0.0	3.2	0.4	0.3	0.4	1.2	0.0	1.5	5.2	0.4	0.4	0.9	1.0	1.4	1.8	0.6	0.2	0.0	0.0	3.0	0.3	94.3	0.2	213.0	2.1	0.1	0.9	1.3	0.6	2.2	0.2	0.4	0.0	1.4	65.9	2.7	0.1	8.6	0.1	1.3	5.9	7.6	5.9	8.1	5.5	6.7	6.2	6.8	6.6	6.0	6.6	9.5	24.9	86.6	22.3	5.2	4.8	11.6	7.0	8.7	0.6	0.1	9.4	7.4	46.2	1.5	14.6	0.0	0.0	0.1	22.6	45.2	1.9	9.1	25.3	3.0	1.6	6.4	8.4	0.8	15.9	35.6	0.2	8.7	16.3	7.8	15.2	1.3	5.7	1.3	0.4	5.0	2.1	17.0	6.1	1.3	0.8	112.5	3.1	3.2	0.0	15.0	0.3	2.1	2.1	11.1	99.9	9.4	30.6	5.7	0.4	12.0	64.0	0.3	2.8	0.3	13.1	7.6	4.5	2.6	4.9	0.5	4.1	0.1	14.9	1.9	19.6	14.0
DCLRE1C	"A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C"	ENSG00000152457	"DNA cross-link repair 1C"	Q96SD1	10	14897359-14954432	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069295			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA069295: AB_2686112"	"unprognostic (8.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (1.30e-4)"	"unprognostic (8.02e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.91e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (9.03e-8)"	"unprognostic (2.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.45e-3)"	4.2	3.3	2.2	8.0	3.2	14.0	6.1	5.7	3.4	4.5	3.7	4.3	5.2	4.4	3.8	7.1	3.7	4.0	2.3	2.2	2.2	3.5	2.6	4.9	14.1	2.8	2.7	4.5	3.1	3.8	2.2	4.4	3.1	4.0	5.2	4.9	4.5	3.7	3.0	6.9	5.4	3.9	2.5	10.4	5.9	1.9	2.9	12.3	5.5	2.7	12.8	5.4	5.1	3.7	16.2	7.8	6.9	13.8	6.4	8.2	6.6	9.7	5.3	13.0	13.5	8.9	13.4	21.7	3.8	7.6	9.2	13.7	7.6	5.1	10.9	13.4	8.0	16.7	8.9	6.0	5.1	10.0	18.4	6.6	4.8	12.7	5.3	8.2	7.4	13.9	10.5	17.4	8.6	7.4	14.9	9.9	4.7	14.4	3.5	17.2	9.2	12.1	6.5	6.0	3.6	6.9	10.7	10.2	27.5	5.3	12.8	18.5	6.0	8.3	11.6	17.1	10.8	9.9	19.1	21.5	8.1	10.5	11.8	27.4	13.9	20.0	12.1	18.9	14.5	25.1	14.1	15.0	20.9	28.1	12.2	13.2	13.2	11.0	17.5	22.4	11.9	8.9	2.2	3.2	5.7	3.4	2.2	2.2	2.8	2.7	3.1	2.5	2.9	3.7	6.6	3.2	6.9	17.9	27.6	17.3	20.8	10.9	5.7	24.8	7.8	4.3	4.4	11.5	26.1	14.7	62.6	15.1	21.8	10.9	3.9	9.9	26.8	8.5	8.6	8.2	6.7	22.7	12.4	11.1	21.9	10.2	7.1	13.1	6.3	14.1	10.4	1.9	10.2	32.0	10.6	7.3	10.2	19.8	20.6	2.3	12.5	13.3	19.6	16.9	21.8	10.4	35.0	12.5	11.9	14.9	15.5	11.3	13.4	21.5	12.3	2.7	22.3	47.9	19.7	18.1	11.9	13.9	18.5	7.3	21.2	5.1	14.8	12.4	8.6	41.4
DELE1	"DELE, KIAA0141"	ENSG00000081791	"DAP3 binding cell death enhancer 1"	Q14154	5	141923855-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	42.5	54.2	26.5	22.5	29.1	39.7	42.0	30.4	32.9	43.3	33.6	43.8	30.3	41.2	14.6	35.4	38.8	24.9	78.9	26.8	27.7	44.5	53.5	46.2	30.2	29.9	28.6	37.9	42.9	38.1	34.0	29.4	28.9	41.4	31.2	14.0	33.1	24.5	71.1	32.3	39.6	30.1	27.7	65.7	42.4	15.6	29.5	19.3	40.3	49.7	27.1	43.4	38.7	29.6	23.6	31.5	44.7	65.9	34.7	45.5	29.7	29.8	48.8	51.6	56.8	46.0	54.0	55.1	33.2	32.9	29.9	35.1	27.2	62.8	28.4	31.7	24.0	33.4	37.9	34.5	43.8	48.3	63.3	55.8	31.3	45.4	37.0	46.0	54.5	11.5	21.4	72.9	26.9	30.8	13.0	26.8	17.2	28.6	49.9	43.5	29.7	61.8	37.2	33.7	25.0	31.8	35.2	54.0	72.6	28.8	70.3	42.6	44.1	38.9	23.8	20.7	27.0	20.1	23.3	34.0	32.0	38.1	43.4	21.2	43.0	14.8	21.2	56.7	19.7	20.6	16.5	20.7	56.1	19.1	13.8	18.2	18.2	24.7	66.9	22.2	27.2	25.3	26.5	29.1	30.4	32.9	26.8	27.7	29.9	28.6	28.9	27.7	29.5	29.6	31.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	16.0	17.0	0.0	0.0	0.0	11.0	0.0	26.2	13.7	0.0	13.7	12.4	0.0	12.0	13.7	10.9	0.0	0.0	0.0	24.3	13.8	6.3	0.0	12.1	0.0	24.4	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	17.2	0.0	0.0	5.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	25.7	4.8	34.5	0.0	0.0
DENND4B	KIAA0476	ENSG00000198837	"DENN domain containing 4B"	O75064	1	153929501-153946718	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040188, HPA071133"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040188: AB_10671168, HPA071133: AB_2732173"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-3)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (9.27e-9)"	"unprognostic (4.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.56e-3)"	18.2	13.4	10.9	24.3	11.1	37.1	15.7	2.3	19.1	17.1	0.0	15.6	9.5	16.3	3.4	10.2	16.2	10.0	21.3	10.2	6.5	13.8	11.4	24.2	30.1	12.0	7.8	19.6	15.5	7.7	13.1	10.3	13.0	13.0	6.0	9.5	11.7	7.0	49.2	11.0	22.0	8.9	3.1	41.0	12.9	7.6	9.8	14.6	15.2	29.5	17.3	15.1	12.9	10.0	12.0	22.7	17.1	17.3	10.0	9.7	17.8	11.5	12.4	17.8	16.6	13.8	13.4	29.9	19.1	7.8	13.5	20.9	15.5	10.6	8.0	27.5	14.0	26.5	26.1	13.3	13.9	28.0	51.5	8.8	18.3	16.6	17.8	14.8	12.8	32.3	28.7	16.4	10.3	24.6	34.2	25.7	23.8	14.1	21.8	36.2	11.5	17.3	8.5	17.6	20.3	24.9	12.1	28.4	16.7	17.0	20.6	68.0	13.5	19.2	18.5	16.1	18.7	49.3	37.7	39.5	13.2	21.7	23.5	1.5	1.6	0.4	1.1	2.4	1.4	1.0	0.9	0.7	1.4	0.9	0.4	1.0	1.5	0.7	1.9	1.9	0.7	1.5	10.9	11.1	2.3	19.1	10.2	6.5	12.0	7.8	13.0	3.1	9.8	10.0	14.7	9.6	10.3	18.6	20.3	4.7	3.7	4.6	1.2	22.3	7.1	6.9	22.9	8.6	5.7	7.3	6.2	4.6	31.9	4.8	5.9	5.2	1.2	4.0	8.0	11.8	4.9	9.5	21.8	6.5	4.7	7.2	13.7	7.4	17.2	12.5	10.8	9.2	18.0	35.3	23.6	4.6	2.0	30.2	11.7	1.9	7.5	31.1	5.4	18.7	22.5	5.8	30.9	19.1	27.9	6.1	4.8	7.9	7.1	6.8	7.6	2.7	4.4	17.8	6.6	7.9	6.0	6.4	8.1	5.7	3.4	3.4	17.0	9.2	7.1	5.2
DENND5A	"FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1"	ENSG00000184014	"DENN domain containing 5A"	Q6IQ26	11	9138825-9265959	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 287.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052923, HPA055009"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"		"HPA052923: AB_2681989, HPA055009: AB_2682669"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (9.86e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.40e-2)"	45.8	23.5	72.4	23.2	90.5	21.7	36.3	85.0	80.7	36.1	45.5	44.2	5.8	38.5	14.1	17.4	37.5	23.3	58.0	65.1	85.4	25.5	15.7	46.1	16.8	81.5	86.6	30.2	23.2	18.5	20.5	28.8	77.0	24.5	12.9	34.7	19.5	40.0	26.7	17.3	20.2	47.5	74.9	31.4	23.7	15.8	87.3	28.0	22.0	33.7	15.9	40.4	25.1	81.3	18.8	23.3	63.7	56.1	113.0	92.0	61.7	69.2	99.8	85.7	104.5	16.4	13.6	0.0	30.5	129.0	82.4	12.7	64.3	22.5	111.4	73.0	30.9	6.2	32.2	34.5	61.0	34.4	13.9	76.8	11.5	51.1	74.6	59.7	83.8	21.9	33.6	0.3	101.9	11.0	19.4	15.1	19.7	3.2	28.6	34.2	46.1	0.3	41.6	13.4	15.9	32.1	65.8	29.7	27.2	70.4	15.7	24.6	59.2	63.0	41.0	78.7	47.3	1.4	0.4	18.7	63.4	14.1	51.9	4.4	5.0	5.7	0.1	6.3	0.6	1.8	1.3	1.3	4.6	0.2	3.8	1.9	10.8	1.0	9.2	1.1	0.0	1.9	72.4	90.5	85.0	80.7	65.1	85.4	81.5	86.6	77.0	74.9	87.3	81.3	34.1	19.2	14.5	43.8	7.4	21.7	19.3	10.3	10.2	9.7	15.3	13.8	33.2	14.3	8.0	14.7	60.5	15.9	6.4	0.3	0.0	7.3	1.1	26.3	31.8	31.3	6.6	7.8	47.7	6.7	20.1	27.1	3.1	57.8	2.5	11.6	21.4	10.9	21.8	13.5	74.2	2.2	4.1	36.3	63.4	2.0	21.5	48.9	19.6	68.4	41.1	11.6	3.1	136.2	287.1	8.4	1.4	20.7	0.9	32.5	0.1	10.3	4.8	10.5	26.3	34.4	31.6	7.9	12.3	6.3	8.2	11.2	6.3	16.0	0.8	15.0
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591879-36600804	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"intestine: 216.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 129.3;Distal enterocytes: 317.3;Paneth cells: 154.2;Proximal enterocytes: 527.9;Undifferentiated cells: 148.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted to digestive system"	NA	NA		42000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Golgi apparatus"	"HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209"	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	10.0	10.5	6.9	5.4	7.9	4.4	10.9	6.7	9.8	9.5	9.0	74.3	216.0	5.7	1.9	14.6	7.3	2.4	17.2	8.6	9.0	21.9	14.8	4.3	2.4	7.4	7.5	5.1	15.4	9.5	13.3	2.0	7.9	8.0	57.1	22.4	10.3	4.5	16.7	14.4	177.0	6.3	6.6	4.7	11.7	17.0	8.2	2.1	11.9	9.9	3.6	6.8	10.5	7.7	13.9	10.0	3.6	13.8	1.2	2.5	10.6	3.8	2.6	11.9	10.7	22.2	10.1	0.8	1.9	4.0	4.8	13.9	11.5	6.7	10.5	7.1	15.2	3.7	10.1	35.6	5.5	3.0	1.2	2.2	7.3	8.6	6.5	1.9	8.8	11.2	36.1	9.3	5.9	12.5	12.6	5.5	4.5	14.2	0.4	15.2	12.8	22.0	9.9	11.4	10.4	4.9	16.0	12.9	33.3	6.6	19.1	3.6	4.8	1.6	18.2	7.6	10.0	14.1	16.7	4.4	6.5	9.3	5.5	0.1	0.1	0.4	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.0	6.9	7.9	6.7	9.8	8.6	9.0	7.4	7.5	7.9	6.6	8.2	7.7	9.1	0.0	1.5	4.2	3.3	4.2	8.9	2.8	4.0	20.7	14.6	13.3	9.6	2.8	2.4	7.3	129.3	7.9	1.4	317.3	58.7	10.7	22.9	10.2	5.0	6.7	12.1	31.5	8.2	11.4	4.7	3.4	8.6	6.8	0.0	5.3	5.3	12.7	3.5	16.8	9.6	72.2	2.0	1.9	4.2	30.5	4.1	2.6	19.6	2.8	3.6	15.8	1.0	4.0	2.0	7.5	154.2	5.3	9.1	11.7	527.9	43.1	3.8	71.0	0.0	5.9	5.9	27.7	6.5	12.0	6.0	7.0	3.1	9.3	148.5	15.2
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DPH5	CGI-30	ENSG00000117543	"Diphthamide biosynthesis 5"	Q9H2P9	1	100989623-101026088	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046439, HPA076234"	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	Nucleoli	"HPA046439: AB_2679667, HPA076234: AB_2797274"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.00e-2)"	12.5	23.2	17.2	8.4	17.8	10.7	28.8	17.3	22.5	23.2	18.3	14.6	7.1	17.2	23.8	13.7	26.2	11.6	23.5	17.4	18.7	19.5	25.3	10.1	18.1	17.8	18.0	49.8	31.4	20.0	15.5	12.3	17.8	15.0	17.5	8.8	11.9	17.1	20.8	15.0	11.2	19.7	17.6	15.4	14.1	9.8	19.0	29.0	20.7	25.0	25.4	14.7	13.3	18.0	28.1	30.1	40.1	37.0	48.3	154.7	34.9	24.9	42.9	41.0	34.5	35.3	7.7	46.0	33.2	22.2	23.1	20.0	47.5	41.1	62.6	20.0	35.8	22.1	26.7	71.4	84.1	33.4	13.8	97.1	63.9	38.8	118.6	67.4	64.8	33.4	62.6	16.7	70.3	26.3	40.7	36.7	31.5	15.2	46.4	37.8	51.1	32.6	50.0	25.7	44.2	22.2	13.7	36.2	114.0	29.6	27.3	18.3	25.1	23.0	28.7	28.8	34.4	20.0	24.1	31.9	31.5	29.6	7.9	5.7	7.5	4.6	16.1	8.9	21.7	19.2	17.9	17.7	13.6	15.1	24.0	20.9	2.7	24.7	10.6	9.8	12.8	10.2	17.2	17.8	17.3	22.5	17.4	18.7	17.8	18.0	17.8	17.6	19.0	18.0	8.1	6.4	14.6	17.0	30.3	15.8	17.0	24.2	19.9	5.3	18.7	12.3	23.8	21.5	12.7	7.3	0.0	26.2	10.1	4.7	23.5	14.0	1.8	14.2	19.6	11.2	10.2	17.7	12.0	18.4	27.8	13.5	5.6	8.2	25.4	29.0	12.1	29.3	18.9	1.7	14.6	15.0	22.4	28.4	13.1	3.0	27.1	14.0	12.4	8.4	27.7	16.5	27.8	27.2	28.3	8.9	12.9	13.9	10.3	10.8	8.1	30.9	16.8	6.5	6.6	16.6	12.5	15.7	17.6	17.0	18.0	13.0	19.4	33.4	23.7	11.3
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110546-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 997.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.0;THP-1: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	60.2	98.8	42.1	28.0	43.2	45.8	56.8	43.4	64.9	45.4	83.6	65.3	28.4	46.3	16.7	46.0	53.6	31.3	116.4	43.8	52.0	58.7	70.0	57.3	41.7	53.4	48.0	37.7	82.8	54.3	112.3	26.7	45.7	81.1	7.3	8.0	92.3	46.2	52.8	56.6	51.7	12.8	45.6	79.0	69.4	75.3	48.3	19.8	83.7	21.4	14.4	59.3	48.0	49.2	28.0	43.1	3.5	3.6	51.1	40.5	5.7	42.2	66.2	26.6	17.4	41.0	22.2	56.2	44.4	27.2	1.2	60.3	30.7	8.2	1.3	54.8	2.1	26.4	63.6	1.3	113.5	69.1	135.5	50.0	31.7	11.6	24.1	38.3	35.1	65.8	57.5	41.2	18.0	76.4	35.7	65.7	14.8	99.9	42.8	52.8	0.5	232.0	43.3	30.5	67.7	46.7	47.8	122.6	118.9	0.8	43.5	218.1	44.1	67.4	23.5	43.4	29.5	51.7	31.8	14.9	80.9	41.1	31.1	40.2	194.8	59.2	148.8	176.2	151.8	86.6	131.4	127.9	190.6	83.4	117.1	106.2	12.0	95.0	110.6	276.6	173.6	204.1	42.1	43.2	43.4	64.9	43.8	52.0	53.4	48.0	45.7	45.6	48.3	49.2	80.5	54.5	80.9	54.9	96.8	67.0	103.2	109.2	59.7	74.5	90.3	82.2	66.5	94.4	76.8	53.3	35.5	55.2	129.2	28.2	37.2	121.0	288.7	35.9	40.7	58.2	88.1	35.9	31.4	68.1	115.3	97.2	33.6	47.3	74.3	178.7	64.6	77.1	315.7	121.1	27.9	32.3	107.8	171.7	106.2	997.8	155.4	150.1	167.2	9.4	165.5	123.9	122.6	16.6	26.4	58.2	54.3	169.2	190.2	108.5	97.3	84.9	75.4	83.6	52.6	57.4	58.4	106.2	46.2	47.3	64.9	51.4	115.4	19.0	43.1	90.4
DPY30	"Cps25, HDPY-30, Saf19"	ENSG00000162961	"Dpy-30 histone methyltransferase complex regulatory subunit"	Q9C005	2	31867809-32039805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043761	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		29000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA043761: AB_10960501"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-1)"	40.2	75.2	66.9	34.3	68.6	31.4	61.3	72.1	84.4	53.2	73.6	50.9	43.4	38.3	78.3	60.2	90.5	42.4	46.7	68.4	73.6	79.1	84.8	44.1	51.8	71.6	71.5	42.7	48.1	58.3	50.9	43.9	73.6	57.3	46.4	33.3	64.6	47.0	48.8	49.7	44.4	37.4	73.2	36.1	46.8	22.6	69.1	52.3	81.6	45.4	49.3	51.8	50.0	77.5	201.8	136.8	100.8	78.1	86.7	128.8	134.9	102.1	90.8	81.2	79.5	197.2	158.3	123.2	102.2	90.8	148.3	79.9	93.1	118.6	88.1	146.4	149.5	110.8	89.7	225.5	76.5	114.3	66.8	87.4	135.6	87.4	76.9	109.1	130.4	55.1	132.5	85.3	125.6	219.4	128.8	228.9	139.2	184.3	140.5	104.0	118.9	155.7	144.2	137.1	162.5	115.9	101.2	141.1	143.6	118.2	98.3	82.1	100.5	73.9	119.1	69.2	125.4	99.9	161.3	166.2	77.6	123.2	91.7	177.6	101.0	150.8	95.5	99.9	116.5	165.9	133.5	119.4	100.5	135.6	118.1	112.0	117.3	105.8	112.8	91.5	200.3	130.6	66.9	68.6	72.1	84.4	68.4	73.6	71.6	71.5	73.6	73.2	69.1	77.5	65.7	51.3	61.5	10.1	61.7	98.0	107.7	233.5	53.5	17.9	110.5	135.1	71.3	80.1	140.8	103.0	0.0	190.2	41.0	84.2	283.7	114.3	64.5	388.8	59.7	62.9	92.1	55.5	16.0	117.2	252.4	63.1	44.4	107.3	46.9	65.1	63.1	102.7	123.5	21.9	17.7	107.6	175.0	65.4	67.2	18.5	72.4	58.7	65.8	13.1	106.8	50.8	55.6	13.6	26.7	125.7	117.8	88.0	40.6	130.5	138.4	296.7	396.4	26.8	85.5	52.4	108.4	65.7	57.4	72.0	122.6	138.7	67.3	67.7	109.0	127.5
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117163-111140203	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	38.0	23.1	13.9	33.1	14.5	17.9	26.8	17.7	19.9	23.1	22.7	26.7	28.6	17.7	17.6	15.0	30.1	36.4	23.7	13.5	15.2	26.5	24.9	25.0	55.3	15.6	14.9	24.3	25.6	28.3	4.6	41.2	16.2	17.8	30.7	16.9	25.8	16.7	16.6	17.9	26.3	17.0	15.5	45.3	23.4	10.3	15.0	27.8	22.0	23.6	50.3	29.4	4.2	17.8	38.0	12.9	24.0	10.8	57.3	56.2	23.4	28.7	29.9	24.7	24.9	12.5	38.2	28.7	17.2	25.6	12.1	37.4	30.5	24.0	31.9	26.8	25.6	16.8	18.4	16.4	41.4	19.4	15.4	38.5	41.4	18.3	38.4	53.6	29.9	29.1	34.1	19.6	30.1	19.6	16.6	28.8	14.5	43.3	13.2	11.1	40.0	14.0	42.5	25.8	19.1	18.2	16.8	52.4	80.1	33.1	16.7	84.6	24.8	20.6	13.8	16.2	18.9	25.7	9.6	29.8	33.4	34.7	29.6	41.7	47.3	11.5	14.2	61.0	19.4	65.7	17.5	15.3	45.1	54.1	22.3	19.0	7.2	25.0	49.8	28.6	17.7	35.5	13.9	14.5	17.7	19.9	13.5	15.2	15.6	14.9	16.2	15.5	15.0	17.8	34.5	12.8	12.0	17.3	146.2	47.0	54.4	82.5	34.1	11.6	53.6	43.9	29.7	32.9	53.1	44.1	2.1	98.1	38.9	41.2	43.0	59.2	8.5	51.7	19.5	36.4	13.2	28.6	20.6	46.6	102.3	39.2	24.5	17.6	23.6	18.5	42.8	26.0	183.1	20.2	31.7	45.7	77.3	189.4	97.8	7.8	33.5	110.3	81.8	39.4	89.0	27.1	56.7	31.7	42.6	41.9	64.3	24.8	54.7	46.3	88.4	80.4	95.8	10.1	39.5	26.4	32.5	4.7	14.6	40.8	53.0	73.3	38.6	26.3	43.7	70.1
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559596-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040688, HPA055316"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		2500000	"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus"	"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	1237.6	883.6	646.7	951.1	663.7	1897.3	1890.9	640.9	722.0	1595.1	659.8	1229.0	1094.9	1078.6	1079.3	1634.9	1555.9	749.8	1089.3	616.4	690.9	1162.4	885.3	818.1	1532.7	678.1	661.0	2604.5	2191.5	835.7	708.1	780.5	675.9	1219.1	1272.4	416.0	1588.0	875.6	4810.2	2215.7	1098.5	991.5	690.1	1073.0	1090.2	441.9	677.4	1281.7	1050.2	3030.5	1951.7	1173.7	1440.6	676.7	1773.6	1824.3	1859.1	2656.2	2742.6	3529.1	1866.2	1505.0	2692.9	1830.1	1392.3	2045.9	2161.9	5161.2	2365.4	2392.2	1048.0	2018.3	2229.8	2200.1	1663.3	1693.2	2071.2	1348.7	2061.8	2120.7	2974.2	2810.2	1523.6	4060.8	3913.9	1812.1	4419.8	3014.9	2562.7	1777.2	2755.8	2451.2	2190.6	3611.0	3035.5	4895.3	2304.9	1546.3	1575.0	2545.1	2390.9	4978.7	2454.9	2276.4	1608.2	2002.3	901.7	3010.3	4214.5	1179.1	3496.3	3012.0	1759.8	1057.1	1476.4	2070.0	1338.6	1680.0	1783.1	2609.2	1210.8	2005.2	1517.1	883.9	2365.5	589.6	2182.3	2151.6	4333.1	5399.6	4153.2	2825.0	3623.0	5080.7	6117.7	4188.5	320.6	3285.2	1837.0	2869.7	3307.5	11090.3	646.7	663.7	640.9	722.0	616.4	690.9	678.1	661.0	675.9	690.1	677.4	676.7	2.8	150.6	366.9	14.4	403.6	7.9	2.5	8.8	1021.0	0.5	21.9	10.3	0.0	14.3	300.8	1.8	2.1	17.7	9.6	63.7	3.9	124.8	4.3	2.2	7.2	70.2	148.5	405.0	8.4	188.5	26.8	149.5	252.8	3.5	375.6	1.8	11.0	4.9	12.5	0.0	13.8	152.0	4.1	8.8	4.9	18.8	3.1	134.7	1.8	24.4	126.4	0.8	16.5	6.0	13.0	114.9	121.0	2.2	770.5	3.0	132.1	12.1	152.0	0.5	0.0	1.6	43.9	1.4	0.8	1166.7	6.1	21.1	235.3	1.1	223.8	2.3
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 414.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9"	"Cancer enriched"	"Detected in all"	5	"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"		No	NA		14000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	86.3	7.0	199.7	3.7	303.2	0.8	180.7	244.9	261.3	86.9	129.9	16.9	4.4	72.4	33.7	9.6	73.7	12.0	46.0	196.6	217.4	186.2	54.6	15.3	3.9	253.6	258.7	76.5	86.5	10.5	16.5	77.9	261.8	25.6	5.7	9.5	22.2	27.7	35.5	30.9	16.2	20.6	201.4	52.5	17.6	20.1	237.8	3.0	32.7	42.7	2.4	22.0	44.5	414.6	0.0	3.4	5.7	1.4	2.2	0.1	125.8	26.8	2.1	2.3	1.9	0.9	0.6	0.1	2.0	11.6	2.9	0.2	19.0	0.0	0.3	0.5	9.2	0.0	2.4	1.9	0.0	0.1	0.3	1.0	0.4	0.2	0.0	0.4	0.0	5.5	3.9	0.5	0.5	2.3	0.6	0.2	8.4	0.0	0.2	0.6	7.2	0.4	68.6	0.7	0.3	3.2	9.1	301.8	18.3	42.3	236.9	2.6	0.0	0.0	1.8	0.4	0.8	0.2	0.1	0.1	0.3	0.1	13.4	1.0	0.2	0.1	0.2	0.1	0.4	0.3	0.3	0.4	0.1	0.1	0.6	0.6	2.2	0.1	0.1	0.2	0.1	0.1	199.7	303.2	244.9	261.3	196.6	217.4	253.6	258.7	261.8	201.4	237.8	414.6	15.6	0.0	0.0	37.5	1.5	3.6	2.8	1.3	1.2	0.5	241.8	129.0	7.4	1.5	4.6	35.0	0.0	112.0	3.0	0.3	393.2	0.0	9.0	1.1	37.8	16.8	0.0	2.7	2.6	0.0	19.7	41.1	0.0	1.7	0.0	3.2	6.4	89.4	8.7	0.0	5.3	0.1	59.0	1.3	3.0	7.0	44.4	2.1	8.8	18.7	0.0	48.0	0.0	1.5	173.4	0.0	0.0	57.2	0.1	4.6	0.0	116.5	1.9	1.4	197.2	8.7	130.9	17.3	13.6	0.4	3.1	263.9	2.5	1.5	0.3	2.0
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34663288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 287.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"myeloid DC: 1.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.9	1.1	0.9	14.7	1.7	0.2	199.5	0.9	0.6	120.8	1.3	99.3	42.2	13.9	95.0	200.7	129.6	32.2	0.3	1.1	0.8	25.7	1.3	23.4	1.5	2.6	4.0	0.2	41.1	18.5	0.7	0.1	2.8	82.7	126.3	0.8	287.7	153.4	0.2	53.6	34.1	3.5	2.5	1.2	59.5	0.7	1.3	1.3	2.5	0.0	67.3	50.7	79.2	4.7	46.5	26.8	0.0	0.3	0.0	0.0	0.8	0.0	3.9	0.0	0.2	0.4	138.4	0.1	17.1	0.0	0.2	95.7	0.0	107.6	0.5	0.1	0.2	0.0	1.5	0.2	0.0	0.2	0.0	0.0	41.7	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.8	0.2	132.9	1.0	0.0	0.1	1.0	20.2	214.8	0.0	0.2	0.5	14.8	0.2	0.0	213.5	0.5	0.0	0.2	1.2	5.1	0.4	0.5	0.2	0.3	0.3	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.9	0.6	1.1	0.8	2.6	4.0	2.8	2.5	1.3	4.7	0.8	48.1	97.2	1.3	0.6	109.6	400.8	271.6	133.1	0.0	123.0	51.9	0.9	60.1	323.3	55.2	0.0	0.1	1.1	62.7	15.6	77.8	14.2	229.6	17.7	4.0	23.3	0.0	0.7	86.5	0.0	3.2	53.5	281.8	1.3	0.0	0.0	0.4	0.1	0.0	0.0	82.8	116.0	0.0	17.7	1.0	0.0	5.1	12.4	0.0	5.6	3.8	0.0	0.0	2.4	104.8	30.2	0.0	1.2	173.1	14.1	0.3	204.6	0.0	0.0	0.0	9.6	0.4	0.1	251.1	170.1	1.4	4.9	0.0	74.5	397.3
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA049476: AB_2680784"	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	13.5	12.9	13.9	8.3	14.7	17.4	12.7	14.7	13.6	9.7	13.2	12.5	10.6	12.7	7.2	13.1	9.2	6.3	19.5	13.9	13.9	13.8	12.8	9.3	10.1	14.8	14.3	8.2	10.9	11.0	10.2	9.3	13.8	9.9	8.7	7.1	9.9	8.7	20.8	10.5	10.5	9.3	15.1	10.9	11.7	12.2	14.8	10.3	9.6	12.5	9.5	11.7	9.4	16.0	29.8	34.1	21.3	19.5	22.6	21.6	41.4	28.7	28.4	46.9	20.8	54.7	33.5	25.6	32.5	29.1	21.0	33.3	32.0	30.1	41.5	10.9	45.7	21.1	17.3	50.3	34.2	21.7	13.7	23.8	20.1	35.7	41.5	20.2	27.1	30.9	48.6	9.6	29.2	50.7	34.5	61.4	42.5	27.4	43.3	50.0	17.4	21.8	29.9	20.7	35.9	21.4	52.8	17.1	33.9	18.9	33.9	38.1	23.8	28.1	28.7	24.9	37.1	26.6	27.3	102.8	24.1	41.3	30.2	17.9	18.1	25.6	10.9	19.2	12.7	11.1	11.8	14.8	24.2	15.6	14.7	14.4	7.5	19.2	19.5	17.8	12.3	12.3	13.9	14.7	14.7	13.6	13.9	13.9	14.8	14.3	13.8	15.1	14.8	16.0	60.1	6.4	8.6	10.4	25.0	61.3	30.1	28.9	25.0	33.7	26.7	26.0	19.9	15.7	18.5	25.8	12.5	48.5	25.0	28.8	60.7	46.9	230.2	37.1	28.3	33.6	46.6	21.5	6.1	42.1	60.7	26.2	18.8	40.9	9.5	25.1	23.6	23.3	47.0	15.2	7.8	27.4	26.4	28.0	38.0	55.0	24.8	27.1	28.4	8.4	41.9	27.8	27.8	8.0	12.2	50.0	27.2	31.6	33.3	51.1	29.1	46.5	12.5	18.6	26.3	22.5	28.9	54.2	56.5	33.5	54.6	51.0	22.4	37.0	35.6	41.9
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: AB_2674600"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	4.7	6.8	4.3	3.7	4.9	6.4	9.2	4.4	5.5	3.9	4.8	7.4	8.1	4.1	7.6	6.7	5.7	4.5	4.4	4.1	4.4	6.5	12.1	4.7	3.8	4.9	4.4	4.5	7.4	14.0	5.0	5.4	4.9	7.5	10.2	4.2	5.1	4.8	5.1	7.1	7.8	4.6	4.6	3.6	8.4	13.1	4.7	7.5	6.2	3.7	4.4	4.5	4.7	5.7	17.1	7.9	21.6	9.5	6.5	8.3	13.0	13.3	7.9	11.8	14.9	10.2	17.0	4.8	14.6	7.3	8.2	12.7	21.8	13.7	21.8	15.3	11.4	11.5	9.7	17.6	6.0	22.3	9.0	7.5	16.7	15.9	13.2	6.3	7.2	0.0	37.1	13.5	20.0	15.3	3.2	19.8	13.4	17.5	4.5	25.5	17.7	10.5	11.0	13.4	11.0	13.5	8.5	16.0	10.3	11.4	33.7	24.7	5.5	12.5	7.0	12.2	17.9	8.3	13.4	2.9	11.9	17.9	17.6	13.8	1.8	1.7	0.4	1.3	0.3	0.5	0.4	0.4	1.9	0.0	0.3	0.2	0.1	0.5	2.6	0.6	0.8	0.4	4.3	4.9	4.4	5.5	4.1	4.4	4.9	4.4	4.9	4.6	4.7	5.7	4.0	16.0	6.7	18.3	1.0	5.0	5.3	5.6	8.0	5.3	11.3	5.8	7.3	5.7	8.5	9.2	0.0	8.3	0.9	8.0	9.8	4.1	22.5	6.9	5.5	3.0	0.0	22.7	10.4	5.2	9.1	4.3	9.7	6.0	0.0	7.1	2.9	10.9	8.4	3.3	10.6	9.6	6.1	8.2	4.1	14.7	6.2	5.8	1.8	5.6	6.7	5.0	3.1	10.6	20.3	4.7	6.6	5.3	2.8	4.5	7.5	6.8	12.6	3.5	0.0	5.6	3.5	39.3	20.0	9.7	3.7	3.7	2.5	4.5	8.5	5.7
ERMAP	"BTN5, RD, SC"	ENSG00000164010	"Erythroblast membrane associated protein (Scianna blood group)"	Q96PL5	1	42817122-42844991	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 38.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA042573, HPA054672"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Cytosol	"HPA042573: AB_10794282, HPA054672: "	"unprognostic (9.46e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.48e-2)"	8.0	9.2	3.9	4.7	4.2	30.5	8.3	3.8	4.6	8.6	4.8	7.3	6.5	6.0	15.8	7.2	10.1	7.5	4.3	3.8	5.0	7.1	13.2	7.2	4.9	5.0	4.5	5.5	9.5	8.4	5.8	5.9	4.4	7.8	8.1	4.3	8.6	6.2	2.3	9.3	6.1	6.3	4.4	5.2	7.8	4.1	4.8	5.3	13.0	3.6	5.4	5.5	3.9	5.0	5.2	7.1	2.1	7.0	7.7	22.4	2.0	10.5	17.8	9.3	9.3	2.9	9.6	4.6	3.5	11.2	4.4	6.5	2.4	3.2	8.3	7.8	8.2	38.3	5.2	2.3	9.5	5.2	18.8	13.7	11.8	4.3	9.9	16.8	6.1	5.6	26.4	4.7	8.6	3.6	2.3	1.6	5.1	3.3	3.8	2.6	2.8	4.3	8.0	8.1	4.7	3.2	9.0	3.3	4.0	3.7	6.6	19.6	9.6	6.9	3.9	5.9	4.8	1.8	4.4	2.0	5.6	5.8	4.4	0.0	4.3	2.1	1.2	4.5	0.6	1.3	1.2	0.9	5.1	0.7	1.0	1.0	1.3	2.2	3.0	1.0	3.2	1.9	3.9	4.2	3.8	4.6	3.8	5.0	5.0	4.5	4.4	4.4	4.8	5.0	2.4	12.8	10.9	9.8	2.9	3.8	2.9	3.2	6.2	1.8	6.6	6.3	2.2	4.3	6.2	3.7	22.9	3.1	4.4	4.8	1.9	3.6	4.3	4.7	6.2	3.3	5.4	81.7	5.5	7.2	1.6	3.6	6.1	5.6	2.5	10.4	3.6	12.9	7.8	11.8	2.2	4.4	0.0	11.7	2.9	25.7	2.8	7.4	5.4	14.0	7.1	4.8	1.0	9.5	10.6	4.8	3.9	4.1	2.1	2.9	3.5	4.0	6.5	4.5	0.0	4.7	2.6	0.1	0.7	5.7	3.8	2.9	2.3	7.4	5.5	2.3
EVI5	NB4S	ENSG00000067208	"Ecotropic viral integration site 5"	O60447	1	92508696-92792404	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027339	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027339: AB_1848308"	"unprognostic (1.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.04e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.35e-2)"	5.7	8.1	5.9	4.5	8.3	2.7	4.4	8.5	5.8	5.9	8.2	4.8	4.3	6.4	4.6	4.0	5.1	5.8	7.1	4.2	7.7	5.0	16.4	7.1	3.2	8.1	6.2	3.8	3.8	7.9	3.9	12.1	6.8	5.3	5.5	4.9	4.5	5.6	2.9	5.0	4.0	7.1	8.6	4.5	6.4	9.6	6.3	1.3	6.6	3.6	3.3	5.5	3.8	10.9	5.4	5.9	9.1	8.9	14.5	18.2	8.6	12.2	18.5	8.2	9.4	10.4	1.4	2.4	16.8	14.0	15.2	6.1	8.6	9.0	14.6	0.2	3.3	4.3	5.6	6.2	14.2	3.1	4.8	11.5	7.2	14.2	8.5	23.9	17.9	0.2	7.7	3.8	13.9	2.7	0.3	3.6	2.6	3.5	4.8	2.2	21.7	3.2	6.3	15.5	3.4	7.0	14.4	7.4	16.6	9.8	3.6	7.1	11.8	9.1	6.6	12.2	8.1	5.5	3.4	3.8	6.0	5.0	7.6	0.9	2.7	2.8	0.1	1.9	0.0	1.2	0.1	0.0	1.3	1.2	0.0	0.0	3.4	0.1	2.9	0.8	0.0	0.4	5.9	8.3	8.5	5.8	4.2	7.7	8.1	6.2	6.8	8.6	6.3	10.9	27.2	60.9	29.9	91.4	18.7	43.5	29.3	23.0	18.2	24.5	20.5	17.7	51.8	22.8	32.3	16.5	25.0	48.4	7.5	22.9	17.6	27.9	3.0	67.8	39.4	31.2	22.1	11.4	158.4	29.9	26.0	42.5	42.3	26.2	13.3	21.9	43.2	52.4	32.2	30.3	149.3	27.0	14.2	54.0	27.0	5.8	28.3	45.1	26.6	114.3	48.9	28.5	5.2	112.6	199.6	68.4	19.3	54.2	28.8	28.1	21.8	20.1	46.9	25.4	13.1	51.4	56.4	37.4	42.4	21.2	50.0	65.5	5.5	60.9	20.0	32.1
FAM107B	"C10orf45, FLJ45505, HITS, MGC11034"	ENSG00000065809	"Family with sequence similarity 107 member B"	Q9H098	10	14518557-14774897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 526.5;Proximal tubular cells: 359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2"	"Cell line enhanced"	"Detected in all"		"Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4"	"Low region specificity"	"Detected in all"							"HPA039661, HPA058814, HPA073195"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		15000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus"	"HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.82e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.53e-2)"	48.4	44.7	82.3	90.2	150.8	171.5	44.3	112.4	112.5	42.2	90.8	64.2	32.7	48.2	11.4	22.8	20.6	66.1	11.1	84.2	102.1	119.6	147.3	64.8	152.3	136.8	125.9	7.3	70.6	70.0	21.3	22.2	130.7	27.6	42.5	15.2	68.6	113.7	3.5	22.2	55.9	31.4	95.5	50.6	122.8	37.3	118.7	48.0	12.6	9.3	134.0	66.7	17.1	223.6	60.8	129.1	50.3	3.4	7.6	1.7	21.3	59.7	85.8	35.9	25.6	79.9	49.9	373.0	52.8	27.5	13.4	18.6	16.1	36.4	63.5	449.6	13.9	10.3	55.6	95.0	26.7	136.6	23.3	4.2	28.0	14.9	7.2	42.4	154.6	72.5	1.1	309.6	28.2	15.6	33.6	39.5	12.5	72.7	28.2	240.8	39.1	140.2	81.9	39.0	18.7	53.5	23.6	12.4	39.0	44.7	46.0	294.4	50.8	37.0	31.2	118.3	20.3	136.2	131.7	241.3	6.5	117.5	10.1	52.3	6.0	63.8	100.2	7.1	97.7	12.4	79.4	85.0	5.2	12.6	105.7	106.2	25.2	53.8	14.9	3.5	78.0	74.8	82.3	150.8	112.4	112.5	84.2	102.1	136.8	125.9	130.7	95.5	118.7	223.6	12.8	105.8	44.4	7.2	203.6	89.7	147.1	25.4	16.5	4.8	94.6	30.4	4.1	134.4	52.5	286.9	2.1	18.1	194.7	65.9	223.0	44.3	27.0	234.9	98.7	37.8	14.3	22.7	1.6	106.8	38.2	49.7	175.3	268.2	119.2	32.7	72.8	177.4	37.1	201.9	7.3	110.5	36.7	53.9	120.9	53.2	2.5	110.7	51.6	15.0	68.8	13.6	198.8	11.1	526.5	90.3	44.3	4.9	176.6	139.6	25.9	359.9	85.3	15.0	0.0	5.4	64.6	56.2	35.7	8.3	82.3	62.5	237.7	3.8	39.9	240.2
FAM174A	"NS5ATP6, TMEM157, UNQ1912"	ENSG00000174132	"Family with sequence similarity 174 member A"	Q8TBP5	5	100535374-100586741	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 154.5;Respiratory ciliated cells: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 55.8"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.8"	"Cell line enhanced"	"Detected in all"		"U-266/84: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019539	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	Cytosol	"HPA019539: AB_2293743"	"unprognostic (2.34e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-3)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (5.55e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	16.1	23.1	13.0	8.1	14.4	2.8	15.3	13.4	16.5	11.4	23.3	12.6	11.2	12.1	12.1	24.3	34.8	7.5	19.5	13.8	18.6	17.3	15.7	17.2	5.6	13.9	14.0	10.1	22.6	29.3	27.4	15.1	14.9	18.2	8.5	16.8	17.4	11.8	42.8	30.3	10.3	8.0	13.9	10.2	15.5	22.0	14.6	5.3	13.6	24.7	5.4	13.0	16.9	14.6	10.3	10.7	4.3	13.6	10.3	8.4	15.1	23.1	12.9	9.3	12.7	2.2	13.1	1.8	46.2	10.1	16.2	8.6	3.6	15.1	7.0	12.8	10.9	1.3	18.6	6.4	13.9	5.3	12.4	10.7	35.4	7.2	5.5	21.3	14.3	5.3	3.8	13.7	15.9	20.7	1.6	11.1	2.4	1.2	29.1	3.6	16.2	18.2	17.0	12.3	8.6	23.4	16.2	14.5	13.7	5.0	13.9	11.5	16.1	11.7	7.4	19.0	18.5	44.3	61.5	2.4	14.5	7.1	10.4	7.9	4.9	7.1	3.3	5.5	5.1	2.8	3.3	4.0	4.4	3.3	2.9	3.8	55.8	5.5	5.7	4.4	4.4	3.3	13.0	14.4	13.4	16.5	13.8	18.6	13.9	14.0	14.9	13.9	14.6	14.6	40.8	32.1	31.8	13.1	13.8	88.1	31.4	80.3	43.3	29.7	57.3	31.2	17.4	34.3	54.7	29.5	4.2	44.5	10.0	17.8	43.0	30.6	33.2	154.5	13.8	27.1	34.8	20.6	26.0	30.0	40.3	26.9	18.8	25.3	13.3	8.1	35.0	30.6	23.5	30.3	38.3	32.3	85.5	16.8	22.1	10.1	18.0	14.1	49.8	15.9	17.1	75.4	6.2	19.1	25.1	30.2	23.3	24.5	60.7	28.1	23.2	40.0	222.5	42.3	13.1	48.7	24.3	91.5	20.7	59.6	115.1	50.3	13.8	18.4	18.9	43.1
FAM174C	"C19orf24, FLJ20640"	ENSG00000228300	"Family with sequence similarity 174 member C"	Q9BVV8	19	1275530-1279244	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 89.9;Extravillous trophoblasts: 148.9;Hofbauer cells: 121.6;Syncytiotrophoblasts: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043279, HPA047026"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Golgi apparatus"	"HPA043279: AB_10794656, HPA047026: AB_2679906"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.25e-2)"	43.0	73.4	32.9	27.6	34.5	24.8	38.9	34.2	45.8	34.0	36.2	36.6	27.6	36.6	11.5	52.3	29.5	20.0	33.4	32.6	31.5	52.3	121.9	31.7	31.8	34.9	33.4	27.7	56.1	12.1	42.3	16.5	35.5	49.2	7.2	2.1	40.8	16.4	21.8	48.5	36.4	9.5	32.7	54.1	42.9	44.7	34.6	17.7	44.7	4.8	10.4	40.1	33.4	34.9	97.3	90.3	8.6	72.6	13.8	32.7	34.0	48.0	24.8	48.2	42.4	102.8	52.2	29.5	64.3	16.5	32.0	51.5	15.3	48.8	5.6	103.2	87.0	31.2	79.1	61.1	57.6	67.1	65.3	39.2	61.1	36.3	16.0	14.0	35.2	85.3	61.1	153.8	19.6	96.0	78.9	94.4	43.7	45.4	96.4	58.2	17.4	172.4	26.9	50.5	60.4	39.6	31.0	69.2	109.0	5.9	50.5	105.1	24.2	86.6	27.9	106.6	111.2	102.4	146.1	36.6	93.5	80.2	79.2	46.6	94.6	35.3	107.8	104.2	106.6	153.2	114.9	114.2	97.9	136.8	106.2	109.0	16.4	78.5	93.5	165.3	121.5	81.4	32.9	34.5	34.2	45.8	32.6	31.5	34.9	33.4	35.5	32.7	34.6	34.9	16.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	89.9	17.6	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	148.9	7.3	0.0	0.0	0.0	0.0	0.0	0.0	121.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	96.2	3.0	0.0	0.0	0.0
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 18.9;brain: 10.5;epididymis: 5.5;lymphoid tissue: 12.1;testis: 8.2"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 88.3"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 25.7;OE19: 7.0;RPMI-8226: 28.0;WM-115: 27.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 2.4"	"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear speckles"	"Golgi apparatus"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	1.7	0.0	4.9	0.0	8.7	18.9	0.9	6.3	7.3	0.5	2.3	2.2	0.0	1.6	5.5	0.7	1.3	0.1	0.4	4.7	6.8	0.1	0.0	0.4	0.1	7.7	8.0	0.5	0.0	0.0	0.1	0.9	7.4	1.1	0.1	0.1	0.3	0.8	0.2	1.2	0.5	0.4	6.5	12.1	0.3	8.2	7.3	0.1	0.1	0.0	0.0	2.1	0.8	10.5	6.2	0.0	0.0	2.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.5	2.5	0.0	0.0	0.2	7.0	0.0	0.0	6.7	28.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.9	8.7	6.3	7.3	4.7	6.8	7.7	8.0	7.4	6.5	7.3	10.5	0.2	0.0	0.0	1.0	1.2	0.8	0.6	0.4	0.0	0.2	0.5	1.4	0.4	0.0	0.0	0.0	2.1	3.2	0.5	0.1	0.0	0.0	3.6	0.1	0.3	0.2	0.0	88.3	7.2	0.0	7.1	3.0	0.0	0.1	0.0	0.2	0.4	0.0	1.2	1.7	1.1	0.0	10.2	0.0	0.9	7.8	0.9	1.0	3.6	1.0	0.2	2.9	1.0	1.0	20.7	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.2	0.0	2.8	1.6	3.2	20.1	0.6	1.7	2.5	0.2	0.3	0.1	0.4
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076567	"Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		14000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	20.9	22.4	15.0	11.2	17.2	11.7	15.9	12.7	17.1	16.1	7.7	22.2	9.9	18.0	15.4	17.6	15.4	13.6	23.4	18.0	17.2	17.3	16.5	16.3	11.3	14.0	14.6	19.9	11.4	21.4	14.4	17.0	14.5	16.5	14.4	28.7	11.8	19.4	19.6	12.8	11.5	19.4	13.5	12.4	13.6	8.0	15.3	11.5	17.9	25.6	10.8	16.2	12.3	14.7	41.4	37.1	28.2	30.0	49.1	51.4	31.2	33.7	38.3	23.2	20.7	18.7	40.1	21.3	43.2	59.7	19.1	29.3	29.0	24.8	33.8	27.3	19.5	67.9	34.8	23.9	24.5	45.5	41.1	30.1	26.5	31.7	24.5	35.4	29.0	29.2	77.0	30.2	37.5	23.1	19.9	16.4	37.1	46.2	7.9	24.1	29.7	28.4	19.5	46.1	37.5	91.8	35.5	39.7	34.5	39.8	34.4	32.8	30.8	36.7	32.2	51.1	46.0	24.5	48.5	18.2	36.5	21.7	37.3	0.9	0.6	0.2	1.3	0.6	1.3	1.4	0.7	1.1	0.8	1.5	1.1	1.0	0.6	1.6	0.8	1.2	1.0	0.5	15.0	17.2	12.7	17.1	18.0	17.2	14.0	14.6	14.5	13.5	15.3	14.7	16.8	6.4	11.4	16.0	7.5	15.6	12.6	8.9	4.6	15.7	12.2	9.3	40.1	12.8	9.0	18.4	25.0	9.0	9.0	10.6	3.9	8.8	5.2	8.8	17.8	13.8	14.4	43.3	28.3	13.0	7.7	14.6	9.2	14.5	17.1	20.2	9.3	14.2	7.6	38.7	32.0	7.9	10.2	11.6	8.1	5.1	17.7	9.6	16.0	19.7	14.1	9.0	2.1	17.6	32.5	13.7	3.8	21.4	6.2	19.7	5.0	5.9	8.8	21.0	13.1	20.0	17.7	17.6	13.8	9.6	12.9	7.5	8.0	24.1	8.5	24.7
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C golgi associated secretory pathway kinase"	Q8IXL6	7	192571-260772	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 55.2;Hepatocytes: 94.0;Hofbauer cells: 54.9;Peritubular cells: 56.4;Proximal tubular cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 55.3;hTERT-RPE1: 39.9;U-87 MG: 36.0;WM-115: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		240000000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	32.5	14.8	7.0	7.3	5.7	1.5	32.8	5.0	7.0	19.4	0.8	44.3	4.5	19.4	2.1	14.3	20.2	5.9	30.2	4.3	5.0	34.9	56.5	27.9	1.1	12.5	9.7	20.3	13.4	1.6	18.3	2.6	6.7	29.9	1.4	1.1	20.3	3.6	30.7	14.7	23.3	6.8	6.4	8.9	38.9	7.8	12.6	0.6	19.6	6.3	0.6	36.8	15.1	6.2	19.6	6.4	0.3	10.3	11.8	20.3	0.0	17.4	23.2	7.9	5.9	0.9	10.1	0.0	9.3	21.8	10.4	14.9	1.1	0.6	1.6	4.5	0.6	0.0	3.1	3.4	8.8	0.0	1.0	55.3	1.6	0.3	0.7	39.9	5.0	0.0	0.0	0.0	1.8	1.9	0.0	0.7	8.9	0.1	0.3	2.3	0.5	0.0	4.9	0.0	4.4	0.2	17.2	0.0	2.3	1.1	9.7	6.5	14.6	10.3	5.3	7.7	5.3	0.0	0.0	0.0	36.0	1.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	5.7	5.0	7.0	4.3	5.0	12.5	9.7	6.7	6.4	12.6	6.2	5.0	6.4	5.1	11.8	1.2	10.1	2.3	4.5	1.8	26.9	27.6	18.7	9.9	21.5	1.0	55.2	0.0	0.5	4.6	3.4	5.9	1.8	0.0	4.1	19.0	4.5	11.9	0.4	7.4	4.8	0.5	22.6	13.7	9.5	3.8	3.1	9.3	94.0	54.9	1.7	17.0	5.3	2.0	24.4	9.8	2.6	16.1	34.5	1.8	5.6	10.8	17.1	0.0	8.5	15.3	6.3	3.7	56.4	0.1	6.6	33.7	48.7	3.4	9.0	13.1	8.7	17.3	0.3	1.0	3.5	8.1	0.5	0.9	0.6	9.0	1.9
FAM219B	"C15orf17, FLJ00005"	ENSG00000178761	"Family with sequence similarity 219 member B"	Q5XKK7	15	74899992-74906883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048929, HPA058064"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus"	"HPA048929: AB_2680561, HPA058064: AB_2683592"	"unprognostic (1.12e-1)"	"unprognostic (6.10e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.11e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.91e-3)"	21.9	19.8	31.5	9.9	30.8	6.4	13.7	31.9	35.5	15.4	32.5	17.1	12.0	16.8	22.5	23.6	22.3	10.6	30.3	31.6	36.3	16.1	6.6	16.9	15.2	32.7	33.6	19.5	13.0	32.4	28.1	13.3	35.0	24.0	14.6	44.7	18.2	17.0	18.7	22.0	13.9	17.8	31.6	24.3	15.3	6.3	34.4	8.5	18.2	25.1	17.4	20.1	16.0	31.3	6.6	9.6	25.9	11.4	42.9	31.6	11.6	18.7	9.8	16.7	10.5	9.1	18.0	12.9	10.4	13.0	16.8	16.8	35.9	10.3	9.1	32.5	20.4	12.3	22.9	7.7	20.3	11.9	16.2	19.2	47.3	7.3	13.7	36.0	18.7	9.6	9.6	15.4	17.1	5.5	7.1	10.4	14.3	19.4	14.4	19.0	9.0	9.7	25.7	21.1	21.7	14.1	20.9	11.6	33.7	27.1	23.3	14.0	21.7	13.5	7.3	11.4	15.2	11.6	12.1	5.5	17.1	24.2	13.8	3.8	1.0	6.9	1.4	0.9	2.4	2.2	2.1	1.2	1.0	2.0	0.9	1.5	1.2	1.8	1.3	0.1	0.2	1.3	31.5	30.8	31.9	35.5	31.6	36.3	32.7	33.6	35.0	31.6	34.4	31.3	13.3	19.2	20.6	22.5	18.4	6.4	21.2	17.9	13.6	41.6	16.2	13.5	5.1	10.0	18.9	27.6	58.4	17.1	22.3	23.3	13.7	14.4	1.0	22.9	14.8	16.0	20.9	7.6	23.9	10.5	11.4	17.4	9.7	13.9	24.7	15.0	17.2	5.8	17.9	23.5	20.8	16.0	28.5	13.3	8.5	4.7	23.3	13.0	14.2	13.1	19.8	26.7	30.9	11.1	9.4	17.5	16.2	28.6	15.7	19.9	23.3	11.9	30.6	69.2	26.3	15.8	15.2	9.1	17.5	18.2	7.7	8.3	16.0	15.0	14.0	22.6
FAM78B		ENSG00000188859	"Family with sequence similarity 78 member B"	Q5VT40	1	166057426-166167001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 87.6;Excitatory neurons: 55.4;Horizontal cells: 82.4;Inhibitory neurons: 85.0;Oligodendrocyte precursor cells: 45.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HDLM-2: 8.6;RT4: 4.9;SK-MEL-30: 10.1;U-2 OS: 2.6;WM-115: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052789, HPA073246"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA052789: AB_2681949, HPA073246: AB_2686588"	"unprognostic (7.38e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.87e-11)"	"unprognostic (7.41e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.69e-2)"	0.7	0.2	0.9	0.0	0.7	0.0	0.5	0.5	2.6	1.1	0.0	0.5	0.2	0.7	0.0	0.4	0.2	0.1	0.6	1.0	0.1	0.2	0.7	0.2	0.1	0.6	0.1	0.3	0.4	0.1	0.5	0.0	0.1	0.4	0.1	0.8	0.3	0.1	0.7	0.5	0.1	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.4	0.1	0.1	0.8	0.5	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	8.6	0.0	0.0	0.1	0.3	0.2	0.0	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	4.9	0.8	0.5	0.0	0.1	10.1	0.0	0.3	0.2	0.1	0.6	2.6	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.5	2.6	1.0	0.1	0.6	0.1	0.1	0.2	0.1	0.5	1.2	0.0	1.7	5.5	0.4	0.5	0.5	0.0	1.8	15.5	1.0	0.8	9.9	2.8	0.0	0.0	87.6	0.0	0.0	0.4	1.9	0.7	2.5	0.1	1.7	1.6	0.0	0.0	55.4	0.2	0.0	1.6	0.0	0.1	0.0	1.1	0.4	1.6	0.0	82.4	85.0	0.6	0.0	0.3	0.6	2.6	1.2	0.1	1.8	5.6	0.6	2.2	0.0	45.8	5.7	0.3	0.3	0.7	0.0	0.2	0.1	1.3	0.0	12.9	0.0	4.5	1.0	0.6	4.4	0.6	0.1	0.0	0.7	0.4	1.1	0.2
FAR2	"FLJ10462, MLSTD1, SDR10E2"	ENSG00000064763	"Fatty acyl-CoA reductase 2"	Q96K12	12	29149103-29340980	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 36.2;intestine: 34.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 114.3;Inhibitory neurons: 172.1;Microglial cells: 63.7;Syncytiotrophoblasts: 193.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 50.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 76.2;HUVEC TERT2: 84.0;NB-4: 74.2;SK-BR-3: 89.6;TIME: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015884	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoli	"HPA015884: AB_1853998"	"unprognostic (6.32e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.13e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-3)"	8.3	9.0	4.1	9.3	8.3	17.1	9.3	1.2	8.5	4.3	0.0	34.5	17.6	5.6	36.2	7.4	3.6	5.2	6.6	6.2	9.2	5.0	3.8	11.3	7.9	1.2	2.9	2.3	3.2	1.3	2.4	18.1	1.3	2.6	28.2	9.4	4.4	1.9	6.3	9.0	19.2	7.6	1.4	12.2	4.9	9.2	5.2	7.0	4.4	2.6	3.0	6.5	3.7	4.9	2.5	4.9	4.9	1.2	6.8	26.9	2.1	21.3	24.7	5.8	5.4	8.2	28.0	3.7	5.4	3.4	4.3	1.5	13.4	0.2	1.4	1.8	32.2	76.2	10.7	2.7	14.7	30.0	24.0	7.5	0.2	8.7	11.0	14.3	84.0	2.9	6.6	2.7	0.9	0.8	19.9	74.2	19.3	1.6	54.5	16.1	7.9	3.1	25.7	7.2	8.6	7.9	4.8	89.6	37.8	9.7	4.1	28.2	68.2	15.6	4.6	5.6	9.3	4.4	4.9	1.8	24.5	38.5	13.7	3.8	22.8	50.0	5.0	13.9	3.4	2.0	8.3	6.2	8.1	1.8	2.9	3.2	41.0	4.0	8.0	3.1	16.1	9.6	4.1	8.3	1.2	8.5	6.2	9.2	1.2	2.9	1.3	1.4	5.2	4.9	9.1	0.0	3.3	7.8	0.6	1.3	0.1	0.2	0.6	2.0	1.4	0.8	12.1	0.0	1.4	0.0	0.0	16.0	1.1	35.7	0.0	0.1	31.5	0.4	2.9	11.9	7.2	4.6	114.3	0.2	19.6	4.8	5.6	0.4	10.8	0.0	9.7	0.0	19.3	5.0	172.1	21.8	0.0	22.2	3.7	6.4	1.2	12.2	16.0	63.7	6.9	0.5	1.0	24.6	6.9	3.3	36.8	0.4	8.0	0.4	15.1	0.4	3.2	1.2	0.0	4.2	3.6	16.6	1.0	0.3	0.3	193.9	4.2	0.9	23.7	0.3
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.0;skeletal muscle: 81.2;tongue: 74.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.5;monocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	9.4	7.3	6.6	2.0	5.5	5.4	6.7	4.3	6.8	3.0	12.0	5.5	2.9	2.7	15.7	2.5	2.2	2.5	85.0	6.3	7.7	14.9	0.7	4.0	1.3	10.1	8.5	1.4	1.6	20.6	4.2	14.8	7.3	2.8	6.6	21.6	2.9	7.8	81.2	2.1	6.7	3.5	7.6	7.2	2.8	9.9	9.9	1.1	7.1	74.7	0.5	4.6	2.6	5.4	0.0	4.3	3.8	0.3	0.7	0.2	0.3	4.1	0.3	0.1	0.0	0.5	5.2	0.9	4.7	1.9	0.9	0.2	0.2	0.0	0.0	0.2	0.2	24.0	4.8	2.8	0.2	0.0	0.3	1.0	0.1	0.0	0.2	0.2	2.7	0.1	0.1	0.1	4.9	0.7	0.0	0.1	0.4	49.2	7.2	0.1	3.0	79.6	6.2	10.1	28.4	13.8	1.4	0.3	0.9	0.6	1.7	0.8	4.4	0.2	0.6	0.1	2.9	0.4	0.3	0.0	0.9	7.6	2.8	0.0	2.0	0.0	0.2	3.4	0.4	0.3	0.1	0.0	0.2	0.4	0.0	0.0	2.5	0.3	1.5	0.4	0.0	6.0	6.6	5.5	4.3	6.8	6.3	7.7	10.1	8.5	7.3	7.6	9.9	5.4	38.4	22.4	1.1	6.2	0.4	1.0	1.0	0.6	0.6	108.6	2.6	1.9	73.7	15.7	1.8	1.8	79.2	0.4	0.2	28.9	17.6	2.8	121.9	2.8	1.4	25.8	1.2	0.8	37.9	2.0	1.2	8.8	2.0	3.9	0.0	0.4	4.2	0.3	0.8	101.0	70.0	38.3	0.0	4.4	0.6	122.8	2.1	8.3	0.0	27.2	4.2	3.9	1.0	10.1	16.0	2.3	10.0	4.9	0.0	1.6	43.6	12.4	3.2	7.0	72.3	66.6	50.7	4.1	1.4	0.2	1.3	0.1	0.9	29.8	2.4	2.3
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.8"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	60.8	5.2	38.9	11.7	28.1	5.4	18.7	0.0	29.2	8.6	0.0	13.1	5.7	5.7	4.0	9.4	8.8	9.6	16.7	24.1	8.5	19.5	12.2	14.2	9.1	15.6	10.9	6.8	15.5	2.4	8.7	22.5	6.2	10.3	6.4	14.1	13.6	10.2	8.1	32.0	7.4	6.5	10.0	32.8	7.9	8.8	14.4	15.6	8.1	7.3	8.4	10.4	8.9	18.9	7.0	7.1	90.1	0.5	12.3	22.0	16.9	40.8	36.5	35.2	48.7	12.1	4.2	0.1	28.3	21.5	48.6	13.5	0.3	3.3	30.7	0.3	9.9	1.4	0.9	0.2	11.0	0.5	1.1	12.8	3.2	134.0	16.4	98.9	105.8	3.1	13.6	0.4	64.7	8.5	4.6	0.8	24.6	0.3	9.6	0.4	30.8	0.2	16.6	5.8	4.3	15.9	0.2	32.7	64.4	16.1	18.5	3.3	191.6	48.8	17.4	47.6	49.3	0.3	0.4	0.3	41.7	1.0	163.4	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	2.3	0.3	0.0	0.3	0.2	0.0	0.4	0.4	0.0	38.9	28.1	0.0	29.2	24.1	8.5	15.6	10.9	6.2	10.0	14.4	18.9	48.6	32.1	2.6	168.1	1.7	35.1	13.1	3.0	9.1	54.2	17.1	14.4	11.4	45.8	4.1	33.1	18.8	69.6	0.4	1.1	11.7	15.8	42.5	13.1	5.5	44.0	4.8	81.7	1527.6	4.0	42.1	14.9	4.6	26.9	15.2	58.1	44.3	6.2	35.9	80.8	1622.8	3.4	6.1	95.6	19.9	98.8	2.1	25.5	16.0	1329.4	2.7	46.0	0.0	442.3	61.0	1.8	1.4	1.9	0.9	8.0	0.3	2.7	2.5	12.9	13.1	41.2	45.5	1.3	2.1	20.6	32.7	28.7	3.0	5.3	5.4	4.3
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868588-90883564	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 305.6;salivary gland: 220.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		130000	"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	54.5	24.4	12.8	36.4	10.5	73.8	42.4	10.6	14.5	26.4	11.7	32.8	27.6	32.3	9.8	33.7	30.4	19.4	58.5	14.9	9.0	56.8	305.6	63.2	13.0	12.5	10.8	22.4	108.6	27.3	45.9	40.6	11.3	60.1	12.1	12.9	220.5	17.7	61.3	62.7	35.5	14.3	10.4	51.4	34.0	8.6	15.6	11.8	56.1	25.3	11.2	30.2	33.3	9.3	50.8	31.2	6.8	29.8	49.4	32.1	77.5	64.4	48.1	26.3	18.1	45.4	54.3	1.9	148.8	47.5	46.1	91.5	14.0	32.5	5.4	148.0	35.2	90.9	52.8	57.7	26.2	13.0	141.2	35.6	35.3	29.5	13.2	62.4	84.7	14.6	70.5	8.5	17.8	32.3	5.0	29.2	21.5	44.2	9.3	7.9	26.6	10.9	35.2	39.1	13.1	9.2	54.5	28.5	42.5	31.9	10.7	31.4	125.9	29.4	60.1	43.7	95.5	15.2	93.4	3.4	55.8	40.1	60.7	2.0	0.9	1.5	0.7	0.1	0.2	0.4	0.2	0.3	0.6	0.1	0.0	0.1	0.7	0.4	0.0	0.3	0.0	1.1	12.8	10.5	10.6	14.5	14.9	9.0	12.5	10.8	11.3	10.4	15.6	9.3	44.1	3.2	27.4	4.2	7.3	19.4	10.0	10.4	2.8	12.8	12.0	9.0	16.3	21.5	8.5	22.0	25.0	20.9	26.9	49.5	0.0	47.1	0.5	15.2	9.7	29.4	37.8	26.5	7.9	117.5	16.5	11.4	21.9	32.3	15.8	7.0	23.9	131.8	24.8	8.4	7.5	31.7	10.2	35.3	42.1	1.4	11.1	33.6	16.0	5.6	14.0	13.6	24.7	2.0	4.4	108.3	26.4	10.9	7.2	24.3	28.7	7.8	2.0	28.0	26.3	10.5	18.6	2.8	3.6	8.5	23.0	84.3	19.6	4.7	17.9	16.4
FUT11	MGC33202	ENSG00000196968	"Fucosyltransferase 11"	Q495W5	10	73772276-73780251	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.6;Late spermatids: 234.7;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014033	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"	"Golgi apparatus"	"HPA014033: AB_1849192"	"prognostic unfavorable (6.78e-4)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.30e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	9.4	5.1	2.5	6.8	3.2	6.4	5.2	4.4	2.8	8.9	1.8	4.5	3.1	6.0	3.2	7.0	4.7	9.0	9.4	2.1	3.8	4.7	5.1	8.7	6.4	4.9	4.8	6.3	4.1	3.7	3.1	17.4	4.1	4.3	3.8	10.0	4.1	6.4	4.1	4.5	3.7	8.3	4.1	10.2	4.9	10.2	5.0	4.3	7.0	4.8	6.2	7.0	4.8	4.9	26.4	14.2	9.9	20.8	19.2	22.2	2.9	13.1	31.3	16.3	31.7	4.7	13.8	6.1	9.3	21.7	5.5	10.9	5.2	13.3	18.1	14.4	10.9	8.1	11.4	7.6	7.5	11.6	24.5	14.8	3.0	15.5	15.9	50.3	30.1	2.7	8.1	10.5	16.4	3.2	2.0	6.0	4.7	2.5	35.1	2.8	6.1	7.2	5.9	4.7	3.0	9.6	11.5	12.0	7.5	8.4	8.2	5.0	31.3	21.1	9.0	10.6	16.4	13.8	5.1	1.4	29.6	10.2	7.0	5.4	1.4	1.4	20.0	1.6	14.2	2.1	5.9	14.3	1.7	1.8	4.3	8.9	0.3	10.9	1.8	3.5	2.6	6.9	2.5	3.2	4.4	2.8	2.1	3.8	4.9	4.8	4.1	4.1	5.0	4.9	22.4	16.0	13.1	6.2	12.1	13.6	5.6	22.7	5.2	14.6	6.1	6.1	12.2	7.2	9.8	11.0	14.6	10.7	23.1	4.9	0.0	13.3	171.6	6.7	12.0	28.0	4.8	15.8	6.0	6.8	25.2	15.8	2.6	10.5	14.0	7.1	38.2	5.2	12.5	20.2	5.7	4.6	2.0	18.1	16.7	234.7	16.1	11.0	17.8	11.2	11.4	8.3	69.0	5.0	6.5	10.3	5.2	14.7	10.2	8.9	2.6	3.4	9.8	13.0	6.6	14.3	11.7	20.7	19.0	5.5	11.5	9.7	19.9	6.8	3.1	6.4
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor subunit delta"	O14764	1	2019329-2030758	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 49.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.7;Excitatory neurons: 30.0;Horizontal cells: 13.5;Inhibitory neurons: 37.4;Spermatogonia: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HMC-1: 1.2;MCF7: 4.4;NB-4: 2.7;SH-SY5Y: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA044371: AB_2678916"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	0.3	1.5	12.8	0.0	16.9	0.0	0.5	49.6	40.5	0.1	0.1	0.2	0.0	0.3	0.1	0.3	0.2	0.4	0.7	14.7	5.4	0.7	0.2	0.9	0.2	14.3	18.1	0.2	0.1	0.7	2.7	0.1	20.2	0.2	0.0	1.4	0.3	0.0	0.3	0.4	0.2	0.3	1.0	0.3	0.1	3.6	29.7	0.1	0.9	0.4	0.0	0.2	0.2	14.7	0.0	0.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.7	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.8	16.9	49.6	40.5	14.7	5.4	14.3	18.1	20.2	1.0	29.7	14.7	1.0	3.2	3.6	4.9	0.1	0.5	0.0	0.0	0.0	14.7	0.3	0.0	0.9	0.0	6.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	3.4	0.0	0.0	30.0	0.0	0.3	0.5	0.0	0.2	2.5	0.3	0.0	0.0	0.1	13.5	37.4	0.0	0.0	0.0	0.3	0.2	0.0	0.9	0.0	8.4	0.0	1.4	0.0	3.0	4.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.4	1.6	0.0	0.0	4.8	0.1	11.3	0.1	0.0	0.3	0.4	0.2	0.1	0.1
GAK	DNAJC26	ENSG00000178950	"Cyclin G associated kinase"	O14976	4	849276-932373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027405, HPA027459, HPA027463"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-3)"	"prognostic favorable (1.70e-6)"	"unprognostic (1.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (7.41e-4)"	31.9	40.7	21.1	25.9	22.5	35.5	34.0	20.1	29.7	42.7	20.1	56.3	51.2	41.9	8.0	49.7	43.0	17.7	25.4	21.5	17.8	55.0	47.7	46.0	25.6	28.7	19.8	40.5	53.1	22.7	37.1	15.6	22.1	41.8	14.8	9.4	71.0	13.3	31.4	40.4	57.4	9.8	17.7	61.5	54.2	45.8	20.6	21.6	38.5	6.6	12.9	38.7	39.3	20.5	36.0	28.3	16.9	29.0	16.6	14.2	43.6	33.0	19.7	22.3	18.5	35.9	49.8	30.4	20.9	20.1	40.3	29.7	17.7	27.4	10.5	30.7	27.9	35.3	29.5	27.5	31.1	36.2	53.0	20.5	23.2	22.7	11.0	14.2	24.7	35.3	38.4	37.4	15.2	34.7	61.6	92.1	30.4	38.2	46.3	50.2	19.4	27.4	18.2	28.8	29.0	31.3	19.3	24.2	23.3	14.1	39.2	30.7	40.8	30.9	18.0	31.8	45.1	59.5	41.3	33.8	34.9	43.7	29.0	3.0	10.3	12.8	8.8	9.8	7.6	4.9	5.8	6.1	6.5	3.9	3.3	4.8	7.4	4.8	24.6	7.6	5.6	9.4	21.1	22.5	20.1	29.7	21.5	17.8	28.7	19.8	22.1	17.7	20.6	20.5	24.7	25.6	33.2	34.0	33.9	17.0	15.3	17.9	14.8	27.2	25.3	17.7	12.2	18.6	28.2	25.8	64.6	19.0	46.2	131.3	9.8	18.8	99.1	32.2	21.6	26.7	29.4	26.1	25.7	28.0	17.5	19.5	93.8	52.5	18.3	31.2	18.5	31.6	36.6	11.8	23.5	66.5	26.4	35.9	18.4	134.7	25.1	35.5	16.0	59.0	28.8	16.3	35.0	9.0	24.4	37.6	71.1	18.8	26.1	28.4	65.8	31.0	33.8	26.9	19.7	17.9	18.0	32.9	27.4	19.9	22.3	31.1	34.6	41.6	65.0	44.6
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"brain: 645.9;pituitary gland: 885.8"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.2"	"Region enriched"	"Detected in many"	13	"hypothalamus: 645.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 82.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000	200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	3.2	0.9	2.8	14.9	2.1	0.7	4.4	1.1	5.2	1.0	0.8	17.6	1.8	0.2	0.0	0.8	1.0	0.2	1.0	2.2	645.9	1.5	0.3	0.5	0.1	48.5	5.1	0.2	2.1	0.1	885.8	0.3	13.8	4.4	4.0	0.0	0.9	0.2	0.4	33.3	4.1	9.9	0.6	0.3	9.7	1.0	19.5	0.7	0.4	0.0	0.0	0.7	2.9	2.6	0.0	11.0	1.1	0.3	0.0	0.0	24.0	36.7	0.0	0.7	0.0	267.2	9.9	0.0	12.7	1.3	0.4	0.1	0.0	0.2	0.0	0.0	119.3	6.4	74.6	0.0	1.3	3.7	0.0	1.7	4.0	0.0	0.1	0.0	6.3	0.0	139.5	0.0	0.2	77.2	0.0	493.5	60.3	2.9	23.7	0.0	0.1	51.1	0.6	0.0	49.8	189.6	25.8	1.5	0.0	26.8	1.5	57.6	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.1	1.1	5.2	2.2	645.9	48.5	5.1	13.8	0.6	19.5	2.6	0.6	0.0	0.0	0.0	0.2	2.0	22.2	0.1	0.0	0.0	3.2	5.8	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.7	0.0	38.9	0.1	64.2	50.8	3.4	1.8	4.2	2.1	52.1	48.7	6.6	2.0	26.4	4.5	0.4	0.0	0.0	2.0	0.0	0.2	1.1	4.1	0.0	1.2	0.2	0.0	0.7	1.8	0.0	0.6	0.0	0.0	0.0	0.3	39.5	0.1	0.0	1.0	82.5	0.0	0.4	0.0	0.0	0.0	1.6	6.7	2.2	10.9	1.1	3.4	1.9	0.8	0.0	1.3	24.3
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800781	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 122.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 149.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070023			Approved	"Golgi apparatus,Cytosol"		NA	NA		16000	"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"		"HPA070023: "	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	8.9	12.8	12.3	16.0	12.5	6.0	12.8	12.2	17.7	22.3	11.5	58.6	54.6	6.7	12.7	63.1	16.6	31.5	7.1	12.5	12.5	34.0	61.2	20.6	7.5	12.5	12.3	4.6	15.2	15.5	6.7	17.8	12.4	11.0	60.0	6.3	59.7	16.4	4.3	9.7	38.3	10.8	12.6	17.6	122.4	8.7	13.2	8.0	4.7	5.4	15.8	20.9	22.2	12.6	60.3	71.5	27.8	44.5	9.8	13.9	26.9	40.7	53.4	68.6	50.9	65.3	195.4	14.3	54.7	23.5	91.9	65.8	24.5	101.8	51.5	29.4	16.2	40.6	34.4	71.6	102.0	18.4	11.6	30.1	53.4	63.4	156.8	69.2	59.5	30.1	45.9	3.8	49.5	64.5	29.0	19.5	7.8	83.1	67.7	33.6	27.1	18.5	112.7	41.4	10.7	24.1	73.9	66.7	70.6	31.1	47.9	14.5	33.7	52.0	74.9	52.0	50.3	18.5	46.4	18.9	53.0	74.5	27.8	1.7	13.5	3.0	8.5	29.3	8.5	5.4	5.0	6.9	19.0	1.7	5.8	4.1	3.4	37.3	37.1	5.2	9.5	8.8	12.3	12.5	12.2	17.7	12.5	12.5	12.5	12.3	12.4	12.6	13.2	12.6	9.6	12.8	49.3	6.8	7.5	7.6	18.8	110.4	6.2	17.2	26.7	10.9	3.5	37.1	90.6	40.5	16.7	54.1	7.4	131.8	35.2	67.6	21.5	19.9	9.1	14.3	12.1	8.2	9.4	114.8	106.3	14.0	276.8	36.2	10.8	17.4	10.8	38.3	99.3	8.4	10.8	149.5	73.2	5.7	6.8	5.0	4.7	12.5	24.9	5.6	19.4	21.2	7.2	4.5	2.1	92.0	109.0	3.4	9.4	24.9	78.6	89.5	37.0	14.8	0.0	3.7	13.1	14.5	9.7	19.6	4.8	96.3	7.6	99.6	73.8	46.0
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 126.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 42.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		57000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	18.6	12.5	5.9	7.8	6.7	5.6	17.1	6.4	8.4	17.5	5.9	12.5	20.6	16.5	1.0	24.4	14.9	4.3	19.7	6.0	6.6	32.0	126.4	18.7	7.4	7.9	6.3	13.7	31.2	10.6	5.7	5.8	7.5	13.3	2.0	0.7	20.0	5.7	8.6	20.6	18.3	3.9	7.0	24.5	17.6	16.0	6.8	6.1	11.6	3.6	3.4	13.0	17.8	8.2	20.4	65.2	4.9	20.7	6.8	16.6	16.7	16.9	14.3	16.8	15.8	35.4	4.2	31.2	19.5	9.3	12.6	11.9	5.0	4.4	1.9	14.2	39.3	20.1	25.1	62.4	22.1	13.0	41.9	15.3	6.9	8.5	3.5	8.5	39.1	16.9	15.9	21.2	11.7	77.3	38.6	44.7	4.7	9.8	32.3	43.6	50.1	50.9	9.8	7.3	9.9	26.1	14.6	35.8	35.0	3.8	29.8	20.9	33.4	24.3	22.3	21.7	14.6	44.4	12.4	8.2	26.7	30.3	18.3	7.2	77.2	23.0	23.0	67.8	20.8	27.7	18.5	21.2	70.1	18.9	10.0	14.5	53.1	16.2	55.6	93.3	23.6	40.8	5.9	6.7	6.4	8.4	6.0	6.6	7.9	6.3	7.5	7.0	6.8	8.2	42.1	16.0	12.9	3.3	17.7	8.7	10.0	4.4	7.4	7.3	22.4	20.6	22.6	22.8	10.6	12.9	0.0	48.4	16.3	8.4	68.4	28.5	1.3	4.9	24.5	23.5	8.4	9.0	1.5	55.2	100.1	25.3	10.2	8.6	27.9	16.6	29.3	116.7	56.1	3.3	1.7	20.9	22.4	49.0	25.2	5.6	31.1	33.3	39.2	0.0	42.3	19.2	20.6	2.5	1.6	19.3	49.6	24.0	29.1	5.7	139.4	122.0	4.0	6.1	6.6	19.2	20.8	1.7	22.1	16.6	12.5	42.3	14.9	6.1	28.2	9.2
GALNT14	"FLJ12691, GalNac-T10, GalNac-T14"	ENSG00000158089	"Polypeptide N-acetylgalactosaminyltransferase 14"	Q96FL9	2	30910467-31155202	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	8	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030138			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		27000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA030138: AB_2673332"	"unprognostic (5.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.51e-3)"	1.2	1.5	3.9	1.0	10.6	5.9	0.8	2.0	4.5	1.3	3.6	0.3	0.5	0.3	0.3	11.8	1.2	2.2	0.3	2.9	3.2	41.3	1.3	0.6	2.2	1.7	6.7	0.1	3.1	4.0	5.9	0.0	0.8	1.6	0.1	0.6	1.2	0.0	0.1	2.1	3.3	0.7	1.8	2.4	0.5	2.5	10.9	0.4	0.9	0.4	4.8	2.3	1.3	3.3	23.6	28.6	0.0	0.0	0.0	0.0	0.0	7.9	4.1	4.9	0.6	0.0	0.0	22.1	7.8	0.4	0.0	0.0	1.0	1.0	0.8	0.6	2.8	12.1	0.0	0.0	0.0	18.2	0.0	0.1	4.5	0.0	17.0	0.2	0.0	0.6	0.0	19.0	0.0	10.7	0.1	0.0	12.6	0.0	0.0	15.5	0.0	32.3	41.3	35.3	24.4	18.3	0.0	0.0	0.1	4.4	0.1	0.0	0.0	0.0	19.6	0.0	0.5	1.9	6.2	0.1	0.0	11.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	3.9	10.6	2.0	4.5	2.9	3.2	1.7	6.7	0.8	1.8	10.9	3.3	2.2	0.0	0.0	1.0	1.4	2.8	4.1	5.3	21.6	0.3	0.6	2.4	1.1	0.0	6.2	9.2	0.0	0.0	0.0	0.3	13.7	2.9	5.7	0.0	0.1	1.2	0.0	0.0	29.1	0.4	0.0	1.1	0.5	0.4	0.0	0.0	8.2	0.2	0.1	0.0	79.2	0.9	2.0	0.6	0.3	12.0	0.0	0.4	0.0	2.8	0.0	0.2	0.0	4.0	8.7	2.6	0.0	0.0	3.1	14.2	21.9	45.5	1.1	0.4	6.6	0.4	2.2	3.4	6.9	9.2	0.9	0.0	0.4	0.2	1.8	5.1
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174680-16231992	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 157.4;brain: 141.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 103.9;Astrocytes: 34.6;Early spermatids: 26.6;Endothelial cells: 26.9;Hepatic stellate cells: 41.7;Muller glia cells: 47.4;Oligodendrocytes: 69.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 133.0;ASC TERT1: 128.8;HSkMC: 102.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		40000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	157.4	4.9	45.1	1.7	55.8	2.7	87.2	62.5	49.3	12.3	14.4	21.7	3.0	11.4	11.9	12.4	24.9	5.6	18.1	47.9	90.8	11.8	4.0	9.4	4.1	137.6	60.4	22.3	3.6	2.4	3.5	32.3	130.8	6.0	3.9	13.4	25.5	4.7	36.3	41.7	21.2	7.0	102.4	12.3	15.3	9.1	62.8	4.0	18.3	35.3	1.3	33.0	22.8	141.7	0.4	1.3	0.9	1.0	133.0	128.8	0.3	3.4	2.5	0.4	1.3	0.0	0.5	0.5	1.9	7.8	2.3	0.8	0.5	1.4	2.0	0.6	1.4	1.1	1.9	0.0	7.4	1.5	0.4	102.8	0.0	1.2	1.8	2.4	2.8	0.7	0.2	3.0	1.1	1.9	0.0	2.1	0.5	0.8	1.1	0.3	1.1	24.1	0.5	0.5	0.4	0.3	0.4	1.0	0.6	0.6	0.7	1.8	3.9	0.6	4.3	26.8	0.6	1.4	5.1	1.4	2.5	0.4	0.4	0.5	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	45.1	55.8	62.5	49.3	47.9	90.8	137.6	60.4	130.8	102.4	62.8	141.7	103.9	0.0	1.7	34.6	0.1	0.5	0.4	0.0	0.0	3.8	1.1	0.9	2.8	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	26.6	0.5	3.3	26.9	0.0	0.0	4.9	0.0	0.1	24.7	0.0	1.0	1.3	0.1	41.7	1.8	0.1	0.0	3.9	0.0	0.0	0.8	2.1	16.7	1.8	0.5	0.0	22.5	0.1	47.4	0.0	5.0	69.3	0.2	0.0	0.7	1.8	2.1	0.0	0.1	0.0	3.2	0.0	7.3	2.1	25.5	0.5	0.1	0.9	0.0	0.2	0.3	0.0	0.3
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 62.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 31.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	1.7	3.1	3.3	8.0	11.8	9.6	18.1	7.2	9.1	32.2	0.2	6.7	21.2	1.3	24.7	2.4	6.5	2.4	0.4	4.2	7.3	2.9	1.2	5.7	7.2	8.8	11.1	0.9	8.3	1.4	1.1	9.6	10.8	0.9	6.9	0.1	31.0	3.2	0.4	5.6	21.6	1.6	5.2	8.2	62.6	0.6	9.7	6.8	2.5	0.1	5.9	3.7	1.8	18.1	39.0	4.1	0.7	0.1	0.0	0.6	59.8	63.0	107.0	25.4	17.0	104.1	19.0	0.5	5.8	34.4	0.0	35.9	1.5	27.3	17.1	8.3	4.1	24.6	0.7	0.8	1.0	13.6	82.2	2.3	25.2	23.1	23.0	0.2	65.7	14.2	5.4	1.0	0.1	73.7	43.2	10.1	5.3	97.6	66.6	0.2	0.1	10.3	21.3	2.2	0.5	23.5	0.4	110.5	0.1	12.2	59.3	5.9	75.7	0.2	12.9	0.2	0.3	2.1	0.5	3.6	7.2	29.5	0.2	7.1	5.8	29.1	3.8	5.2	1.6	1.2	2.2	3.1	4.5	3.3	3.4	2.9	1.1	15.5	9.7	4.1	1.7	3.2	3.3	11.8	7.2	9.1	4.2	7.3	8.8	11.1	10.8	5.2	9.7	18.1	0.8	3.2	2.4	0.3	11.8	2.9	3.8	5.8	5.7	0.4	38.9	18.4	1.3	1.5	15.6	1.8	0.0	14.1	11.3	12.4	3.9	2.6	2.0	3.5	0.3	4.1	0.0	15.3	1.0	10.9	49.2	1.6	130.5	5.8	164.5	3.8	1.4	0.3	14.4	0.0	0.5	17.4	2.0	16.3	10.3	1.5	0.0	15.1	1.8	1.0	7.2	0.2	9.2	0.0	57.6	24.3	33.9	0.4	5.5	7.6	39.6	2.0	12.4	0.0	0.0	1.5	1.5	0.4	1.6	2.6	9.2	4.8	14.9	1.8	11.8	5.8
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168811-173323967	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		6200000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	6.4	6.4	6.4	16.3	8.8	11.5	23.3	34.2	8.3	25.1	3.5	47.8	29.1	16.9	7.0	14.9	9.8	15.6	5.9	6.6	7.8	7.8	2.9	9.6	12.2	12.6	8.3	11.2	22.2	8.7	5.2	13.0	11.7	39.7	52.8	22.4	27.4	8.1	1.4	3.9	33.7	16.7	10.1	11.0	65.7	11.9	8.4	60.0	13.5	3.9	9.8	17.0	5.9	16.0	71.1	37.2	35.0	11.2	18.6	27.1	50.3	18.1	20.5	16.7	23.0	11.5	109.9	39.4	13.3	16.6	45.2	59.2	15.0	32.0	22.7	154.3	29.1	47.8	72.2	0.4	12.2	71.6	32.8	17.5	28.3	37.6	18.9	63.4	112.3	28.2	32.6	59.3	86.0	23.5	52.7	39.4	34.8	70.2	24.0	52.1	32.4	10.2	123.2	32.8	28.2	21.5	8.5	50.4	25.4	45.3	20.2	21.0	135.6	11.9	52.3	0.6	40.0	17.2	0.2	20.8	48.6	42.3	43.6	13.2	14.3	18.9	5.1	7.5	7.2	6.2	5.7	5.3	12.4	3.3	4.4	3.3	21.3	7.5	8.0	5.0	9.2	6.4	6.4	8.8	34.2	8.3	6.6	7.8	12.6	8.3	11.7	10.1	8.4	16.0	10.0	6.4	38.0	72.8	12.1	1.8	9.0	12.3	4.0	47.9	41.1	19.8	9.6	8.6	36.0	20.2	2.1	1.4	16.4	143.4	0.0	14.4	2.5	28.3	13.3	11.3	22.8	12.0	74.4	48.9	3.7	12.1	102.4	52.9	24.1	14.8	12.1	0.2	10.3	10.1	172.0	126.8	24.4	17.9	6.2	4.2	9.3	17.2	8.8	62.8	16.3	8.1	5.2	71.4	54.1	39.9	50.0	5.3	6.6	52.8	63.7	10.0	17.4	25.5	13.1	16.1	11.7	3.8	5.5	14.9	1.1	0.8	9.9	13.1	48.6	19.4
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	Q9NY28	12	4720400-4851927	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 31.3;testis: 13.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 23.4;U-266/84: 7.6"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Supported		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	0.4	0.6	3.2	1.8	3.3	0.0	0.6	2.7	5.1	0.5	2.0	14.0	5.7	0.3	0.1	0.1	0.6	0.0	2.5	3.2	2.8	0.4	0.2	0.3	0.2	3.4	3.2	0.7	0.2	0.0	2.8	0.1	3.3	0.4	31.3	0.2	0.4	0.3	0.1	0.2	12.6	0.8	2.9	0.5	0.5	13.5	3.3	0.0	0.2	0.0	0.0	0.4	0.3	4.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	23.4	0.0	0.0	0.0	0.1	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	3.2	3.3	2.7	5.1	3.2	2.8	3.4	3.2	3.3	2.9	3.3	4.1	0.1	6.4	0.5	1.3	0.5	0.0	0.0	0.1	0.6	2.1	0.1	2.3	4.5	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	95.2	0.5	0.1	0.5	6.6	0.0	1.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	47.0	0.0	0.0	0.0	150.2	1.5	0.1	0.0	3.7	0.2	0.5	0.0	15.1	7.4	0.2	0.6	2.6	0.0	0.1	1.0	1.0	0.0	0.6	6.6	0.7	0.1	12.3	8.3	0.0	0.0	0.0	0.8	0.3	2.2	0.0
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181144-89198942	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	11.3	5.2	4.0	29.5	3.9	6.6	6.7	4.4	4.8	4.2	2.6	6.6	12.4	8.8	4.5	7.2	9.1	8.8	11.0	3.8	4.3	9.8	14.1	31.2	34.3	7.1	3.7	16.4	1.6	6.5	2.7	11.9	7.7	5.8	7.2	3.4	7.1	6.7	7.1	2.1	11.8	7.7	3.9	29.0	11.9	2.9	4.4	10.0	7.8	9.4	11.0	13.1	4.5	3.9	0.8	0.0	0.1	0.3	0.1	0.1	0.6	1.8	7.6	8.0	7.2	0.1	12.1	0.6	1.0	2.3	0.6	0.9	0.0	0.3	0.4	9.9	0.1	13.0	0.4	0.3	1.0	0.2	0.3	0.4	0.0	0.1	0.0	1.2	1.9	0.3	0.4	2.3	0.0	0.2	6.6	0.3	0.4	0.1	0.1	11.1	0.2	0.4	0.1	18.3	0.2	0.5	0.3	0.7	0.3	0.6	0.5	1.4	0.4	0.3	1.6	0.2	0.2	16.0	0.3	0.3	0.3	0.1	2.3	0.6	4.1	0.4	7.1	14.1	6.1	2.5	7.6	7.9	2.2	3.3	5.6	5.2	5.6	13.8	14.5	0.9	9.0	5.5	4.0	3.9	4.4	4.8	3.8	4.3	7.1	3.7	7.7	3.9	4.4	3.9	84.4	32.1	39.3	0.0	28.3	4.6	9.1	20.7	1.8	2.8	3.5	2.4	3.6	8.6	25.3	5.5	8.4	0.9	29.0	5.1	0.0	2.2	1.9	4.8	8.4	81.2	0.0	11.2	0.5	3.3	1.6	22.2	9.2	7.4	21.5	17.9	92.4	6.5	8.3	0.0	2.5	4.3	4.1	29.2	10.9	1.2	3.7	33.7	5.4	15.9	33.8	15.5	36.0	1.0	0.6	36.3	1.9	1.9	7.2	24.4	4.4	1.5	43.3	12.2	0.0	5.3	11.3	2.4	3.4	2.9	3.0	1.5	34.2	122.6	2.4	13.6
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108449191-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	9.0	12.7	3.4	17.6	5.1	25.2	17.4	0.0	5.5	12.5	26.2	19.2	21.7	15.3	41.7	7.5	15.0	21.4	8.4	3.2	3.8	16.6	10.7	14.8	21.5	2.5	4.2	15.5	12.5	15.0	4.1	13.7	2.8	19.6	20.8	17.3	15.2	17.1	2.3	7.9	22.9	9.4	0.9	18.8	26.4	16.6	1.4	18.9	20.5	9.4	16.3	14.1	3.6	6.0	12.5	10.4	12.6	5.5	14.2	22.6	27.4	17.6	26.8	9.2	12.9	18.4	17.2	14.9	22.3	16.0	16.7	10.4	10.0	14.1	15.8	16.9	13.6	18.7	16.3	15.8	12.7	26.4	14.3	29.1	13.3	23.1	16.3	20.0	13.6	13.9	25.3	12.4	17.4	7.1	13.6	18.1	21.9	11.5	12.0	11.7	17.9	16.1	12.2	20.1	13.6	12.5	21.1	16.7	18.7	18.2	8.3	12.8	21.3	13.3	20.2	12.4	6.7	18.0	26.9	18.2	17.2	7.0	9.8	47.3	8.9	25.9	25.5	8.0	25.1	27.0	28.2	27.8	7.3	24.3	38.2	33.5	35.6	14.9	17.6	31.8	23.0	8.2	3.4	5.1	0.0	5.5	3.2	3.8	2.5	4.2	2.8	0.9	1.4	6.0	92.6	150.6	103.3	44.1	125.2	23.8	68.6	54.8	29.6	155.9	60.3	57.5	85.6	75.8	95.7	104.8	139.7	44.2	157.6	152.1	50.9	114.5	73.9	253.3	85.1	68.1	85.6	39.5	104.9	81.6	56.3	74.2	65.7	118.6	82.2	113.9	65.0	36.7	37.0	70.7	73.6	152.6	52.9	49.8	39.3	39.9	71.4	66.0	33.8	62.8	88.5	59.0	134.9	50.8	66.1	116.1	125.2	82.8	108.7	91.7	134.0	63.1	259.7	127.2	52.6	61.4	66.2	163.0	120.7	21.0	17.5	65.0	139.1	138.0	88.3	114.5
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.9	0.3	8.3	0.2	0.7	8.1	9.5	2.8	7.4	0.5	0.1	1.2	0.8	0.4	1.2	0.5	8.8	8.2	11.0	1.2	21.5	0.4	0.2	9.0	9.9	1.4	1.8	0.1	23.9	1.6	9.1	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	8.3	0.6	0.6	0.4	12.6	0.1	0.5	0.1	0.2	1.1	2.0	7.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.9	8.3	8.1	9.5	8.2	11.0	9.0	9.9	9.1	8.3	12.6	7.9	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.2	0.7	0.2	11.9	0.2	0.5	0.4	0.6	0.4	19.2	0.2	142.9	97.5	2.0	0.0	15.8	4.2	75.5	0.1	0.2	0.1	17.9	0.4	0.7	0.9	0.1	0.4	0.1	2.1	0.9	0.1	0.1	0.2	1.2	123.2	0.1	55.8	0.3	0.2	0.3	123.3	4.6	0.0	0.1	25.8	4.3	0.2	1.3	2.1	0.0	10.6	9.1	29.9	0.4	0.1	147.4	0.0	0.2	0.0	1.0	0.2	0.1	7.7	0.0	0.0	6.3	6.0	0.6	24.6	0.0	9.5	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.5	30.3	0.0	0.2	0.2	0.3	3.5	0.7	0.0	0.1	0.0	0.2	0.0	0.4	1.4	0.6	0.1	0.2	0.2	75.9	0.3	0.4	0.0	0.6	10.2	1.2	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	0.1	0.2	0.4	7.3	0.1	0.2	0.5	0.8	8.9	0.3	0.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.1	0.0	0.2	0.2	0.6	0.4	0.2	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.0	0.0	2.2	0.0	1.0	0.0	18.3	8.9	0.0	0.0	0.5	0.0	0.7	11.5	40.5	104.8	0.0	0.0	0.1	360.1	0.0	92.6	9.8	23.3	8.6	0.3	7.8	0.0	0.0	14.9	0.0	0.2	27.5	75.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	26.9	8.2	0.6	0.0	19.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.4	163.2	0.0	0.1	8.0	85.5	4.4	9.8	0.0	6.6	0.6	1.5	3.0	0.3	1.4	0.0	0.0	0.8	0.0	48.5	52.4
GCNT4	"C2GNT3, LINC01336"	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4"	Q9P109	5	75025346-75052558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 22.4"	"Group enriched"	"Detected in many"	53	"granulocytes: 22.4;T-cells: 18.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 37.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"		No	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favorable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.9	0.8	1.1	2.9	1.8	0.7	1.3	0.0	3.3	1.4	0.0	1.4	24.0	1.2	1.9	2.2	2.1	5.3	0.4	2.1	0.0	4.1	1.1	1.7	4.4	0.0	0.0	1.0	4.6	9.6	0.2	6.3	0.0	1.7	1.3	0.1	0.5	4.8	1.0	2.1	20.2	2.3	0.0	1.7	18.5	1.6	0.0	15.4	0.5	1.4	3.0	4.1	1.8	1.4	0.3	0.2	1.4	2.3	2.5	0.8	0.1	2.8	7.2	1.5	1.2	3.7	0.2	0.0	0.4	2.2	0.8	1.0	1.4	2.5	0.3	0.0	0.1	1.2	0.3	0.3	1.1	0.0	0.0	0.4	3.9	0.1	0.5	0.0	0.0	2.2	0.0	0.5	0.2	0.0	2.1	0.1	0.6	8.0	0.0	0.0	0.0	3.6	0.3	37.1	0.0	0.1	0.3	0.0	0.1	7.0	0.0	0.0	0.0	0.8	0.2	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	22.4	0.0	0.0	1.2	0.0	5.0	0.0	11.4	3.7	0.0	0.0	11.1	8.1	0.2	0.3	0.2	0.1	18.2	2.3	1.1	1.8	0.0	3.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.2	5.0	0.7	0.3	0.6	8.7	0.5	0.0	0.0	0.9	2.3	0.5	32.9	2.7	12.9	0.0	39.6	0.8	4.9	9.8	7.1	0.1	11.9	2.4	1.8	0.0	0.0	1.3	4.4	0.9	2.5	14.8	16.7	7.6	2.0	3.3	0.7	2.3	0.0	0.0	2.7	0.0	0.3	0.0	0.3	4.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.2	6.9	2.6	0.5	3.0	28.0	0.7	0.6	0.0	6.6	1.6	2.5	0.2	1.7	0.6	0.1	24.4	3.7	0.0	4.4	4.2
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069146	Supported		Approved	"Golgi apparatus,Cytosol"	"Secreted in female reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.3	0.6	1.3	0.2	1.5	0.3	0.8	1.3	2.0	0.4	0.9	0.3	0.4	0.3	4.1	0.3	0.8	0.2	0.3	1.3	1.4	1.4	0.6	0.3	0.5	1.2	1.4	0.5	1.0	0.7	1.7	0.2	1.4	0.6	0.3	1.3	0.8	0.5	0.7	1.0	0.4	0.2	1.4	0.4	1.0	8.9	1.3	0.7	1.0	0.7	0.4	0.6	0.3	1.4	0.2	0.1	0.5	1.1	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.8	0.2	0.6	0.1	0.9	0.2	0.4	0.4	0.1	0.4	0.7	0.5	0.5	0.1	0.1	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	3.9	0.0	1.2	0.2	0.2	0.7	0.8	0.2	0.1	0.0	0.6	0.0	0.2	0.3	0.2	1.0	0.9	0.2	0.1	0.5	0.7	0.5	0.1	0.1	0.9	0.4	0.2	0.1	1.3	1.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.3	2.0	1.3	1.4	1.2	1.4	1.4	1.4	1.3	1.4	0.9	0.0	0.0	1.6	0.1	0.1	0.4	0.1	0.0	0.4	1.9	2.2	0.6	0.0	0.1	0.0	4.2	0.4	0.3	0.7	3.9	0.1	19.9	1.4	0.9	0.5	0.0	0.0	0.5	0.2	0.3	0.4	0.0	1.9	0.0	0.5	0.4	0.2	0.1	0.0	0.8	0.9	0.0	0.3	0.0	5.2	0.6	0.5	0.0	0.0	0.0	1.0	0.0	2.0	0.9	0.1	0.1	0.4	0.1	0.6	0.3	0.4	0.6	1.0	0.0	1.6	0.8	15.2	2.5	1.1	0.1	0.7	0.2	0.2	0.5	0.2
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000		"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.9	3.4	7.2	4.2	14.9	0.0	23.2	2.6	9.5	9.9	0.3	18.3	1.7	4.9	20.5	6.9	17.2	5.6	4.8	9.7	18.0	6.0	16.0	2.8	4.0	7.8	28.5	4.5	6.6	2.7	3.2	0.0	7.2	4.5	3.9	3.2	6.0	5.4	4.3	7.2	8.2	4.8	6.2	3.9	8.2	3.1	7.6	4.1	2.8	13.9	6.4	7.0	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	14.9	2.6	9.5	9.7	18.0	7.8	28.5	7.2	6.2	7.6	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514872-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 170.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 265.8;Endothelial cells: 263.3;Hepatic stellate cells: 267.4;Kupffer cells: 156.8;monocytes: 140.8;NK-cells: 632.4;T-cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"monocytes: 666.6;NK-cells: 1121.0;T-cells: 2269.3"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 92.9;MOLT-4: 78.6"	"Not detected"	"Not detected"							"HPA020266, HPA020268"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (7.43e-4)"	"prognostic favorable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	49.8	15.0	16.3	73.6	17.4	6.6	37.4	17.1	21.3	19.2	16.0	20.3	21.1	27.8	19.8	12.6	21.5	22.1	40.1	15.5	17.2	20.9	20.4	61.0	170.1	19.0	17.8	7.4	7.6	10.5	5.6	31.5	19.1	10.9	23.3	1.2	13.7	12.0	27.8	9.3	40.1	33.6	17.6	124.3	22.0	4.5	18.0	52.5	28.2	56.1	99.2	29.6	13.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	92.9	9.4	0.0	0.0	0.0	0.0	78.6	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.7	656.5	9.6	1184.0	595.9	1164.2	6.5	1762.9	1440.6	286.3	6.5	2269.3	1597.2	52.5	1121.0	666.6	16.3	1076.9	2581.7	16.3	17.4	17.1	21.3	15.5	17.2	19.0	17.8	19.1	17.6	18.0	17.6	265.8	0.0	13.2	0.3	13.1	2.4	0.4	0.0	2.8	0.0	2.8	5.6	14.6	5.7	0.6	1.8	0.0	0.2	125.1	0.2	0.0	0.5	1.3	0.9	0.6	263.3	0.0	17.0	0.0	0.7	0.0	8.0	3.1	0.7	13.9	0.0	267.4	5.3	15.5	0.0	0.0	0.1	0.0	156.8	10.6	2.0	2.5	54.9	1.8	22.5	140.8	0.4	632.4	0.5	0.1	0.4	1.2	0.4	19.3	0.2	0.0	1.7	0.7	0.4	0.0	6.0	9.4	0.2	0.9	1.1	3.3	0.4	255.9	0.9	0.2	0.0
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLIPR1L2	MGC39497	ENSG00000180481	"GLIPR1 like 2"	Q4G1C9	12	75391089-75432688	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 46.8"	"Group enriched"	"Detected in many"	7	"Early spermatids: 254.0;Spermatocytes: 306.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.2;SK-BR-3: 5.6;U-2 OS: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039795, HPA039866"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA039795: AB_10805595, HPA039866: AB_10795235"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.57e-2)"	1.0	2.7	5.1	0.8	5.2	0.3	2.4	6.5	5.9	2.1	2.5	0.9	0.6	2.3	3.7	1.0	3.1	1.0	2.3	5.5	5.0	2.0	1.5	1.2	0.7	4.0	4.3	7.1	2.6	4.1	2.6	0.9	4.4	1.5	0.4	3.0	1.0	3.0	2.3	1.9	0.8	1.1	4.0	1.6	0.7	46.8	4.7	1.3	2.4	1.6	0.4	0.9	0.9	6.3	0.2	0.4	0.2	0.4	2.9	1.6	0.5	0.4	0.3	0.1	0.2	0.1	0.3	0.2	1.0	0.3	0.7	0.1	0.0	0.1	0.3	0.6	0.2	0.1	0.6	4.2	2.1	0.4	0.0	0.5	0.9	0.4	1.5	2.5	0.1	0.1	0.2	0.5	0.8	0.1	0.4	0.3	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	0.7	0.3	0.5	5.6	1.7	0.2	1.7	0.1	0.8	0.6	7.6	0.9	0.3	0.7	0.7	0.2	0.2	0.2	0.5	0.7	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.5	0.1	0.3	0.5	0.9	0.6	0.3	0.1	0.7	1.0	0.2	5.1	5.2	6.5	5.9	5.5	5.0	4.0	4.3	4.4	4.0	4.7	6.3	1.5	0.0	3.1	15.0	0.3	0.9	4.6	1.7	3.4	5.6	2.9	3.0	4.0	1.5	1.8	0.0	0.0	1.7	1.5	0.1	9.8	0.6	254.0	4.9	1.4	1.5	0.0	0.4	7.4	0.0	0.2	3.0	1.1	0.5	1.3	1.4	0.0	0.2	0.6	1.7	13.3	0.1	0.0	0.3	0.3	39.0	7.5	0.7	0.0	10.3	0.0	6.7	0.0	27.2	28.1	0.1	0.0	5.7	0.1	1.2	0.1	1.4	14.1	2.0	6.6	5.6	1.9	306.8	19.4	0.3	0.4	0.4	0.6	2.1	0.3	2.1
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988987-104064183	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	16.9	10.9	4.2	5.2	4.9	1.5	19.5	2.6	5.1	29.6	11.2	17.6	5.8	27.4	21.6	7.5	22.3	35.8	15.4	4.8	3.7	4.3	2.7	10.2	6.0	2.9	3.1	41.6	4.5	6.6	9.6	9.4	3.1	13.3	11.4	1.0	7.7	16.0	3.2	4.1	7.7	21.8	2.8	1.6	8.4	6.8	3.7	2.2	26.3	11.5	5.8	20.8	18.9	4.4	0.3	0.6	0.7	22.2	28.3	69.3	0.5	32.0	89.4	8.3	10.5	0.4	0.2	0.9	1.8	37.5	0.4	0.1	0.4	11.9	7.0	1.6	10.0	0.6	11.2	0.2	12.7	0.9	0.5	63.2	0.7	10.0	13.8	51.9	4.4	0.6	0.4	1.3	36.5	0.3	0.8	0.5	2.7	0.1	6.7	1.0	33.6	0.2	45.5	0.4	1.3	1.7	33.5	0.8	0.4	2.4	6.0	0.5	0.7	13.2	6.2	1.3	1.9	3.9	0.8	0.3	1.0	0.7	1.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	4.9	2.6	5.1	4.8	3.7	2.9	3.1	3.1	2.8	3.7	4.4	8.0	0.0	4.6	2.9	0.3	2.8	4.2	2.4	0.0	0.8	1.0	26.3	3.9	1.5	0.1	0.0	2.1	4.1	0.4	0.0	0.0	0.1	41.2	0.6	8.3	7.5	1.8	0.0	10.2	0.0	0.8	55.9	1.1	0.4	0.0	0.1	20.7	0.3	0.6	0.0	10.5	1.3	0.0	0.6	2.8	11.5	55.9	0.4	3.6	4.7	0.6	0.5	0.0	1.0	2.6	0.3	0.0	51.9	1.2	1.4	0.0	0.0	0.1	0.5	6.6	25.2	18.0	1.1	1.1	0.2	2.4	1.4	0.6	10.7	0.0	0.1
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 576.3"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 234.3;Proximal tubular cells: 797.1"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.3	0.4	0.1	0.4	0.3	1.6	0.1	0.7	0.1	1.3	0.9	0.0	0.1	0.3	141.4	576.3	0.0	0.1	0.9	0.2	0.0	1.7	2.6	0.0	0.0	1.1	11.1	0.3	0.2	1.9	0.0	0.0	0.6	0.2	0.0	0.3	0.1	2.7	0.1	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.1	0.5	0.4	2.0	0.0	4.9	0.0	0.3	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.3	0.9	0.2	1.1	0.3	0.3	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.3	12.8	0.0	14.7	0.0	0.0	0.0	0.1	107.6	0.1	0.0	2.5	0.1	0.5	0.0	8.0	0.7	0.6	0.0	0.1	0.0	0.1	0.0	0.1	5.0	234.3	0.0	0.0	0.8	0.1	0.0	8.1	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	1.3	0.0	797.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.9	0.1	0.9	0.2
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"	A0A0U1RQE8	11	59086307-59094786	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"breast: 7.3;lymphoid tissue: 2.8"	"Cell type enriched"	"Detected in single"	57	"Proximal tubular cells: 5.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;T-47d: 1.2;U-266/70: 1.8"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0	0.0	0.8	0.0	0.0	7.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.9	0.0	1.8	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2629.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	178.1	123.8	167.9	179.9	212.3	147.6	119.7	147.8	234.4	124.3	87.1	165.7	173.7	127.1	90.8	126.7	114.4	110.9	119.6	228.3	172.0	125.1	103.3	146.7	160.0	159.5	153.2	130.2	105.9	148.2	106.8	141.1	169.5	118.3	123.1	2629.0	120.6	118.9	66.8	111.8	208.2	156.1	131.6	142.6	129.7	99.0	168.9	167.3	113.6	97.1	145.6	152.6	102.7	203.9	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	167.9	212.3	147.8	234.4	228.3	172.0	159.5	153.2	169.5	131.6	168.9	203.9	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"retina: 426.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 471.3;Cone photoreceptor cells: 932.0;Rod photoreceptor cells: 462.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;NTERA-2: 17.0;U-698: 40.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.1"	HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.9	1.4	6.3	1.6	6.0	1.0	0.6	6.7	9.5	2.3	6.7	1.4	1.7	2.2	0.7	0.4	1.6	1.1	4.4	5.9	6.6	2.0	0.2	0.7	1.6	5.7	5.3	2.8	0.7	1.5	36.2	0.4	5.6	2.1	0.6	426.5	2.1	1.4	1.3	0.7	1.5	3.2	5.2	0.9	1.0	0.6	5.7	0.3	1.6	0.3	1.6	1.6	1.1	6.4	0.4	1.2	9.4	3.1	1.3	2.0	0.9	4.8	0.8	2.5	2.1	1.9	0.5	14.1	0.1	5.1	0.1	0.5	9.2	0.3	2.3	1.2	2.1	3.4	6.8	1.5	0.9	1.1	2.3	2.4	0.5	2.4	2.7	9.6	2.5	1.8	1.5	1.3	1.2	0.7	0.7	0.8	17.0	0.1	0.5	0.7	2.8	0.9	0.5	0.4	1.1	2.2	0.4	0.1	1.0	2.5	0.1	0.6	4.0	3.2	3.8	4.8	6.7	1.4	1.0	40.9	1.3	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	6.0	6.7	9.5	5.9	6.6	5.7	5.3	5.6	5.2	5.7	6.4	0.3	0.0	0.0	5.2	1.3	0.4	0.4	0.2	1.2	471.3	0.8	1.3	6.1	0.0	0.1	0.0	932.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	3.3	0.0	1.3	12.3	0.0	0.0	2.3	2.0	0.1	0.0	0.1	1.1	0.0	0.1	74.0	12.4	0.0	4.1	0.3	0.4	0.0	3.7	0.1	1.8	3.7	0.1	86.7	0.0	6.0	1.2	0.1	0.0	3.4	3.2	0.8	0.0	0.1	0.6	462.8	0.0	0.3	1.4	0.1	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.2
GNPDA1	"GNPDA, GNPI, GPI, HLN, KIAA0060"	ENSG00000113552	"Glucosamine-6-phosphate deaminase 1"	P46926	5	141991749-142013041	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 127.2;Proximal tubular cells: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 382.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		930000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.05e-3)"	18.8	38.4	26.9	17.3	28.8	8.1	20.9	26.2	35.2	26.7	27.7	19.7	29.5	28.7	51.9	13.6	18.4	22.3	17.3	28.1	30.8	76.4	16.6	17.6	22.7	27.0	27.7	31.8	11.3	27.9	20.5	22.2	29.3	22.2	21.9	17.7	14.6	28.3	26.4	14.8	22.5	29.2	27.0	30.9	14.5	18.8	29.7	24.9	27.8	25.7	19.8	33.3	17.1	30.7	42.6	61.0	23.2	115.8	77.1	51.9	54.6	32.6	78.7	84.7	95.8	91.3	49.2	0.2	72.9	23.6	382.3	44.0	109.9	98.0	74.8	32.9	46.5	31.3	33.1	65.5	137.2	86.4	39.2	63.5	56.9	54.5	144.8	63.2	91.6	80.6	37.3	110.1	93.0	27.2	66.8	9.8	88.0	62.8	121.4	25.5	76.3	94.3	81.8	114.8	20.6	54.0	65.0	67.8	127.9	67.5	54.6	26.5	43.3	50.9	33.3	76.9	47.5	61.2	126.9	47.1	74.2	29.3	45.0	0.3	48.6	7.1	37.2	59.1	77.9	19.4	30.0	34.2	51.7	11.1	35.3	38.8	12.7	15.8	56.3	29.6	27.6	40.2	26.9	28.8	26.2	35.2	28.1	30.8	27.0	27.7	29.3	27.0	29.7	30.7	10.5	9.6	14.9	10.7	8.2	6.0	40.8	20.9	21.1	11.6	12.6	17.8	12.6	12.8	20.1	18.4	8.4	26.7	11.1	6.9	35.2	29.3	1.1	5.8	19.8	14.6	15.0	9.9	11.5	14.2	48.6	22.8	7.7	9.6	12.0	30.8	15.4	7.4	127.2	6.7	12.7	6.2	12.2	60.2	10.7	3.6	19.9	48.5	14.2	12.2	23.5	40.5	15.5	7.1	11.5	21.6	7.1	26.7	7.8	32.9	19.4	102.3	8.0	7.9	0.0	10.4	11.7	10.4	17.0	17.6	7.4	29.7	16.6	64.8	9.1	34.7
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		820000	"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	13.1	12.6	9.6	9.8	10.8	8.4	14.5	21.9	13.3	13.9	7.5	12.3	7.9	16.6	14.0	10.1	12.6	10.5	17.5	10.8	9.9	13.8	4.0	10.0	12.6	9.5	9.8	22.6	8.2	13.0	12.8	6.7	9.9	14.7	8.2	18.5	9.2	15.2	11.3	9.7	8.5	16.5	10.4	11.8	9.1	11.6	9.8	13.2	18.1	10.1	10.5	12.0	10.0	12.5	15.7	10.9	11.4	9.7	17.8	24.7	3.9	27.1	30.3	17.9	16.7	5.6	19.1	13.6	15.5	23.4	29.8	5.3	10.6	26.3	19.7	18.4	11.9	19.3	16.6	9.2	18.8	20.8	17.7	28.5	18.1	17.9	13.1	22.6	26.5	18.1	12.2	17.9	33.6	0.7	25.2	11.6	5.5	10.4	19.5	16.3	24.3	8.0	17.3	9.5	19.5	15.8	12.1	7.0	27.2	5.4	14.9	12.1	25.9	23.7	22.6	38.5	31.6	23.0	38.7	19.7	38.6	14.3	21.3	9.3	2.4	5.0	9.7	3.6	11.2	12.2	9.0	9.3	3.7	10.5	11.2	10.8	1.1	9.8	4.9	2.8	10.7	4.7	9.6	10.8	21.9	13.3	10.8	9.9	9.5	9.8	9.9	10.4	9.8	12.5	18.4	9.6	4.6	17.0	19.8	12.5	8.9	18.6	8.0	15.6	9.2	8.1	14.1	2.8	9.4	14.7	8.4	1.2	15.7	3.0	15.6	13.3	30.3	7.9	21.9	14.4	6.7	6.5	29.1	15.1	1.1	22.0	7.1	8.5	15.8	8.5	11.4	1.6	4.8	13.5	29.2	4.4	18.3	3.7	8.7	5.0	16.1	4.2	8.8	8.4	4.3	19.8	13.4	31.2	20.4	14.2	2.9	23.7	6.3	5.2	2.9	13.2	8.0	18.2	13.1	14.3	20.0	34.4	29.9	5.7	10.7	0.5	13.7	20.0	4.4	5.2
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768914-132829078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	12.4	12.3	19.2	12.5	18.8	13.7	11.6	14.8	20.2	15.9	20.6	15.8	7.9	14.7	9.2	16.2	12.8	8.7	13.7	19.1	18.6	9.7	14.0	13.5	12.8	18.6	19.1	17.0	19.6	7.8	26.9	10.5	20.1	14.7	11.7	26.3	17.3	10.8	14.7	15.4	13.6	12.3	13.3	15.1	15.1	11.6	20.5	17.7	12.5	8.6	11.1	14.5	14.3	17.4	19.7	39.1	13.4	23.2	42.2	28.7	25.9	34.1	23.3	23.8	20.9	40.7	8.7	25.6	16.8	45.4	17.1	19.7	16.3	19.6	14.1	6.4	17.3	27.6	44.6	26.0	25.9	29.5	36.2	23.4	22.8	26.8	26.6	23.4	22.7	19.1	27.1	9.8	21.0	30.2	27.0	26.7	14.0	15.1	24.8	21.8	14.1	10.9	13.4	47.1	16.1	10.5	27.0	22.9	14.6	15.2	31.1	22.2	38.7	23.5	17.6	26.8	21.9	31.0	32.0	40.4	28.8	16.3	28.7	3.2	2.0	2.6	3.4	2.9	3.1	2.5	2.6	3.3	2.3	3.4	2.7	2.9	1.5	3.9	2.3	3.9	3.6	2.0	19.2	18.8	14.8	20.2	19.1	18.6	18.6	19.1	20.1	13.3	20.5	17.4	22.9	44.8	40.6	25.8	22.0	21.7	12.7	17.0	13.1	26.0	21.2	16.1	35.4	8.6	26.8	14.7	100.1	13.4	20.6	63.0	7.9	15.2	23.8	21.8	46.9	24.8	22.2	16.4	40.2	27.8	24.2	29.0	48.9	47.5	12.0	33.3	14.6	24.1	16.0	18.5	41.1	50.2	10.2	15.1	16.4	34.6	25.7	18.2	17.8	21.5	18.4	20.1	23.7	22.6	33.3	31.5	27.1	22.6	54.2	32.3	17.9	8.6	26.4	110.6	6.6	32.1	27.7	25.1	24.8	19.0	33.1	23.1	21.7	24.6	32.5	29.4
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	38.6	36.3	18.3	19.5	26.7	21.2	28.8	26.6	22.3	27.6	58.3	28.1	38.8	20.0	23.5	37.3	21.1	19.3	63.7	17.6	20.8	34.5	60.8	25.7	17.0	27.2	24.6	23.4	48.0	33.5	40.6	36.1	27.5	29.6	28.1	56.8	38.4	20.7	118.8	48.2	36.9	19.5	21.8	24.1	38.2	44.3	22.3	17.6	47.2	102.3	19.6	25.0	28.9	29.9	62.6	42.3	21.4	27.1	55.2	47.2	54.4	78.3	65.2	30.2	36.3	36.5	33.9	21.4	19.9	67.1	34.7	35.9	34.4	55.5	62.3	27.4	25.2	28.9	37.9	58.5	55.2	30.9	20.3	25.4	51.8	47.7	92.1	48.8	44.4	15.8	35.9	32.6	49.1	26.8	23.7	13.4	23.4	31.7	39.9	5.4	64.8	22.8	37.4	64.4	13.7	18.1	48.6	51.8	61.4	40.8	76.3	22.4	54.0	30.7	35.6	60.0	56.7	39.8	30.1	18.3	54.4	26.6	36.8	30.7	6.6	15.5	16.2	7.6	14.0	9.9	10.3	11.9	5.5	11.6	10.7	8.1	8.9	15.7	15.2	11.8	7.6	4.3	18.3	26.7	26.6	22.3	17.6	20.8	27.2	24.6	27.5	21.8	22.3	29.9	85.4	237.2	312.9	142.0	98.2	158.3	134.0	70.2	128.1	171.9	97.0	84.1	683.5	84.4	147.4	46.0	358.6	112.7	126.4	154.3	29.4	117.5	240.7	131.6	141.8	102.2	89.6	127.1	154.5	120.2	117.8	128.0	140.2	242.7	62.0	112.9	63.1	147.5	92.0	188.4	168.6	166.2	65.1	73.1	73.9	46.7	119.9	80.3	69.4	107.7	91.9	145.8	132.8	133.7	223.2	136.4	109.1	113.6	150.2	169.7	181.2	64.5	82.4	361.0	85.5	161.8	95.7	435.6	227.2	98.5	175.7	249.6	97.2	125.7	139.3	189.2
GOLGA8A	"CFAP286, FAP286, GM88, GOLGIN-67"	ENSG00000175265	"Golgin A8 family member A"	A7E2F4	15	34379068-34437466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.0;HeLa: 80.1"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (4.80e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.58e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.68e-6)"	24.5	18.6	16.1	10.4	11.7	7.9	32.4	18.5	21.4	56.3	11.0	32.7	10.5	31.6	31.8	31.2	37.6	7.3	23.6	13.1	10.0	33.2	6.8	22.4	14.0	17.8	8.8	62.5	22.9	6.3	22.8	2.2	11.9	37.8	2.2	26.4	26.8	10.2	7.6	36.8	38.2	3.2	7.0	48.1	30.3	40.0	12.8	1.2	56.8	1.0	2.1	33.0	40.2	12.2	2.4	13.4	3.7	12.5	0.1	0.0	2.8	20.3	0.1	3.4	1.5	23.3	0.0	0.1	3.6	2.4	6.9	21.7	9.5	6.8	5.3	20.1	7.6	48.0	80.1	15.0	1.3	18.4	12.6	0.0	19.5	2.3	0.5	2.3	0.3	7.0	46.0	40.0	9.2	4.3	4.7	34.6	6.9	6.4	7.2	19.6	11.2	16.2	7.7	13.8	17.1	8.2	13.6	9.2	2.2	0.1	3.6	11.4	10.5	15.7	3.5	0.0	3.6	37.5	13.4	5.5	4.7	38.9	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.1	11.7	18.5	21.4	13.1	10.0	17.8	8.8	11.9	7.0	12.8	12.2	37.3	211.5	71.6	82.9	16.1	26.1	10.9	13.4	7.4	95.3	36.1	41.9	35.0	5.7	127.6	1.8	100.1	2.9	21.1	6.5	0.0	4.2	37.5	17.6	83.9	18.4	16.1	2.5	114.4	2.6	5.0	17.4	13.7	52.3	13.9	39.3	14.6	1.5	2.4	84.1	91.8	11.9	14.2	6.8	20.1	8.4	31.4	8.5	23.2	38.4	1.7	14.8	6.2	146.8	62.5	4.7	6.9	21.1	19.3	8.5	6.6	0.9	52.0	117.6	0.0	26.7	22.4	33.0	23.5	7.8	21.6	3.3	32.9	39.9	11.7	9.4
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 228.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 14.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA051808: AB_2681620"	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favorable (5.79e-4)"	16.5	28.8	10.9	7.2	11.0	18.4	20.8	13.8	15.0	28.7	10.8	18.6	0.9	16.8	11.9	10.0	27.9	6.9	15.5	11.0	11.1	41.1	41.8	23.8	19.6	11.2	10.9	55.6	228.4	0.7	60.6	3.0	10.9	37.8	1.4	8.0	18.1	10.6	10.1	13.4	25.2	2.0	10.9	38.5	28.7	43.2	11.1	2.8	113.8	1.3	7.4	19.7	13.4	11.2	2.6	2.8	0.3	5.3	2.8	5.4	7.3	2.3	0.7	2.5	4.0	2.8	3.5	0.0	4.7	2.5	0.3	2.1	0.9	2.4	1.9	3.6	8.4	0.4	20.4	16.2	3.9	2.3	2.5	7.8	3.3	1.5	4.5	2.7	2.6	4.0	0.9	0.2	2.3	1.2	1.2	24.5	3.2	5.0	4.6	0.1	0.0	0.4	2.2	4.9	3.8	5.8	1.3	0.4	3.2	3.9	2.2	4.8	0.0	3.7	8.8	1.1	4.0	1.8	1.7	3.9	1.2	1.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	11.0	13.8	15.0	11.0	11.1	11.2	10.9	10.9	10.9	11.1	11.2	19.0	192.3	66.5	95.0	34.8	21.9	8.8	10.9	33.0	53.6	30.9	34.3	37.4	20.0	74.7	31.3	73.0	7.6	30.6	2.8	1.9	9.2	53.8	17.3	27.1	11.0	7.2	13.0	133.4	13.0	5.4	12.7	20.4	24.5	9.5	36.4	11.0	28.7	1.5	45.4	126.1	10.1	12.2	6.6	9.9	10.8	39.4	5.0	21.4	12.2	6.4	9.3	32.0	112.1	24.2	16.8	4.9	37.6	45.1	7.6	7.1	5.8	39.9	67.8	13.1	13.5	13.8	48.9	28.4	10.0	14.8	2.9	49.8	22.0	9.4	6.6
GOLPH3	"GOPP1, GPP34, MIDAS, Vps74"	ENSG00000113384	"Golgi phosphoprotein 3"	Q9H4A6	5	32124716-32174319	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044564, HPA055841"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus, Vesicles"		"HPA044564: AB_10795169, HPA055841: AB_2682940"	"unprognostic (1.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	50.1	38.3	28.5	41.9	29.2	20.8	50.0	29.8	34.5	56.2	32.9	76.6	46.3	41.6	58.7	43.1	41.0	77.7	38.4	26.5	29.6	61.5	110.1	50.7	49.2	30.2	29.5	51.5	62.6	54.9	29.8	68.4	29.9	75.3	60.2	19.8	64.8	50.4	37.3	32.8	49.3	52.3	29.1	39.5	52.9	27.0	29.7	43.9	48.0	57.0	52.4	60.5	41.3	32.3	57.7	37.9	59.9	65.5	111.3	106.1	171.6	77.8	103.3	71.5	67.7	51.9	101.3	51.7	75.0	105.7	69.3	52.8	75.1	54.9	89.7	67.7	44.9	56.9	119.9	99.4	89.4	88.8	64.0	81.3	77.1	70.3	80.1	65.8	57.9	33.6	60.5	121.8	80.4	58.0	57.1	115.3	51.8	78.0	38.5	52.8	86.4	53.8	89.9	72.1	45.6	51.0	180.8	186.9	79.4	75.6	76.4	97.1	56.5	62.7	58.5	49.7	55.6	136.1	179.3	62.5	56.3	125.8	76.4	6.8	8.0	19.2	7.8	10.6	6.8	11.5	8.4	10.1	8.9	16.0	9.9	7.2	7.9	8.5	10.5	6.9	13.2	4.2	28.5	29.2	29.8	34.5	26.5	29.6	30.2	29.5	29.9	29.1	29.7	32.3	33.9	60.9	49.2	26.8	53.3	70.0	44.5	30.0	51.2	13.5	59.6	30.7	31.7	88.6	42.8	44.1	10.4	67.3	52.0	72.6	52.8	58.0	5.2	46.3	35.8	46.2	52.0	50.5	47.9	44.1	111.6	51.7	57.6	71.3	14.5	16.8	59.3	153.6	54.4	13.5	45.8	86.3	40.7	63.7	56.2	16.1	50.7	49.1	44.4	43.1	48.7	20.2	36.0	53.8	60.1	49.7	35.1	57.2	120.0	83.9	59.8	59.8	49.1	10.0	39.5	30.8	52.1	15.4	25.1	68.2	73.6	110.0	45.6	50.4	50.2	80.7
GOLPH3L	GPP34R	ENSG00000143457	"Golgi phosphoprotein 3 like"	Q9H4A5	1	150646230-150697154	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 313.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072016			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA072016: "	"unprognostic (1.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.24e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-2)"	10.9	14.3	8.8	11.8	9.3	6.0	20.8	9.3	11.4	21.8	13.5	31.1	17.9	14.7	33.3	30.3	25.3	14.1	10.3	8.7	11.4	18.6	9.6	13.6	12.6	9.3	13.3	21.4	22.8	19.0	11.0	13.0	11.7	15.8	36.4	12.8	23.3	17.6	14.7	18.9	20.1	15.2	9.0	11.0	22.7	14.4	10.9	15.8	25.7	13.5	18.5	21.5	13.5	8.5	25.2	23.0	12.2	7.6	31.8	22.5	21.8	22.6	33.0	23.7	32.9	10.3	45.1	29.3	31.5	14.7	16.1	21.6	20.8	18.5	28.6	21.1	21.5	33.8	13.2	15.2	26.7	27.8	28.2	16.1	31.8	24.2	54.4	26.1	37.5	21.1	27.6	19.6	14.1	25.4	24.2	13.1	25.7	46.1	21.6	16.8	14.5	36.5	30.6	17.5	19.3	18.8	11.6	33.2	18.0	31.4	25.6	32.5	29.3	7.3	13.3	10.2	18.5	23.8	22.9	313.5	22.3	28.3	10.9	7.5	1.6	2.8	9.5	1.6	13.0	10.5	9.9	9.7	8.7	9.8	12.7	9.4	1.4	18.0	3.6	12.6	11.6	5.4	8.8	9.3	9.3	11.4	8.7	11.4	9.3	13.3	11.7	9.0	10.9	8.5	11.7	9.6	10.3	12.1	9.8	12.9	11.3	16.7	9.6	9.0	26.3	14.4	10.4	24.3	22.6	12.9	6.2	22.1	9.7	50.0	25.4	21.6	22.2	27.5	10.3	14.1	21.0	10.9	12.7	36.6	17.9	12.9	17.9	15.6	11.4	48.6	16.1	10.9	12.4	0.0	13.6	46.6	14.2	9.1	7.4	12.7	16.4	7.5	16.0	24.4	13.1	14.9	6.2	11.6	13.5	21.2	34.6	19.9	15.0	27.7	31.6	26.9	51.2	13.3	0.0	10.0	9.5	14.6	4.3	15.7	17.8	30.8	10.4	22.0	36.0	39.6
GOSR2	"Bos1, GS27"	ENSG00000108433	"Golgi SNAP receptor complex member 2"	O14653	17	46923075-46975524	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 303.0;Late spermatids: 796.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB017456, HPA048956, HPA054472"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499"	"unprognostic (3.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.29e-2)"	23.2	25.6	28.5	21.7	28.7	16.4	24.8	31.6	37.6	24.8	32.9	22.8	49.8	23.8	31.6	21.5	21.3	18.3	32.5	29.3	29.3	42.2	33.9	23.6	26.4	28.7	29.7	26.1	31.3	35.5	37.1	28.7	29.2	23.1	27.4	25.0	32.5	30.5	43.1	21.9	43.2	29.8	28.1	30.1	23.1	48.3	29.5	27.1	26.6	34.3	31.8	25.2	18.6	30.9	44.6	47.2	33.5	40.3	54.9	39.3	37.8	59.7	58.5	63.5	56.7	60.1	25.7	37.7	33.1	75.4	66.5	30.1	43.4	48.5	77.8	83.0	33.3	56.8	37.4	60.1	60.3	44.9	44.1	40.8	47.1	52.2	73.2	49.0	52.6	43.7	56.5	50.9	46.2	46.8	50.0	24.2	31.1	60.1	65.8	43.5	64.0	44.5	40.7	37.7	28.8	61.5	33.3	19.2	47.9	57.1	55.1	31.3	62.1	60.0	38.8	47.4	58.9	64.6	39.4	60.1	56.1	28.6	67.1	39.5	33.1	29.2	33.9	63.2	31.3	29.8	29.7	27.8	32.7	38.6	29.1	25.4	3.6	31.2	86.0	29.7	38.8	35.2	28.5	28.7	31.6	37.6	29.3	29.3	28.7	29.7	29.2	28.1	29.5	30.9	23.7	25.6	18.7	17.9	22.0	16.6	17.3	16.7	4.6	18.5	21.1	18.0	16.2	15.7	14.5	33.1	6.2	30.2	23.8	15.9	23.5	34.5	303.0	9.1	18.0	25.2	7.2	20.6	24.2	42.7	33.1	18.4	15.3	11.0	14.5	22.7	21.8	22.4	45.1	23.5	26.3	16.8	16.2	22.0	14.7	796.1	16.8	15.0	10.6	21.5	22.0	16.4	14.4	17.1	28.4	58.1	24.2	14.3	23.5	22.1	96.5	90.0	13.7	20.4	0.0	9.3	26.8	33.1	26.7	7.4	16.9	52.7	14.9	18.4	12.6	20.5
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226807-94408020	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	9.1	2.2	0.8	8.9	1.9	0.1	2.2	1.7	1.5	3.6	1.1	6.3	2.3	2.4	2.4	5.2	4.1	17.0	6.2	1.3	3.1	7.7	17.7	3.5	0.4	1.7	2.4	7.3	1.6	1.8	2.9	1.3	2.3	6.2	6.5	5.6	3.1	15.1	0.6	1.1	4.3	7.8	2.0	2.2	5.4	2.0	1.9	1.7	1.7	1.9	0.9	11.6	2.4	2.1	0.0	4.7	10.2	4.5	62.5	19.5	0.0	7.2	0.0	4.9	6.4	0.0	0.0	0.2	0.0	16.0	0.0	0.0	5.7	1.2	9.1	0.0	4.1	0.0	0.1	20.2	37.8	0.1	0.1	70.8	0.5	11.7	8.1	64.3	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.1	6.4	0.0	3.4	0.0	1.6	0.1	5.5	0.0	4.1	16.8	0.0	1.9	0.0	39.5	14.0	0.0	0.0	26.9	22.6	25.4	12.3	15.9	0.1	0.0	52.8	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.9	1.7	1.5	1.3	3.1	1.7	2.4	2.3	2.0	1.9	2.1	0.6	0.0	0.5	163.2	0.0	0.6	0.5	0.5	0.6	50.3	0.6	1.9	1.7	4.3	0.7	7.3	10.4	0.2	0.0	0.1	0.0	0.3	6.7	1.6	25.9	1.1	0.0	0.0	333.6	0.0	0.1	31.2	0.0	3.1	0.0	36.0	5.7	41.2	0.5	0.0	496.1	0.1	2.0	1.3	1.0	5.0	4.7	0.5	1.8	31.9	0.0	2.7	0.0	691.6	13.2	0.1	0.0	1.9	0.1	1.6	0.0	14.5	0.0	115.0	0.0	34.4	20.9	4.2	2.7	0.5	0.4	0.1	0.7	11.9	0.1	0.2
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	18.9	17.3	21.0	15.1	22.1	12.2	20.3	21.9	21.3	20.1	24.4	21.3	11.6	18.8	15.3	18.7	22.0	16.1	18.3	19.5	23.9	20.5	13.0	20.3	11.0	23.4	25.3	17.9	18.8	28.7	16.6	23.3	25.6	23.6	22.6	26.3	18.3	19.9	17.8	22.7	12.9	23.2	21.8	13.4	16.7	17.3	23.5	14.3	34.9	17.0	14.2	15.8	14.2	23.8	29.7	42.0	39.6	31.7	42.4	44.6	39.9	45.9	52.5	37.9	37.5	40.6	39.5	16.4	33.4	52.1	44.5	73.0	30.7	28.6	32.3	24.7	20.3	17.0	49.1	23.8	40.9	36.2	24.4	37.5	44.3	38.1	38.7	44.1	35.9	19.0	25.0	15.8	33.6	36.6	19.4	14.7	26.8	60.0	31.7	18.3	58.7	25.9	32.1	40.2	13.6	30.7	59.8	42.8	33.1	34.9	75.0	19.3	42.9	48.1	25.1	40.3	35.3	9.8	35.6	15.2	43.5	17.0	46.9	1.5	2.8	1.9	0.7	3.4	1.0	1.0	0.7	0.8	1.8	1.0	0.5	1.2	3.3	0.9	3.6	1.1	0.7	1.3	21.0	22.1	21.9	21.3	19.5	23.9	23.4	25.3	25.6	21.8	23.5	23.8	14.8	25.6	19.3	47.7	8.0	6.4	5.1	14.8	5.2	16.9	17.8	12.2	23.0	14.3	16.4	16.5	39.6	15.4	11.4	20.7	0.0	13.4	6.5	23.7	19.3	14.3	9.6	4.6	32.7	17.6	19.2	16.2	16.8	26.4	6.3	17.9	24.3	11.6	15.1	18.5	39.7	19.4	6.1	17.0	17.6	5.7	19.0	13.8	14.2	22.5	15.6	11.0	9.2	38.2	48.6	21.9	15.9	19.2	11.2	13.2	9.3	6.5	24.5	15.5	0.0	16.3	15.3	16.2	11.5	12.2	10.9	26.7	10.4	13.5	18.4	10.9
GPR108	LUSTR2	ENSG00000125734	"G protein-coupled receptor 108"	Q9NPR9	19	6729914-6737603	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041924, HPA041951, HPA063863"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	Vesicles	"HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.04e-7)"	"unprognostic (1.58e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (8.68e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.13e-3)"	29.9	45.2	26.9	18.8	29.3	26.2	32.7	29.7	27.2	36.8	29.9	39.9	32.9	31.6	31.6	39.6	40.1	32.2	22.5	24.2	29.4	42.1	34.4	32.4	23.2	28.9	28.1	34.5	46.7	49.0	23.2	22.2	27.5	34.4	28.1	27.8	57.5	40.2	18.4	31.2	36.6	26.3	27.7	33.3	35.8	25.5	29.1	23.5	41.3	20.5	27.8	31.0	32.9	27.8	33.5	35.9	21.7	42.6	83.0	44.8	24.4	25.6	77.0	34.7	36.7	22.2	37.5	15.8	46.4	52.4	41.6	28.1	24.7	53.3	17.8	64.1	28.4	25.7	37.7	29.6	81.3	16.7	33.7	48.7	100.2	33.5	67.2	45.9	41.3	37.9	26.4	102.7	35.6	23.3	29.5	24.0	15.6	60.2	31.5	23.7	24.7	61.0	72.7	32.6	0.2	23.4	25.9	41.8	38.7	18.4	39.9	40.0	34.4	19.7	12.5	63.2	27.6	66.2	39.3	11.4	68.0	52.9	21.7	79.3	116.1	123.0	82.6	109.7	75.2	48.2	65.2	70.4	84.6	49.9	45.9	52.8	178.4	80.9	130.5	30.0	81.2	132.7	26.9	29.3	29.7	27.2	24.2	29.4	28.9	28.1	27.5	27.7	29.1	27.8	40.8	9.6	14.5	12.7	26.3	26.5	43.7	107.4	21.1	28.3	42.7	33.0	8.0	45.8	59.7	36.8	22.9	58.7	31.1	76.4	37.2	87.7	38.0	30.8	23.6	32.7	21.7	6.9	5.4	110.1	37.2	27.4	39.3	44.1	26.0	15.0	40.7	26.7	57.1	21.9	6.0	57.6	81.4	30.3	46.7	94.9	23.6	42.4	30.2	5.6	50.3	46.0	42.2	7.5	9.6	83.3	83.7	18.4	27.8	29.1	121.2	55.0	39.8	43.0	39.5	22.2	26.4	34.3	19.9	27.2	31.8	58.6	38.9	28.3	47.1	36.1
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.1;Bipolar cells: 37.2;Cone photoreceptor cells: 22.9;Muller glia cells: 36.0;Rod photoreceptor cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	13.0	21.7	32.6	4.2	30.6	4.5	12.4	50.9	44.4	38.7	12.7	18.5	3.3	23.3	7.2	6.0	20.3	4.7	74.9	30.5	26.7	19.6	4.7	35.4	2.1	34.9	29.8	38.1	42.3	3.8	19.7	6.6	28.7	30.6	1.2	18.7	8.6	5.9	2.7	17.0	9.3	4.0	25.1	19.9	17.2	29.4	28.6	2.0	12.4	0.7	1.1	15.1	24.4	28.6	3.9	6.2	14.5	25.4	8.1	14.1	12.1	43.0	17.6	11.8	6.4	12.5	4.1	0.0	17.8	26.0	9.9	2.9	2.3	8.8	2.6	35.1	25.5	5.0	23.4	2.3	34.7	0.3	6.1	23.0	5.8	10.8	6.2	14.5	12.0	5.9	13.5	0.2	7.9	14.2	2.4	4.9	15.5	1.4	22.5	82.3	26.2	12.7	3.2	2.8	35.6	44.4	8.0	1.0	13.7	5.6	17.7	8.6	20.0	21.7	17.5	25.7	8.9	7.6	0.3	0.1	13.0	0.0	21.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	32.6	30.6	50.9	44.4	30.5	26.7	34.9	29.8	28.7	25.1	28.6	28.6	4.7	3.2	3.3	26.1	0.6	4.2	2.3	0.8	0.0	37.2	2.5	5.8	12.4	0.0	0.8	0.0	22.9	0.6	1.6	0.0	11.7	3.3	0.6	2.7	18.1	3.9	1.8	2.5	9.0	1.9	0.8	9.1	0.5	5.5	5.7	14.2	3.6	0.0	1.1	10.1	11.6	0.0	0.0	0.3	2.8	1.3	10.5	1.5	8.8	6.5	0.5	36.0	0.0	9.5	10.4	7.3	0.0	9.4	0.3	10.6	0.0	0.1	0.6	43.0	0.0	5.8	6.0	0.4	3.7	0.1	3.3	0.3	1.1	3.3	0.0	4.0
HDAC3	"HD3, KDAC3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636849	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	24.3	39.8	7.8	22.7	8.4	37.3	25.3	7.8	9.5	25.7	9.9	23.3	18.7	23.5	26.4	34.1	26.5	20.3	24.4	8.7	8.4	24.2	39.6	21.4	32.7	8.2	8.0	26.0	28.4	44.9	18.4	22.4	7.9	20.6	24.5	16.4	25.5	21.9	40.2	40.8	23.5	26.1	8.5	27.8	23.3	15.8	8.5	38.3	24.1	34.1	42.7	26.2	25.8	8.2	59.8	40.2	74.0	109.5	68.5	54.3	47.0	42.6	93.5	94.8	134.8	86.5	49.7	86.4	54.0	56.2	67.3	51.2	72.9	98.8	117.0	74.6	79.0	68.8	33.3	50.4	48.1	83.5	60.1	47.0	63.2	55.3	71.3	49.6	61.9	76.8	67.6	44.7	61.5	55.8	92.1	72.9	63.9	36.8	31.0	65.8	76.2	62.3	49.9	59.7	60.2	49.4	57.0	57.1	71.7	46.2	61.8	52.3	32.1	58.3	36.1	45.8	71.8	36.6	47.8	82.1	48.8	78.6	50.8	41.3	51.7	39.6	34.1	53.8	45.5	47.8	42.5	41.9	107.5	47.5	45.9	38.5	21.5	35.1	46.8	55.1	55.6	43.8	7.8	8.4	7.8	9.5	8.7	8.4	8.2	8.0	7.9	8.5	8.5	8.2	19.1	9.6	13.2	16.6	36.0	44.2	26.8	38.1	37.0	33.2	29.0	25.5	15.9	18.6	19.6	12.9	60.5	55.3	43.8	18.5	21.5	33.4	10.4	10.0	21.0	21.3	18.0	50.7	40.6	35.4	51.6	28.8	19.9	10.2	18.4	33.9	21.4	18.7	38.8	50.5	38.2	19.7	28.5	19.5	44.9	4.2	22.4	31.7	32.0	10.3	51.1	33.3	38.1	22.1	21.9	33.4	16.3	22.2	36.3	28.7	19.5	20.5	10.8	36.5	26.3	18.1	24.7	25.4	27.5	38.1	51.4	61.2	30.3	42.6	25.9	30.3
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"Helicase for meiosis 1"	A2PYH4	1	91260766-91404856	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.3;testis: 13.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.4	0.3	1.0	0.1	1.0	0.2	0.4	5.1	1.0	0.9	0.0	0.5	0.3	2.3	1.1	0.1	0.8	0.2	0.6	0.7	1.6	0.7	0.1	0.2	0.1	1.7	1.6	3.9	0.7	0.1	9.3	0.5	1.1	0.6	0.3	4.5	0.5	1.1	1.5	0.1	0.2	0.9	1.1	0.4	0.2	13.8	1.6	0.1	1.6	1.1	0.2	0.4	0.3	1.3	0.0	0.1	5.2	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.7	1.4	0.0	0.5	0.0	0.0	0.5	0.5	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	5.1	1.0	0.7	1.6	1.7	1.6	1.1	1.1	1.6	1.3	0.2	0.0	1.1	50.9	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.3	3.1	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.4	17.8	0.2	1.9	0.4	0.0	2.5	17.6	0.2	0.2	0.6	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	38.4	0.0	0.0	0.0	0.0	5.0	4.1	0.0	0.0	10.3	0.0	2.4	0.0	90.5	9.5	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	6.2	0.0	2.0	1.4	58.9	15.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0
HID1	"C17orf28, DMC1, HID-1"	ENSG00000167861	"HID1 domain containing"	Q8IV36	17	74950742-74973166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 111.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031406	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"		"HPA031406: AB_2673866"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.47e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.34e-4)"	13.2	5.8	21.7	6.6	26.9	2.0	23.2	41.5	33.3	19.9	2.8	17.9	39.1	11.9	29.1	5.5	19.0	21.6	12.4	22.0	24.3	12.3	4.4	20.4	5.3	27.4	22.7	3.0	111.2	14.4	44.0	20.1	30.3	36.2	17.9	8.7	86.2	20.2	4.6	7.6	27.3	6.3	10.4	16.7	68.7	6.8	25.4	2.8	16.8	5.7	6.3	12.3	7.6	39.1	5.2	11.4	1.3	15.8	0.0	0.0	2.7	0.0	0.6	1.1	1.0	10.6	5.8	0.0	1.0	0.0	1.4	4.9	14.5	1.0	0.8	0.0	11.4	0.1	0.3	10.1	2.7	0.0	1.1	0.2	6.0	0.1	2.4	0.3	26.0	3.8	0.7	4.0	0.0	115.9	0.7	0.2	0.4	99.2	7.1	0.2	0.0	21.8	14.5	44.8	21.1	56.7	0.0	172.6	0.0	3.6	101.2	0.0	0.5	0.1	1.4	0.4	0.0	2.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.9	0.7	0.0	0.1	1.0	1.1	0.0	0.0	0.0	2.6	0.0	0.4	21.7	26.9	41.5	33.3	22.0	24.3	27.4	22.7	30.3	10.4	25.4	39.1	21.4	0.0	5.5	4.9	4.6	1.5	2.6	3.1	0.6	14.3	20.4	12.3	3.8	4.3	8.6	0.0	0.0	26.3	1.1	16.0	3.9	19.0	0.4	10.2	3.0	19.1	35.3	0.0	16.1	26.9	1.7	1.0	71.4	20.3	0.0	1.1	20.7	0.4	2.5	20.2	15.5	89.5	16.2	0.8	0.4	1.0	0.9	0.7	7.2	6.5	0.6	2.8	0.0	8.0	50.9	22.9	87.8	0.0	22.7	17.8	107.4	0.5	6.5	4.4	0.0	1.5	1.8	0.4	2.1	0.5	0.4	35.0	1.8	0.1	15.6	13.9
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	P04439	6	29941260-29945884	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 3747.8;Proximal enterocytes: 5267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA		170000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	635.4	714.2	15.0	34.8	15.5	137.7	566.7	14.7	36.5	504.9	18.0	737.5	278.3	476.1	181.1	366.8	390.3	239.9	473.4	14.6	17.0	687.0	392.0	1007.3	132.0	19.1	15.8	338.8	200.0	18.5	406.5	52.1	16.5	370.9	94.6	9.9	364.1	1.2	246.5	673.3	959.1	14.5	16.8	1413.1	442.2	132.6	18.0	138.9	531.9	14.5	178.3	412.3	466.8	18.3	1363.9	35.0	0.0	0.0	205.9	193.7	1.4	1.4	2.5	2.1	2.3	0.2	0.1	4.0	0.6	360.3	179.1	31.2	0.2	366.7	0.5	3.1	13.5	237.5	9.5	7.4	11.2	0.5	14.4	2.0	0.0	2.5	1.1	0.6	0.2	177.8	0.4	1.4	0.5	0.0	1.1	24.3	2.9	0.2	4.1	27.5	2.5	372.1	246.7	276.5	0.6	12.4	29.3	0.2	11.8	82.8	1.6	30.4	5.8	18.7	0.8	5.8	4.0	344.6	92.6	77.7	0.4	199.9	0.2	321.6	119.0	182.7	164.7	95.5	134.8	96.9	125.4	146.3	18.6	64.3	86.5	119.2	248.7	133.1	109.6	54.6	222.2	191.9	15.0	15.5	14.7	36.5	14.6	17.0	19.1	15.8	16.5	16.8	18.0	18.3	1622.4	371.8	478.6	22.9	1316.2	856.4	886.2	1417.5	228.8	30.8	289.6	188.5	147.4	936.5	952.5	503.9	6.2	18.3	1879.4	2631.8	88.0	3747.8	52.2	239.4	374.0	1717.8	955.2	499.4	3.6	1310.0	18.5	743.5	853.7	556.2	603.0	253.3	1266.2	276.4	1840.9	37.0	19.3	1755.3	1265.4	1575.0	1124.0	95.6	704.6	1419.1	635.0	67.5	3258.0	170.4	3201.9	49.3	16.1	1802.9	2452.4	484.1	1110.7	1026.6	5267.3	294.9	609.6	24.4	558.8	397.3	579.2	197.4	23.8	216.5	947.7	31.7	2234.9	1021.3	1225.4	1262.8
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 179.1;lymphoid tissue: 301.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5"	"Group enriched"	"Detected in all"	6	"B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 599.9"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	56.6	23.9	2.2	77.8	2.2	40.0	45.3	2.7	3.1	19.9	3.0	45.8	0.2	18.9	126.9	21.3	22.2	43.6	21.6	2.0	3.6	34.3	37.1	179.1	301.8	4.7	3.8	7.4	14.3	10.6	21.3	10.1	2.9	17.1	39.0	1.7	24.2	11.9	9.6	31.8	78.0	11.2	4.6	139.3	128.0	7.0	3.1	108.2	26.3	0.0	122.3	89.9	16.9	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	93.9	2.2	0.0	0.0	19.2	0.0	19.2	0.0	599.9	13.4	0.0	0.0	0.0	0.0	0.2	7.8	0.0	3.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	7.2	0.1	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	1.6	1.1	1.4	0.0	3.3	10.9	0.2	0.0	0.6	0.8	0.4	68.7	2.1	66.0	47.1	0.1	0.0	0.3	153.5	27.9	12.8	142.9	6.6	159.2	6.9	20.0	386.3	169.1	0.4	6.3	11.8	10.4	41.1	116.5	41.1	217.0	2.2	2.2	2.7	3.1	2.0	3.6	4.7	3.8	2.9	4.6	3.1	5.5	162.9	41.7	181.1	0.0	995.1	89.9	8.7	23.1	31.3	5.1	16.8	32.1	3.2	27.1	40.7	18.4	10.4	1.4	188.2	10.3	7.9	38.8	16.5	4.1	1.0	135.3	22.8	37.2	0.2	20.0	3.0	18.8	41.8	5.2	38.5	7.9	25.0	2.3	422.1	0.0	0.8	24.7	12.2	487.3	4144.8	7.5	6.5	1090.5	97.8	8.4	1038.0	1.1	25.7	0.0	0.1	28.3	27.4	9.8	86.9	8.7	417.9	18.5	53.0	2.7	6.6	4.8	9.6	2.7	2.5	18.5	66.3	3.0	84.5	0.9	36.1	49.1
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734391-186190949	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.8;Endothelial cells: 21.4;Fibroblasts: 22.2;Horizontal cells: 26.9;Microglial cells: 45.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.3;hTERT-RPE1: 20.1;MCF7: 76.5;SK-MEL-30: 50.2;WM-115: 43.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 9.9"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 35: T-regs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	9.7	1.4	1.3	0.6	1.2	0.0	8.4	0.9	1.1	3.7	1.3	9.0	0.9	1.9	2.5	5.4	1.8	6.5	8.4	0.8	1.1	2.5	7.8	20.3	0.4	1.5	1.9	3.9	0.9	0.9	3.2	4.8	1.5	7.5	2.8	0.6	7.7	1.4	4.8	4.1	3.1	4.3	1.4	8.4	1.7	2.6	1.7	0.8	3.2	7.0	2.4	1.8	3.8	0.9	0.2	0.1	1.6	0.0	4.7	4.7	0.0	0.5	0.9	0.3	0.5	0.0	0.1	1.9	0.2	22.3	1.6	5.0	0.1	0.2	0.1	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.7	0.0	5.6	0.4	20.1	2.8	0.0	0.2	0.0	0.0	76.5	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	50.2	4.5	0.1	0.0	0.0	13.7	1.3	0.0	5.1	0.2	0.0	0.3	2.7	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	1.2	0.9	1.1	0.8	1.1	1.5	1.9	1.5	1.4	1.7	0.9	33.8	3.2	7.0	0.3	0.0	3.2	0.2	4.9	2.2	1.7	1.2	1.8	2.8	0.0	0.8	0.0	0.0	0.1	0.2	0.3	0.0	0.0	8.3	0.6	1.5	21.4	0.0	0.0	1.1	0.0	0.8	22.2	0.0	0.9	0.0	5.2	7.9	1.9	0.1	26.9	3.8	0.0	0.0	0.3	2.8	2.7	3.7	0.4	5.4	45.0	0.0	0.1	0.0	3.0	1.5	0.0	0.0	2.2	1.2	0.1	0.0	0.2	1.0	0.0	0.0	2.5	7.7	0.5	0.1	0.4	1.7	0.0	0.4	0.1	0.0	0.2
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 612.2"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2"	"Lineage enriched"	"Detected in all"	7	"monocytes: 329.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		170000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	150.2	48.9	40.9	64.6	48.8	99.3	20.6	42.4	66.3	28.2	46.4	35.2	106.0	10.4	7.6	48.4	40.7	52.6	18.2	40.6	46.6	96.2	136.5	113.6	57.2	52.3	46.5	139.0	41.7	7.4	9.6	72.2	56.3	6.7	31.1	1.7	15.1	4.0	107.1	74.1	64.5	38.7	45.9	612.2	19.9	17.8	60.7	25.1	11.3	21.4	49.4	46.2	29.2	56.2	12.2	179.1	1.8	37.7	170.9	49.6	869.1	83.2	57.6	42.9	48.6	82.1	11.3	0.1	18.3	83.3	631.2	10.1	11.4	1.9	16.1	308.6	9.2	4.3	51.5	179.3	218.9	11.5	54.8	146.3	4.2	282.3	19.7	74.6	130.9	0.5	0.0	87.4	152.5	6.9	0.2	4.3	18.1	130.4	20.7	1.2	15.6	28.4	35.2	104.5	2.7	2.4	215.8	19.1	15.5	92.5	8.9	3.0	44.3	506.2	22.1	82.5	82.5	53.5	77.0	9.3	489.4	5.7	8.6	11.3	98.8	7.7	1.1	238.8	0.4	24.8	0.7	1.7	44.6	2.9	0.1	0.5	47.1	5.3	329.2	1.1	1.8	70.9	40.9	48.8	42.4	66.3	40.6	46.6	52.3	46.5	56.3	45.9	60.7	56.2	19.3	3.2	19.0	0.0	11.5	16.4	27.5	11.0	10.8	0.0	25.0	9.1	2.9	24.3	10.5	5.5	0.0	50.5	3.5	59.1	21.5	13.6	2.1	39.6	12.9	327.1	16.0	5.7	0.2	1.5	285.2	64.1	9.2	74.6	11.4	98.4	23.6	23.6	494.9	0.0	0.4	8.3	18.3	954.1	175.8	4.1	31.1	271.5	35.6	1.9	184.7	0.4	9.2	0.5	1.4	8.3	26.1	5.3	2.5	110.6	61.5	157.9	7.1	0.6	0.0	40.8	52.7	0.9	4.4	5.5	15.6	502.0	6.8	6.9	6.1	118.3
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 40.3;kidney: 60.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Group enriched"	"Detected in some"	17	"medulla oblongata: 12.9;spinal cord: 22.6;white matter: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1"	"Region enriched"	"Detected in single"	102	"pons and medulla: 10.1"	"Group enriched"	"Detected in some"	168	"medulla oblongata: 8.1;spinal cord: 25.4"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	10.2	7.4	0.2	4.4	0.1	0.2	4.6	0.3	0.2	18.3	0.0	16.1	1.0	4.3	40.3	0.3	13.4	0.3	0.7	0.1	0.0	60.2	0.8	6.2	0.4	12.9	0.0	0.3	1.2	1.3	0.1	2.6	0.8	2.0	6.1	0.0	0.2	21.1	1.7	1.2	14.0	2.3	22.6	3.0	9.3	1.1	0.1	0.0	0.7	0.5	0.0	3.8	2.2	6.3	5.2	11.9	0.0	6.2	5.3	5.5	0.1	0.0	0.0	0.0	0.0	6.5	7.7	0.0	28.2	14.2	2.0	0.1	1.4	0.4	0.0	0.2	80.3	7.1	23.8	0.0	7.9	0.6	18.0	6.9	0.2	11.4	0.2	4.3	5.4	0.5	4.7	0.1	15.7	0.3	0.0	0.3	0.0	20.0	4.7	0.0	13.1	0.7	53.2	2.6	0.0	0.0	4.4	0.0	8.2	0.1	2.1	2.5	30.1	1.0	6.0	5.0	22.2	0.0	0.0	0.1	0.9	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	12.9	0.0	0.8	22.6	0.1	6.3	10.6	0.0	0.0	0.0	0.4	0.8	0.5	0.0	0.0	0.0	0.4	0.5	0.4	0.0	0.0	136.1	0.0	0.2	0.0	18.1	113.5	0.1	1.0	80.7	5.5	10.6	7.7	0.4	0.0	2.0	2.9	3.0	0.0	56.4	0.0	0.0	4.2	0.0	1.7	0.0	0.0	9.0	0.0	18.6	3.1	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.8	0.0	0.0	0.6	9.5	2.8	0.0	0.0	0.0	0.9	6.4	4.8	6.2	0.0	1.1	0.3	1.2	0.0	11.0	1.2
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3 biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129638-149173732	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 115.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	7.6	9.2	4.2	11.4	4.7	5.6	7.9	4.8	4.2	7.5	8.3	7.5	11.0	9.9	4.9	5.6	8.6	9.0	5.0	3.7	6.0	12.0	8.0	9.7	17.6	6.7	5.6	14.0	6.7	5.7	3.7	10.6	6.8	9.3	9.1	9.6	6.6	8.5	2.8	4.7	10.8	10.3	5.6	16.0	9.2	6.9	5.2	16.8	8.8	3.9	16.4	8.4	5.2	8.5	49.1	26.5	15.7	16.3	21.4	27.4	11.7	19.7	38.4	25.3	32.4	9.1	31.8	12.4	23.8	23.7	115.3	16.5	17.4	13.4	32.4	30.6	13.9	5.8	11.8	9.9	19.1	15.7	9.1	18.0	13.5	24.4	10.0	51.6	26.2	20.2	6.5	29.4	32.5	30.3	11.3	22.1	37.7	26.3	21.1	13.4	10.3	33.7	13.9	24.1	4.7	12.4	16.8	17.7	35.9	33.4	19.2	20.5	13.2	25.2	4.5	26.0	29.0	24.0	10.0	30.6	37.7	30.1	6.3	20.7	12.5	12.1	12.0	15.2	14.5	15.4	10.9	12.9	19.5	12.2	8.4	10.9	5.7	9.8	10.3	11.0	10.7	10.9	4.2	4.7	4.8	4.2	3.7	6.0	6.7	5.6	6.8	5.6	5.2	8.5	9.9	12.8	19.5	17.6	28.6	3.7	3.9	11.5	6.8	6.7	9.1	7.4	2.5	5.7	22.9	7.3	2.1	21.0	24.3	8.0	5.9	10.7	3.0	10.6	11.6	9.9	9.0	7.4	13.3	18.1	14.6	10.8	16.8	10.4	15.2	18.0	17.5	6.9	19.8	3.3	16.5	8.8	14.2	29.3	23.8	4.8	11.5	33.1	14.2	38.4	14.4	25.1	19.6	19.1	27.3	12.9	4.9	30.1	15.4	6.8	13.6	22.8	20.7	5.2	0.0	7.4	8.4	4.4	8.4	8.7	5.3	14.1	18.9	5.4	7.5	5.1
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322886	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 573.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.4"	"Not detected"	"Not detected"							HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	9.4	0.3	0.6	0.2	0.6	1.4	6.4	2.4	1.0	2.7	0.1	0.7	0.4	2.7	0.2	0.2	1.0	0.2	0.4	0.6	0.5	0.4	573.7	3.6	0.2	0.8	0.5	0.5	1.8	0.1	0.2	0.8	0.9	4.5	0.4	0.8	0.2	0.2	0.3	6.5	0.7	4.2	0.4	0.7	0.3	0.4	0.5	0.3	0.2	0.1	0.1	1.2	7.8	0.9	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.7	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.1	1.4	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.2	1.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.6	0.6	2.4	1.0	0.6	0.5	0.8	0.5	0.9	0.4	0.5	0.9	100.0	3.2	6.4	1.6	0.0	2.5	22.6	0.3	0.0	0.2	0.2	0.3	0.3	4.3	42.9	1.8	0.0	0.1	0.4	1.0	0.0	0.1	2.7	0.4	0.5	2.4	1.8	5.3	3.7	0.4	0.3	0.8	0.0	0.1	0.0	0.2	1.8	131.3	0.2	0.0	3.0	0.5	0.0	2.4	0.4	2.7	0.0	0.7	0.0	0.0	0.3	0.3	0.0	1.5	2.8	0.1	1.4	0.4	0.1	4.7	0.2	0.5	34.0	0.1	0.0	0.7	0.4	0.0	0.9	0.2	0.4	0.0	0.7	0.2	0.7	57.0
HSPA12A	"FLJ13874, KIAA0417"	ENSG00000165868	"Heat shock protein family A (Hsp70) member 12A"	O43301	10	116671192-116850251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0"	"Group enriched"	"Detected in many"	14	"B-cells: 1.7;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011273, HPA073244"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA011273: AB_1851190, HPA073244: AB_2686586"	"unprognostic (7.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.31e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (2.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.55e-4)"	15.8	21.9	10.9	1.5	13.5	0.0	8.8	11.2	28.2	13.7	7.9	12.4	0.7	9.2	12.5	3.9	10.3	2.3	9.6	16.6	11.1	17.4	1.6	3.0	2.7	17.3	12.2	20.5	2.7	20.0	7.9	0.8	16.4	5.6	1.9	11.0	2.6	5.5	4.9	5.7	4.1	4.6	2.7	3.8	4.7	6.2	27.3	2.1	9.4	3.4	2.8	7.9	10.0	14.7	8.0	10.0	0.1	7.1	6.6	4.4	0.1	5.5	10.1	1.9	1.0	10.0	2.8	0.0	4.1	7.6	5.2	6.1	8.4	0.7	4.9	0.0	3.2	0.0	0.8	5.5	1.9	0.0	1.0	1.7	6.6	7.3	0.9	13.9	0.0	3.3	0.0	0.0	2.1	4.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	1.2	22.1	1.8	5.3	12.7	4.0	2.9	3.0	2.4	3.2	0.0	0.0	1.4	5.5	12.3	10.2	0.1	3.2	0.0	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.9	13.5	11.2	28.2	16.6	11.1	17.3	12.2	16.4	2.7	27.3	14.7	2.1	6.4	3.6	27.7	1.0	11.1	1.6	0.5	2.8	35.8	5.2	6.9	7.8	2.8	2.0	12.9	22.9	0.1	0.1	1.6	15.6	4.2	4.4	12.5	16.1	3.1	0.0	0.0	205.0	3.5	0.1	17.8	0.0	4.4	0.0	2.4	2.9	0.4	0.1	30.3	186.4	0.3	0.0	0.0	5.2	9.7	63.3	0.5	26.6	9.4	0.0	35.8	0.0	27.6	54.8	2.4	0.0	68.4	0.1	2.1	0.0	25.4	11.3	10.2	13.1	14.7	14.9	1.0	5.2	0.5	5.1	0.3	0.8	82.0	0.3	0.7
IFNGR2	"AF-1, IFNGT1"	ENSG00000159128	"Interferon gamma receptor 2"	P38484	21	33403413-33479348	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Prostatic glandular cells: 433.1;Urothelial cells: 602.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 661.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001535	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Golgi apparatus"		"HPA001535: AB_1078432"	"unprognostic (9.58e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (1.13e-10)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.15e-3)"	72.9	41.1	5.9	8.6	7.0	46.6	65.6	2.4	8.2	48.3	7.9	46.8	14.2	31.2	3.4	67.4	37.8	11.6	46.4	7.0	11.2	53.1	43.1	61.8	10.6	8.8	6.4	38.8	32.0	5.6	37.8	18.6	7.6	48.2	7.9	1.0	64.5	6.3	30.0	53.3	51.6	8.6	10.0	80.8	35.8	29.5	12.2	8.1	52.3	10.3	11.9	46.4	56.8	14.0	10.1	10.2	5.9	9.7	16.6	28.2	13.1	30.4	30.0	8.9	13.8	11.3	7.7	15.6	19.8	23.8	24.2	8.6	10.9	25.6	3.1	76.3	44.9	6.0	5.0	12.2	11.0	19.5	17.7	21.4	17.0	14.7	16.6	15.9	20.1	9.9	33.4	11.9	10.2	4.4	5.0	23.2	18.1	15.8	48.0	20.2	14.1	19.6	8.5	10.8	7.9	15.5	19.3	1.9	38.4	1.5	7.1	17.7	30.8	10.1	22.0	8.9	8.8	24.6	28.2	25.4	8.5	23.3	44.7	221.7	283.8	181.7	0.9	281.2	1.2	145.6	16.4	1.7	104.0	158.2	37.7	16.3	661.8	3.5	314.8	31.9	19.2	198.5	5.9	7.0	2.4	8.2	7.0	11.2	8.8	6.4	7.6	10.0	12.2	14.0	72.2	41.7	20.5	9.1	101.4	72.0	225.1	164.8	147.4	9.0	69.3	39.2	18.4	38.6	58.2	27.6	8.4	33.6	11.2	185.3	27.4	117.8	44.6	32.1	51.0	55.1	51.6	17.7	18.7	55.7	86.1	66.8	62.7	50.4	60.3	52.1	40.0	29.6	167.6	15.2	18.9	56.2	57.0	154.5	146.7	60.8	42.0	190.8	56.9	45.0	246.6	8.7	6.2	15.6	5.0	138.6	150.3	32.7	67.9	433.1	151.9	50.1	25.4	8.4	13.1	61.3	33.7	13.4	2.8	90.5	70.0	17.4	16.9	3.4	41.3	602.7
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.5"	"Cell type enhanced"	"Detected in many"		"NK-cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		190000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	20.3	21.9	1.8	11.4	3.7	13.3	16.0	3.9	4.3	15.2	11.7	17.4	7.4	19.3	4.8	16.7	13.9	10.7	21.8	3.2	4.2	14.8	23.9	22.2	8.2	4.3	3.6	17.0	16.6	14.3	9.5	15.3	3.8	11.0	11.6	3.2	18.4	6.7	69.5	16.5	14.7	16.0	3.2	23.2	15.5	7.7	4.8	15.9	14.5	27.2	7.8	15.3	16.5	5.9	20.8	18.1	32.6	44.6	108.4	76.4	36.9	30.1	80.4	30.3	52.8	28.3	37.2	7.3	30.9	38.4	101.7	25.4	27.0	140.0	52.0	47.7	19.4	3.6	30.0	32.1	49.2	20.7	31.2	52.7	45.4	57.6	144.8	65.4	19.2	36.0	42.2	48.2	46.4	10.1	8.8	13.4	13.1	19.3	23.2	23.2	20.6	46.1	29.9	20.8	11.3	25.4	45.0	34.5	44.8	41.4	15.7	49.4	25.3	27.0	27.9	57.3	60.4	16.7	40.2	9.1	49.0	23.7	38.9	0.5	1.0	0.8	1.1	0.3	0.4	0.2	0.5	0.4	0.2	0.2	0.5	0.7	4.4	0.7	0.4	1.3	0.2	0.3	1.8	3.7	3.9	4.3	3.2	4.2	4.3	3.6	3.8	3.2	4.8	5.9	44.7	48.1	47.3	34.6	16.7	22.2	10.0	16.0	17.1	13.0	20.2	14.7	33.6	24.3	22.1	16.5	20.9	7.5	107.0	46.2	0.0	29.3	7.5	25.8	38.7	29.6	22.3	9.5	33.0	19.4	12.3	29.9	16.8	39.7	3.8	41.7	28.9	63.4	22.2	15.2	34.2	18.4	12.2	59.4	12.8	5.2	47.5	37.6	12.4	31.9	65.9	11.7	264.7	30.7	40.0	40.8	17.2	38.4	35.9	17.1	23.2	23.6	12.2	15.1	65.7	63.7	32.6	10.9	10.4	28.9	19.7	9.3	38.8	38.8	20.9	16.7
IGSF9B	"KIAA1030, LINC00947, LOC283174, MIR4697HG"	ENSG00000080854	"Immunoglobulin superfamily member 9B"	Q9UPX0	11	133896438-133956968	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.8;choroid plexus: 20.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 25.2;Inhibitory neurons: 11.6;Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 38.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 10.0;SCLC-21H: 17.7;SH-SY5Y: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010802	Uncertain		Approved	"Golgi apparatus,Cell Junctions"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cell Junctions"		"HPA010802: AB_1079194"	"unprognostic (9.04e-4)"	"unprognostic (1.74e-2)"	"unprognostic (7.52e-3)"	"unprognostic (4.38e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.99e-4)"	"unprognostic (3.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-4)"	"unprognostic (3.12e-3)"	1.0	1.4	9.4	1.4	3.8	0.2	0.8	38.8	30.7	2.2	20.2	4.7	0.5	4.8	3.0	2.8	4.6	1.2	6.7	8.3	0.0	0.4	0.0	0.8	0.7	0.0	0.9	1.0	0.9	0.7	2.6	0.6	1.1	2.6	1.3	9.3	0.8	4.1	4.7	2.3	1.3	4.5	0.0	0.9	1.9	3.3	0.0	0.5	2.5	3.5	0.7	2.6	1.6	0.0	0.0	0.6	1.2	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.1	2.6	1.6	0.7	0.6	0.3	3.7	3.9	0.0	0.1	2.8	3.1	0.0	0.0	0.0	0.1	1.0	5.1	0.1	0.0	0.0	0.5	0.5	0.0	4.7	0.0	0.0	0.0	1.9	0.5	0.4	2.5	10.0	0.0	0.0	0.0	0.0	0.9	0.0	17.7	11.1	0.1	0.2	0.0	3.7	1.8	0.0	0.0	1.2	1.3	1.0	0.9	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.4	3.8	38.8	30.7	8.3	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	3.4	0.1	0.2	0.0	2.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.4	0.0	0.0	0.9	0.0	0.0	25.2	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.5	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	30.7	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.2	0.6	0.0	0.3	0.1	4.8	0.0	0.6	0.1	0.2	0.1
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	1.9	0.8	4.7	0.9	5.7	0.0	7.4	5.2	4.0	6.0	28.0	5.9	0.4	13.5	10.6	2.4	6.4	3.3	1.9	5.5	6.5	5.7	0.2	0.6	0.3	8.9	8.8	7.4	0.9	9.4	2.3	0.3	5.5	5.1	1.8	0.3	6.0	8.5	0.6	2.0	1.0	12.0	6.2	2.5	1.2	9.7	4.8	0.3	0.5	2.6	0.5	2.8	3.3	6.5	4.0	0.8	25.0	67.9	0.1	0.6	4.0	0.4	0.2	0.3	0.8	0.5	1.9	0.0	0.2	1.4	5.3	0.2	4.8	1.0	0.8	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.1	1.0	2.6	0.0	0.5	16.6	1.1	0.6	0.0	0.1	1.4	0.5	0.0	0.1	39.2	2.2	1.9	0.0	9.1	0.0	5.2	1.0	0.6	102.0	1.0	1.5	2.9	8.1	0.9	0.0	0.7	1.3	1.6	1.2	4.2	0.0	0.0	0.1	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.7	5.2	4.0	5.5	6.5	8.9	8.8	5.5	6.2	4.8	6.5	1.4	0.0	2.3	11.4	0.0	0.9	2.0	3.1	0.0	0.1	1.5	14.0	1.6	1.5	2.4	0.0	0.0	0.3	0.1	0.1	0.0	3.1	17.9	0.5	5.5	4.0	0.0	0.0	0.6	0.2	0.1	10.1	0.0	1.0	0.0	2.0	1.1	0.1	0.1	0.0	0.9	0.3	2.0	0.0	1.2	23.7	11.5	0.6	0.0	15.0	0.0	0.6	0.0	7.5	2.1	0.7	0.7	25.9	0.0	2.9	0.0	5.0	1.8	0.0	0.0	4.8	1.3	10.6	7.5	1.1	0.9	0.1	0.3	6.5	0.3	0.7
IL6ST	"CD130, GP130, sGP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55995022	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 580.3;Hepatic stellate cells: 808.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 16.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 151.3;BJ hTERT+: 175.2;HHSteC: 155.1;HSkMC: 135.1;TIME: 147.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		160000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	67.1	46.0	26.8	14.1	31.0	9.6	51.3	30.9	36.7	43.0	21.3	33.9	4.2	35.2	18.5	18.4	34.2	23.6	35.1	23.5	31.4	30.0	77.6	53.3	15.9	32.1	27.0	36.9	21.9	39.6	22.5	101.7	35.9	32.6	14.3	28.6	31.9	29.9	41.0	17.8	31.1	28.7	35.1	34.7	27.8	8.9	25.3	23.6	40.4	34.7	16.2	37.7	35.1	42.9	14.4	35.6	9.4	18.8	75.5	151.3	22.3	54.5	175.2	44.1	62.4	40.5	16.3	1.1	33.7	52.5	71.6	7.8	9.8	19.2	84.1	1.6	8.5	4.6	20.1	14.2	155.1	0.4	6.2	135.1	11.1	103.1	42.7	43.6	101.8	1.9	3.7	51.0	47.0	2.9	0.7	0.8	1.5	1.8	10.1	1.1	22.5	14.4	22.5	12.1	3.8	5.9	26.6	5.7	19.7	13.7	29.5	3.1	147.8	12.4	10.1	44.5	24.6	14.6	8.2	0.5	28.9	1.1	31.1	0.0	3.9	0.1	0.7	3.4	0.3	0.8	3.7	0.8	2.1	0.4	16.7	4.8	0.6	0.8	0.5	1.9	4.1	4.0	26.8	31.0	30.9	36.7	23.5	31.4	32.1	27.0	35.9	35.1	25.3	42.9	221.6	134.6	149.8	59.4	30.0	103.9	98.0	60.6	71.2	56.5	202.4	81.3	81.5	124.4	105.4	68.0	35.5	77.9	33.1	34.5	7.9	85.3	12.3	76.4	227.6	256.2	19.8	41.1	25.7	62.0	75.5	285.5	59.1	580.3	32.9	58.6	808.5	219.8	56.0	16.8	70.0	34.1	46.8	93.7	99.1	16.7	105.9	60.3	80.0	188.3	45.8	190.8	7.2	75.4	64.2	80.8	35.6	130.5	100.6	163.9	33.6	52.2	80.3	39.3	98.6	158.7	150.3	54.4	38.6	44.9	83.5	101.8	75.5	228.7	17.1	106.1
ILVBL	"209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535"	ENSG00000105135	"IlvB acetolactate synthase like"	A1L0T0	19	15114984-15125786	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 148.2;Syncytiotrophoblasts: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067682	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus, Vesicles"		"HPA067682: AB_2685885"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.91e-8)"	"unprognostic (4.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.40e-1)"	29.7	45.5	22.7	13.9	27.5	15.5	27.5	30.9	25.1	29.7	32.8	46.2	50.1	24.3	14.4	40.9	22.6	25.5	73.7	21.4	25.5	41.6	56.8	19.2	15.5	29.2	25.3	28.3	42.5	65.8	34.4	19.2	26.3	24.2	18.6	13.8	27.7	23.2	18.7	43.4	43.7	13.7	24.8	17.6	41.1	25.5	25.2	10.5	48.0	25.0	10.6	28.5	30.6	32.3	68.8	41.0	34.4	40.7	43.8	29.7	39.6	31.6	42.2	37.2	47.5	65.5	162.1	29.7	61.1	34.2	22.3	50.6	20.9	38.5	10.8	27.5	41.1	43.7	41.3	72.4	70.1	37.2	37.0	44.6	43.9	21.7	28.3	30.4	35.0	29.6	17.9	37.6	29.3	159.0	24.9	29.6	31.9	54.9	58.8	36.0	31.1	46.5	32.3	33.6	28.4	38.3	18.8	81.2	62.1	13.2	37.2	31.2	37.7	55.9	30.7	71.0	45.1	26.1	29.2	15.1	35.9	35.8	43.1	22.7	22.2	5.5	21.1	31.8	24.0	11.9	17.7	22.0	26.3	12.9	22.9	23.6	2.5	23.7	30.3	19.1	20.2	23.3	22.7	27.5	30.9	25.1	21.4	25.5	29.2	25.3	26.3	24.8	25.2	32.3	28.0	25.6	11.7	18.3	12.7	12.7	26.8	53.8	22.2	95.3	18.0	14.9	36.1	62.9	43.0	25.8	27.1	84.2	15.8	67.8	19.6	48.4	6.2	9.9	13.4	23.2	44.4	12.6	4.9	50.6	148.2	21.4	40.2	13.0	11.4	29.0	26.7	59.3	43.2	18.5	8.3	60.6	28.5	12.1	9.5	6.5	25.7	15.8	83.6	5.6	6.8	48.0	7.2	9.0	15.7	32.3	68.4	19.9	17.2	18.6	123.0	50.4	26.1	36.8	19.7	14.7	21.2	20.3	20.8	25.0	16.2	253.4	11.8	48.2	73.2	23.4
INHA		ENSG00000123999	"Inhibin subunit alpha"	P05111	2	219569162-219575711	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 75.6;ovary: 104.4;testis: 95.3"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB000047, HPA019141, HPA048834"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Golgi apparatus"	"CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: "	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	1.2	75.6	3.4	0.2	3.7	0.1	1.4	2.7	4.8	2.0	2.2	0.9	0.2	2.0	2.2	0.8	3.0	0.4	16.3	3.5	3.2	3.1	0.7	0.8	0.1	3.4	2.9	104.4	12.3	0.7	6.6	11.3	3.5	3.1	0.0	1.9	1.5	1.1	0.8	2.1	0.4	0.4	2.5	0.4	0.7	95.3	3.4	0.0	3.3	0.0	0.0	1.0	1.8	3.0	0.4	0.2	0.0	1.9	0.6	0.1	3.5	0.3	0.2	0.5	0.2	0.3	3.2	0.0	0.2	0.7	0.5	2.0	0.2	0.5	0.0	0.0	0.6	4.5	1.8	2.4	0.3	0.0	0.0	0.6	0.8	0.0	0.5	1.4	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.1	1.2	0.1	0.9	0.1	0.2	0.0	0.5	0.2	0.3	0.8	1.1	9.9	0.3	4.9	0.5	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	2.7	4.8	3.5	3.2	3.4	2.9	3.5	2.5	3.4	3.0	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.8	0.0	2.7	0.3	0.3	2.2	0.0	0.1	7.3	2.1	11.8	0.0	0.0	0.0	2.8	0.8	0.5	0.5	0.2	0.0	0.0	5.9	8.9	35.5	1.2	0.0	0.5	0.0	254.3	0.7	0.1	2.6	6.7	6.9	0.0	0.0	0.3	0.0	5.0	4.1	0.2	0.0	0.0	0.0	3.7	0.0	1.0	0.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	1.5	3.4	0.6	0.0	0.0	331.0	0.0	75.6	0.0	0.0
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 205.8"	"Group enriched"	"Detected in many"	7	"Endothelial cells: 150.4;Hepatic stellate cells: 268.4;Leydig cells: 285.2;Peritubular cells: 455.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 16.7;HHSteC: 6.7"									HPA061343			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA061343: AB_2684483"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-4)"	"prognostic favorable (5.72e-4)"	"unprognostic (3.08e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.58e-2)"	64.5	51.2	3.1	2.7	6.0	0.7	10.2	7.9	13.1	6.4	9.3	9.5	2.8	16.0	25.4	15.0	43.8	8.3	75.6	7.6	8.7	20.0	23.3	205.8	7.6	9.6	6.0	17.7	11.3	5.7	7.8	33.7	5.6	29.6	4.6	0.5	9.1	48.0	14.4	4.2	8.5	25.7	2.5	13.0	12.7	15.8	4.8	1.7	21.3	13.2	4.0	11.1	7.2	16.6	0.0	0.1	0.0	0.1	1.5	2.1	0.3	0.2	2.1	0.0	0.0	16.7	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	6.7	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.2	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.5	0.1	0.6	0.0	0.6	0.1	0.0	1.0	0.0	0.6	0.2	0.0	0.7	0.3	0.0	0.2	0.1	0.3	1.6	0.2	0.2	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.5	0.1	0.3	0.1	0.2	3.1	6.0	7.9	13.1	7.6	8.7	9.6	6.0	5.6	2.5	4.8	16.6	39.4	0.0	3.6	0.0	1.0	2.2	0.1	0.0	1.2	0.0	0.4	0.6	10.0	7.2	2.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	2.3	0.1	0.8	150.4	1.2	8.0	0.0	0.0	0.4	38.2	0.0	0.0	0.0	0.9	268.4	5.1	0.8	0.0	0.0	0.2	0.0	16.6	4.4	16.0	285.2	0.7	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	455.5	1.5	0.2	0.0	0.1	0.7	0.0	32.9	5.0	19.6	1.3	1.3	0.4	2.3	1.8	1.3	0.2	0.0	0.4
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439845	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Focal adhesion sites"		"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	12.1	10.8	15.0	6.9	15.0	6.4	11.7	15.3	19.9	15.1	11.3	13.1	5.7	15.2	2.3	10.6	17.6	5.3	13.7	14.0	14.3	13.3	12.2	11.9	8.2	15.1	13.3	16.2	10.8	6.6	14.3	5.7	15.5	12.3	3.3	7.4	9.5	5.3	8.5	11.2	11.7	5.6	11.4	20.8	8.9	20.1	14.8	6.4	15.1	3.8	4.7	12.2	12.0	13.9	8.9	10.3	12.6	13.2	6.5	7.1	14.9	10.7	5.7	7.4	5.1	12.5	6.0	10.8	10.5	11.1	11.9	25.2	6.2	8.6	2.8	36.8	25.4	8.5	27.1	8.4	10.3	9.5	11.9	10.9	8.8	9.8	7.2	10.3	8.9	14.8	14.5	14.0	7.0	22.3	11.4	19.9	8.1	5.3	16.0	21.1	8.7	8.3	7.4	9.8	14.1	12.2	10.4	8.5	7.6	7.6	15.1	15.6	11.8	24.1	9.4	10.1	18.2	11.6	10.6	4.5	12.0	7.8	9.7	0.0	0.1	0.5	0.5	0.0	0.3	0.7	0.6	0.4	0.1	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.1	15.0	15.0	15.3	19.9	14.0	14.3	15.1	13.3	15.5	11.4	14.8	13.9	14.7	3.2	6.9	17.0	5.0	5.5	1.8	2.6	5.7	7.4	6.5	6.9	5.0	7.2	3.4	3.7	2.1	2.3	7.6	4.0	1.9	4.8	0.9	11.8	8.1	7.4	6.1	0.8	12.2	5.6	2.8	5.7	3.6	6.8	8.9	8.3	6.1	3.8	3.2	15.2	12.9	2.6	6.1	3.5	3.5	1.3	7.5	3.7	5.4	6.5	3.5	8.9	1.0	8.5	8.5	6.7	1.6	5.7	2.5	3.3	3.4	2.4	10.0	10.8	0.0	5.5	7.5	15.3	9.1	5.4	4.8	0.8	5.3	5.6	3.9	1.6
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239147	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 344.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	45.2	56.4	39.0	34.4	43.4	51.3	44.7	41.3	40.5	63.8	47.3	87.5	35.9	56.1	18.2	34.6	61.3	33.7	73.6	33.2	42.5	60.0	36.6	61.8	36.8	53.9	43.2	68.6	55.7	36.4	60.5	39.7	45.8	68.7	23.3	14.9	53.8	39.5	116.6	31.4	57.1	33.4	45.0	66.1	60.8	24.2	48.8	19.3	67.7	43.0	23.2	59.9	43.4	41.2	28.7	62.1	71.5	49.8	35.4	41.1	122.5	118.9	61.2	80.6	49.6	84.3	72.2	79.5	125.6	101.7	57.8	106.7	60.4	37.6	28.0	101.9	59.1	84.8	344.5	31.9	68.1	56.1	176.7	58.2	39.1	78.0	31.4	100.5	44.2	29.3	59.7	34.7	45.1	78.8	42.1	224.9	67.7	20.7	93.7	185.0	161.0	18.2	94.8	48.6	33.8	48.6	133.9	85.1	182.8	36.6	88.8	106.0	74.5	86.4	96.7	129.9	43.1	94.5	17.5	80.1	24.7	51.7	47.2	2.5	3.5	3.3	1.9	2.0	1.7	0.9	1.6	1.3	2.4	1.0	1.1	1.6	2.3	2.2	3.6	1.8	1.5	1.8	39.0	43.4	41.3	40.5	33.2	42.5	53.9	43.2	45.8	45.0	48.8	41.2	13.9	3.2	12.8	47.0	8.1	7.1	4.9	10.8	14.2	1.7	20.3	17.3	13.6	11.5	11.7	12.9	27.1	27.9	9.1	28.3	1.9	11.6	1.5	14.6	16.3	11.2	22.7	5.7	2.6	12.5	15.4	10.8	24.5	25.5	7.6	21.0	8.9	12.5	21.7	10.1	2.2	16.4	18.3	27.6	16.2	2.1	9.9	29.8	10.6	18.7	17.6	16.8	14.4	15.1	6.1	14.9	17.5	13.9	7.8	7.8	15.2	16.2	10.2	17.2	6.6	12.9	14.5	1.4	4.9	6.7	4.8	32.4	11.6	10.1	21.8	5.4
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3595832-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.5;breast: 16.2;kidney: 28.9;salivary gland: 17.8"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;REH: 37.8;U-251 MG: 15.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		7.3	0.0	3.6	0.0	4.2	0.6	16.2	6.8	1.6	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.8	5.4	28.9	0.0	3.1	0.1	16.9	10.2	0.0	0.2	0.2	1.0	0.0	17.5	0.1	0.0	0.1	17.8	0.5	0.1	8.9	0.0	0.0	7.5	0.0	0.0	0.1	6.8	0.3	0.3	0.0	0.0	0.0	0.5	6.4	0.0	0.0	8.8	0.0	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	37.8	0.0	0.0	2.8	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.2	6.8	1.6	1.8	5.4	16.9	10.2	17.5	7.5	6.8	6.4	2.5	6.4	3.7	0.0	0.4	3.6	0.0	1.6	1.2	0.8	51.4	87.6	3.5	0.0	1.5	5.5	0.0	0.3	1.0	0.0	15.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	1.0	0.0	0.5	3.7	0.0	0.2	1.1	3.0	0.3	0.6	0.0	0.0	0.0
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173710-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 118.0"	"Region enriched"	"Detected in all"	5	"spinal cord: 124.7"	"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		130000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	89.3	17.5	4.4	5.5	11.8	0.0	66.9	1.7	10.4	216.2	5.4	75.1	5.7	181.4	18.9	17.1	78.7	38.6	63.3	4.6	5.2	20.9	8.2	37.7	9.9	2.8	3.2	170.9	10.1	2.1	44.6	10.2	2.8	51.4	5.2	0.3	33.6	22.9	18.5	46.7	31.3	26.3	2.3	33.0	32.5	14.9	4.5	3.3	63.4	19.7	5.3	63.5	111.9	5.0	0.0	1.5	0.1	0.0	62.7	33.5	0.2	10.2	0.1	0.0	0.0	0.0	4.0	0.0	0.6	148.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	25.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.5	5.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.4	7.6	0.1	0.1	1.1	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.8	1.7	10.4	4.6	5.2	2.8	3.2	2.8	2.3	4.5	5.0	10.3	0.0	1.3	0.7	0.1	11.7	0.1	0.2	0.0	0.1	4.8	3.9	3.9	1.5	0.7	0.0	0.0	1.3	0.8	0.0	0.0	0.2	2.4	7.2	193.5	14.0	0.0	0.0	1.9	0.2	1.4	154.5	2.0	4.2	0.0	0.0	7.5	0.0	3.8	0.0	0.2	0.0	0.0	0.0	16.2	6.1	214.9	2.6	12.4	34.7	0.0	0.2	0.0	0.5	0.7	0.8	0.0	159.9	0.0	0.1	0.0	0.1	1.5	0.5	26.3	7.0	49.8	0.7	0.7	1.3	8.8	1.0	2.6	7.0	0.0	0.2
ITIH5	MGC10848	ENSG00000123243	"Inter-alpha-trypsin inhibitor heavy chain 5"		10	7559270-7666998	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 112.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038305	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Vesicles	"HPA038305: AB_10670662"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.48e-2)"	112.7	3.7	17.9	19.4	18.6	0.2	53.3	19.7	23.2	17.4	28.6	62.7	13.9	24.3	6.3	21.4	10.5	27.7	16.8	14.7	18.0	16.4	1.6	22.4	12.5	18.9	18.1	21.2	15.0	6.3	5.4	86.9	19.7	24.0	16.8	3.5	9.5	46.6	17.8	12.0	21.6	28.8	15.7	3.4	24.0	6.2	22.5	3.8	24.5	22.5	13.4	51.4	15.3	15.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	18.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	14.8	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	102.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.6	19.7	23.2	14.7	18.0	18.9	18.1	19.7	15.7	22.5	15.2	74.9	3.2	2.7	1.3	0.2	11.3	3.0	0.1	6.8	2.7	1.6	17.3	8.7	8.6	3.7	0.0	2.1	282.7	0.8	0.1	0.0	25.7	2.0	18.7	1.5	58.8	0.0	0.0	0.5	0.4	70.2	111.3	0.0	34.1	2.5	0.5	1.8	0.1	20.7	0.0	0.7	0.0	8.2	1.2	19.6	2.2	5.3	3.6	14.2	160.2	1.1	21.9	0.0	1.5	1.0	0.3	0.0	15.4	0.9	1.8	0.2	2.1	0.7	3.2	78.9	32.3	110.1	1.7	7.7	0.7	8.8	221.9	3.0	0.3	0.0	1.6
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48232612-48270357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Amyloidosis, Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4375.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 4375.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 731.2;RPTEC TERT1: 1718.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		5800000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	510.2	367.4	286.9	172.5	301.0	125.6	323.8	328.6	489.0	416.1	406.6	260.1	289.2	388.8	1171.8	399.9	305.4	257.5	381.0	320.1	339.2	1306.3	391.2	376.1	236.7	334.9	308.0	507.2	179.6	233.7	290.5	573.8	304.4	312.5	191.4	174.4	408.7	386.2	164.7	399.6	287.4	232.5	373.6	435.2	312.8	121.4	308.8	188.3	386.1	206.2	187.4	305.1	402.2	394.8	67.6	51.8	73.1	116.3	348.5	254.5	119.2	215.0	202.2	87.5	100.6	29.1	248.3	16.6	168.8	121.6	48.5	214.1	61.3	107.0	107.4	69.9	147.3	137.9	29.0	99.0	138.5	140.6	731.2	113.4	149.1	45.1	62.0	375.7	131.2	78.3	24.5	90.9	174.8	29.6	200.4	310.1	266.0	116.5	103.6	100.1	100.5	73.6	1718.9	268.6	26.2	119.5	154.5	110.2	111.0	306.0	74.0	119.4	180.5	62.9	73.8	95.7	85.4	72.9	59.6	2.5	78.0	75.3	155.3	3091.4	864.5	2737.9	387.4	661.3	512.5	235.3	523.1	476.4	428.9	245.3	551.3	466.8	4375.2	356.5	692.7	196.2	563.4	1723.5	286.9	301.0	328.6	489.0	320.1	339.2	334.9	308.0	304.4	373.6	308.8	394.8	1380.0	695.5	300.4	174.6	408.6	862.4	1661.1	2606.2	1006.2	653.1	460.1	573.5	384.8	722.0	1121.9	1991.8	187.7	1164.3	448.2	754.2	545.9	910.2	23.6	751.8	802.2	1166.2	283.3	307.0	114.2	682.9	2362.8	1334.0	302.8	1177.2	578.0	421.2	1319.7	557.3	2117.8	353.3	142.6	503.2	1129.1	1569.8	900.6	76.7	1867.0	1381.5	681.3	252.0	1415.7	1634.9	425.3	174.4	237.9	515.7	788.3	2011.6	445.4	922.5	1259.3	2748.9	795.6	219.4	1222.7	602.4	1022.9	143.6	256.4	1384.6	1149.6	1471.5	723.2	665.5	440.9	1613.4
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged canonical Notch ligand 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 211.1;Endometrial ciliated cells: 197.4;Smooth muscle cells: 190.1;Squamous epithelial cells: 343.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 219.2;hTERT-HME1: 131.1;U-251 MG: 187.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	44.2	10.1	10.3	13.0	9.5	21.8	30.3	8.4	12.0	44.0	8.9	23.7	13.8	27.3	19.5	52.4	27.0	21.6	20.7	12.8	9.8	21.7	6.2	23.9	8.4	12.4	14.2	20.3	22.0	20.9	8.2	67.9	10.0	25.9	23.0	22.1	15.8	26.7	9.8	57.2	13.6	23.6	9.7	23.3	25.1	4.5	12.1	9.3	19.9	22.8	15.6	28.5	50.0	8.5	4.1	20.6	63.1	78.1	11.8	11.3	2.3	2.4	11.9	3.3	1.8	18.5	11.2	0.7	59.0	2.4	17.7	85.8	9.4	219.2	2.7	0.2	4.5	7.0	2.2	87.9	5.8	28.4	0.5	4.6	63.7	10.6	131.1	12.5	21.1	0.3	0.1	8.8	6.0	0.2	0.0	20.2	18.2	68.7	20.3	5.3	3.9	13.1	29.9	25.6	2.8	2.1	6.3	4.4	26.2	49.8	0.3	3.3	80.5	14.2	9.9	11.8	187.9	3.6	0.6	0.9	9.1	10.3	11.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	10.3	9.5	8.4	12.0	12.8	9.8	12.4	14.2	10.0	9.7	12.1	8.5	73.0	41.7	15.4	5.9	1.1	104.6	54.9	76.3	211.1	9.7	13.2	29.1	20.6	30.0	34.4	16.5	43.8	16.9	6.8	64.3	1.9	31.6	5.0	197.4	22.2	102.5	5.3	0.0	6.9	30.4	1.0	41.9	76.0	96.4	7.0	2.7	60.0	1.8	4.2	21.9	9.2	12.8	20.3	5.9	33.9	9.6	21.5	9.1	14.2	22.5	2.8	11.9	2.1	24.6	1.3	97.3	18.3	33.8	4.3	24.5	7.8	2.3	30.2	69.1	85.5	46.7	190.1	0.9	3.2	343.9	106.8	2.2	4.3	107.2	39.1	33.7
JHY	"C11orf63, FLJ23554"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882683-122963862	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 13.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360"	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (7.79e-2)"	6.0	1.8	1.7	2.2	2.7	1.1	3.6	3.4	2.4	3.1	17.3	3.5	1.5	2.1	2.7	1.8	7.4	2.6	2.2	1.8	3.8	7.8	0.4	4.5	2.2	4.1	5.4	3.2	2.8	5.6	4.8	1.3	3.8	3.5	1.7	1.6	1.4	2.5	0.2	1.9	1.9	2.0	3.8	2.5	2.0	35.7	3.2	3.2	5.1	0.8	2.0	2.6	1.8	3.6	2.8	3.9	2.2	0.1	0.6	0.4	0.7	5.9	6.8	2.5	1.1	0.3	10.3	0.1	1.5	9.1	13.6	2.4	2.7	1.4	1.1	9.5	2.8	0.1	1.8	0.1	0.9	1.7	4.7	2.8	7.4	0.4	0.6	6.3	3.8	4.1	0.0	0.1	2.0	1.8	0.1	0.6	0.3	8.2	3.5	1.0	0.0	1.3	7.0	3.2	5.8	4.2	7.1	3.9	2.6	2.8	4.7	0.6	1.2	7.9	1.0	0.2	4.8	0.1	0.0	0.1	2.1	2.1	5.3	0.5	0.3	0.1	1.3	0.1	1.8	1.1	1.3	1.7	2.4	0.6	0.9	1.0	0.4	2.4	0.1	0.6	0.3	0.5	1.7	2.7	3.4	2.4	1.8	3.8	4.1	5.4	3.8	3.8	3.2	3.6	4.4	12.8	4.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.2	0.0	0.0	7.4	5.5	0.0	0.2	2.2	0.0	3.9	5.5	0.0	41.5	3.1	1.1	0.0	0.0	0.0	1.4	0.9	2.2	0.0	8.7	0.0	2.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	12.0	19.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	1.8	1.3	0.0	0.0
KCTD15	MGC25497	ENSG00000153885	"Potassium channel tetramerization domain containing 15"	Q96SI1	19	33795933-33815763	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050822			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA050822: AB_2681250"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.65e-8)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.30e-2)"	19.2	6.3	29.4	11.3	28.0	6.1	14.2	24.9	34.9	38.8	15.0	41.3	7.0	43.1	3.2	34.8	36.1	10.8	19.1	28.7	29.6	24.7	12.9	24.7	3.0	26.0	30.2	22.7	32.5	4.5	10.3	11.0	24.2	25.0	6.0	15.2	11.6	19.0	6.0	73.2	15.7	20.7	25.8	17.4	23.3	10.5	30.2	1.3	23.0	6.4	4.1	32.0	31.3	23.3	16.7	37.5	33.2	50.8	10.8	5.7	26.2	21.6	4.0	11.7	6.1	21.2	11.1	0.1	47.6	30.3	5.5	19.3	24.3	16.9	4.4	18.1	42.7	68.5	25.3	20.7	29.8	13.3	12.0	11.2	69.4	4.5	26.5	0.0	23.2	9.8	17.3	0.4	2.0	42.0	0.5	37.8	30.4	27.9	62.8	32.0	17.9	6.3	13.3	7.5	25.7	88.0	42.0	59.0	80.0	14.1	43.7	34.7	38.3	54.7	48.9	1.1	3.8	40.9	2.3	27.2	0.1	23.0	68.4	0.6	1.8	5.9	0.0	3.3	0.1	0.0	0.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.5	0.7	29.4	28.0	24.9	34.9	28.7	29.6	26.0	30.2	24.2	25.8	30.2	23.3	17.8	0.0	1.7	44.4	0.3	15.8	3.3	4.1	10.8	3.5	5.4	5.0	3.2	1.5	2.9	0.0	10.4	0.2	0.4	0.9	3.9	0.7	0.7	3.4	15.1	15.3	1.2	4.2	1.9	8.4	0.4	5.5	1.5	2.5	8.8	94.8	27.8	2.0	1.2	1.7	5.3	3.6	0.0	3.7	5.4	1.9	4.4	3.7	5.4	4.7	3.1	5.0	0.0	11.1	0.3	2.1	1.0	9.1	0.1	3.9	0.3	0.2	0.7	11.7	0.0	3.1	8.7	0.0	1.9	14.3	19.5	0.3	0.7	2.4	1.9	3.1
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433492-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 47.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoli	"HPA072692: AB_2686549"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	14.3	26.6	28.3	13.0	28.0	15.9	27.8	23.4	28.0	25.6	28.9	25.6	26.3	14.4	26.2	18.3	35.1	21.3	44.5	28.0	27.6	38.2	34.2	30.9	17.7	26.9	29.2	14.9	42.1	45.6	26.9	30.6	25.5	34.9	30.0	34.1	33.5	18.5	37.7	20.1	24.8	14.4	24.8	20.1	34.4	17.1	32.4	17.8	41.4	40.1	16.8	15.8	15.1	24.9	13.5	19.6	39.8	31.5	52.7	36.9	37.8	17.9	37.8	25.5	37.5	21.2	52.9	15.0	48.0	19.6	38.1	26.1	29.7	28.8	28.9	23.8	21.7	20.3	23.4	23.6	41.3	16.9	26.8	52.3	36.2	29.5	38.0	84.3	42.2	18.1	27.2	21.0	35.2	13.6	10.1	14.3	45.3	37.4	11.7	11.3	33.8	18.7	41.8	32.4	8.7	24.6	25.8	30.6	53.3	86.9	32.3	23.1	43.6	17.4	18.7	14.9	28.0	31.1	26.7	9.8	44.3	21.8	17.7	8.8	19.4	9.4	5.0	6.1	4.8	3.4	4.1	4.7	5.6	4.1	5.5	4.0	47.2	9.8	4.0	3.7	4.0	8.7	28.3	28.0	23.4	28.0	28.0	27.6	26.9	29.2	25.5	24.8	32.4	24.9	24.2	73.7	74.1	85.2	18.3	7.9	14.4	16.5	15.4	74.8	33.9	26.0	55.0	47.1	42.4	35.0	108.4	33.3	16.6	35.4	3.9	19.2	9.6	21.0	17.7	24.6	21.6	14.7	93.2	32.5	22.5	19.4	28.5	30.8	21.5	42.7	28.9	47.4	19.1	63.9	95.2	59.5	16.2	31.4	7.6	7.5	17.4	19.2	14.2	62.8	31.4	30.5	29.9	115.1	99.3	30.3	27.6	17.3	17.2	26.0	36.8	17.5	45.4	61.9	6.6	24.5	15.7	22.5	21.2	17.8	9.2	31.2	21.9	30.1	31.2	14.8
KIAA1210		ENSG00000250423	KIAA1210	Q9ULL0	X	119078635-119150579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 39.4;seminal vesicle: 19.8;testis: 30.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Endometrial stromal cells: 25.2;Granulosa cells: 11.1;Late spermatids: 11.5;Peritubular cells: 6.0"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.0"	"Not detected"	"Not detected"							"HPA000551, HPA048322"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus, Vesicles"		"HPA000551: AB_1079165, HPA048322: AB_2680358"	"unprognostic (2.48e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.26e-4)"	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	1.6	39.4	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	19.8	0.3	0.0	0.0	0.2	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.4	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.0	1.9	25.2	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.6	0.0	11.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	11.5	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.4	1.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0
KIAA2013	"MGC33867, RP5-1077B9.1"	ENSG00000116685	KIAA2013	Q8IYS2	1	11919591-11926428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.7;Proximal enterocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052677, HPA060536"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Cytosol	"HPA052677: AB_2681911, HPA060536: AB_2684313"	"unprognostic (3.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.51e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.74e-3)"	27.9	25.6	23.6	17.3	28.7	19.3	25.5	28.0	24.1	25.4	24.9	43.7	65.5	35.5	35.7	30.1	27.1	20.6	39.1	23.9	24.3	30.2	59.4	23.8	21.8	32.3	28.8	19.7	42.4	20.0	31.8	20.9	27.7	27.8	20.1	6.1	40.4	25.7	51.9	37.8	61.8	17.2	27.6	35.1	31.4	37.2	27.3	16.8	26.8	23.2	13.1	32.2	25.5	31.6	61.2	44.5	20.5	40.6	34.0	23.2	33.8	38.1	39.8	45.0	46.4	55.1	61.7	39.8	56.9	36.2	35.2	69.3	27.8	37.6	23.8	46.3	71.4	27.4	39.7	95.7	38.4	57.2	54.3	29.7	41.0	44.1	19.4	48.7	43.6	31.2	42.6	51.5	27.2	46.2	36.6	80.1	27.0	27.0	60.6	46.3	37.4	97.6	29.0	16.5	76.1	43.0	30.9	34.1	74.8	20.4	28.6	52.6	42.1	37.9	49.2	56.3	52.6	61.8	47.1	46.0	45.1	91.8	41.1	3.3	4.9	5.1	4.7	4.2	3.7	5.2	2.5	3.6	3.5	6.8	2.5	3.3	11.1	4.1	3.5	8.5	5.5	2.6	23.6	28.7	28.0	24.1	23.9	24.3	32.3	28.8	27.7	27.6	27.3	31.6	26.1	22.4	13.4	12.4	18.7	22.2	9.2	13.6	6.8	20.7	30.5	27.1	18.7	18.6	13.0	25.8	12.5	18.1	32.6	116.7	3.9	15.5	24.4	23.7	18.4	22.9	40.9	11.8	9.9	19.3	30.8	18.7	17.3	27.7	13.3	23.1	27.1	75.2	26.5	32.0	8.8	50.1	22.4	40.3	23.0	41.5	22.7	27.1	19.6	6.5	26.5	18.7	28.8	8.5	22.1	24.7	72.2	23.0	18.4	17.3	139.9	22.3	17.8	22.1	19.7	27.5	15.7	17.6	8.6	15.0	28.1	13.3	16.0	31.1	59.4	17.3
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 162.3;pancreas: 85.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 105.8;Collecting duct cells: 90.1;Distal tubular cells: 80.3;Ductal cells: 43.3;Enteroendocrine cells: 64.1;Proximal enterocytes: 60.3;Proximal tubular cells: 79.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;OE19: 17.2;RPTEC TERT1: 44.8;SCLC-21H: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020192, HPA024127"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Plasma membrane"		"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	2.2	1.1	2.1	0.0	25.3	0.4	3.6	11.4	2.8	7.8	25.5	4.2	1.0	0.2	8.0	24.7	0.2	2.0	0.9	162.3	27.7	1.6	0.5	0.6	1.1	0.7	85.4	0.8	0.6	1.1	1.0	7.0	4.2	0.1	3.6	4.8	0.0	1.4	16.1	0.4	0.4	0.2	11.0	2.4	1.3	1.3	31.8	0.0	0.1	0.2	0.3	0.8	0.0	4.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.6	0.2	0.0	5.2	0.0	0.6	0.0	0.2	0.1	0.2	0.0	0.9	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0	0.0	0.4	0.1	17.2	0.6	0.0	0.0	0.1	44.8	0.2	6.6	0.1	0.0	0.9	0.0	0.2	4.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	0.4	3.6	2.0	0.9	0.6	1.1	1.0	0.4	1.3	0.8	0.1	0.0	4.4	0.0	1.3	0.0	0.9	0.6	0.0	0.0	20.3	10.8	0.4	105.8	0.0	90.1	0.0	0.1	0.0	7.9	80.3	43.3	7.0	8.3	1.5	0.3	64.1	0.0	0.7	11.8	9.3	0.4	14.8	15.6	0.0	0.0	0.0	10.2	0.3	0.0	0.3	22.0	0.0	0.3	0.0	14.7	0.6	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.7	21.3	0.0	0.0	2.2	60.3	79.1	0.0	0.0	0.0	0.0	0.3	3.2	7.9	0.0	0.0	0.5	0.9	0.3	28.9	0.5
KLHL20	"KHLHX, KLEIP"	ENSG00000076321	"Kelch like family member 20"	Q9Y2M5	1	173714941-173786692	"Predicted intracellular proteins"	"Protein transport, Transport, Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 132.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025034, HPA053704"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA025034: AB_1852578, HPA053704: AB_2682234"	"unprognostic (2.97e-3)"	"unprognostic (3.11e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.62e-2)"	13.8	10.2	5.8	7.6	7.1	5.9	8.7	7.3	6.7	11.8	4.7	9.7	6.7	13.6	6.9	9.8	8.1	9.3	10.8	6.5	6.3	10.8	16.2	10.0	9.7	7.4	6.7	12.0	6.0	7.9	5.3	11.4	7.1	13.1	8.9	9.0	6.1	9.3	12.5	9.5	7.8	13.4	6.9	10.3	7.5	15.9	6.5	12.3	8.4	13.9	9.1	10.0	8.2	6.9	12.8	8.0	12.5	13.1	28.7	26.4	10.2	19.7	19.2	14.9	15.6	5.8	8.7	9.0	16.4	21.3	7.9	12.5	11.2	14.2	17.4	11.0	6.0	8.2	10.8	6.9	18.4	15.5	9.3	22.6	16.1	13.8	18.4	17.3	22.2	9.0	18.5	10.0	27.6	4.7	9.1	8.0	13.3	11.3	36.1	9.7	15.4	9.8	11.4	8.1	5.3	14.7	18.0	12.1	12.3	16.9	10.8	18.0	22.2	14.3	8.6	17.6	15.7	13.3	7.4	13.5	9.4	11.0	16.2	7.0	2.9	4.3	4.5	3.2	4.0	3.6	4.4	5.5	2.8	3.5	5.6	5.7	1.6	3.2	2.4	4.6	5.6	2.3	5.8	7.1	7.3	6.7	6.5	6.3	7.4	6.7	7.1	6.9	6.5	6.9	21.8	16.0	25.9	36.2	17.3	11.1	8.1	13.5	8.0	13.3	8.0	8.0	12.8	17.2	12.8	12.9	37.5	13.1	18.1	13.5	1.9	9.9	132.4	4.4	14.0	23.4	9.6	11.1	28.1	12.1	10.1	18.2	16.3	5.6	7.6	14.9	42.1	21.0	11.2	11.8	37.3	9.1	10.2	18.5	9.1	30.2	22.4	10.0	3.6	18.7	9.4	16.4	20.6	33.7	35.2	11.4	8.9	28.6	12.3	8.8	16.3	14.1	8.2	20.7	0.0	20.9	16.4	55.8	35.6	11.3	10.5	9.9	16.9	24.1	9.7	7.8
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	24	"testis: 197.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 250.9;Late spermatids: 111.3;Spermatocytes: 883.9;Spermatogonia: 176.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.2;CAPAN-2: 50.0;EFO-21: 22.6;GAMG: 35.2;hTEC/SVTERT24-B: 33.7;hTERT-HME1: 23.0;U-2197: 67.7"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA046901: AB_2797232"	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	3.4	4.7	2.9	0.2	2.9	0.5	3.9	3.1	3.8	5.8	2.8	4.9	1.7	5.3	8.1	4.3	3.9	1.2	3.8	3.0	3.0	6.0	0.6	1.5	0.9	3.1	2.9	6.9	3.9	0.8	4.0	1.3	2.9	3.6	2.0	1.9	2.3	5.3	1.6	5.1	1.8	4.7	2.9	1.2	2.7	197.8	2.9	1.5	5.2	1.1	1.6	3.8	3.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	8.7	22.2	0.2	0.0	0.1	50.0	0.0	22.6	1.8	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	9.7	0.0	33.7	23.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	17.0	0.0	67.7	0.0	7.4	2.6	0.0	3.8	0.0	1.4	0.0	0.3	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	4.0	0.7	1.0	0.3	0.0	2.9	2.9	3.1	3.8	3.0	3.0	3.1	2.9	2.9	2.9	2.9	3.1	2.2	0.0	2.6	1.6	0.1	0.0	2.6	0.0	0.6	8.8	4.2	11.3	5.6	2.8	1.8	5.5	2.1	12.0	0.2	0.4	19.6	4.2	250.9	4.4	7.7	1.6	0.0	0.0	0.8	12.0	10.1	6.1	0.0	2.5	0.0	3.8	1.4	1.0	2.2	1.7	1.4	1.4	0.0	0.0	0.0	111.3	20.2	1.0	0.0	1.0	0.0	18.3	1.0	1.5	1.0	6.8	3.2	13.5	0.0	1.8	1.2	3.1	0.7	8.8	13.1	5.2	6.9	883.9	176.0	0.6	0.0	9.0	0.2	14.3	2.8	1.0
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183245127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 39.3"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 1531.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, HPA046539, CAB078165"	Enhanced		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	No	No		130000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum, Golgi apparatus"		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: "	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	3.5	0.1	0.2	16.2	1.9	0.1	20.9	2.6	0.6	15.1	0.2	12.1	2.6	12.3	2.1	7.7	34.9	13.0	3.0	0.2	0.2	13.8	0.7	24.9	8.0	0.0	0.1	1.0	3.3	0.0	4.2	10.9	0.1	5.4	12.9	0.1	12.9	6.1	1.7	17.5	15.0	3.3	0.0	0.9	14.9	2.8	0.1	11.3	18.5	2.3	12.3	39.3	6.3	0.2	574.7	25.4	0.0	0.7	4.9	11.9	40.2	4.3	4.7	2.1	0.7	41.4	501.6	0.0	207.9	1.4	16.4	252.4	0.1	2492.2	2.7	0.7	0.2	0.0	0.5	0.1	1.2	0.0	0.2	6.1	189.7	6.0	1487.5	2.3	32.6	0.0	0.0	0.2	2.5	1.1	0.0	0.1	4.5	206.7	35.2	0.1	1.2	0.0	579.4	147.1	30.5	0.1	14.7	0.4	0.9	14.9	2.0	2.7	3.8	2.2	30.2	15.0	7.8	0.9	0.7	0.7	4.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	2.6	0.6	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	218.0	17.8	0.0	0.2	86.3	227.1	232.7	105.3	0.0	8.2	26.2	2.3	10.0	56.8	23.9	0.0	30.7	0.4	74.4	0.0	183.4	19.6	68.9	3.6	7.8	9.0	0.0	0.4	94.0	11.7	17.2	59.7	97.4	0.0	0.0	0.0	0.0	2.5	0.0	0.3	34.1	14.2	0.0	4.9	11.8	3.4	3.1	8.8	1.0	2.6	0.0	0.0	0.0	0.3	1531.1	91.2	0.4	0.3	302.0	16.7	0.2	69.3	0.0	0.0	3.4	9.6	3.6	1.0	60.3	29.7	83.3	5.3	0.1	15.3	169.9
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990784	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 80.7;granulocytes: 78.9;Macrophages: 55.9;NK-cells: 152.4;T-cells: 151.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"basophil: 307.7;gdT-cell: 303.4;MAIT T-cell: 212.5;memory CD4 T-cell: 295.1;memory CD8 T-cell: 307.2;naive CD4 T-cell: 276.0;naive CD8 T-cell: 266.9;NK-cell: 114.6;T-reg: 410.8"	"Group enriched"	"Detected in all"	142	"granulocytes: 307.7;NK-cells: 114.6;T-cells: 410.8"	"Cell line enhanced"	"Detected in many"		"HEL: 189.8;HMC-1: 765.9;MOLT-4: 279.5"	"Not detected"	"Not detected"							"CAB002223, HPA011157, CAB012978, CAB079960"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		140000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , CAB079960: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	8.1	4.4	9.1	23.9	9.6	17.5	6.6	9.0	11.9	15.6	8.1	31.3	9.2	19.3	5.2	8.1	11.6	9.6	3.9	9.2	8.5	15.3	10.5	14.1	65.9	9.2	8.5	7.7	5.7	2.0	14.2	3.9	9.0	21.6	5.2	3.5	7.8	9.5	4.2	10.7	22.7	5.7	8.0	32.0	13.4	4.1	9.7	117.9	17.6	1.6	29.0	24.7	13.3	8.9	1.0	2.3	1.5	2.5	3.7	2.4	4.9	5.5	1.4	1.7	2.2	2.3	3.0	0.7	7.2	2.2	0.6	2.9	2.6	1.3	0.8	1.6	3.3	189.8	5.4	3.3	1.0	5.9	765.9	2.1	3.8	1.7	0.7	2.8	0.9	62.7	2.6	21.7	0.8	5.6	279.5	38.3	3.4	0.4	2.7	3.2	0.8	24.9	1.9	1.6	5.3	1.0	0.9	1.8	2.7	1.4	2.7	31.7	3.6	3.6	18.0	3.9	1.3	7.6	7.0	3.1	45.5	2.7	2.9	307.7	1.4	0.7	303.4	1.5	212.5	1.7	295.1	307.2	1.1	1.7	276.0	266.9	14.6	114.6	1.3	1.9	410.8	196.5	9.1	9.6	9.0	11.9	9.2	8.5	9.2	8.5	9.0	8.0	9.7	8.9	5.2	0.0	13.1	4.6	6.2	7.1	2.1	1.1	2.8	11.0	3.7	4.3	1.7	7.2	3.1	9.2	6.2	2.6	80.7	1.2	1.9	1.7	0.3	1.5	2.3	4.7	0.0	16.6	4.7	0.5	0.9	3.0	7.7	2.7	78.9	4.9	8.6	2.9	14.3	6.7	5.5	1.5	0.0	7.3	9.4	0.1	1.5	55.9	10.6	5.6	9.2	3.0	152.4	3.0	3.5	1.0	0.7	0.7	17.0	2.2	1.3	1.3	1.3	9.6	0.0	3.0	3.8	1.7	2.1	1.9	5.3	2.7	151.7	1.7	1.4	1.3
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007298-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"fallopian tube: 116.2"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.2;Hep G2: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.5	0.2	0.1	0.1	0.1	0.6	0.6	0.2	4.4	0.2	0.1	0.0	0.7	0.1	0.6	116.2	0.8	0.0	0.1	0.1	0.1	0.1	6.9	0.1	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.2	0.1	3.4	0.1	0.2	0.3	0.1	0.0	0.0	0.2	1.4	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.2	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.2	0.5	0.0	6.4	7.2	0.0	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.1	0.1	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	98.1	0.8	0.7	20.9	0.0	0.1	0.2	0.0	1.1	0.0	2.1	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	329.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439798-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;fallopian tube: 16.8;placenta: 19.0;skeletal muscle: 22.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 26.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 37.1;SH-SY5Y: 104.5"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 34.1"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	1.4	1.6	2.7	0.4	7.6	0.0	1.5	4.6	4.7	1.5	0.1	3.3	5.1	4.0	1.1	0.1	16.8	0.4	0.2	2.9	5.7	0.8	0.9	0.9	0.1	9.5	5.2	0.7	0.0	0.2	1.0	19.0	9.0	1.2	3.6	0.2	1.9	7.3	22.3	2.9	5.5	0.2	6.0	0.0	2.3	0.1	5.6	0.1	0.3	0.8	1.7	0.1	0.4	19.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.5	0.0	11.9	0.0	1.0	37.1	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	12.2	1.6	2.4	0.0	0.0	0.0	14.6	0.2	104.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	7.6	4.6	4.7	2.9	5.7	9.5	5.2	9.0	6.0	5.6	19.2	0.0	0.0	0.0	1.3	0.2	0.9	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	55.2	0.0	1.2	0.0	0.0	0.6	35.7	5.3	0.5	4.9	0.0	6.8	0.0	2.3	1.4	0.0	84.4	0.0	0.0	0.0	1.0	6.4	0.0	12.3	3.0	0.0	0.0	1.6	0.2	0.0	0.4	1.8	0.0	0.0	0.0	0.0	45.2	105.0	0.1	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	3.4	0.0	0.0	0.0	1.3	26.4	0.5	0.0	20.3	0.0
LHFPL4	GARLH4	ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553822	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.5;pituitary gland: 12.2;retina: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4"	"Group enriched"	"Detected in some"	4	"glioma: 6.8;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.0	2.0	11.1	0.0	11.4	0.0	0.0	7.1	15.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.7	0.0	0.0	0.0	0.0	10.4	7.4	0.0	0.5	0.1	12.2	0.0	10.2	0.0	0.2	9.3	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	11.3	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	11.4	7.1	15.5	11.3	12.7	10.4	7.4	10.2	3.3	12.1	9.8	0.4	0.0	0.0	4.6	0.5	0.0	2.9	0.0	0.0	42.4	0.4	0.3	0.8	0.0	0.0	0.0	18.8	0.6	0.6	0.6	0.0	0.3	0.6	0.7	1.1	0.8	1.2	0.0	60.0	0.2	1.4	0.6	0.0	1.3	1.3	0.5	4.2	0.2	0.3	15.2	67.2	0.7	0.0	0.3	0.0	0.7	0.0	0.8	0.0	1.0	0.1	2.0	3.1	34.2	5.6	0.4	1.7	0.0	0.0	6.3	0.8	0.2	0.0	17.4	0.0	2.7	0.4	1.7	1.1	0.0	0.0	1.4	0.4	0.3	0.8	2.5
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151805419	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 21.3;tongue: 5.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4"	"Region enriched"	"Detected in many"	7	"spinal cord: 19.7"	HPA060781	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 80: Striated muscle - Unknown function"		"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA060781: AB_2684361"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.0	0.1	0.1	0.1	0.0	0.1	4.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.7	0.1	0.7	0.3	0.5	0.3	1.1	0.2	0.2	2.8	1.6	0.0	0.4	0.5	1.4	0.0	3.9	0.7	0.1	0.1	0.6	0.2	21.3	0.6	0.2	0.0	1.3	0.1	0.4	0.6	1.6	1.2	0.6	5.6	0.2	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.2	0.3	0.5	2.8	1.6	3.9	1.3	1.6	2.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753120	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"NTERA-2: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.2	0.2	0.6	0.2	0.7	0.5	0.4	0.7	2.6	0.2	1.6	0.5	1.2	0.1	0.3	0.0	0.2	0.5	0.1	0.7	1.2	0.1	2.1	0.3	0.1	1.0	1.1	0.3	0.8	0.2	0.2	0.1	1.3	0.4	0.1	1.0	0.1	0.5	0.8	0.4	1.6	0.1	0.7	0.1	0.3	0.8	0.7	0.0	1.5	0.0	0.1	0.1	0.1	0.9	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.1	1.4	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.6	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	1.5	0.2	0.1	0.1	0.8	0.2	0.2	0.2	0.1	2.2	0.6	0.7	0.7	2.6	0.7	1.2	1.0	1.1	1.3	0.7	0.7	0.9	0.2	0.0	4.4	4.6	0.1	1.1	4.4	4.0	0.6	0.5	8.6	9.1	0.3	11.5	1.7	0.0	0.0	0.1	0.3	0.8	3.9	1.2	15.2	0.9	0.5	0.3	0.0	0.0	2.2	0.8	0.1	1.5	2.0	2.2	0.0	104.4	1.4	2.2	0.1	0.0	0.6	0.9	2.0	0.8	2.8	3.2	0.0	0.3	5.4	0.0	0.0	3.9	0.0	1.0	2.2	1.2	0.0	0.0	0.0	2.4	12.3	1.0	0.9	0.8	0.0	1.4	8.1	10.5	4.7	1.4	1.1	0.3	0.6	0.0	1.2	0.6
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264435-151015727	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		340000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favorable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.3	10.7	3.4	9.3	6.9	11.1	22.7	11.1	3.8	13.1	18.6	16.7	13.3	6.9	14.2	13.9	15.2	9.9	8.3	2.9	2.2	23.5	13.4	11.0	15.8	5.1	4.5	8.9	13.5	34.2	6.5	7.0	6.1	20.0	17.4	14.9	13.8	8.9	7.2	19.3	11.5	6.6	3.4	9.6	17.0	9.4	3.7	18.7	19.1	8.9	17.7	12.3	7.0	6.3	27.6	14.3	11.9	11.1	12.2	18.5	17.0	6.0	15.8	10.9	10.2	30.9	35.6	33.7	7.2	8.6	7.5	13.7	22.1	36.6	15.3	25.9	15.8	20.8	19.8	19.0	7.5	29.0	16.2	14.6	21.1	16.0	24.6	23.9	32.9	14.8	22.4	24.3	12.9	21.9	21.9	7.7	10.7	23.7	10.3	18.4	12.0	12.6	42.0	33.7	39.3	13.0	15.1	32.1	7.4	18.1	32.4	6.1	17.2	16.8	12.2	8.7	11.4	20.9	20.5	20.5	26.2	16.0	6.6	5.7	0.6	1.2	5.0	0.2	3.3	4.9	3.3	4.7	1.0	2.1	2.3	4.0	0.1	3.2	2.1	2.1	4.6	1.8	3.4	6.9	11.1	3.8	2.9	2.2	5.1	4.5	6.1	3.4	3.7	6.3	10.4	16.0	14.9	148.5	42.5	17.5	16.4	21.0	28.5	33.5	30.8	18.2	55.9	21.5	21.5	51.5	148.0	23.7	37.7	19.7	9.8	15.2	25.5	51.2	11.0	13.3	42.0	40.2	213.7	13.5	10.6	12.8	56.6	61.8	6.3	22.4	10.0	20.5	6.1	30.3	192.6	23.8	24.4	11.1	12.8	5.5	9.6	17.7	16.0	161.1	8.2	17.7	46.4	239.8	217.4	17.2	20.2	10.1	38.3	22.4	22.0	15.8	36.7	72.6	6.6	13.7	9.8	16.6	22.3	37.3	23.7	24.2	45.6	25.9	27.2	24.0
LRIG2	KIAA0806	ENSG00000198799	"Leucine rich repeats and immunoglobulin like domains 2"	O94898	1	113073198-113132260	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015538	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		2100000	"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA015538: AB_2250170"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	2.6	2.2	3.1	2.1	4.6	1.0	2.7	4.7	3.4	3.2	3.2	2.9	2.8	3.1	3.8	2.3	2.5	1.4	2.4	2.8	3.6	2.2	2.0	2.0	2.6	4.2	3.8	3.8	2.6	2.9	2.9	2.4	3.9	2.5	2.1	6.4	2.4	2.2	3.9	4.5	3.0	1.7	3.8	3.0	2.3	1.7	3.9	2.9	3.4	2.1	2.4	2.5	2.7	6.8	2.6	1.3	3.8	2.9	3.6	3.6	2.1	1.6	2.4	1.9	3.2	2.0	1.6	2.6	2.8	2.0	1.1	2.8	2.6	1.7	3.2	1.8	1.5	2.8	2.9	1.0	3.6	3.4	1.3	3.6	3.1	3.0	4.0	2.9	2.5	3.6	3.4	2.4	2.4	1.9	3.5	3.5	3.5	1.0	2.3	3.1	4.8	1.3	1.9	1.7	2.6	2.1	2.8	1.8	3.6	3.1	1.4	3.8	3.9	3.5	1.9	4.9	2.6	2.6	1.3	2.6	3.8	2.1	3.3	1.9	0.7	0.5	0.8	0.6	1.0	0.9	1.0	0.9	0.6	1.4	1.1	1.0	0.4	1.4	0.7	0.7	0.8	0.5	3.1	4.6	4.7	3.4	2.8	3.6	4.2	3.8	3.9	3.8	3.9	6.8	9.4	0.0	15.5	14.4	12.7	8.4	3.1	5.7	8.0	21.0	7.0	7.2	11.6	7.2	7.1	14.7	37.5	7.8	14.6	13.5	0.0	3.2	1.3	6.9	14.6	9.4	5.4	5.5	22.9	2.6	5.1	10.2	13.7	8.0	5.7	22.0	6.1	5.4	4.8	18.5	23.8	8.7	0.0	8.2	5.6	0.9	18.3	6.4	7.2	19.7	11.9	20.6	17.5	25.1	40.9	3.3	7.5	16.1	7.8	5.5	8.9	4.4	10.8	23.4	0.0	12.6	8.2	11.1	16.1	5.5	6.7	5.3	10.3	20.4	9.8	3.3
LRRC27	KIAA1674	ENSG00000148814	"Leucine rich repeat containing 27"	Q9C0I9	10	132332154-132381508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 75.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 491.0;Late spermatids: 953.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;hTERT-RPE1: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037595, HPA067395"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA037595: , HPA067395: AB_2732766"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-4)"	"unprognostic (1.48e-3)"	"unprognostic (1.94e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.27e-4)"	3.2	4.1	11.6	1.9	12.1	1.6	5.0	9.4	13.3	4.5	12.0	4.7	2.5	4.5	6.7	2.0	13.1	4.3	3.5	13.0	11.2	7.1	3.0	3.9	2.6	12.1	11.8	6.3	3.9	8.0	8.0	2.6	10.9	5.2	2.5	10.9	3.3	4.7	2.0	2.7	3.3	4.2	11.5	5.5	3.9	75.6	11.8	2.8	6.4	1.6	1.4	4.0	2.8	10.9	3.1	5.6	12.2	17.2	10.4	10.6	1.2	3.0	9.7	4.9	4.4	1.0	6.3	1.7	1.7	7.0	3.7	2.1	2.7	1.5	3.1	3.6	2.4	0.5	4.5	3.0	7.4	1.4	2.0	4.6	9.4	5.0	6.6	21.9	3.5	4.2	1.1	1.3	3.8	5.2	2.7	3.9	3.4	2.2	1.9	2.4	1.9	1.0	8.9	0.8	2.2	6.1	1.5	1.0	3.9	2.4	2.8	3.1	4.7	1.9	2.4	4.4	1.9	0.9	0.4	1.0	8.9	2.7	1.2	4.1	4.7	0.8	1.1	4.1	0.9	2.3	0.7	0.7	5.2	2.9	1.8	1.0	0.6	2.4	2.8	5.6	0.5	2.0	11.6	12.1	9.4	13.3	13.0	11.2	12.1	11.8	10.9	11.5	11.8	10.9	2.9	9.6	12.8	23.8	5.0	2.8	2.5	5.1	3.4	8.2	6.3	3.8	5.2	5.7	6.9	3.7	10.4	3.6	6.0	1.7	19.6	8.2	491.0	18.8	5.4	4.9	5.4	2.5	14.2	5.1	1.3	5.5	7.1	4.8	8.8	10.3	11.4	2.2	7.7	8.4	10.9	2.3	2.0	10.4	6.0	953.9	4.7	6.7	7.2	6.5	9.0	10.5	8.2	8.0	9.3	3.3	1.3	11.7	0.9	2.9	3.8	13.9	37.7	18.3	6.6	3.8	3.5	119.9	19.2	2.3	3.1	1.4	2.9	6.2	3.5	1.8
LRRC43	MGC35140	ENSG00000158113	"Leucine rich repeat containing 43"	Q8N309	12	122167738-122203471	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 4.9;choroid plexus: 16.1;fallopian tube: 19.0;testis: 6.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 23.2;Endometrial ciliated cells: 21.8;Late spermatids: 43.5;Proximal tubular cells: 15.9;Respiratory ciliated cells: 35.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 1.1;HSkMC: 1.3;HUVEC TERT2: 2.7;SCLC-21H: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA039425			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	Vesicles	"HPA039425: AB_2676501"	"unprognostic (6.42e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.03e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.21e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.49e-1)"	0.5	0.3	2.1	0.0	2.7	0.5	0.3	1.5	2.2	1.1	16.1	0.3	0.5	0.7	1.8	0.1	19.0	0.9	0.7	2.3	2.7	2.1	0.1	1.6	0.0	3.5	4.9	0.3	0.6	1.9	2.2	0.1	2.8	0.7	0.1	0.6	1.1	1.2	0.1	0.3	0.1	0.2	3.7	0.3	0.2	6.4	2.9	0.0	1.6	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.7	0.2	0.2	0.2	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.1	0.0	0.2	1.3	0.0	0.4	0.0	0.0	2.7	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.1	0.0	0.3	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.9	0.2	0.2	0.0	0.2	2.1	2.7	1.5	2.2	2.3	2.7	3.5	4.9	2.8	3.7	2.9	1.4	0.0	6.4	0.0	4.6	0.1	0.0	0.1	1.0	0.0	0.4	0.3	0.3	0.5	0.0	2.7	1.8	4.2	0.1	1.7	0.2	1.9	0.1	23.2	21.8	0.4	0.1	0.0	0.8	3.5	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	2.8	0.0	2.0	0.0	0.3	43.5	0.6	0.3	0.0	1.0	0.0	0.9	2.1	2.0	0.7	0.0	0.0	0.4	0.1	0.1	0.0	15.9	35.2	0.1	0.0	0.1	0.5	8.2	1.2	0.0	0.0	0.1	0.5	0.0	0.1	0.1
MAB21L4	"C2orf54, FLJ22671"	ENSG00000172478	"Mab-21 like 4"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 262.6;vagina: 80.4"	"Cell type enriched"	"Detected in single"	7	"Cytotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052722			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.2	0.1	0.3	1.0	0.5	0.0	1.8	0.5	1.3	36.0	0.0	2.9	11.5	0.2	0.1	262.6	0.9	0.5	0.1	0.8	0.0	13.3	13.0	10.0	0.3	0.3	0.0	0.1	1.2	0.0	0.2	0.8	0.5	1.5	2.5	0.3	29.2	0.2	0.3	60.8	4.9	0.1	0.0	0.2	5.8	0.2	0.2	1.1	0.1	0.0	23.5	2.0	80.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	45.9	2.7	0.3	0.3	0.0	0.0	34.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	5.7	0.1	0.1	0.2	7.3	0.0	0.1	0.0	11.4	0.3	5.9	2.3	0.0	0.0	117.0	0.0	0.2	0.9	0.7	0.0	0.0	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.3	0.8	0.0	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MAGEA9	"CT1.9, MAGE9, MGC8421"	ENSG00000123584	"MAGE family member A9"	P43362	X	149781930-149787737	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 3.7"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 2.3;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"U-266/70: 45.2;U-266/84: 32.9"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA9B		ENSG00000267978	"MAGE family member A9B"	P43362	X	149581653-149587453	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"testis: 10.0"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 39.6;Spermatogonia: 16.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"OE19: 82.4;RT4: 131.1;U-266/70: 55.1;U-266/84: 73.7"									"HPA045401, HPA051687"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA045401: AB_2679315, HPA051687: "															"unprognostic (6.12e-3)"		"unprognostic (3.26e-1)"	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.0	0.1	82.4	0.0	0.2	0.0	6.3	0.0	131.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	55.1	73.7	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	39.6	16.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MAL	"MVP17, VIP17"	ENSG00000172005	"Mal, T cell differentiation protein"	P21145	2	95025677-95053992	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2817.9;vagina: 863.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 373.3;Distal tubular cells: 236.7;Muller glia cells: 91.5;Oligodendrocytes: 168.1;Skeletal myocytes: 82.3;Squamous epithelial cells: 90.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 101.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 217.6;naive CD4 T-cell: 293.3;naive CD8 T-cell: 138.1;T-reg: 233.6"	"Lineage enriched"	"Detected in many"	38	"T-cells: 293.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 516.4;MOLT-4: 722.0;RPMI-8226: 256.7;RPTEC TERT1: 2531.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065691			Approved	"Golgi apparatus,Centrosome"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	Centrosome	"HPA065691: AB_2685533"	"unprognostic (1.57e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (5.18e-6)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.89e-2)"	"prognostic favorable (3.96e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.57e-1)"	5.3	1.8	251.3	10.8	333.9	12.7	4.4	264.8	400.2	450.7	177.4	50.8	2.2	2.6	8.3	2817.9	8.9	2.9	17.9	260.8	256.7	400.4	1.7	25.3	25.1	281.3	282.1	3.2	3.0	0.4	3.9	3.4	272.9	21.8	6.3	10.1	544.0	11.1	2.8	12.6	17.0	2.4	264.0	9.4	52.7	1.1	303.2	261.2	21.3	4.3	352.8	15.0	863.2	449.3	51.3	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	12.0	0.0	0.3	2.4	0.2	0.0	0.5	516.4	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.4	0.1	0.1	0.0	722.0	0.2	0.2	0.0	0.0	0.7	0.0	256.7	2531.4	65.3	0.6	0.0	0.1	9.4	1.6	2.1	0.3	0.9	0.8	0.0	0.2	0.1	0.5	0.4	0.3	0.3	0.3	0.4	0.1	0.7	0.6	0.1	4.7	0.3	2.1	3.1	217.6	38.4	0.5	3.5	293.3	138.1	2.6	7.7	0.6	1.2	233.6	71.0	251.3	333.9	264.8	400.2	260.8	256.7	281.3	282.1	272.9	264.0	303.2	449.3	0.9	0.0	0.0	12.1	3.1	1.1	0.2	0.0	1.8	1.5	1.2	0.9	11.3	0.0	1.3	373.3	4.2	0.2	0.9	0.0	236.7	0.1	5.3	4.3	0.6	0.5	0.0	46.1	0.5	0.0	0.0	4.7	24.5	8.2	1.3	3.2	2.5	0.0	0.1	5.0	0.5	0.0	14.2	0.0	1.3	19.5	0.9	1.0	17.8	1.9	2.5	91.5	4.1	6.6	168.1	0.1	0.0	0.0	8.9	0.2	0.0	3.2	0.0	2.7	6.6	82.3	5.3	0.0	0.6	90.9	1.0	0.3	35.8	0.0	0.1	0.8
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350242	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 70.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"neutrophil: 98.3"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 98.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9"	"Low region specificity"	"Detected in all"							"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	18.9	12.1	3.4	4.3	4.1	3.5	19.5	3.9	6.5	16.9	5.0	22.9	11.7	22.1	11.5	42.3	16.6	10.2	11.2	4.1	3.0	13.2	9.7	12.3	2.3	3.2	3.3	11.3	25.2	11.3	17.9	9.5	3.2	15.1	15.8	5.4	70.0	10.8	4.0	21.7	15.2	12.1	2.6	11.3	21.5	8.4	3.8	1.4	13.8	4.4	6.4	16.3	20.6	4.0	0.3	5.7	1.8	0.1	5.6	5.5	6.2	3.9	4.6	2.0	2.5	4.8	18.2	0.0	4.2	3.9	2.1	0.8	7.1	3.3	1.5	0.0	6.9	8.3	6.4	4.2	0.9	1.4	2.3	3.5	5.3	1.3	0.9	13.8	50.7	0.1	5.6	0.1	0.6	11.0	0.0	0.6	6.5	54.3	3.0	0.2	0.0	0.1	25.9	18.8	2.6	10.3	2.1	16.9	6.0	2.8	15.4	5.0	20.5	2.8	2.3	0.7	5.5	0.4	0.2	2.8	2.0	0.0	2.1	6.6	1.2	1.0	0.1	0.9	0.0	0.2	0.3	0.0	0.6	0.4	2.5	0.4	98.3	0.6	0.4	0.1	0.0	0.6	3.4	4.1	3.9	6.5	4.1	3.0	3.2	3.3	3.2	2.6	3.8	4.0	29.0	9.6	21.2	8.8	3.3	4.0	7.1	7.2	6.2	6.1	21.2	13.5	2.6	28.6	11.9	23.9	8.4	35.4	4.5	33.6	1.9	19.0	0.9	15.1	5.2	28.8	21.7	3.6	16.6	37.9	7.4	10.4	23.0	20.5	2.5	8.6	37.1	9.8	8.0	10.1	13.5	33.4	8.2	5.5	0.7	2.2	13.7	2.0	0.0	15.0	2.7	11.4	9.2	7.5	11.4	16.3	25.2	16.6	1.0	7.4	16.7	3.0	18.1	13.1	0.0	4.8	6.5	2.1	1.5	22.1	4.7	17.0	3.0	9.7	26.5	8.8
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942194-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 94.9;lung: 199.6;lymphoid tissue: 87.9"	"Cell type enriched"	"Detected in many"	6	"Kupffer cells: 1269.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 21.6"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 4.1;thalamus: 12.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 33.7;intermediate monocyte: 56.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 56.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		30000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	64.7	31.1	0.4	87.9	1.4	3.4	7.4	0.7	4.1	0.7	4.4	5.7	2.0	0.7	1.3	2.4	25.5	2.4	19.0	0.9	1.0	1.6	94.9	199.6	17.7	1.2	1.7	7.5	0.8	0.3	1.5	2.8	1.9	1.8	2.1	0.0	4.4	2.3	1.5	2.5	3.1	29.8	1.2	37.1	3.5	2.0	12.6	1.3	1.5	5.0	1.1	25.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.6	0.4	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	33.7	0.0	0.0	56.5	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.7	0.0	7.2	1.0	0.0	9.2	0.4	1.4	0.7	4.1	0.9	1.0	1.2	1.7	1.9	1.2	12.6	0.7	0.7	25.6	45.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	3.4	1.8	0.4	1.5	16.7	3.7	0.0	0.7	1.4	0.1	0.0	3.9	0.0	0.0	0.0	5.2	0.0	8.0	0.0	0.2	1.1	2.6	0.0	0.0	12.6	0.0	11.4	3.4	169.6	0.0	0.0	0.0	0.0	1269.8	46.4	0.1	0.0	199.3	0.0	2.8	23.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.5	0.1	0.0	0.2	13.1	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.9	1.9	4.1	0.0	0.0	0.1
MARF1	"KIAA0430, LKAP, LMKB, PPP1R34"	ENSG00000166783	"Meiosis regulator and mRNA stability factor 1"	Q9Y4F3	16	15594387-15643154	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017992	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Vesicles"		"HPA017992: AB_1852921"	"unprognostic (2.33e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.94e-2)"	10.5	7.1	2.1	10.8	5.2	9.7	9.4	1.5	6.6	10.0	3.7	16.0	10.4	12.8	1.0	12.3	13.7	12.5	9.2	4.5	3.4	13.5	8.3	9.3	14.6	3.6	4.5	18.2	12.9	12.3	5.9	9.4	2.6	10.4	12.1	8.4	14.4	13.7	18.3	10.5	11.2	12.0	0.0	12.1	10.1	4.9	4.4	12.7	14.8	15.2	22.0	12.1	8.8	4.5	8.3	9.4	15.0	8.2	12.1	22.4	7.2	9.6	12.4	8.2	13.5	2.7	6.2	29.8	17.0	12.3	6.7	5.6	7.7	12.4	13.6	11.6	5.0	13.1	12.3	10.4	13.4	15.7	10.5	13.4	13.4	15.3	15.5	16.9	19.5	12.8	12.6	13.3	15.6	7.7	13.9	2.6	5.6	7.1	7.2	19.5	22.0	5.9	7.1	6.4	9.1	10.8	7.7	8.9	14.3	6.7	9.2	13.2	19.7	11.2	5.5	11.6	6.3	12.3	12.9	15.9	12.4	9.6	16.4	2.5	0.7	4.6	1.1	1.2	0.7	4.1	1.7	1.3	0.8	5.2	1.9	1.4	7.1	0.9	1.8	0.3	1.7	0.9	2.1	5.2	1.5	6.6	4.5	3.4	3.6	4.5	2.6	0.0	4.4	4.5	21.4	22.4	28.7	0.0	10.7	0.0	0.0	0.0	0.0	0.0	26.3	19.8	0.0	0.0	18.6	23.9	0.0	5.7	14.7	0.0	15.6	10.4	0.0	17.8	27.5	8.4	0.0	0.0	0.0	14.2	5.9	7.7	0.0	20.0	11.4	23.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	7.2	0.0	0.0	0.0	0.0	13.7	0.0	0.0	6.8	0.0	0.0	19.0	17.5	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	7.7	7.8	17.9	0.0	0.0
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992052-20012668	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.2;placenta: 11.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.5;Sertoli cells: 26.3"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"Hep G2: 143.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 1.7"	HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		440000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: AB_2681406"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.2	0.6	5.1	0.5	3.2	0.0	2.7	3.4	5.7	2.5	2.5	0.6	0.4	2.1	0.9	0.5	1.9	2.1	0.4	3.4	3.9	1.9	0.0	13.2	0.3	5.2	6.0	0.7	0.4	0.4	0.3	11.3	5.2	1.6	0.5	0.3	0.6	4.6	0.3	0.8	0.4	1.7	4.7	0.3	1.8	0.9	7.6	0.1	1.3	0.6	0.3	0.8	1.2	3.6	6.4	4.9	16.1	0.1	4.5	9.7	1.0	2.0	1.1	6.5	8.2	4.7	2.7	0.0	0.8	1.7	6.2	1.1	0.4	12.7	9.2	0.0	0.4	0.0	1.1	143.4	1.1	0.0	0.0	21.3	0.7	7.1	1.7	4.5	8.7	0.0	0.0	0.0	13.8	2.5	0.0	0.0	5.0	0.2	2.4	0.0	0.0	0.0	19.5	4.5	0.1	2.1	10.6	1.8	6.5	27.1	19.2	0.1	4.9	9.5	11.4	0.4	1.2	0.1	0.0	0.0	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	3.2	3.4	5.7	3.4	3.9	5.2	6.0	5.2	4.7	7.6	3.6	1.6	38.5	2.2	0.0	0.0	0.3	0.3	2.6	0.0	0.0	5.4	1.3	0.3	0.0	2.3	1.8	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.8	2.8	0.0	0.0	0.1	0.2	1.9	1.9	0.0	0.5	0.0	4.4	0.0	0.0	0.1	0.0	0.2	0.0	4.1	0.0	0.3	0.4	1.5	0.1	3.6	4.7	0.0	0.0	0.0	0.5	0.2	1.1	0.0	4.5	0.0	0.3	0.0	0.8	1.6	0.0	26.3	0.8	6.8	0.0	1.3	0.0	0.1	0.1	0.1	6.3	0.0	0.2
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.3;placenta: 170.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 123.8;Hep G2: 171.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.8	11.6	1.3	8.7	1.9	14.8	4.7	1.7	1.0	3.7	2.4	11.7	9.9	4.9	24.3	10.9	9.4	5.7	9.7	1.1	4.4	8.0	59.3	5.9	13.8	3.6	3.1	4.8	10.0	4.2	1.6	170.8	3.2	4.0	11.5	0.1	6.6	11.1	0.6	12.6	9.8	4.0	2.0	11.3	13.0	42.8	1.6	14.3	8.2	3.4	15.1	8.5	2.8	3.7	7.2	0.0	8.6	1.4	1.6	3.6	15.7	0.5	3.2	1.1	0.0	123.8	22.7	32.6	0.7	1.3	1.1	7.7	19.8	8.2	0.8	3.3	7.6	29.1	25.9	171.5	1.5	32.9	10.2	1.5	7.1	0.0	3.6	0.1	1.1	20.4	2.6	9.2	1.6	19.2	56.3	12.5	1.3	27.5	1.6	53.2	10.7	18.6	5.7	18.6	3.1	10.5	14.8	8.6	4.3	15.1	3.1	8.4	3.9	6.3	1.2	8.2	6.7	18.2	13.0	47.0	1.2	21.8	20.2	11.9	7.9	5.5	16.6	9.9	14.4	20.6	9.8	11.6	8.8	25.5	10.0	11.2	1.2	18.7	21.7	17.0	2.2	9.1	1.3	1.9	1.7	1.0	1.1	4.4	3.6	3.1	3.2	2.0	1.6	3.7	4.1	3.2	6.8	16.0	16.9	8.8	2.2	2.1	5.2	0.7	3.5	3.6	14.7	41.5	5.0	11.0	0.0	328.3	9.5	12.8	3.9	1.5	5.8	12.6	1.3	3.6	6.7	55.8	0.9	5.4	56.6	7.5	15.3	6.6	8.8	6.8	6.4	119.6	29.3	0.0	0.9	9.8	0.0	27.2	6.5	9.4	23.0	9.6	7.2	30.0	10.6	0.2	9.2	0.0	20.6	1.3	3.6	50.8	12.2	1.4	6.4	9.7	4.5	1.9	0.0	3.1	2.7	2.1	1.7	13.6	8.5	344.1	10.3	5.7	10.3	3.3
MDFIC	"HIC, MDFIC1"	ENSG00000135272	"MyoD family inhibitor domain containing"	Q9P1T7	7	114922359-115019202	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 139.7;Skeletal myocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 109.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030716	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030716: AB_10671364"	"unprognostic (1.24e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (6.13e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-1)"	44.9	17.3	4.9	22.5	4.3	11.1	14.5	4.7	5.2	21.1	25.5	10.6	7.2	20.6	5.1	17.2	12.2	13.2	24.6	4.1	7.2	12.6	13.3	23.3	32.1	12.1	9.0	16.1	5.0	16.7	4.6	20.2	8.8	10.2	10.3	21.1	15.7	11.1	27.6	10.3	9.4	17.7	12.8	33.7	10.5	1.8	6.0	17.2	19.3	14.2	30.0	16.4	8.2	9.2	0.1	13.2	18.3	0.1	37.8	52.0	7.1	69.9	83.9	15.9	19.8	0.4	41.7	9.8	0.8	46.4	25.4	7.7	5.7	12.2	27.1	34.0	12.3	0.0	16.8	0.0	19.5	22.2	14.2	43.7	11.5	35.7	11.1	40.2	10.7	9.7	0.0	66.8	54.2	0.2	0.1	1.8	14.8	0.6	15.6	0.2	53.5	21.5	16.2	16.9	0.7	0.0	30.5	28.3	32.5	24.7	9.0	19.7	30.2	58.2	16.4	109.1	34.1	27.5	0.1	0.2	40.8	0.1	50.9	0.2	0.9	0.6	1.8	1.2	2.8	2.3	4.1	3.6	1.5	2.4	2.3	2.1	0.0	1.6	1.8	5.5	3.5	0.7	4.9	4.3	4.7	5.2	4.1	7.2	12.1	9.0	8.8	12.8	6.0	9.2	61.3	16.0	26.1	32.7	41.5	9.4	7.0	2.2	17.6	0.5	13.1	10.2	24.8	24.3	12.2	14.7	0.0	7.5	58.1	1.5	9.8	2.3	2.5	9.4	12.7	42.8	0.0	1.7	27.2	2.9	5.3	25.8	5.6	1.3	2.5	29.9	59.6	18.6	21.9	0.0	5.4	2.7	0.0	55.6	34.0	1.3	4.4	41.1	37.4	55.3	22.0	139.7	21.6	6.6	0.8	9.2	2.0	2.6	63.2	6.6	0.1	5.1	15.1	5.0	6.6	131.8	13.8	0.2	1.0	20.0	13.8	3.7	70.6	38.2	4.6	10.2
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 79.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.0;Cone photoreceptor cells: 50.1;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 79.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	2.6	2.9	4.2	2.6	3.9	0.3	1.6	79.9	5.3	5.4	0.0	2.6	0.5	3.4	1.8	3.7	2.7	3.2	2.3	8.8	4.9	1.2	0.6	3.1	2.6	4.3	4.7	6.5	2.4	4.1	4.8	0.3	7.4	2.1	1.1	4.0	1.1	1.3	1.1	4.9	2.8	2.5	1.0	3.1	2.0	1.5	2.1	0.8	1.4	1.7	2.1	1.9	4.4	3.2	0.2	3.5	4.8	2.4	12.3	4.3	2.2	2.8	2.2	3.5	3.2	0.0	0.0	0.7	0.5	1.7	3.0	5.4	0.5	0.0	1.0	4.9	3.4	0.0	0.3	0.0	0.5	0.0	1.1	1.0	0.0	1.4	0.0	6.8	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.4	5.9	1.7	0.0	0.8	3.7	4.3	0.0	1.5	0.3	2.6	0.2	3.1	0.6	0.3	3.4	1.4	1.2	4.3	0.0	0.1	0.0	4.2	1.0	2.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	4.2	3.9	79.9	5.3	8.8	4.9	4.3	4.7	7.4	1.0	2.1	3.2	3.0	9.6	0.5	12.7	2.0	2.3	2.4	0.7	1.2	34.0	0.4	0.6	5.7	1.5	0.8	3.7	50.1	0.2	3.1	0.0	0.0	0.5	2.6	0.6	1.8	1.6	1.8	0.0	4.9	0.0	1.4	4.4	0.5	0.5	0.0	1.1	1.4	0.0	0.1	57.2	4.9	0.0	0.0	0.3	1.1	0.2	10.2	0.3	1.8	1.9	0.0	2.6	4.1	4.0	2.1	0.6	0.0	4.9	1.7	2.0	0.0	0.5	1.9	2.0	0.0	2.6	3.0	2.1	1.3	2.8	3.0	0.7	2.9	0.2	0.0	5.1
MED13L	"KIAA1025, THRAP2, TRAP240L"	ENSG00000123066	"Mediator complex subunit 13L"	Q71F56	12	115957905-116277693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 303.9;Excitatory neurons: 311.5;Inhibitory neurons: 321.0;Microglial cells: 427.2;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 305.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"T-47d: 124.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA039445: AB_10673532"	"unprognostic (1.81e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.64e-1)"	18.4	7.9	5.5	15.8	7.3	52.7	20.8	27.0	6.3	15.8	5.3	12.9	10.3	20.5	6.5	13.8	12.5	13.2	11.5	6.4	5.9	12.4	7.9	14.4	14.6	9.2	7.3	24.3	17.5	15.3	5.5	16.3	6.9	12.7	13.5	12.6	14.8	12.8	18.6	19.0	13.4	15.9	6.3	16.6	12.2	13.8	7.7	39.1	18.0	25.8	16.2	13.1	12.7	10.7	16.9	33.2	19.6	16.9	23.6	42.0	16.5	15.8	21.3	23.7	16.3	25.2	5.9	13.3	13.6	29.0	14.5	9.9	20.4	14.2	29.6	24.3	14.0	26.9	10.0	7.2	26.2	24.8	28.6	30.6	21.8	26.8	40.7	17.4	15.9	28.2	28.9	11.4	18.7	21.8	42.1	22.2	10.5	7.1	8.2	28.7	25.0	24.8	11.1	18.4	17.7	12.4	14.2	7.8	15.0	34.9	124.8	39.9	20.7	26.0	16.8	17.2	19.5	17.9	9.7	21.6	12.0	22.3	12.8	1.5	0.6	1.5	0.2	0.3	0.2	0.3	0.5	0.2	0.7	0.7	0.3	0.4	3.5	0.3	0.4	1.1	0.0	0.1	5.5	7.3	27.0	6.3	6.4	5.9	9.2	7.3	6.9	6.3	7.7	10.7	84.4	64.1	54.9	303.9	47.5	99.2	38.4	21.7	70.6	52.4	51.4	42.4	35.6	21.5	35.5	25.8	54.2	9.4	38.5	30.5	3.9	13.5	84.0	42.5	115.2	56.9	31.3	49.6	311.5	26.0	19.6	56.0	29.0	96.7	14.0	93.4	53.6	30.6	21.1	57.2	321.0	31.8	14.2	48.7	60.6	47.2	92.2	60.5	32.0	427.2	56.4	22.8	17.5	352.8	305.4	26.8	21.0	67.0	65.6	49.4	22.7	12.3	27.2	44.6	46.0	61.9	57.0	20.3	23.3	48.0	101.6	14.2	30.5	23.7	25.9	51.0
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	30.4	27.8	24.0	20.9	25.1	27.0	26.5	24.6	29.1	24.0	27.3	25.1	23.1	21.8	24.0	43.5	20.6	16.8	20.7	24.6	25.1	27.3	43.6	24.4	21.7	26.8	25.0	21.9	29.5	20.9	36.3	25.5	26.1	23.7	24.7	40.3	26.9	20.5	22.4	36.4	22.9	24.3	24.8	25.9	28.2	22.3	25.3	17.5	25.6	14.5	28.1	24.1	27.3	27.2	56.8	35.3	31.8	38.0	48.7	48.2	42.7	56.5	51.4	65.8	69.3	65.7	40.7	33.2	39.7	71.8	43.2	34.7	50.2	47.7	62.9	47.9	48.5	56.5	60.5	82.8	82.3	50.7	57.5	47.5	60.6	71.2	84.6	39.4	53.3	31.1	50.8	57.1	42.9	36.4	26.1	40.8	30.5	52.3	39.9	30.9	37.3	53.6	43.5	35.8	33.2	25.1	33.2	53.7	111.9	43.6	36.3	97.8	39.9	29.2	52.0	55.9	80.5	67.5	83.4	40.2	60.8	61.2	39.0	44.7	57.0	54.9	33.6	53.1	32.1	44.5	30.5	38.0	57.0	36.8	30.7	32.0	45.3	32.6	48.4	26.2	43.3	38.8	24.0	25.1	24.6	29.1	24.6	25.1	26.8	25.0	26.1	24.8	25.3	27.2	25.6	16.0	12.9	5.9	25.8	18.7	23.2	35.6	11.4	27.7	23.9	23.4	12.6	27.1	28.2	14.7	14.6	52.9	26.2	26.4	33.2	51.1	13.6	16.3	23.9	25.1	19.3	42.5	11.5	75.6	72.3	30.3	23.0	19.7	31.7	21.8	16.4	27.8	60.4	16.8	8.0	29.2	28.5	18.2	32.0	22.8	24.5	26.2	19.6	4.7	35.9	32.3	28.8	6.6	13.8	57.9	30.0	21.8	41.2	24.6	40.8	48.5	16.0	58.7	26.3	12.3	42.9	64.6	45.0	24.3	25.4	88.4	23.3	31.9	22.6	39.9
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 771.8"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 833.5;Syncytiotrophoblasts: 999.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 24.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.1;granulocytes: 19.4;T-cells: 24.2"	"Cell line enriched"	"Detected in many"	6	"AN3-CA: 12338.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	117.5	56.2	30.7	16.1	31.3	12.6	63.1	0.0	27.5	6.1	24.1	27.4	28.7	24.4	6.6	6.8	12.0	23.4	7.5	30.2	73.5	17.8	51.8	43.4	5.5	10.2	19.3	18.8	30.0	8.0	33.2	771.8	14.0	12.7	20.9	39.2	21.4	5.5	6.9	4.6	21.6	17.8	2.5	90.2	8.8	26.3	68.4	10.3	11.8	5.2	4.8	11.0	3.9	9.8	77.9	41.7	197.1	12338.6	3.9	1.2	1.1	84.7	38.5	85.1	40.3	237.2	114.4	37.7	27.1	2.6	74.7	11.0	2.9	1.1	33.3	0.4	0.5	66.8	57.0	39.9	322.2	3.2	0.5	5.9	3.1	64.3	0.1	427.5	32.3	0.1	76.5	0.3	164.9	107.6	7.8	85.0	124.1	113.3	20.0	0.8	2168.8	24.5	92.0	72.0	693.2	2.0	71.9	234.0	1.0	195.6	9.2	57.3	33.6	29.2	0.7	276.1	5.6	3.4	8.6	0.7	103.3	1.2	9.7	19.4	2.6	9.1	0.9	2.9	2.2	3.9	2.5	1.8	9.1	3.4	9.4	24.2	1.5	4.3	1.7	0.4	0.1	6.7	30.7	31.3	0.0	27.5	30.2	73.5	10.2	19.3	14.0	2.5	68.4	9.8	7.4	6.4	6.2	12.7	3.3	4.5	47.3	8.6	9.1	13.5	33.3	36.1	0.9	20.0	5.7	16.5	4.2	833.5	2.1	9.3	11.7	20.3	62.7	8.2	12.7	6.0	29.5	35.9	40.8	40.0	187.8	200.3	3.1	9.5	0.0	6.3	44.6	20.4	92.7	1.7	28.1	19.4	6.1	8.8	3.2	37.5	84.8	6.6	1.8	11.2	1.3	45.3	0.0	18.1	1.8	22.8	27.5	13.5	2.3	27.1	24.6	12.3	2.9	22.0	19.7	205.6	12.0	35.7	36.7	10.0	0.6	999.6	2.1	124.8	31.5	23.4
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038959-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.3;Inhibitory neurons: 24.5;Microglial cells: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: AB_2680672"	"unprognostic (6.02e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	16.0	8.5	5.4	13.2	5.4	12.1	12.5	8.1	7.0	13.2	10.1	10.8	9.5	12.0	9.8	14.7	9.7	11.8	14.1	5.3	6.3	13.5	13.7	11.3	10.6	5.8	6.2	9.4	7.1	24.4	3.1	19.6	6.3	9.4	10.8	12.2	7.2	9.0	10.4	7.6	9.6	16.6	6.5	11.4	9.6	5.7	5.7	11.8	13.4	17.1	13.0	16.1	6.5	6.0	14.9	19.7	36.5	37.7	29.8	24.7	31.5	26.4	28.0	27.0	37.1	27.4	34.1	25.0	30.6	26.3	25.8	33.5	32.5	35.6	41.9	9.5	21.0	15.7	26.5	12.9	29.5	27.7	16.0	29.2	32.4	35.0	29.1	22.6	38.4	19.9	17.5	20.5	21.4	11.0	15.2	9.9	20.0	16.0	9.9	14.6	40.7	20.8	20.8	21.0	32.1	40.3	27.4	35.0	31.1	30.1	34.6	14.8	32.9	34.3	26.4	19.4	26.9	25.7	33.5	21.4	18.7	19.2	27.4	6.7	7.5	11.9	5.0	7.9	6.9	2.4	4.0	3.5	8.1	2.5	5.2	4.1	6.8	6.5	5.6	3.7	3.9	4.3	5.4	5.4	8.1	7.0	5.3	6.3	5.8	6.2	6.3	6.5	5.7	6.0	9.7	0.0	0.5	14.0	3.5	6.0	1.0	6.1	6.2	3.2	1.6	1.5	2.7	0.0	3.9	5.5	6.2	4.3	2.7	1.9	1.9	1.4	7.1	1.4	4.3	7.6	0.0	9.1	24.3	1.1	3.0	3.9	4.1	2.2	4.5	2.1	1.4	1.9	1.9	3.3	24.5	1.2	8.2	0.6	4.4	4.9	1.8	2.7	8.8	17.8	0.7	6.9	1.0	12.1	15.1	1.1	0.3	0.0	9.5	1.3	2.1	1.1	4.6	4.6	0.0	1.5	3.3	3.9	2.0	4.3	5.5	6.0	4.0	1.2	1.0	1.5
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.4;Hofbauer cells: 15.7;Horizontal cells: 21.9;Syncytiotrophoblasts: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	2.3	2.5	10.0	3.2	13.0	5.2	2.1	14.1	12.8	2.4	2.3	5.0	5.5	3.1	0.7	3.0	2.3	2.3	3.2	10.8	7.2	2.5	6.3	9.0	3.2	7.7	7.7	1.4	3.8	1.7	4.1	2.3	7.8	3.1	3.2	4.9	1.8	0.9	2.3	11.7	4.4	2.5	6.5	6.9	4.0	3.7	9.2	1.8	5.4	1.4	3.6	2.2	2.6	9.4	12.0	5.4	4.0	9.6	0.4	0.4	6.2	2.3	6.0	4.6	10.5	10.7	16.0	10.6	11.8	0.9	4.4	14.6	7.4	6.3	1.7	13.5	6.8	13.1	8.2	5.6	10.1	6.7	12.3	5.2	2.6	2.6	4.6	3.7	5.3	14.2	3.0	5.7	0.4	2.4	11.3	4.3	6.8	10.5	5.2	13.6	0.6	1.8	2.0	3.1	10.0	9.5	2.2	1.2	5.2	1.4	6.0	4.0	1.6	2.1	2.5	2.6	3.3	1.9	5.5	14.0	11.6	10.9	2.9	0.4	4.3	3.5	2.9	3.2	2.8	3.4	2.7	2.3	4.5	1.4	2.8	3.2	2.5	1.2	1.8	0.4	0.8	2.6	10.0	13.0	14.1	12.8	10.8	7.2	7.7	7.7	7.8	6.5	9.2	9.4	4.1	19.2	15.4	0.0	1.1	0.0	1.5	0.0	0.6	8.2	1.5	1.9	0.0	1.5	0.6	1.8	4.2	1.8	5.7	2.6	0.0	2.8	1.8	1.0	1.0	3.8	2.4	3.6	0.0	3.6	2.6	1.6	5.6	1.6	1.3	2.8	6.4	4.0	15.7	21.9	0.0	3.8	0.0	4.8	0.0	1.0	0.9	8.7	0.0	0.0	5.6	3.2	2.1	0.0	0.0	3.2	4.6	2.2	0.8	1.4	5.6	1.5	0.7	13.8	0.0	2.8	1.1	4.5	3.0	2.4	0.0	28.5	3.2	4.0	4.5	1.4
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 64.8;endometrium 1: 142.8;placenta: 39.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 84.9;Extravillous trophoblasts: 37.6;Granulosa cells: 61.9;Smooth muscle cells: 35.8"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 119.1"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.4;hTERT-RPE1: 19.7;REH: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA055204, HPA068864"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		640000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	Cytosol	"CAB002593: , HPA055204: , HPA068864: AB_2686051"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	3.3	1.6	0.4	1.4	0.3	0.5	2.2	0.3	1.2	64.8	0.3	3.9	6.8	142.8	0.1	1.0	5.7	6.8	7.2	0.3	0.4	2.5	0.6	1.4	3.9	0.4	0.4	12.5	1.3	3.3	0.5	39.6	0.4	1.9	3.5	0.0	5.3	1.5	0.9	3.8	6.0	9.4	0.4	1.4	2.6	6.7	0.4	3.1	1.3	0.9	1.7	2.9	3.6	0.4	0.3	0.0	4.8	38.4	5.7	8.3	0.1	0.6	10.4	1.3	0.8	0.4	1.3	1.3	5.1	2.8	1.8	0.2	2.2	0.0	0.4	0.0	0.8	0.0	0.0	2.2	4.2	0.0	0.0	5.4	0.9	1.1	0.1	19.7	6.0	0.4	0.6	0.0	1.4	0.3	0.1	0.1	1.4	1.2	0.2	16.6	0.0	0.4	0.7	0.0	6.0	10.3	3.9	0.6	0.0	5.9	3.6	0.0	2.7	0.6	0.0	1.6	0.1	0.1	0.2	5.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.4	0.3	0.3	1.2	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.2	0.0	2.5	0.3	3.4	1.0	0.8	0.8	0.6	0.4	1.9	0.5	6.1	1.5	0.1	0.0	0.0	0.7	1.8	0.4	1.9	8.6	10.3	4.4	84.9	0.9	1.8	0.0	0.2	0.7	37.6	8.4	1.5	4.1	1.3	61.9	1.1	0.0	0.8	0.0	0.4	1.3	2.0	0.0	1.1	10.5	0.6	1.0	1.8	1.0	0.0	0.3	0.0	0.0	0.2	1.4	0.2	0.4	0.2	0.5	0.1	2.2	0.8	0.5	0.0	2.7	35.8	3.1	5.5	0.5	0.6	18.6	2.0	5.7	1.0	0.3
MPPE1	"Cdc1, PGAP5"	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11908366	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, GPI-anchor biosynthesis, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 100.8;neutrophil: 293.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 293.9"	"Cell line enhanced"	"Detected in all"		"OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	14.9	13.1	11.3	20.0	11.7	28.3	15.4	11.0	11.9	16.1	11.7	21.5	17.7	17.0	20.6	17.2	16.4	21.8	18.6	10.9	11.9	28.8	23.8	25.6	16.0	12.6	11.8	12.7	31.8	20.1	15.0	14.1	12.5	16.3	21.4	15.9	15.0	19.0	23.5	29.0	20.3	15.8	10.6	15.9	22.8	8.5	12.1	16.0	47.1	11.7	14.7	14.9	13.7	13.1	7.8	11.1	8.4	19.9	22.9	26.7	7.9	18.6	26.0	10.6	16.5	20.8	21.6	15.8	39.2	17.6	10.7	8.6	5.8	10.1	9.9	17.7	10.4	4.6	22.9	4.9	31.9	20.3	30.9	40.1	13.3	9.4	6.6	15.7	6.5	13.9	5.8	14.5	17.8	18.1	15.1	13.6	5.6	65.9	3.1	6.0	5.4	18.8	17.2	11.9	11.8	6.7	17.1	13.5	16.0	9.3	9.8	25.9	13.5	21.4	8.3	20.5	10.3	22.6	21.5	19.7	15.8	10.4	21.5	20.6	42.9	100.8	24.8	34.5	18.1	17.9	15.2	23.9	37.3	21.7	18.5	23.8	293.9	29.2	24.6	29.6	27.0	31.8	11.3	11.7	11.0	11.9	10.9	11.9	12.6	11.8	12.5	10.6	12.1	13.1	19.3	57.7	33.0	13.4	24.5	18.0	16.2	20.7	12.5	17.4	14.6	11.6	2.4	24.3	23.1	22.0	12.5	27.9	35.7	43.9	21.5	30.5	20.5	17.9	14.8	15.5	9.6	13.3	20.9	41.9	32.5	16.6	29.6	22.6	27.8	23.5	15.7	27.6	25.4	8.4	21.4	23.4	14.2	33.2	25.7	36.0	12.8	24.8	19.6	20.6	24.2	23.3	52.5	12.5	24.4	36.3	18.4	15.1	16.0	10.1	36.3	27.0	26.7	20.5	13.1	17.2	13.9	7.0	8.7	21.8	20.0	16.7	33.7	16.4	16.1	22.0
MVB12B	"C9orf28, FAM125B, FLJ00001"	ENSG00000196814	"Multivesicular body subunit 12B"	Q9H7P6	9	126326829-126507041	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 99.3"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 505.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043683, HPA049383"			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Vesicles"		"HPA043683: AB_2678616, HPA049383: AB_2680737"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.82e-2)"	"unprognostic (9.59e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.12e-3)"	5.8	5.2	32.5	4.5	63.6	12.3	4.8	58.6	44.5	6.4	27.6	8.2	3.7	6.8	3.0	4.1	9.9	3.8	5.4	32.0	40.1	4.4	4.2	18.0	6.9	81.1	59.4	6.4	3.2	7.7	8.3	15.0	68.4	6.6	6.2	6.2	3.1	8.4	24.6	5.0	5.5	6.4	57.2	11.1	6.4	5.7	56.7	8.4	5.8	13.0	2.6	7.9	5.0	99.3	4.8	6.5	34.6	19.1	1.2	0.4	20.4	4.0	3.1	7.0	1.3	5.6	0.3	0.0	2.4	3.8	10.3	2.1	10.7	1.9	4.3	8.0	6.7	1.7	1.1	24.6	2.7	3.2	1.5	2.6	3.5	1.4	0.1	5.8	5.4	25.5	0.0	0.0	5.2	3.9	5.3	10.0	7.6	0.8	8.6	7.6	18.9	0.0	0.3	19.5	8.7	15.9	6.4	4.6	4.1	14.4	4.6	19.2	7.9	7.8	5.8	4.4	8.2	0.1	0.0	1.9	2.2	14.2	4.2	0.0	0.8	0.1	1.4	0.2	2.5	0.1	0.6	2.3	1.0	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.9	32.5	63.6	58.6	44.5	32.0	40.1	81.1	59.4	68.4	57.2	56.7	99.3	6.3	6.4	7.3	75.4	1.8	3.6	3.2	1.0	6.8	9.4	3.3	3.6	3.6	4.3	1.3	1.8	4.2	12.4	4.7	8.8	0.0	1.6	0.8	6.2	3.0	5.8	2.4	1.7	64.5	1.4	2.6	3.1	2.6	2.4	7.0	5.5	2.2	6.2	1.6	10.1	58.2	2.5	6.1	23.3	6.2	2.7	2.8	10.2	0.0	74.9	3.9	9.1	2.1	56.8	505.6	1.0	5.5	6.4	2.2	1.2	0.9	0.3	6.9	5.3	0.0	2.6	2.7	3.4	6.4	2.9	2.6	3.4	10.9	0.8	3.0	1.6
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N-alpha-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112108796	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	5.5	6.1	4.6	6.0	5.0	9.8	6.8	6.4	8.1	6.8	8.5	6.8	3.9	5.5	4.3	7.6	5.8	3.7	5.6	5.3	5.1	4.6	5.6	4.9	6.6	5.6	4.7	7.0	6.9	5.9	4.3	5.3	7.7	5.4	4.2	14.8	4.9	4.4	14.9	7.5	4.8	5.4	3.6	5.3	4.9	5.1	4.9	6.0	5.7	9.9	6.9	6.4	6.7	8.0	16.7	16.1	14.8	11.9	8.1	14.0	17.9	15.3	12.4	18.3	12.4	16.2	8.6	28.9	14.4	12.3	10.5	19.2	32.8	13.0	25.1	16.6	22.9	23.6	15.9	15.0	13.2	34.0	13.7	12.1	15.9	21.3	21.8	15.5	16.1	12.6	35.3	3.7	16.7	13.5	19.6	24.9	22.1	34.2	18.6	21.5	15.2	19.7	14.0	27.0	19.1	10.5	16.9	19.8	15.0	14.0	19.3	13.4	13.7	15.2	13.6	17.0	21.3	15.0	30.4	33.0	19.4	14.7	15.5	0.0	1.7	0.5	2.4	1.9	3.7	2.5	3.0	2.3	3.5	2.8	4.2	4.1	0.0	1.6	2.5	3.7	2.5	1.6	4.6	5.0	6.4	8.1	5.3	5.1	5.6	4.7	7.7	3.6	4.9	8.0	16.1	9.6	16.2	44.1	23.3	66.7	34.5	17.1	22.8	38.9	18.9	12.4	23.5	12.8	26.5	7.3	146.0	25.6	20.4	10.1	3.9	15.3	26.5	15.1	23.9	17.4	16.2	17.0	71.6	19.4	21.6	17.8	15.8	14.8	20.3	20.7	15.4	19.4	14.0	23.5	68.0	11.9	28.5	15.4	25.2	8.6	17.4	16.5	16.0	30.0	83.8	13.0	12.3	48.2	109.6	17.4	7.5	12.8	15.7	61.5	7.4	4.7	25.0	67.7	6.6	28.7	22.7	31.5	29.5	28.5	70.2	22.6	15.3	20.0	14.7	48.1
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933331-90003228	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 265.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	22.5	12.4	9.2	27.8	12.8	54.0	25.4	9.3	10.0	16.9	7.4	18.3	15.1	22.3	11.4	20.0	14.5	22.5	12.1	10.2	12.5	20.7	22.3	18.1	24.3	10.7	8.6	16.9	15.5	15.4	9.0	14.1	9.9	17.5	22.5	9.8	16.6	14.9	10.0	10.3	16.0	24.2	11.0	23.4	12.7	16.4	11.0	19.0	22.7	16.2	26.4	21.8	9.6	15.0	54.8	30.1	29.3	15.6	16.5	38.7	18.9	37.9	49.5	46.6	50.8	17.2	41.8	83.8	42.2	35.5	19.1	17.7	35.7	35.7	59.8	38.0	19.7	67.7	16.8	23.6	30.8	40.0	35.2	30.5	18.3	27.2	57.9	22.8	39.5	33.9	50.6	46.6	55.3	46.9	65.6	26.0	8.5	39.5	31.4	42.3	25.3	47.0	62.8	73.8	8.1	26.6	23.5	265.1	23.1	16.3	49.8	31.4	29.2	40.9	28.0	25.5	38.0	21.2	25.0	45.5	41.3	39.4	39.1	32.4	17.7	32.9	11.9	19.7	12.7	15.2	8.5	8.8	18.9	8.9	8.1	9.0	34.4	16.1	31.5	10.4	5.9	13.1	9.2	12.8	9.3	10.0	10.2	12.5	10.7	8.6	9.9	11.0	11.0	15.0	36.9	48.1	14.2	24.5	39.8	11.9	13.5	20.4	23.9	25.4	29.7	22.9	30.3	14.3	33.7	27.6	2.1	23.0	29.3	11.2	43.0	35.1	17.6	45.4	46.9	22.9	12.1	31.7	45.0	32.0	19.7	36.3	19.9	31.2	79.7	38.3	18.9	30.6	25.9	13.5	39.9	16.9	16.2	29.2	27.1	7.2	19.0	51.1	12.4	32.8	54.7	29.4	36.0	40.7	40.3	24.7	9.9	26.4	38.8	11.6	9.9	40.5	36.4	11.2	6.6	50.3	31.7	20.2	46.0	31.5	13.5	10.8	35.3	68.7	19.4	11.0
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lung: 53.1;thyroid gland: 172.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Region enhanced"	"Detected in many"		"thalamus: 17.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SCLC-21H: 78.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.2;hypothalamus: 10.2"	"Group enriched"	"Detected in some"	13	"basal ganglia: 4.3;hypothalamus: 10.4"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.0	0.1	1.1	0.0	2.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	10.1	0.0	0.0	53.1	0.0	0.0	0.3	0.1	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	17.8	0.0	172.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	78.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.0	4.0	0.1	10.1	0.0	0.3	0.0	0.0	17.8	0.1	0.0	137.8	124.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;seminal vesicle: 12.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: AB_2732397"	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	0.5	6.6	10.1	0.8	8.5	1.4	0.4	6.4	11.1	1.9	0.0	1.8	0.2	2.7	6.4	0.6	4.3	1.4	1.1	10.3	10.2	0.3	0.1	0.6	0.4	7.3	7.0	4.4	0.3	0.5	1.0	0.6	4.8	6.0	0.5	1.9	0.6	12.5	0.1	0.7	0.7	1.9	5.5	0.6	0.6	2.6	7.3	0.4	0.4	0.4	0.2	0.7	1.2	9.7	0.0	0.5	6.7	0.2	1.6	0.6	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.5	0.1	0.0	0.1	0.2	0.0	0.1	0.4	0.9	0.4	0.4	0.0	0.0	0.1	0.4	0.4	0.1	0.2	0.0	0.3	0.1	2.0	0.5	1.5	0.0	0.3	0.5	1.2	5.3	0.0	0.0	0.6	0.2	0.3	0.0	0.8	1.7	2.5	0.2	0.0	0.6	0.8	0.0	0.3	0.1	0.1	0.8	0.2	0.0	1.1	1.1	0.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.1	8.5	6.4	11.1	10.3	10.2	7.3	7.0	4.8	5.5	7.3	9.7	0.3	0.0	0.0	19.6	0.0	0.6	0.3	0.2	1.2	2.6	0.3	0.9	0.4	0.0	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.1	1.3	0.2	1.1	0.5	0.0	0.0	11.3	0.0	0.2	1.3	0.0	0.4	0.0	1.0	0.7	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.8	3.9	2.1	0.2	0.0	2.8	0.1	2.5	0.0	92.0	43.7	0.2	0.1	17.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	0.4	0.3	0.2	4.5	0.1	0.3
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"parathyroid gland: 22.4"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Karpas-707: 1.3;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047260, HPA056271"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"HPA047260: , HPA056271: AB_2683083"	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 388.9"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 3913.2;Skeletal myocytes: 1639.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 204.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		410000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	130.9	11.4	1.0	25.2	1.1	0.9	91.9	1.4	1.5	36.0	1.9	37.1	1.5	31.0	2.8	15.4	55.0	43.1	35.5	1.3	1.4	24.1	388.9	64.6	9.6	3.9	1.6	21.3	11.4	1.6	10.6	23.8	2.2	31.9	8.7	0.3	21.1	3.1	73.1	49.3	32.2	30.1	1.7	36.7	30.1	2.2	1.2	2.7	33.0	5.3	8.8	48.6	33.9	3.1	0.2	17.6	0.3	18.6	92.0	118.3	0.1	21.2	58.7	35.2	69.2	0.0	17.5	0.2	58.1	45.1	4.2	0.2	0.0	8.0	34.1	0.2	0.0	0.2	16.7	0.0	123.3	0.2	0.0	255.3	89.4	24.1	37.3	29.8	50.1	0.1	0.3	0.2	144.1	0.1	0.1	0.2	0.1	0.0	0.5	0.2	79.0	0.0	479.6	0.1	0.2	0.2	97.7	0.1	0.3	5.3	0.0	0.2	37.4	18.3	34.3	23.8	3.1	0.3	0.3	0.4	6.4	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.1	1.4	1.5	1.3	1.4	3.9	1.6	2.2	1.7	1.2	3.1	411.8	44.8	411.3	1.0	11.2	103.6	13.2	16.5	2.2	1.9	38.5	73.9	4.7	75.8	13.3	80.9	0.0	1.0	1.6	0.0	9.8	238.3	0.3	19.0	89.9	190.0	5.3	147.2	1.3	157.0	2.5	452.2	5.1	80.5	13.9	0.5	195.2	3913.2	28.4	0.0	1.6	0.0	0.0	126.8	142.1	1.6	74.3	9.2	96.0	1.9	5.7	0.0	0.0	0.0	0.2	323.1	0.0	13.2	1.5	10.8	0.0	99.2	11.9	0.2	0.0	1639.1	154.3	0.3	0.8	1.9	92.1	2.2	20.1	0.0	0.0	3.1
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	1.5	0.5	0.5	5.9	0.2	13.6	1.5	0.2	1.0	5.6	0.7	0.9	1.5	0.6	0.3	11.7	0.9	1.3	0.7	0.2	0.4	0.6	1.7	4.3	2.7	1.0	0.9	0.4	0.3	0.2	0.4	1.2	0.7	0.9	0.9	0.0	4.3	0.4	0.6	14.4	1.3	1.8	0.7	4.4	1.4	0.5	1.4	0.8	0.4	0.3	2.3	1.6	12.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.0	5.8	7.3	0.0	0.0	0.0	0.0	0.0	15.9	7.2	0.0	0.3	0.1	0.0	3.0	23.0	6.0	0.4	13.1	0.7	0.1	1.3	1.4	21.3	0.0	0.1	0.5	10.5	3.4	9.0	1.0	0.9	11.1	0.5	0.2	0.2	1.0	0.2	0.4	1.0	0.9	0.7	0.7	1.4	0.8	0.2	0.0	3.7	0.0	1.9	5.9	0.3	1.2	0.0	0.0	1.4	1.1	0.4	1.5	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	5.6	0.8	0.6	1.2	0.8	0.1	0.0	0.0	0.4	0.0	8.3	1.3	0.5	0.0	0.5	2.5	0.0	0.1	0.0	2.0	9.0	22.5	0.0	0.0	15.2	1.8	1.9	15.6	0.0	1.0	0.0	0.2	0.0	0.0	0.4	4.3	0.4	0.0	0.1	1.0	0.0	0.0	0.1	0.4	0.1	0.4	6.1	15.5	0.3	2.3	0.1	0.1	0.3
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 276.3;Inhibitory neurons: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	13.5	20.2	29.9	8.0	28.8	5.7	12.5	7.7	58.7	14.1	0.0	18.3	4.9	11.8	7.3	21.6	9.7	8.0	11.3	39.2	28.6	12.9	13.7	11.6	9.6	36.8	14.3	7.0	22.9	15.3	43.1	7.7	36.6	12.4	13.9	63.0	18.4	5.8	38.9	16.5	16.1	6.4	4.1	14.9	15.6	16.7	15.6	7.9	11.9	13.5	10.0	13.2	14.3	21.1	11.7	25.4	16.6	1.2	9.6	13.4	13.5	15.6	18.2	14.7	14.3	17.5	0.1	28.5	27.3	34.8	15.3	2.0	18.9	5.8	23.9	10.1	24.6	1.0	17.4	24.2	14.3	0.8	6.1	12.3	7.8	29.8	12.3	7.8	23.4	7.0	19.4	15.0	32.9	22.8	19.4	7.5	9.4	36.0	29.9	13.7	16.1	26.7	16.7	24.0	15.2	17.2	23.1	0.1	11.1	17.5	28.5	35.1	19.3	41.2	14.4	22.0	23.7	32.0	19.9	16.4	11.5	15.2	29.7	9.3	11.5	6.6	6.1	9.8	6.7	5.4	6.2	8.1	12.6	6.1	5.1	6.1	4.8	5.9	10.8	5.0	9.4	7.5	29.9	28.8	7.7	58.7	39.2	28.6	36.8	14.3	36.6	4.1	15.6	21.1	16.3	9.6	11.3	54.9	28.2	4.0	3.6	6.7	6.2	106.6	14.0	10.0	8.1	7.2	10.9	22.0	87.6	13.0	18.8	32.3	11.7	12.4	45.2	8.3	19.7	11.5	30.5	8.6	276.3	16.2	14.4	10.9	13.7	11.2	9.5	8.2	11.0	19.3	18.8	43.7	284.7	26.3	24.4	29.9	10.9	45.8	5.9	20.5	10.6	69.3	35.4	24.5	8.2	98.5	71.8	13.7	17.4	8.6	21.7	9.0	18.5	14.7	8.7	89.9	0.0	10.6	12.9	40.6	31.4	9.5	5.7	18.5	14.8	18.3	20.6	8.6
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037854-15056079	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 17.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 18.5;REH: 9.2;U-266/84: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	38.6	10.2	3.6	0.5	3.9	2.2	28.1	3.8	8.9	25.3	2.1	30.3	0.1	20.7	1.4	19.4	18.8	1.2	19.3	3.4	3.7	15.9	15.2	21.6	0.7	3.8	4.1	19.7	11.0	0.5	6.5	0.4	4.1	20.2	0.3	1.3	15.8	0.4	24.5	21.6	15.6	0.8	2.9	20.5	17.9	20.3	3.7	0.8	13.5	0.6	0.4	27.8	21.8	3.5	3.6	0.0	1.8	0.7	1.2	0.6	0.6	6.2	2.6	1.0	2.8	0.0	0.0	3.2	2.5	4.7	1.7	0.1	0.9	0.7	0.9	5.0	5.9	0.3	0.0	0.0	1.1	1.7	4.3	0.8	0.4	3.4	1.5	1.5	1.3	2.6	0.5	3.2	0.9	0.3	5.3	18.5	1.1	0.0	0.2	9.2	0.1	1.3	1.2	0.0	0.7	2.1	0.0	0.1	1.5	0.4	0.0	0.6	4.1	1.1	3.8	1.1	1.1	4.2	10.1	2.5	1.5	1.3	2.2	4.9	1.3	17.5	2.8	1.7	3.0	4.2	3.4	2.6	1.9	3.8	3.9	1.3	1.6	3.8	2.0	5.7	5.9	3.1	3.6	3.9	3.8	8.9	3.4	3.7	3.8	4.1	4.1	2.9	3.7	3.5	79.7	3.2	3.9	7.8	24.7	33.6	16.4	24.1	7.4	6.1	20.2	33.4	3.2	12.8	13.8	18.4	10.4	77.4	30.4	25.1	45.0	49.3	48.9	8.8	29.3	55.0	6.7	25.3	12.6	23.6	23.8	51.3	8.2	12.7	8.8	22.0	62.8	23.0	116.6	25.2	15.6	7.2	30.5	75.0	48.3	32.4	83.0	53.9	58.7	12.2	46.0	15.2	37.0	3.0	6.6	56.9	14.6	75.2	37.6	21.2	9.6	38.6	6.0	9.4	39.5	20.8	52.3	33.3	30.7	16.0	21.7	56.9	25.6	23.5	13.5	23.9
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900312-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"	NA	NA		27000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	181.3	103.5	55.8	106.8	60.4	82.3	141.6	65.5	68.1	115.0	79.4	122.1	179.9	127.6	61.3	111.2	116.9	108.3	204.0	58.2	63.0	154.6	264.5	157.1	82.1	65.9	62.9	125.6	130.1	173.5	69.5	114.8	67.5	109.2	54.8	30.2	117.8	103.0	180.1	96.6	163.6	106.0	57.7	111.1	118.8	34.7	73.1	49.5	122.2	110.7	53.1	130.1	108.9	61.6	54.8	182.1	84.2	188.5	304.6	249.2	97.6	208.1	189.9	103.3	144.2	92.9	203.1	54.7	151.8	250.6	98.9	132.0	48.6	107.0	43.3	194.6	90.3	141.6	119.0	131.6	156.6	85.1	183.6	288.0	52.1	96.8	62.9	275.2	167.2	60.7	173.1	278.8	107.0	71.6	42.3	68.6	42.2	132.1	93.5	78.7	125.3	114.9	90.2	134.6	61.2	123.2	247.1	152.2	88.1	79.7	78.8	112.1	234.6	172.3	114.3	107.0	99.3	210.8	501.1	37.1	132.5	54.3	207.3	102.9	108.5	105.7	100.6	128.5	75.3	46.8	67.5	77.2	79.0	37.3	55.3	56.7	104.7	69.2	114.2	113.9	74.6	129.5	55.8	60.4	65.5	68.1	58.2	63.0	65.9	62.9	67.5	57.7	73.1	61.6	154.5	41.7	72.1	17.6	51.0	48.3	67.2	81.3	66.0	21.7	57.6	57.5	58.0	78.6	51.5	69.9	14.6	101.5	69.6	153.0	41.1	148.0	10.8	27.4	65.5	116.0	74.4	54.5	14.5	118.3	150.9	126.7	76.0	50.2	95.2	64.1	122.0	149.2	213.7	20.2	18.9	109.9	69.2	138.3	74.6	9.3	110.3	101.9	101.4	17.8	120.3	52.6	74.2	8.5	11.8	100.0	149.2	124.1	126.3	63.8	453.3	135.4	24.4	20.5	92.1	51.0	79.0	21.9	37.6	65.6	49.9	102.1	73.0	103.9	123.3	68.1
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106874-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	7.4	6.4	5.1	4.8	5.2	4.4	6.7	5.4	5.5	4.9	4.3	5.7	6.5	5.4	12.9	8.0	5.3	4.2	4.8	5.4	4.8	6.8	5.6	6.1	8.8	5.3	4.8	2.3	17.0	2.7	9.1	2.7	5.7	7.8	4.7	1.2	8.5	4.6	2.3	7.1	7.6	3.6	4.4	10.4	8.9	7.7	5.4	6.8	8.2	1.2	6.3	5.7	5.5	4.6	8.1	16.8	0.5	3.6	12.4	4.6	9.0	4.8	12.6	6.1	7.0	4.0	6.3	6.0	7.5	5.7	15.5	13.8	2.3	7.7	2.0	7.5	2.3	5.1	4.9	3.9	8.3	1.7	15.2	8.5	7.2	2.4	6.4	7.9	7.7	13.0	3.8	9.9	6.0	8.6	6.9	4.6	0.9	4.8	4.1	3.0	1.5	6.5	9.0	7.1	1.8	2.8	3.3	4.0	4.2	3.7	9.4	8.3	6.4	4.0	2.2	5.4	2.5	4.4	0.5	1.9	7.0	4.5	9.8	0.0	1.5	3.0	2.2	1.6	2.1	1.4	1.8	1.3	1.0	2.0	2.0	1.1	0.3	4.0	1.3	1.9	0.7	0.9	5.1	5.2	5.4	5.5	5.4	4.8	5.3	4.8	5.7	4.4	5.4	4.6	5.6	3.2	2.2	1.0	7.3	2.0	3.4	5.2	1.2	3.3	5.9	4.6	1.9	8.6	3.0	5.5	0.0	6.7	6.8	12.5	5.9	9.5	14.6	5.9	2.4	4.7	3.0	5.2	1.6	13.6	9.6	5.9	6.1	4.1	0.0	6.3	5.7	4.0	14.5	3.3	1.7	10.9	2.0	16.8	1.3	15.1	3.1	9.0	5.4	2.8	15.3	4.1	19.6	0.5	1.6	10.1	14.6	3.4	6.2	4.6	41.2	13.6	7.0	1.2	0.0	3.1	3.7	3.5	2.7	6.3	1.8	3.1	7.9	5.3	7.0	2.3
NUDT7		ENSG00000140876	"Nudix hydrolase 7"	P0C024	16	77722492-77742260	"Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Proximal tubular cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 49.7;U-698: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042042	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	Nucleoplasm	"HPA042042: AB_10806232"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (5.36e-11)"	"unprognostic (1.19e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.42e-2)"	14.4	23.6	5.9	5.2	6.0	2.2	9.2	6.4	7.4	5.8	15.6	12.0	10.8	7.8	17.5	6.6	10.2	6.8	37.6	5.6	7.8	22.1	70.1	6.1	8.9	5.5	5.4	7.3	9.5	16.3	6.0	4.5	6.0	6.6	12.3	9.7	9.0	7.2	8.1	9.0	8.7	7.4	5.3	7.0	7.5	8.7	6.8	6.4	11.8	12.1	9.1	8.2	5.8	6.1	2.1	7.0	6.2	3.5	28.4	7.2	5.8	1.8	9.1	2.7	3.5	2.0	8.8	10.3	6.6	6.9	6.5	6.9	4.7	7.6	1.6	3.3	6.4	0.1	0.4	9.6	3.1	7.1	1.4	12.2	9.4	1.5	5.3	1.2	4.8	14.7	7.6	4.4	1.1	19.1	3.7	16.8	6.6	12.4	1.7	7.8	0.8	3.1	14.1	0.0	5.1	5.0	6.5	2.6	5.7	10.6	18.6	49.7	3.7	3.1	0.4	1.4	0.3	0.0	0.0	40.6	12.1	8.8	0.0	3.8	12.4	1.7	12.6	17.5	14.4	14.2	14.8	15.1	10.2	19.8	19.5	13.5	2.0	3.5	17.5	11.7	31.5	8.8	5.9	6.0	6.4	7.4	5.6	7.8	5.5	5.4	6.0	5.3	6.8	6.1	8.3	16.0	8.7	12.7	4.1	9.7	6.5	14.6	14.2	2.5	10.9	14.5	17.9	18.6	7.9	14.7	0.0	20.3	7.9	12.1	58.7	8.0	11.6	19.5	4.7	8.2	6.7	3.6	4.3	9.5	9.1	8.5	3.6	6.6	1.3	7.0	5.3	41.2	5.9	6.7	5.6	6.6	10.2	9.2	4.4	4.6	5.6	4.1	8.8	1.9	2.1	25.0	10.3	3.5	2.7	4.0	10.4	4.9	1.1	2.0	22.6	42.2	21.0	7.3	6.6	7.1	8.9	14.2	20.0	12.2	13.9	6.7	6.9	10.7	14.8	4.5
NYAP1	"C7orf51, FLJ37538, KIAA1486L"	ENSG00000166924	"Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1"	Q6ZVC0	7	100483927-100494802	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;pituitary gland: 22.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Bipolar cells: 6.2;Excitatory neurons: 11.1;Granulosa cells: 5.6;Horizontal cells: 13.5;Inhibitory neurons: 10.3"	"Cancer enhanced"	"Detected in some"		"glioma: 4.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.8;HUVEC TERT2: 3.9;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022251	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Golgi apparatus"	"HPA022251: AB_1848915"	"unprognostic (6.59e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.65e-2)"	2.1	2.5	6.4	0.3	8.4	0.1	1.6	0.0	22.5	2.9	0.0	1.3	0.2	4.6	0.0	1.1	2.2	0.2	0.7	11.4	2.9	1.9	0.4	0.3	0.1	6.6	0.6	5.3	0.9	0.0	22.0	0.3	6.8	2.0	0.1	1.9	0.9	0.9	0.1	1.4	0.8	0.5	0.0	0.8	0.8	9.1	2.0	0.1	0.7	0.1	0.0	0.6	2.0	8.2	0.0	1.1	3.0	1.4	2.0	1.2	0.2	0.1	1.0	0.1	0.4	0.4	0.2	0.0	1.0	0.3	7.8	0.1	0.6	0.1	0.0	1.4	0.2	0.1	0.3	0.2	1.4	0.0	0.8	1.3	0.0	0.4	0.5	0.3	3.9	0.2	0.5	0.1	0.0	0.3	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	9.4	0.3	0.2	1.0	1.1	0.1	0.0	1.4	0.0	1.9	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.4	0.0	22.5	11.4	2.9	6.6	0.6	6.8	0.0	2.0	8.2	3.2	0.0	0.0	9.4	0.0	0.1	0.2	0.1	0.6	6.2	0.3	1.9	1.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.2	0.4	1.4	0.0	0.8	11.1	0.0	0.0	0.9	0.0	0.4	0.0	5.6	0.7	0.0	0.1	13.5	10.3	0.1	0.0	0.0	0.7	0.7	2.5	0.1	0.0	2.8	0.0	3.3	0.0	2.5	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.5	0.7	1.3	2.6	0.2	0.1	0.0	0.1	0.8	0.0	0.0
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288811-71309059	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Langerhans cells: 144.0;Macrophages: 155.7;monocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	25.2	11.2	32.9	16.1	28.1	26.7	51.0	40.5	26.3	7.9	7.8	9.3	3.6	10.4	13.7	33.2	6.5	10.8	6.8	40.9	47.7	7.1	6.4	11.5	14.5	50.8	60.5	6.6	8.0	6.2	7.6	13.5	51.5	8.4	5.3	13.2	46.3	12.8	5.1	20.1	6.8	33.4	55.3	16.8	6.3	2.8	47.9	11.4	5.3	12.1	25.5	7.4	12.5	69.6	9.7	2.9	10.0	0.0	26.5	24.1	3.6	42.2	26.5	16.9	17.0	3.7	1.8	59.1	56.3	18.5	15.6	4.7	7.8	29.4	59.5	12.5	6.1	13.0	10.0	1.5	21.4	6.2	4.4	24.4	24.7	12.5	38.8	14.2	13.7	0.0	0.8	4.5	58.8	8.1	0.0	9.7	4.0	3.8	2.3	4.2	30.4	13.8	38.8	0.7	33.8	15.3	12.6	7.8	2.8	14.3	13.4	48.0	21.1	41.3	20.5	4.3	14.1	6.0	0.4	7.6	13.8	41.0	7.2	3.4	2.6	0.1	0.4	1.7	0.4	0.3	0.3	0.4	2.1	0.5	0.0	0.3	11.1	0.5	1.3	0.8	0.1	0.6	32.9	28.1	40.5	26.3	40.9	47.7	50.8	60.5	51.5	55.3	47.9	69.6	40.3	6.4	18.6	175.3	17.4	38.9	22.3	18.4	22.8	42.8	79.4	86.4	8.7	11.5	14.1	11.0	25.0	23.2	31.7	1.4	1.9	17.0	0.5	8.0	14.2	30.2	14.4	11.1	29.1	32.9	11.0	50.8	5.6	19.1	6.3	6.6	8.9	5.1	61.7	38.7	28.0	2.2	8.2	95.5	144.0	1.2	16.4	155.7	32.0	71.2	133.5	87.0	18.6	13.0	4.0	19.3	2.4	33.1	11.6	16.2	0.1	4.9	3.2	6.0	26.3	26.8	31.3	0.6	1.2	57.9	46.5	19.0	19.3	3.4	4.4	19.3
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	193	"liver: 42973.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 58657.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 193.9"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 193.9"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 1182.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	61000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	13.4	10.3	0.1	12.7	0.3	223.1	6.6	0.0	0.4	2.7	0.2	1.5	0.1	2.7	0.3	1.9	1.9	1.0	3.4	0.2	0.2	4.9	42973.6	24.4	0.7	0.4	0.2	1.6	8.1	0.0	1.4	1.3	0.1	57.6	0.0	1.1	1.4	0.0	2.0	1.7	2.3	0.3	0.2	51.3	19.2	2.7	0.1	1.2	2.8	0.3	0.1	1.6	2.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	3.4	0.6	1182.7	0.1	5.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.2	1.0	0.1	0.0	0.7	7.1	0.0	0.0	0.4	0.0	0.0	5.7	5.5	0.0	0.0	0.4	102.0	1.2	0.0	0.5	0.0	0.0	1.2	0.6	3.5	0.0	4.3	0.1	0.0	4.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.9	0.0	1.0	0.0	0.0	1.8	0.1	0.3	0.0	0.4	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.2	0.0	3.2	18.1	0.0	81.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1166.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	1.3	0.2	34.4	0.0	890.4	0.0	4.9	0.3	0.2	0.0	2.5	0.0	0.0	930.9	58657.7	0.1	0.0	0.0	0.0	0.0	1260.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	327	"liver: 8873.2"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 10792.5"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	40	"neutrophil: 12.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	232	"Hep G2: 831.1"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	41000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	4.0	4.0	0.2	3.2	0.4	27.1	3.0	0.0	0.2	1.3	0.2	0.3	0.2	2.1	0.1	0.4	0.4	0.6	0.8	0.1	0.1	1.7	8873.2	5.8	1.1	0.2	0.3	0.3	2.1	0.0	0.2	0.2	0.1	23.6	0.1	3.6	0.3	0.0	0.4	0.4	0.4	0.1	0.2	7.3	21.9	1.4	0.1	0.5	0.3	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	831.1	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.1	1.1	0.4	2.5	0.0	0.3	1.9	0.1	0.0	0.3	0.1	0.0	2.6	2.0	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.2	0.1	0.2	0.0	0.0	10.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	263.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.6	1.1	0.1	7.0	0.0	141.7	0.0	6.0	0.0	0.0	15.8	1.3	0.0	0.0	162.8	10792.5	0.0	0.0	0.0	0.0	0.0	236.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2
OSBPL11	"FLJ13012, FLJ13164, ORP-11, ORP11"	ENSG00000144909	"Oxysterol binding protein like 11"	Q9BXB4	3	125528858-125595497	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.3;tongue: 80.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039144			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA039144: AB_10794086"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.73e-3)"	"unprognostic (6.38e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.13e-1)"	10.0	5.4	11.6	10.9	13.3	7.0	6.0	8.6	10.5	6.3	4.4	8.2	6.8	7.6	5.6	8.4	5.7	6.5	6.6	9.1	15.2	8.5	28.9	14.0	13.1	11.0	14.1	5.5	3.7	13.3	3.9	10.9	12.6	5.6	8.1	6.0	4.2	7.7	57.3	7.5	6.2	8.8	9.9	15.4	5.2	10.3	12.3	12.4	7.4	80.1	12.2	8.4	4.9	12.3	21.2	10.9	20.4	11.7	22.4	12.0	27.5	15.6	11.9	18.7	21.3	21.3	7.2	34.2	19.2	12.5	15.5	15.5	22.7	13.3	24.7	9.6	10.2	15.6	12.5	14.0	12.6	11.9	20.8	9.7	15.8	15.6	13.6	7.5	13.8	16.2	16.5	15.0	17.1	12.2	24.4	5.8	28.8	15.1	10.0	21.1	11.8	40.4	15.5	12.6	4.6	12.4	18.9	10.6	16.3	13.9	11.2	6.1	14.8	15.2	13.9	22.4	12.2	9.8	11.1	41.5	10.7	4.1	14.9	16.5	12.3	3.1	2.1	12.1	1.8	4.3	1.3	2.2	14.9	3.3	1.4	1.6	18.2	2.5	10.1	6.2	2.9	4.5	11.6	13.3	8.6	10.5	9.1	15.2	11.0	14.1	12.6	9.9	12.3	12.3	14.4	9.6	14.4	33.3	16.0	9.9	7.3	3.9	10.8	18.7	12.1	11.6	9.4	7.2	9.9	9.2	12.5	12.4	22.8	29.1	5.9	8.5	1.3	34.5	13.7	9.7	4.2	9.4	14.8	6.9	10.3	9.4	6.6	24.3	3.8	10.6	10.8	37.6	26.6	8.4	18.6	6.0	0.0	74.0	27.5	4.0	6.5	40.3	12.4	38.4	48.6	12.2	13.4	15.1	18.1	11.4	21.3	7.2	10.5	7.8	10.7	9.7	8.9	33.8	6.6	18.0	10.5	13.0	18.6	9.2	15.8	23.1	11.1	5.3	9.5	10.4
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 216.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	27.5	38.1	17.9	18.1	23.8	30.1	32.6	26.3	23.5	25.5	28.3	20.8	17.4	31.1	31.0	17.7	23.3	17.6	37.0	17.6	23.9	42.8	60.8	27.5	25.9	25.0	21.8	30.5	33.3	60.0	21.1	21.8	26.6	27.8	19.1	53.5	22.0	22.4	70.0	19.6	21.7	24.2	23.0	27.2	34.3	28.4	22.2	21.8	24.7	35.2	33.0	23.7	24.7	32.2	66.3	31.7	69.0	11.2	38.1	17.9	90.7	30.1	50.8	54.9	60.0	53.0	46.6	105.8	54.4	34.1	120.9	26.9	59.2	57.4	76.9	71.9	41.9	77.4	62.7	104.7	36.9	81.7	35.5	44.7	55.0	56.8	31.4	66.8	68.9	52.1	154.4	31.1	26.7	45.4	20.3	92.5	97.0	26.8	15.1	58.2	102.8	110.5	74.0	47.4	31.8	45.2	22.4	79.6	93.7	154.7	38.0	82.8	22.9	11.6	51.2	17.2	58.1	80.2	52.5	120.4	39.3	32.8	23.0	52.7	12.2	30.5	20.1	9.9	28.9	32.6	19.7	20.8	25.0	23.9	21.0	22.2	16.9	16.3	9.4	23.2	20.5	16.4	17.9	23.8	26.3	23.5	17.6	23.9	25.0	21.8	26.6	23.0	22.2	32.2	32.5	80.1	56.8	75.4	39.2	17.7	33.8	25.7	34.1	102.0	34.2	33.0	47.9	38.6	50.5	46.0	41.7	89.2	30.4	20.5	125.2	47.6	40.7	36.3	46.3	30.1	29.8	35.7	64.8	47.8	50.2	48.6	54.0	52.9	33.6	75.7	18.2	61.7	40.1	26.9	113.0	18.3	38.7	22.7	16.0	38.3	62.4	25.3	65.8	63.7	50.1	43.8	29.9	62.8	216.4	41.9	14.3	50.0	81.4	38.5	26.4	59.7	32.1	35.3	46.0	36.9	62.9	32.3	18.9	26.9	18.9	75.5	32.0	52.2	21.2	27.4
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49834264	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 871.9;placenta: 1023.1"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1"					"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Golgi apparatus"	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.3	5.7	0.1	0.3	0.2	0.0	0.0	0.1	0.5	7.0	0.1	0.2	0.4	51.2	871.9	0.0	21.4	0.0	0.4	0.1	0.2	3.1	0.3	0.2	0.0	0.1	0.1	3.7	2.5	0.0	1.3	1023.1	0.1	171.8	0.0	0.0	0.6	77.2	2.3	0.0	0.3	24.2	0.0	0.3	0.2	5.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.0	0.1	11.7	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13314.7	0.0	0.0	0.0	0.0	4.4	1.9	72.5	25.9	0.0	0.0	0.0	0.0	905.4	72.5	0.0	1.9	0.0	0.0	0.0	0.0	1052.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	48.8	20.7	0.0	0.0	8524.1	0.3	0.0	0.0	0.1
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1560.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1406.5;Enteroendocrine cells: 321.4;Inhibitory neurons: 487.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 529.9;fHDF/TERT166: 714.5;hTERT-RPE1: 562.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		98000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	119.3	202.5	71.6	34.6	81.4	10.1	99.0	50.7	82.5	595.0	96.2	125.1	52.6	140.9	678.2	69.4	87.6	97.3	1560.4	75.2	179.9	116.0	20.1	88.3	27.7	86.5	99.8	136.4	104.4	257.8	137.0	60.0	170.9	91.6	80.4	37.6	205.4	236.5	155.3	66.9	52.1	157.9	55.7	52.5	131.6	22.4	106.0	17.9	95.1	159.4	30.5	103.3	116.1	50.0	111.3	16.3	195.9	87.2	529.9	314.8	78.0	307.6	457.0	89.1	268.9	53.5	143.2	0.1	65.0	714.5	125.7	36.8	11.0	135.3	244.0	13.5	44.7	22.9	60.0	17.7	80.3	7.4	23.9	173.4	57.3	65.6	49.2	562.6	186.8	8.9	0.9	15.0	255.6	22.9	0.1	3.2	35.3	19.7	59.3	8.5	108.9	62.4	346.1	13.0	92.3	63.9	131.2	8.3	83.3	114.0	34.0	7.3	144.9	280.8	72.4	133.3	93.4	33.1	8.6	0.4	322.3	30.8	247.6	4.2	8.0	0.2	20.7	1.5	14.9	0.8	12.3	15.6	3.1	0.4	4.1	6.8	16.6	26.3	3.4	1.6	19.9	10.8	71.6	81.4	50.7	82.5	75.2	179.9	86.5	99.8	170.9	55.7	106.0	50.0	45.7	54.5	39.3	47.0	3.9	28.2	12.0	26.1	12.0	19.1	27.5	12.1	1406.5	0.0	30.4	60.7	2.1	1.6	12.6	13.7	7.9	12.6	8.8	47.6	48.6	63.5	321.4	3.4	229.2	21.5	40.6	220.4	26.0	83.0	9.5	68.3	74.6	3.5	5.9	8.4	487.7	13.8	18.3	10.3	48.3	8.1	60.3	9.3	37.4	192.0	9.5	11.6	22.6	154.8	9.3	30.6	6.3	58.6	12.1	26.4	4.8	43.8	19.2	3.8	19.7	36.4	44.9	2.6	5.6	8.0	23.7	6.7	16.6	19.3	6.3	18.2
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins, Transporters"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 168.5;Distal enterocytes: 154.3;Microglial cells: 74.0;Oligodendrocytes: 298.2;Paneth cells: 80.7;Proximal enterocytes: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 41.8;OE19: 87.9;SuSa: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.7	4.0	83.7	9.2	113.9	1.2	2.3	122.9	86.7	4.7	42.0	38.9	19.3	5.1	8.0	17.6	6.3	6.0	3.5	74.4	89.7	8.0	1.5	7.3	10.3	133.8	110.7	24.3	2.8	5.2	2.2	7.0	123.1	4.3	36.7	2.9	2.2	23.3	0.9	3.1	33.7	6.3	102.8	6.2	32.3	3.7	106.4	9.2	2.8	1.5	7.6	9.7	5.5	144.9	0.9	1.0	10.7	4.6	6.3	10.2	7.3	3.2	12.1	2.0	4.4	4.1	3.8	1.1	1.2	2.2	4.7	0.4	1.4	5.3	3.2	14.8	1.7	6.6	1.0	41.8	1.7	1.8	0.9	2.9	0.7	1.4	7.5	7.4	11.5	12.9	1.5	6.4	8.3	1.5	4.4	6.1	5.4	87.9	0.5	11.5	1.7	2.8	12.4	3.1	4.0	8.7	0.8	0.3	12.4	34.4	0.3	14.7	4.8	4.0	1.6	1.2	1.9	1.9	2.6	1.6	3.7	16.9	21.5	3.0	3.2	1.4	2.8	0.6	4.2	1.1	8.3	5.7	7.0	1.0	17.8	8.3	0.6	8.5	0.6	3.5	6.2	4.2	83.7	113.9	122.9	86.7	74.4	89.7	133.8	110.7	123.1	102.8	106.4	144.9	4.9	3.2	10.6	168.5	3.6	2.0	3.7	3.1	0.6	2.1	0.7	1.3	4.4	14.3	3.5	3.7	8.4	1.7	7.6	154.3	0.0	4.4	0.5	12.2	3.9	7.4	22.9	4.2	21.1	1.1	3.1	6.8	18.8	7.5	4.5	23.7	4.2	0.2	8.8	0.0	19.4	45.5	6.1	19.8	3.5	1.6	5.6	7.3	14.2	74.0	11.4	4.2	3.1	19.1	298.2	4.9	80.7	10.1	0.6	6.6	100.5	0.1	8.9	3.3	0.0	1.0	3.6	12.1	3.3	5.3	1.0	0.8	9.2	10.0	42.5	7.3
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 28.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.2;Excitatory neurons: 24.8;Inhibitory neurons: 18.6;Muller glia cells: 25.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.0	0.0	5.8	0.0	12.1	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	4.5	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	1.4	0.0	1.3	1.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	5.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	12.1	0.0	19.7	28.4	4.5	1.1	1.2	1.3	5.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.1	2.1	0.0	0.0	18.2	0.4	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	24.8	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	3.7	0.0	25.8	0.0	2.5	2.2	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.4	0.1	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.1
PCED1B	"FAM113B, MGC16044"	ENSG00000179715	"PC-esterase domain containing 1B"	Q96HM7	12	47079603-47236662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1;lymphoid tissue: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.3;Excitatory neurons: 32.4;Granulosa cells: 47.8;Hofbauer cells: 37.6;Microglial cells: 60.0;T-cells: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 63.3;K-562: 48.9;SK-BR-3: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043901	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	Vesicles	"HPA043901: AB_10959888"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (4.55e-6)"	"unprognostic (4.79e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.74e-2)"	"prognostic favorable (5.36e-5)"	6.5	40.1	3.4	17.9	3.2	10.6	6.1	2.7	3.3	6.7	2.3	10.1	2.2	8.7	2.0	3.1	9.3	5.9	3.3	2.4	3.7	6.0	3.9	9.1	36.0	4.8	5.3	23.4	2.7	1.2	2.3	3.6	4.4	5.8	2.7	0.8	3.3	2.3	1.3	2.7	12.2	4.5	3.6	29.5	3.8	13.7	4.8	7.1	3.4	1.2	24.1	9.6	5.4	5.0	3.4	63.3	1.5	0.0	0.5	0.0	3.0	2.0	3.5	0.7	0.3	3.2	12.3	11.5	3.4	6.5	1.2	9.2	0.0	9.4	0.0	13.5	0.0	0.4	0.6	1.3	1.3	2.7	0.5	0.2	4.1	1.1	7.1	8.8	2.7	0.8	48.9	10.6	4.4	1.5	0.7	2.3	10.6	7.9	0.9	0.2	1.6	8.2	9.7	5.2	0.4	0.0	5.7	31.0	0.0	3.2	5.7	4.0	0.8	0.2	0.9	0.1	2.2	11.4	8.6	20.3	3.0	8.7	0.3	1.7	1.1	2.8	42.5	2.3	48.3	50.1	50.7	54.1	6.4	35.6	88.8	83.5	4.5	30.1	2.6	38.1	59.1	35.4	3.4	3.2	2.7	3.3	2.4	3.7	4.8	5.3	4.4	3.6	4.8	5.0	3.4	3.2	5.6	30.3	23.6	1.1	0.9	4.2	9.1	2.5	4.4	6.2	0.5	0.0	1.5	1.8	0.0	0.5	21.1	0.2	0.0	3.2	0.9	5.1	1.4	3.4	10.2	0.4	32.4	12.8	9.1	3.1	1.5	10.3	1.3	47.8	9.7	0.3	37.6	0.0	2.2	1.4	0.0	4.3	1.8	2.5	3.7	10.7	1.8	60.0	5.3	0.9	23.7	17.6	0.6	11.7	0.8	0.7	28.1	1.4	0.1	0.4	0.8	0.1	0.0	1.3	4.4	0.7	0.2	2.8	0.6	2.1	36.2	22.4	0.3	4.2
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5;brain: 109.1"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 88.9"	"Group enriched"	"Detected in all"	5	"B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	18.3	3.1	40.1	39.5	82.5	75.5	20.0	63.3	53.5	7.2	1.6	8.3	4.6	8.3	1.1	4.5	4.2	10.1	21.4	45.7	68.4	5.4	10.9	14.7	23.2	85.9	74.4	2.1	1.6	1.4	3.8	17.2	78.5	23.0	10.5	14.1	21.1	12.1	44.3	8.9	12.2	12.4	66.4	22.6	5.1	3.8	62.9	14.0	7.2	15.0	19.9	32.1	4.6	109.1	0.2	18.5	34.7	61.8	1.6	1.7	0.1	11.5	13.3	10.1	13.4	0.0	0.0	5.3	0.2	20.7	0.4	0.1	0.3	0.0	9.7	15.5	0.1	0.3	5.2	0.0	1.2	13.1	0.0	3.4	0.5	4.5	0.2	1.6	93.2	0.0	0.0	3.3	4.7	0.3	0.0	7.5	56.1	0.0	0.7	2.6	6.2	3.6	8.7	0.0	0.2	26.6	0.0	3.0	58.6	2.9	0.2	4.5	52.6	7.2	1.9	4.6	1.9	1.5	51.6	19.3	8.6	13.4	3.7	10.8	6.8	22.0	10.1	5.8	19.5	36.8	19.4	14.8	6.2	37.4	21.3	15.0	88.9	11.3	5.7	6.4	34.7	9.6	40.1	82.5	63.3	53.5	45.7	68.4	85.9	74.4	78.5	66.4	62.9	109.1	24.7	9.6	12.2	531.8	233.3	20.3	28.4	0.5	27.9	40.9	51.6	34.3	25.4	0.0	6.9	5.5	0.0	7.3	79.8	0.4	0.0	0.8	14.4	1.7	14.9	36.8	4.2	0.0	315.6	0.9	2.0	20.2	9.7	4.2	15.2	0.2	11.7	2.4	13.0	114.4	559.7	1.9	8.2	40.6	187.4	9.4	0.3	176.9	51.6	173.3	67.0	19.3	1.0	1722.6	4039.6	0.1	0.4	2.6	351.9	93.6	0.0	2.1	1.5	4.0	0.0	54.0	10.3	0.7	0.8	4.8	8.1	5.6	143.1	0.4	1.3	9.4
PDGFD	"IEGF, MSTP036, SCDGF-B"	ENSG00000170962	"Platelet derived growth factor D"	Q9GZP0	11	103907189-104164379	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 106.5;ovary: 78.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 32.9;dendritic cells: 30.0;Ductal cells: 30.6;Fibroblasts: 44.3;Inhibitory neurons: 95.0;Microglial cells: 28.1;NK-cells: 46.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 9.5;gdT-cell: 16.4;memory CD8 T-cell: 7.2;naive CD8 T-cell: 6.0;NK-cell: 17.1"	"Group enriched"	"Detected in many"	29	"granulocytes: 9.5;NK-cells: 17.1;T-cells: 16.4"	"Group enriched"	"Detected in many"	6	"ASC diff: 139.8;HHSteC: 42.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 39.4"	"HPA046183, HPA066271"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		95000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA046183: AB_2679573, HPA066271: AB_2685645"	"unprognostic (2.21e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (9.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.57e-3)"	20.4	106.5	0.5	3.4	0.8	0.9	21.7	0.7	1.3	25.1	9.0	8.8	4.1	11.8	7.1	1.9	9.3	34.0	23.2	0.8	2.2	7.7	2.3	3.1	7.4	5.1	6.6	78.0	25.7	17.1	13.4	7.0	9.4	10.0	9.8	1.5	8.6	37.4	2.2	7.9	4.8	9.7	1.8	2.8	23.4	3.3	2.0	3.7	18.3	8.8	5.4	15.8	15.4	2.3	0.0	7.8	4.0	0.0	139.8	4.2	0.1	0.9	0.8	0.7	0.8	0.0	1.3	7.4	1.4	7.3	5.2	0.4	0.0	0.2	0.3	0.0	3.2	0.2	1.6	0.3	42.6	0.0	0.1	14.7	0.0	0.1	0.0	0.2	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	1.4	0.0	2.1	0.0	6.7	0.0	0.1	9.6	0.0	13.8	3.2	1.8	0.0	2.0	1.0	0.1	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.0	9.5	16.4	0.0	1.4	0.4	1.7	7.2	0.0	0.0	0.2	6.0	0.2	17.1	0.1	0.0	0.1	4.2	0.5	0.8	0.7	1.3	0.8	2.2	5.1	6.6	9.4	1.8	2.0	2.3	15.6	0.0	0.0	1.0	1.6	3.1	7.7	0.2	1.8	2.3	1.7	9.4	4.5	32.9	0.6	5.5	0.0	0.2	30.0	0.2	0.0	30.6	8.2	0.8	1.8	10.3	1.8	1.3	13.9	4.4	0.2	44.3	0.0	1.4	0.0	8.1	2.9	0.0	0.3	26.9	95.0	1.0	0.0	1.3	3.7	13.3	0.3	0.8	0.0	28.1	0.9	1.5	46.4	2.0	2.8	3.0	0.5	2.2	8.4	1.6	0.0	0.3	0.0	0.5	6.6	1.9	3.7	0.4	4.3	0.3	2.0	0.0	10.2	5.2	0.6	3.2
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 1288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC diff: 1350.1;ASC TERT1: 462.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		39000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	171.2	25.1	25.4	27.5	27.2	0.7	106.3	20.5	33.3	155.9	43.5	41.6	11.9	101.1	24.2	24.1	89.6	124.5	75.7	22.1	23.2	49.7	13.4	98.3	27.5	22.1	24.6	105.5	20.8	21.9	23.0	113.3	22.8	56.2	14.1	6.3	34.5	43.3	38.1	65.0	37.9	68.9	19.4	41.4	27.9	18.4	27.7	8.7	66.5	44.1	13.8	58.3	98.6	21.6	0.1	0.3	8.3	0.4	1350.1	462.7	3.0	48.9	202.3	33.5	56.4	5.4	0.0	0.0	6.4	142.0	19.0	0.1	0.1	0.4	15.8	0.0	0.0	0.1	3.3	3.5	190.7	0.0	0.4	210.0	0.0	46.3	0.6	106.6	0.1	0.1	0.1	5.5	5.5	0.0	0.1	0.6	9.0	0.2	0.2	3.7	2.5	0.2	0.0	0.0	0.1	24.8	0.5	0.1	0.0	38.2	0.1	0.6	0.4	53.7	17.2	23.1	2.8	0.4	0.0	0.3	33.4	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	25.4	27.2	20.5	33.3	22.1	23.2	22.1	24.6	22.8	19.4	27.7	21.6	50.8	0.0	1.1	81.9	0.5	24.0	0.5	0.0	2.2	6.6	1.4	3.3	17.3	1.5	0.0	1.8	4.2	0.6	6.0	0.3	0.0	0.8	1.6	2.8	99.5	32.2	0.0	0.0	7.9	0.0	1.1	123.5	2.0	2.3	0.0	2.5	6.4	1.9	1.5	0.0	1.3	0.7	0.0	0.0	35.6	10.9	165.3	3.1	24.9	45.0	0.7	50.7	23.7	10.1	3.3	0.1	0.1	203.8	2.3	0.7	0.3	0.1	0.7	2.9	1288.5	6.6	288.3	1.9	1.6	0.8	15.3	0.8	4.8	4.0	0.4	1.1
PDXDC1	KIAA0251	ENSG00000179889	"Pyridoxal dependent decarboxylase domain containing 1"	Q6P996	16	14974591-15139339	"Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.6;Late spermatids: 733.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047369, HPA049121, HPA051484"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		9600	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"		"HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502"	"unprognostic (3.67e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.47e-3)"	"unprognostic (4.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	33.3	37.9	4.9	20.9	5.0	12.9	33.1	14.7	6.5	35.7	7.9	61.3	52.5	31.9	17.0	43.4	29.2	20.8	39.1	6.0	4.1	47.6	104.5	34.6	13.4	6.2	4.7	31.1	70.4	27.1	63.2	23.5	7.5	55.8	47.8	13.4	80.5	25.2	52.0	27.8	61.1	18.5	1.2	31.8	56.7	113.2	7.2	11.7	42.9	16.5	15.0	39.1	34.7	5.7	21.4	30.9	31.1	26.1	16.9	20.4	51.4	19.6	17.4	14.3	19.7	38.0	45.3	40.7	42.0	26.5	20.5	34.0	22.1	20.1	20.5	25.0	30.2	24.7	51.8	100.2	44.3	19.7	56.4	21.5	20.4	25.0	20.9	28.0	15.3	21.6	18.5	26.0	34.1	52.2	12.9	10.4	15.3	20.8	11.7	19.9	12.9	48.6	22.7	33.9	31.9	22.8	52.6	30.0	50.9	19.7	121.0	30.3	23.8	11.0	10.0	12.3	25.7	24.2	25.1	39.3	22.7	16.4	35.8	2.9	7.8	11.6	9.4	7.7	10.8	8.3	6.8	7.7	11.7	9.0	8.2	8.1	1.0	7.5	6.2	5.4	6.6	8.2	4.9	5.0	14.7	6.5	6.0	4.1	6.2	4.7	7.5	1.2	7.2	5.7	29.6	38.5	64.6	32.7	33.0	38.2	42.2	21.6	18.8	32.1	57.9	27.8	45.7	58.6	52.9	29.5	31.3	51.7	30.6	149.8	27.4	38.2	483.6	48.1	41.7	35.1	161.2	33.2	80.7	58.3	56.5	36.0	71.9	75.3	39.3	42.1	27.5	123.6	30.5	40.4	68.3	216.7	24.4	33.1	16.8	733.8	49.0	30.9	26.6	31.9	27.5	19.7	39.1	55.8	45.0	46.5	114.4	45.5	45.4	58.1	115.6	53.4	48.3	47.4	46.0	24.0	28.0	142.3	72.7	24.6	42.6	80.7	33.9	21.2	127.2	76.5
PEX5	"PTS1R, PXR1"	ENSG00000139197	"Peroxisomal biogenesis factor 5"	P50542	12	7188685-7218574	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Early spermatids: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 156.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039259, HPA039260"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA039259: AB_10673419, HPA039260: AB_2676417"	"unprognostic (7.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.31e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.13e-1)"	33.1	27.8	43.7	13.2	42.8	8.8	34.2	38.0	43.3	25.0	33.5	25.3	12.1	26.0	10.9	18.8	23.2	13.6	22.0	39.1	38.5	24.5	37.8	22.1	18.6	40.9	41.2	29.2	30.4	18.9	44.1	10.0	41.2	19.7	11.8	13.6	22.2	13.6	74.1	26.2	20.3	15.2	43.1	16.0	22.2	50.9	45.4	39.3	20.0	28.4	20.8	21.7	21.2	40.9	14.7	24.7	13.0	34.2	29.1	19.9	24.3	14.0	16.6	16.2	17.2	36.9	21.8	156.1	8.3	16.2	23.6	18.2	22.1	19.5	16.8	20.8	18.2	13.8	19.0	25.7	15.4	21.3	13.6	22.2	35.2	11.1	34.5	22.0	14.2	75.0	28.2	5.3	14.7	20.0	49.7	18.5	38.6	28.0	13.1	23.7	28.1	21.4	13.0	21.4	10.9	22.6	20.9	45.4	20.1	26.2	10.2	12.5	12.7	18.2	29.9	15.8	17.2	9.5	11.6	53.4	18.0	22.8	12.2	0.0	1.6	2.1	2.9	1.4	3.6	1.9	2.0	2.9	2.6	1.4	2.6	2.6	1.2	2.8	4.1	4.6	0.9	2.2	43.7	42.8	38.0	43.3	39.1	38.5	40.9	41.2	41.2	43.1	45.4	40.9	8.6	12.8	20.1	11.4	5.6	14.5	7.2	5.2	8.0	7.8	9.2	8.5	13.7	14.3	5.6	7.3	8.4	11.3	5.1	9.9	9.8	10.1	277.8	7.0	13.6	10.3	7.2	4.6	31.5	14.9	6.4	7.8	4.1	5.2	3.8	7.2	5.7	17.6	4.7	13.5	22.1	7.2	4.1	5.4	5.0	43.7	14.3	5.2	5.4	1.0	4.6	12.7	5.2	16.1	13.3	10.2	14.2	13.9	2.9	14.1	9.9	19.3	9.8	7.0	19.7	12.0	10.2	32.2	16.6	7.4	15.3	7.7	5.8	9.6	10.4	5.7
PHACTR2	"C6orf56, KIAA0680"	ENSG00000112419	"Phosphatase and actin regulator 2"	O75167	6	143536845-143831185	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 164.2;placenta: 83.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031719, HPA031720, HPA031725"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279"	"unprognostic (3.25e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.99e-4)"	"unprognostic (3.60e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	11.6	25.4	7.0	7.8	9.0	7.6	5.5	4.3	5.7	8.1	164.2	8.5	7.5	9.9	3.6	22.0	5.7	8.4	12.4	10.0	4.9	5.9	7.9	15.7	7.8	12.3	10.3	6.5	4.9	13.1	4.0	83.8	15.1	10.3	8.5	2.7	6.0	6.9	4.5	2.7	6.1	9.8	3.5	13.5	12.0	6.5	16.5	2.7	15.5	7.3	6.7	7.6	6.4	4.5	21.9	13.5	3.6	26.6	3.7	8.0	15.3	18.0	27.2	7.7	9.6	23.9	9.5	1.2	47.5	51.7	5.4	6.5	2.0	17.9	9.1	18.1	8.5	35.5	14.7	14.0	6.1	9.1	10.5	11.2	9.8	7.7	24.9	11.8	47.0	6.7	10.2	0.1	12.4	24.0	1.3	2.1	26.8	7.7	3.8	3.3	26.3	0.2	9.3	19.2	5.2	5.2	20.0	26.1	0.3	13.4	9.8	13.1	82.2	34.9	18.2	15.2	11.8	0.2	0.1	0.3	8.6	9.5	3.2	6.0	3.5	6.7	3.3	2.5	12.3	0.4	4.0	4.4	3.3	0.2	2.4	1.6	1.8	3.5	2.7	3.2	5.5	1.9	7.0	9.0	4.3	5.7	10.0	4.9	12.3	10.3	15.1	3.5	16.5	4.5	160.9	214.7	94.5	41.4	11.7	24.2	16.0	19.5	47.3	37.0	14.2	13.8	71.8	32.9	73.2	22.0	2.1	84.7	27.5	58.9	13.7	30.5	10.1	49.6	43.7	158.6	21.6	32.8	55.2	22.5	49.8	144.8	54.6	64.7	38.7	34.9	157.1	27.6	35.4	101.0	133.8	19.2	24.4	121.1	40.2	23.2	103.2	52.5	24.9	77.8	71.7	10.3	15.5	5.5	20.9	49.4	22.3	120.0	10.6	63.3	20.2	24.8	51.1	3.0	98.6	95.9	83.5	3.1	2.3	33.0	17.2	52.5	51.3	127.9	26.3	30.9
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410660-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	212	"testis: 1216.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.8;U-266/70: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: AB_2686248"	"prognostic favorable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	4.8	2.8	0.6	1.3	0.6	4.1	5.0	0.9	1.3	2.1	0.6	4.3	2.7	1.6	3.3	2.6	2.0	1.1	1.9	0.6	0.7	2.9	4.7	2.4	2.1	0.8	0.8	1.4	4.4	5.7	1.7	2.0	0.8	4.3	4.6	0.6	3.5	1.7	2.3	5.0	4.2	1.4	0.7	3.2	2.5	1216.7	0.7	2.8	2.2	0.9	2.2	2.4	2.3	0.8	2.2	0.6	1.6	6.8	1.1	1.6	2.8	2.1	2.2	1.7	2.1	1.1	0.9	3.6	0.2	1.6	1.0	1.2	1.2	3.4	2.9	4.5	1.6	4.1	0.6	2.5	1.1	4.6	7.5	1.0	3.7	1.6	3.5	0.5	2.5	8.3	2.5	14.8	1.3	1.0	5.4	1.7	0.7	0.7	4.6	2.4	1.5	4.5	1.8	0.9	1.1	1.3	2.0	0.1	1.6	2.0	1.0	2.3	1.8	2.8	1.9	3.0	4.5	17.4	9.0	2.1	1.2	10.4	1.7	0.3	1.1	1.8	0.9	1.2	1.1	3.4	1.0	1.6	0.5	1.8	0.7	1.5	0.2	1.1	0.6	1.1	2.5	0.9	0.6	0.6	0.9	1.3	0.6	0.7	0.8	0.8	0.8	0.7	0.7	0.8	4.3	3.2	4.6	15.7	7.8	4.6	4.8	3.5	13.6	11.2	6.2	5.0	9.7	4.3	1.3	7.3	8.4	3.5	5.8	7.7	13.7	3.6	2630.6	5.3	3.1	6.7	11.5	14.7	10.9	2.8	2.0	5.7	6.1	2.1	7.0	3.7	3.3	4.5	4.2	13.5	12.4	4.2	2.0	4.1	2.3	8698.5	77.0	7.9	8.8	1.9	4.4	8.1	7.2	5.5	16.3	3.7	2.4	63.2	7.6	1.7	12.7	7.3	6.0	15.3	52.6	6.0	4.5	1456.7	71.6	7.6	3.0	0.5	5.5	7.2	10.2	2.2
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	Apoptosis	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473, HPA066948"	Supported		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"CAB012647: , HPA055473: AB_2682827, HPA066948: "	"unprognostic (1.38e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favorable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.3	3.1	2.3	2.3	2.8	7.4	3.3	2.5	4.1	3.6	2.8	3.9	3.0	3.0	0.1	4.0	3.3	1.1	2.9	2.1	2.2	3.1	5.5	2.7	3.2	3.6	2.6	2.8	3.7	0.9	2.8	1.9	3.5	4.3	0.6	0.2	3.2	1.0	6.5	5.5	4.5	0.7	2.5	5.0	4.0	2.4	3.0	3.2	3.8	0.8	1.0	3.2	3.1	4.6	5.4	6.2	2.9	6.2	0.6	2.2	26.6	7.5	2.0	2.7	3.6	5.7	10.2	4.4	2.3	1.1	2.5	7.9	2.1	3.0	0.5	9.0	12.3	3.8	5.0	12.0	6.8	4.3	9.4	8.4	5.3	1.4	0.3	0.5	5.0	10.3	4.5	3.3	1.1	2.6	12.0	7.2	4.0	5.8	4.3	19.4	4.2	8.6	1.1	1.9	5.1	6.8	3.1	8.2	2.0	1.6	6.0	7.3	2.7	3.4	7.6	2.5	4.9	10.5	6.4	8.5	4.4	3.5	5.6	0.0	0.5	0.0	0.4	0.4	0.4	0.3	0.3	0.4	0.8	0.4	0.4	0.4	0.0	0.1	0.4	0.2	0.9	0.4	2.3	2.8	2.5	4.1	2.1	2.2	3.6	2.6	3.5	2.5	3.0	4.6	4.9	3.2	8.8	25.8	7.2	0.0	3.6	0.0	6.2	14.9	7.3	8.1	4.2	5.7	5.6	3.7	10.4	29.2	8.9	12.0	1.9	2.5	1.4	6.7	4.2	3.7	9.0	5.7	12.8	4.6	7.5	4.4	10.7	4.2	1.3	14.0	2.2	10.3	5.5	1.7	14.2	8.1	0.0	3.5	0.0	1.9	7.2	3.8	0.0	7.5	4.1	7.0	2.1	6.6	26.9	3.5	9.9	4.1	6.0	4.4	10.0	3.8	0.0	15.4	0.0	5.7	3.5	25.2	20.8	6.7	0.0	9.7	6.3	7.5	10.5	3.6
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1"	ENSG00000258724	"PIN2 (TERF1) interacting telomerase inhibitor 1"		8	10725399-10839847	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"cervix: 2.9;vagina: 5.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"									HPA009065	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"									"unprognostic (2.57e-1)"					"unprognostic (6.34e-2)"				0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.9	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.2	6.7	12.4	10.4	26.6	20.7	12.0	14.2	5.6	0.0	0.0	0.0	8.6	8.2	3.7	12.5	0.0	4.0	6.9	11.7	0.0	37.0	0.0	0.0	7.3	8.4	6.9	25.0	0.0	0.0	5.3	7.7	0.0	14.0	0.0	12.5	7.0	0.0	3.3	22.4	5.0	8.2	5.4	10.3	32.7	9.3	3.9	7.2	13.1	3.3	9.0	7.2	17.6	15.3	0.0	5.3	6.4	14.0	20.2	6.5	13.3	7.0	22.1	0.0	12.5	5.5	21.5	22.7	12.0	28.6	0.0	8.3	0.0	9.6	8.9
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"	"Cataract, Deafness, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 80.7"					"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.27e-5)"	34.1	13.7	6.7	12.2	6.3	18.7	16.0	14.3	9.8	7.4	7.5	8.9	8.8	10.1	4.8	7.3	10.8	7.1	7.3	6.1	7.5	18.9	6.3	14.7	8.4	7.0	6.0	7.6	9.2	5.0	12.6	19.9	6.8	9.0	2.0	3.5	7.5	5.3	5.3	7.8	7.8	3.2	3.8	18.0	8.2	20.3	7.2	3.8	11.5	3.2	4.3	7.3	7.1	5.1	21.7	19.7	5.8	5.8	17.3	6.6	13.2	17.4	13.6	11.9	12.9	28.6	6.6	12.9	18.0	8.8	15.8	24.0	7.9	15.5	1.9	14.4	16.9	13.5	12.8	23.7	35.9	28.7	34.2	12.4	8.5	21.2	9.1	4.9	10.6	9.0	40.3	7.6	6.9	80.7	12.5	12.4	5.7	14.2	8.1	17.4	6.5	13.0	7.6	18.9	14.2	8.4	10.1	31.8	11.0	4.7	26.5	15.5	21.0	14.9	17.7	9.6	16.3	8.9	13.3	16.2	14.2	19.0	12.1	24.1	21.7	16.1	10.6	15.8	10.3	11.9	7.7	9.0	18.3	11.9	10.3	8.6	47.0	10.4	8.7	8.9	8.2	13.8	6.7	6.3	14.3	9.8	6.1	7.5	7.0	6.0	6.8	3.8	7.2	5.1	11.1	16.0	15.6	17.3	12.4	25.6	34.7	31.5	38.7	26.0	18.6	12.6	55.5	12.8	31.1	42.3	20.9	223.5	12.9	12.0	11.7	33.2	60.0	36.2	17.9	19.6	20.9	32.4	40.3	16.8	25.9	13.6	17.3	87.3	18.3	13.2	8.9	7.5	36.4	18.5	35.5	12.9	22.4	36.4	12.7	81.9	9.6	19.8	3.6	9.4	27.1	11.8	24.7	16.1	19.9	15.9	8.4	7.2	11.4	52.1	12.3	13.9	10.9	25.8	19.7	4.9	11.1	25.0	17.9	27.7	21.3	245.0	11.8	8.3	14.2	43.5
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134807-31140508	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 5.9;esophagus: 13.8;skin 1: 15.4;vagina: 7.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 7.5;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 15.1;AN3-CA: 15.3;NTERA-2: 7.8;SCLC-21H: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021016	Uncertain		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.8	0.2	5.9	0.7	0.1	0.3	0.0	0.0	13.8	0.0	0.0	0.0	0.4	0.1	0.5	0.0	2.5	0.0	1.6	0.1	0.0	0.0	1.0	0.1	0.0	1.7	0.3	0.0	0.0	1.8	0.3	0.2	15.4	0.2	0.0	0.1	0.0	0.6	0.5	0.1	0.1	0.6	0.0	1.7	0.0	7.1	0.2	0.0	0.0	15.1	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.1	1.6	0.1	1.7	0.1	0.1	0.2	0.0	0.0	3.6	1.6	0.0	1.3	0.2	0.2	0.0	0.0	7.5	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	17.8	0.0	0.0	0.0	0.0	0.4
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917496	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.8;urinary bladder: 128.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.0;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	647000	88000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	57.6	4.8	2.5	41.7	2.7	36.2	17.6	2.7	8.9	9.3	4.4	13.1	11.9	22.0	16.7	14.4	10.3	28.5	23.1	2.4	2.9	103.8	5.0	22.0	14.3	3.8	2.9	2.3	10.1	8.3	2.9	36.5	5.4	9.1	18.2	0.3	17.3	13.7	10.8	25.5	13.7	23.4	3.3	40.6	15.7	3.7	4.7	5.9	17.9	18.9	7.2	128.5	16.2	4.7	171.1	88.9	36.8	1.7	3.1	59.5	2.0	101.9	461.6	40.0	62.2	2.3	856.0	0.1	184.0	14.5	416.9	114.1	0.9	165.8	44.8	9.9	0.0	0.1	4.4	1.7	72.6	15.6	32.3	158.7	20.2	271.4	103.7	447.0	114.7	1.0	1.1	0.9	822.4	0.2	0.2	22.7	10.8	0.3	244.5	0.4	112.6	0.9	3100.7	130.6	0.1	0.2	0.3	4.0	2.4	25.4	1.2	22.9	300.6	3.5	20.3	21.6	869.8	0.2	1.3	1.6	216.0	25.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.1	2.5	2.7	2.7	8.9	2.4	2.9	3.8	2.9	5.4	3.3	4.7	4.7	29.0	3.2	4.6	0.3	1.4	37.3	635.9	237.3	19.9	0.0	3.0	24.4	2.5	0.0	103.6	29.5	0.0	28.0	1.6	0.6	68.4	62.7	0.5	50.7	22.2	46.4	3.5	0.0	0.2	21.3	21.7	69.7	0.0	68.9	31.1	0.1	3.9	0.0	39.8	0.0	0.3	0.1	140.4	4.0	33.1	1.3	2.5	53.4	7.2	4.7	23.8	0.0	0.0	0.5	0.2	613.9	0.3	0.0	0.5	695.0	0.0	1.4	35.4	0.0	6.6	27.6	65.2	0.0	0.2	60.6	29.5	17.5	4.7	0.6	1.7	869.6
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251530-64269150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 113.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		210000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	12.8	19.1	6.8	9.7	7.3	7.4	11.2	8.2	8.0	19.7	7.0	22.8	113.8	17.8	3.6	35.3	16.5	7.1	11.5	6.5	7.3	11.7	6.4	15.6	4.4	9.2	7.6	15.8	8.6	10.0	5.8	10.3	8.1	13.1	12.5	1.4	13.5	10.4	6.7	20.3	101.6	11.4	7.7	14.5	14.7	9.5	9.2	3.9	10.3	4.2	5.3	13.8	18.8	7.7	45.2	24.9	24.0	36.0	24.6	18.9	23.8	35.3	26.4	29.5	17.9	22.1	33.5	3.2	20.8	44.4	25.4	75.9	27.2	33.0	10.1	21.8	15.1	35.1	54.9	16.7	17.0	8.6	22.3	16.0	21.5	32.1	23.6	32.2	43.5	13.4	17.6	3.8	37.9	54.5	10.9	17.9	38.8	56.9	26.9	23.5	54.0	13.3	18.2	46.8	6.4	26.4	52.0	64.4	25.2	14.8	33.9	16.4	76.4	27.1	32.0	62.7	23.2	4.6	2.4	3.6	44.8	19.9	25.5	0.0	0.4	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.4	0.0	0.1	0.1	0.2	0.1	0.4	1.2	0.0	0.1	6.8	7.3	8.2	8.0	6.5	7.3	9.2	7.6	8.1	7.7	9.2	7.7	11.2	3.2	7.9	7.5	1.8	13.0	6.0	6.4	6.2	1.2	6.1	4.6	3.3	8.6	6.3	16.5	0.0	9.2	8.3	52.3	1.9	7.8	1.3	3.5	8.7	13.2	2.4	7.8	0.6	7.7	19.1	7.6	28.5	7.1	5.7	20.2	18.2	3.4	9.8	3.3	0.9	46.2	12.2	10.1	13.5	1.4	9.9	8.8	8.8	8.4	22.1	4.7	2.1	1.5	0.6	17.3	23.8	12.4	2.6	7.4	161.7	4.0	2.8	1.1	26.3	6.0	9.8	3.1	8.3	19.4	11.8	14.6	2.7	6.8	65.5	8.3
PLEKHA8	"FAPP2, MGC3358"	ENSG00000106086	"Pleckstrin homology domain containing A8"	Q96JA3	7	30027404-30130483	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072314			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA072314: AB_2686511"	"unprognostic (5.49e-3)"	"unprognostic (8.62e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.07e-2)"	3.6	2.4	3.7	3.2	3.7	1.5	3.6	5.2	4.4	5.0	3.6	4.0	3.7	3.7	4.2	4.1	3.1	3.0	2.8	4.0	3.1	6.1	3.0	3.5	4.3	4.2	3.5	4.1	3.6	4.2	3.2	8.0	3.3	3.6	3.6	11.8	4.0	3.7	2.4	3.9	4.2	3.8	3.2	2.4	3.4	3.5	4.0	2.8	2.8	2.4	4.7	3.8	4.3	4.3	11.4	7.8	34.5	35.3	9.4	7.3	23.2	8.2	6.6	6.3	8.3	14.1	4.9	25.8	10.5	7.4	16.4	8.2	18.2	9.1	8.9	5.0	12.5	15.1	12.8	13.4	7.9	6.9	5.2	3.8	7.3	8.6	12.4	7.8	13.6	12.3	14.3	9.3	9.1	7.2	13.2	4.6	22.7	5.5	8.6	0.0	9.4	18.2	7.1	9.0	4.4	25.2	8.8	28.9	11.5	30.5	10.2	7.0	11.5	5.7	22.8	5.6	9.4	18.9	35.6	15.4	10.8	4.4	12.8	0.3	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.0	0.2	0.1	0.0	0.1	0.0	3.7	3.7	5.2	4.4	4.0	3.1	4.2	3.5	3.3	3.2	4.0	4.3	8.9	3.2	2.6	32.7	6.6	11.2	6.3	2.3	10.8	14.8	7.0	4.7	3.7	1.5	2.8	12.9	25.0	21.6	4.4	7.2	3.9	11.7	2.0	11.4	10.3	5.8	2.4	3.8	36.0	7.1	19.6	6.0	2.6	14.8	4.5	10.0	3.9	4.6	6.7	10.1	30.2	5.0	8.2	3.4	4.6	1.1	3.4	4.7	10.6	14.0	6.5	6.3	10.3	33.7	24.2	10.2	23.9	4.9	15.8	8.7	9.6	12.2	4.4	18.7	6.6	4.9	10.3	14.0	12.4	7.6	12.6	20.2	4.7	4.9	4.8	10.2
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"cervix: 80.5;endometrium 1: 32.2;skin 1: 115.2"	"Cell type enriched"	"Detected in many"	32	"Melanocytes: 1472.7"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	68	"SK-MEL-30: 8590.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Cluster 6: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	3.3	0.8	0.2	0.8	0.2	1.8	8.3	0.7	0.5	80.5	0.3	1.3	1.6	32.2	1.5	0.7	1.2	1.6	0.6	0.3	0.0	2.1	5.0	0.9	5.6	0.0	0.4	4.3	2.3	1.7	0.7	2.8	0.1	0.9	1.2	0.4	3.5	0.8	0.3	115.2	2.1	3.5	0.0	0.5	1.1	4.8	0.0	0.7	1.1	0.2	2.2	1.3	4.0	0.3	14.8	1.1	5.6	0.2	83.6	0.6	126.2	0.9	0.8	1.9	2.0	12.8	6.0	2.6	6.1	0.8	0.3	2.5	0.6	1.0	1.6	3.0	2.1	2.4	2.5	0.7	0.3	1.0	1.4	0.5	1.0	1.2	0.6	1.3	1.0	1.1	0.5	1.8	0.5	2.7	0.4	1.0	17.1	2.8	0.3	1.6	3.5	1.5	1.4	2.7	0.5	2.6	0.3	2.5	8590.9	4.6	4.4	8.8	1.4	0.9	6.5	0.7	7.9	2.1	10.4	3.2	1.0	2.7	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.7	0.5	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.1	45.9	0.8	1.1	2.8	0.0	1.0	0.9	0.4	1.5	2.2	0.0	0.0	12.1	0.0	1.5	0.0	2.1	8.0	0.7	0.2	1.2	0.0	0.8	0.1	2.3	12.4	1.6	1.1	0.5	0.0	11.1	0.0	2.9	1.7	0.0	0.1	1.6	0.0	0.3	14.6	5.3	12.2	0.6	1472.7	1.0	0.6	0.2	0.0	0.0	0.1	1.0	0.6	0.7	1.2	0.5	2.4	2.8	1.0	0.0	0.0	0.2	1.7	3.9	2.6	1.0	10.2	24.9	0.4	1.3	1.6	0.4
PNRC2		ENSG00000189266	"Proline rich nuclear receptor coactivator 2"	Q9NPJ4	1	23956839-23963462	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027820, HPA045837"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA027820: AB_10602147, HPA045837: AB_2679467"	"prognostic favorable (6.02e-4)"	"unprognostic (5.99e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.44e-2)"	"prognostic favorable (4.05e-4)"	82.7	82.5	49.5	80.6	52.1	141.0	78.5	53.4	62.0	69.6	56.1	98.1	99.5	87.4	68.6	62.8	58.3	80.5	75.2	49.6	51.9	99.6	66.8	76.0	137.0	52.6	50.7	79.3	52.2	94.3	34.8	103.3	54.4	70.5	92.2	56.2	55.0	56.9	49.8	46.1	84.2	71.8	50.9	87.5	81.9	33.7	51.9	133.5	122.2	63.6	109.5	100.1	51.4	57.8	107.8	42.0	179.5	124.9	121.5	110.7	68.6	116.7	103.7	132.7	106.1	122.7	132.5	291.7	111.5	74.8	49.9	93.5	121.6	101.8	146.7	208.6	78.7	277.5	131.8	130.2	103.3	272.1	122.3	83.9	125.8	109.2	101.0	86.8	130.3	148.4	239.6	159.5	79.0	87.5	169.4	103.3	243.8	101.7	76.5	189.7	116.7	125.0	134.8	113.8	107.4	93.5	101.0	85.7	123.7	130.9	93.6	168.6	105.3	85.6	82.2	84.6	75.4	133.7	164.8	197.6	58.0	259.0	89.8	230.8	112.7	126.8	103.5	115.0	108.8	129.1	112.5	112.2	109.1	131.1	124.9	106.8	74.2	108.6	112.2	77.4	129.4	178.3	49.5	52.1	53.4	62.0	49.6	51.9	52.6	50.7	54.4	50.9	51.9	57.8	119.0	185.9	109.2	11.4	122.5	13.3	231.7	2.0	99.0	33.6	110.5	109.6	84.8	58.6	62.2	62.5	18.8	129.8	104.7	160.5	238.7	90.5	6.9	86.0	96.1	97.3	100.4	157.0	7.9	127.8	101.4	128.7	66.3	130.9	76.5	84.1	86.7	30.0	68.6	20.2	6.4	109.3	0.0	82.3	10.9	14.2	78.9	109.0	1.8	13.1	81.8	66.9	127.7	6.0	11.8	119.2	157.7	81.3	48.8	187.6	90.3	112.0	56.1	28.7	46.0	104.3	104.5	21.2	24.4	97.8	12.6	141.7	104.0	203.9	110.2	314.0
PODXL2	"endoglycan, PODLX2"	ENSG00000114631	"Podocalyxin like 2"	Q9NZ53	3	127629185-127672802	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6;pituitary gland: 59.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 118.1;SCLC-21H: 167.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024934, HPA042265"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"CAB024934: , HPA042265: AB_2677920"	"unprognostic (2.07e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-3)"	3.8	17.3	45.0	2.7	39.9	1.8	8.8	34.1	50.9	2.9	1.9	9.4	7.2	4.4	2.3	4.2	4.3	4.5	4.1	42.3	65.6	7.2	1.6	2.0	2.2	49.2	50.9	11.2	13.5	5.3	59.0	1.0	54.6	13.1	8.2	21.6	24.9	2.0	3.2	7.6	6.7	1.8	32.9	2.0	14.1	30.8	53.6	1.9	5.5	1.8	2.7	3.1	2.8	40.5	0.3	13.8	37.5	89.2	0.0	0.0	55.2	4.3	0.2	7.9	1.6	28.7	1.5	34.0	33.3	0.6	12.1	0.2	30.9	0.0	0.7	0.2	63.3	0.7	30.9	29.3	1.2	78.1	75.7	1.5	6.6	0.2	0.0	20.9	2.2	0.2	45.6	0.2	2.9	17.6	0.3	0.3	56.2	7.9	66.6	0.2	1.0	118.1	10.9	3.9	167.0	94.0	40.9	86.3	77.2	3.7	22.0	39.2	0.4	0.2	17.2	1.5	27.3	0.2	0.0	26.9	0.9	50.1	25.1	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.6	0.5	0.1	45.0	39.9	34.1	50.9	42.3	65.6	49.2	50.9	54.6	32.9	53.6	40.5	1.6	0.0	1.1	10.4	3.4	5.5	3.7	1.3	9.1	96.3	17.5	18.4	0.5	4.3	1.7	9.2	31.3	2.2	4.4	14.3	1.9	6.8	73.5	8.7	2.5	2.2	63.5	5.5	21.3	20.1	5.9	8.2	25.0	12.3	1.3	9.5	0.7	0.7	1.3	82.4	57.7	23.2	4.1	1.3	2.8	153.1	8.7	1.6	21.4	5.6	8.1	19.0	6.2	29.1	12.5	12.9	16.7	5.7	10.4	9.9	10.8	2.9	1.7	49.9	6.6	3.8	9.8	20.4	80.4	10.0	5.5	1.5	3.3	7.5	21.8	3.1
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
POLR1D	"AC19, MGC9850, RPA16, RPA9, RPAC2, RPO1-3"	ENSG00000186184	"RNA polymerase I and III subunit D"	"P0DPB5, P0DPB6"	13	27620742-27744237	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 819.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039337	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Golgi apparatus"		"HPA039337: AB_10672961"	"unprognostic (1.33e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	72.1	124.8	56.0	57.4	58.5	150.8	90.6	77.5	75.5	102.5	67.2	98.7	86.2	67.5	78.1	142.3	75.7	55.8	90.7	58.4	57.3	84.4	81.2	76.5	90.8	53.4	54.7	118.7	267.3	54.2	69.3	62.3	54.9	88.6	87.4	58.5	112.5	65.7	119.9	143.4	86.6	66.4	52.7	75.6	132.9	76.0	55.3	117.5	62.2	85.0	87.3	91.7	111.7	56.3	103.2	94.8	106.8	110.5	121.6	213.4	143.4	99.2	171.2	129.2	127.7	155.0	203.9	331.3	73.2	113.9	215.7	155.4	200.4	319.8	152.3	102.5	119.0	236.0	97.4	262.9	181.4	215.7	178.0	195.5	330.2	106.0	194.6	143.9	180.9	187.9	132.3	56.6	126.8	106.7	213.2	257.7	259.1	320.2	100.4	144.0	182.6	151.1	204.7	157.2	182.2	142.3	67.3	132.0	381.4	133.9	81.3	198.6	124.9	56.5	90.1	97.9	110.3	92.2	113.1	188.4	49.5	152.3	112.9	80.0	115.9	56.3	71.0	124.4	94.5	83.9	114.9	91.8	130.9	83.8	121.8	98.4	42.0	88.8	113.5	95.9	179.0	83.8	56.0	58.5	77.5	75.5	58.4	57.3	53.4	54.7	54.9	52.7	55.3	56.3	122.5	89.8	108.8	13.7	147.4	336.6	303.0	247.7	385.3	56.6	171.4	241.4	73.5	118.7	123.8	29.5	16.7	155.0	133.9	104.5	74.3	137.2	464.1	100.9	98.4	111.8	124.4	182.4	30.0	309.2	273.2	100.5	126.4	106.3	95.7	125.8	112.5	81.2	165.7	45.4	22.2	203.5	65.1	205.2	148.2	819.5	116.5	142.5	80.0	19.7	260.9	56.5	151.4	13.6	22.3	232.1	124.6	79.0	105.9	256.2	210.1	152.1	58.5	44.0	78.9	105.2	164.4	268.0	81.9	307.8	317.0	145.8	148.5	179.8	197.2	345.7
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 207.2;stomach 1: 174.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000		"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	71.4	5.2	4.5	23.8	0.1	0.3	84.0	0.0	4.4	20.3	2.9	61.3	5.1	53.2	13.0	20.5	83.5	64.3	83.2	3.0	0.0	28.1	13.0	45.1	12.8	0.9	0.0	3.6	2.2	21.6	2.4	60.9	2.0	16.1	84.9	0.0	17.7	44.8	10.6	207.2	15.0	66.6	0.0	1.1	174.6	3.4	0.1	5.8	19.1	29.9	3.9	91.4	10.7	0.4	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	4.4	3.0	0.0	0.9	0.0	2.0	0.0	0.1	0.4	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 337.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	26.0	30.5	21.9	34.9	23.2	51.9	33.2	23.4	26.6	27.7	22.1	29.0	23.2	31.0	31.9	28.2	28.3	28.6	35.7	23.3	22.9	30.1	30.5	28.0	58.4	17.7	19.7	34.1	19.2	25.9	22.9	29.8	20.4	26.0	31.7	25.8	25.9	28.3	34.1	25.9	28.8	33.9	18.9	36.2	25.7	56.1	23.5	52.8	27.4	31.2	59.1	37.0	22.4	23.3	60.7	54.7	63.5	53.4	56.0	61.3	55.8	68.3	79.1	71.8	59.1	89.1	74.3	99.0	86.4	74.6	33.9	53.6	66.2	72.4	87.6	87.3	68.9	159.5	53.8	81.9	58.8	190.4	88.0	74.4	71.9	57.5	54.6	80.3	89.5	87.3	79.2	76.0	78.9	46.3	107.8	111.7	55.0	166.0	54.2	90.4	73.7	93.3	111.7	50.7	44.7	66.0	61.1	48.7	60.1	60.7	75.1	90.7	63.1	41.5	74.5	39.9	60.7	87.4	129.9	163.3	69.8	337.5	27.7	51.7	23.9	44.1	32.7	26.7	39.4	44.3	41.9	44.5	43.8	35.8	37.9	38.1	14.9	44.6	25.9	41.5	61.5	22.6	21.9	23.2	23.4	26.6	23.3	22.9	17.7	19.7	20.4	18.9	23.5	23.3	28.9	41.7	51.8	46.0	78.4	75.8	68.1	116.9	44.9	60.2	30.8	31.0	32.5	40.0	70.7	42.3	29.2	88.1	77.4	31.8	37.2	62.3	243.3	47.5	56.1	48.1	33.6	58.5	128.7	68.3	75.4	47.0	24.5	60.7	57.0	238.1	36.0	35.5	52.9	37.0	93.2	35.8	71.2	40.6	65.4	76.7	58.4	49.1	64.0	49.6	92.9	46.3	72.1	64.3	85.0	71.4	42.1	52.3	63.4	46.4	45.8	55.6	58.6	60.5	52.6	44.6	47.9	120.3	58.8	50.3	59.1	44.2	81.8	84.0	42.4	50.7
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40072710-40097260	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1082.7;THP-1: 1449.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		240000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	69.8	59.4	92.9	92.7	95.6	117.5	95.7	100.4	135.9	70.1	106.1	50.5	32.1	72.7	60.1	45.1	55.4	57.1	45.3	93.6	101.2	75.8	54.1	128.5	93.9	97.0	96.7	68.6	42.6	79.2	39.0	74.8	99.6	73.4	58.8	89.4	56.8	63.2	21.3	40.3	39.2	95.3	101.6	177.0	45.1	37.6	99.1	78.0	60.0	37.1	75.1	79.1	34.7	113.5	115.6	62.5	93.7	81.0	106.5	92.1	209.8	68.4	127.9	153.0	183.3	350.1	270.5	140.1	118.1	65.2	112.2	209.5	154.9	112.7	163.6	186.4	151.4	100.3	127.2	155.5	137.5	233.7	158.9	103.1	107.5	108.7	126.4	79.7	190.9	108.8	167.7	247.0	80.6	168.1	109.8	88.3	258.3	163.9	93.8	116.0	263.7	226.1	89.2	152.0	114.1	96.9	247.9	1082.7	298.6	111.7	199.3	1449.6	85.2	100.7	147.1	70.7	174.9	161.2	383.8	133.9	109.4	408.7	155.5	85.7	1254.3	624.2	122.2	1006.3	137.9	118.8	171.5	131.3	1091.1	118.6	227.0	168.3	683.9	100.3	815.7	101.8	204.1	1586.9	92.9	95.6	100.4	135.9	93.6	101.2	97.0	96.7	99.6	101.6	99.1	113.5	45.2	28.9	47.7	19.9	33.3	39.6	77.1	30.8	34.7	46.6	55.3	37.5	15.7	41.5	40.0	38.6	16.7	51.7	28.9	4.7	5.9	59.0	64.8	13.8	46.4	49.6	19.9	40.1	28.4	42.1	66.5	56.6	14.8	18.2	84.9	34.6	47.5	9.3	251.9	25.2	39.2	8.1	20.3	315.8	328.8	87.6	31.4	271.3	67.6	31.9	227.2	120.3	28.8	27.6	22.7	22.2	6.0	39.5	34.2	42.4	3.2	18.5	32.3	37.0	19.7	30.5	49.3	17.5	33.0	19.1	27.3	41.2	43.5	39.4	11.4	35.6
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 182.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"	21.7	15.2	19.4	19.3	21.2	79.4	21.9	27.5	38.7	27.8	7.6	27.1	13.0	24.2	16.4	21.9	20.9	17.0	19.9	21.5	18.2	14.2	13.1	21.4	27.3	18.5	16.6	34.3	14.9	14.7	16.3	16.7	18.7	24.3	13.8	18.1	21.2	17.6	43.8	27.2	23.6	15.0	12.9	20.2	19.2	18.7	16.9	22.6	24.3	30.0	25.0	27.0	26.8	34.7	15.3	8.5	30.3	11.8	23.5	18.0	14.6	19.5	11.8	13.0	14.5	13.5	16.9	46.4	16.7	18.9	11.0	18.5	22.8	11.4	14.4	28.9	16.3	31.2	10.6	6.4	12.9	10.5	25.8	19.1	19.7	13.8	11.4	12.4	13.0	18.0	28.2	52.0	16.5	7.7	16.9	16.6	9.0	12.1	11.4	23.3	16.4	13.9	7.4	17.0	26.3	17.0	15.7	9.8	21.4	18.0	13.9	16.8	23.2	16.7	18.1	15.3	10.9	75.8	55.4	65.5	14.8	24.1	21.9	4.7	4.9	7.5	5.5	3.2	3.5	18.5	4.4	5.2	3.0	13.4	4.9	4.4	9.9	6.2	6.0	5.6	4.4	2.8	19.4	21.2	27.5	38.7	21.5	18.2	18.5	16.6	18.7	12.9	16.9	34.7	41.3	38.5	39.7	34.3	182.9	62.1	54.8	17.1	61.5	49.5	43.8	33.8	41.3	27.1	33.0	23.9	45.9	25.6	77.7	26.9	17.6	17.3	21.7	84.5	62.5	35.1	37.8	21.7	114.5	13.8	16.2	47.6	25.5	121.2	40.5	50.0	26.0	18.8	16.6	70.7	97.0	24.1	14.2	45.6	39.9	15.6	44.1	42.1	30.2	75.9	41.5	21.2	59.8	70.4	122.5	15.5	25.7	45.1	71.7	54.5	34.2	9.0	43.8	39.7	26.3	86.3	34.4	52.7	49.4	65.4	52.1	18.3	74.4	25.8	19.6	64.5
PRICKLE2	DKFZp686D143	ENSG00000163637	"Prickle planar cell polarity protein 2"	Q7Z3G6	3	64092236-64445476	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.3;Excitatory neurons: 185.5;Inhibitory neurons: 232.4;Microglial cells: 112.4;Oligodendrocyte precursor cells: 103.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1;ASC TERT1: 14.9;HSkMC: 22.1;U-87 MG: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035493			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Vesicles	"HPA035493: AB_10696504"	"unprognostic (2.87e-1)"	"unprognostic (4.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.77e-1)"	20.8	3.0	14.1	3.9	14.9	0.3	8.0	3.4	15.8	16.4	9.1	18.4	2.3	17.3	6.8	7.7	11.7	8.8	5.6	28.5	10.0	3.8	3.1	10.6	0.8	4.4	8.9	8.4	3.8	5.4	5.6	5.6	6.2	7.3	4.6	10.1	4.9	13.8	1.9	4.3	5.9	16.6	6.3	1.4	8.1	1.7	11.7	1.0	6.9	3.9	1.0	12.4	8.8	9.3	0.0	4.7	1.3	0.1	24.1	14.9	0.0	3.5	4.5	2.8	4.2	8.3	0.1	0.0	0.5	3.4	7.6	0.1	0.0	3.2	2.8	3.3	0.1	0.0	0.5	0.1	6.7	0.0	0.0	22.1	4.0	8.2	3.5	8.4	1.7	0.0	0.0	1.8	3.9	4.6	0.0	0.1	3.0	0.0	0.1	0.0	0.2	0.1	4.5	11.7	1.2	0.2	0.0	0.9	0.1	7.7	1.6	0.1	0.1	11.9	5.4	2.9	6.9	3.7	0.0	0.7	15.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.1	14.9	3.4	15.8	28.5	10.0	4.4	8.9	6.2	6.3	11.7	9.3	12.4	0.0	10.9	114.3	1.5	6.2	4.1	7.3	7.4	25.6	4.3	8.4	6.2	1.5	7.3	3.7	64.6	1.4	0.3	1.6	0.0	2.7	15.1	24.7	47.5	9.5	0.0	0.0	185.5	0.4	0.4	20.3	0.0	8.7	0.0	5.2	33.5	1.7	4.1	16.8	232.4	0.6	4.1	1.2	1.8	3.5	9.9	0.6	5.4	112.4	0.0	7.5	1.0	103.5	26.4	0.7	0.3	23.0	0.2	0.9	0.0	6.2	7.6	4.4	13.1	14.6	14.3	2.0	1.0	6.2	3.0	4.9	0.6	6.6	1.1	2.7
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645314-56715335	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;skeletal muscle: 38.7;tongue: 36.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	1.4	1.4	2.0	0.5	3.5	0.0	3.3	3.0	3.5	1.4	4.1	5.0	0.5	1.8	1.1	4.7	2.7	1.9	40.8	3.9	2.1	13.6	0.7	1.4	0.1	0.9	1.3	1.5	1.8	8.3	1.3	0.5	0.9	3.8	1.4	13.5	4.3	2.6	38.7	0.7	1.3	3.1	0.3	1.3	2.2	1.1	1.3	0.4	3.3	36.4	0.1	1.8	1.3	1.5	0.0	3.8	2.1	0.0	0.7	0.5	2.3	1.9	1.5	2.5	4.3	3.9	4.9	0.0	0.6	0.6	7.5	0.1	8.0	0.0	7.1	0.0	8.8	0.0	7.0	5.5	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.8	0.8	2.0	0.0	0.0	1.1	0.1	0.0	0.0	5.6	0.0	5.5	0.0	0.0	0.0	14.1	1.3	2.0	5.5	6.0	0.1	0.0	6.0	3.3	0.0	0.0	1.5	2.3	2.8	6.6	0.0	0.0	0.0	4.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.5	3.0	3.5	3.9	2.1	0.9	1.3	0.9	0.3	1.3	1.5	1.1	9.6	4.8	30.7	2.0	0.9	8.0	6.7	2.2	42.0	19.4	9.5	328.5	24.3	14.3	49.7	50.1	1.0	0.2	6.1	54.8	9.5	3.9	14.4	2.9	10.3	14.4	0.0	109.4	4.8	0.4	15.3	5.1	17.4	2.5	11.7	9.7	8.1	0.1	26.9	119.0	6.3	8.2	0.0	1.6	4.8	6.8	1.4	5.4	18.7	0.0	18.6	0.0	84.9	20.4	6.2	3.0	29.3	0.0	21.2	0.2	82.4	10.7	115.5	6.6	24.5	17.2	7.2	3.7	17.7	0.4	0.4	1.2	5.3	6.1	13.4
PROCA1	MGC39650	ENSG00000167525	"Protein interacting with cyclin A1"	Q8NCQ7	17	28703197-28711854	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 177.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 6882.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.6;NB-4: 6.0;REH: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023648, HPA030218"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Golgi apparatus"	"HPA023648: AB_1855726, HPA030218: AB_10601152"	"unprognostic (5.78e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.26e-3)"	"unprognostic (6.90e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.01e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-2)"	2.4	1.7	3.3	1.4	3.2	1.5	1.9	3.8	4.9	3.9	2.9	2.0	1.1	2.9	0.4	1.5	4.3	0.7	2.3	3.1	3.4	8.2	1.2	2.6	2.2	3.7	3.5	6.1	0.9	0.3	2.9	0.6	3.4	3.5	0.4	1.2	1.7	0.5	0.9	1.5	4.0	0.7	3.3	9.8	2.0	177.5	3.2	1.4	1.8	0.5	0.8	2.2	2.7	3.4	0.6	0.9	1.6	5.6	1.0	1.6	1.6	0.9	0.6	0.7	0.6	0.9	2.0	0.0	0.3	0.8	0.1	0.8	1.7	0.2	0.3	1.1	0.4	2.7	1.7	0.4	0.4	4.5	0.1	0.7	0.3	1.2	0.0	0.7	0.1	0.7	2.6	1.6	0.6	0.2	3.3	6.0	4.4	0.3	0.5	7.1	2.4	0.1	0.6	0.2	0.4	0.7	0.4	0.1	0.5	1.0	2.5	3.9	0.5	0.2	1.0	0.6	0.3	0.7	1.0	1.2	0.4	4.1	0.8	4.9	1.1	3.5	0.5	1.6	0.2	1.9	1.1	0.3	0.6	0.5	0.4	0.8	0.7	0.6	1.2	2.5	0.6	0.5	3.3	3.2	3.8	4.9	3.1	3.4	3.7	3.5	3.4	3.3	3.2	3.4	2.3	0.0	1.1	4.6	2.8	1.0	1.2	1.0	0.6	3.7	1.5	1.9	6.6	1.5	1.9	0.0	4.2	0.8	3.9	0.8	0.0	0.6	1682.9	5.3	2.4	2.7	2.4	3.0	0.8	0.2	1.9	2.7	1.1	2.4	15.2	4.2	4.2	0.2	2.8	3.3	1.1	1.5	2.0	5.3	2.9	6882.6	25.4	6.8	0.0	3.7	2.5	7.9	1.0	2.0	0.9	0.6	0.3	19.5	1.2	0.8	2.0	1.2	3.9	4.4	19.7	1.5	2.4	79.2	21.7	1.1	0.3	0.7	2.6	7.5	1.7	0.7
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444379-32483319	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 308.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		95000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: AB_2685838"	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.9	26.5	25.6	29.4	26.4	34.5	22.6	24.6	29.5	22.8	20.3	27.3	27.2	28.8	23.1	36.3	21.8	22.7	37.0	26.0	25.6	30.1	37.7	24.3	30.2	27.0	25.3	20.6	25.9	35.0	18.5	34.1	28.1	25.0	32.0	23.8	23.3	21.8	96.0	33.8	23.2	35.0	24.4	24.0	22.9	34.2	25.9	38.4	21.6	58.6	39.1	34.0	24.8	31.2	127.0	136.8	98.4	106.2	65.4	48.4	103.8	71.5	90.0	151.9	122.0	139.9	111.5	99.1	110.7	77.0	145.9	143.0	114.5	98.5	147.8	50.9	81.2	81.0	68.7	108.3	63.3	95.5	81.6	43.7	51.0	134.3	91.8	49.0	108.7	87.0	155.5	110.9	90.8	78.0	143.1	57.4	134.5	67.4	68.8	89.2	127.2	132.4	75.2	92.2	86.3	58.8	89.8	63.4	71.0	100.3	154.2	45.1	77.8	84.3	99.5	105.6	166.5	62.2	105.0	129.1	122.5	74.8	145.2	48.3	41.2	26.7	40.2	41.8	44.2	36.3	39.1	40.6	46.6	34.2	34.5	36.4	19.1	47.7	45.6	38.2	51.5	45.6	25.6	26.4	24.6	29.5	26.0	25.6	27.0	25.3	28.1	24.4	25.9	31.2	62.7	48.1	31.5	36.6	56.3	126.9	108.7	116.3	44.9	44.5	47.8	40.8	71.9	41.5	78.0	25.8	31.3	178.2	57.8	87.5	80.3	117.8	205.4	45.8	46.2	69.7	48.8	100.8	36.0	107.3	146.1	63.8	43.8	59.9	45.7	79.8	55.3	107.0	92.3	37.0	36.4	58.7	77.3	48.4	72.6	48.0	49.0	61.1	26.6	15.9	77.5	63.1	40.2	33.2	55.6	117.2	48.0	48.5	79.3	131.9	66.4	120.6	52.6	43.3	52.6	68.0	189.7	152.7	98.4	85.3	117.5	308.9	54.8	52.0	67.6	109.5
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.3;skin 1: 152.5;urinary bladder: 175.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 28.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	12.8	2.9	3.1	10.5	3.2	9.0	6.7	4.2	4.8	5.8	5.5	108.3	10.8	6.1	2.2	67.3	43.2	9.6	12.6	7.4	5.5	9.3	3.0	11.3	4.6	6.5	5.2	2.0	1.8	2.0	4.8	2.2	6.3	21.1	24.2	0.7	4.3	6.1	2.1	152.5	17.7	16.1	6.7	8.0	20.5	0.9	7.0	2.2	3.2	4.0	11.6	175.0	15.9	11.9	0.3	0.5	0.4	0.0	113.7	89.5	0.0	115.2	156.0	1.0	1.1	0.0	0.2	4.2	5.4	19.7	0.3	7.1	0.4	10.5	0.9	0.0	0.2	73.6	0.6	0.0	32.9	5.2	298.4	46.1	1.2	5.7	0.3	0.0	42.3	0.1	0.1	0.3	2.3	0.0	0.2	6.6	1.6	0.0	0.5	0.3	1.4	8.6	14.7	0.0	0.5	0.6	0.6	9.5	0.2	0.5	0.3	8.4	1.0	0.7	0.6	1.7	0.1	0.3	0.2	0.0	0.4	31.6	0.3	28.9	12.1	23.3	0.0	13.1	0.0	2.4	0.0	0.0	20.0	3.5	0.1	0.0	5.2	2.8	10.2	1.4	0.2	21.9	3.1	3.2	4.2	4.8	7.4	5.5	6.5	5.2	6.3	6.7	7.0	11.9	0.9	0.0	6.6	0.0	5.9	9.9	2.6	7.7	0.0	0.1	1.1	1.4	1.6	4.3	2.2	42.3	0.0	0.1	0.2	0.1	0.0	0.6	0.1	109.9	10.4	24.7	1.8	18.7	0.8	0.5	0.3	10.7	2.0	191.9	208.0	0.1	61.8	0.8	26.1	0.0	0.5	0.6	4.1	15.5	20.7	0.3	1.5	55.3	3.6	16.9	11.7	0.0	7.2	1.0	0.1	0.6	0.6	0.0	0.3	2.8	0.0	0.0	0.8	0.1	0.0	1.4	3.6	0.0	0.2	18.2	58.7	0.4	3.4	0.1	1.0	0.8
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase non-receptor type 21"	Q16825	14	88465778-88555007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Syncytiotrophoblasts: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Golgi apparatus"	"CAB011468: AB_442979, HPA073999: AB_2732247"	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favorable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.0	5.4	6.7	4.1	7.2	0.0	9.2	6.4	6.6	11.5	10.1	11.9	6.0	12.0	5.9	10.3	10.1	8.7	21.3	6.2	8.0	7.8	7.7	17.9	2.1	9.7	7.8	17.5	9.4	8.3	4.5	10.3	7.2	9.3	7.6	9.1	7.4	9.5	11.8	29.0	8.2	10.4	7.9	4.0	9.0	20.2	7.4	1.1	18.7	9.8	1.9	10.1	9.8	7.4	5.8	4.6	11.8	4.6	12.3	10.6	12.1	15.2	11.6	8.8	12.2	8.1	10.2	0.0	3.6	19.6	7.9	5.4	1.7	5.4	12.9	0.3	2.7	0.0	5.6	3.4	13.6	0.1	0.2	7.1	10.4	7.4	8.8	11.4	7.2	0.0	1.8	0.2	22.9	4.7	0.0	0.3	3.5	6.2	8.7	0.1	35.3	0.1	7.7	4.1	0.8	13.6	8.7	21.6	5.2	10.0	10.7	2.3	14.5	16.3	12.8	6.7	10.6	0.5	1.9	0.0	6.0	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.2	6.4	6.6	6.2	8.0	9.7	7.8	7.2	7.9	7.4	7.4	7.2	57.7	6.0	14.4	0.0	10.5	6.3	4.0	4.0	7.2	7.1	5.8	34.9	5.7	7.1	7.3	35.5	10.3	0.1	18.1	0.0	5.0	19.1	10.2	11.4	6.0	4.8	8.0	12.8	8.4	5.4	12.0	7.1	7.1	2.5	9.2	6.1	9.7	1.9	1.7	14.4	15.0	8.2	1.3	3.9	5.3	17.1	0.4	0.0	13.1	0.0	4.7	1.0	28.1	20.3	10.7	6.1	27.1	0.0	8.8	6.7	3.5	10.3	9.4	0.0	12.7	10.5	20.2	6.6	3.5	11.9	101.9	0.6	7.4	6.2	4.7
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685799-107713162	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli rim,Golgi apparatus"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli rim"	"Golgi apparatus"	"HPA038708: AB_2676163"	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.65e-4)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"	29.7	20.9	18.6	26.4	19.0	31.9	33.7	18.8	23.6	24.9	29.5	27.7	17.7	30.3	24.8	28.7	24.7	20.4	17.3	18.9	19.1	30.4	32.2	21.4	32.0	17.4	18.0	32.8	25.8	33.0	17.8	29.5	20.0	25.2	26.0	26.9	24.4	27.5	22.9	28.8	21.7	32.3	18.1	23.7	23.1	30.1	18.8	33.2	25.9	17.6	37.4	31.4	24.5	19.0	71.0	86.9	51.8	49.4	70.9	77.2	68.5	72.9	81.9	100.8	84.8	88.5	32.9	108.8	38.4	112.9	68.4	60.7	70.8	77.0	99.2	54.7	80.6	82.9	50.5	103.2	72.7	101.8	56.9	70.2	69.1	93.5	83.0	79.0	119.8	66.0	110.8	29.8	109.1	78.3	71.6	99.3	62.0	64.8	141.2	58.3	61.2	101.4	62.7	98.3	58.4	46.9	59.6	42.4	104.1	64.8	75.3	49.7	94.9	76.7	38.9	63.0	84.1	42.5	62.8	84.9	34.3	55.3	68.7	29.4	20.8	16.2	41.7	27.8	37.8	68.5	40.6	43.9	35.0	64.1	34.5	47.9	6.6	44.2	34.4	47.3	48.6	29.7	18.6	19.0	18.8	23.6	18.9	19.1	17.4	18.0	20.0	18.1	18.8	19.0	44.1	41.7	38.1	13.7	80.1	48.4	52.3	70.6	36.5	50.4	41.0	41.3	22.1	25.8	48.9	27.6	37.5	69.1	48.4	14.6	58.7	69.7	24.4	34.5	47.3	52.0	21.0	52.2	15.6	63.0	74.5	51.6	30.5	35.8	57.6	41.5	43.5	52.0	46.2	33.7	19.0	31.9	26.4	34.3	28.0	11.1	50.4	33.2	30.2	4.7	75.2	41.4	38.1	15.1	16.7	68.0	19.8	44.0	46.0	50.2	24.5	70.8	42.8	46.2	26.3	41.8	50.9	124.3	79.2	41.9	49.7	45.7	44.0	45.8	34.1	40.5
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154869-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 1616.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1918.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		2600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	84.8	84.9	35.8	52.1	39.4	115.5	53.2	42.7	47.3	81.7	41.1	100.1	67.5	75.2	70.2	178.4	82.3	150.3	244.9	41.5	43.4	73.8	81.7	200.0	16.3	50.0	40.7	196.1	136.3	21.0	60.2	158.9	43.2	92.3	80.9	15.2	105.6	57.5	91.2	58.6	85.7	60.0	44.0	61.9	178.3	172.9	42.6	12.1	31.9	46.0	19.6	174.1	108.7	57.7	441.4	62.0	14.8	181.0	179.1	367.8	712.5	456.5	456.6	381.6	267.1	7.3	137.7	6.8	276.7	367.8	52.6	93.7	17.6	123.5	185.0	26.4	28.0	14.1	33.6	19.4	1918.6	48.6	129.2	197.9	55.5	408.0	484.3	499.9	569.4	32.1	20.2	66.3	255.3	76.4	10.4	89.7	49.4	302.6	174.6	19.7	33.0	11.8	63.1	123.6	51.9	52.6	133.8	179.8	91.9	32.2	33.0	226.3	678.3	473.8	187.5	322.0	392.9	48.3	84.4	12.2	180.9	153.9	146.0	16.2	53.1	20.6	14.0	29.9	10.2	5.4	9.1	9.6	39.2	3.2	8.1	8.0	40.2	16.9	28.6	8.0	11.5	28.6	35.8	39.4	42.7	47.3	41.5	43.4	50.0	40.7	43.2	44.0	42.6	57.7	36.6	57.7	101.6	8.5	7.7	13.8	27.4	81.2	7.4	11.5	86.2	47.9	48.3	51.5	112.5	71.7	25.0	19.5	10.7	138.1	0.0	230.4	49.2	49.2	19.4	41.7	46.2	6.9	17.2	130.1	1616.7	78.0	136.6	80.4	25.4	27.1	89.3	4.3	68.6	6.7	17.0	185.7	132.2	45.2	35.3	20.1	177.7	48.9	44.4	8.4	49.7	53.5	10.3	24.6	23.9	249.8	165.6	71.1	12.8	35.7	9.0	9.1	47.8	6.7	32.9	13.6	31.3	30.2	32.7	10.2	9.9	154.3	13.9	13.9	89.9	68.0
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245812	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		9600000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.5	7.6	7.3	11.2	7.6	15.9	5.9	12.9	8.1	7.3	5.9	6.7	5.1	8.3	10.6	5.3	8.6	4.6	7.6	7.3	7.6	7.5	8.6	7.0	17.5	7.3	7.6	9.5	18.8	8.1	32.3	4.9	6.9	6.4	5.4	12.3	5.9	3.7	5.6	11.1	11.8	6.7	6.0	15.7	7.1	10.8	8.0	8.1	11.7	3.4	14.6	6.3	5.8	7.3	14.7	35.0	28.6	38.2	15.8	19.0	35.9	18.3	20.4	34.9	31.9	26.4	31.1	22.6	29.5	24.7	64.1	46.7	34.2	26.5	28.0	33.5	17.2	12.1	59.8	29.3	22.5	36.4	17.8	15.3	26.3	34.8	41.8	15.4	25.9	23.3	29.8	59.1	18.8	25.0	13.6	24.2	34.0	44.2	22.3	24.8	37.1	37.2	12.0	13.1	30.5	23.1	28.9	22.6	15.9	18.5	16.3	21.1	15.0	42.2	30.4	35.1	42.6	20.9	29.9	49.7	28.3	18.9	40.5	0.4	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	7.3	7.6	12.9	8.1	7.3	7.6	7.3	7.6	6.9	6.0	8.0	7.3	8.8	9.6	7.9	13.7	17.7	5.7	2.8	2.2	1.8	24.4	2.3	2.9	4.3	0.0	4.4	5.5	18.8	1.3	5.8	1.6	1.9	3.4	6.7	5.7	7.4	6.6	16.3	14.5	10.1	4.0	2.8	5.2	4.1	5.6	1.3	7.1	2.9	4.4	2.3	5.0	11.1	3.8	0.0	3.7	8.2	7.3	5.9	3.3	0.0	8.4	4.3	2.6	4.1	6.0	10.7	3.4	0.7	7.2	5.4	7.9	0.9	2.3	9.0	8.8	6.6	9.2	4.7	19.4	24.2	1.8	11.5	1.0	5.1	7.3	3.9	3.6
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268590-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: AB_2683051"	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	127.1	129.7	121.7	84.0	117.4	91.1	120.9	117.7	137.7	113.7	106.2	129.3	112.5	111.2	82.3	180.9	105.7	83.0	146.7	117.5	116.8	127.2	126.4	116.5	90.3	122.7	121.0	103.5	96.1	132.9	112.6	88.4	119.3	140.6	90.3	46.5	128.0	105.1	233.2	147.6	112.9	86.9	119.3	125.3	125.5	79.9	124.2	105.5	111.5	152.8	86.1	113.6	119.2	118.9	226.5	248.0	126.2	166.1	205.6	150.9	113.8	182.7	212.8	232.2	163.4	141.4	223.7	91.7	235.7	263.1	172.1	209.0	140.7	253.9	125.9	190.3	128.0	144.7	156.0	124.2	135.0	124.3	258.2	158.7	212.4	199.6	102.4	163.2	221.1	144.9	153.1	158.8	223.6	434.5	219.1	197.1	131.5	196.1	230.8	133.0	101.8	237.2	234.7	204.5	122.9	137.1	132.7	319.2	133.7	91.4	487.5	141.6	228.1	221.4	152.9	267.9	164.9	89.9	77.9	121.5	251.2	104.3	207.8	173.1	199.8	329.3	227.5	211.9	171.7	109.8	135.5	188.1	163.0	130.2	115.3	140.6	420.5	203.5	243.9	188.3	165.5	375.6	121.7	117.4	117.7	137.7	117.5	116.8	122.7	121.0	119.3	119.3	124.2	118.9	56.3	38.5	59.6	7.8	41.7	33.6	31.4	42.4	53.5	22.0	55.0	53.1	1.1	40.0	47.9	36.8	29.2	56.2	50.8	137.1	50.9	49.3	13.4	41.3	38.6	50.6	54.0	27.1	7.2	71.3	84.2	36.5	58.1	44.9	53.8	24.6	48.9	47.8	54.2	16.8	8.0	85.0	36.7	55.2	26.4	27.2	35.8	51.4	24.9	5.6	47.7	37.8	43.3	5.5	13.1	71.6	80.6	42.2	61.0	41.4	79.6	49.5	36.0	18.2	39.5	36.2	39.7	23.8	17.4	64.5	42.1	80.2	57.4	28.1	64.9	43.5
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561722	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002882, HPA052111, HPA068647"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013"	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.48e-4)"	31.1	55.4	5.7	21.7	5.5	25.3	23.4	5.6	7.9	11.7	9.6	20.7	27.6	6.9	4.8	4.6	11.5	18.0	21.4	5.2	7.0	26.1	51.4	30.7	16.4	7.0	6.0	20.5	24.2	6.2	9.7	22.8	6.8	12.1	14.3	2.6	10.7	5.0	5.8	4.6	25.3	7.6	6.6	44.5	28.6	10.6	7.4	3.9	22.0	2.3	5.1	20.6	6.7	8.4	20.1	2.9	1.9	3.8	12.4	3.3	31.3	1.7	6.2	8.1	12.5	47.9	39.9	0.0	13.9	1.7	10.8	7.5	3.8	12.3	4.2	22.5	3.0	19.8	3.6	22.6	7.8	2.8	5.7	6.9	2.0	4.2	1.2	6.3	3.1	3.3	3.8	0.0	1.8	24.0	0.1	29.0	4.0	60.9	8.5	1.9	0.1	9.0	14.2	26.3	0.5	2.1	3.8	85.7	27.4	6.2	54.4	30.5	2.3	2.0	4.2	0.2	2.7	0.1	0.0	0.2	27.7	38.9	4.2	7.8	35.5	7.1	1.0	33.3	1.3	3.5	2.8	0.9	15.8	2.8	6.5	2.3	26.3	0.0	26.6	0.8	0.9	11.2	5.7	5.5	5.6	7.9	5.2	7.0	7.0	6.0	6.8	6.6	7.4	8.4	18.6	19.2	20.4	4.2	10.6	4.5	10.9	14.1	10.8	0.2	12.8	13.0	5.0	48.6	16.2	25.8	0.0	34.6	1.8	31.1	31.3	60.3	1.6	20.7	2.6	10.3	18.0	0.0	0.4	67.9	91.3	11.5	15.3	23.2	21.0	41.1	53.6	34.5	105.0	0.0	0.4	23.9	28.5	92.1	19.9	1.6	3.7	100.5	7.2	8.4	16.2	7.4	0.0	4.5	0.1	36.4	17.2	6.4	0.4	8.0	48.1	68.9	20.4	2.0	13.1	6.2	26.2	1.0	13.2	1.9	3.0	20.0	3.6	7.2	24.0	11.1
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 221.9;fallopian tube: 206.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 217.1;Club cells: 621.4;Prostatic glandular cells: 312.9;Urothelial cells: 737.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 93.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	10	"CAPAN-2: 1319.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	221.9	21.3	1.0	65.1	1.5	0.6	44.6	1.5	1.7	74.6	11.3	31.7	5.1	25.9	27.0	11.3	206.4	19.7	81.5	1.5	0.8	25.1	4.2	52.7	18.9	0.6	0.4	60.5	10.0	0.2	27.7	3.5	0.4	78.6	36.2	0.9	165.3	37.2	5.6	8.3	38.5	51.2	0.4	2.7	23.7	4.5	1.0	1.8	20.4	2.8	6.2	92.1	32.2	1.4	19.2	6.9	0.2	1.0	4.0	12.6	0.3	1.8	5.7	1.0	1.4	1.4	1319.3	0.0	1.2	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.1	12.0	0.0	0.0	131.3	0.0	0.5	0.0	8.9	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.7	5.8	0.0	0.0	0.0	0.1	0.3	22.9	0.5	1.7	16.7	1.3	0.3	0.0	1.9	2.3	1.3	1.1	0.0	4.6	0.0	0.0	0.0	0.0	1.5	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	1.5	1.5	1.7	1.5	0.8	0.6	0.4	0.4	0.4	1.0	1.4	5.2	0.0	0.6	2.3	0.9	0.5	217.1	92.7	11.4	0.4	99.7	35.6	0.9	11.5	621.4	14.7	0.0	2.9	1.6	59.0	0.0	10.5	29.5	14.4	98.4	18.1	37.5	3.6	14.2	4.7	0.8	101.3	1.1	16.9	29.9	0.3	31.8	6.0	10.8	0.0	10.6	102.3	40.7	1.6	1.7	33.1	10.8	11.0	5.4	1.9	0.0	4.2	0.0	4.5	7.6	2.3	106.1	1.2	1.2	312.9	140.7	19.7	149.3	0.7	0.0	7.7	46.7	3.8	0.7	7.8	0.4	11.4	3.3	0.1	88.3	737.7
RASGRP3	"CalDAG-GEFIII, GRP3, KIAA0846"	ENSG00000152689	"RAS guanyl releasing protein 3"	Q8IV61	2	33436324-33564750	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;skeletal muscle: 42.0"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 186.5;Plasma cells: 64.8;Urothelial cells: 106.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 13.9;memory B-cell: 12.3;naive B-cell: 15.2"	"Group enriched"	"Detected in many"	16	"B-cells: 15.2;granulocytes: 13.9"	"Group enriched"	"Detected in many"	7	"Daudi: 88.7;HEL: 92.0;U-266/70: 143.5;U-266/84: 59.1;U-698: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058937			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA058937: AB_2683858"	"unprognostic (2.64e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.82e-2)"	7.8	2.9	17.7	15.1	35.2	4.8	5.3	29.8	21.6	3.7	10.2	4.7	7.3	2.5	1.1	2.4	2.5	6.5	34.2	15.1	20.2	6.5	5.5	7.7	27.9	37.4	27.1	1.0	3.4	6.8	2.4	11.0	34.6	1.6	6.6	1.0	6.1	2.0	42.0	1.8	4.7	4.7	25.0	14.8	7.4	0.9	30.7	4.2	6.7	17.6	33.6	6.7	1.2	56.4	0.1	0.0	0.0	0.0	0.0	0.5	0.2	1.2	0.7	4.3	12.4	2.3	0.5	88.7	0.4	0.7	1.0	0.1	0.0	0.0	1.1	9.0	0.8	92.0	0.6	0.0	1.3	0.4	12.4	0.1	0.0	0.1	0.2	1.8	5.3	0.8	0.3	4.8	2.0	0.0	0.7	7.2	0.4	0.5	0.1	0.2	4.1	0.1	1.0	5.3	0.6	0.0	0.0	0.3	4.6	0.1	0.1	0.4	1.7	0.3	0.3	0.4	0.8	143.5	59.1	38.7	0.2	0.4	0.3	13.9	0.0	0.0	0.3	0.0	0.4	12.3	0.6	0.6	0.3	15.2	0.9	0.2	0.0	0.3	0.1	0.0	0.8	1.1	17.7	35.2	29.8	21.6	15.1	20.2	37.4	27.1	34.6	25.0	30.7	56.4	41.4	0.0	5.8	2.0	46.7	5.4	31.2	0.9	0.0	1.6	4.8	2.8	50.8	1.5	3.7	5.5	0.0	0.5	3.6	1.1	11.7	21.1	1.6	10.0	3.9	57.9	0.0	7.4	4.9	54.6	1.3	4.4	3.6	31.0	17.8	2.4	60.7	6.0	44.5	0.0	3.5	0.0	2.0	9.4	26.1	0.8	0.9	29.1	40.9	34.7	13.8	0.2	0.0	2.5	186.5	44.8	0.1	1.9	64.8	37.0	0.2	14.3	3.9	1.3	0.0	5.5	4.1	1.4	2.1	0.4	3.7	0.5	8.1	3.8	0.4	106.4
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.6;stomach 1: 34.9"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 120.3;Gastric mucus-secreting cells: 171.8;Ionocytes: 103.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 2.7"	"Lineage enriched"	"Detected in single"	13	"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.0;hTERT-HME1: 21.5;RPTEC TERT1: 23.5;RT4: 70.2;U-266/70: 20.2;U-698: 61.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.2	0.1	0.0	4.9	0.0	0.1	8.4	0.0	0.2	2.3	5.0	11.9	9.8	0.5	2.8	1.9	2.7	4.4	0.0	0.1	0.2	6.0	2.2	1.3	5.7	0.0	0.8	1.3	16.6	0.7	0.4	7.4	0.0	5.7	12.7	1.6	3.5	3.7	0.0	5.3	12.3	0.3	0.0	0.2	34.9	0.1	0.7	30.6	5.7	0.4	6.9	9.2	1.8	0.1	0.3	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.2	12.0	76.0	1.1	0.0	0.3	3.8	0.0	6.0	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	5.8	0.0	21.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	11.1	0.2	0.0	0.1	0.5	23.5	70.2	2.8	0.0	0.2	1.8	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	20.2	0.1	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.0	0.7	0.1	0.3	12.8	5.1	0.0	25.0	9.8	38.5	70.5	18.8	0.1	25.1	42.2	1.2	21.5	37.7	7.3	0.0	55.7	0.1	81.1	17.6	18.2	0.3	45.4	2.0	0.8	120.3	0.4	0.3	80.9	23.0	1.7	171.8	22.8	1.3	2.2	0.4	4.0	4.4	0.0	0.1	57.9	103.7	0.3	1.0	0.0	0.0	1.2	1.8	0.0	0.6	18.7	0.0	0.0	0.3	67.1	65.8	0.0	21.3	24.6	30.1	37.8	29.8	0.5	0.0	0.0	1.6	0.0	0.2	11.9	1.4	47.2	3.5	0.7	23.2	60.5
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 443.5;liver: 324.2"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	6.4	11.7	0.0	15.0	0.1	1.6	5.1	0.3	0.3	11.2	0.2	8.5	4.6	8.6	3.2	3.8	8.1	5.9	1.4	0.0	0.0	443.5	324.2	3.8	31.2	0.5	0.3	4.9	5.2	1.3	6.2	0.3	0.3	10.0	4.9	0.8	3.7	5.0	0.7	2.4	20.6	5.4	0.0	97.1	5.2	2.2	0.2	14.2	7.9	0.0	21.4	7.4	4.6	0.0	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.3	0.3	0.0	0.2	0.0	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
RCBTB2	CHC1L	ENSG00000136161	"RCC1 and BTB domain containing protein 2"	O95199	13	48488963-48533256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	9	"MOLT-4: 278.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040242	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040242: AB_10795362"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.98e-1)"	12.9	11.1	10.0	12.9	11.2	5.2	10.8	11.1	13.9	15.6	17.4	8.9	5.3	15.0	12.3	13.0	12.9	12.3	12.5	9.5	13.2	16.6	9.5	10.5	11.3	11.9	11.7	19.9	6.8	6.6	13.4	17.7	12.5	13.5	8.0	8.3	23.3	19.9	7.0	5.4	7.2	13.7	13.0	17.4	8.8	7.1	10.8	11.8	27.5	10.8	10.7	11.5	12.4	14.4	1.5	1.2	22.0	1.4	17.1	15.1	0.0	6.8	8.4	4.0	3.0	0.8	1.4	4.7	5.0	10.7	2.7	3.1	3.2	2.8	4.6	5.7	4.3	12.2	3.2	1.2	6.6	5.6	7.4	15.6	6.5	5.3	2.6	9.2	12.3	29.8	0.9	7.1	14.6	0.5	278.7	15.6	12.3	0.5	3.7	23.9	2.2	20.3	7.5	3.7	5.1	4.3	5.3	1.1	8.7	9.1	0.5	14.2	10.3	4.6	2.0	1.2	2.7	0.3	0.4	5.7	2.7	12.5	9.1	4.6	39.8	4.6	14.0	28.8	8.7	1.1	11.4	14.2	27.1	1.1	6.6	10.2	55.0	15.5	27.9	0.5	15.5	20.5	10.0	11.2	11.1	13.9	9.5	13.2	11.9	11.7	12.5	13.0	10.8	14.4	23.1	3.2	3.3	9.1	5.5	6.1	11.6	9.5	21.1	1.9	4.9	9.3	16.1	4.3	9.8	5.5	2.1	1.4	20.7	1.3	7.9	1.2	9.0	5.1	6.6	19.7	8.3	6.1	12.3	0.8	1.4	11.6	2.6	5.0	8.8	9.9	24.7	5.2	25.0	1.7	17.0	2.2	2.0	26.6	24.4	8.1	9.3	30.6	8.8	66.5	38.3	33.7	24.7	6.6	13.2	1.3	1.6	14.3	17.4	6.0	0.7	11.2	6.9	4.9	13.1	14.9	14.1	9.6	4.4	12.6	5.7	1.0	24.0	11.9	2.4	6.7
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471381-103989658	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 64.4"	"Group enriched"	"Detected in some"	8	"Hepatic stellate cells: 128.5;Inhibitory neurons: 372.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	10	"cerebellum: 64.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.2;PC-3: 8.6;SCLC-21H: 11.1;SH-SY5Y: 13.7;TIME: 33.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 110.0"	HPA077891			Approved	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA		30000000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Vesicles	"HPA077891: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	1.3	1.8	2.0	0.6	1.8	0.0	2.7	64.4	3.8	1.5	0.6	0.8	0.2	0.4	0.1	0.8	2.8	0.7	1.7	3.3	6.4	0.4	13.4	0.5	0.4	2.6	4.2	0.4	0.1	0.0	0.5	0.0	6.3	0.6	0.9	2.9	0.8	0.9	0.2	0.6	0.9	0.7	3.9	0.3	0.5	0.7	0.5	0.0	1.7	1.1	0.2	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	2.1	0.0	0.1	0.0	0.0	4.3	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.0	11.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.8	64.4	3.8	3.3	6.4	2.6	4.2	6.3	3.9	0.5	0.5	1.0	0.0	0.0	9.1	0.5	0.6	0.0	0.0	0.6	30.2	0.5	0.4	5.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	13.6	0.1	0.0	8.3	0.0	7.0	2.6	1.2	0.1	7.5	0.0	0.1	0.0	0.0	128.5	3.3	0.2	0.0	372.4	0.0	0.0	5.3	2.2	6.1	0.0	0.1	0.0	2.8	0.0	0.2	0.0	3.0	10.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.8	0.7	0.1	0.8	0.0	0.6	0.3	0.4	0.0	0.0	0.0
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favorable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	12.2	9.5	10.6	13.4	10.9	27.4	15.5	11.4	11.5	12.6	11.1	13.4	9.0	9.6	8.4	18.6	10.1	8.6	10.1	10.5	10.9	14.7	21.2	11.3	23.5	11.7	11.3	11.3	13.3	11.8	7.9	18.4	11.4	11.5	15.0	8.8	12.2	7.6	18.8	20.3	11.2	12.6	11.5	14.2	13.6	10.0	10.7	20.2	9.2	12.2	30.8	11.5	12.6	11.8	74.3	55.6	65.2	64.6	13.1	15.2	29.4	42.5	46.7	85.2	101.4	62.6	67.3	69.2	11.5	30.7	78.7	49.7	53.3	69.2	87.5	49.6	91.5	42.9	76.4	46.7	10.1	64.6	25.3	15.4	15.9	79.8	55.0	18.5	46.0	63.9	89.4	41.9	66.4	87.2	65.1	124.7	74.1	116.3	47.4	95.0	72.0	85.8	45.7	58.1	52.4	65.5	50.7	94.8	34.7	79.2	68.7	58.0	17.4	83.4	54.9	64.6	96.3	25.1	35.1	120.6	42.4	98.4	89.3	33.4	36.7	27.3	18.0	42.3	18.1	31.6	15.5	16.5	31.9	36.8	19.5	14.3	46.4	42.9	40.1	17.1	23.9	29.1	10.6	10.9	11.4	11.5	10.5	10.9	11.7	11.3	11.4	11.5	10.7	11.8	15.4	12.8	11.1	2.6	19.0	23.8	24.3	24.3	19.9	13.2	12.6	17.4	6.1	5.7	16.5	5.5	2.1	68.6	17.5	12.4	5.9	21.0	2.8	8.1	13.3	13.5	4.8	38.3	3.0	19.0	65.0	17.4	10.7	11.5	23.4	25.1	13.6	14.0	37.7	3.3	2.6	13.1	20.3	14.4	28.2	2.5	8.7	18.2	21.4	1.9	26.3	16.1	23.7	1.5	2.2	13.8	6.9	10.9	17.5	11.0	13.2	13.8	8.8	9.5	6.6	14.6	17.5	33.8	44.6	20.1	17.0	46.1	16.9	12.9	19.1	15.3
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 94.7"	"Cell type enriched"	"Detected in some"	22	"Pancreatic endocrine cells: 113.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	3.4	1.1	3.2	2.2	3.8	0.0	1.8	5.7	3.2	10.2	5.4	15.2	13.9	1.7	0.4	0.6	2.9	0.6	0.7	2.7	3.4	2.4	0.1	1.2	0.2	19.1	4.2	2.9	0.3	0.3	2.1	0.6	19.4	4.3	10.4	0.3	2.2	0.3	5.5	1.3	15.2	0.5	3.9	0.1	94.7	0.2	3.7	0.2	0.1	3.2	0.1	0.5	1.3	3.4	0.0	0.0	2.7	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.4	1.8	1.3	0.0	0.1	4.9	0.2	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.2	0.8	0.0	13.8	0.1	0.8	19.8	2.1	0.0	0.0	34.8	0.0	0.1	0.0	2.9	37.0	0.0	0.0	11.1	0.2	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.8	5.7	3.2	2.7	3.4	19.1	4.2	19.4	3.9	3.7	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.1	0.5	0.1	0.0	0.0	0.0	2.6	0.1	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: AB_2732299"	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	6.5	13.3	11.5	26.6	9.9	47.4	5.5	21.6	12.0	14.3	10.6	24.3	31.8	13.2	21.8	11.7	10.0	9.8	15.0	10.4	11.0	16.2	3.9	20.6	41.0	13.0	12.2	8.9	6.1	7.7	5.1	5.7	13.4	9.2	19.3	9.9	11.5	9.8	11.8	9.2	32.3	11.5	8.7	33.3	28.2	9.0	10.6	25.6	14.6	2.8	31.4	9.1	7.3	11.7	58.3	69.2	12.4	15.3	4.4	6.4	5.6	5.3	5.2	2.5	4.4	28.8	129.0	6.3	42.6	6.0	1.4	8.6	23.2	33.7	2.2	177.1	8.0	37.9	47.5	27.7	10.1	38.6	25.8	9.0	7.5	5.4	2.9	23.8	17.6	44.7	5.6	9.9	1.4	41.7	50.7	56.7	10.4	13.6	147.3	26.5	0.7	10.8	127.9	4.9	9.9	9.4	38.5	4.5	2.6	5.6	19.9	15.0	21.4	4.0	40.1	12.5	1.5	12.3	7.6	20.0	5.0	42.9	2.6	23.8	10.9	41.5	97.0	36.5	92.7	55.5	77.2	82.5	31.0	45.2	59.5	73.2	24.4	61.4	69.8	74.3	90.2	43.3	11.5	9.9	21.6	12.0	10.4	11.0	13.0	12.2	13.4	8.7	10.6	11.7	3.1	38.5	10.7	1.0	54.1	8.7	1.9	5.5	3.4	8.1	9.3	3.8	1.5	15.7	11.3	23.9	0.0	2.7	111.8	273.9	41.1	34.0	20.2	16.5	5.6	3.5	6.7	12.2	5.3	55.3	3.9	5.3	50.4	37.1	20.8	13.1	10.0	4.0	14.4	0.0	3.9	28.6	2.0	10.9	224.9	53.8	4.1	40.3	21.4	3.7	241.2	4.7	103.0	1.0	1.2	191.7	279.6	2.2	39.4	3.8	121.6	15.1	13.5	9.7	6.6	2.6	4.5	17.7	2.9	2.5	13.2	5.5	99.2	23.4	17.3	44.3
RHOH	"ARHH, TTF"	ENSG00000168421	"Ras homolog family member H"	Q15669	4	40191053-40246967	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.9;lymphoid tissue: 98.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 273.0;dendritic cells: 90.5;granulocytes: 141.8;NK-cells: 64.9;Plasma cells: 183.1;T-cells: 223.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 126.3;HMC-1: 92.5;JURKAT: 123.7;MOLT-4: 179.4;U-266/70: 65.5;U-266/84: 56.8;U-698: 116.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030345, HPA061314"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Vesicles"		"HPA030345: AB_10601607, HPA061314: "	"unprognostic (4.00e-2)"	"unprognostic (1.83e-4)"	"unprognostic (1.24e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.31e-6)"	"unprognostic (2.96e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.44e-2)"	2.2	0.9	0.7	36.4	0.6	62.9	13.2	0.5	0.8	2.9	0.6	6.3	4.8	1.6	0.9	2.9	1.5	6.4	0.7	0.6	0.8	1.2	2.7	5.7	86.0	1.1	1.3	0.9	1.4	0.4	0.7	0.9	0.9	2.7	5.6	0.0	3.9	0.9	0.6	1.2	20.6	1.5	1.0	42.6	8.2	0.7	0.8	98.2	1.8	0.3	85.2	10.6	1.6	1.0	0.2	0.4	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	126.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	2.6	0.0	18.8	0.1	0.0	0.0	21.1	92.5	1.5	0.0	0.0	0.0	0.1	0.1	123.7	1.4	1.2	0.0	0.0	179.4	13.3	2.3	0.0	0.4	19.1	0.3	4.3	0.0	0.0	0.1	0.1	0.3	0.8	0.2	0.1	5.7	0.5	0.5	0.0	0.5	0.1	0.2	65.5	56.8	116.3	0.1	4.4	0.1	210.3	1.1	168.7	112.2	0.8	99.3	164.3	176.9	151.1	1.9	212.1	274.3	220.5	8.4	74.2	1.2	26.1	268.4	124.1	0.7	0.6	0.5	0.8	0.6	0.8	1.1	1.3	0.9	1.0	0.8	1.0	2.9	3.2	9.9	0.3	273.0	7.1	1.4	0.3	1.8	0.0	11.1	6.7	1.1	1.5	2.9	0.0	0.0	0.1	90.5	0.3	0.0	0.1	0.6	0.6	0.5	2.3	0.0	23.4	0.3	0.0	0.2	3.6	9.7	1.0	141.8	0.0	1.8	0.2	2.2	0.0	0.3	0.4	0.0	4.4	16.2	0.7	0.0	28.4	56.9	8.4	11.3	0.0	64.9	0.5	0.1	0.0	0.1	0.0	183.1	1.4	0.0	0.4	1.0	0.0	0.0	2.0	2.0	0.3	0.2	0.3	7.0	0.3	223.6	0.1	0.3	2.0
RIPOR1	"FAM65A, FLJ13725"	ENSG00000039523	"RHO family interacting cell polarization regulator 1"	Q6ZS17	16	67518418-67546788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005923	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Cytosol"		"HPA005923: AB_1078809"	"unprognostic (7.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.82e-8)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.46e-2)"	44.4	28.1	27.6	23.4	30.6	27.2	37.7	26.4	38.6	39.9	7.5	36.0	8.8	45.2	6.0	18.5	36.2	21.5	53.6	33.6	16.3	67.6	16.7	55.8	20.8	26.6	17.1	33.2	30.1	20.6	26.5	29.8	25.4	30.6	7.4	43.8	22.8	20.2	34.9	21.4	32.7	25.2	12.3	61.2	25.9	18.6	21.5	10.8	36.4	22.3	17.5	37.1	30.4	18.6	44.0	36.6	16.1	25.3	40.0	35.7	35.7	45.7	44.9	51.6	43.0	75.7	31.5	6.0	62.4	78.8	26.0	24.4	32.7	41.3	33.2	19.3	17.0	57.9	53.6	17.4	44.7	4.6	28.0	35.5	18.8	69.7	47.1	36.8	55.2	10.2	6.5	6.4	38.7	47.7	13.8	14.4	4.4	8.5	29.1	46.8	29.0	31.2	39.0	22.1	12.1	31.9	85.1	13.8	28.6	15.9	30.2	10.7	96.8	58.3	34.2	49.8	32.2	9.0	6.8	17.8	38.8	11.1	31.7	0.1	11.2	9.3	1.2	15.6	1.8	15.8	1.0	0.5	10.2	9.4	0.7	0.7	6.6	1.7	15.1	14.4	0.8	6.0	27.6	30.6	26.4	38.6	33.6	16.3	26.6	17.1	25.4	12.3	21.5	18.6	49.2	16.0	16.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	12.1	8.8	0.0	0.0	1.8	7.3	0.0	0.8	3.7	0.0	0.0	15.8	0.0	9.3	17.9	23.6	0.0	0.0	0.0	12.5	1.3	6.9	0.0	18.5	10.1	7.9	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	37.0	0.0	0.0	2.3	0.0	0.0	5.8	2.2	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	2.1	2.3	16.6	0.0	0.0
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018825-32073219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 8.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	10.2	1.3	2.0	5.2	3.7	18.4	6.3	2.7	2.7	3.9	1.6	5.0	10.5	2.9	0.5	2.5	3.4	3.3	2.6	1.9	2.3	1.0	12.5	4.7	7.0	3.6	3.2	1.4	3.1	1.7	0.3	3.7	3.4	1.8	6.4	0.3	2.2	1.4	2.3	4.9	11.3	3.3	2.6	5.9	3.4	1.0	3.8	5.3	1.4	2.9	4.0	3.0	1.7	6.2	1.2	0.1	0.2	0.4	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	1.2	0.1	0.4	0.9	1.6	1.2	0.2	6.6	2.6	0.3	0.4	0.3	0.1	8.9	51.5	1.6	2.4	0.0	2.8	0.3	0.4	2.7	0.1	1.9	0.1	2.0	2.3	8.2	4.2	8.9	1.5	9.2	0.6	0.2	0.5	0.5	0.9	0.3	0.2	0.1	13.2	1.6	1.3	4.2	0.2	0.1	0.7	0.1	0.1	5.9	0.2	0.1	0.6	11.5	6.9	13.3	4.5	4.5	15.0	2.5	9.9	2.5	12.0	12.8	4.2	2.3	9.5	12.3	1.9	15.5	2.8	4.3	13.7	6.9	2.0	3.7	2.7	2.7	1.9	2.3	3.6	3.2	3.4	2.6	3.8	6.2	62.2	3.2	5.8	3.3	16.3	9.8	3.1	1.0	14.2	0.8	5.3	3.7	2.1	4.3	3.8	12.9	0.0	0.4	169.6	24.6	1.9	1.0	90.7	4.9	2.1	28.4	1.2	15.8	2.7	1.8	0.1	5.3	8.6	13.4	18.9	0.2	12.5	25.1	10.5	0.0	3.0	8.3	0.0	19.2	12.6	17.4	2.8	18.4	1.8	30.9	23.8	0.7	160.6	3.5	64.3	1.1	4.5	0.0	49.9	2.7	41.4	4.5	1.7	0.9	0.0	3.2	3.2	0.5	1.8	5.8	6.8	0.8	114.8	0.2	14.7	2.4
RNF157	KIAA1917	ENSG00000141576	"Ring finger protein 157"	Q96PX1	17	76142465-76240493	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 86.9;retina: 59.0;skeletal muscle: 73.9;testis: 31.4;tongue: 43.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 114.1;Cone photoreceptor cells: 189.7;Excitatory neurons: 64.6;Horizontal cells: 180.0;Inhibitory neurons: 92.7;Rod photoreceptor cells: 70.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.2;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 100.9;U-266/70: 50.6;U-266/84: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021854, HPA021991, HPA023922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	Vesicles	"HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202"	"unprognostic (4.21e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.02e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-1)"	13.6	3.3	36.4	3.7	39.1	2.2	4.9	34.1	86.9	1.4	9.8	9.8	9.6	1.4	3.4	1.0	1.8	1.3	6.4	56.9	34.5	5.8	2.5	1.4	5.2	59.7	41.9	1.2	3.4	14.6	6.3	1.6	61.1	1.9	7.0	59.0	1.9	1.5	73.9	1.0	10.3	1.8	34.1	3.5	3.9	31.4	51.5	2.8	3.4	43.7	2.7	3.0	1.0	58.1	0.2	7.1	29.3	10.7	8.8	4.4	13.4	0.3	8.9	1.9	1.3	3.3	3.1	0.0	4.2	0.5	6.9	0.2	26.0	0.1	1.6	100.9	8.9	0.0	2.9	4.7	1.7	1.4	10.9	2.4	0.1	3.7	0.1	1.5	0.2	4.7	16.0	0.3	3.6	8.0	4.4	0.8	4.8	5.5	21.1	0.0	0.3	0.1	3.4	3.2	5.1	24.0	5.3	0.1	11.5	6.5	0.7	5.1	0.2	1.9	2.3	14.4	9.6	50.6	45.5	0.1	0.8	0.1	15.1	2.2	0.2	0.3	1.6	0.1	3.4	0.2	3.4	2.7	0.1	0.4	5.8	3.9	1.2	0.7	0.2	0.3	1.3	1.0	36.4	39.1	34.1	86.9	56.9	34.5	59.7	41.9	61.1	34.1	51.5	58.1	2.8	3.2	3.3	33.3	1.5	2.0	0.8	0.2	0.6	114.1	0.8	0.9	9.0	11.5	1.3	1.8	189.7	0.6	5.0	5.3	0.0	1.9	27.8	0.6	3.7	4.4	2.4	5.5	64.6	1.1	0.4	3.1	0.0	1.5	0.0	0.9	0.7	4.3	0.4	180.0	92.7	7.4	0.0	0.8	6.0	29.1	11.5	1.1	1.8	3.7	1.4	35.9	8.2	62.8	35.0	0.1	3.4	13.9	2.1	0.9	19.3	9.1	0.7	70.9	0.0	2.9	1.3	22.7	25.0	0.0	2.3	0.3	15.5	1.3	18.2	1.5
RNF214	DKFZp547C195	ENSG00000167257	"Ring finger protein 214"	Q8ND24	11	117232625-117286454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 20.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 6.4;T-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039332	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA039332: AB_10671874"	"unprognostic (7.36e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.06e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	10.9	11.7	8.9	8.8	10.2	12.4	10.8	10.5	9.9	11.4	6.0	10.8	9.4	11.0	8.5	9.2	9.9	8.9	10.5	7.8	10.1	10.3	13.2	9.1	10.8	9.9	9.4	13.2	21.8	11.5	12.5	11.0	9.6	9.6	9.4	12.2	11.3	10.0	17.9	10.1	10.1	11.2	7.3	11.4	12.7	18.6	10.4	14.4	13.5	13.4	10.6	11.0	9.6	11.9	12.0	14.1	31.7	19.1	15.6	15.6	17.9	19.3	17.5	20.5	21.7	21.6	28.1	16.8	32.7	22.6	19.6	15.7	34.8	16.9	21.1	31.3	10.2	53.3	11.7	16.6	30.5	25.2	19.8	14.4	18.2	25.4	37.6	23.1	25.7	29.0	30.7	17.9	21.1	9.0	20.8	21.0	17.2	20.7	14.0	22.5	21.1	22.4	19.3	17.8	20.5	22.2	22.1	14.8	10.4	24.7	25.1	16.9	24.4	20.7	16.6	11.4	16.3	10.3	7.7	20.2	7.6	20.3	24.3	6.4	2.5	2.7	2.3	2.4	1.4	1.9	7.8	4.0	2.2	1.9	2.2	2.1	1.1	1.2	2.5	2.5	20.5	1.6	8.9	10.2	10.5	9.9	7.8	10.1	9.9	9.4	9.6	7.3	10.4	11.9	19.1	25.6	15.1	23.5	14.8	5.0	9.6	10.6	21.6	23.8	11.1	14.5	12.8	15.7	14.8	5.5	10.4	14.9	10.0	9.0	9.8	13.3	46.8	15.7	26.2	11.9	9.0	14.7	20.9	12.7	13.6	12.9	14.8	15.5	5.1	21.6	7.9	7.1	12.8	13.5	24.7	8.5	10.2	10.6	6.3	20.0	10.2	13.5	8.8	12.2	12.7	14.0	14.4	33.7	24.5	10.6	9.8	12.8	14.9	7.1	10.6	12.1	10.0	37.1	13.1	20.9	19.5	64.6	57.5	15.5	5.1	19.4	17.8	28.2	8.8	7.6
RNF224		ENSG00000233198	"Ring finger protein 224"	P0DH78	9	137227502-137229640	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 3.4;pituitary gland: 5.8"	"Cell type enhanced"	"Detected in single"		"Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA079078			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"		"HPA079078: "	"unprognostic (2.45e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.01e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	0.2	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.5	0.0	0.3	0.3	0.2	0.0	3.4	1.4	0.3	0.5	0.1	0.1	2.1	0.0	0.8	0.1	0.8	1.2	0.1	0.8	0.0	5.8	0.0	0.3	1.0	0.0	0.2	1.4	0.0	0.1	0.6	0.5	0.0	0.5	0.2	0.6	1.2	0.5	0.0	0.9	0.0	0.1	0.4	0.9	0.2	0.6	1.0	0.4	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	5.5	0.1	0.2	0.0	0.3	2.7	0.0	0.1	0.0	1.8	0.2	0.0	4.3	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.2	0.4	0.0	9.8	0.1	0.0	0.4	0.7	1.3	0.6	0.2	0.1	0.1	0.6	0.0	1.1	0.5	2.0	0.0	0.7	1.9	0.2	0.2	0.2	0.1	1.1	0.0	0.6	0.2	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.8	1.2	0.3	0.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.9	2.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.0;Late spermatids: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	23.3	34.8	40.6	16.4	44.4	11.3	24.7	40.7	59.9	21.1	34.6	29.6	19.0	25.7	115.2	23.6	25.3	18.5	29.1	45.5	43.2	26.7	21.8	19.2	19.5	39.5	40.3	24.1	23.4	26.1	27.8	17.8	40.0	29.6	20.5	41.5	28.3	28.9	54.7	20.9	19.0	21.3	41.4	22.3	21.3	28.0	42.6	19.9	32.1	46.5	19.3	27.6	20.0	44.4	31.6	34.1	57.0	60.8	30.6	35.8	35.5	55.6	54.5	31.7	44.5	9.4	34.2	44.1	57.2	40.7	16.9	51.2	64.1	56.3	44.7	39.2	36.6	46.9	48.9	37.0	53.9	78.9	24.3	27.6	73.7	30.2	85.4	39.8	46.0	51.5	42.8	46.7	41.1	39.3	42.4	33.3	45.9	16.2	24.4	34.7	18.3	70.8	48.4	66.9	99.1	83.4	46.5	25.7	48.3	46.2	35.2	55.9	56.4	33.0	20.6	17.7	46.0	52.5	77.6	45.0	33.6	64.1	33.9	0.7	4.7	2.2	2.9	6.3	4.4	5.0	4.0	3.4	7.8	5.4	5.0	4.0	3.5	7.0	4.2	5.4	2.3	3.3	40.6	44.4	40.7	59.9	45.5	43.2	39.5	40.3	40.0	41.4	42.6	44.4	19.0	32.1	20.7	54.9	40.6	34.4	35.9	23.6	54.7	49.6	29.9	22.2	39.4	17.2	21.0	35.0	31.3	17.1	28.7	13.6	27.4	21.0	233.0	36.3	30.2	23.1	28.8	24.6	105.0	19.9	17.6	19.0	25.0	52.5	13.3	50.7	20.7	29.3	9.8	37.0	91.0	16.7	22.4	20.1	24.2	362.4	22.1	18.8	30.2	58.1	18.1	32.2	18.6	84.9	98.5	20.4	25.2	23.0	33.1	41.5	17.8	26.2	20.3	50.8	13.1	26.1	27.0	39.5	42.2	45.2	38.2	14.6	21.9	51.9	22.2	38.2
RRAGA	"FIP-1, RAGA"	ENSG00000155876	"Ras related GTP binding A"	Q7L523	9	19049427-19051025	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (6.30e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (6.74e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.05e-1)"	79.3	73.7	73.6	39.6	75.1	30.2	72.8	77.5	82.5	67.3	74.6	74.0	38.6	94.8	77.4	62.1	74.7	49.7	87.1	76.7	83.5	67.7	68.3	51.9	46.4	73.5	74.2	83.0	46.7	47.6	68.7	71.0	77.5	58.1	45.6	39.7	53.3	73.8	128.9	72.5	57.1	82.7	80.2	52.9	57.1	40.2	78.1	53.2	57.1	104.5	47.9	70.7	58.0	84.5	115.2	92.7	74.9	78.4	263.8	167.0	51.5	112.7	134.4	96.2	117.7	35.8	34.7	22.6	61.1	190.8	86.7	42.8	64.8	106.6	101.2	97.7	72.8	145.3	122.6	139.0	172.8	20.3	52.7	148.8	101.3	82.2	55.7	132.4	116.1	36.9	33.4	32.1	202.5	72.5	56.2	118.8	41.9	59.5	70.6	43.0	48.8	32.6	147.9	98.8	61.4	76.6	61.9	55.5	60.4	67.5	71.3	54.0	91.0	116.2	44.6	83.6	85.3	22.5	39.4	51.6	127.9	30.8	43.1	155.3	85.6	147.8	74.5	98.0	72.7	49.4	77.1	74.6	81.0	50.4	70.1	69.8	58.9	81.9	109.3	58.2	100.0	107.8	73.6	75.1	77.5	82.5	76.7	83.5	73.5	74.2	77.5	80.2	78.1	84.5	84.3	25.6	27.7	16.0	35.0	61.1	123.7	138.8	50.7	47.8	43.2	57.9	51.8	41.5	63.8	53.3	18.8	130.9	28.1	32.9	105.7	95.9	92.5	74.0	70.6	86.5	17.5	38.1	17.5	61.4	98.6	80.3	28.1	47.2	33.6	38.0	71.4	61.9	64.6	48.8	20.0	29.8	81.4	37.1	33.2	28.3	93.8	39.2	56.9	20.6	51.0	95.4	49.4	21.1	29.6	52.3	44.3	103.0	24.0	50.8	51.4	130.1	75.4	37.0	32.9	65.3	79.1	113.8	22.9	47.7	59.2	121.4	37.3	61.6	34.8	74.8
RRAGB		ENSG00000083750	"Ras related GTP binding B"	Q5VZM2	X	55717749-55758774	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 72.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.31e-5)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (3.64e-6)"	"unprognostic (8.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	12.6	14.8	13.1	7.1	13.4	8.2	14.7	11.0	12.9	14.0	9.9	12.3	6.9	18.5	34.7	8.9	20.5	13.0	15.2	13.5	14.2	16.2	8.0	11.1	8.3	11.2	14.0	22.2	8.0	23.1	14.9	11.4	12.5	16.4	9.6	17.1	8.9	18.0	12.0	12.1	8.8	17.3	12.4	11.3	9.6	9.2	15.2	10.2	22.9	15.9	8.7	12.0	10.0	12.5	11.9	8.9	10.0	7.6	34.7	32.2	2.6	10.3	19.0	9.1	12.2	5.2	7.7	3.5	72.6	14.4	7.6	7.5	9.1	5.8	8.4	6.5	12.7	5.2	12.1	10.5	24.6	8.4	8.0	38.4	21.9	6.8	8.8	36.8	12.3	9.3	7.3	8.1	15.3	8.8	4.5	11.7	10.4	3.2	14.4	17.0	11.1	10.0	13.9	15.3	10.0	8.9	14.2	4.4	15.6	25.4	12.9	8.8	6.8	11.2	5.2	10.4	5.6	11.1	16.4	6.7	8.5	18.2	5.0	7.1	4.7	4.1	5.0	6.7	7.5	6.8	6.5	6.9	7.3	10.4	7.4	7.5	1.4	6.5	3.9	4.6	7.5	4.0	13.1	13.4	11.0	12.9	13.5	14.2	11.2	14.0	12.5	12.4	15.2	12.5	14.5	12.8	17.4	22.9	16.0	8.7	15.3	16.1	19.4	20.4	9.7	10.2	16.4	4.3	10.4	18.4	14.6	7.4	6.8	4.9	27.4	9.8	1.8	14.3	16.1	12.7	4.2	11.1	32.4	5.0	5.5	15.6	10.7	11.9	17.1	16.7	5.7	2.6	7.3	20.2	29.6	5.1	8.2	5.4	7.8	2.9	9.9	7.9	5.4	23.4	7.8	27.0	2.1	28.6	38.2	4.3	10.8	15.4	6.4	9.0	7.3	19.3	10.4	25.6	0.0	17.9	16.6	7.7	14.6	11.2	7.7	4.8	11.8	26.9	6.9	6.9
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 218.9;Kupffer cells: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 19.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.5;monocytes: 12.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	40.5	22.7	33.5	14.5	36.4	18.9	11.2	25.5	29.4	12.2	16.9	16.6	25.8	13.5	8.7	28.5	16.5	13.6	19.4	27.1	30.2	16.0	32.9	18.8	8.2	32.9	31.3	21.7	25.4	45.1	3.5	14.5	30.8	15.6	10.0	5.4	21.7	17.1	106.5	88.1	28.0	11.1	30.4	25.1	14.7	7.9	42.7	6.0	17.6	51.9	7.6	16.2	8.2	22.6	19.6	36.4	14.7	21.9	42.8	19.1	66.7	14.1	16.1	9.6	6.5	20.7	28.0	0.0	25.8	22.5	15.1	105.5	7.7	32.8	2.9	26.3	7.2	0.1	47.5	30.0	20.4	18.8	4.8	29.0	52.1	11.5	10.6	12.9	12.8	1.6	26.0	1.1	8.7	61.8	1.1	59.5	17.5	63.4	16.9	7.4	30.3	36.7	12.2	64.3	17.2	10.5	37.3	46.9	10.6	7.1	44.9	78.8	16.5	16.2	23.4	17.4	9.7	1.7	0.2	0.4	11.6	33.9	12.7	1.3	8.1	6.6	1.4	12.9	0.2	0.3	0.9	1.0	3.2	0.1	0.2	1.2	19.5	2.2	11.2	0.7	1.2	3.2	33.5	36.4	25.5	29.4	27.1	30.2	32.9	31.3	30.8	30.4	42.7	22.6	32.1	32.1	22.9	36.2	4.6	34.5	16.5	21.1	12.5	6.0	16.7	14.4	38.8	72.9	26.2	9.2	25.0	30.1	11.0	72.3	1.9	13.9	4.3	19.8	16.6	28.9	9.6	30.9	9.1	14.1	29.5	23.7	17.9	17.4	1.3	21.3	71.0	218.9	31.9	33.7	17.6	21.2	10.2	134.2	30.0	18.8	32.3	50.4	12.4	10.3	80.4	36.5	14.4	29.1	6.0	15.9	32.4	21.1	7.4	17.7	55.6	19.9	34.4	19.9	19.7	34.6	30.6	0.9	9.4	34.4	46.9	23.9	12.6	15.5	27.5	32.8
RXYLT1	"HP10481, TMEM5"	ENSG00000118600	"Ribitol xylosyltransferase 1"	Q9Y2B1	12	63779842-63809562	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transferase	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 37.2;Endometrial stromal cells: 34.5;Extravillous trophoblasts: 33.8;Syncytiotrophoblasts: 37.1;Theca cells: 45.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064014			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Golgi apparatus"		"HPA064014: AB_2685176"	"unprognostic (1.19e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.33e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	6.6	12.0	6.9	4.9	7.6	4.4	10.8	7.1	8.5	7.1	7.2	6.9	5.7	6.7	15.3	5.6	7.9	5.5	14.3	6.8	7.9	10.9	8.5	5.2	7.4	7.5	7.0	12.0	11.8	15.4	9.0	5.7	7.7	8.4	7.5	9.9	8.3	7.0	10.7	8.3	4.2	6.1	7.5	5.7	5.5	11.8	7.3	7.3	12.8	8.7	7.2	7.4	5.5	9.3	9.6	19.9	14.2	11.7	12.2	16.4	13.5	10.4	18.5	17.7	11.9	6.6	10.1	20.5	17.7	13.4	14.2	9.3	17.5	16.0	22.3	18.5	13.4	11.5	5.1	12.2	18.1	17.6	10.0	14.6	15.6	17.1	22.6	16.8	10.4	16.5	14.0	19.8	27.8	18.3	10.2	8.1	8.1	10.4	20.6	9.0	14.8	13.1	17.8	15.1	30.7	5.9	10.4	9.5	24.5	9.0	20.2	9.9	10.1	14.9	15.2	9.7	15.4	10.6	17.9	15.6	10.9	11.4	20.9	0.8	1.7	1.0	1.9	1.6	3.5	3.0	2.4	2.6	1.7	2.2	2.8	2.6	0.3	3.0	2.2	4.1	4.3	1.2	6.9	7.6	7.1	8.5	6.8	7.9	7.5	7.0	7.7	7.5	7.3	9.3	17.5	9.6	8.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	26.8	26.8	0.0	0.0	10.5	16.5	0.0	24.7	6.9	0.0	37.2	23.1	0.0	28.6	34.5	8.1	0.0	0.0	0.0	30.7	33.8	12.1	0.0	16.6	7.6	15.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	8.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	2.4	0.0	0.0	30.3	13.8	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	37.1	4.8	45.0	0.0	0.0
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor like tyrosine kinase"	P34925	3	134065303-134250859	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293"	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	31.8	25.2	15.7	15.7	16.2	17.1	42.8	15.4	19.8	40.2	19.9	34.5	20.1	46.1	40.0	29.6	33.4	24.3	30.3	14.5	15.3	25.4	22.3	25.3	18.9	15.9	15.6	82.1	24.5	29.7	17.0	36.6	15.5	36.3	26.2	15.9	26.9	43.9	25.3	34.7	21.4	40.6	16.3	22.9	23.2	47.0	16.5	21.2	40.9	32.2	20.5	34.7	32.6	16.4	78.8	20.6	63.3	48.7	79.8	84.4	48.8	51.0	117.7	66.4	74.2	65.6	58.8	15.3	82.4	63.1	63.7	71.6	45.5	64.3	94.5	25.9	20.5	40.6	22.4	42.4	62.2	20.0	34.4	56.1	74.0	41.2	82.2	72.5	56.5	26.4	14.5	7.5	66.0	37.6	28.0	25.9	53.4	65.2	24.3	13.7	48.4	32.4	54.5	57.3	31.0	45.6	61.7	44.5	79.1	40.5	55.7	35.8	42.1	54.8	49.6	57.8	41.8	3.1	4.2	8.3	34.8	33.1	39.6	4.6	0.8	1.6	1.1	0.8	1.3	0.6	2.0	1.3	0.3	1.2	1.9	1.5	0.3	1.6	0.8	0.0	0.5	0.5	15.7	16.2	15.4	19.8	14.5	15.3	15.9	15.6	15.5	16.3	16.5	16.4	62.5	12.8	27.9	31.6	20.6	41.3	36.6	26.3	39.3	23.1	45.4	37.2	34.9	18.6	23.7	44.1	29.2	19.4	23.1	15.9	0.0	15.9	16.2	27.6	41.7	31.0	13.9	13.2	69.5	21.1	14.7	41.3	15.8	32.7	17.7	121.2	40.7	24.1	11.3	13.5	59.7	20.9	12.2	18.6	21.6	7.4	33.2	16.1	14.2	65.6	12.8	26.8	13.4	65.9	57.9	21.7	19.7	32.7	12.9	42.8	15.4	10.5	13.9	39.8	46.0	33.8	38.1	24.6	40.9	33.7	38.1	10.8	18.4	50.8	22.2	38.9
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 45.0;T-cells: 12.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	7.7	2.5	1.9	6.4	1.8	1.2	5.5	1.7	1.8	10.4	1.9	4.8	1.8	8.3	2.7	3.3	8.4	6.2	6.6	1.6	2.0	3.1	5.6	13.7	10.9	2.8	1.9	5.6	2.9	2.5	3.0	18.5	2.2	6.9	2.4	1.2	4.1	2.3	0.8	5.4	4.8	4.2	2.0	1.9	4.3	13.2	2.1	1.4	3.4	1.3	10.9	8.3	7.0	2.9	3.0	0.4	3.4	6.9	18.2	22.2	29.4	4.4	8.9	1.9	4.1	1.9	1.7	54.1	5.1	8.2	2.3	1.7	1.2	2.1	1.3	5.5	2.7	1.2	1.2	1.3	6.1	1.4	1.1	12.2	1.1	3.8	1.3	5.3	0.2	2.6	1.3	11.1	1.3	2.5	0.6	2.5	3.4	0.9	1.7	3.8	1.4	2.0	1.6	2.5	2.4	4.7	2.5	1.5	3.8	2.6	1.2	1.3	0.4	6.9	2.2	15.9	1.3	38.9	19.6	57.3	2.6	2.7	38.6	45.0	2.8	0.6	7.2	2.4	8.9	0.3	9.2	7.0	2.6	0.5	3.7	3.8	0.7	3.6	1.0	0.4	12.4	2.0	1.9	1.8	1.7	1.8	1.6	2.0	2.8	1.9	2.2	2.0	2.1	2.9	2.0	0.0	1.1	0.3	2.0	0.0	4.6	0.0	1.2	0.6	8.3	4.6	0.6	2.8	0.6	1.8	2.1	92.9	5.4	0.0	0.0	3.6	92.3	8.6	21.5	2.0	2.4	0.0	0.3	3.3	18.1	17.7	0.0	18.1	0.0	2.0	3.9	7.6	13.2	0.0	0.9	0.5	0.0	3.1	0.0	184.9	22.1	7.2	0.0	0.0	4.0	7.1	3.1	6.6	0.5	2.7	0.3	13.2	2.6	4.9	0.0	0.9	0.0	0.5	13.1	2.0	4.6	1.5	1.2	2.0	0.0	68.4	4.2	1.1	0.2	4.1
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745409	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	23.5	26.3	13.2	26.2	13.8	21.1	22.0	17.1	16.1	22.1	13.6	24.0	23.3	20.6	23.3	20.2	16.9	19.2	16.3	14.0	18.8	38.1	28.2	28.9	26.8	15.5	14.9	16.2	21.8	35.8	10.9	25.0	14.7	24.3	23.6	20.3	22.9	20.6	8.8	18.4	21.6	21.2	14.6	26.2	25.0	14.2	15.9	32.5	43.5	11.4	25.0	22.9	10.8	16.3	31.0	23.0	38.0	22.0	58.8	39.2	29.6	50.1	43.0	36.9	33.1	30.5	21.8	47.8	24.3	39.8	49.8	22.7	50.4	27.0	48.9	34.3	26.8	50.8	38.2	25.7	37.6	78.0	61.5	26.5	41.1	39.9	29.6	29.9	25.6	43.2	57.9	45.7	60.6	14.0	59.5	41.4	40.1	29.6	40.1	17.2	20.0	48.4	41.2	42.7	15.0	36.1	35.5	36.3	44.7	38.0	31.0	64.1	33.7	36.2	21.1	37.0	44.5	25.3	71.7	32.5	45.1	106.8	36.2	10.3	17.1	27.5	24.6	14.2	27.5	11.0	17.8	26.0	27.2	11.9	17.6	23.5	14.1	65.2	13.0	11.1	16.7	27.6	13.2	13.8	17.1	16.1	14.0	18.8	15.5	14.9	14.7	14.6	15.9	16.3	18.4	28.9	37.3	22.5	22.2	19.6	9.1	14.6	22.2	22.8	15.2	12.3	16.6	14.3	15.7	7.3	31.3	22.9	55.4	16.4	19.6	11.1	1.6	15.9	31.9	17.6	12.0	23.4	44.7	10.0	11.2	19.5	17.3	18.5	17.1	17.2	17.2	15.4	24.5	33.7	42.7	9.4	18.3	23.0	18.7	2.9	16.8	22.6	17.8	30.9	25.5	15.8	46.4	40.7	43.6	12.9	20.7	23.0	33.2	14.6	18.5	22.3	14.1	20.7	6.6	15.8	16.6	12.3	12.0	15.7	17.3	18.3	44.5	19.5	13.6	11.6
SAMD12	FLJ39458	ENSG00000177570	"Sterile alpha motif domain containing 12"	Q8N8I0	8	118189455-118622112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 34.6;U-266/70: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024634	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"		"HPA024634: AB_1856549"	"unprognostic (6.96e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (3.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.35e-3)"	0.7	1.4	2.4	1.1	4.9	0.4	3.0	0.7	8.8	2.3	0.0	4.0	3.7	1.1	4.0	4.1	5.3	3.6	6.9	7.5	0.8	5.2	1.6	4.2	0.7	1.4	0.5	0.9	1.9	9.6	3.3	0.1	2.6	3.7	4.7	5.9	2.4	5.0	0.8	0.8	2.0	0.7	0.9	2.6	5.7	1.3	2.1	1.0	10.2	0.1	2.0	4.4	1.1	8.4	10.2	0.7	0.9	0.0	0.0	0.0	2.1	3.4	10.4	7.8	4.3	1.1	12.1	3.4	0.8	8.2	1.6	1.9	2.0	4.7	11.9	0.1	1.1	0.0	5.7	0.0	0.0	0.0	0.2	0.0	2.3	4.6	0.4	2.8	0.2	5.9	0.0	6.0	6.0	2.0	1.6	0.0	0.8	13.2	1.3	0.0	0.0	9.7	5.4	13.5	4.0	0.0	2.8	34.6	0.0	2.1	0.5	0.0	0.0	0.1	3.8	1.4	1.2	14.9	10.2	0.4	1.8	0.0	1.1	0.1	0.0	0.0	0.1	0.0	1.0	1.5	0.8	0.5	0.0	1.0	1.0	0.6	0.1	0.6	0.0	0.3	0.8	0.2	2.4	4.9	0.7	8.8	7.5	0.8	1.4	0.5	2.6	0.9	2.1	8.4	4.7	112.2	95.0	53.5	8.0	1.7	10.1	10.3	13.1	16.8	10.9	5.1	12.1	12.8	57.5	29.5	43.8	0.0	3.3	10.5	19.6	12.9	5.2	12.1	1.5	13.0	14.3	2.1	537.6	12.4	0.1	9.1	26.5	16.4	56.8	4.4	7.5	5.2	0.1	30.3	531.7	11.2	14.2	0.3	0.0	6.1	0.3	6.5	7.2	163.0	0.7	4.5	4.1	122.6	1158.0	13.0	3.5	0.4	16.9	5.0	8.6	17.4	68.0	26.9	0.0	0.5	0.9	0.5	2.4	15.9	1.7	0.0	8.9	4.5	11.9	13.6
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP"	O43290	11	65961728-65980137	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	24.6	18.3	15.5	18.3	16.8	41.6	23.1	15.4	17.4	29.2	14.7	26.0	15.6	29.1	8.0	22.7	25.6	8.6	23.2	14.9	16.1	20.4	21.8	22.9	20.3	16.6	16.2	29.2	25.8	11.7	21.4	14.0	15.9	21.7	7.7	8.0	22.2	14.4	38.1	32.0	24.3	10.9	14.6	32.7	24.8	23.5	15.7	20.9	23.5	13.0	13.3	26.2	24.6	17.9	50.4	60.8	27.2	36.8	26.1	20.7	40.8	37.5	27.2	43.8	28.6	44.2	34.3	56.9	42.4	33.8	52.9	48.7	34.6	35.6	22.0	45.8	33.5	65.6	43.6	41.4	39.0	57.4	52.7	26.2	26.4	40.8	36.3	17.4	27.6	42.3	42.2	39.8	25.6	92.6	74.0	83.5	45.7	27.3	55.9	80.8	39.0	60.7	18.4	33.7	30.5	43.0	35.6	37.2	45.5	12.6	41.7	47.0	40.6	54.5	53.0	53.9	54.1	59.6	49.4	48.3	45.0	28.8	47.0	1.4	2.8	8.1	4.3	3.5	3.6	3.9	4.8	4.4	3.6	3.5	3.5	3.9	4.1	2.8	2.0	3.2	5.4	1.8	15.5	16.8	15.4	17.4	14.9	16.1	16.6	16.2	15.9	14.6	15.7	17.9	17.5	6.4	9.1	7.8	27.8	22.7	24.0	12.2	17.6	19.2	12.2	9.1	9.4	21.5	11.3	16.5	10.4	34.1	27.2	30.5	5.9	23.7	9.0	14.2	16.3	19.8	12.5	32.8	5.1	29.3	31.9	17.6	21.9	16.8	32.4	21.8	21.0	15.6	29.4	16.8	4.8	26.5	16.2	22.5	23.6	8.7	37.0	22.9	17.8	6.5	35.7	23.8	34.0	7.1	7.8	26.3	20.1	33.1	31.2	20.5	28.3	18.5	17.5	26.0	32.9	27.6	34.9	26.7	29.7	18.3	21.7	45.3	28.4	15.5	27.5	18.2
SAXO2	"DKFZp666G057, FAM154B"	ENSG00000188659	"Stabilizer of axonemal microtubules 2"	Q658L1	15	82262810-82284930	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 59.9;testis: 21.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 90.9;Endometrial ciliated cells: 71.5;Late spermatids: 175.4;Respiratory ciliated cells: 201.9;Spermatocytes: 57.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;K-562: 10.0;SCLC-21H: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040487, HPA040833"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA040487: AB_10796457, HPA040833: AB_10796561"	"unprognostic (3.03e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.13e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.87e-2)"	0.9	1.1	2.1	0.3	2.2	0.6	3.2	2.3	2.7	2.3	8.3	1.3	0.7	2.2	17.9	0.6	59.9	1.0	1.3	2.5	2.3	2.7	0.9	8.0	1.2	3.2	5.0	1.7	1.6	4.7	4.9	0.4	2.4	2.6	2.0	6.9	2.8	1.2	1.3	2.1	1.6	0.6	3.1	1.2	2.5	21.6	2.5	2.6	3.5	0.8	1.6	1.3	1.0	3.7	1.4	1.9	1.1	4.1	0.9	1.8	0.5	0.5	0.3	0.8	1.5	0.2	2.3	1.4	1.0	0.0	2.2	10.5	1.8	1.6	1.8	1.0	6.8	0.5	3.4	0.0	0.1	0.3	0.4	1.2	2.2	1.4	1.2	2.3	1.7	2.9	10.0	0.7	1.0	1.0	0.5	0.0	2.7	0.5	0.8	1.4	0.5	0.9	0.8	0.9	7.8	1.2	1.1	0.0	1.5	0.6	4.0	0.4	0.2	2.0	1.1	4.2	0.8	2.1	2.6	0.9	1.9	0.5	1.3	0.0	0.0	3.0	0.5	0.0	0.8	1.3	0.2	1.5	0.1	3.3	0.9	0.4	0.0	2.0	0.1	0.8	0.0	0.3	2.1	2.2	2.3	2.7	2.5	2.3	3.2	5.0	2.4	3.1	2.5	3.7	1.8	0.0	2.7	9.1	1.5	0.0	2.0	0.0	2.8	2.7	4.5	4.1	2.7	1.5	24.1	3.7	4.2	0.5	0.9	0.1	1.9	0.7	90.9	71.5	1.5	0.9	2.4	0.8	21.1	0.5	0.4	1.5	10.2	2.0	1.3	3.7	0.4	0.3	0.1	0.0	16.4	1.9	0.0	0.6	0.0	175.4	2.5	0.5	0.0	3.7	0.0	3.7	0.0	9.0	8.0	0.3	0.1	2.2	1.9	1.5	0.3	4.6	201.9	5.0	6.6	1.0	1.0	57.7	12.7	0.9	0.0	0.3	0.7	3.0	0.5	1.6
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		71000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	43.1	46.7	27.8	40.3	32.8	51.5	40.7	31.9	31.2	40.5	38.8	76.0	75.7	36.9	36.9	103.4	47.4	35.4	32.4	26.1	29.8	44.9	42.0	49.6	47.9	40.7	30.9	26.5	54.5	85.6	29.4	48.9	36.7	35.5	72.7	4.7	92.7	32.4	34.2	68.3	80.1	33.6	33.6	66.8	64.9	36.2	33.3	33.0	38.3	18.9	53.4	38.1	49.4	35.4	44.7	57.3	24.2	37.6	72.0	37.2	72.0	45.0	56.6	46.9	50.1	83.0	102.6	36.5	57.8	68.1	67.7	157.8	72.3	55.9	19.4	145.8	71.1	92.8	31.2	57.6	54.3	48.0	170.9	48.0	97.6	44.4	32.0	37.0	46.0	42.0	31.3	67.5	33.3	68.1	24.6	55.3	24.1	111.0	36.6	42.6	22.3	126.4	54.0	63.1	24.9	25.0	36.7	64.3	42.4	35.4	88.5	76.3	43.4	40.2	23.9	43.8	53.0	46.1	73.2	37.6	37.8	112.2	30.2	118.3	111.3	90.0	94.1	106.9	76.1	80.8	85.3	95.9	81.8	70.9	69.4	75.8	74.4	83.8	119.3	128.7	105.3	120.8	27.8	32.8	31.9	31.2	26.1	29.8	40.7	30.9	36.7	33.6	33.3	35.4	36.0	73.7	31.7	17.9	49.5	17.5	41.7	40.5	19.4	6.8	28.0	24.8	14.4	24.3	53.1	40.5	2.1	156.9	63.4	116.8	15.6	67.4	132.3	30.8	22.0	36.2	37.3	29.0	7.7	92.8	61.9	37.2	54.0	40.6	79.2	31.3	26.4	27.7	164.7	6.7	6.1	77.5	42.7	78.3	44.5	56.2	32.0	77.0	32.0	21.5	56.9	41.4	63.8	12.1	17.9	96.1	75.5	23.0	73.1	54.0	105.7	48.1	52.6	8.4	26.3	25.6	35.8	47.1	35.3	39.6	22.3	136.4	55.1	40.0	64.2	58.5
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602361	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		330000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	9.2	360.1	49.2	30.2	78.4	0.4	0.5	17.1	54.7	1.5	2.2	10.6	47.7	3.5	0.4	0.6	0.2	4.0	1.7	21.7	426.2	0.6	0.2	3.3	0.4	118.3	195.4	6.1	28.3	0.5	269.0	1.1	250.9	3.5	13.0	40.6	0.3	1.2	0.3	1.0	21.3	12.8	77.4	0.2	17.9	0.2	130.7	0.1	6.4	0.8	0.1	0.8	1.3	30.3	0.0	3.1	10.3	8.5	2.3	53.3	0.2	0.5	2.0	4.0	10.1	0.4	1.0	0.0	0.9	0.7	6.2	0.2	0.2	0.0	5.0	0.1	0.5	0.0	0.6	0.0	0.5	0.7	4.6	45.9	0.2	5.8	2.0	46.5	0.0	0.0	0.2	0.4	5.1	0.3	0.0	0.2	7.3	0.1	0.2	0.0	0.3	0.3	0.9	0.1	47.6	20.7	0.0	0.5	2.5	1.6	0.0	0.1	0.1	5.4	2.2	0.2	3.6	0.1	0.0	0.3	1.6	0.1	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	78.4	17.1	54.7	21.7	426.2	118.3	195.4	250.9	77.4	130.7	30.3	0.0	6.4	0.0	12.7	0.0	0.0	0.4	2.8	0.0	212.4	0.0	0.0	0.1	0.0	1.3	0.0	2.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	6.7	283.4	0.0	27.7	0.2	0.0	2.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	8.4	109.9	14.7	138.4	0.3	0.3	0.0	0.6	0.0	1.8	3.7	0.0	11.6	0.0	34.2	8.2	14.8	6.2	0.4	0.0	2.1	0.1	0.1	0.7	14.6	0.0	1.8	1.7	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.5	0.8
SCOC	"HRIHFB2072, SCOCO, UNC-69"	ENSG00000153130	"Short coiled-coil protein"	Q9UIL1	4	140257286-140385728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061198, HPA070321"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		22000	"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA061198: AB_2684449, HPA070321: AB_2686252"	"unprognostic (2.27e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.37e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.82e-12)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-2)"	44.8	66.8	81.8	27.7	84.5	14.7	69.4	87.4	114.6	42.6	72.0	43.9	45.4	48.0	79.5	54.1	44.7	39.7	103.6	85.1	109.1	101.6	74.3	35.9	29.7	91.3	96.8	42.6	51.3	94.1	43.2	48.3	103.1	59.9	49.8	74.5	49.2	47.1	40.8	29.9	37.1	50.9	91.4	27.9	53.7	33.8	95.2	29.3	67.4	59.3	32.8	38.9	19.4	105.6	53.9	38.1	92.6	49.9	80.6	109.3	67.4	85.5	78.0	64.6	71.8	24.4	81.0	22.0	75.5	83.9	60.6	22.6	57.3	113.6	95.7	79.1	40.4	33.5	18.8	59.7	70.1	70.2	40.5	72.5	155.9	59.0	63.1	124.1	87.1	63.8	53.0	60.0	116.3	36.5	94.7	42.5	30.2	47.6	57.1	54.0	39.1	32.1	197.1	52.9	68.4	70.4	57.0	84.5	97.0	81.7	63.4	41.9	68.0	104.4	60.5	86.9	83.1	94.4	193.4	64.9	118.2	32.2	102.3	47.8	16.5	23.0	27.5	23.0	35.1	36.8	32.3	27.3	21.4	30.3	46.8	36.4	9.7	36.9	23.1	26.7	33.2	37.0	81.8	84.5	87.4	114.6	85.1	109.1	91.3	96.8	103.1	91.4	95.2	105.6	63.2	48.1	47.2	15.3	34.4	61.1	69.7	74.1	78.6	135.0	84.9	96.0	140.3	62.9	51.8	126.9	22.9	139.9	31.3	63.4	320.8	99.2	537.1	67.5	52.4	54.4	37.8	34.7	33.8	112.8	82.2	58.3	66.8	58.4	36.8	32.0	51.4	65.0	47.6	171.6	37.1	42.7	114.0	23.0	27.9	91.2	60.0	34.5	138.7	17.8	36.7	205.6	22.6	20.6	42.9	92.9	37.0	66.2	30.8	91.7	46.8	311.1	54.9	71.0	46.0	40.8	64.5	60.7	56.1	83.8	56.7	88.9	36.3	39.6	46.1	56.0
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841289	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 149.7;Proximal tubular cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		370000	"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	81.2	22.9	18.9	11.1	19.4	13.4	48.9	18.8	22.3	28.2	22.0	23.8	43.8	24.5	11.5	19.2	26.5	12.0	31.9	18.5	20.6	68.6	37.2	17.4	12.9	19.9	19.6	25.4	26.4	25.4	31.5	12.9	18.8	28.5	10.4	6.5	33.8	19.7	38.1	22.1	36.7	10.2	20.1	34.0	21.5	10.6	19.4	12.0	39.9	25.0	10.1	22.2	23.3	20.1	28.0	43.8	12.1	11.0	33.7	25.7	36.6	13.7	27.6	20.6	21.0	32.5	33.2	15.3	27.5	7.1	11.0	14.7	3.9	24.6	6.9	37.6	29.7	15.5	33.8	29.2	12.0	7.9	12.7	25.7	18.1	12.8	9.8	31.5	23.5	35.6	5.4	18.2	28.9	25.4	24.6	12.8	6.0	12.1	17.5	32.7	9.0	62.4	16.9	12.9	8.9	37.6	8.0	17.3	17.8	8.3	37.9	14.5	10.7	18.2	20.8	5.6	6.6	70.2	9.8	7.7	52.1	13.2	4.2	24.5	19.9	43.4	24.6	21.1	24.1	24.8	20.4	24.2	25.7	25.3	31.7	17.8	5.4	29.3	10.8	30.1	23.0	16.5	18.9	19.4	18.8	22.3	18.5	20.6	19.9	19.6	18.8	20.1	19.4	20.1	21.9	38.5	29.9	15.0	18.7	15.7	31.5	41.8	20.5	12.0	24.5	25.7	19.3	15.7	35.9	16.5	10.4	43.1	12.4	33.2	74.3	27.7	3.9	16.9	10.0	24.6	22.3	7.2	12.4	61.0	9.3	25.7	17.3	12.4	16.5	22.1	24.3	26.7	22.7	20.2	10.5	33.6	48.8	11.1	13.7	2.8	33.2	12.8	42.7	7.5	13.9	28.8	26.8	11.1	6.0	33.3	36.5	16.6	30.9	14.1	149.7	332.7	40.9	16.8	6.6	19.1	16.0	5.2	16.7	21.9	11.5	33.8	21.6	23.9	40.7	27.0
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 410.9"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 512.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		320000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	68.0	73.1	90.3	26.3	116.8	10.1	113.1	90.2	120.7	53.0	68.5	102.6	37.8	53.0	11.8	124.3	76.6	72.2	65.9	66.4	90.2	166.9	410.9	168.3	9.8	120.5	127.8	26.3	90.3	34.7	43.2	27.3	95.4	53.0	62.6	35.1	103.7	45.9	101.5	190.4	42.4	53.8	89.9	32.3	140.1	47.1	151.9	8.2	51.1	35.4	35.2	124.7	68.7	71.4	162.1	20.7	11.1	0.8	269.2	164.3	474.4	201.5	273.0	222.9	158.6	242.7	400.0	0.2	88.1	255.4	224.5	203.1	8.2	512.2	269.0	46.7	7.4	4.9	15.8	95.8	292.4	1.0	8.2	223.1	336.5	92.4	223.2	123.3	29.9	3.7	8.2	0.5	130.5	159.9	0.2	14.2	20.4	139.9	63.1	0.3	99.7	0.6	367.7	211.7	4.3	15.6	277.2	169.4	51.4	125.2	123.1	9.7	56.4	169.4	141.4	17.3	131.8	8.5	6.7	0.7	266.2	16.4	103.2	1.5	1.6	0.4	0.7	0.6	2.1	0.3	2.0	0.8	1.5	0.3	0.4	0.5	0.8	0.7	0.6	1.4	4.4	0.7	90.3	116.8	90.2	120.7	66.4	90.2	120.5	127.8	95.4	89.9	151.9	71.4	21.9	291.7	391.2	106.7	3.8	373.7	322.2	352.8	75.1	14.5	208.8	90.6	59.3	245.9	218.4	189.4	12.5	38.9	7.8	174.3	64.6	296.0	1.2	116.6	20.8	16.0	55.1	7.4	0.2	515.9	230.0	43.0	170.7	179.0	13.9	10.8	11.4	260.6	18.8	0.0	0.3	131.9	160.7	19.3	106.0	3.8	4.1	39.5	76.5	5.6	33.0	10.0	0.0	3.5	1.8	476.4	121.7	5.3	2.1	284.2	59.0	153.8	178.6	23.6	0.0	34.9	33.5	1.8	2.5	170.9	472.8	67.5	16.8	3.2	90.7	423.9
SEC11A	"SEC11L1, sid2895, SPC18, SPCS4A"	ENSG00000140612	"SEC11 homolog A, signal peptidase complex subunit"	P67812	15	84669538-84716460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047533			Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Golgi apparatus"	"HPA047533: AB_2680078"	"unprognostic (8.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.19e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.99e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.89e-2)"	142.9	138.1	66.2	83.4	69.4	172.2	136.2	69.0	80.4	147.1	76.6	110.8	82.9	111.0	202.5	81.6	103.6	97.5	98.4	63.7	72.6	137.2	152.3	107.9	112.6	74.1	67.2	168.6	139.4	114.6	84.5	115.1	73.9	82.0	124.9	37.0	95.9	87.5	154.3	70.5	86.4	96.3	72.4	86.2	95.3	61.5	69.4	93.2	177.5	147.4	98.2	137.3	94.0	75.3	201.7	320.7	286.7	425.4	368.5	462.8	225.4	310.1	356.5	241.9	291.2	347.1	443.0	99.0	198.8	370.3	277.2	408.3	409.1	243.4	255.5	267.1	239.4	279.4	358.8	324.9	311.7	213.4	281.2	315.8	305.0	169.1	285.1	366.0	337.9	116.7	295.8	244.3	315.1	363.1	89.2	345.8	282.1	266.2	135.4	101.6	368.4	302.9	472.6	424.4	131.2	300.8	257.3	239.5	598.5	407.0	248.5	416.6	254.3	240.0	181.0	209.8	361.9	224.4	509.6	150.0	226.4	331.7	180.6	83.5	161.1	89.7	95.1	173.7	95.0	101.0	114.8	104.7	165.8	90.0	95.1	98.0	111.6	134.3	184.8	160.9	168.8	200.8	66.2	69.4	69.0	80.4	63.7	72.6	74.1	67.2	73.9	72.4	69.4	75.3	261.1	89.8	99.1	25.8	131.8	107.1	179.4	356.6	90.5	30.0	163.7	202.6	68.2	228.8	188.0	128.8	22.9	309.1	171.9	111.1	238.7	258.8	46.3	118.5	268.0	217.2	157.4	101.7	21.2	247.3	655.3	206.0	120.8	184.1	218.4	191.0	197.7	165.5	363.3	20.2	22.8	218.7	168.9	386.7	337.2	100.6	299.5	337.3	158.3	24.4	396.7	110.5	204.9	26.7	38.3	183.4	136.3	166.3	197.9	185.7	142.7	350.9	99.3	38.2	170.9	173.5	225.5	233.5	169.6	135.2	119.9	305.8	153.4	237.6	210.7	242.2
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139866-59158832	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	24.6	76.7	110.0	86.5	117.5	63.1	81.8	122.9	140.5	57.8	94.4	92.3	126.7	40.1	284.6	42.5	41.4	47.3	30.0	112.9	146.4	70.2	219.0	62.7	104.2	137.3	130.2	29.9	374.0	153.9	155.2	28.4	136.8	225.7	78.2	108.1	397.3	62.3	15.7	29.7	97.8	30.1	123.7	81.4	138.5	28.1	113.5	53.0	163.7	20.0	117.8	59.4	21.2	135.8	82.4	100.0	52.9	74.1	31.9	6.8	64.7	72.4	62.9	89.9	55.2	78.3	42.5	176.8	109.9	46.6	67.6	82.8	84.7	59.0	58.4	523.5	113.8	58.5	69.3	242.3	99.3	199.4	87.6	20.4	140.7	56.2	161.1	20.2	33.7	78.4	67.4	546.2	34.6	100.0	79.0	79.2	48.1	140.4	60.5	72.8	50.0	1150.0	67.5	76.1	223.2	90.5	43.1	162.5	252.8	29.9	76.0	148.5	24.7	98.5	45.4	36.5	86.9	587.3	434.4	176.0	99.4	131.8	124.5	76.4	70.7	57.9	146.1	97.6	187.6	197.8	150.4	142.5	78.8	127.9	77.7	105.4	12.2	108.3	108.8	299.6	223.7	222.1	110.0	117.5	122.9	140.5	112.9	146.4	137.3	130.2	136.8	123.7	113.5	135.8	64.8	28.9	120.7	19.2	295.9	32.6	49.3	92.4	12.5	63.6	120.0	128.3	59.3	144.4	102.5	60.7	50.1	70.8	148.7	76.3	88.0	164.4	45.4	58.7	34.2	60.3	339.3	43.8	12.2	263.1	109.1	29.2	60.6	147.1	47.5	21.5	56.4	224.7	112.9	50.5	13.3	223.1	685.6	37.1	56.9	18.8	12.5	63.9	256.1	10.3	46.4	544.7	96.8	17.1	31.2	148.9	78.4	23.0	1164.8	380.9	99.3	118.8	81.3	89.3	6.6	23.1	70.6	110.2	81.5	35.5	45.5	149.7	92.3	40.1	88.3	79.2
SEC14L5	"KIAA0420, PRELID4B"	ENSG00000103184	"SEC14 like lipid binding 5"	O43304	16	4958330-5019157	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 78.7"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 85.5;Excitatory neurons: 67.0;Oligodendrocytes: 189.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;RPMI-8226: 1.6;SCLC-21H: 2.5;T-47d: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041492, HPA041825"			Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"		"HPA041492: AB_10794519, HPA041825: AB_10794526"	"unprognostic (1.90e-3)"	"unprognostic (4.08e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.33e-3)"	"unprognostic (8.71e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	0.4	0.5	12.5	0.3	43.6	0.4	0.3	25.9	29.8	0.9	0.0	0.5	0.3	0.1	0.2	0.6	0.7	0.2	5.1	15.4	17.8	0.2	0.1	0.2	0.3	33.4	35.9	0.4	0.6	0.0	2.2	0.3	29.9	0.4	0.6	3.9	0.6	0.2	5.6	1.0	0.2	0.1	22.9	0.3	1.4	0.4	31.5	0.4	0.1	10.9	0.5	0.2	0.4	78.7	0.0	0.1	0.1	0.1	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.3	0.1	0.0	0.1	1.6	0.0	0.0	2.5	0.0	0.1	0.1	0.1	0.2	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	12.5	43.6	25.9	29.8	15.4	17.8	33.4	35.9	29.9	22.9	31.5	78.7	0.2	0.0	0.0	2.3	0.0	0.3	0.1	0.0	0.0	4.1	0.2	0.1	9.1	1.5	0.1	0.0	85.5	1.1	1.3	0.3	0.0	0.1	1.6	1.0	0.1	0.3	0.0	0.0	67.0	0.2	0.1	0.6	0.0	0.1	0.0	1.5	0.4	0.3	0.3	5.0	7.1	0.6	4.1	0.0	0.3	0.5	0.3	2.0	0.0	1.9	0.5	0.0	0.0	3.5	189.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.7	0.2	0.1	0.3	0.0	0.1	0.3	0.0	0.1	0.6	0.0
SEC16A	"KIAA0310, p250, Sec16L"	ENSG00000148396	"SEC16 homolog A, endoplasmic reticulum export factor"	O15027	9	136440096-136483759	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005684	Supported		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		48000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA005684: AB_1079189"	"unprognostic (1.24e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.41e-1)"	16.8	18.2	6.4	16.6	6.7	35.3	17.1	8.0	9.4	16.6	19.3	17.3	14.9	17.9	9.0	17.9	16.4	12.4	14.5	7.0	5.2	14.3	37.9	19.4	16.9	4.4	4.9	16.2	29.2	14.0	24.3	10.8	3.5	18.7	10.5	9.2	25.8	13.1	23.5	19.7	19.1	10.7	2.4	20.7	27.2	17.6	5.2	17.4	15.3	11.9	12.3	15.9	14.5	5.0	26.5	57.7	28.5	47.2	29.6	30.3	33.6	32.1	27.9	23.4	17.8	41.9	22.1	26.4	22.1	39.2	28.8	71.3	31.8	46.2	12.7	56.2	20.7	26.9	55.1	33.7	28.6	46.2	45.8	32.8	32.5	32.7	38.1	18.9	32.2	34.5	34.1	35.6	25.0	114.3	31.2	24.9	25.1	79.0	40.4	44.3	35.2	45.0	23.8	35.0	40.0	26.6	41.6	62.2	19.8	13.8	63.6	35.9	47.0	37.6	28.1	30.8	25.2	16.9	27.7	33.4	29.2	20.6	38.3	1.7	2.8	1.2	2.5	3.1	2.7	2.3	2.6	3.0	1.6	1.4	1.6	2.8	2.0	1.5	3.4	2.6	1.9	2.4	6.4	6.7	8.0	9.4	7.0	5.2	4.4	4.9	3.5	2.4	5.2	5.0	20.0	25.6	41.7	16.6	16.4	24.9	15.3	18.4	10.8	20.2	38.7	30.6	11.5	12.8	23.6	12.9	25.0	8.1	17.5	30.1	7.9	14.2	5.1	26.9	19.5	18.2	40.7	12.0	27.4	16.4	11.8	16.0	46.9	38.2	23.5	25.4	17.9	62.2	16.5	33.7	19.2	65.5	20.3	23.4	19.5	6.0	13.1	22.3	14.2	17.8	19.5	13.0	11.3	9.5	14.7	22.8	14.7	16.6	25.1	26.3	22.3	10.1	34.7	17.1	13.1	20.5	16.6	24.4	16.1	17.2	26.9	15.1	17.8	15.8	22.8	22.1
SEC22C	"MGC13261, MGC5373, SEC22L3"	ENSG00000093183	"SEC22 homolog C, vesicle trafficking protein"	Q9BRL7	3	42547969-42601080	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031242			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA031242: "	"unprognostic (1.68e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.35e-7)"	"unprognostic (2.59e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-3)"	35.7	23.4	37.3	14.1	40.8	36.5	33.2	39.1	46.8	28.2	33.8	31.1	31.9	29.8	27.4	17.2	27.2	18.9	24.3	34.1	38.0	26.2	16.4	33.1	19.0	41.4	40.3	29.3	29.6	26.4	26.6	19.3	42.0	37.3	15.6	25.6	23.3	25.9	22.2	19.4	32.6	26.3	37.5	20.4	28.3	27.5	39.2	18.2	24.2	26.1	16.4	25.7	23.1	48.1	24.0	22.2	35.9	30.5	72.4	68.1	7.6	43.8	46.7	46.1	47.9	15.5	37.9	24.5	17.6	50.1	28.2	12.6	24.1	39.8	40.7	32.8	28.5	41.7	40.0	21.0	55.4	19.2	39.5	38.3	53.1	51.4	62.5	46.5	51.1	38.7	37.0	46.5	45.8	16.6	27.1	22.3	19.8	16.0	31.9	11.7	21.4	22.9	40.6	21.1	18.5	27.8	30.9	28.0	34.5	26.5	48.4	20.9	42.9	35.1	27.8	63.8	43.1	36.8	55.6	23.5	41.7	26.6	34.0	11.7	11.5	22.0	13.2	9.0	19.6	11.5	17.6	16.3	10.8	9.4	14.9	13.2	7.1	10.2	9.3	11.3	16.3	10.1	37.3	40.8	39.1	46.8	34.1	38.0	41.4	40.3	42.0	37.5	39.2	48.1	31.4	25.6	27.6	27.1	23.2	15.0	18.3	25.3	25.0	16.6	31.6	29.6	18.8	24.3	17.2	11.0	29.2	20.5	28.1	1.9	41.1	29.7	61.2	17.5	19.5	30.5	9.0	48.2	18.9	32.9	20.3	31.8	21.9	12.7	49.4	25.1	32.2	14.5	31.3	26.9	18.4	4.9	32.6	19.0	14.4	15.0	32.6	17.6	40.9	21.5	35.5	39.2	24.7	12.5	44.1	28.8	1.0	42.9	23.0	24.0	36.9	29.6	19.4	39.9	39.5	26.6	31.1	96.9	49.8	11.3	10.2	10.5	34.6	20.3	6.6	9.4
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 2087.6;liver: 6268.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Hep G2: 567.4;HSkMC: 451.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	1800000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	719.1	424.3	164.8	179.9	345.6	40.1	617.5	386.0	290.0	460.0	145.5	644.0	620.0	335.8	459.7	240.7	376.5	670.5	237.2	156.3	231.3	853.7	6268.1	512.0	552.4	519.4	316.4	701.2	229.0	246.0	108.3	973.0	490.3	214.2	714.2	59.2	170.8	374.1	156.4	171.8	2087.6	233.2	310.3	948.8	257.0	87.8	284.7	170.4	147.0	265.6	177.4	414.3	213.1	524.3	0.7	1.7	7.7	1.0	43.6	12.2	7.3	4.1	10.9	0.0	0.0	12.5	65.3	2.0	36.3	1.5	1.4	1.7	0.2	0.1	0.0	2.4	52.7	3.1	0.2	567.4	25.9	3.2	0.4	451.1	0.7	0.0	0.1	1.9	0.1	1.5	6.4	12.9	23.5	1.3	1.1	6.4	30.6	17.0	0.9	1.3	2.0	100.8	12.5	8.0	2.2	2.7	2.7	16.7	1.6	54.6	125.4	0.7	0.7	3.2	1.7	5.2	1.0	8.4	1.5	2.0	1.7	5.9	1.5	0.1	0.1	0.5	0.5	0.1	0.6	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.5	0.6	0.2	0.9	0.3	0.3	164.8	345.6	386.0	290.0	156.3	231.3	519.4	316.4	490.3	310.3	284.7	524.3	312.7	448.7	529.3	0.0	15.2	0.0	0.0	0.0	0.0	0.0	312.0	271.1	0.0	0.0	102.1	125.0	0.0	223.4	9.4	0.0	197.6	73.4	0.0	83.8	231.0	75.8	0.0	0.0	0.0	52.8	17.5	358.7	0.0	116.1	26.5	458.1	0.0	0.0	858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	373.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	4.9	0.0	0.0	1044.7	52.5	0.0	0.0	0.0	133.1	0.0	0.0	0.0	0.0	112.9	10.0	361.8	0.0	0.0
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 47.8;thyroid gland: 45.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 157.4;Leydig cells: 52.5;Peritubular cells: 62.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 28.4;HaCaT: 28.7;TIME: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	NA	NA		120000		"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	3.2	2.9	5.9	1.0	1.9	0.0	5.9	0.8	4.6	5.6	0.0	2.8	1.8	2.4	2.6	1.7	5.1	1.7	2.2	6.2	4.7	3.8	1.0	3.6	3.3	2.3	8.9	1.9	0.7	0.2	0.5	0.7	2.2	8.3	3.4	2.2	4.3	1.9	0.0	2.4	3.3	1.4	3.0	47.8	3.3	3.8	3.2	0.3	45.4	0.9	1.4	3.1	0.7	3.2	0.0	0.0	12.1	0.0	0.0	0.0	0.5	7.6	8.2	8.8	4.2	0.0	0.0	0.0	2.2	28.4	0.2	28.7	3.1	0.0	5.8	0.0	5.8	0.0	3.1	0.0	0.1	0.0	0.0	0.1	0.0	1.5	7.2	10.1	13.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.6	7.5	2.1	8.9	6.8	2.8	0.0	0.1	1.1	0.0	0.0	0.4	13.8	0.4	0.0	44.2	0.0	2.7	0.4	0.0	5.4	3.4	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.9	0.8	4.6	6.2	4.7	2.3	8.9	2.2	3.0	3.2	3.2	2.8	0.0	3.3	18.3	1.8	3.6	2.4	0.1	0.0	2.6	0.8	8.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	157.4	1.6	0.3	14.8	26.5	0.0	12.3	0.2	0.0	15.3	0.0	4.3	2.5	0.2	2.9	0.0	1.3	1.7	5.1	0.7	2.0	0.0	5.7	23.3	52.5	0.5	12.4	19.7	0.0	1.9	0.0	3.0	0.9	0.0	0.0	62.4	0.0	5.8	1.9	4.7	0.8	4.1	0.0	0.7	2.0	0.7	0.8	0.1	2.4	0.0	0.5	11.2	1.0	0.4
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774228	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.5;placenta: 43.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Horizontal cells: 79.1;Inhibitory neurons: 319.5;Oligodendrocytes: 140.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 14.9;SCLC-21H: 13.3;SH-SY5Y: 12.1;SuSa: 14.2;U-266/70: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.5	1.5	11.3	3.9	27.9	0.4	5.0	11.1	21.3	5.8	0.0	10.6	21.8	1.6	2.5	1.7	4.9	4.0	9.4	9.8	16.3	15.1	3.1	8.9	2.1	17.2	31.1	26.7	16.1	10.6	5.5	43.1	23.1	4.5	12.7	15.8	4.5	8.4	20.9	3.0	38.5	3.3	12.0	2.5	3.0	2.6	20.5	2.7	5.8	6.0	0.6	3.1	10.0	28.8	0.0	0.0	2.5	0.0	1.5	1.2	0.2	0.6	14.9	0.4	0.0	0.3	0.1	2.2	0.0	4.0	0.0	7.6	3.4	1.1	0.1	1.1	1.7	0.0	5.0	0.0	4.0	0.0	0.2	1.1	8.3	0.0	0.5	0.0	1.0	5.7	0.1	3.4	0.4	0.8	2.8	0.7	4.6	0.0	0.0	1.6	0.1	2.4	1.1	1.1	13.3	12.1	0.1	1.0	4.3	14.2	0.5	0.0	0.0	6.9	0.3	0.2	0.0	10.0	0.0	2.3	1.8	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.3	27.9	11.1	21.3	9.8	16.3	17.2	31.1	23.1	12.0	20.5	28.8	13.9	51.3	1.5	72.8	0.2	2.0	4.0	1.4	1.2	6.2	0.5	10.7	10.0	4.3	2.1	11.0	114.7	19.7	0.1	40.6	5.9	1.0	0.2	0.5	2.3	10.1	17.4	0.0	120.7	0.2	1.8	10.8	0.0	0.3	3.8	71.0	5.0	0.9	2.6	79.1	319.5	5.4	0.0	0.0	1.9	1.2	23.3	1.0	8.8	15.9	0.0	9.3	0.0	43.2	140.1	0.3	8.5	13.5	0.0	1.2	53.5	0.2	0.1	2.3	0.0	9.3	13.9	0.8	6.3	0.3	1.1	4.7	0.2	3.4	15.1	1.6
SERTAD1	"SEI1, TRIP-Br1"	ENSG00000197019	"SERTA domain containing 1"	Q9UHV2	19	40421589-40425992	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 480.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063323			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	Nucleoplasm	"HPA063323: AB_2684984"	"unprognostic (2.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.08e-3)"	27.1	9.3	8.1	7.3	7.8	28.7	10.7	9.4	12.1	9.1	8.5	12.0	6.7	11.3	2.1	18.8	15.2	12.7	21.2	9.0	7.5	21.9	14.1	22.3	5.8	8.7	7.9	6.9	15.1	4.4	8.9	6.6	8.7	11.1	3.0	0.9	8.4	4.2	15.1	15.5	10.8	7.1	8.4	10.0	18.8	3.8	9.7	5.5	11.6	13.2	3.5	11.0	11.9	8.7	18.5	21.4	3.0	7.4	8.3	5.9	8.0	29.0	8.7	15.4	15.1	9.5	14.6	3.6	13.4	9.8	4.4	7.4	2.4	26.2	4.7	10.1	5.1	3.2	5.0	8.3	9.4	1.1	11.0	9.6	15.8	16.8	3.1	7.4	8.7	3.1	6.8	5.6	14.1	27.7	1.7	5.6	2.3	13.2	14.2	2.2	4.8	9.3	8.2	12.8	0.9	1.4	15.3	14.0	14.5	3.4	14.0	3.1	16.2	15.2	17.2	12.3	19.8	8.1	3.6	4.8	21.3	4.8	7.2	22.5	21.9	15.0	9.7	19.8	5.8	13.3	9.5	9.3	26.1	12.7	10.9	7.8	17.5	15.9	19.4	23.8	14.2	13.6	8.1	7.8	9.4	12.1	9.0	7.5	8.7	7.9	8.7	8.4	9.7	8.7	480.2	73.7	52.3	2.3	138.2	126.2	196.5	83.4	243.6	5.0	221.4	299.7	83.2	32.9	51.5	31.3	0.0	46.0	203.8	246.0	23.5	62.6	1.4	100.0	72.1	156.1	106.1	6.1	1.1	61.7	72.8	159.7	169.7	126.7	132.9	27.9	86.7	12.8	53.9	3.3	0.6	152.3	46.8	28.9	98.3	4.2	16.4	102.6	94.3	4.7	30.0	17.9	6.2	1.5	0.8	91.6	300.8	10.9	69.7	130.9	158.9	18.5	31.7	2.4	39.5	292.5	201.5	1.7	5.4	174.7	130.4	130.2	150.4	24.2	102.0	111.9
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 23.1;ovary: 65.5"	"Group enriched"	"Detected in some"	7	"Granulosa cells: 196.9;Theca cells: 192.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.4;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.4;monocytes: 1.3"	"Cell line enriched"	"Detected in single"	16	"HEL: 10.1"									"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	1.1	7.3	0.5	1.8	0.8	0.4	0.4	0.4	0.7	0.3	0.6	0.5	0.8	0.3	0.2	0.1	0.9	0.3	0.4	0.6	0.6	0.4	1.7	1.7	0.6	1.4	1.0	65.5	2.7	0.1	0.2	1.8	1.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	1.0	1.2	0.8	23.1	4.7	1.5	1.6	0.1	0.2	0.1	0.0	0.6	0.2	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	10.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	1.4	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.1	0.5	0.8	0.4	0.7	0.6	0.6	1.4	1.0	1.3	0.8	1.6	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	19.6	0.0	0.6	0.2	0.3	1.0	0.0	0.0	0.0	1.1	0.1	4.3	0.0	0.3	0.0	196.9	5.3	0.6	7.9	0.0	0.0	0.0	0.0	26.8	0.2	0.1	0.0	6.1	0.0	5.6	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	7.5	1.7	0.7	0.0	0.1	0.1	0.2	192.3	0.0	0.0
SIGLEC15	"CD33L3, HsT1361"	ENSG00000197046	"Sialic acid binding Ig like lectin 15"	Q6ZMC9	18	45825675-45844094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 1.7;intestine: 3.0;urinary bladder: 1.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.6;Hofbauer cells: 10.1;Macrophages: 3.7;Pancreatic endocrine cells: 3.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.0;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.0;monocytes: 3.0"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 124.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053509			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA053509: "	"unprognostic (3.89e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (9.14e-5)"	0.0	0.4	0.1	0.3	0.4	0.0	1.7	0.6	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	1.0	1.3	0.0	0.0	0.2	0.0	0.0	0.6	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.9	0.3	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	2.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	10.9	2.1	0.3	0.0	22.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	5.5	0.0	0.1	1.3	0.0	0.0	0.0	124.2	2.9	0.2	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.0	1.0	3.6	0.9	0.8	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.5	0.4	0.2	1.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.7	0.0	0.0	2.2	0.4	10.1	1.7	0.1	0.2	0.0	1.6	2.5	0.0	0.0	3.7	0.0	0.0	1.6	0.0	1.0	0.0	0.0	3.5	0.1	0.0	0.0	1.1	1.2	0.1	0.0	1.0	0.0	1.5	0.4	1.2	0.1	0.0	0.3	0.0	0.3	0.0	0.1	2.8
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036015-7040117	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.8;GAMG: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	1.4	1.0	1.1	2.1	0.8	0.4	1.4	1.8	1.1	1.8	1.0	2.2	9.2	0.8	1.3	5.3	1.8	3.7	1.6	0.9	1.0	6.8	36.1	2.4	2.8	1.2	1.2	0.5	1.2	2.9	0.8	1.5	1.0	1.4	1.6	0.3	3.3	0.8	0.4	5.3	5.5	0.9	0.9	3.5	1.9	0.5	1.0	1.8	3.3	0.2	2.5	1.2	2.6	0.8	13.1	22.8	5.3	3.2	3.2	1.8	2.2	1.3	3.3	2.9	6.5	7.4	14.3	8.3	2.2	2.1	26.2	20.1	4.1	7.0	1.2	10.3	2.9	3.4	1.8	18.0	3.6	1.2	7.6	2.1	7.8	4.3	3.5	3.9	11.9	7.4	4.0	2.3	3.1	6.5	5.1	2.1	2.2	6.6	1.8	2.4	1.8	1.4	2.7	3.6	0.2	1.4	4.0	2.2	1.8	7.8	6.1	1.8	4.5	1.8	4.1	3.0	1.9	4.0	8.9	0.5	5.4	3.0	0.8	0.0	0.8	1.0	1.2	0.8	0.9	1.1	1.0	1.5	0.8	2.5	1.1	1.1	0.9	1.2	0.9	1.1	1.2	0.5	1.1	0.8	1.8	1.1	0.9	1.0	1.2	1.2	1.0	0.9	1.0	0.8	2.3	0.0	1.5	0.7	5.1	0.5	0.9	1.3	4.0	0.4	1.6	0.9	0.4	1.5	0.8	5.5	0.0	1.9	2.4	1.1	0.0	1.0	0.0	0.5	0.5	2.8	0.0	0.4	1.8	0.2	0.4	0.6	4.1	0.7	3.8	1.1	2.2	8.2	0.5	3.3	1.1	1.2	2.0	0.6	3.1	0.0	0.9	1.6	0.0	1.0	1.4	0.9	6.2	0.5	0.0	0.5	0.1	0.0	2.9	0.9	2.4	1.9	1.4	0.5	0.0	0.3	1.1	0.0	0.0	7.4	1.6	2.5	4.7	0.5	1.0	1.0
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132813339	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Hofbauer cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029747	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Cytosol	"HPA029747: AB_10600797"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.9	8.9	21.0	6.3	21.6	4.6	9.7	22.5	28.0	9.4	23.1	9.7	14.5	6.4	5.8	13.6	9.8	11.9	3.9	21.2	22.2	12.7	7.6	5.7	7.7	21.6	22.3	6.9	9.9	12.9	8.3	15.7	21.0	5.4	10.1	2.6	13.1	4.5	3.2	9.5	10.5	5.9	22.8	8.3	16.1	2.0	25.1	7.9	10.2	3.5	8.1	11.1	7.2	22.8	6.8	6.5	10.0	0.0	1.5	3.2	5.7	2.5	7.2	4.4	13.4	14.9	13.8	0.2	9.2	1.5	7.9	17.3	13.4	15.4	3.3	10.3	27.6	3.6	11.3	16.8	7.5	3.0	0.3	9.3	13.7	7.2	14.5	7.3	13.6	20.7	40.4	2.5	3.8	9.4	10.5	0.3	14.1	15.8	8.7	15.7	11.7	11.8	36.6	11.4	21.2	0.0	12.9	25.2	20.1	6.0	8.9	0.1	6.0	1.9	5.3	2.1	5.7	8.5	0.5	0.4	11.5	0.1	1.7	0.0	14.4	0.8	4.3	3.2	8.1	6.6	6.5	6.0	19.9	9.7	9.5	6.6	0.8	3.4	0.3	15.5	11.9	8.1	21.0	21.6	22.5	28.0	21.2	22.2	21.6	22.3	21.0	22.8	25.1	22.8	10.4	0.0	6.5	93.4	15.2	10.1	10.3	30.4	22.8	5.5	13.0	7.4	3.1	40.0	20.6	27.6	2.1	53.1	8.2	5.4	9.8	32.0	0.2	12.6	4.8	7.8	16.3	49.1	32.2	15.1	19.3	7.8	20.4	5.8	0.0	5.8	18.2	15.6	65.6	0.0	25.3	11.9	32.6	21.5	9.0	0.5	6.8	26.7	14.2	27.2	11.4	9.3	5.2	51.3	4.4	14.6	6.0	4.5	6.6	8.8	7.2	6.4	27.9	3.5	0.0	8.6	4.8	0.3	0.5	25.5	10.9	28.5	7.3	21.7	15.3	13.2
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 99.3;choroid plexus: 88.4;retina: 107.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 236.8;Cone photoreceptor cells: 114.7;Excitatory neurons: 102.8;Inhibitory neurons: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	10.2	99.3	26.3	8.2	27.2	7.8	9.4	24.1	26.0	13.5	88.4	9.4	6.4	12.9	8.7	6.1	15.9	10.1	8.3	28.5	26.7	13.0	57.0	12.1	10.2	28.1	32.0	38.5	10.0	17.7	23.3	8.1	29.5	12.5	6.1	107.2	5.9	10.3	3.3	11.4	12.5	10.0	25.6	20.9	9.4	11.4	34.6	8.2	25.0	4.5	9.9	18.9	8.9	33.1	21.2	24.5	32.2	12.2	22.2	12.4	40.9	8.9	12.1	10.3	9.6	12.7	23.6	9.6	9.4	12.4	29.1	20.1	9.1	24.2	19.2	6.0	16.2	13.3	4.3	48.0	12.5	18.9	7.6	10.6	13.8	25.8	15.4	21.5	15.2	15.5	9.3	7.9	13.7	7.9	20.7	10.5	11.4	16.9	14.9	19.0	21.2	14.3	5.6	34.2	10.7	12.0	17.0	17.7	63.3	11.4	9.8	10.9	13.1	23.0	10.7	27.8	17.4	11.2	22.2	25.5	8.1	11.2	36.8	0.0	1.1	0.1	1.1	0.7	1.0	1.8	0.8	0.8	1.5	1.0	0.8	0.8	1.2	0.3	0.9	2.4	0.5	0.9	26.3	27.2	24.1	26.0	28.5	26.7	28.1	32.0	29.5	25.6	34.6	33.1	9.3	6.4	7.2	50.3	14.5	7.4	4.5	7.0	12.5	236.8	8.3	7.4	7.9	15.7	9.4	14.7	114.7	4.9	12.6	0.8	0.0	5.0	4.6	2.8	10.1	13.0	7.2	8.6	102.8	5.5	6.6	14.2	3.6	1.9	8.2	13.5	17.5	71.3	10.6	85.8	117.4	1.9	0.0	30.2	7.5	9.3	20.2	16.3	16.0	60.0	8.8	24.8	7.2	77.4	78.3	3.4	6.7	29.3	11.9	8.2	0.6	1.3	7.8	71.5	13.1	12.6	12.2	0.6	8.0	5.5	6.1	4.0	8.2	65.6	2.8	14.7
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212642-19722926	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.7"	"Group enriched"	"Detected in many"	9	"Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"basophil: 5.8;eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	10.4	3.1	16.2	4.0	11.7	1.4	4.9	13.3	56.1	17.8	2.7	10.8	3.8	28.3	24.3	20.6	20.0	13.0	1.1	81.7	18.6	1.1	0.7	5.5	1.0	13.6	19.2	14.6	0.7	7.5	1.2	3.0	9.1	10.9	5.4	7.3	4.7	17.5	40.9	7.0	5.0	29.1	10.3	2.4	3.8	1.5	34.8	1.9	3.0	16.9	2.7	8.6	8.9	5.4	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.8	13.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	18.2	0.0	0.0	0.7	0.0	75.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	9.0	0.0	0.6	17.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.2	11.7	13.3	56.1	81.7	18.6	13.6	19.2	9.1	10.3	34.8	5.4	0.2	3.2	1.1	134.5	0.1	1.1	1.1	0.4	0.0	19.1	5.0	2.3	0.4	0.0	1.3	1.8	0.0	8.5	0.1	0.3	0.0	0.1	17.0	1.2	29.8	0.4	7.7	3.4	11.8	0.0	0.3	1.9	0.0	1.6	26.6	0.1	0.4	0.0	0.6	1.7	327.0	4.1	0.0	0.0	0.7	18.3	3.7	1.1	0.0	12.2	0.0	3.1	0.0	375.5	2.4	0.2	2.8	4.1	0.4	0.8	0.4	0.0	0.0	2.2	0.0	2.7	3.0	0.5	0.8	2.9	4.1	3.4	0.4	0.1	0.7	3.8
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093949-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	25.8	25.6	9.8	21.0	10.3	19.6	30.3	11.7	15.9	29.7	17.4	26.9	24.7	25.6	38.2	19.3	24.3	24.0	24.1	9.7	10.6	29.1	29.0	21.1	24.7	10.1	11.4	22.3	33.0	35.9	24.0	27.4	10.2	29.4	24.7	18.5	30.8	24.0	16.4	27.1	23.6	22.8	9.7	21.9	26.3	16.4	10.9	20.8	37.5	16.5	23.7	23.6	19.7	12.1	37.4	29.9	26.3	46.2	69.1	53.2	82.5	58.8	53.6	36.4	55.1	26.0	45.7	50.2	70.6	41.4	63.7	38.8	38.6	46.1	61.5	60.2	43.5	55.7	35.0	43.2	55.0	34.8	58.3	35.7	57.1	38.3	46.5	50.1	36.6	34.2	34.9	57.0	46.1	46.9	46.4	71.6	29.4	25.3	33.3	35.5	33.2	89.9	53.6	34.5	46.0	36.8	47.4	45.0	84.5	36.0	43.7	76.2	33.3	23.2	29.5	58.7	58.2	49.5	67.5	37.9	46.6	62.3	58.9	11.9	5.1	8.5	4.1	5.3	4.4	6.9	6.4	6.2	6.3	4.3	5.9	4.8	4.1	4.0	5.5	9.6	4.9	2.8	9.8	10.3	11.7	15.9	9.7	10.6	10.1	11.4	10.2	9.7	10.9	12.1	17.3	19.2	21.5	14.7	26.9	18.7	27.9	27.5	19.9	15.3	28.5	20.6	29.2	18.6	23.2	25.8	22.9	42.0	35.3	19.9	29.4	22.0	6.9	28.8	35.8	19.3	13.2	29.9	29.6	27.1	80.4	24.8	34.7	23.7	41.3	15.4	21.8	19.8	22.3	8.4	30.6	27.9	32.6	17.2	18.4	9.9	24.2	16.8	14.2	19.7	21.2	14.9	15.5	22.1	23.3	19.0	16.7	22.2	51.8	34.7	16.9	21.3	27.7	24.7	26.3	17.5	21.4	11.0	14.9	26.6	21.5	51.6	23.4	20.9	23.2	28.6
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	23.2	36.3	23.1	17.2	22.3	27.1	23.2	21.3	25.2	26.4	22.6	23.9	21.3	23.1	17.4	31.8	23.2	18.2	17.2	21.8	20.6	27.7	38.3	22.8	24.0	22.6	23.1	25.5	34.9	14.9	20.3	18.2	22.3	31.2	10.1	11.3	30.3	14.0	18.3	32.7	26.4	10.4	21.2	33.6	27.7	25.0	23.4	14.4	29.2	8.2	13.4	22.4	25.6	22.8	35.9	45.1	17.5	15.0	23.9	23.2	36.3	17.6	33.7	19.7	22.6	60.9	54.6	22.5	63.2	19.9	24.7	49.0	9.3	40.5	6.7	19.6	32.5	20.2	29.5	49.0	46.6	27.6	23.6	33.6	51.0	27.4	29.8	20.8	15.2	23.7	33.3	41.5	14.2	85.0	19.8	40.7	24.3	34.1	36.7	18.9	19.7	45.3	25.8	35.1	28.1	39.6	16.4	87.1	60.9	10.4	56.0	47.8	15.7	53.2	33.7	27.5	32.0	55.6	51.5	25.2	58.0	29.7	23.9	42.7	37.9	48.0	37.5	39.9	35.4	29.7	39.0	38.8	42.4	27.9	44.5	40.3	33.5	33.4	30.8	72.9	41.1	44.1	23.1	22.3	21.3	25.2	21.8	20.6	22.6	23.1	22.3	21.2	23.4	22.8	17.0	16.0	19.1	24.5	27.6	14.4	29.0	35.5	29.0	41.3	32.4	25.4	6.7	21.5	29.2	27.6	41.7	89.5	32.6	26.9	13.7	41.3	5.9	12.8	13.0	18.4	21.0	12.4	13.6	61.8	49.2	24.0	26.0	13.9	14.7	20.3	31.8	27.5	38.7	18.5	13.6	35.1	26.4	22.8	8.2	6.7	19.3	23.6	21.4	14.0	36.4	23.4	34.0	11.1	14.2	35.0	26.9	19.2	28.8	50.0	34.8	18.3	18.7	33.6	19.7	20.1	19.0	16.1	23.6	24.8	16.6	79.2	25.9	24.8	30.2	33.1
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904676-234324511	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.7"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	35	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	35	"dendritic cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.0	1.1	6.9	0.3	17.7	0.1	2.5	9.5	15.5	0.3	0.0	0.4	0.1	0.3	0.7	0.5	0.4	0.1	0.0	5.4	0.7	0.7	0.0	0.2	0.8	1.6	0.3	0.1	3.5	1.4	2.6	0.0	1.9	0.5	0.1	0.3	2.5	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.7	0.2	2.5	2.3	0.5	0.1	0.5	0.0	0.5	9.5	3.0	7.9	1.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.1	0.2	0.6	0.1	7.7	0.0	111.9	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.1	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	9.0	0.0	0.0	0.0	7.7	0.0	4.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.9	17.7	9.5	15.5	5.4	0.7	1.6	0.3	1.9	0.2	2.5	9.5	0.1	0.0	0.0	8.5	0.9	0.4	2.4	0.3	10.8	2.1	3.0	8.9	0.7	0.0	0.1	0.0	0.0	0.0	9.5	0.0	3.9	1.4	0.7	5.9	1.6	0.1	1.8	0.0	485.2	3.4	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	216.1	0.1	26.4	0.0	0.0	0.9	0.0	0.6	0.0	9.4	0.9	0.0	0.0	190.5	45.4	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.5	0.0	0.8	0.1	0.6	1.5	0.8	0.1	0.0	0.4	0.0	0.0	0.2
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 232.0"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Group enriched"	"Detected in some"	11	"midbrain: 232.0;pons: 86.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	7	"midbrain: 38.9;pons: 29.1"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.5	10.3	0.0	0.0	2.8	1.7	0.0	0.9	0.1	0.2	0.2	0.0	28.8	0.1	14.8	232.0	0.1	1.4	0.2	0.0	18.4	86.1	0.1	0.1	0.1	0.7	0.2	0.1	0.5	40.3	0.0	0.0	0.1	0.9	0.3	0.2	0.0	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	10.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.2	14.8	232.0	86.1	0.0	0.2	0.2	1.1	16.0	5.0	0.3	0.0	0.1	0.4	0.1	17.1	1.2	0.1	0.0	1.0	0.0	1.9	1.8	0.0	125.4	1.5	0.2	0.0	0.0	2.8	0.2	0.6	3.2	0.0	0.0	0.9	0.0	8.6	1.3	0.0	0.5	2.5	0.2	2.2	0.3	9.5	0.0	0.6	2.3	0.0	1.0	1.2	2.2	0.3	5.9	0.0	0.0	0.1	0.5	2.1	0.5	0.5	0.4	0.0	0.4	0.1	0.3	100.9	0.4	0.7	0.8	0.0	1.3	0.5	0.5	0.9	4.8	0.3	106.4	0.5	0.2	4.1	0.3
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.4;skin 1: 46.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3"	"Cancer enhanced"	"Detected in all"		"glioma: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.3;hTCEpi: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	3.9	31.0	21.7	4.9	45.5	10.8	4.6	53.2	24.2	12.1	6.3	11.0	2.3	7.4	1.1	23.1	9.5	4.8	2.1	16.1	31.3	4.3	2.3	11.6	1.1	66.3	43.5	2.9	8.2	2.8	1.7	1.4	63.6	3.9	6.3	17.2	11.5	5.5	1.1	46.6	6.0	9.1	45.6	1.9	7.4	1.1	45.9	1.4	5.3	0.6	4.3	12.3	25.1	72.4	19.7	13.7	7.1	18.0	11.2	3.7	15.6	14.7	41.0	24.3	30.1	4.8	7.5	0.3	1.6	42.9	0.0	62.3	11.0	12.5	5.0	0.1	1.8	17.1	33.9	5.8	50.3	3.8	0.7	11.3	106.6	11.9	28.5	15.3	0.6	12.3	13.0	48.5	1.0	10.4	2.9	0.1	5.4	7.4	19.1	2.2	0.0	22.9	2.3	2.2	4.4	4.2	7.4	35.3	7.0	1.7	9.1	10.3	0.2	2.8	11.0	2.4	8.0	53.1	39.2	4.4	9.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	45.5	53.2	24.2	16.1	31.3	66.3	43.5	63.6	45.6	45.9	72.4	1.5	0.0	2.0	5.9	1.1	7.5	0.9	3.2	8.0	30.7	2.2	0.9	0.7	4.3	2.2	1.8	16.7	0.5	0.5	17.8	0.0	3.7	5.9	4.8	0.4	0.7	0.0	33.1	2.2	8.9	1.0	0.9	1.5	2.7	0.0	0.0	0.0	0.3	0.3	1.7	1.5	2.7	20.3	0.0	1.0	0.8	1.5	0.1	3.6	0.0	1.0	1.2	0.0	3.0	16.4	4.2	3.0	1.5	1.3	2.0	9.1	1.1	12.5	11.1	6.6	0.1	10.0	0.1	0.4	8.9	12.9	0.5	0.3	1.2	2.6	3.2
SMCO1	"C3orf43, DKFZp313B0440, FLJ41923"	ENSG00000214097	"Single-pass membrane protein with coiled-coil domains 1"	Q147U7	3	196506879-196515346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"heart muscle: 41.5;skeletal muscle: 149.2;tongue: 107.0"	"Cell type enriched"	"Detected in some"	34	"Cardiomyocytes: 89.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061937			Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA061937: AB_2684642"	"unprognostic (4.86e-2)"	"unprognostic (1.62e-1)"		"unprognostic (1.51e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.72e-2)"		"unprognostic (1.73e-1)"		"unprognostic (3.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-2)"		"unprognostic (2.95e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-3)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	2.4	0.0	0.0	41.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.7	0.0	149.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM5	C17orf109	ENSG00000204323	"Small integral membrane protein 5"	Q71RC9	17	75633434-75641404	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	56	"plasmacytoid DC: 207.6"	"Lineage enriched"	"Detected in many"	56	"dendritic cells: 207.6"	"Cell line enhanced"	"Detected in some"		"HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065332, HPA071268"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	"Golgi apparatus"	"HPA065332: AB_2685471, HPA071268: AB_2686377"	"unprognostic (6.97e-2)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.29e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.64e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.58e-1)"	1.3	0.6	4.5	1.9	8.5	11.4	1.5	8.5	6.4	8.4	10.7	10.5	9.6	1.2	0.8	27.4	7.4	4.4	12.2	5.0	5.6	28.4	1.4	3.1	1.1	11.2	8.8	2.7	2.5	3.4	2.4	1.9	9.6	4.2	2.6	0.7	7.8	1.9	0.5	14.3	15.2	0.5	7.2	4.8	10.1	2.2	7.8	0.6	15.9	0.3	3.6	6.1	14.6	16.4	1.8	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.3	0.4	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	10.5	0.1	0.0	0.0	2.8	0.1	0.3	0.3	0.0	0.0	2.0	0.8	0.0	0.0	4.5	0.0	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.5	0.5	1.1	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.1	0.0	207.6	0.0	13.7	4.5	8.5	8.5	6.4	5.0	5.6	11.2	8.8	9.6	7.2	7.8	16.4	0.7	9.6	7.0	0.7	1.6	1.1	7.3	4.8	0.6	1.5	1.2	0.9	25.1	10.0	13.9	125.0	2.1	3.1	51.9	48.4	92.0	2.9	0.1	69.4	10.1	1.8	14.4	142.5	0.0	0.5	5.8	2.3	26.0	67.6	0.0	0.3	1.8	0.2	0.7	0.0	0.0	16.1	44.7	0.6	0.9	0.3	0.6	17.0	7.2	0.0	1.2	3.3	1.0	0.0	17.9	10.7	54.2	1.5	0.9	7.4	15.5	0.9	48.0	2.1	0.0	1.4	3.1	0.4	0.5	10.0	8.4	32.8	0.8	0.3	2.3	90.6
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27935000-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.1;pancreas: 49.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.1;Ductal cells: 31.5;Paneth cells: 47.5;Proximal enterocytes: 37.4;Undifferentiated cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.3;myeloid DC: 1.3;neutrophil: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.3;granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;CAPAN-2: 35.3;NTERA-2: 27.6;RPMI-8226: 30.1;SK-BR-3: 45.9;T-47d: 33.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.5	0.3	0.5	2.2	0.6	2.0	5.7	2.5	0.6	2.8	2.0	22.2	24.1	1.9	15.8	1.1	7.0	2.2	0.3	1.1	0.7	5.2	0.4	6.6	1.2	0.4	0.4	0.2	49.4	7.9	1.0	0.3	0.5	3.6	23.6	0.1	12.5	0.5	0.0	0.9	14.2	1.0	0.6	1.7	16.5	0.7	0.8	0.5	13.9	0.0	3.1	2.2	0.4	0.6	5.4	2.5	0.0	0.3	0.0	0.0	46.0	0.0	1.1	0.6	3.4	12.1	35.3	1.7	8.3	0.0	0.7	5.9	3.8	3.2	0.5	0.0	23.6	7.9	0.5	3.0	0.0	2.6	0.0	0.2	2.9	7.0	0.4	1.0	1.0	0.3	1.0	0.4	0.0	19.5	0.1	0.8	27.6	4.1	4.3	0.5	0.2	30.1	24.6	9.5	23.4	0.5	0.0	45.9	1.3	4.7	33.3	1.4	0.0	0.0	7.6	0.1	0.0	0.3	12.9	0.6	0.8	0.0	0.1	0.1	0.1	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.2	0.1	0.0	1.8	0.3	0.0	0.0	0.0	0.1	0.5	0.6	2.5	0.6	1.1	0.7	0.4	0.4	0.5	0.6	0.8	0.6	0.1	9.6	17.9	0.0	2.3	0.1	2.7	4.0	0.0	0.0	15.0	6.5	0.4	1.5	13.8	9.2	0.0	2.5	0.5	38.1	0.0	31.5	0.4	2.2	0.3	1.1	20.4	1.3	0.8	23.3	0.2	0.2	18.3	5.6	0.0	2.0	0.4	0.0	0.3	0.0	0.1	21.6	10.2	0.0	0.4	0.2	0.0	0.9	0.0	1.0	0.0	0.0	0.0	1.0	0.0	21.7	47.5	0.0	16.6	3.7	37.4	8.7	2.7	0.0	0.0	0.0	0.8	0.0	0.2	0.6	0.1	7.7	0.8	0.1	31.2	3.0
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658703-153661852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA		20000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	34.6	50.8	41.5	18.5	42.9	13.1	30.3	44.3	43.0	23.9	38.7	35.7	12.8	30.7	34.1	35.1	27.5	21.7	63.7	39.9	43.5	37.8	32.1	21.0	27.4	43.1	42.3	24.0	17.5	41.2	16.4	19.0	42.9	24.4	20.2	25.1	22.1	29.4	91.5	27.9	23.2	30.4	44.5	30.9	26.3	19.2	43.0	30.6	25.5	77.0	31.9	31.1	23.5	45.1	50.8	60.6	51.5	31.0	63.2	42.7	32.4	41.7	46.1	57.8	43.9	43.9	39.3	35.8	82.6	42.9	29.0	65.6	42.5	54.4	40.9	49.3	57.4	39.6	41.3	21.1	65.4	39.3	24.4	50.5	41.1	43.6	49.0	61.0	54.8	41.7	34.7	27.8	59.5	82.7	46.0	23.9	27.5	78.6	64.7	42.9	44.1	96.8	65.0	47.6	38.9	67.8	48.0	55.0	57.8	50.3	84.0	43.5	48.4	27.2	40.5	54.4	40.0	65.6	77.4	56.0	51.4	24.9	36.1	106.2	146.9	139.7	86.8	154.1	100.6	130.1	88.2	88.9	153.5	119.6	96.9	87.9	30.4	118.1	126.8	115.6	136.3	146.6	41.5	42.9	44.3	43.0	39.9	43.5	43.1	42.3	42.9	44.5	43.0	45.1	41.7	19.2	16.6	7.2	31.6	20.6	35.1	88.7	35.9	14.2	39.1	44.4	39.8	40.0	45.3	29.5	8.4	64.4	35.9	18.0	74.3	71.4	9.6	31.5	24.2	34.9	13.8	33.6	5.9	65.2	49.5	31.2	16.3	25.6	30.4	31.9	40.7	35.1	90.2	21.9	6.5	20.0	40.7	48.3	21.8	26.6	30.7	34.7	26.6	4.7	76.5	84.8	59.8	8.0	14.4	53.5	25.5	49.7	23.8	34.7	26.6	76.7	40.9	21.7	46.0	25.3	39.7	29.3	42.6	45.5	23.4	73.7	26.9	44.2	24.6	36.2
SOX7		ENSG00000171056	"SRY-box transcription factor 7"	Q9BT81	8	10723768-10730511	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 42.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8"	"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	22.6	3.8	2.5	1.0	2.3	0.1	11.9	1.9	2.6	27.0	1.4	4.2	0.1	4.3	1.1	26.8	4.5	3.6	18.5	2.1	1.8	5.1	4.3	23.2	1.7	2.6	2.2	1.5	2.6	1.0	5.6	17.3	2.5	5.4	1.1	0.4	10.5	2.7	9.8	20.2	3.6	2.3	2.5	2.4	3.7	0.7	2.7	1.5	7.6	6.4	1.9	4.6	42.4	2.0	5.8	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.6	11.8	3.4	4.2	0.1	0.1	0.4	0.1	0.3	0.1	0.0	0.2	0.2	0.1	21.3	0.0	4.3	0.0	25.2	0.0	0.6	0.3	0.0	0.2	0.2	0.2	1.6	0.9	3.2	1.2	0.0	0.0	0.0	2.1	0.6	3.4	2.2	0.0	0.0	1.4	0.0	0.1	6.8	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	1.9	2.6	2.1	1.8	2.6	2.2	2.5	2.5	2.7	2.0	115.4	0.0	11.5	0.3	1.1	61.2	67.6	24.5	148.5	1.2	5.2	4.7	4.8	1.5	6.3	0.0	4.2	4.3	0.1	0.2	0.0	0.2	0.2	14.9	1.9	115.1	0.0	0.0	4.6	0.2	0.8	4.7	0.0	22.9	3.8	0.5	48.5	4.9	0.7	0.0	2.9	0.2	10.2	1.9	8.7	0.1	0.9	0.9	3.6	10.3	0.3	0.5	0.0	1.5	0.8	0.5	0.0	0.4	1.2	17.8	0.1	0.6	3.2	2.2	0.0	8.5	4.4	2.4	1.6	98.9	40.6	12.4	1.8	1.2	0.4	26.6
SPCS1	"HSPC033, SPC1, SPC12, YJR010C-A"	ENSG00000114902	"Signal peptidase complex subunit 1"	Q9Y6A9	3	52704955-52711148	"Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046091, HPA055273"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA046091: AB_10959614, HPA055273: AB_2682768"	"unprognostic (5.47e-2)"	"unprognostic (4.04e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.09e-2)"	95.3	154.7	75.1	64.1	76.6	61.3	100.5	80.7	101.1	97.4	88.7	110.1	94.8	101.0	110.8	117.0	92.1	48.4	119.7	75.4	83.9	137.3	172.8	87.8	71.2	82.3	80.5	91.1	231.2	89.5	141.1	59.4	82.1	96.3	84.7	124.6	145.2	79.1	142.2	109.0	103.9	53.0	81.7	105.6	151.1	153.2	81.4	66.6	113.2	49.7	87.1	103.0	94.7	84.9	114.6	102.2	113.4	139.3	164.9	134.4	157.2	157.6	144.5	139.4	128.4	108.1	171.0	114.6	65.7	145.4	142.5	110.2	109.9	142.5	149.1	154.3	115.8	138.6	169.2	164.6	175.1	213.3	229.1	104.7	190.5	148.5	174.4	130.5	117.4	147.5	118.8	418.0	151.8	105.5	168.8	207.2	195.8	317.2	203.9	67.9	95.7	608.6	232.7	148.3	73.6	157.4	148.7	178.1	224.2	102.4	188.1	248.1	106.2	127.3	119.1	226.3	192.1	406.2	654.1	169.8	196.5	209.4	169.8	292.7	129.9	258.2	131.1	137.0	155.1	202.0	158.5	144.2	143.9	149.3	146.8	152.1	100.1	119.6	152.5	620.5	177.1	253.8	75.1	76.6	80.7	101.1	75.4	83.9	82.3	80.5	82.1	81.7	81.4	84.9	172.5	64.1	104.2	23.8	282.3	156.5	227.9	470.7	136.1	465.4	289.0	351.0	148.7	221.6	283.6	310.8	118.9	373.5	488.1	195.2	361.9	353.8	597.8	286.4	180.8	157.6	167.7	143.9	27.1	339.4	399.8	181.9	119.8	181.5	211.6	138.7	131.4	301.8	311.0	102.6	34.4	291.3	325.5	202.9	189.9	1177.6	216.3	192.5	380.6	13.1	321.9	296.9	213.1	21.1	53.2	274.8	274.1	191.8	888.8	295.0	405.5	665.1	374.1	251.3	164.3	152.6	335.5	746.4	504.5	195.8	184.4	351.2	220.8	283.6	267.7	285.3
SPRY4		ENSG00000187678	"Sprouty RTK signaling antagonist 4"	Q9C004	5	142310427-142326455	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.5;Alveolar cells type 2: 49.0;Endothelial cells: 32.8;Hepatic stellate cells: 37.1;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.2;WM-115: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008086, HPA055471, HPA072661"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"	Cytosol	"CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207"	"unprognostic (9.54e-3)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.21e-2)"	30.6	18.9	8.4	4.8	8.4	0.0	14.3	6.6	9.9	4.9	13.1	9.3	6.4	6.6	1.5	3.2	7.4	8.1	19.7	8.7	9.4	22.1	12.4	26.8	2.7	9.5	8.2	2.6	4.6	7.0	20.1	13.8	8.5	9.1	5.2	4.3	4.4	4.7	5.1	3.9	7.8	6.2	6.4	8.7	8.7	1.8	8.4	2.0	19.5	6.5	1.4	8.1	4.0	6.3	3.0	5.0	48.4	100.2	29.0	20.7	12.7	35.9	12.0	5.7	6.0	5.2	5.1	0.0	25.0	9.2	6.1	2.4	0.0	10.6	7.2	0.1	0.0	0.2	0.0	22.9	9.5	0.0	0.2	16.7	0.2	15.8	8.6	9.3	5.5	0.1	11.7	0.1	21.9	4.3	0.0	14.0	21.5	16.8	31.3	1.1	6.8	1.3	17.7	32.2	0.6	14.1	0.7	4.7	42.5	14.1	0.4	2.1	8.3	12.6	0.2	2.5	32.4	0.1	1.7	0.2	19.4	0.1	139.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	8.4	6.6	9.9	8.7	9.4	9.5	8.2	8.5	6.4	8.4	6.3	39.5	6.4	49.0	6.8	0.2	1.7	3.8	1.7	17.1	9.1	7.6	10.2	3.2	1.5	1.1	3.7	0.0	1.0	0.9	7.3	0.0	2.0	0.8	10.1	4.6	32.8	13.8	0.0	11.2	0.4	2.1	12.4	6.1	17.1	3.8	0.5	37.1	3.2	0.3	0.0	17.1	7.3	0.0	2.6	1.2	1.7	0.3	0.5	7.2	22.5	0.0	1.6	0.0	96.5	0.8	5.1	2.5	0.4	0.1	4.3	5.6	1.2	0.6	0.6	19.7	17.1	24.3	0.1	1.0	3.5	0.3	3.4	1.4	1.3	7.6	1.8
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051347-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 2.9;pancreas: 7.0;pituitary gland: 3.0;testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.3	0.3	0.5	0.0	0.9	0.0	0.1	0.8	1.2	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	2.0	0.3	0.0	0.4	0.0	2.8	2.1	0.0	7.0	0.2	3.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	1.5	1.1	0.0	2.9	1.1	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	12.5	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.9	0.0	3.5	0.0	0.0	0.0	4.2	0.6	0.0	0.0	1.1	3.6	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	1.2	0.3	2.0	2.8	2.1	1.6	1.5	1.1	0.9	0.4	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.1	0.1	0.0	0.0	2.8	0.5	0.0	3.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.0	5.6	0.0	0.0	5.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.4	22.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643786	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.1;intestine: 195.9;stomach 1: 64.9"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 801.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	32	"T-cells: 8.9"	"Group enriched"	"Detected in some"	4	"K-562: 65.5;OE19: 107.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		3500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.9	0.1	6.0	12.6	5.6	2.8	2.0	5.7	9.2	61.1	4.5	155.3	62.5	5.1	3.9	24.4	3.8	18.3	3.4	5.5	6.0	0.4	0.1	5.7	1.2	6.1	6.0	0.8	0.7	0.1	0.0	2.1	6.4	6.9	195.9	1.0	26.3	0.5	1.4	0.9	75.8	5.4	5.8	14.6	64.9	3.1	6.1	0.2	0.3	0.9	2.3	3.1	4.5	5.6	0.2	2.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.2	11.9	0.0	0.0	12.4	0.0	2.9	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	65.5	0.0	0.0	0.0	0.2	0.2	0.0	107.5	0.4	0.0	0.0	0.4	0.1	0.7	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	1.3	0.9	6.0	5.6	5.7	9.2	5.5	6.0	6.1	6.0	6.4	5.8	6.1	5.6	8.6	16.0	7.5	0.7	0.3	0.1	5.7	90.2	12.0	0.1	0.1	0.0	2.0	17.2	143.4	0.0	0.0	0.3	0.0	133.3	0.0	1.4	0.3	85.1	7.6	27.2	33.0	6.7	0.4	18.2	0.1	1.3	65.7	77.6	0.0	0.3	8.6	0.0	0.3	0.0	0.3	801.0	50.8	0.0	0.0	0.9	1.5	1.1	0.0	18.7	0.0	0.0	0.0	1.5	0.3	42.8	76.1	0.0	0.0	2.4	51.6	0.0	117.4	1.2	0.0	0.3	5.3	0.4	0.1	12.8	0.1	0.1	1.8	63.3	123.1	24.5
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917041	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.0"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 67.8;Erythroid cells: 112.2;Plasma cells: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 233.9"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 233.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 105.3;RPMI-8226: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	20.9	16.9	11.2	10.6	10.4	40.0	16.6	11.9	15.2	18.1	12.7	18.6	14.9	18.5	6.3	15.2	19.3	8.6	34.2	11.5	9.9	20.5	9.0	27.7	14.0	10.6	9.8	25.1	72.0	7.4	20.8	5.3	9.6	13.6	6.6	1.0	11.8	15.3	24.4	9.7	19.4	7.5	10.4	37.2	15.1	5.4	10.2	5.9	11.3	10.2	9.4	17.9	14.7	9.7	9.5	15.9	4.1	20.1	27.4	20.8	3.0	16.3	17.6	16.2	9.4	9.1	17.0	60.2	24.0	20.2	22.8	23.0	8.2	17.2	2.7	105.3	7.2	19.3	48.8	34.2	33.3	1.6	19.1	25.6	18.0	14.4	12.9	13.1	43.2	11.4	14.0	38.9	7.8	4.4	3.8	2.2	4.6	30.7	38.9	18.3	10.5	149.6	16.5	0.5	33.8	7.8	23.6	49.8	3.0	1.3	10.3	12.2	31.3	13.1	15.2	41.3	25.8	63.5	35.0	18.8	26.2	8.4	1.9	3.7	9.0	0.3	11.1	8.0	12.3	25.1	6.9	13.3	11.3	18.6	8.6	11.9	1.1	18.9	14.5	233.9	13.3	10.2	11.2	10.4	11.9	15.2	11.5	9.9	10.6	9.8	9.6	10.4	10.2	9.7	15.0	9.6	26.5	2.3	35.5	2.2	12.2	21.1	8.6	3.1	5.2	4.8	12.2	10.0	9.9	1.8	0.0	1.1	48.1	27.0	1.9	16.1	0.2	2.5	13.8	14.8	67.8	112.2	3.7	14.1	15.6	10.7	6.6	2.6	8.2	7.1	12.1	1.9	23.0	0.0	4.9	16.6	8.2	13.3	10.0	0.6	17.4	9.2	7.2	1.9	11.2	15.0	11.3	2.0	1.0	9.3	9.1	42.9	93.9	12.8	17.1	20.6	5.1	1.9	13.1	9.2	10.9	0.3	1.5	9.3	3.1	4.5	10.2	34.0	13.0	10.6
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 291.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	23.4	49.7	188.4	21.3	197.6	11.4	20.0	112.5	291.7	29.2	16.6	26.5	5.5	30.0	5.0	11.6	27.9	10.9	17.1	215.0	162.0	24.8	3.7	23.6	25.8	259.6	158.1	50.5	16.4	17.5	102.2	10.0	266.1	24.3	5.2	38.8	11.7	12.7	4.3	20.2	24.8	14.7	100.8	48.2	15.1	9.0	159.3	43.5	63.9	3.7	12.4	21.9	19.0	179.9	10.4	11.6	74.4	125.1	1.9	7.3	5.1	12.0	0.4	35.8	16.8	73.6	13.7	0.5	36.3	4.6	2.0	68.6	52.2	1.3	11.1	5.2	14.0	5.1	17.0	27.6	9.9	3.9	42.0	15.3	0.3	11.5	2.9	1.5	1.3	34.4	98.8	2.2	9.6	11.7	142.0	17.7	76.5	2.4	81.7	143.8	12.1	58.0	60.9	2.0	192.5	146.6	5.7	3.4	14.9	5.9	2.1	25.9	1.9	0.8	20.4	0.8	2.6	4.9	10.4	3.6	2.1	14.3	48.8	1.1	0.0	1.1	2.5	0.1	2.7	0.2	5.2	4.5	0.1	0.6	6.2	5.3	0.1	0.0	0.1	1.1	0.9	2.0	188.4	197.6	112.5	291.7	215.0	162.0	259.6	158.1	266.1	100.8	159.3	179.9	5.8	6.4	2.5	16.3	17.1	8.2	6.9	11.9	8.6	108.5	4.7	14.7	2.3	4.3	3.2	3.7	52.1	11.7	13.4	1.1	13.7	4.0	10.0	1.6	17.9	7.8	37.2	4.6	56.9	2.5	4.0	25.4	2.0	2.7	4.5	254.2	6.8	0.0	2.3	109.4	67.1	0.6	4.1	2.2	7.6	18.8	30.1	3.5	7.2	7.5	4.6	37.2	16.5	21.1	11.3	2.2	0.1	35.7	5.3	4.5	0.1	5.0	0.8	44.5	13.1	3.0	20.9	3.3	6.7	1.6	4.3	8.8	28.6	51.0	0.6	2.7
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 333.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 45.6;Horizontal cells: 92.5;Oligodendrocyte precursor cells: 27.6;Oligodendrocytes: 217.4"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	0.3	10.2	128.0	0.2	147.2	0.1	0.2	154.9	333.3	0.5	66.3	4.3	0.6	0.4	0.9	0.1	0.3	0.2	0.1	148.1	150.9	0.1	0.1	0.1	0.0	185.1	152.3	0.2	0.1	0.0	1.1	0.0	184.4	0.5	1.4	21.4	0.1	0.2	0.2	0.4	1.6	0.6	151.1	0.0	0.9	0.6	150.9	0.0	0.1	0.0	0.0	0.6	0.6	265.7	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	86.8	3.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.0	147.2	154.9	333.3	148.1	150.9	185.1	152.3	184.4	151.1	150.9	265.7	0.1	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	45.6	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	92.5	18.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.6	0.0	9.7	0.0	27.6	217.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.8	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5
STX10	"hsyn10, SYN10"	ENSG00000104915	"Syntaxin 10"	O60499	19	13144058-13150383	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035303, HPA056439"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA035303: AB_10671932, HPA056439: AB_2683135"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.54e-3)"	"prognostic favorable (8.26e-4)"	"unprognostic (4.09e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.57e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.69e-7)"	"unprognostic (2.39e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-2)"	45.3	58.7	42.1	35.6	44.3	72.3	47.1	45.3	52.3	65.5	47.0	57.2	47.7	48.7	17.1	80.7	49.6	29.5	56.1	42.2	41.7	60.9	78.8	66.9	42.5	44.6	43.3	50.7	48.3	27.9	49.1	17.0	43.1	49.9	19.8	11.6	52.0	20.4	35.8	68.2	60.7	20.9	40.7	87.0	60.3	17.7	43.6	35.3	56.6	16.6	28.2	51.4	55.4	48.5	99.9	68.8	51.8	138.1	51.5	52.8	17.2	55.4	49.4	46.1	48.4	31.8	88.3	66.5	80.5	66.8	33.7	76.3	44.9	67.0	26.6	113.4	86.0	60.8	154.4	66.5	38.2	71.4	63.2	54.3	55.3	57.4	37.2	62.8	58.1	85.9	32.9	34.6	31.8	87.2	105.6	125.2	55.2	51.3	112.5	117.3	54.1	96.6	44.4	47.2	60.0	121.3	57.9	66.2	127.6	14.9	45.1	67.9	58.4	75.3	38.7	145.9	77.5	78.1	75.2	57.0	98.0	172.8	59.8	41.5	162.3	120.4	48.1	128.4	40.7	39.9	41.4	48.7	119.1	40.3	36.3	37.3	267.6	32.1	151.5	31.2	51.4	80.7	42.1	44.3	45.3	52.3	42.2	41.7	44.6	43.3	43.1	40.7	43.6	48.5	31.6	16.0	21.6	13.1	29.9	35.4	34.5	52.0	31.3	21.3	43.0	37.5	12.6	30.0	53.6	20.2	6.2	17.7	32.2	54.3	27.4	42.5	1.0	23.9	28.3	31.3	16.3	33.2	16.6	56.1	26.2	27.6	40.8	24.7	53.8	33.7	31.1	18.8	82.4	13.5	11.8	48.0	46.8	86.7	45.8	3.0	25.1	62.0	48.0	7.5	86.1	21.4	48.4	11.1	14.0	57.0	53.8	31.2	25.3	19.9	77.9	28.3	38.2	17.1	26.3	21.2	31.0	9.0	16.2	38.6	43.2	19.4	39.1	23.6	55.5	38.4
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806860-62832051	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	34.2	31.8	31.2	22.2	32.1	41.9	34.4	35.3	39.0	42.0	34.6	27.5	22.7	30.6	42.6	34.9	33.1	25.0	27.2	31.3	32.1	38.3	51.0	32.7	25.1	34.2	31.8	42.2	51.1	27.0	29.6	27.4	31.7	43.6	22.4	18.8	51.8	26.9	27.7	41.4	28.4	23.9	31.3	35.5	36.0	29.0	32.9	30.4	37.9	20.2	31.6	28.4	34.2	33.5	40.9	25.4	34.5	29.9	44.6	50.2	31.0	39.2	54.9	64.7	52.0	18.8	39.0	26.0	35.9	55.9	37.8	41.7	29.7	37.2	47.8	60.4	28.3	23.0	33.0	39.2	55.3	26.9	33.5	40.7	41.6	58.6	70.3	50.5	31.9	37.0	21.0	71.7	34.5	48.4	36.5	43.8	11.3	36.2	36.8	37.1	32.3	70.2	28.8	20.7	26.3	21.6	31.4	49.4	63.6	25.7	54.4	35.9	36.8	46.8	24.6	54.6	25.1	64.2	38.1	27.4	38.0	18.7	29.6	11.7	11.4	36.2	10.4	14.1	9.3	11.0	8.1	10.1	10.4	11.3	7.5	7.6	17.8	13.1	12.7	12.9	13.0	6.6	31.2	32.1	35.3	39.0	31.3	32.1	34.2	31.8	31.7	31.3	32.9	33.5	30.3	22.4	29.3	12.7	64.1	67.2	79.5	37.9	13.6	21.0	38.0	27.9	5.6	20.0	27.6	11.0	27.1	55.3	57.6	29.8	29.4	45.7	113.1	28.2	28.6	33.1	32.9	23.5	16.0	59.6	75.1	39.5	23.9	34.0	52.7	25.2	30.0	24.4	46.5	18.5	15.4	54.8	22.4	39.5	53.5	143.7	39.1	33.2	46.2	12.2	51.6	30.3	44.3	10.1	16.6	44.1	36.0	25.2	47.2	61.2	44.8	32.6	20.7	18.6	32.9	34.1	33.6	32.2	30.1	19.8	64.2	177.6	40.4	28.0	26.2	75.5
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	9.5	7.4	13.7	11.2	14.9	2.7	9.2	15.9	17.9	9.5	11.6	7.9	7.5	8.2	7.7	17.5	7.4	7.1	5.8	15.6	13.5	8.7	4.8	11.3	10.9	13.8	13.7	8.2	4.1	7.4	4.5	11.5	12.6	7.2	8.1	8.1	8.0	6.7	4.0	12.8	7.6	8.7	13.2	9.3	7.9	5.6	14.1	17.2	11.4	4.9	14.1	14.2	11.2	16.6	16.9	18.6	18.0	24.1	18.5	21.7	30.3	21.2	27.3	16.4	13.9	17.4	16.5	17.0	28.7	23.4	10.2	29.4	16.5	37.4	19.0	12.3	12.1	11.4	14.2	17.2	18.4	16.4	14.1	19.9	33.6	27.6	28.3	29.3	33.6	15.7	21.3	11.8	22.0	24.2	15.9	15.4	28.2	21.0	9.2	13.7	22.0	24.7	19.6	41.7	25.5	27.0	22.2	42.3	23.9	30.7	25.8	14.9	28.0	22.4	11.8	21.2	17.3	19.8	11.8	12.3	11.0	15.8	13.5	2.6	1.6	2.1	0.7	1.3	0.8	0.7	1.1	1.1	2.2	0.7	1.4	0.9	1.4	0.2	1.1	0.7	1.4	0.6	13.7	14.9	15.9	17.9	15.6	13.5	13.8	13.7	12.6	13.2	14.1	16.6	13.9	16.0	18.6	32.3	11.8	48.9	21.3	19.0	41.5	12.8	16.0	11.7	6.4	2.8	13.7	18.4	6.2	25.7	15.8	10.5	11.7	10.7	8.9	19.4	16.6	23.0	23.4	16.0	54.7	9.8	24.9	12.7	19.4	22.7	12.0	12.7	14.6	4.8	26.4	8.4	38.0	11.1	16.2	26.1	28.0	11.8	8.4	31.9	7.2	23.4	25.2	6.7	15.5	50.3	30.7	14.9	13.9	13.2	10.0	22.2	10.2	11.5	13.3	11.4	6.6	8.2	12.2	5.6	15.4	47.8	37.6	20.5	14.0	16.4	10.6	22.8
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.4;stomach 1: 44.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.3	10.7	4.3	5.5	2.1	8.0	6.8	1.5	2.5	69.9	99.4	2.0	2.4	2.0	1.5	1.5	1.9	3.2	1.8	1.9	23.8	2.5	4.2	0.9	0.9	3.0	0.8	0.9	0.1	1.3	2.0	2.5	62.2	3.9	0.8	1.4	1.2	1.3	95.3	5.1	0.3	9.7	44.9	1.2	2.0	3.0	2.7	2.3	7.5	1.6	0.9	5.6	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.3	4.3	8.0	6.8	3.2	1.8	0.9	0.9	2.0	0.3	2.0	5.6	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150043-33218810	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA		17000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"		"HPA052788: AB_2681948"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	4.6	1.4	2.9	0.9	3.0	0.1	1.9	2.2	4.6	6.3	4.4	1.7	0.8	4.6	2.2	1.3	5.2	5.5	1.5	3.1	4.4	1.5	0.5	1.7	2.3	3.4	3.4	3.8	0.6	1.0	0.8	0.2	3.4	1.3	1.2	0.6	0.7	6.3	1.6	1.9	1.9	4.8	3.8	2.5	1.8	2.1	4.7	0.1	3.2	3.3	5.3	1.5	2.4	3.5	0.0	1.1	1.2	0.7	1.7	0.2	0.1	9.6	3.4	31.1	10.5	0.1	0.0	0.0	8.8	2.5	9.5	0.1	13.7	4.5	12.9	0.3	15.3	0.0	2.0	0.0	0.2	0.1	0.1	1.3	2.4	19.9	3.9	15.2	78.5	0.0	0.0	0.1	30.4	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.0	1.0	0.1	0.1	2.5	0.7	1.8	1.9	31.3	0.0	14.4	1.2	4.7	0.0	0.7	0.0	0.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.9	3.0	2.2	4.6	3.1	4.4	3.4	3.4	3.4	3.8	4.7	3.5	0.1	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	2.2	0.5	0.0	0.0	15.4	0.0	0.1	1.4	0.0	0.9	0.0	0.2	0.4	0.0	0.0	3.3	10.5	0.0	0.0	2.1	2.0	0.3	0.0	0.1	1.8	0.0	0.0	0.5	0.0	61.3	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	32.9	3.6	29.0	0.1	2.6	0.1	1.0	0.0	0.2	0.1	0.0	0.1
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877462-34888071	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	23.2	27.9	21.3	19.5	22.4	47.1	23.0	24.8	26.5	23.9	22.0	27.8	19.3	22.6	18.4	25.8	25.1	15.5	29.5	21.4	21.0	27.5	28.5	25.5	27.1	22.0	21.7	27.9	27.2	16.7	19.8	22.6	22.0	26.2	20.6	24.8	20.9	16.9	32.6	29.0	26.5	20.7	21.1	33.8	25.1	33.4	22.3	23.7	24.4	21.6	25.4	24.9	23.1	25.6	37.2	15.4	50.2	91.4	29.5	30.8	44.5	29.5	23.1	47.2	44.8	35.9	23.0	49.5	37.8	27.3	23.1	23.4	61.5	25.1	37.7	30.3	49.6	55.7	30.7	58.8	41.3	74.9	38.6	35.8	41.2	32.2	25.2	28.8	57.6	55.0	89.0	38.1	22.6	65.6	48.1	63.4	45.9	74.3	26.0	51.6	44.9	39.7	34.4	23.0	60.6	55.3	33.9	37.9	68.6	41.5	59.4	88.6	34.6	33.3	44.6	20.1	36.9	35.2	90.5	72.4	12.2	86.3	49.9	43.6	27.8	24.5	14.3	25.8	13.8	13.8	14.9	15.4	24.1	17.1	17.4	15.6	17.5	17.6	21.7	21.5	21.4	15.9	21.3	22.4	24.8	26.5	21.4	21.0	22.0	21.7	22.0	21.1	22.3	25.6	49.9	28.9	19.5	18.3	44.9	46.0	31.4	36.1	24.5	29.0	55.1	44.3	24.0	25.8	31.3	42.3	12.5	71.9	50.4	33.5	64.6	47.9	6.6	37.4	49.7	43.8	39.5	39.5	20.8	63.2	68.9	33.5	29.6	47.7	22.2	57.8	61.1	58.8	44.2	32.0	23.7	38.4	50.8	52.2	32.2	10.6	33.8	36.5	24.9	13.1	48.5	37.8	48.4	16.6	33.6	50.8	51.2	37.2	44.0	32.9	43.5	48.9	17.1	32.9	32.9	34.0	35.5	130.9	71.2	36.3	58.4	76.8	44.3	38.2	40.6	31.2
TAF7	"TAF2F, TAFII55"	ENSG00000178913	"TATA-box binding protein associated factor 7"	Q15545	5	141260225-141320784	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006429	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA006429: AB_1080196"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.78e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-2)"	58.0	62.9	54.7	53.8	56.1	79.7	76.7	63.6	69.2	57.4	63.0	53.4	44.6	73.8	82.1	48.9	73.6	42.7	103.1	56.4	57.5	63.9	66.6	55.7	79.5	55.2	55.5	104.1	52.8	43.4	62.5	60.9	56.8	67.6	56.4	92.0	56.6	57.0	142.9	56.2	59.5	63.0	60.3	69.8	51.8	76.0	57.0	119.6	60.7	130.8	88.8	51.0	43.8	70.7	82.4	67.4	150.3	110.7	131.2	120.9	93.7	104.9	93.0	145.4	141.4	95.3	90.2	220.1	204.6	107.3	157.5	68.7	95.9	97.4	146.0	96.8	106.6	39.8	80.1	79.8	119.4	55.2	80.2	111.1	141.9	56.8	99.9	114.6	106.5	98.7	85.8	167.3	141.7	103.3	124.7	133.1	54.4	103.7	24.4	156.7	200.7	162.4	107.5	109.0	120.0	137.1	85.6	121.7	118.1	114.5	174.1	178.2	98.5	20.5	69.9	67.6	129.2	45.0	195.3	198.9	89.3	126.8	83.6	183.7	35.9	161.5	53.1	44.5	69.1	58.2	62.6	60.2	50.2	54.7	84.9	72.3	104.2	89.1	55.2	55.5	57.7	70.6	54.7	56.1	63.6	69.2	56.4	57.5	55.2	55.5	56.8	60.3	57.0	70.7	142.3	86.6	68.7	0.0	146.0	120.4	353.0	96.4	67.7	132.7	78.9	72.8	168.4	77.2	92.8	82.8	95.9	94.8	147.4	123.7	82.2	113.7	50.8	92.9	115.7	112.6	84.2	52.6	0.0	76.0	73.3	127.3	70.3	90.8	155.1	70.0	96.0	70.9	51.0	121.1	0.0	110.2	69.2	52.5	92.3	36.8	146.9	86.3	112.1	0.0	94.6	141.4	132.8	0.0	0.0	123.7	150.4	129.1	68.0	243.3	120.0	77.3	107.2	101.4	164.3	175.2	135.8	124.7	141.1	75.7	170.5	141.3	161.5	111.9	106.8	245.9
TANGO6	"FLJ12688, KIAA1746, TMCO7"	ENSG00000103047	"Transport and golgi organization 6 homolog"	Q9C0B7	16	68843531-69085182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.2;Excitatory neurons: 45.4;Inhibitory neurons: 57.4;Late spermatids: 50.5;Oligodendrocyte precursor cells: 38.7;Oligodendrocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041312	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA041312: AB_10796342"	"unprognostic (8.55e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (6.02e-2)"	5.1	3.0	2.8	4.5	3.8	3.4	4.6	3.5	3.4	4.8	4.9	3.9	2.4	4.3	1.9	3.6	3.8	2.8	3.2	2.6	3.6	5.7	12.9	3.6	4.9	2.7	3.1	4.2	3.2	6.0	2.5	3.4	2.8	4.0	3.1	4.2	3.2	4.2	8.8	4.2	3.1	4.8	2.4	4.5	4.1	4.3	3.5	4.7	3.3	5.7	4.6	5.5	4.2	3.9	7.1	14.3	4.6	9.9	7.6	8.6	3.3	9.5	7.7	11.5	9.3	9.1	5.7	15.8	5.1	13.2	6.0	5.8	10.6	12.8	14.0	3.8	6.3	3.0	5.4	8.5	6.3	8.0	7.2	6.6	6.7	16.3	14.7	4.7	11.2	7.6	10.6	2.7	10.7	7.1	8.3	6.4	10.2	6.9	7.6	8.9	6.8	17.8	8.4	3.9	4.8	5.6	23.3	1.3	6.3	5.5	4.6	8.9	6.5	10.9	3.9	11.2	6.8	4.9	4.5	10.7	6.9	3.0	7.4	0.0	3.8	2.0	3.4	6.6	3.5	2.7	3.3	3.5	4.8	2.4	2.0	3.3	0.2	2.0	6.2	1.3	4.9	3.1	2.8	3.8	3.5	3.4	2.6	3.6	2.7	3.1	2.8	2.4	3.5	3.9	5.1	0.0	4.2	23.5	5.4	5.2	9.5	5.0	2.8	8.8	1.5	1.8	3.8	5.7	2.2	7.3	10.4	5.6	3.1	2.1	0.0	2.2	110.2	1.5	3.5	4.8	0.0	7.8	45.4	3.3	2.7	4.0	6.1	3.0	1.3	3.7	3.9	12.3	4.7	5.0	57.4	1.8	4.1	7.6	3.5	50.5	5.6	4.2	5.4	25.3	3.5	3.3	4.1	38.7	51.3	2.7	4.4	3.4	2.9	3.7	1.1	6.0	0.5	10.5	0.0	3.9	3.4	5.7	4.7	4.0	3.0	2.5	7.0	3.2	2.2	9.2
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	17.9	17.4	13.7	17.0	21.1	25.2	18.6	18.2	15.5	20.1	6.0	13.5	10.8	17.6	12.1	16.8	22.5	19.2	15.8	13.8	16.1	19.9	14.7	18.0	23.1	21.9	17.7	28.1	18.3	25.7	8.5	17.5	22.8	14.0	13.9	10.9	14.1	16.4	9.3	14.0	13.8	18.3	18.3	24.0	13.8	18.9	16.0	20.3	30.0	11.3	23.2	14.8	10.1	29.9	26.3	28.8	23.2	22.0	45.0	65.5	25.4	27.6	39.7	17.7	15.3	14.0	23.2	48.5	29.1	56.3	27.1	8.0	20.6	33.6	36.6	43.0	7.9	46.6	11.1	16.5	28.8	45.7	39.0	42.6	39.3	38.5	23.2	39.8	40.9	28.3	29.6	43.6	43.5	17.6	22.5	10.5	19.1	16.8	30.0	48.9	29.6	34.7	26.3	20.0	8.8	41.0	52.5	12.2	18.6	21.7	34.6	37.6	44.7	48.7	21.6	25.6	30.4	25.2	36.6	46.7	37.5	42.3	46.5	11.7	8.1	11.9	5.8	6.5	7.5	10.3	4.4	4.2	9.2	11.3	3.2	3.8	10.4	4.3	6.3	5.8	5.2	4.8	13.7	21.1	18.2	15.5	13.8	16.1	21.9	17.7	22.8	18.3	16.0	29.9	40.4	16.0	35.0	226.6	56.0	18.4	20.0	15.8	42.7	20.3	23.0	19.9	18.6	25.8	27.8	14.7	10.4	17.1	28.9	9.2	5.9	17.7	64.1	19.6	28.9	30.7	13.1	31.3	333.2	9.9	16.7	32.5	20.4	28.2	18.9	31.5	34.6	19.9	21.4	35.3	350.5	13.4	10.2	35.6	22.9	40.2	30.7	34.9	14.2	324.2	23.2	26.6	32.0	341.8	565.6	12.3	9.1	30.5	20.7	9.8	13.7	15.9	16.3	22.3	6.6	34.0	20.4	20.7	25.5	28.4	17.0	8.2	30.0	35.5	14.5	17.6
TCP11L1	FLJ11336	ENSG00000176148	"T-complex 11 like 1"	Q9NUJ3	11	33039417-33105943	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005769	Approved		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Golgi apparatus"	"HPA005769: AB_2202398"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.99e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.50e-3)"	6.3	5.0	5.6	5.5	7.9	7.4	4.5	0.7	7.3	4.8	0.0	6.9	6.1	5.0	3.3	4.9	4.0	8.1	4.7	9.6	7.4	5.9	4.0	4.6	4.9	4.9	8.9	5.3	5.7	4.0	5.0	7.0	8.3	5.0	7.2	6.0	4.9	7.0	3.0	5.4	8.9	8.7	1.0	5.4	4.2	5.6	3.1	7.6	3.2	4.1	5.7	5.8	4.5	7.5	11.9	21.3	10.7	10.2	18.3	20.3	7.2	16.9	14.4	12.8	17.3	11.0	5.6	12.3	4.6	33.1	19.0	18.7	14.5	13.2	18.2	16.1	13.0	8.3	23.1	8.1	12.0	8.2	10.8	16.4	16.2	13.2	25.0	14.6	12.8	17.4	5.2	14.3	32.4	17.6	8.1	3.2	8.0	8.8	8.2	9.4	22.4	2.2	11.6	4.6	9.1	18.3	43.3	27.5	7.9	13.5	7.0	3.4	20.0	22.7	32.5	25.7	18.1	17.5	19.7	13.9	16.5	4.0	18.1	18.6	6.1	8.8	3.4	3.9	3.4	2.1	1.8	3.8	5.9	2.8	1.8	2.4	3.6	4.8	1.1	11.1	5.9	3.5	5.6	7.9	0.7	7.3	9.6	7.4	4.9	8.9	8.3	1.0	3.1	7.5	4.9	9.6	1.1	12.7	5.0	2.3	10.7	4.2	12.0	5.6	1.7	2.0	3.1	2.8	1.8	0.0	4.2	3.8	4.6	3.5	1.9	4.6	11.6	1.8	4.4	4.5	1.8	2.1	22.5	4.0	19.2	6.3	3.1	2.3	4.5	2.4	4.2	1.6	6.8	8.4	23.7	1.2	2.0	5.7	5.2	6.3	1.8	6.9	0.0	18.7	20.2	1.6	8.2	23.1	29.6	5.7	1.6	2.6	11.6	8.9	13.3	5.0	0.7	5.7	0.0	7.0	6.4	10.4	5.4	6.1	2.6	4.7	6.7	2.8	1.4	3.9
TCTN2	"C12orf38, FLJ12975, JBTS24, MKS8, TECT2"	ENSG00000168778	"Tectonic family member 2"	Q96GX1	12	123671110-123708399	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.6;Respiratory ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039900	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus, Vesicles"		"HPA039900: AB_10673366"	"unprognostic (3.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-3)"	"unprognostic (3.14e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.68e-1)"	5.3	4.4	5.5	2.6	6.4	1.9	7.2	5.8	5.3	10.0	30.4	5.7	2.1	11.0	11.0	3.4	28.5	6.4	4.8	4.9	9.5	10.0	1.4	8.3	3.3	8.4	11.5	14.7	6.9	14.1	16.3	4.6	6.5	9.6	4.0	17.6	9.1	8.6	1.7	8.3	3.8	6.0	7.1	4.1	5.4	11.1	8.7	2.5	12.4	2.1	3.0	5.2	6.7	4.1	14.9	15.1	10.7	15.6	15.0	16.5	13.1	5.4	10.9	11.5	8.7	7.9	14.5	0.5	9.2	8.9	10.0	19.6	6.2	4.9	11.2	2.5	7.6	1.2	10.6	7.2	5.0	3.7	4.8	8.0	8.8	16.3	4.8	34.9	15.7	5.1	7.1	0.3	7.1	7.9	4.5	7.4	6.8	5.9	9.1	4.0	10.8	1.5	13.7	11.1	6.5	8.3	18.2	6.0	8.4	11.0	25.5	5.6	9.8	16.0	8.2	14.7	7.1	4.3	8.9	1.4	20.9	0.4	9.7	1.7	0.2	1.2	1.9	0.6	2.7	1.9	2.2	2.0	0.4	2.1	2.4	2.4	0.3	0.8	0.5	2.5	1.4	0.2	5.5	6.4	5.8	5.3	4.9	9.5	8.4	11.5	6.5	7.1	8.7	4.1	2.7	3.2	5.3	6.5	1.8	4.1	2.3	2.6	1.2	4.4	4.8	2.3	3.8	5.7	3.9	7.3	12.5	2.8	2.1	1.2	0.0	2.9	6.1	27.6	5.0	1.7	1.2	2.5	10.4	2.1	3.0	4.6	2.6	4.3	3.8	5.0	2.9	0.4	1.3	0.0	14.4	1.8	2.0	0.3	1.2	2.8	2.5	1.0	5.4	2.8	1.4	4.6	1.0	2.5	1.3	2.0	0.8	4.9	1.1	1.4	0.2	1.9	32.1	14.5	0.0	6.0	2.7	11.5	10.9	0.6	2.3	1.1	2.4	2.3	3.0	1.0
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"		19	41301587-41353922	"Human disease related genes, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.3;Extravillous trophoblasts: 452.1;Macrophages: 188.8;NK-cells: 223.5;T-cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	1290000		"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	39.8	28.6	10.8	39.7	10.7	82.9	25.4	11.8	9.4	53.2	9.5	31.0	14.4	45.9	7.4	52.2	27.7	18.1	35.8	9.5	15.5	35.8	14.7	63.4	34.0	24.5	14.9	17.4	14.3	11.5	18.0	32.1	17.6	31.6	8.4	0.6	21.2	19.8	8.1	29.3	37.8	21.8	18.4	88.9	20.1	8.1	19.4	16.7	20.2	8.3	25.7	44.1	45.3	17.7	57.7	87.6	3.4	0.3	41.7	35.3	10.0	81.9	64.4	25.2	15.4	40.4	30.1	57.0	88.6	110.5	26.8	30.1	17.8	54.6	11.1	76.6	17.9	199.0	18.0	50.4	47.7	54.9	119.6	45.0	17.5	50.5	32.7	138.7	135.2	21.1	108.0	116.8	27.9	42.1	43.1	79.6	9.4	12.0	52.7	44.4	13.1	85.4	46.8	20.3	0.3	6.5	23.9	0.1	15.1	32.5	1.9	36.3	170.3	96.4	77.2	20.7	91.2	74.4	31.7	36.3	90.3	106.4	16.4	1.1	0.8	3.9	0.7	1.2	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.3	2.4	0.3	0.8	0.9	0.3	0.9	10.8	10.7	11.8	9.4	9.5	15.5	24.5	14.9	17.6	18.4	19.4	17.7	55.0	0.0	0.0	3.3	120.6	44.4	36.5	64.8	38.7	0.2	14.4	9.7	2.3	4.3	17.2	16.5	0.0	5.4	438.3	1.4	0.0	12.8	1.0	5.7	18.2	63.1	0.0	28.0	1.6	17.1	452.1	34.3	14.3	5.0	64.9	20.0	71.4	2.7	141.2	0.0	2.1	1.4	22.4	136.1	158.6	1.8	12.2	188.8	23.2	30.0	105.8	0.3	223.5	0.0	0.6	45.1	16.4	18.0	156.5	32.9	0.4	9.0	9.7	0.7	39.5	13.9	78.6	3.1	8.0	40.3	18.9	55.7	221.9	4.1	0.8	31.1
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328296	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	70.0	67.5	37.5	82.6	42.1	129.9	58.3	38.5	44.0	63.5	32.2	85.8	110.6	62.0	60.9	41.1	65.1	75.7	63.5	39.6	45.3	120.8	136.5	86.8	73.9	45.5	43.4	61.3	56.0	67.1	26.9	76.6	44.9	66.9	102.3	31.8	59.8	62.5	34.7	40.1	111.9	74.0	40.4	83.2	74.8	37.1	45.1	65.2	91.3	46.2	66.1	61.4	41.0	50.0	46.5	116.4	51.8	68.6	124.0	129.0	120.7	144.1	172.2	98.5	78.5	100.6	142.2	60.6	108.3	207.1	132.9	76.4	37.8	71.9	161.8	96.5	36.7	87.2	41.3	113.3	67.1	173.0	189.5	96.2	45.2	125.5	76.1	152.1	144.4	49.5	50.9	94.1	147.1	43.9	54.0	86.3	46.0	109.3	47.5	55.4	193.1	45.6	104.8	73.2	47.4	40.5	127.2	95.5	83.6	61.7	50.7	77.0	155.7	205.5	73.9	158.6	173.5	58.7	81.9	58.1	152.3	131.1	137.3	62.6	78.0	68.5	32.4	73.3	25.0	25.0	23.8	22.4	41.5	24.4	24.3	23.6	96.3	25.1	103.5	15.9	20.9	75.6	37.5	42.1	38.5	44.0	39.6	45.3	45.5	43.4	44.9	40.4	45.1	50.0	104.4	102.5	96.4	22.5	89.7	38.2	57.1	72.5	43.9	53.3	89.2	56.4	64.3	150.2	84.2	180.3	39.6	59.4	116.9	216.1	9.8	92.7	6.0	86.3	89.5	91.7	89.5	39.5	29.5	93.2	80.9	87.5	64.7	105.7	158.8	70.5	86.7	245.0	113.0	208.6	37.9	99.0	52.9	187.1	85.3	7.8	49.4	145.6	60.5	33.7	126.9	47.8	95.8	25.1	50.6	101.6	121.8	69.2	74.0	62.8	211.2	82.8	111.4	36.5	65.7	85.0	65.8	36.1	37.1	32.6	34.9	44.6	91.1	61.9	100.3	70.8
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71664301-71680644	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 367.4;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	16.1	26.1	5.7	9.1	7.1	14.8	4.2	11.6	9.2	4.8	3.1	4.1	5.7	6.3	17.0	6.5	4.6	8.6	5.2	5.5	6.3	5.6	4.4	4.7	7.9	6.7	6.0	8.6	3.8	3.4	11.1	6.8	6.6	4.7	5.7	11.3	4.7	4.1	5.0	5.7	4.3	4.4	6.9	5.1	6.4	18.2	5.7	5.4	4.6	5.7	7.1	28.2	4.1	10.8	3.9	4.9	11.2	8.6	8.2	7.2	5.6	6.0	5.5	5.7	4.8	5.1	5.1	2.7	4.0	4.0	6.9	6.8	10.9	3.4	7.4	11.5	6.0	7.8	8.6	8.0	7.4	4.8	3.4	5.1	15.1	5.4	12.0	11.9	9.0	13.2	5.7	5.6	7.9	1.3	3.9	4.7	5.7	7.9	8.2	5.5	3.8	13.3	7.1	6.0	7.9	12.4	6.6	3.8	5.8	7.8	7.1	5.4	4.0	5.9	2.8	5.1	4.1	6.9	9.4	6.2	3.4	5.7	3.6	1.4	2.2	2.2	3.7	3.0	6.0	4.1	5.1	3.6	3.0	4.8	8.1	5.5	1.9	6.4	3.7	1.4	5.5	2.1	5.7	7.1	11.6	9.2	5.5	6.3	6.7	6.0	6.6	6.9	5.7	10.8	15.1	0.0	11.0	11.1	36.2	19.6	27.7	13.7	20.5	11.5	9.9	13.6	12.4	4.3	7.9	3.7	4.2	4.0	24.4	8.1	9.8	7.7	367.4	12.2	13.5	10.6	5.4	3.4	14.8	5.4	7.3	47.1	12.8	20.2	58.3	9.4	6.1	4.3	12.3	13.5	20.8	8.1	2.0	11.3	93.2	183.7	11.5	75.2	78.2	5.6	9.9	10.2	9.2	14.1	24.3	7.0	9.4	5.7	44.3	16.7	15.6	19.2	10.5	7.5	0.0	22.2	64.1	26.1	7.2	44.8	29.5	3.0	20.0	6.7	9.5	25.7
TIMP3	SFD	ENSG00000100234	"TIMP metallopeptidase inhibitor 3"	P35625	22	32801705-32863041	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision"	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1663.5;Fibroblasts: 967.5;Leydig cells: 1398.6;Peritubular cells: 1934.1;Sertoli cells: 2327.1;Smooth muscle cells: 1116.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 502.6;BJ: 1173.0;BJ hTERT+: 514.7;fHDF/TERT166: 1073.7;WM-115: 893.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068391			Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"HPA068391: "	"unprognostic (4.98e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (3.92e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.11e-2)"	805.5	288.7	71.7	41.4	74.9	1.1	556.9	68.7	72.6	376.1	221.0	190.4	30.5	393.3	230.4	168.1	373.9	153.5	532.8	64.3	79.2	248.0	92.0	625.1	69.5	83.2	86.7	116.2	81.1	139.5	139.1	999.5	76.0	178.8	81.2	31.7	178.7	341.1	128.1	170.3	122.1	379.6	70.3	187.2	152.1	64.1	106.2	41.1	340.1	325.9	28.8	197.4	261.1	59.5	19.6	0.0	16.9	2.7	502.6	280.6	1.0	1173.0	514.7	94.1	110.8	20.5	0.3	0.1	28.1	1073.7	3.6	18.3	3.2	48.4	135.0	0.1	14.3	147.4	23.5	52.4	197.4	0.1	59.7	47.4	120.4	166.9	9.5	3.4	0.0	0.0	0.1	0.9	44.6	1.2	0.4	5.0	2.5	0.0	0.8	0.1	3.4	0.4	2.1	97.0	12.5	16.8	24.1	0.5	322.9	266.6	0.7	1.3	0.0	7.9	25.2	245.9	19.1	0.2	0.4	0.4	232.3	0.2	893.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	71.7	74.9	68.7	72.6	64.3	79.2	83.2	86.7	76.0	70.3	106.2	59.5	1663.5	365.4	35.9	101.9	5.3	77.4	766.2	49.5	10.2	4.0	31.2	177.2	279.9	14.3	22.2	51.5	4.2	492.2	4.6	0.3	3.9	2.5	14.9	27.9	747.6	677.3	1.8	35.3	26.1	0.7	433.7	967.5	21.4	23.9	89.2	11.4	743.9	102.0	109.2	3.3	15.7	0.0	24.4	39.3	95.0	57.7	1398.6	28.6	76.5	116.2	0.7	146.6	0.0	52.3	0.8	0.9	0.0	1934.1	9.5	159.5	0.0	15.5	8.5	5.5	2327.1	339.2	1116.6	6.2	7.0	14.3	56.4	809.0	21.5	4.8	0.7	163.4
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TM9SF3	SMBP	ENSG00000077147	"Transmembrane 9 superfamily member 3"	Q9HD45	10	96518110-96587452	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039609	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		240000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Golgi apparatus"	"HPA039609: AB_10673535"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.95e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (4.14e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.18e-2)"	57.0	53.4	28.5	54.6	33.0	36.7	58.4	33.2	34.8	65.3	34.9	111.8	116.9	62.5	69.2	57.5	46.0	89.9	39.7	27.7	34.4	68.0	75.0	43.2	42.0	33.8	31.2	62.9	73.3	70.1	22.5	67.8	35.2	91.7	94.5	43.4	83.2	56.4	26.6	38.5	112.4	50.8	35.7	41.8	183.5	34.6	30.7	44.7	87.4	41.1	44.9	72.8	34.8	43.6	146.8	97.2	106.5	149.3	151.4	112.4	127.7	197.8	146.7	84.0	67.5	116.4	281.6	107.3	107.0	175.8	105.5	135.3	97.6	108.1	156.8	121.3	83.6	95.3	81.8	92.0	114.5	197.7	107.2	105.0	108.6	118.6	203.7	253.2	94.7	96.4	97.0	119.9	132.2	66.4	77.1	76.2	68.9	237.9	59.6	94.6	134.4	84.8	120.1	106.8	49.6	110.3	104.1	98.6	103.0	126.2	171.0	73.7	165.3	103.5	87.1	104.6	183.1	123.7	152.3	98.4	140.9	134.9	73.5	5.7	2.2	3.8	3.5	2.3	4.0	2.1	3.6	3.9	2.7	1.5	2.7	3.6	2.4	3.9	2.4	7.1	4.0	1.3	28.5	33.0	33.2	34.8	27.7	34.4	33.8	31.2	35.2	35.7	30.7	43.6	115.7	51.3	43.0	43.1	53.2	116.8	118.8	63.2	51.8	57.8	103.1	73.0	65.0	121.5	88.2	141.6	56.3	77.5	89.5	238.7	21.5	80.7	27.6	93.0	162.0	99.8	123.9	68.8	59.9	146.1	97.6	98.7	212.0	192.2	40.6	75.0	78.9	126.9	60.0	58.9	64.0	368.3	69.2	85.6	125.3	12.8	93.2	73.5	103.2	49.6	56.8	58.1	54.6	69.9	79.2	132.1	140.6	82.4	88.9	196.1	141.5	59.3	65.9	54.7	65.7	89.2	121.0	45.8	38.4	73.2	120.6	140.9	63.0	74.5	246.7	156.2
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776499-74839753	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	6.5	10.7	7.0	5.6	9.1	8.4	5.3	9.2	7.9	3.9	5.6	5.0	3.5	4.7	3.8	6.6	4.2	3.4	7.2	6.5	6.8	7.7	14.9	7.8	4.5	10.4	9.3	3.8	8.1	8.1	9.9	5.0	9.8	5.5	2.9	2.0	7.5	3.8	5.4	5.2	5.3	4.2	8.2	7.0	6.1	8.4	9.3	4.2	7.8	3.8	4.4	5.1	4.2	10.8	10.8	26.0	13.4	15.4	18.9	11.7	8.1	18.2	18.1	22.8	25.1	21.1	11.2	5.6	5.8	20.9	23.4	12.0	13.8	10.2	12.0	4.2	19.5	14.1	10.5	15.0	13.8	23.5	12.6	9.3	10.9	23.1	5.0	6.8	16.5	13.6	8.4	8.5	15.6	10.3	14.1	9.3	7.5	14.2	20.6	8.7	21.3	9.4	9.9	9.3	11.4	15.1	10.1	12.9	13.6	10.0	16.5	35.8	13.2	48.0	12.1	18.4	24.0	5.9	5.5	6.5	18.5	24.0	18.6	1.4	5.0	3.7	4.7	4.1	2.4	3.3	4.5	4.4	5.3	0.8	3.7	2.6	2.1	2.8	4.6	5.5	5.0	3.6	7.0	9.1	9.2	7.9	6.5	6.8	10.4	9.3	9.8	8.2	9.3	10.8	2.3	6.4	5.8	7.8	2.2	2.5	1.1	3.4	0.6	2.7	5.6	3.3	49.5	8.6	4.6	5.5	2.1	4.1	5.2	6.0	0.0	5.0	3.0	3.3	2.7	4.8	8.3	1.7	5.6	5.6	4.3	4.6	5.6	6.4	1.3	3.2	2.9	14.2	13.3	0.0	4.4	4.7	4.1	7.3	3.8	3.5	2.8	9.5	0.0	4.7	4.7	4.1	3.1	4.0	11.1	6.2	3.4	2.2	8.2	2.5	3.4	1.9	2.0	3.1	0.0	3.3	4.2	4.4	3.8	2.8	2.3	3.8	4.3	2.5	3.6	1.6
TMEM168	DKFZp564C012,FLJ13576	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762377-112790423	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favorable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	12.9	10.6	6.0	12.5	7.6	6.7	15.6	7.5	7.1	11.6	9.5	22.4	13.7	13.2	17.9	14.1	10.7	12.2	13.9	5.8	6.8	12.8	8.4	12.1	11.3	8.1	6.6	12.1	6.7	28.6	8.3	14.4	8.2	16.3	24.6	20.2	20.6	13.4	9.4	26.7	14.8	15.3	7.8	12.3	12.6	10.2	6.7	13.5	17.7	9.4	11.2	10.9	12.9	10.1	16.0	13.2	12.2	10.9	20.4	41.5	17.2	17.3	16.2	6.4	5.6	17.0	16.4	16.9	11.4	17.2	14.6	16.8	12.5	15.1	16.5	26.8	12.9	14.7	16.8	9.7	13.7	16.4	17.9	20.3	38.6	7.3	10.9	6.0	18.9	13.6	19.9	15.0	23.3	25.2	14.2	10.3	9.9	16.7	10.2	9.5	6.1	24.9	16.0	29.9	9.2	18.2	23.3	30.6	14.0	14.9	17.5	14.4	27.0	30.5	15.5	14.5	22.6	25.4	23.1	18.9	19.7	14.7	40.0	21.2	14.9	11.6	12.1	12.6	14.4	10.9	12.9	11.8	16.0	13.2	18.6	13.0	8.4	13.5	13.2	11.1	13.0	9.5	6.0	7.6	7.5	7.1	5.8	6.8	8.1	6.6	8.2	7.8	6.7	10.1	17.4	12.8	22.3	43.1	18.6	31.1	19.1	12.0	27.3	31.5	16.4	14.4	18.1	10.0	18.9	33.1	27.1	35.5	14.3	16.9	0.0	5.9	2.9	9.2	22.1	17.3	20.5	14.1	29.9	9.1	8.9	17.6	18.3	11.8	12.0	19.2	18.5	12.6	8.9	16.8	32.6	34.8	16.2	13.5	9.3	1.9	18.3	10.9	24.9	41.2	10.8	16.3	15.5	70.9	71.5	6.1	17.0	14.7	10.2	21.6	15.5	6.0	7.1	29.6	6.6	19.4	16.7	18.1	13.3	24.8	26.0	14.2	13.8	21.1	30.5	14.5
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040189	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	"Golgi apparatus"	"HPA040189: AB_10793959"	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	14.6	12.4	16.6	12.2	17.0	9.1	18.7	9.7	17.5	27.3	8.3	22.7	24.6	15.2	9.0	13.1	12.7	16.5	10.3	17.6	17.5	7.9	14.9	13.3	9.4	13.3	15.1	10.3	34.3	13.4	11.8	15.0	14.1	20.0	24.8	10.5	52.3	20.9	10.2	16.1	28.5	17.4	12.9	14.3	35.7	21.3	22.3	6.3	21.3	8.7	8.2	20.6	13.4	14.9	22.1	12.6	17.5	27.0	45.1	41.1	33.4	49.1	28.6	25.1	28.4	21.5	26.5	9.3	24.7	41.0	53.5	32.0	26.1	32.4	39.6	13.7	18.7	17.3	18.9	45.6	36.8	21.9	15.8	34.3	31.2	27.9	37.6	37.6	40.7	13.1	33.4	11.3	41.4	13.3	9.7	27.1	13.6	43.8	15.9	9.3	20.1	10.6	23.9	17.1	51.3	35.3	36.0	33.3	24.2	23.9	12.7	30.4	39.1	25.7	17.4	43.1	43.0	6.6	4.9	10.0	31.0	26.8	25.1	5.7	1.1	3.0	2.2	1.1	1.7	0.4	1.2	1.8	0.8	0.4	1.1	1.5	0.7	2.0	1.9	1.0	1.3	0.8	16.6	17.0	9.7	17.5	17.6	17.5	13.3	15.1	14.1	12.9	22.3	14.9	26.7	12.8	33.1	19.9	9.4	20.4	15.6	20.5	17.6	15.6	30.0	18.8	14.2	27.1	23.1	16.5	18.8	8.8	46.0	47.2	3.9	23.3	4.2	16.8	27.7	27.5	44.3	21.5	61.1	32.7	12.5	16.6	49.5	40.5	11.4	36.8	21.0	22.5	10.2	20.2	66.3	35.9	18.3	15.3	16.4	6.7	13.1	14.7	14.2	28.1	13.3	6.0	51.5	43.2	61.7	35.3	25.7	17.7	26.6	37.5	39.4	4.6	25.8	14.6	6.6	12.7	17.8	13.1	22.7	23.6	21.0	5.2	27.0	24.2	30.5	37.1
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719315-19773617	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 10.4;retina: 21.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 116.4;Endometrial stromal cells: 90.9;Excitatory neurons: 45.1;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 127.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 4.8;ASC TERT1: 4.5"					"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.3	1.3	2.6	0.0	4.4	0.0	0.0	0.0	4.1	0.4	0.0	0.1	0.0	1.4	0.4	0.0	0.3	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	3.6	6.7	0.0	1.1	0.0	3.7	0.0	3.3	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.7	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	4.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.4	0.0	4.1	2.7	10.4	3.6	6.7	3.3	1.9	7.1	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	116.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	90.9	0.4	0.0	0.0	45.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	3.3	23.9	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	1.9	0.0	2.6	0.0	127.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TMEM241	"C18orf45, FLJ44259, MGC11386"	ENSG00000134490	"Transmembrane protein 241"	Q24JQ0	18	23197144-23437961	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.8;Oligodendrocyte precursor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029489, HPA059922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Vesicles	"HPA029489: AB_2673067, HPA059922: AB_2684164"	"unprognostic (1.44e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.15e-4)"	"unprognostic (7.07e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-3)"	"unprognostic (9.53e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.93e-1)"	"prognostic unfavorable (5.80e-4)"	2.1	0.6	0.7	1.8	0.9	1.1	2.3	0.0	1.7	1.8	0.7	1.7	1.5	2.0	1.6	1.7	1.7	1.6	1.5	1.5	0.2	1.1	1.7	1.4	1.4	0.1	0.1	1.6	1.3	2.4	1.1	2.3	0.0	0.9	2.2	0.3	1.2	0.9	1.0	0.8	1.1	2.9	0.0	1.5	1.4	0.6	0.2	1.0	2.2	0.9	1.5	1.6	1.0	1.1	3.2	4.5	1.2	4.1	5.5	5.3	3.5	1.6	1.9	1.9	3.8	1.3	7.6	13.1	3.4	2.7	6.6	6.0	2.9	7.8	5.3	1.4	1.5	2.4	4.5	3.7	3.3	2.7	2.1	5.3	6.5	6.3	6.6	4.1	6.6	6.3	5.5	4.1	5.3	4.6	2.6	0.5	1.8	10.6	2.9	1.9	5.8	11.2	2.6	1.9	4.6	4.3	7.1	3.2	4.2	4.3	4.0	0.8	3.0	10.3	2.4	3.6	3.9	8.4	8.1	5.3	5.1	8.4	7.2	1.2	0.5	0.0	0.9	2.2	1.3	1.3	0.2	0.9	2.0	2.2	0.8	1.2	0.0	6.0	0.8	0.7	1.2	1.1	0.7	0.9	0.0	1.7	1.5	0.2	0.1	0.1	0.0	0.0	0.2	1.1	3.7	0.0	6.9	4.9	3.5	2.8	3.3	3.9	4.0	1.0	16.1	7.9	1.4	1.5	5.2	3.7	4.2	8.3	4.7	1.8	0.0	2.3	0.0	2.4	4.6	2.5	1.2	3.8	70.8	2.2	8.7	3.9	7.1	3.2	2.5	4.2	3.3	3.8	3.1	10.1	16.0	4.0	6.1	0.6	2.9	0.3	1.8	2.4	1.8	11.2	1.4	1.0	5.2	21.6	9.9	3.0	3.1	1.2	5.7	4.6	2.0	3.3	8.3	1.3	0.0	4.2	3.0	1.4	5.5	6.2	4.4	4.7	2.1	4.2	2.3	2.9
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	6.9	25.3	35.0	3.8	36.0	2.2	14.6	33.9	44.3	14.9	32.2	16.0	46.0	15.3	25.7	11.1	13.7	8.9	8.9	37.5	36.7	18.6	23.1	9.9	4.8	32.1	30.3	23.4	17.6	23.3	29.5	6.0	32.0	15.7	3.7	22.3	21.0	18.3	18.5	8.7	35.2	10.8	31.5	5.3	13.3	6.5	35.1	5.1	15.9	9.9	5.3	14.4	11.6	35.1	3.4	0.7	5.8	9.5	6.0	0.9	5.6	5.2	9.9	4.9	9.8	27.1	18.8	0.3	20.1	5.3	10.9	14.8	0.0	18.3	4.4	11.9	11.1	0.5	5.4	6.0	16.0	0.3	0.5	7.3	10.9	5.3	0.9	35.9	7.2	13.7	2.6	11.7	4.9	4.1	6.0	0.5	4.9	0.1	12.8	8.1	4.2	12.3	25.3	0.3	17.0	11.5	5.1	33.7	0.1	8.7	43.8	0.6	2.5	2.1	10.6	0.4	1.6	11.7	8.3	3.1	0.4	0.2	0.2	0.7	0.2	0.2	5.1	0.2	7.1	4.0	7.3	2.9	0.5	2.6	10.0	5.4	0.4	7.4	0.2	3.4	6.0	3.5	35.0	36.0	33.9	44.3	37.5	36.7	32.1	30.3	32.0	31.5	35.1	35.1	5.1	6.4	3.9	11.1	6.2	5.7	10.7	14.7	13.1	27.7	27.7	30.6	6.1	14.3	9.3	16.5	29.2	37.1	4.8	0.9	11.7	16.6	2.8	4.1	5.0	6.4	11.4	5.2	20.1	6.4	16.9	8.7	2.6	5.5	8.9	18.0	3.6	9.6	2.9	11.8	22.0	7.8	10.2	0.0	1.9	5.5	23.3	1.1	7.2	2.8	3.4	28.8	5.2	8.5	6.5	5.0	5.5	23.3	5.5	5.5	149.1	25.6	7.4	41.1	0.0	12.1	7.5	3.9	5.2	4.0	3.7	16.3	4.7	15.3	15.0	5.7
TMEM251	"C14orf109, DKFZP564F1123"	ENSG00000153485	"Transmembrane protein 251"	Q8N6I4	14	93184951-93188463	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 113.5;Hofbauer cells: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048559	Uncertain		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Golgi apparatus"	"HPA048559: AB_2680441"	"unprognostic (1.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.99e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.17e-2)"	16.6	22.9	7.3	6.4	7.8	2.7	16.9	7.9	10.0	15.5	8.2	22.9	10.3	14.2	16.5	13.1	14.7	6.7	25.6	7.6	7.6	33.2	17.2	17.1	8.0	7.7	7.8	14.2	21.2	10.3	19.8	6.9	7.8	25.7	12.5	20.7	19.6	9.2	30.6	13.7	18.1	6.8	7.4	15.9	21.8	8.4	8.1	8.6	17.6	12.4	6.9	17.2	12.8	9.0	11.0	12.1	15.3	16.1	17.2	7.3	9.4	7.9	8.2	12.7	16.2	7.8	11.1	12.1	12.9	7.9	15.9	15.9	17.8	12.6	17.7	9.3	13.4	10.9	8.8	18.3	15.2	16.0	14.7	9.3	14.6	10.0	16.2	6.8	12.2	13.5	9.3	12.0	11.6	52.5	10.2	12.8	8.3	28.0	11.6	4.7	16.0	11.3	16.6	23.6	12.9	13.4	11.7	6.0	36.9	12.4	17.7	11.4	5.0	6.1	10.8	14.6	9.4	9.3	16.0	11.8	11.4	6.1	9.1	6.8	9.7	13.6	3.9	9.4	2.9	4.7	4.6	4.4	8.0	5.5	5.2	5.9	10.5	5.3	13.0	7.3	4.1	4.2	7.3	7.8	7.9	10.0	7.6	7.6	7.7	7.8	7.8	7.4	8.1	9.0	13.4	3.2	14.4	5.2	22.4	23.2	37.9	33.6	13.1	14.8	41.1	39.1	22.5	32.9	22.0	31.3	27.1	36.6	16.5	44.8	113.5	30.3	1.8	33.1	16.3	11.9	15.0	11.3	5.9	26.6	21.1	16.6	20.9	35.7	17.2	15.2	8.9	19.2	110.1	13.5	7.8	36.1	26.4	28.4	20.0	2.3	11.8	39.6	32.0	2.8	16.2	34.8	12.3	5.0	13.8	17.7	23.8	10.9	13.1	43.3	31.7	69.6	17.2	30.6	39.5	13.9	23.2	4.5	17.8	18.1	31.1	27.4	16.1	17.6	30.9	36.4
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 59.5"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 999.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"plasmacytoid DC: 99.4"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 99.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	12.8	12.0	5.7	4.4	9.2	6.7	12.1	6.8	8.3	6.8	6.3	14.2	16.4	8.9	6.8	6.0	7.0	6.2	13.9	5.7	7.2	18.3	59.5	10.5	4.0	8.5	8.5	10.6	8.3	6.3	10.1	3.9	8.5	7.2	6.9	7.1	7.2	3.3	7.6	6.6	14.6	4.2	5.8	6.3	10.1	34.9	8.8	3.3	7.9	3.7	2.1	7.5	6.1	15.4	12.9	14.7	13.0	9.6	16.6	12.5	15.6	3.8	11.1	7.2	10.5	4.7	39.9	4.1	11.8	3.6	27.4	11.5	3.6	7.8	3.8	6.5	9.2	4.7	6.0	22.7	16.5	3.7	16.6	14.8	11.9	14.4	3.1	7.9	4.0	9.1	2.0	5.1	4.3	7.7	4.5	11.2	7.6	9.9	8.5	6.8	1.8	40.0	21.6	13.4	9.0	8.7	4.1	15.7	21.3	9.3	4.8	9.9	1.7	5.3	8.8	7.5	4.7	3.7	4.7	2.3	13.6	9.6	6.3	14.1	12.9	6.3	7.3	23.1	6.3	13.9	7.4	6.3	6.6	14.8	3.5	4.5	1.4	7.8	16.2	99.4	8.1	7.6	5.7	9.2	6.8	8.3	5.7	7.2	8.5	8.5	8.5	5.8	8.8	15.4	10.9	6.4	12.0	8.1	3.5	1.7	9.5	24.2	1.8	6.9	9.0	7.6	35.5	10.0	20.4	20.2	4.2	14.5	9.5	53.1	45.0	18.6	188.3	14.0	4.6	8.5	14.4	10.1	2.9	25.7	15.5	6.9	8.2	5.7	6.3	8.6	10.0	93.0	34.3	18.5	3.6	22.6	44.7	12.6	0.7	999.9	9.0	14.0	8.8	1.9	3.8	17.1	5.2	3.0	4.8	17.5	51.3	12.4	2.6	8.9	74.3	45.9	32.8	13.8	26.3	3.7	10.6	15.6	13.2	3.9	2.3	9.3	3.7	8.3	18.0	12.7
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787594	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	0.3	0.2	1.8	0.1	2.2	0.0	0.2	4.7	2.4	0.2	1.4	1.3	0.0	0.1	0.0	0.5	0.1	0.1	1.3	3.7	3.0	0.1	0.8	0.1	0.0	3.8	1.7	0.1	0.5	0.0	0.4	0.0	3.5	0.1	0.1	2.5	0.2	0.1	0.8	0.3	0.2	0.4	6.1	0.1	0.3	0.3	1.6	0.3	0.1	0.2	0.1	0.2	0.4	8.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	1.7	0.7	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	1.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.2	4.7	2.4	3.7	3.0	3.8	1.7	3.5	6.1	1.6	8.2	0.4	0.0	0.0	2.0	0.0	0.9	0.7	0.0	4.6	4.7	0.2	0.6	0.8	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	1.8	0.0	5.1	0.2	0.8	0.7	0.0	0.1	0.0	0.5	0.0	0.7	0.1	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	8.3	0.0	0.8	0.9	0.2	4.1	2.0	0.6	0.1	0.1	0.1	0.0	0.0
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 15.6;Horizontal cells: 18.5;Inhibitory neurons: 16.3;Paneth cells: 15.6;Proximal enterocytes: 21.1;Sertoli cells: 19.7;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.3;Hep G2: 9.2;K-562: 16.8;Karpas-707: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	5.8	2.0	17.5	1.0	16.2	0.2	4.9	10.3	19.4	1.9	8.8	4.0	18.2	2.0	0.8	4.0	7.4	3.9	11.2	13.5	16.6	4.5	4.7	27.6	2.0	19.8	13.2	1.0	2.0	7.1	10.1	17.2	18.2	3.1	1.8	3.9	6.3	15.7	5.1	9.8	23.1	2.0	10.8	2.8	4.1	4.1	17.8	0.3	4.1	2.2	1.2	1.2	2.0	11.5	0.0	4.4	2.5	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.3	0.6	0.1	0.9	0.0	2.7	0.3	3.4	0.4	0.1	0.0	4.2	1.1	0.0	9.2	0.0	0.0	1.2	0.0	0.9	0.0	0.1	0.1	0.1	0.6	16.8	7.1	0.0	0.0	0.1	0.0	3.0	1.2	0.3	0.0	0.2	0.0	0.7	0.6	0.5	1.9	0.1	0.0	0.1	0.9	0.0	0.0	1.7	0.0	2.9	0.0	0.1	2.7	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	16.2	10.3	19.4	13.5	16.6	19.8	13.2	18.2	10.8	17.8	11.5	3.7	0.0	0.0	0.7	0.1	0.3	0.7	0.9	0.6	10.5	2.2	1.0	2.3	0.0	0.2	0.0	0.0	0.2	0.2	1.0	0.0	0.5	1.0	0.2	0.1	3.3	15.6	0.0	9.7	0.2	1.8	0.8	2.6	0.1	0.0	0.5	4.6	0.8	0.0	18.5	16.3	9.9	2.0	0.6	0.7	0.7	0.0	1.4	1.8	1.9	1.0	0.5	0.0	0.0	1.1	0.9	15.6	0.0	0.1	0.7	21.1	0.6	1.2	4.0	19.7	0.4	13.3	0.2	2.7	0.2	0.9	1.4	0.2	0.3	3.9	0.3
TMEM86A	FLJ90119	ENSG00000151117	"Transmembrane protein 86A"	Q8N2M4	11	18693122-18704785	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 17.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.6;Theca cells: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057119	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA057119: AB_2683342"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.24e-1)"	2.8	2.7	2.6	2.2	2.2	0.3	3.2	2.1	2.8	2.3	3.8	1.5	1.4	2.2	1.0	2.3	2.6	4.0	2.9	2.1	2.6	9.5	2.6	3.5	4.7	3.1	2.7	7.1	3.4	5.4	2.2	4.3	2.5	1.6	1.8	5.7	2.7	1.4	2.9	17.6	2.0	1.9	2.7	4.9	2.1	2.3	4.0	1.6	2.1	2.5	2.5	2.3	3.6	4.5	0.0	0.2	0.6	3.1	2.7	0.0	0.1	0.6	0.5	0.5	0.5	0.0	0.4	0.0	1.2	0.6	3.0	0.3	0.2	0.1	0.3	0.2	1.9	0.2	0.1	0.0	2.1	0.0	2.8	3.8	1.2	0.1	0.2	0.7	1.7	1.8	0.6	0.0	1.3	1.7	0.0	0.0	0.2	0.5	1.6	0.0	5.1	0.0	17.5	3.8	1.0	1.3	1.0	3.2	1.4	1.1	3.9	0.4	1.9	0.5	0.2	0.1	0.1	3.2	2.7	0.0	1.1	0.0	1.1	0.0	1.9	0.1	0.2	1.4	0.5	0.0	0.2	0.4	3.4	0.1	0.4	0.8	0.0	0.1	0.5	2.0	0.5	0.8	2.6	2.2	2.1	2.8	2.1	2.6	3.1	2.7	2.5	2.7	4.0	4.5	1.9	0.0	0.0	0.3	0.0	0.1	0.8	0.4	0.0	5.2	3.5	1.8	2.2	0.0	0.7	11.0	8.4	0.5	1.4	0.6	7.9	7.8	12.2	1.1	1.9	2.1	3.5	0.0	0.5	8.0	0.3	1.7	1.1	1.0	0.0	3.0	3.9	1.6	40.6	0.0	0.8	0.8	0.0	12.7	0.8	12.1	2.1	8.3	0.0	3.7	2.3	2.6	0.0	2.0	0.1	7.4	0.1	1.9	0.4	0.6	0.0	8.3	0.4	4.8	6.6	0.4	1.2	7.8	2.6	0.2	0.3	2.3	0.7	17.4	0.2	0.4
TMEM87B	FLJ14681	ENSG00000153214	"Transmembrane protein 87B"	Q96K49	2	112055269-112119318	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 89.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035183	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus, Vesicles"		"HPA035183: AB_10600829"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.28e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.32e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.25e-3)"	10.5	12.2	6.8	14.7	6.6	7.9	20.1	6.1	8.0	12.9	6.9	28.4	28.6	11.0	18.5	10.5	8.4	12.1	5.0	5.9	7.1	7.9	7.4	11.7	15.4	7.5	10.0	6.0	11.3	12.9	9.2	15.1	8.0	30.7	27.8	6.9	15.4	15.9	3.1	13.7	30.5	13.4	7.1	15.5	22.8	5.0	8.3	9.7	15.0	4.2	14.6	17.1	9.0	6.9	21.7	6.4	5.9	25.8	24.9	32.6	21.4	35.5	46.8	21.9	26.7	16.6	28.6	20.9	18.2	47.3	30.2	34.9	3.8	21.6	28.7	12.8	4.1	27.5	4.6	15.2	24.7	19.6	28.9	22.3	25.9	28.0	22.0	21.4	23.6	9.6	16.9	13.1	31.8	13.7	9.3	10.8	4.8	35.0	16.4	7.6	8.9	17.0	20.3	30.2	4.6	6.4	15.4	38.6	34.6	15.5	20.4	14.7	26.6	22.3	6.8	17.6	7.8	10.6	18.1	12.9	25.9	10.1	16.3	5.4	3.0	2.6	3.2	5.2	5.6	5.9	6.9	4.4	2.7	4.9	6.2	3.6	1.8	3.5	6.7	2.7	7.4	3.6	6.8	6.6	6.1	8.0	5.9	7.1	7.5	10.0	8.0	7.1	8.3	6.9	18.3	28.9	13.9	18.9	23.3	12.2	14.5	20.9	39.9	5.0	32.9	14.4	4.6	20.0	21.6	18.4	2.1	15.9	12.3	59.5	0.0	42.9	18.7	14.4	26.5	19.9	17.4	6.3	18.4	89.3	25.5	17.5	46.4	24.9	13.3	14.5	35.7	10.1	21.7	6.7	16.4	53.6	12.2	37.7	10.9	24.5	9.9	22.7	3.6	30.0	20.9	4.0	6.2	21.6	23.1	69.7	47.1	3.0	21.6	28.9	44.9	4.7	17.9	7.9	0.0	5.4	17.2	4.9	5.6	29.9	12.8	29.1	20.5	11.8	38.2	23.9
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 180.5;Cone photoreceptor cells: 158.4;Oligodendrocytes: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA		73000	"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Intermediate filaments"	"Golgi apparatus"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (2.58e-4)"	"prognostic favorable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	20.7	30.5	64.0	9.5	62.7	6.1	20.3	52.7	70.0	31.9	21.3	44.2	14.0	33.2	11.0	64.4	26.6	13.0	141.0	66.0	56.4	31.3	13.9	23.2	7.7	91.5	80.3	32.9	19.7	40.3	42.2	9.0	95.3	37.3	13.8	50.2	21.3	28.7	67.1	59.7	20.9	23.3	49.7	16.6	34.9	39.4	74.6	8.8	48.5	55.4	12.9	31.4	35.1	72.7	27.1	29.0	8.2	6.2	19.1	19.3	14.2	43.3	20.1	22.9	19.3	28.2	17.6	5.0	52.9	40.8	13.3	104.3	6.8	24.1	14.0	7.2	12.7	8.0	28.0	6.0	12.2	2.0	5.2	22.9	16.6	20.5	15.2	19.6	23.3	7.3	3.0	6.9	30.3	27.1	3.6	4.6	1.5	34.4	19.5	4.7	20.7	12.0	32.4	48.1	8.7	8.4	19.5	25.2	15.3	55.9	13.4	3.6	31.8	21.9	6.5	46.0	16.8	6.1	5.1	2.3	26.4	2.7	55.2	10.0	3.3	4.8	2.8	1.0	2.0	1.6	2.6	2.4	1.6	2.2	4.3	3.2	12.8	1.4	3.3	1.9	1.3	1.7	64.0	62.7	52.7	70.0	66.0	56.4	91.5	80.3	95.3	49.7	74.6	72.7	10.1	32.1	17.0	180.5	9.5	10.8	14.6	13.9	7.4	74.5	20.9	14.1	73.7	15.7	16.6	11.0	158.4	8.5	10.2	43.3	5.9	12.2	30.8	14.1	9.4	12.4	20.4	4.8	63.2	8.7	17.4	12.7	13.3	15.7	2.5	28.1	16.4	13.4	9.2	95.9	74.2	19.2	18.3	8.5	7.6	64.2	26.4	6.4	12.4	35.6	11.8	28.1	10.3	66.9	123.2	16.1	41.0	25.6	8.4	39.1	22.4	11.1	22.9	78.3	19.7	18.0	13.0	16.7	12.1	37.2	17.2	32.2	10.0	30.8	15.4	64.5
TP53I11	PIG11	ENSG00000175274	"Tumor protein p53 inducible protein 11"	O14683	11	44885903-44951306	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 461.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 41.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 133.9;SCLC-21H: 357.9;T-47d: 209.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059727, HPA061276"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA059727: AB_2684113, HPA061276: AB_2684461"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.87e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	77.8	18.6	41.1	20.4	17.8	29.6	63.7	40.5	27.5	32.8	19.7	43.4	20.2	36.0	4.9	24.5	45.5	24.7	71.7	24.7	27.6	27.9	10.5	45.7	12.7	16.9	30.2	20.0	37.7	5.6	20.3	23.9	24.1	47.8	27.5	2.2	42.7	11.7	15.0	30.3	38.8	32.8	19.5	61.2	29.9	16.2	18.3	9.1	41.0	10.3	12.3	29.2	32.0	13.4	0.0	82.0	27.3	38.2	28.0	2.2	0.5	23.9	46.3	8.5	10.7	5.1	0.5	14.3	20.5	6.9	21.7	14.5	14.6	0.5	2.8	28.0	12.3	1.3	0.8	0.0	52.5	0.8	101.1	118.0	1.9	11.5	4.9	2.0	29.6	31.6	2.2	0.1	11.3	73.0	1.4	133.9	48.9	53.4	26.9	60.3	16.1	7.2	0.0	5.2	357.9	13.0	44.2	96.8	0.1	33.9	209.9	7.5	6.8	55.8	39.3	87.3	0.1	0.5	0.5	0.3	0.1	7.8	16.1	0.0	5.9	0.0	5.2	5.8	7.0	8.0	1.0	5.1	4.7	8.4	0.0	1.7	41.2	8.1	21.2	25.3	0.9	4.8	41.1	17.8	40.5	27.5	24.7	27.6	16.9	30.2	24.1	19.5	18.3	13.4	52.2	22.4	30.9	0.3	13.2	10.8	36.9	12.9	13.6	1.7	29.5	22.7	10.3	24.3	23.7	42.3	0.0	57.8	8.7	31.0	1.9	32.0	96.5	9.0	6.3	45.1	36.0	3.2	2.7	21.3	22.0	15.0	23.0	9.7	0.0	7.8	76.8	1.6	35.7	0.0	10.2	30.1	38.7	7.5	20.3	461.2	12.2	9.3	10.6	5.6	11.5	0.8	0.0	0.0	0.5	28.5	16.0	7.5	2.1	28.6	17.7	0.1	14.5	0.8	13.1	1.4	22.4	3.4	6.3	4.4	4.4	68.3	8.7	5.1	54.0	45.7
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652516-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.0	0.0	0.7	0.7	0.5	0.5	0.8	4.2	0.5	1.4	8.0	0.2	0.0	0.1	0.1	3.7	6.7	0.0	0.1	0.8	0.7	0.1	0.2	0.9	1.0	2.4	2.9	0.1	0.8	0.1	0.3	0.0	1.4	2.6	0.1	0.2	2.9	0.3	0.2	6.6	0.2	0.0	1.4	0.7	0.3	0.7	0.7	1.6	0.2	0.0	1.4	0.1	2.9	1.0	2.6	0.1	0.3	7.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.9	4.0	2.6	2.0	0.0	0.9	4.3	2.7	0.9	0.0	0.8	8.7	0.2	3.9	2.6	0.0	0.0	2.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.8	1.9	15.0	2.0	0.5	0.0	0.1	0.0	11.6	0.1	0.3	3.8	18.0	8.4	0.4	0.0	0.8	0.0	10.9	9.2	0.0	2.9	7.5	0.0	5.8	3.3	0.7	18.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	4.2	0.5	0.8	0.7	2.4	2.9	1.4	1.4	0.7	1.0	0.0	0.0	1.5	0.0	1.2	3.1	3.8	13.0	16.5	0.5	0.2	2.5	1.5	0.0	7.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	21.8	31.0	0.3	0.3	2.4	3.2	0.1	0.2	0.4	0.4	0.0	0.7	0.0	0.1	0.4	0.2	0.3	0.0	0.1	0.5	2.0	0.0	1.3	15.7	0.6	0.1	1.8	0.0	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	6.8	0.2	0.0	0.1	35.8	0.1	0.0	0.0	2.6	0.1	0.4	1.6	2.3	0.3	0.4	0.1	0.3	0.2
TPD52	"D52, hD52, N8L"	ENSG00000076554	"Tumor protein D52"	P55327	8	80034745-80231232	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 187.6"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 50.5"	"Group enriched"	"Detected in many"	5	"B-cells: 50.5;NK-cells: 15.1;T-cells: 22.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 252.6;SK-BR-3: 572.5"									"HPA028427, HPA062167"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		310000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	"Golgi apparatus"	"HPA028427: AB_10610561, HPA062167: AB_2684704"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.77e-3)"	"unprognostic (8.24e-2)"	"unprognostic (3.75e-1)"	"unprognostic (7.99e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-2)"	5.4	9.2	34.9	28.4	40.2	8.9	75.9	34.2	69.4	19.6	36.6	117.7	98.9	9.9	56.2	34.9	15.3	31.1	11.7	42.9	35.4	46.5	30.7	19.8	44.0	33.2	37.1	2.4	41.8	27.4	34.3	22.9	36.3	104.8	129.7	187.6	80.7	18.3	8.6	46.9	100.3	10.4	32.8	16.0	84.1	5.2	53.3	15.5	64.5	9.8	56.2	20.9	20.2	48.1	131.8	34.9	1.6	23.0	0.0	0.0	51.7	8.6	12.9	34.7	17.1	18.0	37.4	189.9	45.2	0.8	25.5	52.5	52.7	36.3	24.6	23.8	44.2	26.8	46.9	29.4	0.2	8.6	0.7	0.0	25.2	0.1	12.2	21.6	2.0	128.9	0.4	252.6	0.1	43.6	42.6	39.4	11.7	148.8	86.0	0.3	0.7	122.0	60.7	31.6	64.9	44.1	40.1	572.5	110.7	51.0	55.9	34.2	2.1	0.0	35.2	0.6	30.8	94.1	87.1	155.2	22.5	0.2	2.6	0.6	0.1	5.5	12.7	0.1	22.0	50.5	12.4	11.1	2.5	44.7	8.1	9.3	0.5	15.1	0.1	5.2	9.1	8.3	34.9	40.2	34.2	69.4	42.9	35.4	33.2	37.1	36.3	32.8	53.3	48.1	17.3	44.8	67.8	10.4	133.6	80.7	89.6	83.4	51.2	171.1	105.6	54.2	22.2	82.9	78.1	66.2	118.9	98.9	28.6	230.9	170.2	112.8	20.6	25.2	8.4	26.2	169.9	11.6	85.4	79.6	116.9	6.7	97.3	72.8	1.3	15.3	25.7	40.6	13.1	32.0	53.9	331.9	476.0	14.6	24.2	13.0	1.2	10.8	104.9	37.5	91.2	50.3	60.8	69.9	181.0	79.7	317.5	1.5	270.5	214.4	132.3	135.3	21.4	232.2	0.0	49.6	8.3	1.6	18.2	91.4	124.6	231.2	51.3	0.3	247.1	135.4
TRAF3IP2	"ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522"	ENSG00000056972	"TRAF3 interacting protein 2"	O43734	6	111555381-111606906	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA036352	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Vesicles	"HPA036352: AB_10672085"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-1)"	"prognostic favorable (4.73e-5)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (1.11e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.31e-1)"	19.7	16.3	24.8	19.5	24.8	32.4	19.9	24.3	29.4	24.9	23.7	34.0	28.6	36.2	47.2	26.5	34.7	14.2	8.3	24.4	26.0	9.3	8.6	17.5	16.3	27.2	28.2	13.9	21.6	13.6	9.3	14.2	25.6	19.2	26.4	5.9	25.3	30.8	11.4	35.0	25.1	22.1	21.7	6.8	35.5	3.0	28.7	21.0	14.8	14.8	22.5	26.5	18.1	22.9	32.2	11.0	6.8	15.7	35.9	39.0	15.6	39.8	62.2	9.9	14.1	8.7	14.1	6.2	13.2	33.5	35.5	58.2	8.0	86.2	18.4	43.2	11.6	12.7	10.6	11.9	13.9	6.9	22.6	47.1	57.5	29.9	110.1	24.9	20.0	15.2	13.6	1.9	13.2	22.0	51.2	19.4	9.0	30.6	8.8	53.3	12.4	2.7	29.5	52.4	27.3	6.9	12.1	71.8	47.8	12.7	31.6	18.0	9.2	19.2	7.6	149.7	35.5	0.8	12.4	16.8	45.8	10.8	50.1	25.8	2.5	5.3	3.8	0.8	12.7	6.4	7.6	5.6	2.6	8.6	7.6	7.4	3.5	5.7	0.3	0.8	17.9	3.1	24.8	24.8	24.3	29.4	24.4	26.0	27.2	28.2	25.6	21.7	28.7	22.9	24.7	3.2	13.8	26.1	10.8	30.1	61.5	46.3	11.4	7.5	8.3	8.6	4.9	7.2	21.6	3.7	12.5	19.3	3.8	30.0	5.9	35.4	0.1	20.9	14.5	18.3	13.2	5.2	5.9	31.9	28.8	14.4	18.3	32.7	20.2	7.7	3.9	5.5	6.0	6.7	10.8	16.9	16.2	1.3	10.7	0.5	7.2	5.8	12.4	7.5	6.2	14.2	8.2	19.6	6.6	20.2	26.3	7.5	4.5	42.9	18.5	5.9	18.3	5.5	0.0	14.7	10.5	0.8	2.1	16.2	24.6	20.9	7.9	4.6	21.9	45.0
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 96.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 293.9;Late spermatids: 504.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	21.7	26.0	13.9	10.9	14.4	10.1	21.8	15.0	23.3	20.2	13.5	27.9	10.1	23.7	6.3	23.0	22.2	10.4	46.7	14.8	15.9	22.6	28.0	17.1	16.0	15.9	14.1	21.4	26.2	18.4	26.7	6.6	17.1	20.6	4.7	9.1	25.8	10.0	45.8	35.7	21.2	5.2	14.6	22.1	28.4	96.6	14.8	15.7	24.7	6.4	5.0	26.1	18.9	15.5	16.4	28.0	9.1	10.4	19.9	24.5	23.9	26.6	6.5	7.6	4.2	17.5	13.6	18.8	28.6	9.0	6.7	20.8	10.5	11.9	3.1	22.8	39.5	16.2	8.1	60.8	9.0	20.4	28.0	18.1	9.0	8.5	21.2	5.8	6.7	21.5	25.5	10.0	13.5	22.5	20.6	34.9	22.1	7.3	39.4	15.4	12.4	15.3	8.1	13.5	23.2	37.8	10.6	11.8	18.5	4.0	13.9	16.3	17.2	18.6	10.6	18.7	23.6	28.5	22.4	15.0	21.8	15.9	10.5	0.7	1.0	3.8	0.8	2.5	2.0	0.5	1.3	2.2	1.4	0.5	0.8	1.0	1.0	0.9	3.6	4.3	2.5	0.8	13.9	14.4	15.0	23.3	14.8	15.9	15.9	14.1	17.1	14.6	14.8	15.5	18.8	9.6	12.8	59.4	20.7	11.5	16.2	15.1	14.2	31.8	13.7	16.0	68.4	21.5	11.2	12.9	33.3	21.3	16.9	17.1	58.7	21.7	293.9	20.3	16.4	18.5	3.5	19.1	56.2	18.0	15.2	23.7	23.0	14.5	5.7	22.3	11.0	16.0	25.9	26.9	62.5	17.7	14.2	17.9	10.0	504.5	26.4	20.7	16.0	30.0	28.5	42.6	15.5	52.3	56.4	23.9	11.9	24.0	19.6	16.0	20.3	30.0	19.4	42.0	26.3	20.9	21.7	125.2	26.3	18.8	17.8	17.6	14.4	33.8	15.7	12.2
TRAPPC3	BET3	ENSG00000054116	"Trafficking protein particle complex 3"	O43617	1	36136570-36156053	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028408	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Golgi apparatus"	"HPA028408: AB_10601826"	"unprognostic (3.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (7.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.10e-3)"	"unprognostic (6.53e-2)"	43.7	74.7	42.5	31.2	43.0	28.8	46.6	47.0	50.7	38.5	53.7	57.0	33.6	41.1	60.7	61.6	37.0	32.6	51.1	43.1	44.9	55.3	51.2	36.4	38.3	48.0	45.1	28.2	46.0	54.4	47.0	37.8	47.2	39.2	42.5	39.9	46.4	45.4	48.9	51.5	38.5	49.9	48.3	41.6	48.2	53.1	46.3	51.3	59.9	44.6	54.4	46.2	41.2	48.9	95.7	65.6	44.9	70.2	114.2	91.4	87.9	85.2	109.0	100.0	97.0	55.9	90.0	40.4	79.0	95.0	79.6	68.8	69.9	114.1	113.8	79.8	103.7	75.8	77.2	81.7	132.6	80.0	76.7	78.3	98.5	93.8	91.5	103.6	126.7	101.2	93.2	67.0	122.0	71.4	95.6	74.6	60.5	79.5	93.7	65.8	63.8	90.9	128.4	76.1	67.8	49.7	69.2	78.5	140.1	115.2	50.2	59.6	95.6	59.1	66.7	116.0	116.3	80.1	87.0	67.3	100.7	88.7	60.5	161.9	130.2	148.7	85.0	142.5	89.4	93.6	100.4	90.4	132.6	89.0	96.0	86.9	134.3	95.8	116.3	109.4	135.4	155.3	42.5	43.0	47.0	50.7	43.1	44.9	48.0	45.1	47.2	48.3	46.3	48.9	41.9	25.6	27.6	12.1	45.6	101.1	111.5	152.1	52.3	41.8	97.8	78.5	57.8	55.8	75.7	38.6	16.7	145.7	43.0	55.1	170.2	157.0	286.1	51.8	38.3	59.1	48.3	63.3	15.4	188.5	146.0	52.1	29.0	55.6	45.7	40.5	33.2	49.8	145.0	53.8	16.9	51.2	132.2	56.1	74.7	131.0	42.9	60.6	96.0	10.3	104.4	68.0	61.8	8.5	17.9	178.4	72.1	51.9	80.7	196.9	73.3	115.9	49.2	30.7	32.9	37.4	69.2	172.5	89.4	63.4	123.6	191.4	50.4	50.3	54.3	134.1
TRAPPC3L	"bA259P20.2, BET3L, FLJ11180"	ENSG00000173626	"Trafficking protein particle complex 3 like"	Q5T215	6	116494989-116545684	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.6;Early spermatids: 1.8;Endothelial cells: 1.5;Hepatic stellate cells: 6.1;Kupffer cells: 4.2;Macrophages: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060912			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA060912: "	"unprognostic (1.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.09e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.47e-3)"	0.7	0.7	1.6	0.8	1.7	3.7	1.0	8.1	5.0	0.4	0.3	0.7	1.0	1.2	1.8	0.7	0.5	1.1	0.9	2.3	0.0	0.7	1.4	1.2	1.7	0.6	0.1	1.0	0.7	3.0	0.0	3.9	1.6	0.7	0.5	4.2	1.2	0.7	1.2	2.3	1.0	0.4	0.1	4.7	1.1	1.5	0.7	0.5	1.8	0.2	0.6	0.5	0.0	3.9	0.8	0.4	1.0	1.5	0.3	1.0	1.1	0.5	0.5	0.4	0.5	0.5	0.7	1.3	0.6	0.2	0.8	1.0	0.3	0.6	0.5	0.6	0.6	1.4	1.9	0.6	0.5	0.9	0.6	0.4	0.3	0.2	0.3	1.5	0.8	1.0	0.8	6.6	0.3	1.5	0.9	1.0	0.9	0.3	0.6	0.8	0.7	2.2	0.7	1.3	1.0	0.7	0.8	0.4	0.5	1.2	0.7	0.8	1.0	1.2	0.9	1.2	0.6	1.2	0.8	0.8	0.8	0.9	0.7	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.3	0.1	2.8	1.6	1.7	8.1	5.0	2.3	0.0	0.6	0.1	1.6	0.1	0.7	3.9	1.6	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	6.1	0.1	1.1	0.0	0.1	0.0	0.0	4.2	0.0	0.4	0.3	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175485	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 61.8;liver: 37.9;skeletal muscle: 29.6;tongue: 33.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 108.9;Endometrial ciliated cells: 64.7;Hepatocytes: 30.4;Skeletal myocytes: 31.0;Spermatocytes: 23.8"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 426.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	1.4	0.0	0.1	0.1	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.1	0.1	3.5	0.8	5.3	0.1	61.8	0.0	0.0	4.8	37.9	0.2	0.0	0.1	0.6	0.0	0.2	0.2	0.4	0.0	0.3	0.7	0.1	0.0	1.3	0.2	29.6	0.4	0.1	0.1	0.0	0.1	0.0	7.3	0.0	0.2	0.3	33.7	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	7.2	0.1	0.3	0.1	0.0	0.4	0.5	0.6	0.0	60.5	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.2	426.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	1.5	27.6	0.0	2.4	0.0	0.0	0.1	0.0	91.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.6	0.0	0.1	2.8	0.0	0.0	0.1	0.0	108.9	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	64.7	0.2	1.2	0.0	0.0	0.2	0.0	0.1	3.8	0.0	3.5	0.0	0.0	0.7	30.4	0.1	0.0	1.5	0.0	0.0	1.3	0.0	6.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	7.4	15.4	0.0	6.6	31.0	2.9	23.8	1.2	0.0	0.0	3.8	0.3	0.0	0.0	0.3
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	10.4	10.5	4.7	8.6	8.8	7.6	10.5	10.8	7.4	11.6	13.5	10.1	10.4	9.7	6.7	12.1	7.7	10.1	10.6	3.5	5.4	13.5	12.9	8.0	9.4	6.2	7.3	11.0	25.5	19.2	4.8	11.6	6.8	9.6	9.8	10.6	11.0	8.5	11.8	8.9	7.9	10.2	6.2	8.6	15.3	13.6	6.5	11.2	16.7	15.6	11.4	10.4	5.8	10.7	22.8	22.5	14.4	15.2	24.8	38.1	21.8	35.3	27.0	17.1	19.5	13.8	36.0	15.8	25.3	31.3	13.3	29.1	19.1	17.1	37.0	24.1	5.8	17.9	20.4	13.1	18.9	21.2	17.1	14.7	20.4	30.3	25.8	18.9	27.8	8.7	11.9	17.8	27.0	31.7	12.2	5.2	6.6	22.1	16.0	14.8	27.5	8.0	15.3	36.5	10.5	9.5	28.5	16.6	11.0	14.5	36.2	10.5	36.9	19.8	13.8	20.8	16.1	15.7	25.9	14.2	23.2	11.7	25.3	9.3	9.7	20.2	13.9	9.0	13.6	13.0	14.7	13.1	7.9	23.7	14.2	14.9	9.6	14.8	16.1	14.3	14.5	4.3	4.7	8.8	10.8	7.4	3.5	5.4	6.2	7.3	6.8	6.2	6.5	10.7	66.8	54.5	79.8	57.5	32.5	16.6	30.7	31.7	21.6	61.1	39.9	40.0	115.7	34.3	54.0	38.6	73.0	44.2	41.4	29.8	17.6	72.5	13.6	58.2	81.2	53.9	32.2	30.7	58.1	46.2	32.0	51.7	39.8	56.5	37.9	68.7	32.9	37.5	24.4	43.7	74.7	40.4	32.6	25.7	11.2	14.7	62.1	30.4	7.2	51.5	41.6	56.5	47.4	66.9	92.4	44.7	29.5	54.2	26.3	39.0	31.6	23.4	56.4	70.4	59.2	76.6	50.4	105.0	65.8	19.5	17.0	72.5	30.2	79.8	32.9	35.1
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA054376: AB_2682467"	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	6.0	8.1	3.4	7.4	3.5	11.1	6.2	10.3	3.7	8.3	5.9	7.7	5.3	8.6	3.5	6.8	8.4	4.9	6.8	3.1	2.6	6.2	6.7	7.0	9.3	1.4	2.2	10.9	8.3	10.3	14.0	6.1	1.9	7.1	5.0	7.5	7.1	5.2	7.6	11.2	8.4	6.2	0.6	8.5	7.1	11.0	2.8	15.8	8.8	7.3	8.7	7.3	7.0	5.0	24.0	27.2	27.7	23.4	12.9	13.8	13.7	10.3	13.6	15.8	15.1	21.2	10.3	32.8	15.9	19.1	30.3	12.2	29.1	14.0	17.7	19.2	28.3	20.2	20.3	11.7	9.4	36.9	14.3	12.6	8.0	25.8	21.7	10.9	20.5	29.2	35.4	59.8	14.8	44.0	45.0	13.5	21.1	14.1	16.6	32.7	16.0	25.2	7.7	26.6	21.6	27.1	26.1	16.6	8.4	22.7	8.5	15.7	22.0	21.1	30.6	28.3	24.2	24.7	30.2	47.8	14.9	18.3	21.3	2.8	0.3	0.2	0.5	0.2	0.9	0.6	0.8	0.4	0.3	0.8	0.6	0.6	1.0	0.5	0.3	1.0	0.7	0.1	3.4	3.5	10.3	3.7	3.1	2.6	1.4	2.2	1.9	0.6	2.8	5.0	12.8	16.0	14.2	30.3	16.4	15.8	4.2	8.2	13.1	15.2	13.7	10.0	10.9	5.7	9.4	14.7	27.1	8.9	15.0	7.9	0.0	7.7	3.6	16.6	20.1	11.1	12.6	12.4	43.7	6.5	5.2	11.1	11.2	24.1	5.7	26.5	8.6	11.0	8.0	21.9	45.5	10.4	8.2	10.4	7.4	5.4	8.7	12.3	8.8	29.0	9.8	6.1	6.2	36.7	42.4	8.3	5.8	8.6	25.3	7.6	6.2	5.2	8.3	9.2	0.0	12.8	12.4	14.8	8.4	18.5	21.3	10.9	17.1	12.1	10.1	7.5
TSHZ2	"C20orf17, OVC10-2, TSH2, ZABC2, ZNF218"	ENSG00000182463	"Teashirt zinc finger homeobox 2"	Q9NRE2	20	52972358-53495330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7"	"Low region specificity"	"Detected in all"							HPA038123	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA038123: AB_10670657"	"unprognostic (9.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (3.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.88e-8)"	"unprognostic (6.26e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.37e-7)"	"unprognostic (2.97e-3)"	21.5	14.8	3.4	4.5	4.7	0.2	10.6	2.9	4.3	9.0	0.0	7.3	2.3	6.8	16.5	8.2	8.7	12.4	3.7	5.7	8.9	3.3	12.6	2.9	3.9	5.9	8.2	18.4	3.5	5.4	2.7	1.3	5.5	5.4	2.0	1.7	12.9	13.6	1.6	5.9	2.8	8.8	10.3	5.1	6.1	4.8	8.1	2.0	5.3	2.6	3.4	7.6	5.7	7.5	0.0	0.0	1.8	26.7	11.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.1	0.0	0.1	0.0	5.2	1.4	0.0	23.6	0.0	0.3	0.0	0.6	4.1	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.7	4.4	15.3	0.1	0.0	0.7	0.0	0.0	0.0	0.1	2.6	13.7	0.0	0.1	0.3	0.0	2.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.4	3.0	0.2	0.6	0.1	0.0	0.1	2.4	0.5	3.4	4.7	2.9	4.3	5.7	8.9	5.9	8.2	5.5	10.3	8.1	7.5	171.4	0.0	0.6	32.7	7.0	45.4	19.9	43.8	37.0	6.7	24.4	161.5	2.8	54.3	41.6	36.8	2.1	1.3	1.3	0.1	0.0	52.2	11.1	32.7	144.4	125.7	6.6	0.0	188.2	9.8	0.5	93.3	3.1	68.9	1.3	395.6	11.7	92.1	1.2	0.0	58.1	1.9	18.3	1.3	16.6	20.3	468.2	2.8	12.4	104.9	1.9	39.0	1.0	23.6	4.9	6.8	2.7	803.8	16.0	27.5	0.8	0.4	19.9	1.9	39.5	10.9	48.2	2.6	1.8	43.9	40.5	0.8	24.2	396.9	2.6	8.2
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078026	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.5;urinary bladder: 12.0"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 108.1;Basal squamous epithelial cells: 338.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.0;HHSteC: 17.1;hTCEpi: 10.3;hTEC/SVTERT24-B: 18.9;hTERT-HME1: 12.5;hTERT-RPE1: 38.6;U-87 MG: 14.1"	"Not detected"	"Not detected"							HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	38400			"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (6.47e-4)"	"unprognostic (3.26e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.74e-3)"	1.6	0.7	0.3	1.3	0.3	0.0	1.5	0.3	0.5	1.4	0.2	1.1	0.7	0.8	0.3	3.8	0.6	8.8	4.3	0.3	0.3	1.2	11.5	1.9	0.4	0.4	0.3	0.3	0.3	0.4	0.4	0.1	0.4	6.2	0.9	0.0	1.2	4.0	1.4	0.8	1.0	0.6	0.3	0.4	1.2	4.8	1.1	0.2	2.7	1.4	0.5	12.0	1.9	0.4	0.0	0.0	0.0	1.8	2.3	15.0	0.0	0.0	2.3	0.4	2.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.5	0.8	0.0	2.4	2.8	0.1	0.0	17.1	0.5	0.0	0.3	10.3	18.9	12.5	38.6	0.0	6.6	0.3	0.0	3.2	0.0	2.5	0.0	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.9	0.0	0.0	4.1	0.0	0.0	14.1	0.3	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.4	0.3	1.1	0.4	6.2	0.0	3.1	0.3	0.1	55.8	26.6	108.1	338.6	0.0	6.5	8.0	7.4	0.0	35.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	38.5	0.1	0.9	10.5	0.0	0.0	0.0	0.0	0.1	10.0	0.0	0.1	0.0	0.9	7.9	9.4	0.2	0.0	0.0	0.0	24.4	1.2	5.0	26.3	0.6	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	24.7	0.2	1.6	3.5	0.0	0.0	6.9	3.8	0.4	0.9	38.0	25.1	0.0	0.8	1.9	0.1	3.1
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 705.9;Muller glia cells: 508.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2"	"Group enriched"	"Detected in all"	5	"B-cells: 488.1;dendritic cells: 313.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	333.8	143.9	257.2	87.3	248.9	33.3	143.3	253.4	292.4	138.2	288.7	364.2	342.1	130.9	432.8	78.4	249.8	186.2	108.8	247.8	296.3	211.3	87.4	202.1	88.0	250.0	267.7	148.1	140.2	283.4	189.7	111.6	260.2	96.2	386.3	418.6	152.2	187.3	429.1	78.3	349.2	128.3	266.7	84.8	221.2	84.8	282.5	71.6	200.3	374.4	106.9	170.1	67.4	281.3	130.6	347.6	282.8	179.3	484.7	295.8	93.3	203.7	220.2	245.1	265.7	213.5	264.7	126.9	294.8	211.6	234.0	289.0	271.2	139.5	182.9	143.4	410.4	91.0	252.5	204.4	234.5	118.4	64.3	280.9	165.5	135.8	120.1	372.6	304.8	83.1	98.0	109.2	243.3	49.5	105.7	112.1	200.5	414.7	152.4	130.8	351.0	135.3	408.0	73.0	255.0	282.1	139.8	116.9	393.7	269.3	125.0	220.8	292.1	225.7	88.4	138.0	290.7	237.4	346.6	67.1	200.1	173.5	131.9	8.8	51.3	10.4	32.6	69.6	34.1	481.0	16.5	23.9	99.2	488.1	42.6	39.3	4.8	60.3	77.1	313.2	4.6	95.2	257.2	248.9	253.4	292.4	247.8	296.3	250.0	267.7	260.2	266.7	282.5	281.3	76.1	112.2	213.4	69.5	83.8	34.7	77.5	114.6	36.5	247.7	43.6	32.3	98.2	108.7	169.0	68.0	183.5	89.9	41.3	705.9	25.4	250.2	28.5	86.1	63.4	57.6	91.3	19.4	47.8	354.0	35.6	90.8	85.1	41.7	23.4	88.6	53.6	29.5	65.4	127.9	54.3	290.4	97.6	58.0	27.5	57.9	64.3	38.2	72.9	29.0	35.1	508.9	36.0	116.6	32.7	245.1	410.7	51.6	81.2	220.1	364.3	65.5	201.7	185.1	26.3	44.8	189.0	108.0	64.6	34.2	34.2	75.9	19.4	149.5	205.2	381.4
TSPYL5	KIAA1750	ENSG00000180543	"TSPY like 5"	Q86VY4	8	97273488-97277928	"Predicted intracellular proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.7"	"Group enriched"	"Detected in many"	8	"Early spermatids: 172.9;Late spermatids: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031347	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Golgi apparatus"	"HPA031347: AB_10601454"	"prognostic favorable (1.21e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.40e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.31e-2)"	"unprognostic (3.13e-1)"	6.0	8.6	11.1	4.3	12.6	1.2	12.1	6.7	11.4	11.4	0.8	9.7	1.8	15.2	15.5	4.5	12.4	6.6	12.4	10.0	17.6	10.0	1.7	7.2	6.2	10.3	8.6	25.2	8.7	8.1	11.8	4.3	12.5	15.3	3.2	11.3	9.7	18.3	12.9	4.1	4.1	14.3	7.6	7.3	8.4	44.7	14.4	7.4	8.3	10.5	7.3	9.7	4.6	8.7	0.0	15.9	0.0	0.0	0.4	0.4	0.1	12.4	0.0	12.2	7.9	0.0	0.5	0.0	16.8	14.8	0.0	4.4	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	19.4	0.0	17.2	0.0	0.0	0.2	34.9	30.5	0.0	0.5	23.4	0.0	0.0	0.0	0.0	0.2	23.1	0.0	0.1	10.2	0.1	60.8	47.1	0.0	4.1	0.0	8.2	0.0	1.9	0.0	0.0	26.2	0.1	0.0	14.4	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.3	0.2	0.1	0.0	0.2	0.0	0.5	0.2	0.0	11.1	12.6	6.7	11.4	10.0	17.6	10.3	8.6	12.5	7.6	14.4	8.7	7.5	6.4	4.1	0.0	5.5	2.3	4.5	0.7	6.8	12.5	9.9	8.8	16.3	2.8	2.1	9.2	20.9	0.2	2.6	0.0	5.9	5.8	172.9	6.4	13.7	9.8	2.4	3.4	0.0	3.5	0.1	12.1	10.2	2.6	0.0	19.2	6.4	0.8	6.3	8.4	0.0	0.3	2.0	5.0	5.9	419.0	24.5	4.6	7.2	0.0	2.2	13.1	0.0	0.0	0.0	3.7	0.0	21.1	0.8	7.8	0.0	1.4	4.1	12.2	6.6	12.4	9.3	35.5	31.0	5.6	1.6	0.1	1.3	9.9	0.3	4.1
TSR3	"C16orf42, MGC24381"	ENSG00000007520	"TSR3 ribosome maturation factor"	Q9UJK0	16	1349240-1351878	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040760, HPA046265"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA040760: AB_2677122, HPA046265: AB_10963942"	"unprognostic (4.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.74e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.14e-1)"	44.0	47.6	47.7	18.9	50.4	17.4	40.4	47.9	54.6	35.5	43.3	60.7	25.6	38.6	11.1	51.2	33.5	12.6	72.8	46.1	44.5	51.8	58.3	34.4	20.4	52.7	50.0	32.2	57.2	18.5	35.0	15.2	46.8	42.6	9.0	8.3	42.6	19.8	86.8	46.5	38.3	11.6	48.7	43.0	49.1	30.5	49.6	15.9	35.0	27.9	11.7	48.9	38.1	47.7	60.0	65.2	26.6	35.7	30.8	37.3	44.7	54.3	23.8	38.1	35.3	72.7	59.6	37.8	70.8	36.7	40.5	61.6	24.2	45.2	13.1	73.8	110.8	16.7	56.3	58.2	56.0	36.2	31.8	39.5	63.8	34.3	33.0	29.5	41.7	60.2	54.1	32.6	31.8	107.4	53.6	61.1	44.6	34.4	78.0	93.5	32.3	103.0	33.5	23.7	41.9	53.9	41.9	52.3	73.0	20.8	50.3	44.8	45.9	63.0	67.3	54.2	67.4	67.8	49.2	51.3	31.9	43.5	43.6	13.8	4.0	12.0	4.7	3.6	5.9	7.4	5.9	4.4	3.4	10.0	6.2	5.7	10.4	2.6	3.9	5.2	4.8	1.7	47.7	50.4	47.9	54.6	46.1	44.5	52.7	50.0	46.8	48.7	49.6	47.7	45.2	19.2	16.2	3.3	33.7	28.2	44.9	7.4	18.8	27.1	54.3	48.9	9.4	44.3	12.1	25.8	12.5	48.6	37.8	43.1	103.7	36.5	3.5	30.7	30.9	30.7	24.0	32.4	4.3	46.6	48.7	28.5	18.3	26.9	8.2	45.0	33.9	54.1	48.8	18.5	5.2	35.3	10.2	42.4	26.7	4.9	28.0	38.0	48.0	1.9	34.6	53.9	49.4	3.5	9.2	38.5	32.6	32.0	47.3	53.8	41.5	125.6	11.1	33.6	6.6	27.7	40.4	15.7	39.7	50.3	41.5	29.8	34.7	38.4	35.7	49.2
TTPAL	"C20orf121, dJ179M20.3"	ENSG00000124120	"Alpha tocopherol transfer protein like"	Q9BTX7	20	44475874-44494603	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 28.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 91.0;HSkMC: 78.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046957, HPA066532"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus, Cytosol"		"HPA046957: AB_10959741, HPA066532: AB_2685686"	"unprognostic (8.71e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.09e-5)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.93e-2)"	8.2	4.4	5.4	5.7	5.5	9.0	5.2	4.7	5.4	6.1	7.1	3.6	3.5	5.0	4.7	5.5	4.9	4.0	2.8	6.3	7.3	4.1	28.7	3.3	8.4	5.2	6.3	4.1	6.4	7.2	7.0	2.8	8.1	4.6	4.0	2.9	5.0	4.3	2.7	12.5	4.0	5.4	3.2	4.6	4.0	3.0	5.2	6.2	7.6	1.7	7.9	5.0	5.3	4.3	21.1	10.8	8.2	14.6	91.0	35.3	8.2	22.4	31.1	21.3	18.1	40.1	12.5	13.1	18.8	20.9	38.8	20.4	10.5	35.2	22.9	13.6	4.8	6.2	11.6	11.8	25.2	9.3	14.1	78.5	22.6	20.9	35.0	10.1	7.3	11.0	8.0	13.4	17.2	24.2	9.1	5.9	9.8	11.4	18.0	2.8	8.8	7.1	8.3	15.0	18.2	8.6	31.1	13.5	14.0	10.1	14.8	6.0	7.5	47.2	18.8	14.2	19.5	19.8	14.5	14.0	22.8	6.6	14.1	0.6	1.1	1.8	4.0	2.2	4.4	3.6	3.6	4.2	1.1	3.8	3.0	4.7	2.6	5.7	2.3	2.0	3.8	2.3	5.4	5.5	4.7	5.4	6.3	7.3	5.2	6.3	8.1	3.2	5.2	4.3	3.9	9.6	11.4	6.2	15.7	6.4	17.2	9.5	1.8	24.4	8.0	5.8	5.3	18.6	10.3	22.0	25.0	7.4	19.8	8.7	1.9	10.2	4.9	8.4	30.5	7.5	9.5	38.9	8.3	9.4	8.6	13.8	2.6	9.3	9.5	8.3	8.2	60.7	4.9	18.5	9.1	5.3	2.0	17.6	6.5	10.3	18.6	6.9	3.6	2.8	8.4	11.5	30.9	8.5	7.1	13.3	9.3	11.3	8.6	14.3	11.0	4.7	8.4	20.3	6.6	16.3	10.1	9.6	11.4	6.1	20.0	10.9	17.9	12.3	9.5	10.9
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	7	"HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	0.4	0.6	0.0	5.2	0.0	2.5	0.2	0.0	0.1	0.5	0.1	0.8	1.6	0.5	0.0	0.4	0.4	2.0	0.4	0.0	0.1	0.4	0.7	1.7	11.1	0.2	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.4	0.9	0.0	0.9	0.1	0.2	0.3	2.4	0.1	0.1	4.4	1.9	0.1	0.0	18.9	0.5	0.1	5.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	23.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.4	0.0	0.0	0.0	47.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.9	0.0	22.9	0.1	28.2	24.8	0.0	0.0	32.2	24.0	0.5	2.5	0.1	0.1	27.9	10.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.8	0.0	0.0	0.2	0.3	1.0	0.0	0.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	3.8	0.0	0.0	0.0	0.4	1.1	0.5	1.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.0	20.5	0.0	0.0	0.0
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457794	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1342.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	99.7	188.7	60.5	35.0	60.9	85.8	89.4	53.3	91.6	94.9	64.0	93.6	49.2	94.5	21.1	89.7	89.1	33.7	116.1	72.3	53.1	118.4	122.2	72.0	35.2	64.0	64.8	115.2	100.3	64.7	146.1	34.8	64.1	93.8	14.1	23.8	86.1	50.7	216.6	113.8	67.7	23.2	52.9	77.8	88.5	174.8	55.1	26.9	111.8	84.3	18.1	91.8	85.3	57.5	71.7	49.4	23.3	50.6	57.7	70.6	35.1	71.3	84.3	50.9	54.1	30.8	58.8	31.8	63.5	70.8	26.3	40.8	18.2	54.8	18.6	56.3	39.4	26.4	53.5	41.4	94.5	33.6	51.1	65.2	70.4	40.1	38.7	62.3	62.9	42.7	55.6	83.6	38.3	45.4	67.2	56.8	37.6	27.4	42.9	30.4	33.3	76.0	48.3	43.9	67.1	97.3	40.1	40.9	116.7	10.8	48.5	54.4	76.8	67.4	51.4	145.0	47.7	186.6	80.7	33.2	128.7	62.5	61.4	6.4	6.6	10.4	3.8	8.0	6.2	5.3	4.5	5.2	6.7	6.0	5.3	4.2	6.7	2.7	4.9	10.2	5.5	4.9	60.5	60.9	53.3	91.6	72.3	53.1	64.0	64.8	64.1	52.9	55.1	57.5	26.7	41.7	30.1	13.7	25.1	37.2	44.9	26.7	15.9	37.2	36.3	25.1	47.2	64.3	21.2	44.1	27.1	54.5	31.9	105.0	80.3	58.1	297.0	29.1	35.6	30.5	46.8	172.0	14.4	65.0	43.1	39.0	28.5	32.2	34.3	50.0	47.5	61.6	54.8	13.5	11.9	66.2	20.3	52.8	35.9	1342.0	100.0	37.5	53.4	1.9	49.0	60.1	25.7	5.5	10.3	65.6	90.1	73.0	16.4	50.9	136.9	112.2	21.4	35.2	72.3	38.8	29.5	139.9	68.9	20.4	41.1	79.6	18.5	41.4	58.4	48.5
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724577-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		170000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	35.0	38.7	13.1	32.3	14.7	13.0	39.0	15.6	19.0	44.3	26.1	33.9	35.6	32.3	64.2	50.1	30.1	32.0	57.4	14.9	16.1	38.7	76.8	30.4	32.5	16.7	14.4	56.9	57.5	37.7	31.5	43.7	16.4	39.9	36.9	39.2	54.7	37.5	219.2	36.2	33.7	35.7	14.9	26.3	40.8	43.1	15.6	30.7	53.4	138.7	39.7	40.2	27.6	19.2	46.8	36.0	49.5	66.7	118.6	155.8	45.5	106.2	129.4	57.2	69.2	36.2	70.4	60.6	64.0	98.0	49.2	52.8	74.9	66.5	85.6	67.2	29.3	41.8	31.4	76.3	93.0	55.8	46.2	89.2	80.6	59.8	116.4	110.6	87.1	41.7	73.7	67.9	85.8	30.9	55.4	29.5	67.9	98.2	21.3	36.3	47.2	49.2	85.5	53.1	39.4	38.3	39.1	82.4	67.3	73.6	60.6	45.1	67.4	52.2	32.2	95.8	40.7	63.6	36.6	29.5	77.6	33.1	63.2	21.9	13.1	11.9	16.4	18.7	22.2	9.8	13.6	15.7	16.8	11.2	13.9	13.8	8.1	22.2	26.9	13.4	15.1	13.7	13.1	14.7	15.6	19.0	14.9	16.1	16.7	14.4	16.4	14.9	15.6	19.2	34.5	60.9	84.5	59.1	43.2	38.0	52.8	59.6	51.2	33.3	35.0	28.4	126.9	28.6	71.7	25.8	43.8	47.9	32.6	32.0	35.2	38.4	11.1	35.7	57.5	36.4	40.1	20.8	70.9	48.6	49.0	62.7	61.2	55.0	48.8	126.2	32.9	62.0	42.8	26.9	68.7	63.7	40.7	38.0	35.1	10.9	78.6	41.3	28.4	60.9	54.8	32.8	45.3	77.4	113.7	48.5	33.4	68.4	106.9	78.2	44.3	50.4	66.4	51.2	39.5	54.0	50.5	73.8	68.2	58.7	40.3	90.6	37.8	36.3	41.9	63.8
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60177327-60422470	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 59.2"	"Group enriched"	"Detected in all"	10	"dendritic cells: 59.2;granulocytes: 29.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 171.4"					"Low region specificity"	"Detected in all"			HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	16.1	21.8	13.6	15.0	27.8	32.1	14.1	23.2	23.6	12.4	25.2	13.0	9.5	10.3	6.8	21.7	10.7	11.8	17.4	14.3	22.8	20.2	26.6	20.7	10.5	22.2	25.0	10.0	12.5	19.2	11.9	13.2	24.8	10.8	11.4	58.8	12.9	11.2	40.8	21.0	10.5	13.7	18.1	18.5	12.2	102.1	22.3	14.4	20.6	29.2	11.6	13.1	14.7	44.4	32.6	38.2	19.0	30.8	44.8	45.3	17.2	26.4	41.9	34.5	45.8	18.6	20.0	19.4	21.5	50.0	56.1	16.3	33.1	36.9	61.5	16.8	13.9	39.7	31.8	19.5	44.1	31.7	33.6	39.6	24.6	49.9	45.2	33.5	38.6	24.4	42.9	17.1	41.1	171.4	32.3	21.3	21.7	29.6	18.8	15.8	51.6	11.5	33.1	24.5	13.1	19.1	22.9	6.0	33.8	32.1	27.4	41.3	32.6	49.7	54.9	33.1	23.5	16.2	37.4	19.6	24.6	23.6	33.4	14.5	4.3	16.5	2.0	3.7	1.4	3.0	1.4	1.7	8.5	2.2	1.0	1.9	29.4	1.3	4.6	59.2	2.6	2.1	13.6	27.8	23.2	23.6	14.3	22.8	22.2	25.0	24.8	18.1	22.3	44.4	8.0	6.4	16.4	58.8	12.5	26.9	13.3	5.8	11.4	17.3	9.2	7.6	8.2	10.0	10.1	5.5	241.8	5.1	12.6	8.5	3.9	11.3	95.0	9.0	9.9	9.8	8.3	44.2	92.3	7.5	8.4	12.6	15.8	11.6	11.4	18.5	12.5	12.0	18.5	13.5	113.1	5.6	6.1	29.7	41.3	33.3	13.1	25.1	5.4	101.2	28.0	10.4	24.7	70.4	268.9	9.6	11.4	5.7	8.3	10.3	7.4	4.6	7.0	136.4	26.3	11.9	9.1	92.7	14.9	11.2	21.9	4.9	10.9	8.5	5.5	8.2
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	40.7	31.2	31.5	24.6	40.4	34.5	34.3	52.0	49.7	24.2	37.3	24.3	25.4	28.0	26.8	21.6	22.5	26.3	21.7	35.4	31.8	31.1	25.4	26.2	28.1	28.6	24.9	29.3	19.5	35.0	20.9	28.0	30.8	28.8	25.2	49.1	25.2	22.9	18.0	24.3	26.9	24.1	22.3	26.0	24.4	25.4	28.6	27.1	30.4	20.7	26.0	22.9	20.0	55.5	42.4	18.8	64.1	44.2	90.0	78.3	54.8	45.3	42.9	54.0	60.1	25.4	35.5	31.4	41.2	44.3	88.2	32.1	47.4	31.1	65.7	28.8	36.6	111.1	44.6	22.2	56.0	37.8	26.8	58.3	23.9	52.4	37.9	51.9	48.7	28.0	43.9	26.3	41.2	16.1	34.9	38.0	62.2	32.6	37.2	33.0	67.7	22.2	51.0	41.1	53.8	41.2	31.9	41.5	64.2	54.3	23.1	41.2	41.2	49.4	34.4	50.1	43.2	21.0	28.4	30.4	37.3	44.5	25.4	67.3	22.5	31.8	21.0	22.6	21.7	20.5	20.6	21.7	17.5	22.3	24.5	21.9	30.5	19.2	30.1	18.4	20.7	16.7	31.5	40.4	52.0	49.7	35.4	31.8	28.6	24.9	30.8	22.3	28.6	55.5	40.2	44.8	40.9	66.3	35.1	17.2	18.8	21.2	32.5	56.7	25.7	22.1	39.9	22.8	25.5	35.0	58.4	25.1	48.8	35.9	9.8	20.8	4.3	54.8	37.8	31.8	35.5	50.9	149.3	15.4	19.0	39.6	43.3	54.6	23.4	43.1	28.2	23.1	19.0	62.2	159.0	28.6	22.4	30.8	20.7	5.5	35.8	35.1	23.2	75.9	38.7	31.4	37.0	98.0	138.5	19.6	27.8	32.0	42.4	22.9	33.2	25.6	37.3	44.5	19.7	34.9	35.6	39.8	30.1	28.4	16.3	11.9	41.0	39.2	24.8	21.8
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514421	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	20.3	18.8	11.5	21.1	11.0	27.6	19.6	14.4	13.3	20.5	18.1	21.5	26.7	19.1	10.4	20.7	18.5	16.4	15.1	9.1	14.6	27.0	28.1	19.5	19.0	14.1	13.1	19.9	17.4	45.1	10.6	20.3	12.5	17.0	20.8	22.2	19.8	17.2	17.6	14.2	24.4	18.4	11.5	18.7	22.5	32.0	13.6	20.9	25.4	22.7	24.3	20.0	12.6	13.2	30.6	35.8	23.7	41.1	32.3	44.3	31.0	45.7	43.9	35.7	40.4	19.5	17.7	28.8	35.0	43.5	46.6	57.8	28.8	28.3	39.9	27.2	19.3	52.9	31.9	27.3	35.9	34.3	34.4	32.4	36.2	26.0	55.8	37.0	36.3	23.3	28.4	36.8	32.9	45.9	26.6	12.0	28.5	32.6	17.1	24.1	39.1	45.8	29.5	61.3	29.1	23.8	42.5	55.9	57.4	48.9	35.8	36.9	45.0	41.1	24.1	122.7	52.7	28.5	69.8	32.4	30.6	65.6	40.1	114.6	27.7	50.1	21.4	26.1	22.1	37.3	22.9	23.3	22.7	34.3	24.0	21.2	47.9	22.1	35.0	20.5	20.0	16.0	11.5	11.0	14.4	13.3	9.1	14.6	14.1	13.1	12.5	11.5	13.6	13.2	63.5	96.1	130.8	36.2	101.8	28.9	40.7	47.3	35.9	54.5	41.7	40.0	69.8	51.5	72.7	47.8	68.8	59.0	92.7	79.5	25.4	53.7	153.7	91.5	79.7	53.8	53.3	36.8	41.0	51.3	45.4	55.8	58.1	65.6	86.7	48.5	51.0	56.6	45.4	33.7	44.3	68.7	36.7	73.2	38.2	28.4	53.7	77.6	40.9	46.9	85.3	45.5	72.1	34.7	46.1	57.3	58.2	61.7	87.1	51.0	88.9	49.9	114.9	74.2	46.0	108.2	56.2	140.5	54.8	39.6	41.5	105.2	72.6	77.1	64.8	55.3
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165569	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 1407.4"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 128.3;Horizontal cells: 225.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Region enriched"	"Detected in all"	6	"hypothalamus: 1407.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	3100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	2.1	3.1	23.7	0.8	24.8	0.1	0.1	5.5	174.6	0.0	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	22.7	1407.4	3.6	0.0	0.1	0.0	235.4	69.9	0.1	16.1	0.0	117.0	0.0	158.8	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.3	0.2	16.6	0.1	1.9	0.9	48.7	0.0	0.6	0.0	0.0	0.0	0.1	27.3	2.2	1.1	1.1	9.5	0.0	0.0	10.3	0.9	0.0	0.0	0.0	2.4	0.9	0.1	3.1	0.0	1.4	1.4	0.5	0.1	0.0	1.0	0.7	0.3	0.0	0.9	0.1	0.6	4.4	0.1	0.2	0.2	0.7	0.0	0.0	0.1	3.7	2.3	0.0	23.4	0.1	2.4	17.6	1.0	2.3	0.8	0.0	0.1	0.3	0.1	14.1	172.0	0.3	0.9	511.5	1.1	0.4	0.3	0.0	0.4	85.9	0.0	2.0	0.1	0.8	4.7	13.5	0.4	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	24.8	5.5	174.6	22.7	1407.4	235.4	69.9	158.8	16.6	48.7	27.3	1.7	0.0	0.0	3.6	0.9	1.5	1.0	0.0	1.2	22.0	0.9	0.6	2.9	0.0	0.0	0.0	0.0	1.5	1.0	1.3	29.4	0.3	0.1	0.4	0.4	0.9	128.3	0.0	22.7	0.0	8.4	0.3	3.1	0.5	0.0	1.4	0.0	0.0	0.6	225.4	37.7	4.5	0.0	0.0	0.4	0.6	0.6	0.7	0.0	11.2	0.0	2.1	0.0	4.0	4.8	5.9	2.8	0.0	0.9	4.3	2.7	1.2	0.0	5.0	0.0	0.1	0.8	0.2	4.3	0.6	2.3	1.4	0.5	5.4	2.3	0.6
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54 subunit of GARP complex"	Q9P1Q0	2	63892146-64019428	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	11.7	11.5	8.1	10.6	9.7	15.0	14.5	13.5	9.6	13.5	10.9	11.6	13.0	14.4	12.3	10.8	12.4	10.4	8.4	7.8	8.5	16.0	14.4	13.1	11.1	8.8	8.7	14.6	17.0	28.3	13.0	13.5	8.9	17.4	13.4	17.3	36.8	12.8	9.3	10.9	12.2	12.8	8.5	12.9	14.4	13.4	8.5	13.2	17.7	9.9	11.2	10.9	9.8	11.0	23.3	11.9	22.5	17.4	15.7	17.1	16.6	14.3	21.4	15.0	14.9	22.0	14.9	15.8	10.5	20.1	22.3	10.7	22.1	12.9	27.1	23.0	15.9	14.7	10.0	38.9	15.0	10.3	6.2	16.3	19.8	10.5	22.7	18.0	23.0	11.3	16.6	13.4	19.4	10.1	10.9	11.5	13.8	22.9	9.1	10.8	21.8	9.0	17.1	13.1	13.1	19.6	12.8	16.3	17.8	17.3	11.9	20.6	16.8	19.3	15.3	11.8	23.9	30.8	8.7	20.4	14.3	20.5	16.4	1.0	0.7	0.3	0.5	0.6	0.5	0.6	0.4	0.5	0.4	0.7	0.6	0.5	0.6	0.7	0.5	0.6	0.9	0.2	8.1	9.7	13.5	9.6	7.8	8.5	8.8	8.7	8.9	8.5	8.5	11.0	16.6	16.0	22.3	62.7	5.2	11.1	8.7	6.4	3.4	20.9	11.8	9.8	14.3	15.7	14.2	1.8	12.5	6.5	6.4	11.1	1.9	6.8	53.9	9.3	16.6	13.4	13.2	2.1	71.6	13.2	6.8	11.8	15.8	11.0	2.5	15.2	10.8	15.4	8.1	23.5	81.8	17.4	2.0	9.8	9.3	37.4	18.6	12.2	5.4	76.8	9.6	9.4	3.1	105.6	108.9	11.3	12.8	12.4	7.7	17.3	11.6	9.9	10.6	16.2	19.7	13.4	12.8	14.9	8.3	9.4	10.4	5.5	7.5	15.9	12.9	13.8
VTI1A	"MVti1, Vti1-rp2"	ENSG00000151532	"Vesicle transport through interaction with t-SNAREs 1A"	Q96AJ9	10	112446998-112818744	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 135.2;Excitatory neurons: 244.7;Inhibitory neurons: 199.5;Late spermatids: 102.8;Microglial cells: 195.8;Oligodendrocyte precursor cells: 172.4;Oligodendrocytes: 218.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054108	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Vesicles"		"HPA054108: AB_2682382"	"unprognostic (9.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.50e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic favorable (7.27e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-1)"	6.6	4.7	3.7	7.0	3.7	13.8	4.7	2.3	4.7	3.5	1.1	6.4	7.2	3.8	4.9	7.3	3.2	4.6	5.8	4.8	2.6	6.8	4.7	5.1	7.7	2.8	3.7	3.1	3.9	7.5	2.6	4.0	3.5	4.7	7.5	4.2	5.2	4.8	7.4	5.9	7.2	5.7	1.8	5.6	5.5	4.5	4.3	8.6	6.3	6.1	9.4	5.2	4.4	4.6	13.5	11.2	10.1	14.1	15.5	13.4	6.1	14.1	17.4	11.0	12.2	12.7	13.6	14.0	5.3	16.0	9.3	15.6	8.8	11.2	14.9	18.0	8.1	11.9	8.1	13.3	11.0	16.8	16.8	10.4	13.9	12.6	25.9	12.4	11.9	14.1	11.3	16.9	14.8	9.5	13.3	12.8	4.4	10.5	6.5	13.9	14.6	6.2	11.5	11.9	4.6	9.0	10.0	8.6	9.5	8.4	7.8	9.3	17.0	8.7	7.4	10.8	15.8	7.4	11.0	15.9	14.2	15.3	8.6	9.2	7.0	9.6	5.4	9.3	5.1	5.5	4.5	4.4	5.2	4.6	4.3	4.4	11.4	5.7	8.7	4.9	7.2	4.6	3.7	3.7	2.3	4.7	4.8	2.6	2.8	3.7	3.5	1.8	4.3	4.6	13.5	12.8	10.3	135.2	33.1	11.2	14.5	8.8	13.6	16.5	7.8	4.6	14.0	7.2	11.6	5.5	43.8	7.6	31.5	17.0	7.9	15.4	42.9	11.4	15.5	13.6	18.5	18.1	244.7	25.0	12.3	12.9	21.9	17.0	19.6	10.2	8.9	8.1	18.8	21.9	199.5	10.7	14.2	17.0	27.0	102.8	6.8	20.9	12.4	195.8	19.0	6.0	25.7	172.4	218.6	29.7	12.2	5.7	23.9	12.6	17.2	9.4	11.7	20.7	0.0	13.5	14.1	11.1	9.2	17.0	16.3	14.4	25.4	9.7	12.1	19.7
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647085-67674820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206"	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	53.8	26.9	55.5	20.4	56.8	22.3	39.8	54.4	102.1	22.7	49.8	42.9	28.3	18.4	53.5	44.3	18.5	28.7	60.1	56.6	58.1	53.0	41.6	26.8	23.8	55.1	56.6	21.0	44.0	23.9	17.1	21.3	56.8	22.3	35.2	23.0	30.1	13.6	46.5	31.0	24.1	22.4	56.0	26.5	40.0	30.8	56.3	12.1	34.0	28.2	27.0	33.3	23.4	56.9	111.7	54.8	31.4	18.1	61.9	37.2	45.4	48.1	30.5	23.8	23.7	27.3	38.5	32.9	40.2	54.5	27.5	30.6	36.8	36.6	37.7	34.3	22.6	33.4	32.5	34.8	26.6	20.9	22.9	36.3	39.6	25.6	26.1	60.5	27.2	23.1	22.2	25.4	34.5	131.1	26.6	77.7	20.3	76.6	88.0	31.8	35.6	12.2	35.1	65.0	17.4	35.5	33.8	45.5	71.4	23.7	41.9	58.0	38.5	62.6	93.8	51.4	45.6	23.8	27.8	53.2	52.9	38.9	29.0	88.8	61.5	143.8	49.4	80.4	42.4	49.0	43.1	51.1	59.6	43.0	40.5	50.3	27.2	56.4	70.2	38.6	60.2	58.3	55.5	56.8	54.4	102.1	56.6	58.1	55.1	56.6	56.8	56.0	56.3	56.9	47.6	25.6	35.0	13.1	48.7	42.3	61.4	91.7	33.0	23.2	82.2	65.4	30.5	67.2	64.4	66.2	22.9	107.4	47.5	138.2	217.2	109.1	141.7	58.5	43.2	51.5	46.6	102.7	15.8	131.4	167.9	51.6	40.8	49.5	64.0	43.6	73.9	95.3	131.4	15.2	18.2	96.0	50.8	99.8	49.2	493.5	41.7	80.9	71.2	11.2	121.6	65.4	78.2	13.6	17.1	130.7	119.4	39.9	51.0	120.5	165.4	268.6	55.3	44.8	19.7	36.5	58.2	104.5	57.2	58.2	52.8	125.9	46.8	35.5	91.9	124.6
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 40.7;brain: 16.4"	"Group enriched"	"Detected in some"	7	"Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9;pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 31.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.9"	"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507"	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.0	40.7	7.8	0.0	1.7	0.1	0.0	0.7	16.4	0.5	0.0	0.4	1.8	0.2	0.1	0.0	1.3	0.0	0.0	6.5	0.7	0.2	0.0	0.1	0.0	7.4	0.5	0.4	5.6	1.4	8.3	0.0	5.0	0.5	0.3	0.2	0.6	2.4	0.0	0.0	1.1	0.0	0.0	0.0	2.8	1.0	2.6	0.0	0.3	0.0	0.0	0.1	0.1	2.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.9	0.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.3	0.0	0.0	31.7	2.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.7	0.7	16.4	6.5	0.7	7.4	0.5	5.0	0.0	2.6	2.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	7.6	0.1	0.1	112.4	0.0	39.2	0.2	0.0	0.0	6.1	0.8	0.0	0.2	1.1	0.0	0.2	3.3	29.2	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	1.7	0.2	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1
WDFY1	"FENS-1, KIAA1435, WDF1, ZFYVE17"	ENSG00000085449	"WD repeat and FYVE domain containing 1"	Q8IWB7	2	223855716-223945357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050603, HPA079597"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Vesicles"		"HPA050603: AB_2681188, HPA079597: "	"unprognostic (2.49e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.55e-2)"	18.6	13.2	9.3	18.0	9.5	48.5	14.4	9.3	12.0	20.5	11.2	20.4	15.6	22.6	19.8	14.4	20.5	17.5	11.7	9.2	10.7	14.8	18.0	18.4	23.3	11.0	10.2	20.2	14.1	19.8	8.7	27.4	11.4	16.2	20.1	15.9	13.5	12.8	11.4	13.5	15.9	19.6	9.7	21.2	19.8	10.9	10.5	15.9	22.1	12.6	18.9	17.9	13.7	11.1	27.9	19.3	34.9	27.2	46.4	44.0	43.7	34.7	48.3	37.5	30.4	81.4	25.0	7.7	30.8	60.6	47.3	19.2	18.7	52.3	40.4	15.6	15.8	19.2	31.9	59.2	36.4	15.2	15.8	39.0	37.9	46.3	71.0	62.4	63.9	16.2	34.3	23.4	44.4	26.8	6.5	11.1	34.5	20.7	16.6	25.3	44.8	8.6	28.4	47.7	29.6	15.7	20.7	19.2	90.9	41.6	12.5	38.1	70.9	74.9	25.7	13.5	18.0	28.8	4.6	21.4	36.3	32.9	26.2	4.4	21.5	8.1	13.7	29.0	16.6	14.1	9.7	13.5	14.8	11.7	10.0	9.5	10.3	24.0	25.7	3.0	9.7	17.6	9.3	9.5	9.3	12.0	9.2	10.7	11.0	10.2	11.4	9.7	10.5	11.1	40.0	16.0	9.3	22.5	22.0	12.5	14.5	19.9	17.1	14.0	11.8	7.6	7.7	12.8	24.4	16.5	8.4	22.6	25.5	36.4	9.8	12.9	0.8	23.2	30.7	34.1	10.3	11.2	28.7	17.2	11.2	21.4	29.6	36.5	17.7	12.5	16.8	25.7	17.9	28.6	28.1	15.2	8.2	26.3	17.2	2.4	14.6	24.4	35.6	27.2	25.6	13.9	24.7	33.7	39.8	18.0	24.4	23.7	21.8	16.6	16.0	14.4	29.9	10.9	6.6	13.1	26.7	3.8	8.8	24.4	15.5	19.0	21.1	15.0	21.8	28.7
WDR88	PQWD	ENSG00000166359	"WD repeat domain 88"	Q6ZMY6	19	33132090-33175799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 8.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 31.3;Late spermatids: 15.9;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041916, HPA050336"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA041916: AB_10804121, HPA050336: AB_2681093"	"unprognostic (1.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.33e-4)"	"unprognostic (5.14e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.67e-2)"	0.2	0.4	0.4	0.9	0.9	0.9	0.1	0.9	0.8	0.1	0.0	0.1	0.6	0.3	0.0	0.6	0.2	0.5	0.9	0.6	0.2	0.3	0.1	0.2	1.2	0.3	0.2	0.7	0.8	0.0	0.2	0.2	0.3	0.3	0.0	1.5	0.8	0.0	0.2	0.7	0.7	0.0	0.2	0.6	0.3	8.9	0.4	0.0	1.0	0.0	0.0	0.2	0.0	0.4	0.5	1.1	0.7	1.3	0.3	0.0	1.0	0.4	0.0	0.1	0.0	0.5	1.1	1.3	0.6	0.0	0.8	0.4	0.0	0.1	0.0	2.8	0.4	1.3	1.0	0.2	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.9	1.4	0.0	1.7	0.5	0.6	0.5	0.4	0.4	1.1	0.4	0.2	0.0	0.6	1.9	1.9	1.3	0.6	0.3	0.9	1.6	1.0	0.7	0.3	1.0	0.6	0.2	1.2	0.9	0.7	0.2	2.1	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.9	0.9	0.8	0.6	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	15.9	0.3	0.0	0.0	1.9	0.0	0.0	0.0	2.5	4.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234632-27308636	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	16.5	24.4	25.4	10.5	22.3	14.7	17.5	20.2	25.4	18.9	12.7	24.7	12.9	19.7	7.0	18.0	19.9	10.5	35.9	21.8	20.0	19.9	18.7	16.9	14.4	25.3	21.0	19.0	22.1	47.7	16.9	10.6	24.4	19.3	9.5	33.5	20.1	15.1	63.0	24.8	18.0	12.0	19.4	17.7	23.2	37.6	23.5	19.8	18.4	54.4	12.7	19.8	18.5	21.1	19.8	8.6	13.5	1.3	18.9	15.8	5.6	12.0	20.1	12.7	15.5	2.9	19.3	17.0	14.0	24.0	9.3	10.1	13.0	18.4	11.0	23.2	22.0	17.7	8.9	7.9	17.0	9.0	22.4	15.1	29.6	15.8	14.4	22.9	17.4	5.4	18.2	17.2	13.6	11.1	14.6	21.6	6.3	13.0	18.1	7.3	10.1	18.7	15.2	4.2	19.7	16.9	15.7	6.6	14.4	10.1	9.8	15.5	15.2	10.3	6.2	14.5	5.9	24.7	14.2	8.1	20.8	17.3	12.5	0.1	0.2	2.7	1.4	0.3	0.5	0.6	0.3	0.6	0.7	0.4	0.2	0.6	2.1	0.4	0.2	0.5	0.4	0.5	25.4	22.3	20.2	25.4	21.8	20.0	25.3	21.0	24.4	19.4	23.5	21.1	10.8	9.6	10.7	19.6	13.8	12.9	10.3	8.4	16.5	31.4	18.5	14.5	15.6	14.3	7.6	31.3	54.2	14.2	14.3	17.3	9.8	15.1	29.8	15.3	8.2	10.1	16.7	32.8	22.4	14.1	4.8	10.6	16.3	13.2	1.3	15.4	18.5	16.6	13.0	21.9	21.2	16.9	6.1	21.0	11.3	66.2	17.1	15.8	10.6	19.7	18.9	15.8	28.8	16.6	22.2	16.0	10.1	16.6	12.3	17.2	26.6	19.1	18.4	70.0	6.6	17.1	10.3	30.9	6.6	13.0	17.3	16.4	13.3	14.1	15.0	16.8
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 99.6;Oligodendrocyte precursor cells: 110.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 40.0;HUVEC TERT2: 24.7;OE19: 26.4;PC-3: 24.8;RH-30: 50.5;SCLC-21H: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	2.2	2.2	19.7	1.0	21.7	0.0	1.8	29.5	19.8	1.1	6.8	6.8	3.4	1.2	0.2	0.6	1.0	0.9	2.0	18.1	19.1	5.9	0.5	1.4	1.3	29.4	23.8	0.5	1.5	0.9	3.5	4.8	24.9	0.6	3.8	5.7	1.2	0.7	11.4	1.3	4.3	1.3	22.2	13.6	1.3	11.2	22.9	1.1	0.9	3.8	0.9	0.8	0.8	26.7	0.0	5.8	40.0	3.2	0.2	0.0	2.1	4.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.4	10.0	0.3	0.0	0.0	13.6	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.5	0.0	24.7	0.1	0.0	0.9	1.2	0.8	0.0	0.0	13.3	26.4	24.8	0.0	50.5	1.6	8.4	2.1	15.5	0.0	0.2	0.0	0.0	4.1	0.0	0.3	0.1	0.0	1.4	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	21.7	29.5	19.8	18.1	19.1	29.4	23.8	24.9	22.2	22.9	26.7	7.7	0.0	0.0	11.8	0.1	0.4	0.0	0.0	0.6	24.1	0.2	0.1	3.8	0.0	0.0	1.8	0.0	0.7	0.1	22.4	1.9	0.3	73.4	0.1	0.0	5.9	0.0	0.0	2.7	0.2	0.1	0.2	0.0	0.0	0.0	0.7	10.0	0.4	1.2	1.7	12.5	3.3	0.0	0.8	0.4	99.6	0.6	0.0	1.8	4.7	0.0	9.8	0.0	110.1	20.6	0.2	6.5	0.0	0.0	0.0	21.5	1.4	0.0	3.5	0.0	6.0	0.7	0.4	3.3	0.1	0.6	0.0	0.3	0.1	5.8	0.1
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099430-79212667	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease variant, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Astrocytes: 927.8;Excitatory neurons: 270.5;Inhibitory neurons: 540.9;Microglial cells: 471.2;Oligodendrocyte precursor cells: 914.9;Oligodendrocytes: 793.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA050992: AB_2681299"	"prognostic unfavorable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favorable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	8.6	6.3	18.6	4.0	23.9	4.2	7.4	24.0	20.3	8.6	21.2	5.2	5.3	8.2	10.1	7.7	9.0	7.4	5.2	18.8	22.5	12.7	12.0	5.3	4.6	24.0	22.4	7.6	8.3	12.1	9.8	5.3	25.3	7.7	3.2	6.9	8.5	6.4	3.3	7.1	4.5	5.1	22.0	4.7	6.0	9.3	21.0	9.0	21.8	2.1	6.0	6.7	7.1	30.0	11.1	9.5	9.2	7.7	11.0	5.3	11.1	1.6	3.2	3.7	3.2	7.0	9.6	19.5	8.6	1.5	5.2	10.0	5.1	1.3	2.6	11.0	26.8	6.0	1.9	15.7	7.5	16.7	3.4	5.9	3.8	2.3	2.4	0.9	4.4	25.9	9.2	4.2	2.6	85.7	27.7	21.9	8.6	5.9	5.7	32.2	3.9	19.1	5.3	3.9	17.6	10.0	7.1	11.9	4.0	9.3	12.8	12.0	1.6	2.7	10.4	2.2	6.4	0.0	18.3	41.2	10.4	8.4	4.6	7.0	9.1	2.1	11.4	7.9	13.4	9.3	8.2	9.1	7.7	6.6	8.4	8.3	0.7	9.1	5.8	14.5	13.5	6.0	18.6	23.9	24.0	20.3	18.8	22.5	24.0	22.4	25.3	22.0	21.0	30.0	12.0	6.4	6.9	927.8	9.0	9.2	21.2	8.0	19.4	7.4	12.1	16.1	8.8	17.2	13.3	14.7	4.2	25.7	10.9	4.5	33.2	12.4	43.1	18.2	13.9	9.5	9.6	13.3	270.5	10.3	11.9	12.0	9.2	7.6	12.7	18.7	13.2	18.9	9.2	5.0	540.9	5.1	0.0	5.6	5.7	38.2	14.0	7.7	5.4	471.2	5.9	46.3	9.2	914.9	793.5	4.5	5.9	17.7	18.4	11.5	8.7	28.3	18.7	12.2	6.6	10.3	11.8	19.7	17.9	13.3	6.8	17.4	9.9	12.1	6.8	13.0
YIF1A	"54TM, FinGER7, YIF1, YIF1P"	ENSG00000174851	"Yip1 interacting factor homolog A, membrane trafficking protein"	O95070	11	66284580-66289145	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014840, HPA076194"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014840: AB_2217189, HPA076194: "	"unprognostic (9.35e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (8.70e-4)"	49.2	54.7	33.4	28.4	36.0	16.7	47.5	38.5	41.4	42.7	42.4	50.8	56.5	53.5	34.5	50.9	45.7	25.5	57.8	33.5	35.6	50.9	149.5	44.9	22.9	38.9	36.1	42.1	86.0	40.6	74.1	34.5	38.2	47.3	37.7	12.3	51.1	29.6	96.2	43.0	47.4	41.1	38.5	35.9	56.1	36.4	35.6	21.6	49.9	59.3	24.7	45.4	40.6	41.9	80.7	131.3	39.4	72.6	130.0	138.7	73.8	114.4	122.3	95.5	94.3	126.0	95.5	67.9	111.5	161.4	107.8	119.9	60.7	107.9	75.6	77.7	72.0	42.5	93.3	158.7	147.4	59.3	61.5	97.4	144.4	98.6	158.9	76.6	91.3	67.0	80.7	114.8	84.3	199.3	71.3	64.4	40.3	147.4	136.6	54.9	61.2	203.9	81.9	70.9	58.5	57.9	62.5	106.7	103.4	49.6	155.5	43.5	81.0	80.8	69.0	165.3	54.1	78.1	86.0	63.0	125.4	56.2	90.2	19.4	95.6	20.6	71.3	141.4	78.4	95.9	60.6	67.2	116.4	82.4	48.0	55.3	9.4	51.2	140.0	141.6	54.9	99.8	33.4	36.0	38.5	41.4	33.5	35.6	38.9	36.1	38.2	38.5	35.6	41.9	63.4	38.5	48.0	6.2	52.2	36.1	88.1	170.4	38.1	27.1	84.4	92.7	34.5	82.9	115.5	46.0	22.9	114.3	42.6	66.8	64.6	137.9	28.1	42.1	84.8	53.6	87.4	21.0	1.9	149.4	248.5	90.4	55.0	42.8	29.9	38.8	49.2	172.0	105.4	26.9	3.9	140.9	116.0	38.4	44.9	48.6	75.5	45.0	72.9	8.4	40.8	73.7	28.8	10.1	10.4	132.1	93.3	82.4	92.4	195.2	202.2	135.2	101.4	34.0	39.5	60.8	150.0	61.0	56.8	63.3	46.3	154.3	36.5	88.1	107.2	112.1
YIF1B	FinGER8	ENSG00000167645	"Yip1 interacting factor homolog B, membrane trafficking protein"	Q5BJH7	19	38303558-38317273	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039328, HPA055257, HPA062675"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		37000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles	"Golgi apparatus"	"HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830"	"unprognostic (2.51e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.53e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.94e-3)"	30.1	30.7	29.3	33.0	32.4	69.1	26.7	37.0	38.3	33.5	29.0	26.6	20.4	24.1	10.9	33.2	25.6	16.5	40.6	30.2	32.6	27.2	58.3	35.7	32.1	36.3	30.9	26.7	27.1	16.9	29.1	23.5	38.6	23.7	16.1	13.6	30.2	12.5	35.0	26.0	24.0	18.1	33.4	47.7	22.0	23.1	34.0	20.9	19.8	26.7	20.9	26.8	25.6	38.5	43.7	108.9	48.3	57.5	68.4	63.5	37.8	103.2	79.0	75.7	110.7	53.5	32.6	75.7	44.4	121.1	81.5	27.4	85.9	54.6	28.7	81.1	43.3	117.0	48.2	56.5	94.8	82.4	132.9	52.3	47.9	78.0	33.8	76.1	71.3	99.4	152.9	205.3	68.5	46.0	87.6	98.9	37.0	74.9	33.7	89.0	58.6	117.9	48.9	40.6	34.8	58.1	34.5	76.7	55.4	37.2	29.9	163.2	68.8	74.6	73.2	108.4	83.9	76.4	122.1	51.8	96.1	150.5	54.6	81.9	155.7	179.0	60.8	119.4	54.4	49.3	57.3	54.8	300.3	42.7	46.7	47.5	42.8	44.0	70.8	127.0	59.0	120.2	29.3	32.4	37.0	38.3	30.2	32.6	36.3	30.9	38.6	33.4	34.0	38.5	27.4	0.0	5.5	5.5	22.8	17.7	19.4	25.8	18.2	12.2	22.6	18.7	4.7	18.6	14.2	22.0	12.5	44.7	17.0	16.0	0.0	39.4	6.3	17.5	18.2	23.9	14.4	33.2	7.3	27.7	52.9	23.8	16.3	18.6	22.9	43.4	37.1	30.5	94.4	11.8	7.4	24.7	32.6	42.3	37.4	8.5	9.0	53.3	35.6	3.7	34.4	20.8	16.5	4.0	12.7	15.5	13.5	9.1	69.4	14.8	8.1	16.1	20.7	15.5	6.6	11.1	40.3	20.6	31.9	30.7	20.0	27.6	18.8	26.2	25.9	19.5
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	29.5	43.5	18.1	15.9	18.7	29.6	34.1	20.5	26.6	41.7	30.7	34.7	31.8	38.1	26.8	51.0	35.2	30.3	31.6	19.4	20.3	45.1	56.1	32.8	16.8	22.4	19.6	39.6	114.3	33.4	108.2	38.9	21.0	40.3	15.8	6.5	105.7	23.6	24.8	33.8	29.9	14.2	18.2	27.7	39.2	76.8	19.4	14.3	47.5	10.3	11.2	32.6	39.6	20.4	64.9	22.3	17.5	25.4	40.0	38.9	30.1	48.9	71.6	36.6	52.9	68.1	51.6	12.8	80.2	56.2	16.7	49.8	11.9	47.6	9.5	41.7	43.2	24.2	27.3	39.1	62.1	42.5	49.3	35.7	33.6	24.7	35.4	47.7	26.2	31.1	31.6	69.2	22.9	109.4	27.4	42.7	29.4	44.3	55.2	22.8	14.1	65.3	33.0	30.2	45.4	22.2	35.2	56.4	48.8	15.3	51.7	60.1	39.1	41.6	15.3	60.2	36.7	96.7	42.5	24.2	65.1	72.9	43.9	39.2	18.8	9.3	13.3	21.3	10.4	16.3	10.4	12.3	22.3	9.5	9.3	13.3	3.1	12.1	19.4	34.1	12.6	10.4	18.1	18.7	20.5	26.6	19.4	20.3	22.4	19.6	21.0	18.2	19.4	20.4	20.5	16.0	21.2	2.6	16.0	6.8	41.6	22.4	17.1	19.4	46.9	37.8	0.5	27.1	27.3	35.0	16.7	109.5	20.6	31.9	27.4	69.3	131.1	23.0	20.1	19.2	43.3	17.2	6.4	80.7	114.1	36.0	33.6	29.3	21.6	22.5	22.5	23.0	38.7	18.5	6.7	69.4	14.2	15.3	5.2	34.6	35.1	20.5	5.4	5.6	21.1	23.8	16.5	3.5	3.3	50.3	47.7	25.6	55.4	51.6	52.5	27.0	26.1	16.4	6.6	20.0	21.9	159.1	16.6	22.6	7.0	174.3	13.9	27.9	50.6	50.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
ZC3H12C	"KIAA1726, MCPIP3"	ENSG00000149289	"Zinc finger CCCH-type containing 12C"	Q9C0D7	11	110093392-110171841	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"HSkMC: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038836, HPA038837"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane, Golgi apparatus"		"HPA038836: AB_2676229, HPA038837: AB_10675953"	"unprognostic (1.22e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.90e-2)"	"prognostic favorable (9.90e-6)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.11e-1)"	4.6	4.2	4.0	2.4	6.7	3.2	2.5	6.5	3.9	4.0	2.7	4.6	1.7	3.7	1.7	3.2	3.2	4.7	4.4	4.2	4.9	3.4	4.0	4.0	1.5	6.8	5.6	6.7	3.5	4.7	3.2	2.6	5.5	3.5	3.7	4.1	2.3	3.3	10.5	5.9	2.6	4.4	4.1	1.8	2.4	3.4	5.4	1.5	8.1	13.2	1.4	5.4	2.1	6.5	6.1	3.6	14.0	0.0	6.4	14.8	2.7	2.3	15.7	4.1	6.8	4.6	5.6	0.1	8.7	7.1	10.3	5.8	2.8	8.5	8.1	23.2	2.0	9.7	4.5	1.7	7.2	0.0	4.4	23.8	8.0	7.2	11.7	8.1	5.8	0.0	0.9	1.3	8.6	0.9	0.0	0.0	2.2	0.1	12.7	0.0	4.9	0.6	4.6	12.4	6.4	11.5	5.6	0.4	10.5	2.7	3.5	3.6	9.8	9.1	4.4	4.8	5.2	0.5	0.0	0.0	5.5	1.7	10.8	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	6.7	6.5	3.9	4.2	4.9	6.8	5.6	5.5	4.1	5.4	6.5	21.1	35.3	8.6	102.2	1.1	47.4	4.8	19.1	7.4	8.8	3.5	5.0	15.5	2.8	9.1	5.5	4.2	1.5	0.2	17.0	0.0	6.1	10.6	8.6	6.7	14.9	8.9	2.1	23.8	3.5	0.5	8.9	5.6	14.1	0.0	5.2	13.6	6.4	10.9	15.2	50.0	8.1	0.0	5.7	39.3	11.8	9.6	9.9	23.2	26.2	3.9	5.6	0.0	52.3	56.1	3.4	15.2	8.2	0.6	21.0	5.7	6.6	8.9	2.7	0.0	9.1	5.7	4.6	0.8	3.2	66.5	0.8	1.1	5.6	8.0	7.8
ZC3H6	"FLJ41410, FLJ45877, KIAA2035, ZC3HDC6"	ENSG00000188177	"Zinc finger CCCH-type containing 6"	P61129	2	112275597-112340063	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036019, HPA036020, HPA076065"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.99e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.45e-2)"	3.9	2.5	3.1	1.8	4.4	1.7	3.3	5.5	4.1	3.2	0.0	3.0	1.4	2.9	3.4	1.8	3.6	1.8	2.9	2.6	3.1	2.1	1.8	2.4	2.9	3.1	3.3	6.1	2.3	3.0	3.4	1.7	3.0	2.4	1.7	9.4	2.8	2.1	5.8	4.4	2.6	1.8	2.9	3.1	2.2	2.9	3.0	3.8	3.7	5.7	2.6	2.9	2.9	5.4	1.1	0.4	2.3	2.2	2.1	4.1	0.7	1.2	1.9	0.7	1.5	0.2	1.4	1.7	0.9	0.7	2.0	0.6	0.7	0.3	1.0	2.0	0.2	0.3	0.5	0.0	1.9	0.4	0.4	1.6	3.3	0.8	5.5	3.4	1.2	2.2	0.4	3.0	1.7	1.0	1.0	0.6	1.5	0.7	0.5	0.6	0.1	1.6	1.0	0.2	1.7	2.3	1.1	0.6	1.2	1.2	0.7	0.6	1.8	1.1	0.1	1.3	0.5	3.1	0.9	1.5	2.2	1.1	3.0	0.5	0.6	0.8	0.9	0.4	1.0	1.3	1.3	1.0	0.6	1.7	1.4	1.2	1.2	0.6	1.3	1.0	1.2	0.4	3.1	4.4	5.5	4.1	2.6	3.1	3.1	3.3	3.0	2.9	3.0	5.4	33.3	38.5	32.0	33.3	24.4	17.3	30.0	12.1	33.0	69.3	31.9	33.4	68.7	20.0	20.6	22.0	54.2	21.1	17.5	7.8	29.4	13.1	16.8	39.3	16.0	27.7	16.2	14.5	46.7	14.8	7.3	31.7	7.7	16.2	26.6	41.2	25.7	16.7	12.4	114.4	62.2	13.5	6.1	19.5	14.2	12.4	46.3	16.2	5.4	29.0	21.1	47.6	30.9	43.7	114.4	16.0	10.4	36.1	12.2	30.7	12.1	22.3	30.6	89.5	32.9	50.8	31.0	75.2	46.4	13.7	18.5	7.9	28.6	26.9	12.9	20.6
ZC3HAV1	"ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043515-139132122	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 85.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		24000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	13.5	12.7	8.7	19.1	8.9	85.9	11.1	8.1	15.2	8.6	12.2	12.9	9.7	8.6	10.3	12.9	9.7	11.4	6.4	8.1	13.6	11.1	11.0	16.1	24.0	12.3	11.5	10.9	7.3	9.2	6.2	9.3	12.3	9.5	13.7	2.5	14.3	9.1	3.2	13.1	13.9	13.8	12.7	21.0	10.4	6.5	14.9	24.0	10.6	5.6	23.8	11.9	8.7	12.4	25.1	29.5	4.1	24.7	37.4	35.9	17.6	27.5	21.2	46.9	47.7	21.6	31.4	21.9	25.2	43.9	40.6	27.6	33.2	32.6	26.3	37.2	12.2	43.8	29.7	26.9	21.8	51.1	38.6	37.0	20.3	53.3	11.8	17.4	35.3	32.1	37.6	23.5	20.1	23.3	41.9	59.0	16.6	18.6	17.6	48.5	14.6	21.0	32.0	31.0	7.5	15.4	43.1	29.2	37.8	9.3	17.4	30.9	45.3	9.9	14.3	27.6	23.1	17.9	20.2	49.9	22.4	47.0	24.0	78.7	19.6	30.8	43.0	26.0	56.0	32.2	61.9	53.1	15.2	35.3	59.0	58.6	52.5	38.7	30.6	17.7	58.8	30.6	8.7	8.9	8.1	15.2	8.1	13.6	12.3	11.5	12.3	12.7	14.9	12.4	150.3	25.6	41.1	8.1	119.4	28.7	21.7	17.5	62.6	2.8	70.8	44.8	6.2	21.5	21.1	53.3	4.2	12.6	194.8	57.0	9.8	20.2	2.8	185.9	77.7	74.5	53.2	64.4	0.8	21.2	23.1	68.1	60.6	359.9	32.3	41.6	49.2	36.1	35.1	0.0	3.0	42.2	8.2	43.9	150.0	1.9	18.6	84.4	39.2	33.7	57.1	13.9	88.6	27.6	1.0	23.8	33.8	26.7	104.2	41.5	28.0	36.4	29.9	1.3	13.1	79.5	53.6	1.0	1.1	61.7	22.3	2.3	222.3	41.3	35.8	28.0
ZCCHC4	"FLJ23024, HSPC052, ZGRF4"	ENSG00000168228	"Zinc finger CCHC-type containing 4"	Q9H5U6	4	25312774-25370383	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 19.6;Oligodendrocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035575, HPA035576"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Golgi apparatus"		"HPA035575: AB_2674682, HPA035576: AB_10671516"	"unprognostic (5.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.07e-2)"	4.5	3.6	2.8	3.5	3.6	3.8	5.0	3.7	3.5	4.3	3.5	3.9	3.8	5.2	4.0	3.3	4.3	3.3	4.6	2.7	3.0	3.8	3.5	3.6	5.2	3.3	3.1	6.1	3.4	6.0	2.7	3.3	3.4	3.9	4.0	4.8	3.9	3.9	7.4	4.3	4.0	3.7	3.0	4.4	3.4	4.4	3.3	4.8	4.5	5.5	4.5	4.1	3.6	4.3	4.5	2.8	9.1	4.2	6.9	8.8	8.1	11.4	12.1	13.1	15.0	4.4	11.9	7.5	3.1	7.0	12.9	3.5	8.9	8.3	18.2	1.8	4.8	7.0	5.8	7.4	8.8	11.6	4.9	7.0	9.2	12.5	9.8	7.8	6.3	11.4	12.7	3.6	11.3	3.4	12.0	15.2	12.5	7.4	6.0	8.0	13.9	4.6	7.1	4.7	8.4	5.8	4.9	4.1	7.4	8.8	6.0	6.9	5.0	11.0	4.6	7.2	15.7	7.2	9.6	11.0	11.8	11.0	10.8	1.4	1.9	0.6	3.0	2.4	4.4	3.5	3.9	3.8	2.8	3.6	3.7	4.1	1.1	4.4	2.3	2.1	4.3	2.3	2.8	3.6	3.7	3.5	2.7	3.0	3.3	3.1	3.4	3.0	3.3	4.3	5.9	0.0	5.8	12.1	7.6	3.7	4.0	4.3	6.8	3.7	3.0	2.9	6.4	1.5	5.5	0.0	2.1	5.9	4.2	2.1	3.9	3.8	1.5	5.5	5.1	4.6	2.4	2.1	10.7	2.3	4.5	4.8	3.1	3.9	1.3	6.4	2.2	3.1	5.1	3.3	15.5	3.6	6.1	4.4	2.2	0.5	4.1	3.3	3.6	5.6	2.6	5.5	5.2	19.6	23.6	2.9	3.9	5.3	3.7	2.7	5.7	4.5	8.2	5.2	0.0	5.2	5.7	9.0	9.1	4.9	3.4	3.7	5.4	4.0	4.4	2.5
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type palmitoyltransferase 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Urothelial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.8	5.7	5.2	7.8	5.2	9.7	8.9	6.6	7.1	9.3	6.6	16.9	11.2	6.7	5.1	37.2	12.9	8.7	9.1	5.4	5.7	9.2	2.2	6.1	9.6	5.5	5.0	5.3	11.2	14.9	11.7	6.2	5.8	8.2	18.2	16.1	10.2	5.4	1.6	18.8	11.3	6.1	5.3	5.7	18.5	14.4	5.0	11.7	8.7	2.9	22.4	22.4	15.4	5.2	41.6	19.3	18.0	15.5	6.3	7.2	17.3	19.4	17.8	21.3	24.4	11.7	9.7	21.1	13.1	16.3	47.9	61.3	26.0	12.8	23.3	26.4	22.6	11.1	12.6	9.7	14.6	15.2	18.5	8.3	14.7	9.0	12.5	19.9	136.8	28.9	10.7	10.3	22.1	13.5	19.6	12.2	15.1	38.7	17.6	21.3	25.0	5.0	21.9	27.0	31.3	23.0	23.2	28.0	10.7	17.3	13.2	17.6	39.6	18.9	13.2	29.2	15.8	8.7	28.5	19.2	22.6	15.5	33.6	11.6	4.7	32.7	8.5	7.9	7.8	8.7	6.6	9.6	5.9	5.5	6.2	8.3	6.0	6.3	6.4	5.6	9.4	4.6	5.2	5.2	6.6	7.1	5.4	5.7	5.5	5.0	5.8	5.3	5.0	5.2	8.1	9.6	10.7	28.7	9.6	24.2	22.3	27.2	14.2	12.0	7.5	4.8	34.1	12.8	41.3	16.5	10.4	8.7	10.6	20.1	5.9	25.1	120.5	21.5	6.6	11.3	15.6	11.6	27.2	19.2	18.8	9.2	24.5	30.8	12.0	16.2	12.8	0.9	6.1	16.8	34.9	24.7	36.7	6.8	8.3	46.6	7.8	6.2	3.6	9.4	20.8	52.8	18.6	19.6	20.9	20.4	16.4	2.2	10.4	47.4	15.5	3.5	57.0	8.8	0.0	5.4	7.4	58.1	31.7	21.3	36.2	6.3	11.4	7.7	21.4	103.0
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type palmitoyltransferase 17"	Q8IUH5	12	76764103-76853696	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 17.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	15.6	14.1	18.6	12.1	20.4	23.7	16.1	23.1	25.9	15.8	11.8	13.7	7.5	21.7	12.3	8.0	12.8	10.5	12.5	19.8	18.9	11.0	9.8	10.6	14.8	18.2	18.6	20.1	10.2	12.7	11.0	16.4	18.9	14.1	10.1	31.0	8.1	12.8	11.8	10.2	10.3	14.6	19.2	14.4	8.5	12.8	19.4	14.9	11.8	14.2	11.4	11.7	11.7	27.8	8.2	9.5	30.1	15.4	17.6	18.5	14.6	16.2	13.4	10.5	9.2	7.8	5.8	11.2	9.5	15.9	10.5	7.5	12.1	10.1	16.2	9.5	12.6	16.4	13.1	12.0	11.9	16.5	13.9	17.6	10.3	10.0	14.7	35.2	12.2	15.2	18.0	5.2	13.8	7.6	12.0	21.9	22.1	3.6	11.3	16.1	10.7	12.3	12.0	12.3	11.7	20.1	17.8	6.4	10.7	25.7	14.4	16.3	16.9	14.3	11.0	8.8	9.3	8.1	8.5	11.9	5.4	7.6	15.0	6.2	2.3	5.7	3.6	2.4	2.9	2.5	2.9	2.6	2.8	3.9	3.0	2.5	5.9	2.0	2.5	17.1	1.3	1.5	18.6	20.4	23.1	25.9	19.8	18.9	18.2	18.6	18.9	19.2	19.4	27.8	33.4	32.1	18.3	75.7	20.1	7.1	10.4	9.8	12.5	54.6	9.9	10.7	21.3	12.8	15.5	12.9	39.6	20.3	74.1	5.0	0.0	8.0	11.3	11.8	23.8	24.8	19.2	12.0	102.2	4.7	10.2	21.2	7.1	10.1	41.2	20.7	20.3	10.6	8.8	28.6	95.1	7.5	8.2	12.3	19.4	13.7	20.2	14.9	5.4	54.4	14.9	26.1	18.6	88.4	115.8	6.8	4.5	21.1	13.5	10.2	8.4	5.5	18.0	38.1	0.0	32.3	22.0	17.7	22.6	9.5	5.5	5.6	18.1	19.6	6.2	5.5
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type palmitoyltransferase 21"	Q8IVQ6	9	14611071-14693432	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.4;Inhibitory neurons: 201.6;Oligodendrocyte precursor cells: 268.9;Oligodendrocytes: 158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	3.7	5.7	4.7	4.6	5.8	2.5	6.2	12.7	6.7	6.2	2.2	4.7	6.8	4.9	6.1	8.5	4.5	3.5	5.1	6.0	4.5	4.9	2.6	5.2	6.6	3.4	3.3	5.2	4.7	4.8	6.5	4.2	3.7	5.2	5.2	10.6	4.6	3.7	4.5	8.7	7.2	4.1	3.4	5.5	4.3	4.1	3.5	2.6	6.1	3.4	6.1	4.2	6.7	4.7	7.1	3.6	6.9	4.6	1.1	1.2	5.3	8.9	2.7	3.1	3.5	1.8	3.3	7.0	2.1	6.2	3.9	4.5	4.8	2.9	4.4	14.1	3.7	29.9	8.3	3.5	3.6	5.3	9.5	2.3	6.6	3.6	2.3	5.7	18.4	2.8	2.5	0.8	5.5	3.9	1.2	5.1	4.8	3.0	6.7	0.0	3.3	3.5	9.6	7.8	4.2	11.3	4.1	5.0	2.8	5.3	6.3	8.6	13.2	2.2	3.3	2.2	8.3	2.8	5.6	0.0	4.6	0.3	2.3	0.2	0.1	0.0	0.4	0.3	0.4	2.0	0.4	0.4	0.0	1.4	0.3	0.4	0.0	1.1	0.2	0.5	0.6	0.2	4.7	5.8	12.7	6.7	6.0	4.5	3.4	3.3	3.7	3.4	3.5	4.7	18.0	22.4	24.1	132.9	46.6	9.6	9.3	8.1	13.1	45.1	23.0	14.1	23.2	24.3	18.2	44.1	43.8	8.8	27.7	31.9	5.9	16.0	5.3	18.1	23.5	18.4	15.6	7.2	219.4	17.9	7.1	14.0	26.5	24.6	10.8	36.7	32.9	10.1	11.1	37.0	201.6	14.6	10.2	15.5	8.2	7.7	19.3	11.8	1.8	107.7	17.7	65.7	41.2	268.9	158.2	35.9	14.1	31.2	20.8	12.4	46.7	11.3	12.7	49.4	6.6	19.7	15.3	22.3	26.6	24.4	20.0	7.7	14.4	10.5	13.9	16.1
ZMYM5	"MYM, ZNF198L1, ZNF237"	ENSG00000132950	"Zinc finger MYM-type containing 5"	Q9UJ78	13	19823482-19863649	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015544, HPA020879"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Golgi apparatus"	"HPA015544: , HPA020879: AB_2670524"	"unprognostic (4.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	7.0	7.8	2.6	7.1	3.6	12.2	7.9	3.5	3.4	6.7	3.9	5.9	6.2	7.6	8.6	7.6	5.4	9.2	5.4	2.2	2.9	6.6	6.9	6.7	10.3	3.9	3.2	6.7	5.4	5.5	4.8	7.1	3.5	8.2	6.2	9.0	5.7	5.5	6.2	7.8	6.6	6.9	2.9	7.5	7.3	23.4	3.3	10.1	8.6	7.7	8.9	7.2	5.8	5.0	8.5	4.4	9.6	7.7	6.5	10.3	3.6	7.8	12.2	12.5	10.3	10.6	16.5	11.8	8.4	11.2	15.5	7.9	7.1	9.3	14.0	9.5	5.7	22.1	7.9	7.4	21.0	15.9	11.4	12.5	11.0	6.8	12.7	12.8	12.7	7.6	9.0	10.0	12.0	21.4	11.9	16.4	5.2	11.0	6.4	13.2	12.3	4.6	10.5	9.4	9.0	8.2	10.1	8.2	27.4	10.2	12.7	13.7	10.6	6.8	5.1	9.2	5.8	15.9	7.7	17.6	6.8	6.9	11.2	16.1	5.4	8.6	8.7	5.2	9.3	9.9	9.9	8.5	5.7	8.6	7.7	8.2	10.7	8.0	7.4	7.8	8.9	4.2	2.6	3.6	3.5	3.4	2.2	2.9	3.9	3.2	3.5	2.9	3.3	5.0	34.1	28.9	17.3	33.0	35.7	24.3	20.8	20.3	43.9	29.7	27.4	26.8	16.2	22.8	18.9	11.0	18.8	17.9	32.4	10.7	7.9	15.5	16.0	24.0	24.0	21.3	27.6	22.3	36.2	10.5	9.6	24.4	19.9	25.4	33.6	19.6	15.0	7.9	11.4	28.6	35.8	11.9	24.4	12.9	24.0	20.8	22.7	23.9	21.4	26.2	17.0	15.2	16.5	30.7	52.9	14.2	16.9	18.4	20.7	16.8	10.7	11.2	10.4	30.3	32.9	27.2	24.7	92.7	51.1	56.5	21.7	8.3	38.3	15.5	11.4	32.9
ZMYND19	MIZIP	ENSG00000165724	"Zinc finger MYND-type containing 19"	Q96E35	9	137582081-137590512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"retina: 287.8"	"Group enriched"	"Detected in many"	14	"Cone photoreceptor cells: 244.0;Rod photoreceptor cells: 680.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020642, HPA050761"	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA020642: AB_1859078, HPA050761: AB_2681228"	"unprognostic (2.30e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.72e-1)"	11.9	16.5	19.6	9.4	19.9	9.1	11.9	18.8	23.9	14.2	18.6	12.4	8.8	11.2	5.0	26.5	11.4	7.2	14.1	20.0	19.5	12.9	21.1	12.0	11.9	18.7	19.2	12.9	16.1	8.0	16.9	8.5	19.7	16.5	5.7	287.8	15.9	7.1	14.2	27.7	12.4	6.8	18.9	15.1	22.2	49.5	19.4	9.5	10.8	8.8	9.4	13.3	16.6	19.8	28.9	44.7	41.8	45.5	22.1	21.3	42.1	38.8	25.8	41.7	31.8	53.1	28.7	51.7	43.6	25.8	40.2	71.7	51.3	38.9	13.2	33.8	49.7	26.9	86.1	41.8	34.4	58.4	33.9	16.8	58.7	38.0	37.1	18.4	22.3	40.5	66.3	22.2	25.6	97.2	68.4	88.7	60.7	86.4	61.9	73.8	36.8	79.6	25.7	24.2	60.1	39.4	37.4	79.4	35.4	18.5	53.7	89.9	21.3	51.1	38.9	76.8	63.8	21.4	54.9	56.8	31.6	44.8	35.9	0.0	0.3	0.3	0.5	1.6	1.2	0.8	0.3	0.2	0.3	0.3	0.5	0.4	0.0	0.1	0.2	0.9	1.0	0.1	19.6	19.9	18.8	23.9	20.0	19.5	18.7	19.2	19.7	18.9	19.4	19.8	6.1	9.6	7.2	3.6	4.0	17.5	5.6	3.2	5.2	23.6	14.9	19.2	6.2	2.8	2.4	1.8	244.0	5.2	6.8	5.3	0.0	3.2	4.5	6.5	12.8	5.6	2.4	6.9	4.1	3.6	6.8	6.3	10.7	8.1	1.3	10.6	3.9	7.6	4.4	11.8	4.0	8.8	6.1	3.2	5.7	4.4	2.8	3.6	5.4	1.9	2.2	31.6	5.2	2.0	2.1	4.2	4.6	3.0	10.9	10.2	1.9	3.1	1.3	680.0	0.0	6.9	6.7	27.8	28.7	4.5	22.9	4.5	4.6	8.5	7.8	7.1
ZMYND8	"PRKCBP1, RACK7"	ENSG00000101040	"Zinc finger MYND-type containing 8"	Q9ULU4	20	47209214-47356889	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020949	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA020949: AB_1857223"	"prognostic unfavorable (2.56e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (7.06e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	13.1	32.7	25.4	10.5	21.3	26.0	14.7	26.2	36.2	11.9	47.8	14.1	11.0	9.8	33.3	16.0	15.9	12.3	12.5	35.5	29.5	18.5	10.9	11.1	12.8	30.5	22.9	13.6	12.3	11.6	25.9	11.8	33.0	11.8	14.5	20.1	14.6	14.6	15.3	19.9	16.2	8.7	9.4	18.3	20.0	14.2	25.2	14.6	11.0	11.0	12.8	14.5	14.9	37.3	27.6	17.2	90.5	36.6	15.2	21.3	59.4	21.7	17.8	22.3	22.8	107.7	26.0	26.5	34.4	16.3	27.1	18.7	39.4	96.0	33.3	11.4	14.9	110.4	6.3	95.9	55.4	11.9	55.9	20.9	43.4	24.8	94.1	40.4	61.0	9.5	90.6	17.7	41.0	32.1	4.4	45.4	85.9	20.3	24.3	55.8	15.0	22.9	30.4	49.6	38.0	14.3	10.3	32.4	44.4	70.3	17.0	22.6	143.6	23.9	16.6	23.3	20.2	12.5	25.2	23.2	80.8	18.3	80.3	34.8	7.4	10.4	8.7	7.5	8.7	15.3	8.8	9.0	4.7	18.3	11.4	11.8	19.8	16.3	6.8	16.5	9.3	4.3	25.4	21.3	26.2	36.2	35.5	29.5	30.5	22.9	33.0	9.4	25.2	37.3	48.2	44.8	78.5	94.0	36.6	8.8	32.2	44.6	15.9	108.1	29.3	20.7	23.7	28.6	74.3	90.1	160.6	23.1	36.2	64.0	15.6	36.5	13.6	111.3	29.8	31.7	56.3	112.9	153.8	28.7	42.0	24.2	41.8	124.4	32.2	44.8	30.7	16.1	21.9	85.8	113.5	49.2	42.7	48.8	12.8	21.9	27.7	31.8	10.6	49.6	25.0	24.4	40.2	89.0	138.7	47.1	42.3	26.7	29.7	23.9	56.8	12.0	82.3	50.0	32.9	33.4	27.5	6.3	29.9	19.2	8.4	66.5	34.2	39.3	32.1	24.2
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225669-125375325	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	8.9	7.5	5.6	9.4	8.9	7.9	12.1	12.9	7.8	12.6	0.0	10.8	7.6	13.9	10.2	10.3	12.4	9.5	15.5	4.5	16.4	12.9	11.7	10.3	12.3	4.2	6.5	17.4	9.5	15.8	4.7	9.7	4.2	11.1	11.5	13.1	10.0	11.1	11.1	5.8	8.9	13.7	2.3	11.9	9.8	10.5	14.5	16.9	30.0	12.0	14.4	10.6	6.1	8.3	30.6	19.8	21.1	18.9	18.4	19.7	16.0	27.2	31.5	29.9	28.4	19.1	16.6	24.4	18.5	40.3	24.1	24.4	23.2	20.5	42.4	10.9	8.9	30.1	23.3	9.8	13.6	20.9	29.1	16.1	21.0	28.0	29.4	19.7	20.7	17.7	15.0	20.2	22.3	23.9	26.1	7.7	13.6	20.6	16.8	18.6	23.2	13.9	17.1	33.6	18.2	15.3	36.2	18.2	29.7	11.7	22.7	20.8	26.6	22.6	24.1	28.5	17.5	17.4	21.5	36.6	16.9	13.1	21.3	4.4	15.3	32.0	21.8	14.5	22.5	24.5	19.2	20.9	13.0	22.2	27.9	22.0	51.4	33.2	23.4	11.3	19.6	20.1	5.6	8.9	12.9	7.8	4.5	16.4	4.2	6.5	4.2	2.3	14.5	8.3	54.7	93.0	41.3	92.7	56.7	35.6	26.0	36.2	48.9	68.0	37.0	35.7	75.2	24.3	43.0	33.1	39.6	28.7	53.7	34.7	25.4	37.5	82.0	28.8	54.3	51.6	47.9	32.0	166.7	37.4	24.3	44.5	31.1	38.1	50.6	75.7	37.9	41.0	31.1	75.7	170.3	34.4	26.4	37.1	21.2	135.2	48.1	41.2	17.8	143.4	50.1	45.7	59.8	154.3	151.4	33.7	25.6	59.0	35.8	36.6	28.2	43.9	27.5	39.4	32.9	63.4	60.7	24.4	24.2	32.5	38.4	31.6	52.0	42.0	33.6	35.6
ZNF208	"PMIDP, ZNF95"	ENSG00000160321	"Zinc finger protein 208"	O43345	19	21932958-22010949	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Late spermatids: 14.1;Oligodendrocytes: 26.3"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 0.6;testis cancer: 1.9;thyroid cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.3;NTERA-2: 33.1;SuSa: 6.9;U-266/84: 11.2"									HPA077100			Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Cytosol	"HPA077100: "	"unprognostic (4.06e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.94e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-3)"	4.2	1.1	4.0	1.9	6.5	1.5	3.4	2.8	4.5	4.0	2.4	4.9	1.4	6.6	4.6	2.2	4.9	3.5	11.4	6.0	7.0	4.6	0.7	1.3	2.8	8.9	7.3	3.4	2.6	13.3	7.1	2.7	8.7	3.5	1.5	2.4	2.8	3.2	0.9	4.0	2.2	6.0	3.0	2.7	1.7	8.6	6.2	0.5	7.9	1.3	1.7	3.2	2.6	6.9	0.4	0.3	0.5	1.1	0.0	0.2	1.5	0.3	0.1	0.2	0.1	1.8	0.6	0.6	0.3	0.3	9.3	0.7	1.2	0.2	0.4	0.2	0.2	0.6	1.5	0.8	0.0	0.4	0.2	1.0	0.3	0.0	0.2	0.7	0.4	0.4	0.5	1.6	0.0	0.5	0.4	0.6	33.1	0.0	1.1	0.2	0.0	1.9	1.1	1.8	0.8	1.6	0.2	0.8	0.3	6.9	0.9	0.8	0.0	0.5	0.3	1.9	0.1	1.0	11.2	0.2	0.1	0.4	0.7	2.4	0.6	0.7	0.8	0.4	0.4	1.3	1.5	0.5	0.3	1.6	0.6	0.9	2.6	1.0	0.3	1.6	1.5	0.3	4.0	6.5	2.8	4.5	6.0	7.0	8.9	7.3	8.7	3.0	6.2	6.9	6.7	0.0	0.0	11.4	4.3	0.0	1.0	0.0	0.6	6.6	4.2	2.5	11.4	0.0	1.3	5.5	0.0	6.8	0.5	0.0	3.9	6.6	15.4	0.2	3.7	3.4	0.0	1.3	11.5	0.2	3.1	5.9	0.5	0.1	0.0	2.7	1.1	0.5	0.7	3.3	1.7	0.0	0.0	0.0	0.7	14.1	1.5	0.2	0.0	9.4	0.0	0.8	1.0	11.1	26.3	0.7	0.0	1.2	0.4	1.2	0.0	2.6	0.0	0.4	0.0	2.5	1.7	8.7	6.2	0.9	0.3	5.3	2.2	0.3	0.0	2.0
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949573-37976647	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	10.2	10.1	12.3	3.5	12.5	2.6	8.2	12.5	19.1	9.7	4.1	12.3	2.2	9.9	6.1	5.4	9.2	6.1	10.0	12.5	15.9	5.7	3.0	6.4	4.8	11.9	10.9	11.1	5.4	7.6	14.3	4.7	12.4	7.3	4.4	10.6	4.6	8.9	22.3	4.8	5.3	8.9	9.8	6.5	5.8	4.7	14.6	4.6	6.0	21.5	4.3	8.8	7.1	12.6	1.6	3.0	3.3	6.7	12.1	9.2	0.6	3.6	4.9	2.8	4.2	0.5	2.3	3.1	1.0	6.4	1.0	0.4	0.9	1.5	4.5	7.3	1.6	5.0	0.0	1.0	7.7	3.3	3.1	6.5	6.6	3.1	3.6	11.1	4.9	4.0	0.4	2.3	6.9	1.0	1.1	2.6	0.6	0.6	2.2	1.2	3.7	0.6	3.3	0.6	1.2	7.6	1.2	0.2	4.7	1.2	2.9	5.3	7.1	4.3	0.8	7.1	2.2	2.8	1.4	1.3	8.2	6.3	2.9	1.3	1.5	3.4	1.6	2.5	1.7	1.0	1.4	1.3	1.9	1.3	1.8	1.5	0.2	1.0	5.2	0.3	1.2	1.2	12.3	12.5	12.5	19.1	12.5	15.9	11.9	10.9	12.4	9.8	14.6	12.6	10.0	3.2	3.2	17.9	4.8	3.4	2.5	2.5	3.4	17.3	3.8	3.6	23.6	4.3	2.9	7.3	6.2	1.2	3.5	1.0	1.9	2.0	27.9	2.4	7.0	7.6	0.0	2.1	46.7	2.5	0.5	10.6	4.1	2.7	8.2	8.2	10.4	2.9	5.7	16.8	44.6	1.2	4.1	13.2	6.8	41.9	12.2	9.5	3.6	14.0	8.1	13.7	5.2	38.2	36.7	1.8	0.3	16.1	1.5	2.6	1.3	3.1	8.1	7.1	0.0	11.4	10.4	4.4	6.4	2.4	4.0	0.3	5.2	4.8	0.8	1.3
ZNF527	KIAA1829	ENSG00000189164	"Zinc finger protein 527"	Q8NB42	19	37371061-37393066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA037740, HPA037741"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Golgi apparatus"	"HPA037740: AB_10672284, HPA037741: AB_2675642"	"unprognostic (4.36e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.26e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.05e-4)"	"unprognostic (8.34e-3)"	"unprognostic (8.92e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.17e-4)"	2.0	2.1	1.9	1.3	1.8	2.5	2.0	2.1	2.4	2.8	1.6	2.5	0.8	2.2	1.7	1.5	2.2	1.3	2.3	1.7	2.1	2.2	1.7	1.5	2.1	1.9	1.6	3.3	1.7	2.7	2.3	1.2	2.0	2.3	1.5	3.2	1.9	1.7	2.3	1.7	1.7	1.9	1.5	1.9	1.7	2.4	1.9	2.5	2.5	3.0	1.5	2.3	2.3	2.3	2.3	2.3	2.1	2.8	1.6	3.3	0.8	2.2	2.2	1.9	2.6	2.1	0.6	2.1	2.6	2.1	1.4	0.9	3.1	1.9	2.5	4.9	1.4	1.7	2.8	0.2	2.3	4.1	2.5	2.6	2.7	2.1	3.6	2.3	2.0	3.4	0.9	1.5	2.4	0.8	2.7	2.2	1.6	2.6	1.0	3.4	2.6	1.7	1.7	2.3	4.1	1.8	3.4	1.0	1.5	1.8	2.3	3.6	3.6	2.0	2.7	2.5	2.4	4.0	5.4	6.4	0.1	3.1	1.7	2.2	1.0	3.4	3.3	1.4	2.9	3.5	2.1	3.0	1.3	2.8	3.0	3.7	1.0	2.4	0.9	1.5	2.3	2.3	1.9	1.8	2.1	2.4	1.7	2.1	1.9	1.6	2.0	1.5	1.9	2.3	2.6	9.6	4.8	5.2	2.5	2.7	1.9	3.3	3.4	6.1	2.4	1.8	8.7	1.5	3.5	0.0	12.5	2.3	5.8	1.2	3.9	1.9	1.3	2.0	2.9	3.0	1.2	2.5	5.8	1.5	1.3	3.5	1.1	2.4	1.3	4.5	2.2	1.9	1.7	6.7	6.9	1.9	4.1	0.8	1.3	0.8	2.5	2.0	0.0	2.8	1.7	3.8	6.2	6.6	7.0	0.5	0.6	1.5	1.8	1.9	1.4	2.4	4.0	10.2	0.0	4.1	3.7	5.3	2.7	2.0	1.6	2.1	4.6	3.3	1.9	1.3
ZNF532	FLJ10697	ENSG00000074657	"Zinc finger protein 532"	Q9HCE3	18	58862600-58986480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.1;Excitatory neurons: 86.9;Inhibitory neurons: 90.9;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 178.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015322	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA015322: AB_2304947"	"unprognostic (3.43e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (4.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (5.76e-4)"	24.0	12.5	33.5	15.7	53.1	1.4	17.9	73.9	39.8	30.3	12.4	25.9	7.2	65.1	20.1	22.3	26.2	24.5	36.0	34.3	45.0	14.1	4.2	19.9	14.2	55.2	44.2	52.8	6.8	16.3	15.7	26.4	56.6	48.0	13.3	25.7	15.8	34.1	61.1	16.5	12.0	41.4	33.8	17.0	12.8	24.2	46.1	11.9	24.7	49.8	17.4	23.0	21.3	84.8	21.3	30.0	118.8	63.4	18.5	42.2	5.8	37.6	35.2	26.0	23.4	10.2	23.0	26.5	28.3	47.2	12.9	34.1	1.0	29.7	26.7	19.5	25.0	0.0	51.8	0.6	24.5	0.2	0.2	33.1	54.5	27.2	49.5	34.4	28.8	0.0	0.3	31.9	30.8	0.0	0.2	0.3	63.0	1.0	19.9	0.6	31.6	4.2	18.1	2.8	27.1	70.3	24.2	2.6	40.8	78.8	30.3	17.3	22.0	70.7	50.1	0.5	30.7	0.4	21.7	7.3	24.0	0.0	55.2	0.0	0.3	0.0	0.4	1.1	0.1	3.7	0.2	0.2	0.7	1.6	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.4	33.5	53.1	73.9	39.8	34.3	45.0	55.2	44.2	56.6	33.8	46.1	84.8	16.6	12.8	12.2	90.1	13.2	10.6	12.5	8.0	12.0	28.8	9.3	8.8	17.0	5.7	10.1	1.8	27.1	2.0	1.4	0.3	0.0	4.9	4.9	8.3	48.3	24.2	4.2	0.0	86.9	0.5	2.7	17.9	3.1	10.0	0.0	15.8	14.6	0.1	4.4	35.3	90.9	0.2	4.1	9.1	14.3	3.5	11.5	9.2	8.8	53.4	5.2	22.1	0.0	130.2	178.2	6.0	1.4	18.0	8.6	33.5	0.0	1.6	8.8	9.7	13.1	15.5	24.2	5.5	17.2	8.9	9.2	3.4	4.3	5.0	0.3	11.9
ZNF576	MGC2508	ENSG00000124444	"Zinc finger protein 576"	Q9H609	19	43596392-43601157	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050064	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA050064: AB_2681003"	"unprognostic (1.28e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.60e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.34e-3)"	10.3	13.9	10.3	7.1	11.2	3.4	10.5	12.5	12.5	10.7	6.0	12.4	9.4	11.4	4.8	11.1	9.8	7.9	11.7	10.1	9.8	12.0	18.7	6.8	8.4	11.3	11.5	11.8	9.4	8.7	15.0	5.1	11.3	15.1	4.8	5.3	10.7	6.8	14.0	9.0	9.7	5.5	9.9	9.3	10.2	13.6	12.1	7.6	9.1	10.7	5.2	11.9	10.1	11.2	21.9	24.9	9.1	11.6	11.7	10.5	8.1	17.8	11.6	17.5	19.4	12.2	16.2	14.3	19.7	13.4	10.2	8.6	13.0	12.6	4.7	15.6	22.3	10.5	16.7	15.4	9.9	14.2	18.8	9.1	15.4	15.3	6.0	8.7	12.6	12.3	13.3	18.0	13.2	21.4	20.0	6.3	6.4	18.0	21.0	16.7	8.0	14.1	10.5	19.2	16.7	10.5	11.7	23.3	9.3	6.5	11.0	16.2	13.2	23.3	13.1	10.5	26.5	9.4	11.4	10.0	20.1	16.4	20.6	10.5	15.2	16.2	17.2	15.4	15.5	28.2	17.2	14.6	15.9	18.6	18.5	14.6	8.5	19.3	15.6	25.4	18.9	11.5	10.3	11.2	12.5	12.5	10.1	9.8	11.3	11.5	11.3	9.9	12.1	11.2	12.7	6.4	7.3	1.3	11.3	10.6	8.7	17.1	11.4	23.2	15.1	20.1	13.1	10.0	12.7	14.7	31.3	13.7	11.0	16.8	21.5	18.9	34.2	8.6	12.5	13.5	11.4	8.6	3.4	18.9	20.3	13.4	6.6	7.9	9.5	42.0	14.6	20.3	15.4	23.5	3.1	11.9	6.1	6.3	9.2	96.2	13.4	6.6	19.6	0.0	11.1	24.8	12.3	4.0	3.7	19.3	13.0	15.4	9.6	18.0	30.6	32.4	10.7	33.4	6.6	11.3	11.3	28.4	19.4	11.8	12.4	5.7	8.7	14.7	16.0	10.9
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778456-30787205	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: AB_2683020"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	5.6	9.0	5.6	3.0	6.0	4.1	5.7	7.1	5.9	6.5	4.3	6.8	5.5	8.0	4.3	5.1	6.6	3.6	12.6	5.9	6.1	7.8	4.3	5.3	1.9	6.2	6.7	6.8	5.9	15.0	6.6	3.6	5.6	6.3	4.5	7.8	6.5	6.0	9.7	8.6	5.3	6.8	5.0	4.0	7.3	4.1	7.0	3.9	5.9	9.6	2.3	6.5	5.1	5.5	9.8	15.8	23.9	18.5	11.5	10.6	3.6	10.8	15.6	16.6	14.0	9.7	8.8	1.8	10.2	17.6	5.2	11.4	11.7	14.3	11.0	0.4	17.6	13.6	14.0	10.2	12.3	4.8	8.0	17.7	10.5	10.3	8.6	13.0	8.9	0.8	20.2	0.4	14.6	20.8	7.2	6.3	12.6	4.7	6.4	24.3	18.4	0.8	13.9	15.9	22.6	25.3	10.5	19.4	2.6	7.8	14.6	17.4	10.8	15.5	10.1	10.6	8.3	0.3	0.1	0.5	10.2	11.9	5.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.3	0.1	0.6	0.0	0.1	5.6	6.0	7.1	5.9	5.9	6.1	6.2	6.7	5.6	5.0	7.0	5.5	4.9	19.2	9.4	5.9	2.6	1.9	3.4	4.3	5.7	16.7	4.2	3.4	28.3	4.3	6.5	9.2	4.2	1.3	1.6	5.4	1.9	8.7	1.7	5.1	9.5	8.0	11.5	4.6	2.4	8.0	0.6	5.3	7.1	5.3	2.5	10.7	8.2	4.7	4.4	16.8	3.7	7.9	6.1	5.2	3.0	4.7	9.3	2.6	1.8	1.0	7.7	13.4	1.0	4.5	3.4	10.9	5.0	4.5	3.0	4.8	5.1	4.3	5.9	12.4	0.0	6.7	5.6	4.6	1.5	3.8	1.8	0.5	1.4	8.3	9.0	3.8
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 202.9;Late spermatids: 378.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.42e-5)"	6.3	14.5	4.8	5.6	4.9	6.9	6.3	4.7	5.3	7.1	5.6	6.7	4.8	6.2	7.5	5.2	7.0	4.7	5.5	4.6	5.6	8.4	11.0	6.7	8.4	5.2	4.9	6.8	9.8	7.1	6.9	5.0	5.4	10.2	5.5	6.7	6.4	5.9	5.1	6.8	8.2	4.9	4.9	13.9	7.5	2.2	5.2	8.6	9.3	3.9	7.2	6.0	5.8	5.3	3.3	4.3	4.6	7.4	7.7	9.3	7.0	5.5	7.5	4.4	9.4	2.6	4.1	3.5	7.9	4.7	8.5	4.5	15.2	2.5	4.2	3.3	4.0	2.4	8.6	3.5	3.3	4.1	6.6	4.6	5.9	2.7	3.4	5.5	4.6	4.4	2.1	5.4	3.9	8.0	5.0	7.5	2.2	6.7	5.8	4.7	4.6	3.1	5.0	4.5	1.5	5.2	3.1	5.2	0.9	4.9	1.8	5.9	4.8	4.2	1.0	7.1	5.3	2.7	4.1	2.5	2.6	4.5	2.7	2.7	1.0	2.0	2.3	0.8	2.1	1.4	2.5	2.7	0.9	1.6	3.1	2.8	1.1	2.8	0.8	0.8	3.4	1.5	4.8	4.9	4.7	5.3	4.6	5.6	5.2	4.9	5.4	4.9	5.2	5.3	6.4	6.4	12.9	23.5	7.5	1.8	1.3	1.4	2.8	4.9	3.9	2.0	4.7	1.5	5.0	0.0	6.2	2.4	8.4	3.7	1.9	2.0	202.9	9.2	4.8	7.1	1.8	0.8	18.5	4.0	1.5	4.2	6.1	4.9	6.3	4.9	5.7	5.3	2.4	5.0	21.8	5.0	6.1	2.9	1.6	378.3	6.5	3.8	0.0	28.1	3.9	4.1	6.2	18.6	21.4	3.1	2.8	3.4	5.0	2.3	3.3	3.7	5.1	5.1	0.0	3.4	3.5	7.6	3.1	3.4	1.4	1.8	7.1	10.2	3.6	2.3
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 217.1;Langerhans cells: 329.2;Smooth muscle cells: 451.1;Suprabasal keratinocytes: 280.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.5;NB-4: 7.9;NTERA-2: 17.0;SuSa: 10.5;U-2197: 7.0"									HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	0.3	0.2	0.1	0.6	0.3	0.6	0.5	1.0	0.2	0.8	0.2	0.5	0.2	0.9	0.6	0.4	0.8	0.3	0.3	0.1	0.2	0.5	0.1	0.7	1.2	0.3	0.2	1.5	0.9	1.8	0.3	1.2	0.3	0.6	0.7	0.0	0.3	1.4	0.2	1.1	0.6	0.6	0.1	0.5	0.8	0.6	0.3	0.8	1.9	0.0	0.8	1.0	0.7	0.4	0.0	0.0	3.7	9.5	0.0	0.0	0.0	0.9	0.3	3.3	4.0	3.2	2.3	1.3	1.7	0.6	2.5	1.1	0.0	0.5	5.7	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	3.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	7.9	17.0	0.0	0.0	0.0	3.1	0.4	2.3	3.3	0.0	3.9	0.0	1.4	0.2	10.5	1.8	0.0	0.0	1.0	0.0	7.0	3.7	0.0	1.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.1	0.2	0.3	0.2	0.3	0.1	0.3	0.4	2.2	6.4	8.4	1.0	31.7	217.1	112.5	32.7	2.8	0.6	7.8	6.6	1.9	50.1	16.7	7.3	2.1	87.5	25.1	4.8	17.6	2.3	8.2	1.9	4.9	28.8	8.5	26.7	0.5	2.0	99.1	27.6	1.5	4.5	1.3	9.3	54.3	57.1	47.8	0.0	0.7	16.9	14.2	107.1	329.2	24.2	60.9	14.9	124.5	5.6	34.6	2.2	44.3	1.5	2.9	1.2	12.3	34.6	1.8	87.8	8.4	14.0	8.6	2.5	19.7	45.2	451.1	8.6	16.7	1.9	280.3	81.5	40.1	16.0	19.0	66.4
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726453-52827336	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.9;tongue: 62.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	9.4	8.4	13.5	5.5	14.5	7.6	7.2	15.9	14.0	9.1	3.5	9.9	4.3	10.8	5.9	9.5	6.8	6.6	17.1	13.7	16.0	12.9	18.6	7.6	5.1	8.5	9.7	10.8	5.1	10.0	4.6	7.1	11.1	9.4	7.5	13.4	6.3	8.6	78.9	6.3	4.6	12.5	8.0	5.6	5.0	8.6	16.3	6.9	12.8	62.0	5.4	7.7	5.7	10.3	10.8	9.9	12.1	15.1	21.7	18.5	10.0	11.7	15.3	9.4	8.7	8.4	3.5	10.2	11.1	23.6	12.6	5.5	14.1	10.6	14.9	7.9	8.6	13.1	10.4	5.3	11.5	9.9	7.7	13.5	11.2	13.4	9.4	13.1	16.6	2.3	12.0	2.1	17.2	4.4	3.9	6.4	12.3	5.4	10.0	6.7	22.4	9.3	9.6	17.2	5.5	10.9	20.6	12.8	10.6	15.2	7.7	7.8	19.1	14.4	8.2	14.3	7.4	8.6	10.8	7.4	9.8	6.6	9.5	0.3	0.7	0.9	0.5	0.3	0.6	0.6	0.7	0.4	0.7	0.5	1.1	0.8	1.7	0.6	0.6	0.4	1.0	0.3	13.5	14.5	15.9	14.0	13.7	16.0	8.5	9.7	11.1	8.0	16.3	10.3	26.8	25.6	28.8	29.0	13.4	11.3	10.5	12.1	10.2	49.5	13.6	11.9	88.3	20.0	14.0	14.7	20.9	24.6	6.9	37.2	7.9	12.2	5.7	13.2	40.9	22.1	10.2	9.0	72.4	11.1	12.0	26.3	12.2	18.6	8.2	32.0	32.5	107.7	20.6	97.6	82.6	11.4	14.2	37.5	11.8	7.9	24.5	21.5	21.4	36.5	21.9	21.6	4.1	46.3	52.0	16.3	17.9	30.9	11.6	26.0	14.0	30.0	11.1	24.4	26.3	35.7	25.9	11.4	23.7	17.3	14.6	34.8	9.7	19.5	15.5	19.0